,Unnamed: 0,link,title,abstract,authors,keywords,fuente,categoria,key,categoria1,categoria2
0,0,http://dialog.proquest.com/professional/docview/596148223?accountid=173210,A new case of Ullrich's disease,"A new case of congenital, hypotonic-sclerotic muscular dystrophy is presented. The patient showed congenital hyperlaxity and looseness of distal joints, muscle weakness, and spur-like protrusion of the calcaneus. Afterwards rapid progressive contractures of both knees and hip joints developed. Muscle biopsies revealed unequivocal dystrophic abnormalities and small atrophic fibers with numerous foldings of basal lamina suggestive of a neurogenic lesion. The disease presents clinical variability but the diagnosis is possible when a newborn shows: no dominant family history, slender body, marked distal joint laxity and hyperflexibility, proximal joint contractures and normal or slightly increased serum enzymes.","['Santoro, L', 'Marmo, C', 'Gasparo-Rippa, P', 'Toscano, A', 'Sadile, F', 'Barbieri, F']","['Child, Preschool', 'Hip Contracture', 'Hip Contracture', 'Humans', 'Joint Instability', 'Joint Instability', 'Knee Joint', 'Kyphosis', 'Kyphosis', 'Male', 'Microscopy, Electron', 'Muscles', 'Muscles', 'Muscular Dystrophies', 'Radiography', 'Scoliosis', 'Scoliosis']",ProQuest,"['sensors', 'medical images', 'optical fibers', 'computerized tomography']",Ullrich congenital muscular dystrophy,"['new', 'case', 'disease']","['new', 'case', 'congenital', 'hypotonic', 'sclerotic', 'muscular', 'dystrophy', 'patient', 'congenital', 'hyperlaxity', 'looseness', 'distal', 'joints', 'muscle', 'weakness', 'spur', 'like', 'protrusion', 'calcaneus', 'rapid', 'progressive', 'contractures', 'knees', 'hip', 'joints', 'Muscle', 'biopsies', 'unequivocal', 'dystrophic', 'abnormalities', 'small', 'atrophic', 'fibers', 'numerous', 'foldings', 'basal', 'lamina', 'suggestive', 'neurogenic', 'lesion', 'disease', 'clinical', 'variability', 'diagnosis', 'possible', 'newborn', 'dominant', 'family', 'history', 'slender', 'body', 'distal', 'joint', 'laxity', 'hyperflexibility', 'proximal', 'joint', 'contractures', 'normal', 'serum', 'enzymes']"
1,1,http://dialog.proquest.com/professional/docview/596143016?accountid=173210,Ullrich's congenital atonic sclerotic muscular dystrophy. A case report,"A 5-year old girl with Ullrich's atonic-sclerotic muscular dystrophy is reported and 16 previously reported cases are reviewed. The clinical features, in particular proximal contractures, distal hyperextensibility, mild dysmorphism and hyperhidrosis, allow recognition of this subtype of congenital muscular dystrophy, which has no specific pathological characteristics. There is evidence in favour of an autosomal recessive mode of inheritance.","['De Paillette, L', 'Aicardi, J', 'Gouti√®res, F']","['Child, Preschool', 'Female', 'Humans', 'Male', 'Muscular Dystrophies', 'Muscular Dystrophies']",ProQuest,"['feature space', 'recognition algorithm', 'classification methods', 'cryptography', 'character recognition', 'face recognition', 'pattern recognition', 'modes of operation']",Ullrich congenital muscular dystrophy,"['congenital', 'atonic', 'sclerotic', 'muscular', 'dystrophy', 'case', 'report']","['old', 'girl', 'atonic', 'sclerotic', 'muscular', 'dystrophy', 'cases', 'clinical', 'features', 'particular', 'proximal', 'contractures', 'distal', 'hyperextensibility', 'mild', 'dysmorphism', 'hyperhidrosis', 'recognition', 'subtype', 'congenital', 'muscular', 'dystrophy', 'specific', 'pathological', 'characteristics', 'evidence', 'favour', 'autosomal', 'recessive', 'mode', 'inheritance']"
2,2,http://dialog.proquest.com/professional/docview/591147820?accountid=173210,A clinical and histological study of Ullrich's disease (congenital atonic-sclerotic muscular dystrophy),"Clinical characteristics recognized in five cases with Ullrich's disease included muscle weakness and wasting, striking contracture of proximal (sclerotic) joints and hyperflexibility of distal (atonic) joints since an early infantile stage, and slowly progressive course. The biopsied muscles demonstrated myopathic changes including a remarkable variation in fiber size, notably proliferated endomysial connective tissue, increased myofibers with centralized nuclei and a few necrotic fibers with active phagocytosis. On histochemical examination, no specific intracytoplasmic structural abnormalities such as nemaline bodies, cores and myotubes were recognized. Although both type 1 and 2 fibers were distributed in checkerboard pattern in most muscle fascicles, type 1 fiber predominance or type 2 fiber deficiency was common in severely damaged muscles, suggesting the presence of some kind of neural influence exerting on the myopathic process as the disease progressed. Since it still remains uncertain whether this disorder belongs to the muscular dystrophies, or to other neuromuscular or mesodermal diseases, we would rather label it Ullrich's disease then Ullrich's muscular ""dystrophy"" until its pathogenesis becomes clear.","['Nonaka, I', 'Une, Y', 'Ishihara, T', 'Miyoshino, S', 'Nakashima, T', 'Sugita, H']","['Adolescent', 'Child', 'Contracture', 'Diagnosis, Differential', 'Elbow Joint', 'Forearm', 'Hip Joint', 'Humans', 'Knee Joint', 'Male', 'Muscles', 'Muscular Dystrophies', 'Muscular Dystrophies', 'Shoulder Joint', 'Syndrome', 'Thigh']",ProQuest,"['single-mode optical fiber', 'distributed architecture', 'optical fibers', 'optical materials', 'multimode fibers', 'centralized architecture', 'sensors', 'single mode fibers', 'optical fibre']",Ullrich congenital muscular dystrophy,"['clinical', 'histological', 'study', 'disease', 'congenital', 'atonic', 'sclerotic', 'muscular', 'dystrophy']","['Clinical', 'characteristics', 'cases', 'disease', 'muscle', 'weakness', 'wasting', 'contracture', 'proximal', 'sclerotic', 'joints', 'hyperflexibility', 'distal', 'atonic', 'joints', 'early', 'infantile', 'stage', 'progressive', 'course', 'biopsied', 'muscles', 'myopathic', 'changes', 'remarkable', 'variation', 'fiber', 'size', 'endomysial', 'connective', 'tissue', 'myofibers', 'centralized', 'nuclei', 'few', 'necrotic', 'fibers', 'active', 'phagocytosis', 'histochemical', 'examination', 'specific', 'intracytoplasmic', 'structural', 'abnormalities', 'such', 'nemaline', 'bodies', 'cores', 'myotubes', 'type', 'fibers', 'checkerboard', 'pattern', 'most', 'muscle', 'fascicles', 'type', 'fiber', 'predominance', 'type', 'fiber', 'deficiency', 'common', 'muscles', 'presence', 'kind', 'neural', 'influence', 'myopathic', 'process', 'disease', 'uncertain', 'disorder', 'muscular', 'dystrophies', 'other', 'neuromuscular', 'mesodermal', 'diseases', 'disease', 'muscular', 'dystrophy', 'pathogenesis', 'clear']"
3,3,http://dialog.proquest.com/professional/docview/590955614?accountid=173210,"Ullrich syndrome: a hypotonic disorder of early infancy, difficult to define as an entity","Three cases, a female and two males, with the diagnosis of Ullrich syndrome are presented. Major clinical findings included congenital hypotonia, joint contractures, high-arched palate, prominent calcaneus, scoliosis, hyperhidrosis and normal intelligence. The course was not progressive or even underwent slow improvement. Our cases followed the autosomal recessive pattern of inheritance. Muscle enzymes were all within the normal ranges. EMG showed findings that were consistent with a chronic myogenic pattern. Muscle biopsy revealed variation in the size of muscle fiber diameters and large increase of the connective tissue without evidence of dystrophic changes. We consider Ullrich syndrome as a nonspecific muscle disturbance of unexplained nature, related, but not identical, to both congenital muscular dystrophy and myogenic type of arthrogryposis multiplex congenita.","['Aparicio Meix, J M', 'Pascual-Castroviejo, I']","['Calcaneus', 'Child', 'Child, Preschool', 'Contracture', 'Female', 'Genes, Recessive', 'Humans', 'Infant', 'Male', 'Muscle Hypotonia', 'Muscle Hypotonia', 'Palate', 'Syndrome']",ProQuest,"['single-mode optical fiber', 'wavelength division multiplexing', 'fiber optic networks', 'optical fibers', 'optical materials', 'multimode fibers', 'frequency division multiplexing', 'sensors', 'time division multiplexing', 'single mode fibers', 'optical fibre']",Ullrich congenital muscular dystrophy,"['syndrome', 'hypotonic', 'disorder', 'early', 'infancy', 'difficult', 'entity']","['cases', 'female', 'males', 'diagnosis', 'syndrome', 'Major', 'clinical', 'findings', 'congenital', 'hypotonia', 'joint', 'contractures', 'palate', 'prominent', 'calcaneus', 'scoliosis', 'hyperhidrosis', 'normal', 'intelligence', 'course', 'progressive', 'underwent', 'slow', 'improvement', 'cases', 'autosomal', 'recessive', 'pattern', 'inheritance', 'Muscle', 'enzymes', 'normal', 'ranges', 'findings', 'consistent', 'chronic', 'myogenic', 'pattern', 'Muscle', 'biopsy', 'variation', 'size', 'muscle', 'fiber', 'diameters', 'large', 'increase', 'connective', 'tissue', 'evidence', 'dystrophic', 'changes', 'syndrome', 'nonspecific', 'muscle', 'disturbance', 'unexplained', 'nature', 'identical', 'congenital', 'muscular', 'dystrophy', 'myogenic', 'type', 'arthrogryposis', 'multiplex', 'congenita']"
4,4,http://dialog.proquest.com/professional/docview/590888071?accountid=173210,Congenital muscular dystrophies and unstructured congenital myopathies,"A satisfactory nosological classification of all congenital myopathies without structural characteristics is not yet available. The term ""congenital dystrophy"" does not describe one but at least three disease states, of which the Fukuyama type and the Ullrich type are entities defined by clinical and morphological criteria. Some patients with nonprogressive dystrophic changes may show marked abnormalities in size and distribution of fiber types. ""Congenital fiber type disproportions"" has been defined as a pattern with many small type I fibers and few large type II fibers. A similar pattern can be found in the rigid spine syndrome. Other abnormal histometric patterns (e.g. predominance of small and large type I fibers, type II fiber atrophy in combination with congestive cardiomyopathy) are not infrequently encountered. The application of a prefabricated diagnostic label should be reserved for cases fulfilling strictly defined morphological and clinical definitions. In the rest, objective description of findings may still be the only appropriate diagnostic approach.","['Lenard, H G', 'Goebel, H H']","['Biopsy', 'Child', 'Child, Preschool', 'Female', 'Humans', 'Infant', 'Male', 'Muscles', 'Muscular Diseases', 'Muscular Diseases', 'Muscular Diseases', 'Muscular Dystrophies', 'Muscular Dystrophies', 'Muscular Dystrophies']",ProQuest,"['single-mode optical fiber', 'classification methods', 'optical fibers', 'optical materials', 'multimode fibers', 'classification models', 'sensors', 'single mode fibers', 'optical fibre']",Ullrich congenital muscular dystrophy,"['Congenital', 'muscular', 'dystrophies', 'unstructured', 'congenital', 'myopathies']","['satisfactory', 'nosological', 'classification', 'congenital', 'myopathies', 'structural', 'characteristics', 'available', 'term', 'congenital', 'dystrophy', 'disease', 'states', 'type', 'type', 'entities', 'clinical', 'morphological', 'criteria', 'patients', 'nonprogressive', 'dystrophic', 'changes', 'marked', 'abnormalities', 'size', 'distribution', 'fiber', 'types', 'Congenital', 'fiber', 'type', 'disproportions', 'pattern', 'many', 'small', 'type', 'fibers', 'few', 'large', 'type', 'fibers', 'similar', 'pattern', 'rigid', 'spine', 'syndrome', 'Other', 'abnormal', 'histometric', 'patterns', 'e.g.', 'predominance', 'small', 'large', 'type', 'fibers', 'type', 'fiber', 'atrophy', 'combination', 'congestive', 'cardiomyopathy', 'application', 'diagnostic', 'label', 'cases', 'morphological', 'clinical', 'definitions', 'rest', 'objective', 'description', 'findings', 'only', 'appropriate', 'diagnostic', 'approach']"
5,5,http://dialog.proquest.com/professional/docview/589610921?accountid=173210,"Congenital, hypotonic-sclerotic muscular dystrophy","Four cases of congenital, hypotonic-sclerotic muscular dystrophy are presented. The patients showed clinically prominent features described by Ullrich, i.e. congenital muscle weakness, hypotonia, and hyperextensibility of distal joints, contractures of proximal joints, high-arched palate, hyperhidrosis, posterior protrusion of calcaneus, and no progression. Muscle biopsies revealed dystrophic changes. Ullrich suggested that this condition was a new entity, but the disease has received little attention. In the present cases superior intelligence and tendency to recurrent upper respiratory tract infections were stressed as characteristics of this disorder. Insufficient cellular immunity was suspected and this may contribute to the recurrent upper respiratory tract infections and pneumonia often observed. This disease is considered a distinct entity of multisystemic involvement inherited as an autosomal recessive trait.","['Furukawa, T', 'Toyokura, Y']","['Adolescent', 'Child', 'Chromosome Aberrations', 'Chromosome Disorders', 'Female', 'Genes, Recessive', 'Humans', 'Hyperhidrosis', 'Immunity, Cellular', 'Intelligence', 'Kyphosis', 'Limb Deformities, Congenital', 'Male', 'Muscular Dystrophies', 'Muscular Dystrophies', 'Recurrence', 'Respiratory Tract Infections', 'Scoliosis', 'Syndrome']",ProQuest,"['cellular telephone systems', 'feature space', 'classification methods', 'crossover operator', 'wireless', 'cellular radio systems', 'genetic operators', 'channel capacity', 'pattern recognition', 'evolutionary algorithms', 'cellular network', 'cellular system', 'cellular']",Ullrich congenital muscular dystrophy,"['Congenital', 'hypotonic', 'sclerotic', 'muscular', 'dystrophy']","['cases', 'congenital', 'hypotonic', 'sclerotic', 'muscular', 'dystrophy', 'patients', 'prominent', 'features', 'congenital', 'muscle', 'weakness', 'hypotonia', 'hyperextensibility', 'distal', 'joints', 'contractures', 'proximal', 'joints', 'palate', 'hyperhidrosis', 'posterior', 'protrusion', 'calcaneus', 'progression', 'Muscle', 'biopsies', 'dystrophic', 'changes', 'condition', 'new', 'entity', 'disease', 'little', 'attention', 'present', 'cases', 'superior', 'intelligence', 'tendency', 'upper', 'respiratory', 'tract', 'infections', 'characteristics', 'disorder', 'Insufficient', 'cellular', 'immunity', 'recurrent', 'upper', 'respiratory', 'tract', 'infections', 'pneumonia', 'disease', 'distinct', 'entity', 'multisystemic', 'involvement', 'autosomal', 'recessive', 'trait']"
6,6,http://dialog.proquest.com/professional/docview/581932661?accountid=173210,Congenital atonic-sclerotic muscular dystrophy (Ullrich type),0,"['GOTT, H', 'JOSTEN, E A']","['Humans', 'Muscle Hypotonia', 'Muscular Dystrophies, Limb-Girdle', 'Musculoskeletal Abnormalities', 'Myotonia Congenita']",ProQuest,[],Ullrich congenital muscular dystrophy,"['Congenital', 'atonic', 'sclerotic', 'muscular', 'dystrophy', 'type']",[]
7,7,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105773256&origin=inward,Presymptomatic treatment of classic late-infantile neuronal ceroid lipofuscinosis with cerliponase alfa,"¬© 2021, The Author(s).Background: Neuronal ceroid lipofuscinosis type 2 (CLN2 disease) is a rare rapidly progressive neurodegenerative disorder, resulting in early death. Intracerebroventricular enzyme replacement therapy (ERT) with cerliponase alfa is now available and has shown to delay disease progression in symptomatic patients. It is yet unknown if cerliponase alfa can prevent disease onset in presymptomatic patients. Results: We evaluated the effect of 2 years of intracerebroventricular ERT in two siblings with CLN2 disease, one symptomatic (age 47 months) and one presymptomatic (age 23 months) at treatment start, using the CLN2 Clinical Rating Scale (CLN2 CRS), Gross Motor Function Measure-66 (GMFM-66) for motor function, Bayley Scales of Infant and Toddler Development, 3rd Edition, Dutch (BSID-III-NL) for neurocognitive development, brain MRI, and visual evoked potentials (VEP), electroretinogram (ERG) and retinoscopy for visual function. On the CLN2 CRS patient 1 showed a decline from 3 to 2 in the combined motor and language score due to regression in language use (CLN2 CRS total score after 2 years of treatment: 8), whereas a decline of 2 or more points in the combined motor and language score would be expected without treatment. Patient 2 retained the maximum score of 3 in all 4 subdomains (CLN2 CRS total score after 2 years of treatment: 12). The GMFM-66 total score declined from 46 to 39 in patient 1 and showed an age-appropriate increase from 66 to 84 in patient 2. Cognitive-developmental age decreased from 24 to 11 months in patient 1, whereas an increase in cognitive-developmental age from 21 to 39 months was seen in patient 2. Cerebral and cerebellar atrophy observed on MRI in patient 1 at age 42 months (before treatment) was not observed in patient 2 at age 48 months (after 2 years of treatment). Conclusion: We show that cerliponase alfa is able to delay the onset of symptoms when treatment is started in a presymptomatic stage of CLN2 disease. Our results advocate the start of treatment at an early age before symptom onset, but should be confirmed in a larger cohort study.",0,0,scopus,"['process engineering', 'recommendation algorithms', 'recommendation', 'development processes', 'recommender systems', 'software design', 'correlation analysis', 'visual informations', 'visual communication', 'regression model', 'user rating']",Ullrich congenital muscular dystrophy,"['Presymptomatic', 'treatment', 'classic', 'late', 'infantile', 'neuronal', 'ceroid', 'lipofuscinosis', 'cerliponase', 'alfa']","['Author(s).Background', 'Neuronal', 'ceroid', 'lipofuscinosis', 'type', 'disease', 'rare', 'progressive', 'neurodegenerative', 'disorder', 'early', 'death', 'Intracerebroventricular', 'enzyme', 'replacement', 'therapy', 'cerliponase', 'alfa', 'available', 'disease', 'progression', 'symptomatic', 'patients', 'unknown', 'cerliponase', 'alfa', 'disease', 'onset', 'presymptomatic', 'patients', 'Results', 'effect', 'years', 'intracerebroventricular', 'siblings', 'disease', 'symptomatic', 'age', 'months', 'presymptomatic', 'age', 'months', 'treatment', 'start', 'Measure-66', 'motor', 'function', 'neurocognitive', 'development', 'brain', 'visual', 'potentials', 'electroretinogram', 'retinoscopy', 'visual', 'function', 'patient', 'decline', 'combined', 'motor', 'language', 'score', 'regression', 'language', 'use', 'total', 'score', 'years', 'treatment', 'decline', 'more', 'points', 'combined', 'motor', 'language', 'score', 'treatment', 'Patient', 'maximum', 'score', 'subdomains', 'total', 'score', 'years', 'treatment', 'total', 'score', 'patient', 'age', 'appropriate', 'increase', 'patient', 'Cognitive', 'developmental', 'age', 'months', 'patient', 'increase', 'cognitive', 'developmental', 'age', 'months', 'patient', 'Cerebral', 'cerebellar', 'atrophy', 'patient', 'age', 'months', 'treatment', 'patient', 'age', 'months', 'years', 'treatment', 'Conclusion', 'cerliponase', 'alfa', 'able', 'onset', 'symptoms', 'treatment', 'presymptomatic', 'stage', 'disease', 'results', 'start', 'treatment', 'early', 'age', 'symptom', 'onset', 'larger', 'cohort', 'study']"
8,8,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105550985&origin=inward,Study of the collagen type VI alpha 3 (COL6A3) gene in Parkinson‚Äôs disease,"¬© 2021, The Author(s).Background: To date, the genetic contribution to Parkinson‚Äôs disease (PD) remains unclear. Mutations in the collagen type VI alpha 3 (COL6A3) gene were recently identified as a cause of isolated dystonia. Since PD and dystonia are closely related disorders with shared clinical and genetic characteristics, we explored the association between COL6A3 and PD in a Chinese cohort. Methods: We performed genetic screening of COL6A3 in a Chinese cohort of 173 patients with sporadic PD and 200 healthy controls. We identified variants that are likely to have pathogenic effects based on: 1) a minor allele frequency of < 0.01; and 2) the variant being recognized as deleterious by at least 15 different in silico predicting tools. Finally, we tested the aggregate burden of COL6A3 on PD via SKAT-O analysis. Results: First, we found compound heterozygous COL6A3 gene mutations in one early-onset PD patients. Then, we explored whether COL6A3 variants contributed to increased risk of developing PD in a Chinese population. We detected 21 rare non-synonymous variants. Pathogenicity predictions identified 7 novel non-synonymous variants as likely to be pathogenic. SKAT-O analysis further revealed that an aggregate burden of variants in COL6A3 contributes to PD (p = 0.038). Conclusion: An increased aggregate burden of the COL6A3 gene was detected in patients with PD.",0,0,scopus,"['variable frequency oscillators', 'bandwidth', 'visualization tools', 'visualization', 'correlation analysis', 'frequencies', 'output frequency', 'mathematics']",Ullrich congenital muscular dystrophy,"['Study', 'collagen', 'type', 'alpha', 'gene', 'disease']","['Author(s).Background', 'date', 'genetic', 'contribution', 'disease', 'PD', 'unclear', 'Mutations', 'collagen', 'type', 'alpha', 'gene', 'cause', 'isolated', 'dystonia', 'dystonia', 'related', 'disorders', 'clinical', 'genetic', 'characteristics', 'association', 'PD', 'Chinese', 'cohort', 'Methods', 'genetic', 'screening', 'Chinese', 'cohort', 'patients', 'sporadic', 'PD', 'healthy', 'controls', 'variants', 'likely', 'pathogenic', 'effects', 'minor', 'allele', 'frequency', 'variant', 'being', 'deleterious', 'different', 'silico', 'predicting', 'tools', 'aggregate', 'burden', 'O', 'analysis', 'Results', 'compound', 'heterozygous', 'gene', 'mutations', 'early', 'onset', 'PD', 'patients', 'variants', 'risk', 'PD', 'Chinese', 'population', 'rare', 'non', '-', 'synonymous', 'variants', 'Pathogenicity', 'predictions', 'novel', 'non', '-', 'synonymous', 'variants', 'likely', 'pathogenic', 'SKAT', 'O', 'analysis', 'aggregate', 'burden', 'variants', 'contributes', 'p', 'Conclusion', 'aggregate', 'burden', 'gene', 'patients']"
9,9,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103407881&origin=inward,Extracellular matrix: an important regulator of cell functions and skeletal muscle development,"¬© 2021, The Author(s).Extracellular matrix (ECM) is a kind of connective tissue in the cell microenvironment, which is of great significance to tissue development. ECM in muscle fiber niche consists of three layers: the epimysium, the perimysium, and the endomysium (basal lamina). These three layers of connective tissue structure can not only maintain the morphology of skeletal muscle, but also play an important role in the physiological functions of muscle cells, such as the transmission of mechanical force, the regeneration of muscle fiber, and the formation of neuromuscular junction. In this paper, detailed discussions are made for the structure and key components of ECM in skeletal muscle tissue, the role of ECM in skeletal muscle development, and the application of ECM in biomedical engineering. This review will provide the reader with a comprehensive overview of ECM, as well as a comprehensive understanding of the structure, physiological function, and application of ECM in skeletal muscle tissue.",0,0,scopus,"['single-mode optical fiber', 'component', 'software', 'optical fibers', 'optical materials', 'engineering', 'sensors', 'single mode fibers', 'optical fibre']",Ullrich congenital muscular dystrophy,"['Extracellular', 'matrix', 'important', 'regulator', 'cell', 'functions', 'skeletal', 'muscle', 'development']","['matrix', 'kind', 'connective', 'tissue', 'cell', 'microenvironment', 'great', 'significance', 'development', 'ECM', 'muscle', 'fiber', 'niche', 'layers', 'epimysium', 'perimysium', 'endomysium', 'basal', 'lamina', 'layers', 'connective', 'tissue', 'structure', 'morphology', 'skeletal', 'muscle', 'important', 'role', 'physiological', 'functions', 'muscle', 'cells', 'such', 'transmission', 'mechanical', 'force', 'regeneration', 'muscle', 'fiber', 'formation', 'neuromuscular', 'junction', 'paper', 'detailed', 'discussions', 'structure', 'key', 'components', 'skeletal', 'muscle', 'tissue', 'role', 'skeletal', 'muscle', 'development', 'application', 'biomedical', 'engineering', 'review', 'reader', 'comprehensive', 'overview', 'comprehensive', 'understanding', 'structure', 'physiological', 'function', 'application', 'skeletal', 'muscle', 'tissue']"
10,10,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102697243&origin=inward,Impacts of Cyclosporin A on clinical pregnancy outcomes of patients with a history of unexplained transfer failure: a retrospective cohort study,"¬© 2021, The Author(s).Background: A rapid development in assisted reproductive technology (ART) has led to a surge in its popularity among target couples. However, elucidation on the molecular mechanism and effective solutions for a common problem posed by ART, namely transfer failure, is still lacking. The new therapeutic potential of cyclosporin A (CsA), a typical immunosuppressant widely used in the treatment of rejection after organ transplantation, in recurrent pregnancy loss (RPL) patients may inspire some novel transfer failure therapies in the future. To further explore the clinical effects of CsA, this study investigated whether its application can improve clinical pregnancy outcomes in patients with a history of unexplained transfer failure in frozen-thawed embryo transfer (FET) cycles. Methods: Data from a retrospective cohort investigation (178 frozen-thawed embryo transfer cycles in 178 patients) were analysed using binary logistic regression to explore the relationship between CsA treatment and clinical pregnancy outcomes; the odds ratios (ORs) and 95 % confidence intervals (CIs) were calculated as a measure of relevancy. Implantation rate was the main outcome measure. Results: There was no difference in the fine adjusted OR (95 % CI) of the implantation rate [1.251 (0.739‚Äì2.120)], clinical pregnancy rate [1.634 (0.772‚Äì3.458)], chemical pregnancy rate [1.402 (0.285‚Äì6.909)], take-home baby rate [0.872 (0.423‚Äì1.798)], multiple births rate [0.840 (0.197‚Äì3.590)], preterm birth [1.668 (0.377‚Äì7.373)], abnormal birth weight [1.834 (0.533‚Äì6.307)] or sex ratio [0.956 (0.339‚Äì2.698)] between the CsA-treated group and control group. No birth defects were observed in the present study. Conclusions: Although CsA does not affect infant characteristics, it has no beneficial effects on the clinical pregnancy outcomes in patients with a history of unexplained transfer failure in FET cycles.",0,0,scopus,"['node failure', 'logistic regression models', 'logistics', 'wireless sensor networks', 'fault tolerance', 'planar graph', 'cycle', 'correlation analysis', 'sensor networks', 'logistic regression']",Ullrich congenital muscular dystrophy,"['Impacts', 'clinical', 'pregnancy', 'outcomes', 'patients', 'history', 'unexplained', 'transfer', 'failure', 'retrospective', 'cohort', 'study']","['Author(s).Background', 'rapid', 'development', 'reproductive', 'technology', 'surge', 'popularity', 'target', 'couples', 'elucidation', 'molecular', 'mechanism', 'effective', 'solutions', 'common', 'problem', 'failure', 'new', 'therapeutic', 'potential', 'cyclosporin', 'typical', 'immunosuppressant', 'treatment', 'rejection', 'organ', 'transplantation', 'recurrent', 'pregnancy', 'loss', 'patients', 'novel', 'transfer', 'failure', 'therapies', 'future', 'clinical', 'effects', 'study', 'application', 'clinical', 'pregnancy', 'outcomes', 'patients', 'history', 'unexplained', 'transfer', 'failure', 'frozen', 'thawed', 'embryo', 'transfer', 'cycles', 'Methods', 'Data', 'retrospective', 'cohort', 'investigation', 'thawed', 'embryo', 'transfer', 'cycles', 'patients', 'binary', 'logistic', 'regression', 'relationship', 'treatment', 'clinical', 'pregnancy', 'outcomes', 'odds', 'ratios', '%', 'confidence', 'intervals', 'measure', 'relevancy', 'Implantation', 'rate', 'main', 'outcome', 'measure', 'Results', 'difference', 'fine', '%', 'implantation', 'rate', 'clinical', 'pregnancy', 'rate', 'chemical', 'pregnancy', 'rate', 'home', 'baby', 'rate', 'multiple', 'births', 'rate', '0.197‚Äì3.590', 'preterm', 'birth', '0.377‚Äì7.373', 'abnormal', 'birth', 'weight', 'sex', 'ratio', 'group', 'control', 'group', 'birth', 'defects', 'present', 'study', 'Conclusions', 'infant', 'characteristics', 'beneficial', 'effects', 'clinical', 'pregnancy', 'outcomes', 'patients', 'history', 'unexplained', 'transfer', 'failure', 'cycles']"
11,11,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102299664&origin=inward,A novel variant in the COL6A1 gene causing Ullrich congenital muscular dystrophy in a consanguineous family: a case report,"¬© 2021, The Author(s).Background: Collagen VI-related dystrophies are a subtype of congenital muscular dystrophy caused by pathogenic variants in COL6A1, COL6A2 or COL6A3 genes affecting skeletal muscles and connective tissue. The clinical phenotype ranges from the milder Bethlem myopathy to the severe Ullrich congenital muscular dystrophy (UCMD). Herein, we report the first consanguineous Sri Lankan family with two children affected with UCMD due to a novel variant in the COL6A1 gene. Case presentation: Two sisters, aged 10-years and 7-years, presented with progressive, bilateral proximal muscle weakness. Both probands had delayed motor milestones and demonstrated difficulty in standing from a squatting position, climbing stairs and raising arms above the shoulders. Cognitive, language and social development were age appropriate. Examination showed proximal muscle weakness of the upper and lower extremities and hyperlaxity of the wrist and fingers in both with some variability in clinical severity noted between the two siblings. Serum creatine kinase levels were elevated, and electromyography showed low polyphasic motor unit potentials in the 10-year-old and myopathic features with short duration motor unit potentials with no polyphasia in the 7-year-old. Whole exome sequencing (WES) was performed and a novel, homozygous missense, likely pathogenic variant in exon 25 of COL6A1 gene [NM_001848: c.1667G > T;NP_001839.2:p.Gly556Val] was identified in both probands. This variant was validated by Sanger sequencing in proband 1 as well as proband 2, and the parents and an unaffected sibling were found to be heterozygote carriers for the same variant. Conclusions: The findings in this family add to the expanding number of COL6A1 variants identified and provides a better understanding of the genotype-phenotype correlations associated with UCMD.",0,0,scopus,"['interactive computer systems', 'feature space', 'classification methods', 'social media', 'social development', 'pattern recognition', 'correlation coefficient', 'online systems', 'case base', 'sociology', 'economic and social effects', 'robotics', 'cbr', 'target position', 'social relations', 'human engineering', 'case representation', 'social relationships', 'routing algorithms', 'correlation analysis', 'economic development', 'mathematics', 'time windows', 'economics', 'target tracking', 'social networks', 'ubiquitous computing', 'social aspect', 'economic growth', 'social computing']",Ullrich congenital muscular dystrophy,"['novel', 'variant', 'COL6A1', 'gene', 'congenital', 'muscular', 'dystrophy', 'consanguineous', 'family', 'case', 'report']","['dystrophies', 'subtype', 'congenital', 'muscular', 'dystrophy', 'pathogenic', 'variants', 'genes', 'skeletal', 'muscles', 'connective', 'tissue', 'clinical', 'phenotype', 'milder', 'myopathy', 'severe', 'congenital', 'muscular', 'dystrophy', 'first', 'consanguineous', 'family', 'children', 'novel', 'variant', 'COL6A1', 'gene', 'Case', 'presentation', 'sisters', 'aged', '10-years', 'progressive', 'bilateral', 'proximal', 'muscle', 'weakness', 'probands', 'motor', 'milestones', 'difficulty', 'squatting', 'position', 'stairs', 'arms', 'shoulders', 'Cognitive', 'language', 'social', 'development', 'age', 'appropriate', 'Examination', 'proximal', 'muscle', 'weakness', 'upper', 'lower', 'extremities', 'hyperlaxity', 'wrist', 'fingers', 'variability', 'clinical', 'severity', 'siblings', 'Serum', 'creatine', 'kinase', 'levels', 'electromyography', 'low', 'polyphasic', 'motor', 'unit', 'potentials', '10-year', 'old', 'myopathic', 'features', 'short', 'duration', 'motor', 'unit', 'potentials', 'polyphasia', 'old', 'Whole', 'exome', 'sequencing', 'novel', 'homozygous', 'missense', 'pathogenic', 'variant', 'exon', 'COL6A1', 'gene', 'G', 'T;NP_001839.2:p', 'probands', 'variant', 'proband', 'proband', 'parents', 'unaffected', 'sibling', 'heterozygote', 'carriers', 'same', 'variant', 'Conclusions', 'findings', 'family', 'number', 'COL6A1', 'variants', 'better', 'understanding', 'genotype', 'phenotype', 'correlations']"
12,12,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105548310&origin=inward,Development and maintenance of vision's first synapse,"¬© 2021 Elsevier Inc.Synapses in the outer retina are the first information relay points in vision. Here, photoreceptors form synapses onto two types of interneurons, bipolar cells and horizontal cells. Because outer retina synapses are particularly large and highly ordered, they have been a useful system for the discovery of mechanisms underlying synapse specificity and maintenance. Understanding these processes is critical to efforts aimed at restoring visual function through repairing or replacing neurons and promoting their connectivity. We review outer retina neuron synapse architecture, neural migration modes, and the cellular and molecular pathways that play key roles in the development and maintenance of these connections. We further discuss how these mechanisms may impact connectivity in the retina.",0,0,scopus,"['wireless networks', 'ad hoc networks', 'wireless sensor networks', 'computer software maintenance', 'personal information', 'cellular', 'relay node', 'software architecture', 'architecture designs', 'network coding', 'user information', 'cellular telephone systems', 'robots', 'recommender systems', 'computer vision', 'vision systems', 'maintenance process', 'wireless', 'cellular radio systems', 'fading channels']",Ullrich congenital muscular dystrophy,"['Development', 'maintenance', 'vision', 'first', 'synapse']","['Synapses', 'outer', 'retina', 'first', 'information', 'relay', 'points', 'vision', 'photoreceptors', 'synapses', 'types', 'interneurons', 'bipolar', 'cells', 'horizontal', 'cells', 'outer', 'retina', 'synapses', 'large', 'useful', 'system', 'discovery', 'mechanisms', 'synapse', 'specificity', 'maintenance', 'processes', 'critical', 'efforts', 'visual', 'function', 'neurons', 'connectivity', 'outer', 'retina', 'neuron', 'synapse', 'architecture', 'neural', 'migration', 'modes', 'cellular', 'molecular', 'pathways', 'key', 'roles', 'development', 'maintenance', 'connections', 'mechanisms', 'connectivity', 'retina']"
13,13,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104146926&origin=inward,Tumor-associated macrophages promote the metastasis and growth of non-small-cell lung cancer cells through NF-Œ∫B/PP2Ac-positive feedback loop,"¬© 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.Non-small-cell lung cancer (NSCLC), with its aggressive biological behavior, is one of the most diagnosed cancers. Tumor-associated inflammatory cells play important roles in the interaction between chronic inflammation and lung cancer, however the mechanisms involved are far from defined. In the present study, by developing an orthotopic NSCLC mouse model based on chronic inflammation, we proved that an inflammatory microenvironment accelerated the growth of orthotopic xenografts in vivo. Tumor-associated macrophages, the most abundant population of inflammatory cells, were identified. Treatment with macrophage-conditioned medium (MCM) promoted the growth and migration of NSCLC cells. Using bioinformatics analysis, we identified downregulated PP2Ac expression in NSCLC cells upon treatment with MCM. We further confirmed that this downregulation was executed in an NF-Œ∫B pathway-dependent manner. As IŒ∫B kinase (IKK) has been proved to be a substrate of PP2Ac, inhibition on PP2Ac could result in amplification of NF-Œ∫B pathway signaling. Overexpression of PP2Ac, or the dominant-negative forms of IKK or IŒ∫B, attenuated the acceleration of growth and metastasis by MCM. Using bioinformatics analysis, we further identified that CXCL1 and COL6A1 could be downstream of NF-Œ∫B/PP2Ac pathway. Luciferase assay and ChIP assay further confirmed the location of response elements on the promoter regions of CXCL1 and COL6A1. Elevated CXCL1 facilitated angiogenesis, whereas upregulated COL6A1 promoted proliferation and migration.",0,0,scopus,"['integrated circuit testing', 'computer systems', 'computer science', 'social sciences', 'electronics packaging', 'correlation analysis', 'feedback systems', 'multichip modules', 'bioinformatics', 'mathematics', 'sociology']",Ullrich congenital muscular dystrophy,"['Tumor', 'macrophages', 'metastasis', 'growth', 'non', '-', 'small', 'cell', 'lung', 'cancer', 'cells', 'positive', 'feedback', 'loop']","['behalf', 'Non', '-', 'small', 'cell', 'lung', 'cancer', 'aggressive', 'biological', 'behavior', 'cancers', 'Tumor', 'inflammatory', 'cells', 'important', 'roles', 'interaction', 'chronic', 'inflammation', 'lung', 'cancer', 'mechanisms', 'present', 'study', 'orthotopic', 'NSCLC', 'mouse', 'model', 'chronic', 'inflammation', 'inflammatory', 'microenvironment', 'growth', 'orthotopic', 'xenografts', 'vivo', 'Tumor', 'macrophages', 'abundant', 'population', 'inflammatory', 'cells', 'Treatment', 'macrophage', 'medium', 'growth', 'migration', 'cells', 'bioinformatics', 'analysis', 'expression', 'cells', 'treatment', 'downregulation', 'NF', 'dependent', 'manner', 'IŒ∫B', 'substrate', 'inhibition', 'amplification', 'NF', 'pathway', 'Overexpression', 'dominant', 'negative', 'forms', 'acceleration', 'growth', 'metastasis', 'bioinformatics', 'analysis', 'COL6A1', 'downstream', 'pathway', 'assay', 'location', 'response', 'elements', 'promoter', 'regions', 'COL6A1', 'Elevated', 'angiogenesis', 'upregulated', 'COL6A1', 'proliferation', 'migration']"
14,14,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106713031&origin=inward,Interventions for promoting physical activity in people with neuromuscular disease,"Copyright ¬© 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.Background: The World Health Organization (WHO) recommends that people of all ages take regular and adequate physical activity. If unable to meet the recommendations due to health conditions, international guidance advises being as physically active as possible. Evidence from community interventions of physical activity indicate that people living with medical conditions are sometimes excluded from participation in studies. In this review, we considered the effects of activity-promoting interventions on physical activity and well-being in studies, as well as any adverse events experienced by participants living with inherited or acquired neuromuscular diseases (NMDs). Objectives: To assess the effects of interventions designed to promote physical activity in people with NMD compared with no intervention or alternative interventions. Search methods: On 30 April 2020, we searched Cochrane Neuromuscular Specialised Register, CENTRAL, Embase, MEDLINE, and ClinicalTrials.Gov. WHO ICTRP was not accessible at the time. Selection criteria: We considered randomised or quasi-randomised trials, including cross-over trials, of interventions designed to promote physical activity in people with NMD compared to no intervention or alternative interventions. We specifically included studies that reported physical activity as an outcome measure. Our main focus was studies in which promoting physical activity was a stated aim but we also included studies in which physical activity was assessed as a secondary or exploratory outcome. Data collection and analysis: We used standard Cochrane procedures. Main results: The review included 13 studies (795 randomised participants from 12 studies; number of participants unclear in one study) of different interventions to promote physical activity. Most studies randomised a minority of invited participants. No study involved children or adolescents and nine studies reported minimal entry criteria for walking. Participants had one of nine inherited or acquired NMDs. Types of intervention included structured physical activity support, exercise support (as a specific form of physical activity), and behaviour change support that included physical activity or exercise. Only one included study clearly reported that the aim of intervention was to increase physical activity. Other studies reported or planned to analyse the effects of intervention on physical activity as a secondary or exploratory outcome measure. Six studies did not report results for physical activity outcomes, or the data were not usable. We judged 10 of the 13 included studies at high or unclear risk of bias from incomplete physical activity outcome reporting. We did not perform a meta-analysis for any comparison because of differences in interventions and in usual care. We also found considerable variation in how studies reported physical activity as an outcome measure. The studies that reported physical activity measurement did not always clearly report intention-to-treat (ITT) analysis or whether final assessments occurred during or after intervention. Based on prespecified measures, we included three comparisons in our summary of findings. A physical activity programme (weight-bearing) compared to no physical activity programme. One study involved adults with diabetic peripheral neuropathy (DPN) and reported weekly duration of walking during and at the end of a one-year intervention using a StepWatch ankle accelerometer. Based on the point estimate and low-certainty evidence, intervention may have led to an important increase in physical activity per week; however, the 95% confidence interval (CI) included the possibility of no difference or an effect in either direction at three months (mean difference (MD) 34 minutes per week, 95% CI ‚Äì92.19 to 160.19; 69 participants), six months (MD 68 minutes per week, 95% CI ‚Äì55.35 to 191.35; 74 participants), and 12 months (MD 49 minutes per week, 95% CI ‚Äì75.73 to 173.73; 70 participants). Study-reported effect estimates for foot lesions and full-thickness ulcers also included the possibility of no difference, a higher, or lower risk with intervention. A sensor-based, interactive exercise programme compared to no sensor-based, interactive exercise programme. One study involved adults with DPN and reported duration of walking over 48 hours at the end of four weeks' intervention using a t-shirt embedded PAMSys sensor. It was not possible to draw conclusions about the effectiveness of the intervention from the very low-certainty evidence (MD ‚Äì0.64 hours per 48 hours, 95% CI ‚Äì2.42 to 1.13; 25 participants). We were also unable to draw conclusions about impact on the Physical Component Score (PCS) for quality of life (MD 0.24 points, 95% CI ‚Äì5.98 to 6.46; 35 participants; very low-certainty evidence), although intervention may have made little or no difference to the Mental Component Score (MCS) for quality of life (MD 5.10 points, 95% CI ‚Äì0.58 to 10.78; 35 participants; low-certainty evidence). A functional exercise programme compared to a stretching exercise programme. One study involved adults with spinal and bulbar muscular atrophy and reported a daily physical activity count at the end of 12 weeks' intervention using an Actical accelerometer. It was not possible to draw conclusions about the effectiveness of either intervention (requiring compliance) due to low-certainty evidence and unconfirmed measurement units (MD ‚Äì8701, 95% CI ‚Äì38,293.30 to 20,891.30; 43 participants). Functional exercise may have made little or no difference to quality of life compared to stretching (PCS: MD ‚Äì1.10 points, 95% CI ‚Äì5.22 to 3.02; MCS: MD ‚Äì1.10 points, 95% CI ‚Äì6.79 to 4.59; 49 participants; low-certainty evidence). Although studies reported adverse events incompletely, we found no evidence of supported activity increasing the risk of serious adverse events. Authors' conclusions: We found a lack of evidence relating to children, adolescents, and non-ambulant people of any age. Many people living with NMD did not meet randomised controlled trial eligibility criteria. There was variation in the components of supported activity intervention and usual care, such as physical therapy provision. We identified variation among studies in how physical activity was monitored, analysed, and reported. We remain uncertain of the effectiveness of promotional intervention for physical activity and its impact on quality of life and adverse events. More information is needed on the ITT population, as well as more complete reporting of outcomes. While there may be no single objective measure of physical activity, the study of qualitative and dichotomous change in self-reported overall physical activity might offer a pragmatic approach to capturing important change at an individual and population level.",0,0,scopus,"['embedded', 'component', 'recommendation', 'software', 'accelerometers', 'information need', 'recommender systems', 'sensors', 'search engines', 'single objective', 'embedded software', 'multi-objective optimisation', 'computer hardware']",Ullrich congenital muscular dystrophy,"['Interventions', 'physical', 'activity', 'people', 'neuromuscular', 'disease']","['Copyright', 'Background', 'people', 'ages', 'regular', 'adequate', 'physical', 'activity', 'unable', 'recommendations', 'due', 'health', 'conditions', 'international', 'guidance', 'active', 'possible', 'Evidence', 'community', 'interventions', 'physical', 'activity', 'people', 'medical', 'conditions', 'participation', 'studies', 'review', 'effects', 'activity', 'interventions', 'physical', 'activity', 'being', 'studies', 'adverse', 'events', 'participants', 'neuromuscular', 'diseases', 'Objectives', 'effects', 'interventions', 'physical', 'activity', 'people', 'intervention', 'alternative', 'interventions', 'Search', 'methods', 'accessible', 'time', 'Selection', 'criteria', '-', 'trials', 'cross', '-', 'trials', 'interventions', 'physical', 'activity', 'people', 'intervention', 'alternative', 'interventions', 'studies', 'physical', 'activity', 'outcome', 'measure', 'main', 'focus', 'studies', 'physical', 'activity', 'aim', 'studies', 'physical', 'activity', 'secondary', 'exploratory', 'outcome', 'Data', 'collection', 'analysis', 'standard', 'procedures', 'Main', 'results', 'review', 'studies', 'participants', 'studies', 'number', 'participants', 'unclear', 'study', 'different', 'interventions', 'physical', 'activity', 'Most', 'studies', 'minority', 'participants', 'study', 'children', 'adolescents', 'studies', 'minimal', 'entry', 'criteria', 'Participants', 'NMDs', 'Types', 'intervention', 'physical', 'activity', 'support', 'exercise', 'support', 'specific', 'form', 'physical', 'activity', 'change', 'support', 'physical', 'activity', 'exercise', 'study', 'aim', 'intervention', 'physical', 'activity', 'Other', 'studies', 'effects', 'intervention', 'physical', 'activity', 'secondary', 'exploratory', 'outcome', 'measure', 'studies', 'results', 'physical', 'activity', 'outcomes', 'data', 'usable', 'studies', 'high', 'unclear', 'risk', 'bias', 'incomplete', 'physical', 'activity', 'outcome', 'meta', 'analysis', 'comparison', 'differences', 'interventions', 'usual', 'care', 'considerable', 'variation', 'studies', 'physical', 'activity', 'outcome', 'measure', 'studies', 'physical', 'activity', 'measurement', 'intention', 'analysis', 'final', 'assessments', 'intervention', 'measures', 'comparisons', 'summary', 'findings', 'physical', 'activity', 'programme', 'weight', 'bearing', 'physical', 'activity', 'programme', 'study', 'adults', 'diabetic', 'peripheral', 'neuropathy', 'weekly', 'duration', 'end', 'year', 'intervention', 'ankle', 'accelerometer', 'point', 'estimate', 'low', 'certainty', 'evidence', 'intervention', 'important', 'increase', 'physical', 'activity', 'week', '%', 'confidence', 'interval', 'possibility', 'difference', 'effect', 'direction', 'months', 'mean', 'difference', 'minutes', 'week', '%', 'participants', 'months', 'minutes', 'week', '%', 'participants', 'months', 'minutes', 'week', '%', 'participants', 'Study', 'effect', 'estimates', 'foot', 'lesions', 'full', 'thickness', 'ulcers', 'possibility', 'difference', 'higher', 'lower', 'risk', 'intervention', 'sensor', 'interactive', 'exercise', 'programme', 'sensor', 'interactive', 'exercise', 'programme', 'study', 'adults', 'duration', 'hours', 'end', 'weeks', 'intervention', 't', 'shirt', 'PAMSys', 'sensor', 'possible', 'conclusions', 'effectiveness', 'intervention', 'low', 'certainty', 'evidence', 'hours', 'hours', '%', 'participants', 'unable', 'conclusions', 'impact', 'Score', 'quality', 'life', 'points', '%', 'participants', 'low', 'certainty', 'evidence', 'intervention', 'little', 'difference', 'quality', 'life', 'points', '%', 'participants', 'low', 'certainty', 'evidence', 'functional', 'exercise', 'programme', 'exercise', 'programme', 'study', 'adults', 'spinal', 'bulbar', 'muscular', 'atrophy', 'daily', 'physical', 'activity', 'count', 'end', 'weeks', 'intervention', 'Actical', 'accelerometer', 'possible', 'conclusions', 'effectiveness', 'intervention', 'compliance', 'low', 'certainty', 'evidence', 'unconfirmed', 'measurement', 'units', '‚Äì8701', '%', 'participants', 'Functional', 'exercise', 'little', 'difference', 'quality', 'life', 'PCS', 'points', '%', 'points', '%', 'participants', 'low', 'certainty', 'evidence', 'studies', 'adverse', 'events', 'evidence', 'activity', 'risk', 'serious', 'adverse', 'events', 'Authors', 'conclusions', 'lack', 'evidence', 'children', 'adolescents', 'non', '-', 'ambulant', 'people', 'age', 'Many', 'people', 'trial', 'eligibility', 'criteria', 'variation', 'components', 'activity', 'intervention', 'usual', 'care', 'such', 'physical', 'therapy', 'provision', 'variation', 'studies', 'physical', 'activity', 'uncertain', 'effectiveness', 'promotional', 'intervention', 'physical', 'activity', 'impact', 'quality', 'life', 'adverse', 'events', 'More', 'information', 'population', 'complete', 'reporting', 'outcomes', 'single', 'objective', 'measure', 'physical', 'activity', 'study', 'qualitative', 'dichotomous', 'change', 'self', 'overall', 'physical', 'activity', 'pragmatic', 'approach', 'important', 'change', 'individual', 'population', 'level']"
15,15,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107307232&origin=inward,Bioinformatics Analysis of a Prognostic miRNA Signature and Potential Key Genes in Pancreatic Cancer,"¬© Copyright ¬© 2021 Chen, Gao, Yu, Qu, Xiao and Huang.Background: In this study, miRNAs and their critical target genes related to the prognosis of pancreatic cancer were screened based on bioinformatics analysis to provide targets for the prognosis and treatment of pancreatic cancer. Methods: R software was used to screen differentially expressed miRNAs (DEMs) and genes (DEGs) downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, respectively. A miRNA Cox proportional hazards regression model was constructed based on the miRNAs, and a miRNA prognostic model was generated. The target genes of the prognostic miRNAs were predicted using TargetScan and miRDB and then intersected with the DEGs to obtain common genes. The functions of the common genes were subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses. A protein-protein interaction (PPI) network of the common genes was constructed with the STRING database and visualized with Cytoscape software. Key genes were also screened with the MCODE and cytoHubba plug-ins of Cytoscape. Finally, a prognostic model formed by the key gene was also established to help evaluate the reliability of this screening process. Results: A prognostic model containing four downregulated miRNAs (hsa-mir-424, hsa-mir-3613, hsa-mir-4772 and hsa-mir-126) related to the prognosis of pancreatic cancer was constructed. A total of 118 common genes were enriched in two KEGG pathways and 33 GO functional annotations, including extracellular matrix (ECM)-receptor interaction and cell adhesion. Nine key genes related to pancreatic cancer were also obtained: MMP14, ITGA2, THBS2, COL1A1, COL3A1, COL11A1, COL6A3, COL12A1 and COL5A2. The prognostic model formed by nine key genes also possessed good prognostic ability. Conclusions: The prognostic model consisting of four miRNAs can reliably predict the prognosis of patients with pancreatic cancer. In addition, the screened nine key genes, which can also form a reliable prognostic model, are significantly related to the occurrence and development of pancreatic cancer. Among them, one novel miRNA (hsa-mir-4772) and two novel genes (COL12A1 and COL5A2) associated with pancreatic cancer have great potential to be used as prognostic factors and therapeutic targets for this tumor.",0,0,scopus,"['computer systems', 'software', 'computer science', 'database systems', 'ins', 'correlation analysis', 'ontology', 'regression model', 'bioinformatics', 'semantics', 'gps']",Ullrich congenital muscular dystrophy,[],"['Copyright', 'Background', 'study', 'critical', 'target', 'genes', 'prognosis', 'pancreatic', 'cancer', 'bioinformatics', 'analysis', 'targets', 'prognosis', 'treatment', 'pancreatic', 'cancer', 'Methods', 'R', 'software', 'genes', 'databases', 'proportional', 'hazards', 'regression', 'model', 'prognostic', 'model', 'target', 'genes', 'prognostic', 'DEGs', 'common', 'genes', 'functions', 'common', 'genes', 'protein', 'protein', 'interaction', 'network', 'common', 'genes', 'STRING', 'database', 'software', 'Key', 'genes', 'cytoHubba', 'plug', 'ins', 'prognostic', 'model', 'key', 'gene', 'reliability', 'screening', 'process', 'Results', 'prognostic', 'model', 'hsa', 'mir-424', 'hsa', 'mir-3613', 'hsa', 'mir-4772', 'hsa', 'mir-126', 'prognosis', 'pancreatic', 'cancer', 'total', 'common', 'genes', 'pathways', 'functional', 'annotations', 'extracellular', 'matrix', 'ECM)-receptor', 'interaction', 'cell', 'adhesion', 'key', 'genes', 'pancreatic', 'cancer', 'COL3A1', 'COL11A1', 'prognostic', 'model', 'key', 'genes', 'good', 'prognostic', 'ability', 'Conclusions', 'prognostic', 'model', 'miRNAs', 'prognosis', 'patients', 'pancreatic', 'cancer', 'addition', 'screened', 'key', 'genes', 'reliable', 'prognostic', 'model', 'occurrence', 'development', 'pancreatic', 'cancer', 'novel', 'miRNA', 'hsa', 'mir-4772', 'novel', 'genes', 'pancreatic', 'cancer', 'great', 'potential', 'prognostic', 'factors', 'therapeutic', 'targets', 'tumor']"
16,16,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105023524&origin=inward,A form of muscular dystrophy associated with pathogenic variants in JAG2,"¬© 2021 American Society of Human GeneticsJAG2 encodes the Notch ligand Jagged2. The conserved Notch signaling pathway contributes to the development and homeostasis of multiple tissues, including skeletal muscle. We studied an international cohort of 23 individuals with genetically unsolved muscular dystrophy from 13 unrelated families. Whole-exome sequencing identified rare homozygous or compound heterozygous JAG2 variants in all 13 families. The identified bi-allelic variants include 10 missense variants that disrupt highly conserved amino acids, a nonsense variant, two frameshift variants, an in-frame deletion, and a microdeletion encompassing JAG2. Onset of muscle weakness occurred from infancy to young adulthood. Serum creatine kinase (CK) levels were normal or mildly elevated. Muscle histology was primarily dystrophic. MRI of the lower extremities revealed a distinct, slightly asymmetric pattern of muscle involvement with cores of preserved and affected muscles in quadriceps and tibialis anterior, in some cases resembling patterns seen in POGLUT1-associated muscular dystrophy. Transcriptome analysis of muscle tissue from two participants suggested misregulation of genes involved in myogenesis, including PAX7. In complementary studies, Jag2 downregulation in murine myoblasts led to downregulation of multiple components of the Notch pathway, including Megf10. Investigations in Drosophila suggested an interaction between Serrate and Drpr, the fly orthologs of JAG1/JAG2 and MEGF10, respectively. In silico analysis predicted that many Jagged2 missense variants are associated with structural changes and protein misfolding. In summary, we describe a muscular dystrophy associated with pathogenic variants in JAG2 and evidence suggests a disease mechanism related to Notch pathway dysfunction.",0,0,scopus,"['component', 'software', 'structural frames', 'competitive intelligence', 'multi core', 'frames', 'application specific integrated circuits', 'correlation analysis', 'information systems', 'multiprocessing systems', 'business intelligence', 'mathematics', 'processor cores', 'data warehouses', 'embedded systems']",Ullrich congenital muscular dystrophy,"['form', 'muscular', 'dystrophy', 'pathogenic', 'variants']","['GeneticsJAG2', 'encodes', 'ligand', 'conserved', 'pathway', 'development', 'homeostasis', 'multiple', 'tissues', 'skeletal', 'muscle', 'international', 'cohort', 'individuals', 'unsolved', 'muscular', 'dystrophy', 'unrelated', 'families', 'Whole', 'exome', 'sequencing', 'rare', 'homozygous', 'compound', 'heterozygous', 'variants', 'families', 'bi', 'allelic', 'variants', 'missense', 'variants', 'amino', 'acids', 'nonsense', 'variant', 'frameshift', 'variants', 'frame', 'deletion', 'microdeletion', 'Onset', 'muscle', 'weakness', 'infancy', 'young', 'adulthood', 'Serum', 'creatine', 'kinase', 'CK', 'levels', 'normal', 'elevated', 'Muscle', 'histology', 'dystrophic', 'MRI', 'lower', 'extremities', 'distinct', 'asymmetric', 'pattern', 'muscle', 'involvement', 'cores', 'affected', 'muscles', 'quadriceps', 'tibialis', 'anterior', 'cases', 'patterns', 'muscular', 'dystrophy', 'Transcriptome', 'analysis', 'muscle', 'tissue', 'participants', 'misregulation', 'genes', 'myogenesis', 'complementary', 'studies', 'downregulation', 'murine', 'myoblasts', 'downregulation', 'multiple', 'components', 'pathway', 'Investigations', 'interaction', 'fly', 'orthologs', 'silico', 'analysis', 'many', 'missense', 'variants', 'structural', 'changes', 'protein', 'misfolding', 'summary', 'muscular', 'dystrophy', 'pathogenic', 'variants', 'evidence', 'disease', 'mechanism', 'pathway', 'dysfunction']"
17,17,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105738322&origin=inward,Role of matricellular ccn proteins in skeletal muscle: Focus on ccn2/ctgf and its regulation by vasoactive peptides,"¬© 2021 by the authors. Licensee MDPI, Basel, Switzerland.The Cellular Communication Network (CCN) family of matricellular proteins comprises six proteins that share conserved structural features and play numerous biological roles. These proteins can interact with several receptors or soluble proteins, regulating cell signaling pathways in various tissues under physiological and pathological conditions. In the skeletal muscle of mammals, most of the six CCN family members are expressed during embryonic development or in adulthood. Their roles during the adult stage are related to the regulation of muscle mass and regeneration, maintaining vascularization, and the modulation of skeletal muscle fibrosis. This work reviews the CCNs proteins‚Äô role in skeletal muscle physiology and disease, focusing on skeletal muscle fibrosis and its regulation by Connective Tissue Growth factor (CCN2/CTGF). Furthermore, we review evidence on the modulation of fibrosis and CCN2/CTGF by the renin-angiotensin system and the kallikrein-kinin system of vasoactive peptides.",0,0,scopus,"['telecommunication networks', 'cellular telephone systems', 'communication', 'optical fibers', 'computer network', 'wireless', 'phase modulation', 'cellular radio systems', 'communication networks', 'channel capacity', 'cellular network', 'bit error rate', 'cellular system', 'cellular']",Ullrich congenital muscular dystrophy,"['Role', 'matricellular', 'ccn', 'proteins', 'skeletal', 'muscle', 'regulation', 'vasoactive', 'peptides']","['authors', 'family', 'matricellular', 'proteins', 'proteins', 'structural', 'features', 'numerous', 'biological', 'roles', 'proteins', 'several', 'receptors', 'soluble', 'proteins', 'cell', 'pathways', 'various', 'tissues', 'physiological', 'pathological', 'conditions', 'skeletal', 'muscle', 'mammals', 'most', 'family', 'members', 'embryonic', 'development', 'adulthood', 'roles', 'adult', 'stage', 'regulation', 'muscle', 'mass', 'regeneration', 'vascularization', 'modulation', 'skeletal', 'muscle', 'fibrosis', 'work', 'CCNs', 'proteins', 'role', 'skeletal', 'muscle', 'physiology', 'disease', 'skeletal', 'muscle', 'fibrosis', 'regulation', 'factor', 'evidence', 'modulation', 'fibrosis', 'CCN2/CTGF', 'renin', 'angiotensin', 'system', 'kallikrein', 'kinin', 'system', 'vasoactive', 'peptides']"
18,18,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105396144&origin=inward,Impact of intrinsic muscle weakness on muscle‚Äìbone crosstalk in osteogenesis imperfecta,"¬© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Bone and muscle are highly synergistic tissues that communicate extensively via mechan-otransduction and biochemical signaling. Osteogenesis imperfecta (OI) is a heritable connective tissue disorder of severe bone fragility and recently recognized skeletal muscle weakness. The presence of impaired bone and muscle in OI leads to a continuous cycle of altered muscle‚Äìbone crosstalk with weak muscles further compromising bone and vice versa. Currently, there is no cure for OI and understanding the pathogenesis of the skeletal muscle weakness in relation to the bone pathogenesis of OI in light of the critical role of muscle‚Äìbone crosstalk is essential to developing and identifying novel therapeutic targets and strategies for OI. This review will highlight how impaired skeletal muscle function contributes to the pathophysiology of OI and how this phenomenon further perpetuates bone fragility.",0,0,scopus,"['target tracking', 'multitarget', 'planar graph', 'crosstalk noise', 'multi-target tracking', 'cycle', 'spurious signal noise', 'multiple targets']",Ullrich congenital muscular dystrophy,"['Impact', 'intrinsic', 'muscle', 'weakness', 'muscle', 'bone', 'crosstalk', 'osteogenesis', 'imperfecta']","['authors', 'Bone', 'muscle', 'synergistic', 'tissues', 'mechan', 'otransduction', 'biochemical', 'signaling', 'Osteogenesis', 'imperfecta', 'heritable', 'connective', 'tissue', 'disorder', 'severe', 'bone', 'fragility', 'skeletal', 'muscle', 'weakness', 'presence', 'impaired', 'bone', 'muscle', 'continuous', 'cycle', 'altered', 'muscle', 'bone', 'crosstalk', 'weak', 'muscles', 'bone', 'vice', 'cure', 'pathogenesis', 'skeletal', 'muscle', 'weakness', 'relation', 'bone', 'pathogenesis', 'light', 'critical', 'role', 'muscle', 'bone', 'crosstalk', 'essential', 'novel', 'therapeutic', 'targets', 'strategies', 'review', 'impaired', 'skeletal', 'muscle', 'function', 'contributes', 'pathophysiology', 'phenomenon', 'further', 'perpetuates', 'bone', 'fragility']"
19,19,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105150458&origin=inward,"Evolving Roles of Muscle-Resident Fibro-Adipogenic Progenitors in Health, Regeneration, Neuromuscular Disorders, and Aging","¬© Copyright ¬© 2021 Theret, Rossi and Contreras.Normal skeletal muscle functions are affected following trauma, chronic diseases, inherited neuromuscular disorders, aging, and cachexia, hampering the daily activities and quality of life of the affected patients. The maladaptive accumulation of fibrous intramuscular connective tissue and fat are hallmarks of multiple pathologies where chronic damage and inflammation are not resolved, leading to progressive muscle replacement and tissue degeneration. Muscle-resident fibro-adipogenic progenitors are adaptable stromal cells with multilineage potential. They are required for muscle homeostasis, neuromuscular integrity, and tissue regeneration. Fibro-adipogenic progenitors actively regulate and shape the extracellular matrix and exert immunomodulatory functions via cross-talk with multiple other residents and non-resident muscle cells. Remarkably, cumulative evidence shows that a significant proportion of activated fibroblasts, adipocytes, and bone-cartilage cells, found after muscle trauma and disease, descend from these enigmatic interstitial progenitors. Despite the profound impact of muscle disease on human health, the fibrous, fatty, and ectopic bone tissues‚Äô origins are poorly understood. Here, we review the current knowledge of fibro-adipogenic progenitor function on muscle homeostatic integrity, regeneration, repair, and aging. We also discuss how scar-forming pathologies and disorders lead to dysregulations in their behavior and plasticity and how these stromal cells can control the onset and severity of muscle loss in disease. We finally explore the rationale of improving muscle regeneration by understanding and modulating fibro-adipogenic progenitors‚Äô fate and behavior.",0,0,scopus,"['tacit knowledge', 'damage detection', 'knowledge management', 'knowledge based systems', 'structural damages', 'structural health monitoring', 'explicit knowledge', 'domain knowledge']",Ullrich congenital muscular dystrophy,['Aging'],"['Copyright', 'Normal', 'skeletal', 'muscle', 'functions', 'trauma', 'chronic', 'diseases', 'neuromuscular', 'disorders', 'cachexia', 'daily', 'activities', 'quality', 'life', 'patients', 'maladaptive', 'accumulation', 'fibrous', 'intramuscular', 'connective', 'tissue', 'fat', 'hallmarks', 'multiple', 'pathologies', 'chronic', 'damage', 'inflammation', 'progressive', 'muscle', 'replacement', 'tissue', 'degeneration', 'Muscle', 'resident', 'fibro', 'adipogenic', 'progenitors', 'adaptable', 'stromal', 'cells', 'multilineage', 'potential', 'muscle', 'homeostasis', 'neuromuscular', 'integrity', 'regeneration', 'Fibro', 'adipogenic', 'progenitors', 'extracellular', 'matrix', 'immunomodulatory', 'functions', 'cross', '-', 'talk', 'multiple', 'other', 'residents', 'non', '-', 'resident', 'muscle', 'cells', 'cumulative', 'evidence', 'significant', 'proportion', 'fibroblasts', 'adipocytes', 'bone', 'cartilage', 'cells', 'muscle', 'trauma', 'disease', 'enigmatic', 'interstitial', 'progenitors', 'profound', 'impact', 'muscle', 'disease', 'human', 'health', 'fibrous', 'fatty', 'ectopic', 'bone', 'tissues', 'origins', 'current', 'knowledge', 'fibro', 'adipogenic', 'progenitor', 'function', 'muscle', 'homeostatic', 'integrity', 'regeneration', 'repair', 'scar', 'pathologies', 'disorders', 'dysregulations', 'behavior', 'plasticity', 'stromal', 'cells', 'onset', 'severity', 'muscle', 'loss', 'disease', 'rationale', 'muscle', 'regeneration', 'understanding', 'fibro', 'adipogenic', 'progenitors', 'fate', 'behavior']"
20,20,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107207060&origin=inward,Texture analysis of t1-weighted turbo spin-echo mri for the diagnosis and follow-up of collagen vi-related myopathy,"¬© 2021 IEEE.Muscle texture analysis in Magnetic Resonance Imaging (MRI) has revealed a good correlation with typical histological changes resulting from neuromuscular disorders. In this research, we assess the effectiveness of several features in describing intramuscular texture alterations in cases of Collagen VI-related myopathy. A T1-weighted Turbo Spin-Echo MRI dataset was used (mathrm{N}-{subj}, =26), consisting of thigh scans from subjects diagnosed with Ullrich Congenital Muscular Dystrophy or Bethlem Myopathy, with different severity levels, as well as healthy subjects. A total of 355 texture features were studied, including attributes derived from the Gray-Level Co-occurrence Matrix, the Run-Length Matrix, Wavelet and Gabor filters. The extracted features were ranked using the Support Vector Machine Recursive Feature Elimination (SVM-RFE) algorithm with Correlation Bias Reduction, prior to cross-validated classification with a Gaussian kernel SVM.",0,0,scopus,"['svm', 'support vector', 'gaussians', 'gaussian distribution', 'classifiers', 'model checking', 'gabor filter', 'face recognition', 'gaussian kernels', 'spin', 'wavelet', 'support vector machine', 'wavelet transforms']",Ullrich congenital muscular dystrophy,"['Texture', 'analysis', 't1-weighted', 'turbo', 'spin', 'echo', 'mri', 'diagnosis', 'up', 'collagen', 'vi', 'myopathy']","['IEEE.Muscle', 'texture', 'analysis', 'good', 'correlation', 'typical', 'histological', 'changes', 'neuromuscular', 'disorders', 'research', 'effectiveness', 'several', 'features', 'intramuscular', 'texture', 'alterations', 'cases', 'myopathy', 'T1-weighted', 'dataset', 'thigh', 'scans', 'subjects', 'different', 'severity', 'levels', 'healthy', 'subjects', 'total', 'texture', 'features', 'attributes', '-', 'occurrence', 'filters', 'features', 'Elimination', 'algorithm', 'cross', '-', 'validated', 'classification', 'Gaussian', 'kernel']"
21,21,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104069595&origin=inward,A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients,"¬© 2021 The AuthorsPreclinical models of ischemia/reperfusion injury (RI) demonstrate the deleterious effects of permeability transition pore complex (PTPC) opening in the first minutes upon revascularization of the occluded vessel. The ATP synthase c subunit (Csub) influences PTPC activity in cells, thus impacting tissue injury. A conserved glycine-rich domain in Csub is classified as critical because, when mutated, it modifies ATP synthase properties, protein interaction with the mitochondrial calcium (Ca2+) uniporter complex, and the conductance of the PTPC. Here, we document the role of a naturally occurring mutation in the Csub-encoding ATP5G1 gene at the G87 position found in two ST-segment elevation myocardial infarction (STEMI) patients and how PTPC opening is related to RI in patients affected by the same disease. We report a link between the expression of ATP5G1G87E and the response to hypoxia/reoxygenation of human cardiomyocytes, which worsen when compared to those expressing the wild-type protein, and a positive correlation between PTPC and RI.",0,0,scopus,"['damage detection', 'particle swarm optimization (pso)', 'standard model', 'mutation strategy', 'correlation analysis', 'structural damages', 'differential evolution', 'the standard model', 'evolutionary algorithms', 'correlation coefficient', 'mutation operators', 'electronic document identification systems', 'structural health monitoring']",Ullrich congenital muscular dystrophy,"['mutation', 'synthase', 'subunit', 'c', 'damage', 'hypoxia', 'reoxygenation', 'patients']","['models', 'ischemia', 'reperfusion', 'injury', 'deleterious', 'effects', 'permeability', 'transition', 'pore', 'complex', 'opening', 'first', 'minutes', 'revascularization', 'occluded', 'vessel', 'synthase', 'subunit', 'PTPC', 'activity', 'cells', 'tissue', 'injury', 'conserved', 'glycine', 'rich', 'domain', 'critical', 'synthase', 'properties', 'protein', 'interaction', 'mitochondrial', 'calcium', 'Ca2', 'uniporter', 'complex', 'conductance', 'role', 'mutation', 'ATP5G1', 'gene', 'position', 'ST', 'segment', 'elevation', 'myocardial', 'infarction', 'patients', 'opening', 'patients', 'same', 'disease', 'link', 'expression', 'response', 'hypoxia', 'reoxygenation', 'human', 'cardiomyocytes', 'wild', 'type', 'protein', 'positive', 'correlation']"
22,22,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103997956&origin=inward,The NIH Somatic Cell Genome Editing program,"¬© 2021, The Author(s).The move from reading to writing the human genome offers new opportunities to improve human health. The United States National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) Consortium aims to accelerate the development of safer and more-effective methods to edit the genomes of disease-relevant somatic cells in patients, even in tissues that are difficult to reach. Here we discuss the consortium‚Äôs plans to develop and benchmark approaches to induce and measure genome modifications, and to define downstream functional consequences of genome editing within human cells. Central to this effort is a rigorous and innovative approach that requires validation of the technology through third-party testing in small and large animals. New genome editors, delivery technologies and methods for tracking edited cells in vivo, as well as newly developed animal models and human biological systems, will be assembled‚Äîalong with validated datasets‚Äîinto an SCGE Toolkit, which will be disseminated widely to the biomedical research community. We visualize this toolkit‚Äîand the knowledge generated by its applications‚Äîas a means to accelerate the clinical development of new therapies for a wide range of conditions.",0,0,scopus,"['sustainable building', 'validation', 'intelligent buildings', 'software frameworks', 'innovative technologies', 'verification and validation', 'computer programming', 'education', 'university', 'service management']",Ullrich congenital muscular dystrophy,['program'],"['move', 'human', 'genome', 'new', 'opportunities', 'human', 'health', 'Editing', 'development', 'safer', 'effective', 'methods', 'genomes', 'disease', 'relevant', 'somatic', 'cells', 'patients', 'tissues', 'difficult', 'consortium', 'plans', 'approaches', 'genome', 'modifications', 'downstream', 'functional', 'consequences', 'genome', 'editing', 'human', 'cells', 'Central', 'effort', 'rigorous', 'innovative', 'approach', 'validation', 'technology', 'third', 'party', 'testing', 'small', 'large', 'animals', 'New', 'genome', 'editors', 'delivery', 'technologies', 'methods', 'cells', 'vivo', 'animal', 'models', 'human', 'biological', 'systems', 'validated', 'datasets', 'biomedical', 'research', 'community', 'toolkit', 'knowledge', 'applications', 'means', 'clinical', 'development', 'new', 'therapies', 'wide', 'range', 'conditions']"
23,23,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103041973&origin=inward,"Muscle weakness, joint laxity and keloids. A more than suggestive association",0,0,0,scopus,[],Ullrich congenital muscular dystrophy,"['Muscle', 'weakness', 'joint', 'laxity', 'keloids', 'more', 'suggestive', 'association']",[]
24,24,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099794094&origin=inward,More than movement: the proprioceptive system as a new regulator of musculoskeletal biology,"¬© 2021The proprioceptive system is essential for the control of coordinated movement and posture. Thus, traditionally, the study of proprioception has focused on its role in motor control. In this review, we present more recent findings on other, non-traditional functions of this system. We focus on its involvement in musculoskeletal development, function and pathology, including the regulation of spinal alignment, bone fracture repair and joint morphogenesis. We present the hypothesis that the proprioceptive system plays a central role in musculoskeletal biology, and that understanding the underlying molecular mechanisms will promote both basic science and medical innovations. As an example, we discuss recent evidence indicating that Piezo2, a key mechanosensitive ion channel of proprioception, regulates spine alignment and joint development. The presented findings show that the proprioceptive system regulates a wide range of developmental and physiological processes and that its dysfunction may contribute to the etiology of various musculoskeletal pathologies.",0,0,scopus,"['process engineering', 'switching systems', 'control systems', 'computer systems', 'development processes', 'switching control', 'social sciences', 'software design', 'education', 'sociology']",Ullrich congenital muscular dystrophy,"['More', 'movement', 'proprioceptive', 'system', 'new', 'regulator', 'musculoskeletal', 'biology']","['proprioceptive', 'system', 'essential', 'control', 'coordinated', 'movement', 'posture', 'study', 'proprioception', 'role', 'motor', 'control', 'review', 'recent', 'findings', 'other', 'non', '-', 'traditional', 'functions', 'system', 'involvement', 'musculoskeletal', 'development', 'function', 'pathology', 'regulation', 'spinal', 'alignment', 'bone', 'fracture', 'repair', 'joint', 'morphogenesis', 'hypothesis', 'proprioceptive', 'system', 'central', 'role', 'musculoskeletal', 'biology', 'molecular', 'mechanisms', 'basic', 'science', 'medical', 'innovations', 'example', 'recent', 'evidence', 'key', 'mechanosensitive', 'ion', 'channel', 'proprioception', 'alignment', 'joint', 'development', 'findings', 'proprioceptive', 'system', 'wide', 'range', 'developmental', 'physiological', 'processes', 'dysfunction', 'etiology', 'various', 'musculoskeletal', 'pathologies']"
25,25,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099481969&origin=inward,COL6A1 related muscular dystrophy in Landseer dogs: A canine model for Ullrich congenital muscular dystrophy,"¬© 2020 Wiley Periodicals LLCBackground: Collagen VI related myopathies are congenital diseases of variable phenotype. The severe phenotype is referred to as Ullrich congenital muscular dystrophy. In this study, we describe analoguos clinical signs and histopathological alterations in Landseer dogs. Materials: We collected clinical data from two affected dogs and investigated the neuromuscular changes in five dogs from two different litters with immunohistochemistry and immunofluorescence. All affected dogs were homozygous for the p.Glu97* nonsense variant in the COL6A1 gene encoding the alpha-1 chain of collagen VI. Results: Muscle biopsies revealed alterations similar to those in human patients with Ullrich congenital muscular dystrophy including the virtual absence of collagen VI in skeletal muscles. Conclusions: The clinical and pathological characterization of the affected Landseer dogs enhances the value of this animal model for human Ullrich congenital muscular dystrophy.",0,0,scopus,"['virtual environments', 'hierarchical system', 'integrated data', 'hierarchical model', 'data integration', 'virtual spaces', 'virtual reality']",Ullrich congenital muscular dystrophy,"['related', 'muscular', 'dystrophy', 'dogs', 'canine', 'model', 'congenital', 'muscular', 'dystrophy']","['related', 'myopathies', 'congenital', 'diseases', 'variable', 'phenotype', 'severe', 'phenotype', 'congenital', 'muscular', 'dystrophy', 'study', 'analoguos', 'clinical', 'signs', 'histopathological', 'alterations', 'dogs', 'Materials', 'clinical', 'data', 'dogs', 'neuromuscular', 'changes', 'dogs', 'different', 'litters', 'immunohistochemistry', 'immunofluorescence', 'dogs', 'homozygous', 'p', 'Glu97', 'nonsense', 'variant', 'COL6A1', 'gene', 'chain', 'collagen', 'Results', 'Muscle', 'biopsies', 'alterations', 'similar', 'human', 'patients', 'congenital', 'muscular', 'dystrophy', 'virtual', 'absence', 'collagen', 'skeletal', 'muscles', 'Conclusions', 'clinical', 'pathological', 'characterization', 'dogs', 'value', 'animal', 'model', 'human', 'congenital', 'muscular', 'dystrophy']"
26,26,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85097085890&origin=inward,A study of the phenotypic variability and disease progression in Laing myopathy through the evaluation of muscle imaging,"¬© 2020 European Academy of NeurologyBackground: Laing myopathy is characterized by broad clinical and pathological variability. They are limited in number and protocol of study. We aimed to delineate muscle imaging profiles and validate imaging analysis as an outcome measure. Methods: This was a cross-sectional and longitudinal cohort study. Data from clinical, functional and semi-quantitative muscle imaging (60 magnetic resonance imaging [MRI] and six computed tomography scans) were studied. Hierarchical analysis, graphic heatmap representation and correlation between imaging and clinical data using Bayesian statistics were carried out. Results: The study cohort comprised 42 patients from 13 families harbouring five MYH7 mutations. The cohort had a wide range of ages, age at onset, disease duration, and myopathy extension and Gardner-Medwin and Walton (GMW) functional scores. Intramuscular fat was evident in all but two asymptomatic/pauci-symptomatic patients. Anterior leg compartment muscles were the only affected muscles in 12% of the patients. Widespread extension to the thigh, hip, paravertebral and calf muscles and, less frequently, the scapulohumeral muscles was commonly observed, depicting distinct patterns and rates of progression. Foot muscles were involved in 40% of patients, evolving in parallel to other regions with absence of a disto-proximal gradient. Whole cumulative imaging score, ranging from 0 to 2.9 out of 4, was associated with disease duration and with myopathy extension and GMW scales. Follow-up MRI studies in 24 patients showed significant score progression at a variable rate. Conclusions: We confirmed that the anterior leg compartment is systematically affected in Laing myopathy and may represent the only manifestation of this disorder. However, widespread muscle involvement in preferential but variable and not distance-dependent patterns was frequently observed. Imaging score analysis is useful to categorize patients and to follow disease progression over time.",0,0,scopus,"['computerized tomography', 'x-ray computed tomography', 'integrated data', 'data integration', 'ranging', 'ultra-wideband (uwb)', 'correlation analysis', 'range finding', 'mathematics', 'parallel coordinates', 'bayesian networks', 'information visualization', 'bayesian']",Ullrich congenital muscular dystrophy,"['study', 'phenotypic', 'variability', 'disease', 'progression', 'myopathy', 'evaluation', 'muscle', 'imaging']","['myopathy', 'broad', 'clinical', 'pathological', 'variability', 'number', 'protocol', 'study', 'muscle', 'profiles', 'analysis', 'outcome', 'measure', 'Methods', 'cross', '-', 'sectional', 'longitudinal', 'cohort', 'study', 'Data', 'clinical', 'functional', 'semi', '-', 'quantitative', 'muscle', 'magnetic', 'resonance', 'tomography', 'scans', 'Hierarchical', 'analysis', 'graphic', 'heatmap', 'representation', 'correlation', 'clinical', 'data', 'Bayesian', 'statistics', 'Results', 'study', 'cohort', 'patients', 'families', 'mutations', 'cohort', 'wide', 'range', 'ages', 'age', 'onset', 'disease', 'duration', 'myopathy', 'extension', 'functional', 'scores', 'Intramuscular', 'fat', 'evident', 'asymptomatic', 'pauci', 'symptomatic', 'patients', 'leg', 'compartment', 'muscles', 'only', 'affected', 'muscles', '%', 'patients', 'Widespread', 'extension', 'thigh', 'hip', 'paravertebral', 'calf', 'muscles', 'scapulohumeral', 'muscles', 'distinct', 'patterns', 'rates', 'progression', 'Foot', 'muscles', '%', 'patients', 'parallel', 'other', 'regions', 'absence', 'disto', 'proximal', 'gradient', 'Whole', 'cumulative', 'imaging', 'score', 'disease', 'duration', 'myopathy', 'extension', 'scales', 'up', 'studies', 'patients', 'significant', 'score', 'progression', 'variable', 'rate', 'Conclusions', 'anterior', 'leg', 'compartment', 'myopathy', 'only', 'manifestation', 'disorder', 'widespread', 'muscle', 'involvement', 'preferential', 'variable', 'distance', 'dependent', 'patterns', 'Imaging', 'score', 'analysis', 'useful', 'patients', 'disease', 'progression', 'time']"
27,27,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103832148&origin=inward,The Role of Autophagy in Skeletal Muscle Diseases,"¬© Copyright ¬© 2021 Xia, Huang, Huang, Zheng, March, Li and Wei.Skeletal muscle is the most abundant type of tissue in human body, being involved in diverse activities and maintaining a finely tuned metabolic balance. Autophagy, characterized by the autophagosome‚Äìlysosome system with the involvement of evolutionarily conserved autophagy-related genes, is an important catabolic process and plays an essential role in energy generation and consumption, as well as substance turnover processes in skeletal muscles. Autophagy in skeletal muscles is finely tuned under the tight regulation of diverse signaling pathways, and the autophagy pathway has cross-talk with other pathways to form feedback loops under physiological conditions and metabolic stress. Altered autophagy activity characterized by either increased formation of autophagosomes or inhibition of lysosome-autophagosome fusion can lead to pathological cascades, and mutations in autophagy genes and deregulation of autophagy pathways have been identified as one of the major causes for a variety of skeleton muscle disorders. The advancement of multi-omics techniques enables further understanding of the molecular and biochemical mechanisms underlying the role of autophagy in skeletal muscle disorders, which may yield novel therapeutic targets for these disorders.",0,0,scopus,"['medial axis', 'multitarget', 'feedback systems', 'geometry', 'sensors', 'fusion techniques', 'fusion reactions', 'fusion methods', 'voronoi diagrams', 'multiple classifiers', 'multiple targets', 'biometrics', 'fusion algorithms', 'data fusion', 'multi-target tracking', 'nuclear physics', 'energy conservation', 'correlation analysis', 'optimization problems', 'remote control', 'target tracking', 'computer systems', 'topology', 'classifier fusion', 'control loop', 'energy utilization', 'image fusion']",Ullrich congenital muscular dystrophy,[],"['Copyright', 'Skeletal', 'muscle', 'abundant', 'type', 'tissue', 'human', 'body', 'diverse', 'activities', 'metabolic', 'balance', 'autophagosome', '‚Äì', 'lysosome', 'system', 'involvement', 'autophagy', 'genes', 'important', 'catabolic', 'process', 'essential', 'role', 'energy', 'generation', 'consumption', 'substance', 'turnover', 'processes', 'skeletal', 'muscles', 'skeletal', 'muscles', 'tight', 'regulation', 'diverse', 'signaling', 'pathways', 'autophagy', 'pathway', 'cross', '-', 'talk', 'other', 'pathways', 'feedback', 'loops', 'physiological', 'conditions', 'metabolic', 'stress', 'Altered', 'autophagy', 'activity', 'formation', 'autophagosomes', 'inhibition', 'lysosome', 'autophagosome', 'fusion', 'pathological', 'cascades', 'mutations', 'autophagy', 'genes', 'deregulation', 'autophagy', 'pathways', 'major', 'causes', 'variety', 'skeleton', 'muscle', 'disorders', 'advancement', 'multi', '-', 'omics', 'techniques', 'further', 'understanding', 'molecular', 'biochemical', 'mechanisms', 'role', 'autophagy', 'skeletal', 'muscle', 'disorders', 'novel', 'therapeutic', 'targets', 'disorders']"
28,28,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102724906&origin=inward,Association of Initial Maximal Motor Ability With Long-term Functional Outcome in Patients With COL6-Related Dystrophies,"¬© 2021 American Academy of Neurology.OBJECTIVE: To accurately categorize the phenotypes of individuals with collagen VI-related dystrophies (COL6-RDs) during the first years of life to predict long-term motor function and pulmonary function, to provide phenotype-specific anticipatory care, and to improve clinical trial readiness. METHODS: This retrospective, multicenter, international study analyzed the relationship of long-term motor and pulmonary function with the initial maximal motor ability achieved in individuals with COL6-RD. RESULTS: We studied 119 patients with COL6-RD from Spain (n = 54) and the United States (n = 65). The early maximal motor milestones of ability to rise from the floor unassisted and ability to climb 4 steps without holding onto a railing demonstrated reliability in distinguishing between 3 COL6-RD phenotypic subgroups: (1) Ullrich congenital muscular dystrophy, (2) intermediate COL6-RD, and (3) Bethlem myopathy. Long-term motor function and pulmonary function are strongly correlated with the maximal motor ability achieved during the first years of life. Maximal motor capacity can predict other disease-relevant events such as the age at loss of ambulation and the need for the initiation of nocturnal noninvasive ventilation. CONCLUSION: This work proposes a prospective phenotypic classification for COL6-RDs that will enable an accurate prediction of a patient's COL6-RD phenotype during the first years of life. The ability to establish a patient's COL6-RD phenotypic classification early will enable a more accurate prognosis of future motor and pulmonary function, thus improving anticipatory clinical care, and it will be instrumental in aiding the design of future clinical trials by allowing early stratification of trial cohorts.",0,0,scopus,"['computer systems', 'classification methods', 'automatic classification', 'classifiers', 'classification models', 'supervised classification', 'image classification', 'support vector machine']",Ullrich congenital muscular dystrophy,"['Long', 'term', 'COL6-Related', 'Dystrophies']","['phenotypes', 'individuals', 'collagen', 'VI', 'dystrophies', 'first', 'years', 'life', 'long', 'term', 'motor', 'function', 'pulmonary', 'function', 'phenotype', 'specific', 'anticipatory', 'care', 'clinical', 'trial', 'readiness', 'METHODS', 'retrospective', 'multicenter', 'international', 'study', 'relationship', 'long', 'term', 'motor', 'pulmonary', 'function', 'initial', 'maximal', 'motor', 'ability', 'individuals', 'RESULTS', 'patients', 'early', 'maximal', 'motor', 'milestones', 'ability', 'floor', 'ability', 'steps', 'reliability', 'phenotypic', 'subgroups', 'congenital', 'muscular', 'dystrophy', 'intermediate', 'myopathy', 'Long', 'term', 'motor', 'function', 'pulmonary', 'function', 'maximal', 'motor', 'ability', 'first', 'years', 'life', 'Maximal', 'motor', 'capacity', 'other', 'disease', 'relevant', 'events', 'such', 'age', 'loss', 'ambulation', 'need', 'initiation', 'nocturnal', 'noninvasive', 'ventilation', 'CONCLUSION', 'work', 'prospective', 'phenotypic', 'classification', 'COL6-RDs', 'accurate', 'prediction', 'patient', 'COL6-RD', 'phenotype', 'first', 'years', 'life', 'ability', 'patient', 'phenotypic', 'classification', 'accurate', 'prognosis', 'future', 'motor', 'pulmonary', 'function', 'anticipatory', 'clinical', 'care', 'instrumental', 'design', 'future', 'clinical', 'trials', 'early', 'stratification', 'trial', 'cohorts']"
29,29,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105530045&origin=inward,Utility of immunohistochemistry and western blot in profiling clinically suspected cases of congenital muscular dystrophy,"¬© 2021 Wolters Kluwer Medknow Publications. All rights reserved.Objective: Immunocharacterization of congenital muscular dystrophy (CMD) to determine the frequency of various subtypes in a large Indian Cohort. Materials and Methods: This retrospective (2014-2017) study was carried on muscle biopsies of clinically suspected cases of CMD with histological evidence of dystrophy/myopathic features. Immunohistochemistry (IHC) to antibodies against laminin (Œ±2, Œ±5,Œ≤1,Œ≥1), Collagen-VI (A1,2,3), and Western blot (WB) for Œ±-dystroglycan and POMT1 was performed. Results: The study included 57 cases, of which 15 cases (26.3%) had mean age at presentation of 3.5 years, M: F = 1.5:1, elevated creatinine kinase (CK) (mean 1657 U/L), global developmental delay, multiple contractures, abnormal facies, white matter hyperintensities and showed laminin-Œ±2 deficiency (Merosin deficient CMD). In addition, secondary reduction in laminin-Œ≤1, over-expression of laminin-Œ±5, and preserved laminin-Œ≥1 was noted. Ullrich CMD constituted 11/57 cases (19.2%) with mean age at presentation of 5.3 years, M: F = 1.2:1 and normal CK. They presented with proximal muscle weakness, soft velvety palms and soles, contractures, and joint hyperextensibility. Collagen-VI (A1,2,3) showed either complete (n = 3) or sarcolemmal specific (n = 8) loss of staining. Out of the remaining 31 cases, WB for Œ±-dystroglycan was performed in 17 cases which showed deficiency in seven (12.3%). Three of these in addition revealed secondary partial loss of laminin-Œ±2. WB for POMT1 showed deficiency in a single case clinically diagnosed Walker-Warburg syndrome, who presented with seizures and classical features of pachygyria, lissencephaly, and cerebellar cyst on MRI. Twenty-four cases (42.2%) remained uncharacterized and need genetic evaluation. Conclusion: The study helped in characterizing 57.8% of the proband. Immunotyping helps to direct mutational analysis for targeted genes and offers a potential route for prenatal diagnosis.",0,0,scopus,"['digital rights', 'feature space', 'digital rights management', 'access control', 'classification methods', 'routing algorithms', 'routing scheme', 'security systems', 'propagation delays', 'network protocols', 'pattern recognition', 'access rights', 'routing protocols']",Ullrich congenital muscular dystrophy,"['Utility', 'immunohistochemistry', 'western', 'blot', 'cases', 'congenital', 'muscular', 'dystrophy']","['rights', 'Objective', 'Immunocharacterization', 'congenital', 'muscular', 'dystrophy', 'frequency', 'various', 'subtypes', 'large', 'Indian', 'Materials', 'retrospective', 'study', 'muscle', 'biopsies', 'cases', 'histological', 'evidence', 'dystrophy', 'myopathic', 'features', 'antibodies', 'laminin', 'Western', 'blot', 'Œ±', 'dystroglycan', 'Results', 'study', 'cases', 'cases', '%', 'mean', 'age', 'presentation', 'years', 'elevated', 'creatinine', 'kinase', 'CK', 'global', 'developmental', 'delay', 'multiple', 'contractures', 'abnormal', 'facies', 'white', 'matter', 'hyperintensities', 'laminin', 'Œ±2', 'deficiency', 'deficient', 'addition', 'secondary', 'reduction', 'laminin', 'Œ≤1', 'expression', 'laminin', 'Œ±5', 'laminin', 'cases', '%', 'mean', 'age', 'presentation', 'years', 'normal', 'CK', 'proximal', 'muscle', 'weakness', 'soft', 'velvety', 'palms', 'soles', 'contractures', 'joint', 'hyperextensibility', 'A1,2,3', 'complete', 'sarcolemmal', 'specific', 'loss', 'staining', 'cases', 'Œ±', 'dystroglycan', 'cases', 'deficiency', '%', 'addition', 'secondary', 'partial', 'loss', 'laminin', 'Œ±2', 'deficiency', 'single', 'case', 'syndrome', 'seizures', 'classical', 'features', 'pachygyria', 'lissencephaly', 'cerebellar', 'cyst', 'cases', '%', 'uncharacterized', 'genetic', 'evaluation', 'Conclusion', 'study', '%', 'proband', 'mutational', 'analysis', 'genes', 'potential', 'route', 'prenatal', 'diagnosis']"
30,30,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100959634&origin=inward,Gene expression profile of human follicle dermal papilla cells in response to Camellia japonica phytoplacenta extract,"¬© 2021 The Authors. FEBS Open Bio published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.Camellia japonica L. is a flowering tree with several medicinal and cosmetic applications. Here, we investigated the efficacy of C. japonica placenta extract (CJPE) as a potential therapeutic agent for promotion of hair growth and scalp health by using various in vitro and in vivo assays. Moreover, we performed transcriptome analysis to examine the relative expression of human follicle dermal papilla cells (HFDPC) in response to CJPE by RNA-sequencing (RNA-seq). In vitro assays revealed upregulation of the expression of hair growth marker genes in HFDPC after CJPE treatment. Moreover, in vivo clinical tests with 42 adult female participants showed that a solution containing 0.5% CJPE increased the moisture content of the scalp and decreased the scalp's sebum content, dead scalp keratin, and erythema. Furthermore, RNA-seq analysis revealed key genes in HFDPC which are associated with CJPE. Interestingly, genes associated with lipid metabolism and cholesterol efflux were upregulated. Genes upregulated by CJPE are associated with several hormones, including parathyroid, adrenocorticotropic hormone, Œ±-melanocyte-stimulating hormone (alpha-MSH), and norepinephrine, which are involved in hair follicle biology. Furthermore, some upregulated genes are associated with the regulation of axon guidance. In contrast, many genes downregulated by CJPE are associated with structural components of the cytoskeleton. In addition, CJPE suppressed genes associated with muscle structure and development. Taken together, this study provides extensive evidence that CJPE may have potential as a therapeutic agent for scalp treatment and hair growth promotion.",0,0,scopus,"['software', 'rijndael', 'digital contents', 'multiagent system', 'cryptography', 'multimedia contents', 'world wide web', 'software agents', 'correlation analysis', 'intelligent agents', 'mathematics', 'agent based', 'multimedia services', 'block ciphers', 'component', 'data encryption standard', 'digital rights management', 'security of data', 'web page', 'autonomous agents']",Ullrich congenital muscular dystrophy,"['Gene', 'expression', 'profile', 'human', 'follicle', 'dermal', 'papilla', 'cells', 'response', 'japonica', 'phytoplacenta', 'extract']","['behalf', 'tree', 'several', 'medicinal', 'cosmetic', 'applications', 'efficacy', 'japonica', 'placenta', 'extract', 'potential', 'therapeutic', 'agent', 'promotion', 'hair', 'growth', 'scalp', 'health', 'various', 'vivo', 'assays', 'transcriptome', 'analysis', 'relative', 'expression', 'human', 'follicle', 'dermal', 'papilla', 'cells', 'response', 'RNA', 'vitro', 'assays', 'upregulation', 'expression', 'hair', 'growth', 'marker', 'genes', 'treatment', 'vivo', 'clinical', 'tests', 'adult', 'female', 'participants', 'solution', '%', 'moisture', 'content', 'scalp', 'scalp', 'sebum', 'content', 'dead', 'scalp', 'keratin', 'erythema', 'RNA', 'seq', 'analysis', 'key', 'genes', 'genes', 'lipid', 'metabolism', 'cholesterol', 'efflux', 'Genes', 'several', 'hormones', 'parathyroid', 'adrenocorticotropic', 'hormone', 'Œ±', 'melanocyte', 'hormone', 'alpha', 'norepinephrine', 'hair', 'follicle', 'biology', 'upregulated', 'genes', 'regulation', 'axon', 'guidance', 'contrast', 'many', 'genes', 'structural', 'components', 'cytoskeleton', 'addition', 'genes', 'muscle', 'structure', 'development', 'study', 'extensive', 'evidence', 'potential', 'therapeutic', 'agent', 'scalp', 'treatment', 'hair', 'growth', 'promotion']"
31,31,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100399097&origin=inward,Skeletal muscle mitochondria in health and disease,"¬© 2021 Elsevier LtdMitochondrial activity warrants energy supply to oxidative myofibres to sustain endurance workload. The maintenance of mitochondrial homeostasis is ensured by the control of fission and fusion processes and by the mitophagic removal of aberrant organelles. Many diseases are due to or characterized by dysfunctional mitochondria, and altered mitochondrial dynamics or turnover trigger myopathy per se. In this review, we will tackle the role of mitochondrial dynamics, turnover and metabolism in skeletal muscle, both in health and disease.",0,0,scopus,"['switching systems', 'control systems', 'computer systems', 'stochastic processes', 'maintenance process', 'data fusion', 'switching control', 'computer software maintenance', 'sensors', 'stochastic dynamics']",Ullrich congenital muscular dystrophy,"['Skeletal', 'muscle', 'mitochondria', 'health', 'disease']","['activity', 'supply', 'oxidative', 'myofibres', 'endurance', 'workload', 'maintenance', 'mitochondrial', 'homeostasis', 'control', 'fission', 'fusion', 'processes', 'mitophagic', 'removal', 'aberrant', 'organelles', 'Many', 'diseases', 'due', 'dysfunctional', 'mitochondria', 'mitochondrial', 'dynamics', 'turnover', 'trigger', 'myopathy', 'review', 'role', 'mitochondrial', 'dynamics', 'turnover', 'metabolism', 'skeletal', 'muscle', 'health', 'disease']"
32,32,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099928555&origin=inward,Treatment with a triazole inhibitor of the mitochondrial permeability transition pore fully corrects the pathology of sapje zebrafish lacking dystrophin,"¬© 2021High-throughput screening identified isoxazoles as potent but metabolically unstable inhibitors of the mitochondrial permeability transition pore (PTP). Here we have studied the effects of a metabolically stable triazole analog, TR001, which maintains the PTP inhibitory properties with an in vitro potency in the nanomolar range. We show that TR001 leads to recovery of muscle structure and function of sapje zebrafish, a severe model of Duchenne muscular dystrophy (DMD). PTP inhibition fully restores the otherwise defective respiration in vivo, allowing normal development of sapje individuals in spite of lack of dystrophin. About 80 % sapje zebrafish treated with TR001 are alive and normal at 18 days post fertilization (dpf), a point in time when not a single untreated sapje individual survives. Time to 50 % death of treated zebrafish increases from 5 to 28 dpf, a sizeable number of individuals becoming young adults in spite of the persistent lack of dystrophin expression. TR001 improves respiration of myoblasts and myotubes from DMD patients, suggesting that PTP-dependent dysfunction also occurs in the human disease and that mitochondrial therapy of DMD with PTP-inhibiting triazoles is a viable treatment option.",0,0,scopus,"['hierarchical model', 'digital signals', 'analog signals', 'hierarchical system']",Ullrich congenital muscular dystrophy,"['Treatment', 'triazole', 'inhibitor', 'mitochondrial', 'permeability', 'transition', 'pore', 'pathology', 'sapje', 'zebrafish']","['¬©', '2021High', 'throughput', 'screening', 'isoxazoles', 'potent', 'unstable', 'inhibitors', 'mitochondrial', 'permeability', 'transition', 'pore', 'effects', 'stable', 'triazole', 'analog', 'TR001', 'inhibitory', 'properties', 'potency', 'nanomolar', 'range', 'recovery', 'muscle', 'structure', 'function', 'sapje', 'zebrafish', 'severe', 'model', 'muscular', 'dystrophy', 'PTP', 'inhibition', 'defective', 'respiration', 'vivo', 'normal', 'development', 'sapje', 'individuals', 'spite', 'lack', 'dystrophin', '%', 'sapje', 'zebrafish', 'alive', 'normal', 'days', 'post', 'fertilization', 'dpf', 'point', 'time', 'single', 'untreated', 'sapje', 'individual', 'survives', 'Time', '%', 'death', 'zebrafish', 'increases', 'dpf', 'sizeable', 'number', 'individuals', 'young', 'adults', 'spite', 'persistent', 'lack', 'dystrophin', 'expression', 'TR001', 'respiration', 'myoblasts', 'myotubes', 'DMD', 'patients', 'dependent', 'dysfunction', 'human', 'disease', 'mitochondrial', 'therapy', 'triazoles', 'viable', 'treatment', 'option']"
33,33,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85098495578&origin=inward,Essential roles of the dystrophin-glycoprotein complex in different cardiac pathologies,"¬© 2020 The AuthorsThe dystrophin-glycoprotein complex (DGC), situated at the sarcolemma dynamically remodels during cardiac disease. This review examines DGC remodeling as a common denominator in diseases affecting heart function and health. Dystrophin and the DGC serve as broad cytoskeletal integrators that are critical for maintaining stability of muscle membranes. The presence of pathogenic variants in genes encoding proteins of the DGC can cause absence of the protein and/or alterations in other complex members leading to muscular dystrophies. Targeted studies have allowed the individual functions of affected proteins to be defined. The DGC has demonstrated its dynamic function, remodeling under a number of conditions that stress the heart. Beyond genetic causes, pathogenic processes also impinge on the DGC, causing alterations in the abundance of dystrophin and associated proteins during cardiac insult such as ischemia-reperfusion injury, mechanical unloading, and myocarditis. When considering new therapeutic strategies, it is important to assess DGC remodeling as a common factor in various heart diseases. The DGC connects the internal F-actin‚Äìbased cytoskeleton to laminin-211 of the extracellular space, playing an important role in the transmission of mechanical force to the extracellular matrix. The essential functions of dystrophin and the DGC have been long recognized. DGC based therapeutic approaches have been primarily focused on muscular dystrophies, however it may be a beneficial target in a number of disorders that affect the heart. This review provides an account of what we now know, and discusses how this knowledge can benefit persistent health conditions in the clinic.",0,0,scopus,"['stability criteria', 'control system stability', 'asymptotic stability', 'global stability', 'machine design', 'numerical example', 'linear matrix inequalities', 'mechanical systems', 'asymptotical stability', 'lyapunov functions', 'adaptive control systems', 'delay control systems', 'sufficient conditions', 'global asymptotic stability']",Ullrich congenital muscular dystrophy,"['Essential', 'roles', 'glycoprotein', 'complex', 'different', 'cardiac', 'pathologies']","['glycoprotein', 'complex', 'sarcolemma', 'cardiac', 'disease', 'review', 'common', 'denominator', 'diseases', 'heart', 'function', 'health', 'broad', 'cytoskeletal', 'integrators', 'critical', 'stability', 'muscle', 'membranes', 'presence', 'pathogenic', 'variants', 'genes', 'proteins', 'absence', 'protein', 'alterations', 'other', 'complex', 'members', 'muscular', 'dystrophies', 'Targeted', 'studies', 'individual', 'functions', 'affected', 'proteins', 'dynamic', 'function', 'number', 'conditions', 'heart', 'genetic', 'causes', 'pathogenic', 'processes', 'alterations', 'abundance', 'dystrophin', 'proteins', 'cardiac', 'insult', 'such', 'ischemia', 'reperfusion', 'injury', 'mechanical', 'unloading', 'myocarditis', 'new', 'therapeutic', 'strategies', 'important', 'remodeling', 'common', 'factor', 'various', 'heart', 'diseases', 'internal', 'cytoskeleton', 'laminin-211', 'extracellular', 'space', 'important', 'role', 'transmission', 'mechanical', 'force', 'extracellular', 'matrix', 'essential', 'functions', 'dystrophin', 'therapeutic', 'approaches', 'muscular', 'dystrophies', 'beneficial', 'target', 'number', 'disorders', 'heart', 'review', 'account', 'knowledge', 'persistent', 'health', 'conditions', 'clinic']"
34,34,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096679214&origin=inward,Novel Protein Biomarkers of Monoamine Metabolism Defects Correlate with Disease Severity,"¬© 2020 International Parkinson and Movement Disorder SocietyBackground: Genetic defects of monoamine neurotransmitters are rare neurological diseases amenable to treatment with variable response. They are major causes of early parkinsonism and other spectrum of movement disorders including dopa-responsive dystonia. Objectives: The objective of this study was to conduct proteomic studies in cerebrospinal fluid (CSF) samples of patients with monoamine defects to detect biomarkers involved in pathophysiology, clinical phenotypes, and treatment response. Methods: A total of 90 patients from diverse centers of the International Working Group on Neurotransmitter Related Disorders were included in the study (37 untreated before CSF collection, 48 treated and 5 unknown at the collection time). Clinical and molecular metadata were related to the protein abundances in the CSF. Results: Concentrations of 4 proteins were significantly altered, detected by mass spectrometry, and confirmed by immunoassays. First, decreased levels of apolipoprotein D were found in severe cases of aromatic L-amino acid decarboxylase deficiency. Second, low levels of apolipoprotein H were observed in patients with the severe phenotype of tyrosine hydroxylase deficiency, whereas increased concentrations of oligodendrocyte myelin glycoprotein were found in the same subset of patients with tyrosine hydroxylase deficiency. Third, decreased levels of collagen6A3 were observed in treated patients with tetrahydrobiopterin deficiency. Conclusion: This study with the largest cohort of patients with monoamine defects studied so far reports the proteomic characterization of CSF and identifies 4 novel biomarkers that bring new insights into the consequences of early dopaminergic deprivation in the developing brain. They open new possibilities to understand their role in the pathophysiology of these disorders, and they may serve as potential predictors of disease severity and therapies. ¬© 2020 International Parkinson and Movement Disorder Society.",0,0,scopus,"['spectrum sensing', 'semantic metadata', 'world wide web', 'viscous flow', 'computer science', 'frequency bands', 'non-newtonian fluids', 'ontology', 'cognitive radio network', 'dynamic spectrum access', 'bioinformatics', 'antennas', 'dynamic spectrum']",Ullrich congenital muscular dystrophy,['Defects'],"['Genetic', 'defects', 'monoamine', 'neurotransmitters', 'rare', 'neurological', 'diseases', 'amenable', 'treatment', 'variable', 'response', 'major', 'causes', 'early', 'parkinsonism', 'other', 'spectrum', 'movement', 'disorders', 'dopa', 'responsive', 'dystonia', 'Objectives', 'objective', 'study', 'proteomic', 'studies', 'cerebrospinal', 'fluid', 'CSF', 'samples', 'patients', 'monoamine', 'defects', 'biomarkers', 'pathophysiology', 'clinical', 'phenotypes', 'treatment', 'response', 'Methods', 'total', 'patients', 'diverse', 'centers', 'study', 'untreated', 'CSF', 'collection', 'unknown', 'collection', 'time', 'Clinical', 'molecular', 'metadata', 'protein', 'abundances', 'CSF', 'Results', 'Concentrations', 'proteins', 'mass', 'spectrometry', 'immunoassays', 'levels', 'apolipoprotein', 'D', 'severe', 'cases', 'aromatic', 'L', 'amino', 'acid', 'decarboxylase', 'deficiency', 'Second', 'low', 'levels', 'apolipoprotein', 'patients', 'severe', 'phenotype', 'tyrosine', 'hydroxylase', 'deficiency', 'concentrations', 'oligodendrocyte', 'myelin', 'glycoprotein', 'same', 'subset', 'patients', 'tyrosine', 'hydroxylase', 'deficiency', 'levels', 'collagen6A3', 'patients', 'tetrahydrobiopterin', 'deficiency', 'Conclusion', 'study', 'largest', 'cohort', 'patients', 'monoamine', 'defects', 'proteomic', 'characterization', 'CSF', 'identifies', 'novel', 'biomarkers', 'new', 'insights', 'consequences', 'early', 'dopaminergic', 'deprivation', 'brain', 'new', 'possibilities', 'role', 'pathophysiology', 'disorders', 'potential', 'predictors', 'disease', 'severity', 'therapies']"
35,35,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102546276&origin=inward,Clinical Characteristics and Genetic Analysis of Klippel-Feil Syndrome,"¬© 2021 Chinese Academy of Medical Sciences. All rights reserved.Objective To summarize clinical characteristics and investigate possible pathogenic gene of Klippel-Feil syndrome(KFS)by the self-designed multigene panel sequencing,so as to decipher the molecular basis for early diagnosis and targeted therapy.Methods From January 2015 to December 2018,we consecutively recruited 25 patients who were diagnosed with KFS in Peking Union Medical College Hospital.The demographic information,clinical manifestations,physical examination and radiological assessments were analyzed.Multigene panel sequencing was performed after DNA extraction from peripheral blood.The possible pathogenic mutations of KFS were explored on the basis of bioinformatics analysis.Results The KFS cohort consisted of 25 patients,including 15 males and 10 females,with a mean age of(12.9¬±7.3)years.Limited cervical range of motion was the most common clinical feature(12 cases,48%).Based on the Samartzis classification,the proportion of patients suffered from short neck(P=0.031)and limited cervical range of motion(P=0.026)in type ? KFS was significantly higher than that in type ? and type ? KFS.Panel sequencing detected a total of 11 pathogenic missense mutations in eight patients,including COL6A1,COL6A2,CDAN1,GLI3,FLNB,CHRNG,MYH3,POR,and TNXB.There was no pathogenic mutation found in five reported pathogenic genes(GDF6,MEOX1,GDF3,MYO18B and RIPPLY2)associated with KFS.Conclusions Our study has shown that patients with multiple contiguous cervical fusions are more likely to manifest short neck,limited cervical range of motion,and clinical triad.Therefore,these patients need additional attention and follow-up.Our analysis highlights novel KFS-related genetic variants,such as COL6A and CDAN1,extending the spectrum of known mutations contributing to this syndrome and providing a basis for elucidating the pathogenesis of KFS.",0,0,scopus,"['computer science', 'classification methods', 'motion estimation', 'classification models', 'motion analysis', 'correlation analysis', 'image analysis', 'motion models', 'bioinformatics', 'mathematics']",Ullrich congenital muscular dystrophy,['Syndrome'],"['rights', 'Objective', 'clinical', 'characteristics', 'possible', 'pathogenic', 'gene', 'self', 'multigene', 'panel', 'sequencing', 'molecular', 'basis', 'early', 'diagnosis', 'therapy', 'Methods', 'patients', 'demographic', 'information', 'clinical', 'manifestations', 'physical', 'examination', 'radiological', 'assessments', 'Multigene', 'panel', 'sequencing', 'DNA', 'extraction', 'peripheral', 'blood', 'possible', 'pathogenic', 'mutations', 'basis', 'bioinformatics', 'analysis', 'Results', 'cohort', 'patients', 'males', 'females', 'mean', 'age', 'of(12.9¬±7.3)years', 'Limited', 'cervical', 'range', 'motion', 'common', 'clinical', 'feature(12', 'classification', 'proportion', 'patients', 'short', 'limited', 'cervical', 'range', 'type', 'higher', 'type', 'type', 'KFS.Panel', 'sequencing', 'total', 'pathogenic', 'missense', 'mutations', 'patients', 'pathogenic', 'mutation', 'pathogenic', 'study', 'patients', 'multiple', 'contiguous', 'cervical', 'fusions', 'likely', 'short', 'neck', 'limited', 'cervical', 'range', 'motion', 'clinical', 'triad', 'patients', 'additional', 'attention', 'follow', 'up', 'analysis', 'novel', 'genetic', 'variants', 'such', 'spectrum', 'mutations', 'syndrome', 'basis', 'pathogenesis']"
36,36,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101235295&origin=inward,"Mitochondrial dynamics: Molecular mechanisms, related primary mitochondrial disorders and therapeutic approaches","¬© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Mitochondria do not exist as individual entities in the cell‚Äîconversely, they constitute an interconnected community governed by the constant and opposite process of fission and fusion. The mitochondrial fission leads to the formation of smaller mitochondria, promoting the biogenesis of new organelles. On the other hand, following the fusion process, mitochondria appear as longer and interconnected tubules, which enhance the communication with other organelles. Both fission and fusion are carried out by a small number of highly conserved guanosine triphosphatase proteins and their interactors. Disruption of this equilibrium has been associated with several pathological condi-tions, ranging from cancer to neurodegeneration, and mutations in genes involved in mitochondrial fission and fusion have been reported to be the cause of a subset of neurogenetic disorders.",0,0,scopus,"['fusion techniques', 'fusion reactions', 'communication', 'data fusion', 'nuclear physics', 'ranging', 'fusion process', 'ultra-wideband (uwb)', 'fusion methods', 'sensors', 'image fusion', 'range finding', 'biometrics']",Ullrich congenital muscular dystrophy,"['Mitochondrial', 'dynamics', 'Molecular', 'mechanisms', 'related', 'primary', 'mitochondrial', 'disorders', 'therapeutic', 'approaches']","['authors', 'individual', 'entities', 'cell', 'community', 'constant', 'opposite', 'process', 'fission', 'fusion', 'mitochondrial', 'fission', 'formation', 'smaller', 'mitochondria', 'biogenesis', 'new', 'organelles', 'other', 'hand', 'fusion', 'process', 'mitochondria', 'tubules', 'communication', 'other', 'organelles', 'fission', 'fusion', 'small', 'number', 'guanosine', 'triphosphatase', 'proteins', 'interactors', 'Disruption', 'equilibrium', 'several', 'pathological', 'tions', 'cancer', 'neurodegeneration', 'mutations', 'genes', 'mitochondrial', 'fission', 'fusion', 'cause', 'subset', 'neurogenetic', 'disorders']"
37,37,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100706743&origin=inward,"Unraveling molecular pathways altered in mecp2-related syndromes, in the search for new potential avenues for therapy","¬© 2021 by the authors. Licensee MDPI, Basel, Switzerland.Methyl-CpG-binding protein 2 (MeCP2) is an X-linked epigenetic modulator whose dosage is critical for neural development and function. Loss-of-function mutations in MECP2 cause Rett Syndrome (RTT, OMIM #312750) while duplications in the Xq28 locus containing MECP2 and Interleukin-1 receptor-associated kinase 1 (IRAK1) cause MECP2 duplication syndrome (MDS, OMIM #300260). Both are rare neurodevelopmental disorders that share clinical symptoms, including intellectual disability, loss of speech, hand stereotypies, vasomotor deficits and seizures. The main objective of this exploratory study is to identify novel signaling pathways and potential quantitative biomarkers that could aid early diagnosis and/or the monitoring of disease progression in clinical trials. We analyzed by RT-PCR gene expression in whole blood and microRNA (miRNA) expression in plasma, in a cohort of 20 females with Rett syndrome, 2 males with MECP2 duplication syndrome and 28 healthy controls, and correlated RNA expression with disease and clinical parameters. We have identified a set of potential biomarker panels for RTT diagnostic and disease stratification of patients with microcephaly and vasomotor deficits. Our study sets the basis for larger studies leading to the identification of specific miRNA signatures for early RTT detection, stratification, disease progression and segregation from other neurodevelopmental disorders. Nevertheless, these data will require verification and validation in further studies with larger sample size including a whole range of ages.",0,0,scopus,"['tcp', 'validation', 'rtt', 'verification', 'verification and validation', 'round-trip time', 'congestion window', 'transmission control protocol']",Ullrich congenital muscular dystrophy,"['molecular', 'pathways', 'mecp2-related', 'syndromes', 'search', 'new', 'potential', 'avenues', 'therapy']","['authors', 'protein', 'X', 'epigenetic', 'modulator', 'dosage', 'critical', 'neural', 'development', 'function', 'Loss', 'function', 'mutations', 'RTT', 'OMIM', 'duplications', 'locus', 'receptor', 'kinase', 'MECP2', 'duplication', 'syndrome', 'OMIM', 'rare', 'neurodevelopmental', 'disorders', 'clinical', 'symptoms', 'intellectual', 'disability', 'loss', 'speech', 'hand', 'stereotypies', 'vasomotor', 'deficits', 'seizures', 'main', 'objective', 'exploratory', 'study', 'novel', 'pathways', 'potential', 'quantitative', 'biomarkers', 'early', 'diagnosis', 'monitoring', 'disease', 'progression', 'clinical', 'trials', 'gene', 'expression', 'whole', 'blood', 'expression', 'plasma', 'cohort', 'females', 'syndrome', 'males', 'MECP2', 'duplication', 'syndrome', 'healthy', 'controls', 'expression', 'disease', 'clinical', 'parameters', 'set', 'potential', 'biomarker', 'panels', 'RTT', 'diagnostic', 'disease', 'stratification', 'patients', 'microcephaly', 'vasomotor', 'deficits', 'study', 'basis', 'larger', 'studies', 'identification', 'specific', 'signatures', 'early', 'RTT', 'detection', 'stratification', 'disease', 'progression', 'segregation', 'other', 'neurodevelopmental', 'disorders', 'data', 'verification', 'validation', 'further', 'studies', 'larger', 'sample', 'size', 'whole', 'range', 'ages']"
38,38,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100549317&origin=inward,Congenital malformations in sea turtles: Puzzling interplay between genes and environment,"¬© 2021 by the authors. Licensee MDPI, Basel, Switzerland.The completion of embryonic development depends, in part, on the interplay between genetic factors and environmental conditions, and any alteration during development may affect embryonic genetic and epigenetic regulatory pathways leading to congenital malformations, which are mostly incompatible with life. Oviparous reptiles, such as sea turtles, that produce numerous eggs in a clutch that is buried on the beach provide an opportunity to study embryonic mortality associated with malformations that occur at different times during development, or that prevent the hatchling from emerging from the nest. In sea turtles, the presence of congenital malformations frequently leads to mortality. A few years ago, a detailed study was performed on external congenital malformations in three species of sea turtles from the Mexican Pacific and Caribbean coasts, the hawksbill turtle, Eretmochelys imbricata (n = 23,559 eggs), the green turtle, Chelonia mydas (n = 17,690 eggs), and the olive ridley, Lepidochelys olivacea (n = 20,257 eggs), finding 63 types of congenital malformations, of which 38 were new reports. Of the three species, the olive ridley showed a higher incidence of severe anomalies in the craniofacial region (49%), indicating alterations of early developmental pathways; however, several malformations were also observed in the body, including defects in the carapace (45%) and limbs (33%), as well as pigmentation disorders (20%), indicating that deviations occurred during the middle and later stages of development. Although intrinsic factors (i.e., genetic mutations or epigenetic modifications) are difficult to monitor in the field, some environmental factors (such as the incubation temperature, humidity, and probably the status of feeding areas) are, to some extent, less difficult to monitor and/or control. In this review, we describe the aetiology of different malformations observed in sea turtle embryos, and provide some actions that can reduce embryonic mortality.",0,0,scopus,"['clutch', 'anomalous behavior', 'image retrieval', 'discrete cosine transforms', 'gear', 'clutches', 'anomaly detection', 'gears', 'gear teeth']",Ullrich congenital muscular dystrophy,"['Congenital', 'malformations', 'sea', 'turtles', 'interplay', 'genes', 'environment']","['authors', 'completion', 'embryonic', 'development', 'part', 'interplay', 'genetic', 'factors', 'environmental', 'conditions', 'alteration', 'development', 'embryonic', 'genetic', 'epigenetic', 'regulatory', 'pathways', 'congenital', 'malformations', 'incompatible', 'life', 'Oviparous', 'reptiles', 'such', 'sea', 'turtles', 'numerous', 'eggs', 'clutch', 'beach', 'opportunity', 'embryonic', 'mortality', 'malformations', 'different', 'times', 'development', 'hatchling', 'nest', 'sea', 'turtles', 'presence', 'congenital', 'malformations', 'mortality', 'few', 'years', 'detailed', 'study', 'external', 'congenital', 'malformations', 'species', 'sea', 'turtles', 'Caribbean', 'coasts', 'hawksbill', 'turtle', 'imbricata', 'eggs', 'green', 'turtle', 'mydas', 'eggs', 'olive', 'ridley', 'olivacea', 'eggs', 'types', 'congenital', 'malformations', 'new', 'reports', 'species', 'olive', 'ridley', 'higher', 'incidence', 'severe', 'anomalies', 'craniofacial', 'region', '%', 'alterations', 'early', 'developmental', 'pathways', 'several', 'malformations', 'body', 'defects', 'carapace', '%', 'limbs', '%', 'pigmentation', 'disorders', '%', 'deviations', 'middle', 'later', 'stages', 'development', 'intrinsic', 'factors', 'genetic', 'mutations', 'epigenetic', 'modifications', 'difficult', 'field', 'environmental', 'factors', 'such', 'incubation', 'temperature', 'humidity', 'status', 'feeding', 'areas', 'extent', 'difficult', 'review', 'aetiology', 'different', 'malformations', 'sea', 'turtle', 'embryos', 'actions', 'embryonic', 'mortality']"
39,39,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096661654&origin=inward,Clinical and radiological profile of patients with spinal muscular atrophy type 4,"¬© 2020 European Academy of NeurologyBackground and purpose: Spinal muscular atrophy (SMA) is the most important cause of motor neuron disease in childhood, and continues to represent the leading genetic cause of infant death. Adulthood-onset SMA (SMA type 4) is rare, with few isolated cases reported. The objective of the present study was to describe a cohort of patients with SMA type 4. Methods: A cross-sectional study was conducted to characterize clinical, genetic, radiological and neurophysiological features of patients with adulthood-onset SMA. Correlation analysis of functional assessment with genetic, radiological and neurophysiological data was performed. Results: Twenty patients with SMA type 4 were identified in a Brazilian cohort of 227 patients with SMA. The most common clinical symptom was limb-girdle muscle weakness, observed in 15 patients (75%). The most frequent neurological findings were absent tendon reflexes in 18 (90%) and fasciculations in nine patients (45%). Sixteen patients (80%) had the homozygous deletion of exon 7 in the SMN1 gene, with 12 patients (60%) showing four copies of the SMN2 gene. The functional scales Hammersmith Functional Motor Scale Expanded, Amyotrophic Lateral Sclerosis Functional Rating Scale Revised, Revised Upper Limb Module and Spinal Muscular Atrophy Functional Rating Scale, as well as the six-minute walk and the Time Up and Go tests showed a correlation with duration of disease. Motor Unit Number Index was correlated both with duration of disease and with performance in functional assessment. Radiological studies exhibited a typical pattern, with involvement of biceps femoris short head and gluteus minimus in all patients. Conclusion: This study represents the largest cohort of patients with SMA type 4 and provides functional, genetic, radiological and neurophysiological features that can be used as potential biomarkers for the new specific genetic therapies for SMA.",0,0,scopus,"['recommendation algorithms', 'recommendation', 'feature space', 'mathematics', 'classification methods', 'correlation analysis', 'recommender systems', 'pattern recognition', 'correlation coefficient', 'user rating']",Ullrich congenital muscular dystrophy,"['Clinical', 'radiological', 'profile', 'patients', 'spinal', 'muscular', 'atrophy', 'type']","['purpose', 'muscular', 'atrophy', 'important', 'cause', 'motor', 'neuron', 'disease', 'childhood', 'genetic', 'cause', 'infant', 'death', 'Adulthood', 'onset', 'type', 'rare', 'few', 'cases', 'objective', 'present', 'study', 'cohort', 'patients', 'type', 'Methods', 'cross', '-', 'sectional', 'study', 'clinical', 'genetic', 'radiological', 'neurophysiological', 'features', 'patients', 'adulthood', 'onset', 'Correlation', 'analysis', 'functional', 'assessment', 'genetic', 'radiological', 'neurophysiological', 'data', 'Results', 'patients', 'type', 'Brazilian', 'cohort', 'patients', 'common', 'clinical', 'symptom', 'limb', 'girdle', 'muscle', 'weakness', 'patients', '%', 'frequent', 'neurological', 'findings', 'absent', 'tendon', 'reflexes', '%', 'fasciculations', 'patients', '%', 'patients', '%', 'homozygous', 'deletion', 'exon', 'gene', 'patients', '%', 'copies', 'gene', 'functional', 'scales', 'minute', 'walk', 'Time', 'tests', 'correlation', 'duration', 'disease', 'duration', 'disease', 'performance', 'functional', 'assessment', 'Radiological', 'studies', 'typical', 'pattern', 'involvement', 'biceps', 'short', 'head', 'minimus', 'patients', 'Conclusion', 'study', 'largest', 'cohort', 'patients', 'type', 'functional', 'genetic', 'radiological', 'neurophysiological', 'features', 'potential', 'biomarkers', 'new', 'specific', 'genetic', 'therapies']"
40,40,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096310239&origin=inward,Human Induced Pluripotent Stem Cells as a Disease Model System for Heart Failure,"¬© 2020, The Author(s).Purpose of Review: Heart failure is among the most prevalent disease complexes overall and is associated with high morbidity and mortality. The underlying aetiology is manifold including coronary artery disease, genetic alterations and mutations, viral infections, adverse immune responses, and cardiac toxicity. To date, no specific therapies have been developed despite notable efforts. This can especially be attributed to hurdles in translational research, mainly due to the lack of proficient models of heart failure limited translation of therapeutic approaches from bench to bedside. Recent Findings: Human induced pluripotent stem cells (hiPSCs) are rising in popularity, granting the ability to divide infinitely, to hold human, patient-specific genome, and to differentiate into any human cell, including cardiomyocytes (hiPSC-CMs). This brings magnificent promise to cardiological research, providing the possibility to recapitulate cardiac diseases in a dish. Advances in yield, maturity, and in vivo resemblance due to straightforward, low-cost protocols, high-throughput approaches, and complex 3D cultures have made this tool widely applicable. In recent years, hiPSC-CMs have been used to model a wide variety of cardiac diseases, bringing along the possibility to not only elucidate molecular mechanisms but also to test novel therapeutic approaches in the dish. Summary: Within the last decade, hiPSC-CMs have been exponentially employed to model heart failure. Constant advancements are aiming at improvements of differentiation protocols, hiPSC-CM maturity, and assays to elucidate molecular mechanisms and cellular functions. However, hiPSC-CMs are remaining relatively immature, and in vitro models can only partially recapitulate the complex interactions in vivo. Nevertheless, hiPSC-CMs have evolved as an essential model system in cardiovascular research.",0,0,scopus,"['node failure', 'cellular telephone systems', 'stochastic processes', 'hierarchical system', 'wireless sensor networks', 'hierarchical model', 'fault tolerance', 'wireless', 'standard model', 'cellular radio systems', 'the standard model', 'sensor networks', 'electronic document identification systems', 'probability', 'cellular']",Ullrich congenital muscular dystrophy,[],"['Heart', 'failure', 'prevalent', 'disease', 'complexes', 'high', 'morbidity', 'mortality', 'underlying', 'aetiology', 'manifold', 'coronary', 'artery', 'disease', 'genetic', 'alterations', 'mutations', 'viral', 'infections', 'adverse', 'immune', 'responses', 'cardiac', 'toxicity', 'date', 'specific', 'therapies', 'notable', 'efforts', 'hurdles', 'translational', 'research', 'lack', 'proficient', 'models', 'heart', 'failure', 'limited', 'translation', 'therapeutic', 'approaches', 'bench', 'Recent', 'Findings', 'Human', 'induced', 'pluripotent', 'stem', 'cells', 'popularity', 'ability', 'human', 'patient', 'specific', 'genome', 'human', 'cell', 'cardiomyocytes', 'magnificent', 'promise', 'cardiological', 'research', 'possibility', 'cardiac', 'diseases', 'dish', 'Advances', 'yield', 'maturity', 'vivo', 'due', 'straightforward', 'low', 'cost', 'protocols', 'high', 'throughput', 'approaches', 'complex', '3D', 'cultures', 'tool', 'applicable', 'recent', 'years', 'CMs', 'wide', 'variety', 'cardiac', 'diseases', 'possibility', 'molecular', 'mechanisms', 'novel', 'therapeutic', 'approaches', 'dish', 'Summary', 'last', 'decade', 'CMs', 'heart', 'failure', 'Constant', 'advancements', 'improvements', 'differentiation', 'protocols', 'maturity', 'molecular', 'mechanisms', 'cellular', 'functions', 'CMs', 'immature', 'models', 'complex', 'interactions', 'vivo', 'CMs', 'essential', 'model', 'system', 'cardiovascular', 'research']"
41,41,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088855779&origin=inward,Computational Models Provide Insight into In Vivo Studies and Reveal the Complex Role of Fibrosis in mdx Muscle Regeneration,"¬© 2020, Biomedical Engineering Society.Duchenne muscular dystrophy is a pro-fibrotic, muscle wasting disease. Reducing fibrosis is a potential therapeutic target; however, its effect on muscle regeneration is not fully understood. This study (1) used an agent-based model to predict the effect of increased fibrosis in mdx muscle on regeneration from injury, and (2) experimentally tested the resulting model-derived hypothesis. The model predicted that increasing the area fraction of fibrosis decreased regeneration 28 days post injury due to limited growth factor diffusion and impaired cell migration. WT, mdx, and TGFŒ≤-treated mdx mice were used to test this experimentally. TGFŒ≤ injections increased the extracellular matrix (ECM) area fraction; however, the passive stiffness of the treated muscle, which was assumed to correlate with ECM protein density, decreased following injections, suggesting that ECM protein density was lower. Further, there was no cross-sectional area (CSA) difference during recovery between the groups. Additional simulations revealed that decreasing the ECM protein density resulted in no difference in CSA, similar to the experiment. These results suggest that increases in ECM area fraction alone are not sufficient to reduce the regenerative capacity of mdx muscle, and that fibrosis is a complex pathological condition requiring further understanding.",0,0,scopus,"['relational database', 'hierarchical system', 'ecm proteins', 'hierarchical model', 'software agents', 'engineering', 'intelligent agents', 'multiagent system', 'sql', 'electric discharge machining', 'agent based']",Ullrich congenital muscular dystrophy,"['mdx', 'Regeneration']","['muscular', 'dystrophy', 'pro', '-', 'fibrotic', 'muscle', 'disease', 'fibrosis', 'potential', 'therapeutic', 'target', 'effect', 'muscle', 'regeneration', 'study', 'agent', 'model', 'effect', 'fibrosis', 'mdx', 'muscle', 'regeneration', 'injury', 'model', 'hypothesis', 'model', 'area', 'fraction', 'fibrosis', 'regeneration', 'days', 'injury', 'limited', 'growth', 'factor', 'diffusion', 'impaired', 'cell', 'migration', 'WT', 'mdx', 'mdx', 'mice', 'TGFŒ≤', 'injections', 'extracellular', 'matrix', 'area', 'fraction', 'passive', 'stiffness', 'treated', 'muscle', 'protein', 'density', 'injections', 'protein', 'density', 'lower', 'cross', '-', 'sectional', 'area', 'difference', 'recovery', 'groups', 'Additional', 'simulations', 'protein', 'density', 'difference', 'similar', 'experiment', 'results', 'increases', 'area', 'fraction', 'sufficient', 'regenerative', 'capacity', 'mdx', 'muscle', 'fibrosis', 'complex', 'pathological', 'condition', 'further', 'understanding']"
42,42,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107152208&origin=inward,MYH7-related disorders in two Bulgarian families: Novel variants in the same region associated with different clinical manifestation and disease penetrance,"¬© 2021 Elsevier B.V.Pathogenic variants in MYH7 cause a wide range of cardiac and skeletal muscle diseases with childhood or adult onset. These include dilated and/or hypertrophic cardiomyopathy, left ventricular non-compaction cardiomyopathy, congenital myopathies with multi-minicores and myofiber type disproportion, myosin storage myopathy, Laing distal myopathy and others (scapulo-peroneal or limb-girdle muscle forms). Here we report the results from molecular genetic analyses (NGS and Sanger sequencing) of 4 patients in two families with variable neuromuscular phenotypes with or without cardiac involvement. Interestingly, variants in MYH7 gene appeared to be the cause in all the cases. A novel nonsense variant c.5746C>T, p.(Gln1916Ter) was found in the patient in Family 1 who deceased at the age of 2 years 4 months with the clinical diagnosis of dilated cardiomyopathy, whose father died before the age of 40 years, due to cardiac failure with clinical diagnosis of suspected limb-girdle muscular dystrophy. A splice acceptor variant c.5560‚Äì2A>C in MYH7 was detected in the second proband and her sister, with late onset distal myopathy without cardiac involvement. These different phenotypes (muscular involvement with severe cardiomyopathy and pure late onset neuromuscular phenotype without heart involvement) may result from novel MYH7 variants, which most probably impact the LMM (light meromyosin) domain's function of the mature protein.",0,0,scopus,"['node failure', 'computer systems', 'storage systems', 'storage management', 'wireless sensor networks', 'fault tolerance', 'information management', 'correlation analysis', 'sensor networks', 'random access storage', 'digital storage', 'mathematics', 'flash memory', 'storage devices', 'nonvolatile storage']",Ullrich congenital muscular dystrophy,"['disorders', 'Bulgarian', 'families', 'Novel', 'variants', 'same', 'region', 'different', 'clinical', 'manifestation', 'disease', 'penetrance']","['B.V.Pathogenic', 'variants', 'wide', 'range', 'cardiac', 'skeletal', 'muscle', 'diseases', 'childhood', 'adult', 'onset', 'hypertrophic', 'cardiomyopathy', 'ventricular', 'non', '-', 'compaction', 'cardiomyopathy', 'congenital', 'myopathies', 'multi', '-', 'minicores', 'myofiber', 'type', 'disproportion', 'storage', 'myopathy', 'distal', 'myopathy', 'others', 'scapulo', 'peroneal', 'limb', 'girdle', 'muscle', 'forms', 'results', 'molecular', 'genetic', 'analyses', 'sequencing', 'patients', 'families', 'variable', 'neuromuscular', 'phenotypes', 'cardiac', 'involvement', 'variants', 'gene', 'cause', 'cases', 'novel', 'nonsense', 'variant', 'c.5746C', 'T', 'patient', 'age', 'years', 'months', 'clinical', 'diagnosis', 'dilated', 'cardiomyopathy', 'father', 'age', 'years', 'cardiac', 'failure', 'clinical', 'diagnosis', 'limb', 'girdle', 'muscular', 'dystrophy', 'splice', 'acceptor', 'variant', 'C', 'second', 'proband', 'sister', 'late', 'onset', 'distal', 'myopathy', 'cardiac', 'involvement', 'different', 'phenotypes', 'muscular', 'involvement', 'severe', 'cardiomyopathy', 'pure', 'late', 'onset', 'neuromuscular', 'phenotype', 'heart', 'involvement', 'novel', 'variants', 'light', 'meromyosin', 'domain', 'function', 'mature', 'protein']"
43,43,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107129282&origin=inward,Ltbp4 in health and disease,"¬© 2021 by the authors. Licensee. MDPI, Basel, Switzerland.Latent transforming growth factor Œ≤ (TGFŒ≤)-binding protein (LTBP) 4, a member of the LTBP family, shows structural homology with fibrillins. Both these protein types are characterized by calcium-binding epidermal growth factor-like repeats interspersed with 8-cysteine domains. Based on its domain composition and distribution, LTBP4 is thought to adopt an extended structure, facilitating the linear deposition of tropoelastin onto microfibrils. In humans, mutations in LTBP4 result in autosomal recessive cutis laxa type 1C, characterized by redundant skin, pulmonary emphysema, and valvular heart disease. LTBP4 is an essential regulator of TGFŒ≤ signaling and is related to development, immunity, injury repair, and diseases, playing a central role in regulating inflammation, fibrosis, and cancer progression. In this review, we focus on medical disorders or diseases that may be manipulated by LTBP4 in order to enhance the understanding of this protein.",0,0,scopus,"['dynamic composition', 'gaussian processes', 'latent variable', 'latent factor', 'correlation analysis', 'latent variable models', 'web service composition', 'matrix factorizations', 'bayesian networks', 'service compositions', 'automatic composition']",Ullrich congenital muscular dystrophy,"['health', 'disease']","['authors', 'Latent', 'growth', 'factor', 'Œ≤', 'protein', 'member', 'family', 'structural', 'homology', 'fibrillins', 'protein', 'types', 'calcium', 'epidermal', 'growth', 'factor', 'like', 'repeats', 'domains', 'domain', 'composition', 'distribution', 'extended', 'structure', 'linear', 'deposition', 'tropoelastin', 'microfibrils', 'humans', 'mutations', 'LTBP4', 'autosomal', 'recessive', 'cutis', 'laxa', 'type', '1C', 'redundant', 'skin', 'pulmonary', 'emphysema', 'valvular', 'heart', 'disease', 'essential', 'regulator', 'TGFŒ≤', 'development', 'immunity', 'injury', 'repair', 'diseases', 'central', 'role', 'inflammation', 'fibrosis', 'cancer', 'progression', 'review', 'medical', 'disorders', 'diseases', 'order', 'understanding', 'protein']"
44,44,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106731278&origin=inward,Laminopathies' Treatments Systematic Review: A Contribution towards a 'Treatabolome',"¬© 2021-The authors. Published by IOS Press.Background: Variants in the LMNA gene, encoding lamins A/C, are responsible for a growing number of diseases, all of which complying with the definition of rare diseases. LMNA-related disorders have a varied phenotypic expression with more than 15 syndromes described, belonging to five phenotypic groups: Muscular Dystrophies, Neuropathies, Cardiomyopathies, Lipodystrophies and Progeroid Syndromes. Overlapping phenotypes are also reported. Linking gene and variants with phenotypic expression, disease mechanisms, and corresponding treatments is particularly challenging in laminopathies. Treatment recommendations are limited, and very few are variant-based. Objective: The Treatabolome initiative aims to provide a shareable dataset of existing variant-specific treatment for rare diseases within the Solve-RD EU project. As part of this project, we gathered evidence of specific treatments for laminopathies via a systematic literature review adopting the FAIR (Findable, Accessible, Interoperable, and Reusable) guidelines for scientific data production. Methods: Treatments for LMNA-related conditions were systematically collected from MEDLINE and Embase bibliographic databases and clinical trial registries (Cochrane Central Registry of Controlled Trials, clinicaltrial.gov and EudraCT). Two investigators extracted and analyzed the literature data independently. The included papers were assessed using the Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence. Results: From the 4783 selected articles by a systematic approach, we identified 78 papers for our final analysis that corresponded to the profile of data defined in the inclusion and exclusion criteria. These papers include 2 guidelines/consensus papers, 4 meta-analyses, 14 single-arm trials, 15 case series, 13 cohort studies, 21 case reports, 8 expert reviews and 1 expert opinion. The treatments were summarized electronically according to significant phenome-genome associations. The specificity of treatments according to the different laminopathic phenotypical presentations is variable. Conclusions: We have extracted Treatabolome-worthy treatment recommendations for patients with different forms of laminopathies based on significant phenome-genome parings. This dataset will be available on the Treatabolome website and, through interoperability, on genetic diagnosis and treatment support tools like the RD-Connect's Genome Phenome Analysis Platform.",0,0,scopus,"['computer systems', 'android', 'scientific data', 'recommendation', 'database systems', 'information management', 'ios', 'correlation analysis', 'recommender systems', 'mathematics', 'data visualization']",Ullrich congenital muscular dystrophy,"['Laminopathies', 'Treatments', 'Contribution']","['authors', 'Background', 'Variants', 'gene', 'C', 'responsible', 'number', 'diseases', 'definition', 'rare', 'diseases', 'disorders', 'varied', 'phenotypic', 'expression', 'more', 'syndromes', 'phenotypic', 'groups', 'phenotypes', 'gene', 'variants', 'phenotypic', 'expression', 'disease', 'mechanisms', 'treatments', 'laminopathies', 'Treatment', 'recommendations', 'limited', 'few', 'variant', 'Objective', 'initiative', 'shareable', 'dataset', 'variant', 'specific', 'treatment', 'rare', 'diseases', 'project', 'part', 'project', 'evidence', 'specific', 'treatments', 'laminopathies', 'systematic', 'literature', 'review', 'Findable', 'Accessible', 'Interoperable', 'guidelines', 'scientific', 'data', 'production', 'Methods', 'Treatments', 'conditions', 'bibliographic', 'databases', 'clinical', 'trial', 'registries', 'investigators', 'literature', 'data', 'papers', 'Evidence', 'Results', 'articles', 'systematic', 'approach', 'papers', 'final', 'analysis', 'profile', 'data', 'inclusion', 'exclusion', 'criteria', 'papers', 'guidelines', 'consensus', 'papers', 'meta', 'analyses', 'single', 'arm', 'trials', 'case', 'series', 'cohort', 'studies', 'case', 'reports', 'expert', 'reviews', 'expert', 'opinion', 'treatments', 'significant', 'phenome', 'genome', 'associations', 'specificity', 'treatments', 'different', 'laminopathic', 'phenotypical', 'presentations', 'variable', 'Conclusions', 'worthy', 'treatment', 'recommendations', 'patients', 'different', 'forms', 'laminopathies', 'significant', 'phenome', 'genome', 'parings', 'dataset', 'available', 'website', 'interoperability', 'genetic', 'diagnosis', 'treatment', 'support', 'tools']"
45,45,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106579797&origin=inward,A functional outside-in signaling network of proteoglycans and matrix molecules regulating autophagy,"¬© 2021 Elsevier B.V.Proteoglycans and selected extracellular matrix constituents are emerging as intrinsic and critical regulators of evolutionarily conversed, intracellular catabolic pathways. Often, these secreted molecules evoke sustained autophagy in a variety of cell types, tissues, and model systems. The unique properties of proteoglycans have ushered in a paradigmatic shift to broaden our understanding of matrix-mediated signaling cascades. The dynamic cellular pathway controlling autophagy is now linked to an equally dynamic and fluid signaling network embedded in a complex meshwork of matrix molecules. A rapidly emerging field of research encompasses multiple matrix-derived candidates, representing a menagerie of soluble matrix constituents including decorin, biglycan, endorepellin, endostatin, collagen VI and plasminogen kringle 5. These matrix constituents are pro-autophagic and simultaneously anti-angiogenic. In contrast, perlecan, laminin Œ±2 chain, and lumican have anti-autophagic functions. Mechanistically, each matrix constituent linked to intracellular catabolic events engages a specific cell surface receptor that often converges on a common core of the autophagic machinery including AMPK, Peg3 and Beclin 1. We consider this matrix-evoked autophagy as non-canonical given that it occurs in an allosteric manner and is independent of nutrient availability or prevailing bioenergetics control. We propose that matrix-regulated autophagy is an important outside-in signaling mechanism for proper tissue homeostasis that could be therapeutically leveraged to combat a variety of diseases.",0,0,scopus,"['cellular telephone systems', 'embedded', 'hierarchical system', 'hierarchical model', 'network components', 'wireless', 'cellular radio systems', 'network protocols', 'program compilers', 'channel capacity', 'network architecture', 'cellular network', 'cellular system', 'embedded software', 'cellular']",Ullrich congenital muscular dystrophy,"['functional', 'outside', 'in', 'network', 'proteoglycans', 'matrix', 'molecules', 'autophagy']","['B.V.Proteoglycans', 'extracellular', 'matrix', 'constituents', 'intrinsic', 'critical', 'regulators', 'intracellular', 'catabolic', 'pathways', 'secreted', 'molecules', 'evoke', 'autophagy', 'variety', 'cell', 'types', 'tissues', 'model', 'systems', 'unique', 'properties', 'proteoglycans', 'paradigmatic', 'shift', 'understanding', 'matrix', 'signaling', 'cascades', 'dynamic', 'cellular', 'pathway', 'autophagy', 'dynamic', 'fluid', 'network', 'complex', 'meshwork', 'matrix', 'molecules', 'field', 'research', 'multiple', 'matrix', 'candidates', 'menagerie', 'soluble', 'matrix', 'constituents', 'decorin', 'biglycan', 'endorepellin', 'endostatin', 'collagen', 'plasminogen', 'matrix', 'constituents', 'pro', '-', 'autophagic', 'anti', '-', 'angiogenic', 'contrast', 'perlecan', 'laminin', 'chain', 'lumican', 'anti', '-', 'autophagic', 'functions', 'matrix', 'constituent', 'intracellular', 'catabolic', 'events', 'specific', 'cell', 'surface', 'receptor', 'common', 'core', 'autophagic', 'machinery', 'matrix', 'evoked', 'autophagy', 'non', '-', 'canonical', 'allosteric', 'manner', 'independent', 'nutrient', 'availability', 'bioenergetics', 'control', 'matrix', 'regulated', 'autophagy', 'important', 'outside', 'in', 'mechanism', 'proper', 'tissue', 'homeostasis', 'leveraged', 'variety', 'diseases']"
46,46,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106475261&origin=inward,Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons,"¬© 2021 The Authors. Published by American Chemical Society.The accumulation and propagation of hyperphosphorylated tau (p-Tau) is a neuropathological hallmark occurring with neurodegeneration of Alzheimer's disease (AD). Extracellular vesicles, exosomes, have been shown to initiate tau propagation in the brain. Notably, exosomes from human-induced pluripotent stem cell (iPSC) neurons expressing the AD familial A246E mutant form of presenilin 1 (mPS1) are capable of inducing tau deposits in the mouse brain after in vivo injection. To gain insights into the exosome proteome cargo that participates in propagating tau pathology, this study conducted proteomic analysis of exosomes produced by human iPSC neurons expressing A246E mPS1. Significantly, mPS1 altered the profile of exosome cargo proteins to result in (1) proteins present only in mPS1 exosomes and not in controls, (2) the absence of proteins in the mPS1 exosomes which were present only in controls, and (3) shared proteins which were upregulated or downregulated in the mPS1 exosomes compared to controls. These results show that mPS1 dysregulates the proteome cargo of exosomes to result in the acquisition of proteins involved in the extracellular matrix and protease functions, deletion of proteins involved in RNA and protein translation systems along with proteasome and related functions, combined with the upregulation and downregulation of shared proteins, including the upregulation of amyloid precursor protein. Notably, mPS1 neuron-derived exosomes displayed altered profiles of protein phosphatases and kinases involved in regulating the status of p-tau. The dysregulation of exosome cargo proteins by mPS1 may be associated with the ability of mPS1 neuron-derived exosomes to propagate tau pathology.",0,0,scopus,"['signal processing', 'machine translations', 'acquisition process', 'statistical machine translation', 'information theory', 'translation systems', 'computer science', 'natural language processing', 'computer aided language translation', 'correlation analysis', 'translation (languages)', 'bioinformatics', 'mathematics', 'mergers and acquisitions']",Ullrich congenital muscular dystrophy,[],"['accumulation', 'propagation', 'tau', 'Tau', 'neuropathological', 'hallmark', 'neurodegeneration', 'disease', 'AD', 'Extracellular', 'vesicles', 'exosomes', 'tau', 'propagation', 'brain', 'exosomes', 'human', 'induced', 'pluripotent', 'stem', 'cell', 'neurons', 'AD', 'familial', 'A246E', 'mutant', 'form', 'presenilin', 'capable', 'tau', 'deposits', 'mouse', 'brain', 'vivo', 'injection', 'insights', 'exosome', 'proteome', 'cargo', 'propagating', 'tau', 'pathology', 'study', 'proteomic', 'analysis', 'exosomes', 'human', 'neurons', 'profile', 'exosome', 'cargo', 'proteins', 'proteins', 'present', 'mPS1', 'exosomes', 'controls', 'absence', 'proteins', 'mPS1', 'exosomes', 'present', 'controls', 'proteins', 'mPS1', 'exosomes', 'controls', 'results', 'proteome', 'cargo', 'exosomes', 'acquisition', 'proteins', 'extracellular', 'matrix', 'protease', 'functions', 'deletion', 'proteins', 'protein', 'translation', 'systems', 'proteasome', 'related', 'functions', 'upregulation', 'downregulation', 'proteins', 'upregulation', 'amyloid', 'precursor', 'protein', 'neuron', 'exosomes', 'altered', 'profiles', 'protein', 'phosphatases', 'kinases', 'status', 'p', 'tau', 'dysregulation', 'exosome', 'cargo', 'proteins', 'ability', 'neuron', 'exosomes', 'tau', 'pathology']"
47,47,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106391631&origin=inward,The mitochondrial calcium homeostasis orchestra plays its symphony: Skeletal muscle is the guest of honor,"¬© 2021 Elsevier Inc.Skeletal muscle mitochondria are placed in close proximity of the sarcoplasmic reticulum (SR), the main intracellular Ca2 + store. During muscle activity, excitation of sarcolemma and of T-tubule triggers the release of Ca2 + from the SR initiating myofiber contraction. The rise in cytosolic Ca2 + determines the opening of the mitochondrial calcium uniporter (MCU), the highly selective channel of the inner mitochondrial membrane (IMM), causing a robust increase in mitochondrial Ca2 + uptake. The Ca2 +-dependent activation of TCA cycle enzymes increases the synthesis of ATP required for SERCA activity. Thus, Ca2 + is transported back into the SR and cytosolic [Ca2 +] returns to resting levels eventually leading to muscle relaxation. In recent years, thanks to the molecular identification of MCU complex components, the role of mitochondrial Ca2 + uptake in the pathophysiology of skeletal muscle has been uncovered. In this chapter, we will introduce the reader to a general overview of mitochondrial Ca2 + accumulation. We will tackle the key molecular players and the cellular and pathophysiological consequences of mitochondrial Ca2 + dyshomeostasis. In the second part of the chapter, we will discuss novel findings on the physiological role of mitochondrial Ca2 + uptake in skeletal muscle. Finally, we will examine the involvement of mitochondrial Ca2 + signaling in muscle diseases.",0,0,scopus,"['cellular telephone systems', 'component', 'hypervisor', 'microcontrollers', 'software', 'planar graph', 'fading (radio)', 'cycle', 'wireless', 'cellular radio systems', 'radio transmission', 'virtualizations', 'antennas', 'cellular', 'radio channels', 'virtual machines', 'embedded systems']",Ullrich congenital muscular dystrophy,"['mitochondrial', 'calcium', 'homeostasis', 'orchestra', 'symphony', 'Skeletal', 'muscle', 'guest', 'honor']","['Skeletal', 'muscle', 'mitochondria', 'close', 'proximity', 'sarcoplasmic', 'reticulum', 'main', 'intracellular', 'Ca2', 'store', 'muscle', 'activity', 'excitation', 'sarcolemma', 'T', 'tubule', 'release', 'Ca2', 'SR', 'myofiber', 'contraction', 'rise', 'cytosolic', 'Ca2', 'opening', 'mitochondrial', 'calcium', 'uniporter', 'selective', 'channel', 'inner', 'mitochondrial', 'membrane', 'robust', 'increase', 'mitochondrial', 'Ca2', 'uptake', 'Ca2', 'activation', 'cycle', 'synthesis', 'SERCA', 'activity', 'Ca2', 'SR', 'cytosolic', 'Ca2', 'levels', 'muscle', 'relaxation', 'recent', 'years', 'thanks', 'molecular', 'identification', 'complex', 'components', 'role', 'mitochondrial', 'Ca2', 'uptake', 'pathophysiology', 'skeletal', 'muscle', 'chapter', 'reader', 'general', 'overview', 'mitochondrial', 'Ca2', 'accumulation', 'key', 'molecular', 'players', 'cellular', 'pathophysiological', 'consequences', 'mitochondrial', 'Ca2', 'dyshomeostasis', 'second', 'part', 'chapter', 'novel', 'findings', 'physiological', 'role', 'mitochondrial', 'Ca2', 'uptake', 'skeletal', 'muscle', 'involvement', 'mitochondrial', 'Ca2', 'muscle', 'diseases']"
48,48,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105972091&origin=inward,New insights into hallux valgus by whole exome sequencing study,"¬© 2021 by the Society for Experimental Biology and Medicine.The traditional view is that the occurrence and development of hallux valgus (HV) are mainly due to environmental factors. Recent studies have suggested the large contribution of genetic heritability to HV, but it remains elusive about the genetic variants underlying the development of HV. To gain knowledge about the molecular mechanisms of HV pathogenesis by genetic approach, whole exome sequencing studies were performed in 10 individuals (7 affected by HV and 3 unaffected) from three independent families. Specific mutations were found to be related to the pathogenesis of HV and conform to the laws of inheritance. A total of 36 genes with functional candidate single nucleotide variants were identified. Genetic predisposition plays an important role in the development of HV. Interestingly, some of these genes are related to chronic arthritis, such as the complement encoding gene C7, or are related to long toe or long fingers, such as TTN, COL6A3, LARS, FIG4, and CBS. This study identified rare potentially pathogenic mutations represented by genes related to digital anomalies and chronic arthritis underlying the familial types of HV, which acquired new insights into the genetic and physiological foundations of HV, thereby might improve accurate prevention and drug development for HV.",0,0,scopus,"['tacit knowledge', 'software architecture', 'anomalous behavior', 'viewpoint', 'knowledge management', 'knowledge based systems', 'anomaly detection', 'explicit knowledge', 'domain knowledge']",Ullrich congenital muscular dystrophy,"['New', 'insights', 'hallux', 'valgus', 'whole', 'exome', 'sequencing', 'study']","['traditional', 'view', 'occurrence', 'development', 'hallux', 'valgus', 'due', 'environmental', 'factors', 'Recent', 'studies', 'large', 'contribution', 'genetic', 'heritability', 'elusive', 'genetic', 'variants', 'development', 'knowledge', 'molecular', 'mechanisms', 'pathogenesis', 'genetic', 'approach', 'whole', 'exome', 'sequencing', 'studies', 'individuals', 'unaffected', 'independent', 'families', 'Specific', 'mutations', 'pathogenesis', 'laws', 'inheritance', 'total', 'genes', 'functional', 'candidate', 'single', 'nucleotide', 'variants', 'Genetic', 'predisposition', 'important', 'role', 'development', 'genes', 'chronic', 'arthritis', 'such', 'complement', 'gene', 'C7', 'long', 'toe', 'long', 'fingers', 'such', 'study', 'rare', 'pathogenic', 'mutations', 'genes', 'digital', 'anomalies', 'arthritis', 'familial', 'types', 'new', 'insights', 'genetic', 'physiological', 'foundations', 'accurate', 'prevention', 'drug', 'development']"
49,49,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105804601&origin=inward,Therapeutic Modulation of RNA Splicing in Malignant and Non-Malignant Disease,"¬© 2021 The AuthorsRNA splicing is the enzymatic process by which non-protein coding sequences are removed from RNA to produce mature protein-coding mRNA. Splicing is thereby a major mediator of proteome diversity as well as a dynamic regulator of gene expression. Genetic alterations disrupting splicing of individual genes or altering the function of splicing factors contribute to a wide range of human genetic diseases as well as cancer. These observations have resulted in the development of therapies based on oligonucleotides that bind to RNA sequences and modulate splicing for therapeutic benefit. In parallel, small molecules that bind to splicing factors to alter their function or modify RNA processing of individual transcripts are being pursued for monogenic disorders as well as for cancer.",0,0,scopus,"['programming theory', 'source coding', 'coding techniques', 'image coding', 'optical fibers', 'phase modulation', 'channel coding', 'coding scheme', 'data compression', 'bit error rate', 'network coding', 'signal encoding']",Ullrich congenital muscular dystrophy,"['-', 'Malignant']","['AuthorsRNA', 'splicing', 'enzymatic', 'process', 'non', '-', 'protein', 'coding', 'sequences', 'mature', 'protein', 'Splicing', 'major', 'mediator', 'proteome', 'diversity', 'dynamic', 'regulator', 'gene', 'expression', 'Genetic', 'alterations', 'splicing', 'individual', 'genes', 'function', 'factors', 'wide', 'range', 'human', 'genetic', 'diseases', 'cancer', 'observations', 'development', 'therapies', 'oligonucleotides', 'bind', 'sequences', 'modulate', 'splicing', 'therapeutic', 'benefit', 'parallel', 'small', 'molecules', 'factors', 'function', 'processing', 'individual', 'transcripts', 'monogenic', 'disorders', 'cancer']"
50,50,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105318664&origin=inward,Mutation spectrum of hereditary myopathies in Turkish patients and novel variants,"¬© 2021 John Wiley & Sons Ltd/University College LondonHereditary myopathies are a heterogeneous disorder known to be associated with more than 100 genes. Although hereditary myopathy subgroups can be partially described with traditional methods such as muscle biopsy, next-generation sequencing (NGS) is essential to reveal the disease's underlying genetic etiology and molecular mechanisms. In this study, we performed clinical exome sequencing or whole-exome sequencing (CES/WES) in 20 unrelated Turkish patients. Thirteen pathogenic or likely pathogenic variants, including five novel variantswere detected in the 16 known hereditary myopathy genes. We achieved a high rate of diagnosis (65%) compared to previous studies. The most common condition noticed was limb-girdle muscular dystrophy (LGMD), which should not be ignored in patients diagnosed with myopathy. CES or WES provides a certain molecular diagnosis from a broad perspective to demonstrate underlying genetic causes in heterogeneous disorders. Therefore, exome sequencing offers a higher and more complete diagnosis than the gene panel.",0,0,scopus,"['wireless networks', 'particle swarm optimization (pso)', 'frequency bands', 'mutation strategy', 'differential evolution', 'evolutionary algorithms', 'heterogeneous networks', 'education', 'mutation operators', 'university', 'antennas']",Ullrich congenital muscular dystrophy,"['Mutation', 'spectrum', 'hereditary', 'myopathies', 'Turkish', 'patients', 'novel', 'variants']","['myopathies', 'heterogeneous', 'disorder', 'more', 'genes', 'hereditary', 'myopathy', 'subgroups', 'traditional', 'methods', 'such', 'muscle', 'biopsy', 'next', 'generation', 'sequencing', 'essential', 'disease', 'genetic', 'etiology', 'molecular', 'mechanisms', 'study', 'clinical', 'exome', 'sequencing', 'whole', 'exome', 'sequencing', 'unrelated', 'Turkish', 'patients', 'pathogenic', 'likely', 'pathogenic', 'variants', 'novel', 'hereditary', 'myopathy', 'genes', 'high', 'rate', 'diagnosis', '%', 'previous', 'studies', 'common', 'condition', 'limb', 'girdle', 'muscular', 'dystrophy', 'patients', 'myopathy', 'CES', 'certain', 'molecular', 'diagnosis', 'broad', 'perspective', 'underlying', 'genetic', 'causes', 'heterogeneous', 'disorders', 'exome', 'sequencing', 'higher', 'complete', 'diagnosis', 'gene', 'panel']"
51,51,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105070492&origin=inward,Tissue-specific parameters for the design of ECM-mimetic biomaterials,"¬© 2021 Acta Materialia Inc.The extracellular matrix (ECM) is a complex network of biomolecules that mechanically and biochemically directs cell behavior and is crucial for maintaining tissue function and health. The heterogeneous organization and composition of the ECM varies within and between tissue types, directing mechanics, aiding in cell-cell communication, and facilitating tissue assembly and reassembly during development, injury and disease. As technologies like 3D printing rapidly advance, researchers are better able to recapitulate in vivo tissue properties in vitro; however, tissue-specific variations in ECM composition and organization are not given enough consideration. This is in part due to a lack of information regarding how the ECM of many tissues varies in both homeostatic and diseased states. To address this gap, we describe the components and organization of the ECM, and provide examples for different tissues at various states of disease. While many aspects of ECM biology remain unknown, our goal is to highlight the complexity of various tissues and inspire engineers to incorporate unique components of the native ECM into in vitro platform design and fabrication. Ultimately, we anticipate that the use of biomaterials that incorporate key tissue-specific ECM will lead to in vitro models that better emulate human pathologies. Statement of significance: Biomaterial development primarily emphasizes the engineering of new materials and therapies at the expense of identifying key parameters of the tissue that is being emulated. This can be partially attributed to the difficulty in defining the 3D composition, organization, and mechanics of the ECM within different tissues and how these material properties vary as a function of homeostasis and disease. In this review, we highlight a range of tissues throughout the body and describe how ECM content, cell diversity, and mechanical properties change in diseased tissues and influence cellular behavior. Accurately mimicking the tissue of interest in vitro by using ECM specific to the appropriate state of homeostasis or pathology in vivo will yield results more translatable to humans.",0,0,scopus,"['cellular telephone systems', 'communication', 'component', 'software', 'topology', 'optical fibers', 'wireless', 'engineering', 'cellular radio systems', 'engineers', 'complex networks', 'cellular']",Ullrich congenital muscular dystrophy,"['Tissue', 'specific', 'parameters', 'design', 'mimetic', 'biomaterials']","['extracellular', 'matrix', 'complex', 'network', 'biomolecules', 'cell', 'behavior', 'crucial', 'tissue', 'function', 'health', 'heterogeneous', 'organization', 'composition', 'tissue', 'types', 'mechanics', 'cell', 'cell', 'communication', 'tissue', 'assembly', 'development', 'injury', 'disease', 'technologies', '3D', 'advance', 'researchers', 'able', 'vivo', 'properties', 'vitro', 'tissue', 'specific', 'variations', 'composition', 'organization', 'enough', 'consideration', 'part', 'due', 'lack', 'information', 'ECM', 'many', 'tissues', 'homeostatic', 'diseased', 'states', 'gap', 'components', 'organization', 'examples', 'different', 'tissues', 'various', 'states', 'disease', 'many', 'aspects', 'biology', 'unknown', 'goal', 'complexity', 'various', 'tissues', 'engineers', 'unique', 'components', 'native', 'platform', 'design', 'fabrication', 'use', 'biomaterials', 'key', 'tissue', 'specific', 'models', 'human', 'pathologies', 'Statement', 'significance', 'Biomaterial', 'development', 'engineering', 'new', 'materials', 'therapies', 'expense', 'key', 'parameters', 'tissue', 'difficulty', '3D', 'composition', 'organization', 'mechanics', 'different', 'tissues', 'material', 'properties', 'function', 'homeostasis', 'disease', 'review', 'range', 'tissues', 'body', 'ECM', 'content', 'cell', 'diversity', 'mechanical', 'properties', 'diseased', 'tissues', 'cellular', 'behavior', 'tissue', 'interest', 'vitro', 'specific', 'appropriate', 'state', 'homeostasis', 'pathology', 'vivo', 'results', 'translatable', 'humans']"
52,52,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104989705&origin=inward,MR imaging of inherited myopathies: a review and proposal of imaging algorithms,"¬© 2021, European Society of Radiology.Purpose of review: The aims of this review are to discuss the imaging modalities used to assess muscle changes in myopathies, to provide an overview of the inherited myopathies focusing on their patterns of muscle involvement in magnetic resonance imaging (MR), and to propose up-to-date imaging-based diagnostic algorithms that can help in the diagnostic workup. Conclusion: Familiarization with the most common and specific patterns of muscular involvement in inherited myopathies is very important for radiologists and neurologists, as imaging plays a significant role in diagnosis and follow-up of these patients. Key Points: ‚Ä¢ Imaging is an increasingly important tool for diagnosis and follow-up in the setting of inherited myopathies. ‚Ä¢ Knowledge of the most common imaging patterns of muscle involvement in inherited myopathies is valuable for both radiologists and neurologists. ‚Ä¢ In this review, we present imaging-based algorithms that can help in the diagnostic workup of myopathies.",0,0,scopus,"['signal processing', 'computerized tomography', 'x-ray computed tomography', 'computational efficiency', 'imaging algorithm', 'adaptive algorithms', 'efficient algorithm', 'synthetic apertures', 'imaging systems', 'correlation analysis', 'optimization problems', 'image reconstruction']",Ullrich congenital muscular dystrophy,"['imaging', 'myopathies', 'review', 'proposal', 'algorithms']","['Purpose', 'review', 'aims', 'review', 'modalities', 'muscle', 'changes', 'myopathies', 'overview', 'myopathies', 'patterns', 'muscle', 'involvement', 'magnetic', 'resonance', 'imaging', 'date', 'imaging', 'diagnostic', 'algorithms', 'diagnostic', 'workup', 'Conclusion', 'Familiarization', 'common', 'specific', 'patterns', 'muscular', 'involvement', 'myopathies', 'important', 'radiologists', 'neurologists', 'imaging', 'significant', 'role', 'diagnosis', 'up', 'patients', 'Key', 'Imaging', 'important', 'tool', 'diagnosis', 'up', 'setting', 'myopathies', 'common', 'imaging', 'patterns', 'muscle', 'involvement', 'myopathies', 'valuable', 'radiologists', 'neurologists', 'review', 'imaging', 'algorithms', 'diagnostic', 'workup', 'myopathies']"
53,53,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104275744&origin=inward,Anesthesia and Ullrich Congenital Muscular Dystrophy: Comment,0,0,0,scopus,[],Ullrich congenital muscular dystrophy,['Comment'],[]
54,54,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103917298&origin=inward,SMART approaches for genome-wide analyses of skeletal muscle stem and niche cells,"¬© 2021 Informa UK Limited, trading as Taylor & Francis Group.Muscle stem cells (MuSCs) also called satellite cells are the building blocks of skeletal muscle, the largest tissue in the human body which is formed primarily of myofibers. While MuSCs are the principal cells that directly contribute to the formation of the muscle fibers, their ability to do so depends on critical interactions with a vast array of nonmyogenic cells within their niche environment. Therefore, understanding the nature of communication between MuSCs and their niche is of key importance to understand how the skeletal muscle is maintained and regenerated after injury. MuSCs are rare and therefore difficult to study in vivo within the context of their niche environment. The advent of single-cell technologies, such as switching mechanism at 5‚Äô end of the RNA template (SMART) and tagmentation based technologies using hyperactive transposase, afford the unprecedented opportunity to perform whole transcriptome and epigenome studies on rare cells within their niche environment. In this review, we will delve into how single-cell technologies can be applied to the study of MuSCs and muscle-resident niche cells and the impact this can have on our understanding of MuSC biology and skeletal muscle regeneration.",0,0,scopus,"['communication', 'geostationary satellites', 'innovative technologies', 'direction of arrival', 'sub-arrays', 'satellite system', 'service management', 'communication satellites']",Ullrich congenital muscular dystrophy,"['SMART', 'genome', 'wide', 'analyses', 'skeletal', 'muscle', 'stem', 'niche', 'cells']","['trading', 'Muscle', 'stem', 'cells', 'satellite', 'cells', 'building', 'blocks', 'skeletal', 'muscle', 'largest', 'tissue', 'human', 'body', 'myofibers', 'principal', 'cells', 'formation', 'muscle', 'fibers', 'ability', 'critical', 'interactions', 'vast', 'array', 'nonmyogenic', 'cells', 'niche', 'environment', 'nature', 'communication', 'niche', 'key', 'importance', 'skeletal', 'muscle', 'injury', 'MuSCs', 'rare', 'difficult', 'vivo', 'context', 'niche', 'environment', 'advent', 'single', 'cell', 'technologies', 'such', 'mechanism', 'end', 'template', 'tagmentation', 'technologies', 'hyperactive', 'transposase', 'unprecedented', 'opportunity', 'whole', 'transcriptome', 'epigenome', 'studies', 'rare', 'cells', 'niche', 'environment', 'review', 'single', 'cell', 'technologies', 'study', 'muscle', 'resident', 'niche', 'cells', 'impact', 'understanding', 'biology', 'skeletal', 'muscle', 'regeneration']"
55,55,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103281847&origin=inward,Nonsense suppression therapies in human genetic diseases,"¬© 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG.About 11% of all human disease-associated gene lesions are nonsense mutations, resulting in the introduction of an in-frame premature translation-termination codon (PTC) into the protein-coding gene sequence. When translated, PTC-containing mRNAs originate truncated and often dysfunctional proteins that might be non-functional or have gain-of-function or dominant-negative effects. Therapeutic strategies aimed at suppressing PTCs to restore deficient protein function‚Äîthe so-called nonsense suppression (or PTC readthrough) therapies‚Äîhave the potential to provide a therapeutic benefit for many patients and in a broad range of genetic disorders, including cancer. These therapeutic approaches comprise the use of translational readthrough-inducing compounds that make the translational machinery recode an in-frame PTC into a sense codon. However, most of the mRNAs carrying a PTC can be rapidly degraded by the surveillance mechanism of nonsense-mediated decay (NMD), thus decreasing the levels of PTC-containing mRNAs in the cell and their availability for PTC readthrough. Accordingly, the use of NMD inhibitors, or readthrough-compound potentiators, may enhance the efficiency of PTC suppression. Here, we review the mechanisms of PTC readthrough and their regulation, as well as the recent advances in the development of novel approaches for PTC suppression, and their role in personalized medicine.",0,0,scopus,"['machine translations', 'translation process', 'computational efficiency', 'structural frames', 'theoretical computer science', 'frames', 'security systems', 'sensors', 'video surveillance', 'surveillance applications']",Ullrich congenital muscular dystrophy,"['Nonsense', 'suppression', 'therapies', 'human', 'genetic', 'diseases']","['exclusive', 'licence', '%', 'human', 'disease', 'gene', 'lesions', 'nonsense', 'mutations', 'introduction', 'frame', 'premature', 'translation', 'termination', 'codon', 'protein', 'gene', 'sequence', 'PTC', 'originate', 'dysfunctional', 'proteins', 'non', '-', 'functional', 'gain', 'function', 'dominant', 'negative', 'effects', 'Therapeutic', 'strategies', 'deficient', 'protein', 'function', 'nonsense', 'suppression', 'PTC', 'readthrough', 'therapies', 'potential', 'therapeutic', 'benefit', 'many', 'patients', 'broad', 'range', 'genetic', 'disorders', 'cancer', 'therapeutic', 'approaches', 'use', 'translational', 'readthrough', 'compounds', 'translational', 'machinery', 'frame', 'PTC', 'sense', 'codon', 'most', 'PTC', 'surveillance', 'mechanism', 'nonsense', 'decay', 'levels', 'PTC', 'cell', 'availability', 'PTC', 'readthrough', 'use', 'inhibitors', 'readthrough', 'compound', 'potentiators', 'efficiency', 'suppression', 'mechanisms', 'PTC', 'readthrough', 'regulation', 'recent', 'advances', 'development', 'novel', 'approaches', 'PTC', 'suppression', 'role', 'personalized', 'medicine']"
56,56,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102619204&origin=inward,Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition),"¬© 2020 Informa UK Limited, trading as Taylor & Francis Group.In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field.",0,0,scopus,"['commerce', 'trade', 'cellular telephone systems', 'recommendation', 'component', 'software', 'knowledge based systems', 'wireless', 'knowledge base', 'cellular radio systems', 'recommender systems', 'cellular']",Ullrich congenital muscular dystrophy,"['Guidelines', 'use', 'interpretation', 'assays', 'autophagy', '4th', 'edition']","['trading', 'first', 'set', 'guidelines', 'research', 'autophagy', 'topic', 'attention', 'many', 'scientists', 'field', 'knowledge', 'base', 'relevant', 'new', 'technologies', 'important', 'regular', 'basis', 'guidelines', 'autophagy', 'different', 'organisms', 'numerous', 'reviews', 'confusion', 'acceptable', 'methods', 'autophagy', 'multicellular', 'eukaryotes', 'set', 'guidelines', 'investigators', 'methods', 'autophagy', 'related', 'processes', 'reviewers', 'realistic', 'reasonable', 'critiques', 'reports', 'processes', 'guidelines', 'dogmatic', 'set', 'rules', 'appropriateness', 'assay', 'question', 'system', 'individual', 'assay', 'perfect', 'situation', 'use', 'multiple', 'techniques', 'autophagy', 'experimental', 'setting', 'several', 'core', 'components', 'autophagy', 'machinery', 'distinct', 'autophagic', 'processes', 'canonical', 'noncanonical', 'autophagy', 'genetic', 'approaches', 'block', 'autophagy', 'more', 'autophagy', 'genes', 'distinct', 'steps', 'pathway', 'similar', 'lines', 'multiple', 'proteins', 'autophagy', 'other', 'cellular', 'pathways', 'apoptosis', 'specific', 'marker', 'bona', 'fide', 'autophagic', 'responses', 'current', 'methods', 'autophagy', 'information', 'ultimate', 'goal', 'intellectual', 'technical', 'innovation', 'field']"
57,57,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102251524&origin=inward,The linkage between inflammation and fibrosis in muscular dystrophies: The axis autotaxin‚Äìlysophosphatidic acid as a new therapeutic target?,"¬© 2021, The Author(s).Muscular dystrophies (MDs) are a diverse group of severe disorders characterized by increased skeletal muscle feebleness. In many cases, respiratory and cardiac muscles are also compromised. Skeletal muscle inflammation and fibrosis are hallmarks of several skeletal muscle diseases, including MDs. Until now, several keys signaling pathways and factors that regulate inflammation and fibrosis have been identified. However, no curative treatments are available. Therefore, it is necessary to find new therapeutic targets to fight these diseases and improve muscle performance. Lysophosphatidic acid (LPA) is an active glycerophospholipid mainly synthesized by the secreted enzyme autotaxin (ATX), which activates six different G protein-coupled receptors named LPA1 to LPA6 (LPARs). In conjunction, they are part of the ATX/LPA/LPARs axis, involved in the inflammatory and fibrotic response in several organs-tissues. This review recapitulates the most relevant aspects of inflammation and fibrosis in MDs. It analyzes experimental evidence of the effects of the ATX/LPA/LPARs axis on inflammatory and fibrotic responses. Finally, we speculate about its potential role as a new therapeutic pharmacological target to treat these diseases.",0,0,scopus,"['target tracking', 'password', 'cryptographic key', 'multitarget', 'private key', 'multi-target tracking', 'cryptography', 'encryption', 'security of data', 'public key cryptography', 'multiple targets', 'smart cards', 'biometrics']",Ullrich congenital muscular dystrophy,"['linkage', 'inflammation', 'fibrosis', 'muscular', 'dystrophies', 'axis', 'autotaxin', 'lysophosphatidic', 'acid', 'new', 'therapeutic', 'target']","['dystrophies', 'MDs', 'diverse', 'group', 'severe', 'disorders', 'skeletal', 'muscle', 'feebleness', 'many', 'cases', 'respiratory', 'cardiac', 'muscles', 'Skeletal', 'muscle', 'inflammation', 'fibrosis', 'hallmarks', 'several', 'skeletal', 'muscle', 'diseases', 'MDs', 'several', 'keys', 'pathways', 'factors', 'inflammation', 'fibrosis', 'curative', 'treatments', 'available', 'necessary', 'new', 'therapeutic', 'targets', 'diseases', 'muscle', 'performance', 'Lysophosphatidic', 'acid', 'active', 'glycerophospholipid', 'secreted', 'enzyme', 'autotaxin', 'different', 'G', 'protein', 'receptors', 'conjunction', 'part', 'axis', 'inflammatory', 'fibrotic', 'response', 'several', 'organs', 'tissues', 'review', 'relevant', 'aspects', 'inflammation', 'fibrosis', 'MDs', 'experimental', 'evidence', 'effects', 'axis', 'inflammatory', 'fibrotic', 'responses', 'potential', 'role', 'new', 'therapeutic', 'pharmacological', 'target', 'diseases']"
58,58,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102247211&origin=inward,Epigenetic and metabolic regulation of epidermal homeostasis,"¬© 2021 The Authors. Experimental Dermatology published by John Wiley & Sons Ltd.Continuous exposure of the skin to environmental, mechanical and chemical stress necessitates constant self-renewal of the epidermis to maintain its barrier function. This self-renewal ability is attributed to epidermal stem cells (EPSCs), which are long-lived, multipotent cells located in the basal layer of the epidermis. Epidermal homeostasis ‚Äì coordinated proliferation and differentiation of EPSCs ‚Äì relies on fine-tuned adaptations in gene expression which in turn are tightly associated with specific epigenetic signatures and metabolic requirements. In this review, we will briefly summarize basic concepts of EPSC biology and epigenetic regulation with relevance to epidermal homeostasis. We will highlight the intricate interplay between mitochondrial energy metabolism and epigenetic events ‚Äì including miRNA-mediated mechanisms ‚Äì and discuss how the loss of epigenetic regulation and epidermal homeostasis manifests in skin disease. Discussion of inherited epidermolysis bullosa (EB) and disorders of cornification will focus on evidence for epigenetic deregulation and failure in epidermal homeostasis, including stem cell exhaustion and signs of premature ageing. We reason that the epigenetic and metabolic component of epidermal homeostasis is significant and warrants close attention. Charting epigenetic and metabolic complexities also represents an important step in the development of future systemic interventions aimed at restoring epidermal homeostasis and ameliorating disease burden in severe skin conditions.",0,0,scopus,"['component', 'software', 'software architecture patterns', 'requirements engineering', 'layered', 'fingerprint', 'biometrics', 'quality requirements', 'system requirements']",Ullrich congenital muscular dystrophy,"['Epigenetic', 'metabolic', 'regulation', 'epidermal', 'homeostasis']","['Experimental', 'Continuous', 'exposure', 'skin', 'environmental', 'mechanical', 'chemical', 'stress', 'constant', 'self', 'renewal', 'epidermis', 'barrier', 'function', 'self', 'renewal', 'ability', 'epidermal', 'stem', 'cells', 'multipotent', 'cells', 'basal', 'layer', 'epidermis', 'Epidermal', 'homeostasis', 'proliferation', 'differentiation', 'adaptations', 'gene', 'expression', 'turn', 'specific', 'epigenetic', 'signatures', 'metabolic', 'requirements', 'review', 'basic', 'concepts', 'EPSC', 'biology', 'epigenetic', 'regulation', 'relevance', 'epidermal', 'homeostasis', 'intricate', 'interplay', 'mitochondrial', 'energy', 'metabolism', 'epigenetic', 'events', 'mechanisms', 'loss', 'epigenetic', 'regulation', 'epidermal', 'homeostasis', 'manifests', 'skin', 'disease', 'Discussion', 'epidermolysis', 'bullosa', 'disorders', 'cornification', 'evidence', 'epigenetic', 'deregulation', 'failure', 'epidermal', 'homeostasis', 'stem', 'cell', 'exhaustion', 'signs', 'premature', 'ageing', 'epigenetic', 'metabolic', 'component', 'epidermal', 'homeostasis', 'significant', 'warrants', 'close', 'attention', 'epigenetic', 'metabolic', 'complexities', 'important', 'step', 'development', 'future', 'systemic', 'interventions', 'epidermal', 'homeostasis', 'disease', 'burden', 'severe', 'skin', 'conditions']"
59,59,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102144213&origin=inward,Intrafamilial Phenotypic Variability of Collagen VI-Related Myopathy Due to a New Mutation in the COL6A1 Gene,"¬© 2021 - The authors. Published by IOS Press.A family of five male siblings (three survivors at 48, 53 and 58 years old; two deceased at 8 months old and 2.5 years old) demonstrating significant phenotypic variability ranging from intermediate to the myosclerotic like Bethlem myopathy is presented. Whole-exome sequencing (WES) identified a new homozygous missense mutation chr21:47402679 T > C in the canonical splice donor site of the second intron (c.227 + 2T>C) in the COL6A1 gene. mRNA analysis confirmed skipping of exon 2 encoding 925 amino-acids in 94-95% of resulting transcripts. Three sibs presented with intermediate phenotype of collagen VI-related dystrophies (48, 53 and 2.5 years old) while the fourth sibling (58 years old) was classified as Bethlem myopathy with spine rigidity. The two older siblings with the moderate progressive phenotype (48 and 53 years old) lost their ability to maintain a vertical posture caused by pronounced contractures of large joints, but continued to ambulate throughout life on fully bent legs without auxiliary means of support. Immunofluorescence analysis of dermal fibroblasts demonstrated that no type VI collagen was secreted in any of the siblings' cells, regardless of clinical manifestations severity while fibroblast proliferation and colony formation ability was decreased. The detailed genetic and long term clinical data contribute to broadening the genotypic and phenotypic spectrum of COL6A1 related disease.",0,0,scopus,"['android', 'mathematics', 'particle swarm optimization (pso)', 'ranging', 'ios', 'frequency bands', 'mutation strategy', 'correlation analysis', 'ultra-wideband (uwb)', 'differential evolution', 'evolutionary algorithms', 'mutation operators', 'range finding', 'antennas']",Ullrich congenital muscular dystrophy,['COL6A1'],"['¬©', 'authors', 'family', 'male', 'siblings', 'survivors', 'years', 'old', 'months', 'old', 'years', 'old', 'significant', 'phenotypic', 'variability', 'intermediate', 'myosclerotic', 'myopathy', 'Whole', 'exome', 'sequencing', 'new', 'homozygous', 'missense', 'mutation', 'chr21:47402679', 'T', 'C', 'canonical', 'splice', 'donor', 'site', 'second', 'intron', 'C', 'COL6A1', 'gene', 'mRNA', 'analysis', 'exon', 'amino', 'acids', '%', 'transcripts', 'sibs', 'intermediate', 'phenotype', 'collagen', 'dystrophies', 'years', 'old', 'fourth', 'sibling', 'years', 'old', 'myopathy', 'spine', 'rigidity', 'older', 'siblings', 'moderate', 'progressive', 'phenotype', 'years', 'old', 'ability', 'vertical', 'posture', 'pronounced', 'contractures', 'large', 'joints', 'life', 'bent', 'legs', 'auxiliary', 'means', 'support', 'Immunofluorescence', 'analysis', 'dermal', 'fibroblasts', 'type', 'collagen', 'siblings', 'cells', 'clinical', 'manifestations', 'severity', 'fibroblast', 'proliferation', 'colony', 'formation', 'ability', 'detailed', 'genetic', 'long', 'term', 'clinical', 'data', 'genotypic', 'phenotypic', 'spectrum', 'COL6A1', 'related', 'disease']"
60,60,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101870764&origin=inward,The critical role of collagen VI in lung development and chronic lung disease,"¬© 2021Type VI collagen (collagen VI) is an obligate extracellular matrix component found mainly in the basement membrane region of many mammalian tissues and organs, including skeletal muscle and throughout the respiratory system. Collagen VI is probably most recognized in medicine as the genetic cause of a spectrum of muscular dystrophies, including Ullrich Congenital Myopathy and Bethlem Myopathy. Collagen VI is thought to contribute to myopathy, at least in part, by mediating muscle fiber integrity by anchoring myoblasts to the muscle basement membrane. Interestingly, collagen VI myopathies present with restrictive respiratory insufficiency, thought to be due primarily to thoracic muscular weakening. Although it was recently recognized as one of the (if not the) most abundant collagens in the mammalian lung, there is a substantive knowledge gap concerning its role in respiratory system development and function. A few studies have suggested that collagen VI insufficiency is associated with airway epithelial cell survival and altered lung function. Our recent work suggested collagen VI may be a genomic risk factor for chronic lung disease in premature infants. Using this as motivation, we thoroughly assessed the role of collagen VI in lung development and in lung epithelial cell biology. Here, we describe the state-of-the-art for collagen VI cell and developmental biology within the respiratory system, and reveal its essential roles in normal developmental processes and airway epithelial cell phenotype and intracellular signaling.",0,0,scopus,"['process engineering', 'spectrum sensing', 'component', 'software', 'development processes', 'optical fibers', 'frequency bands', 'software design', 'sensors', 'cognitive radio network', 'dynamic spectrum access', 'antennas', 'dynamic spectrum']",Ullrich congenital muscular dystrophy,"['critical', 'role', 'collagen', 'lung', 'development', 'chronic', 'lung', 'disease']","['collagen', 'collagen', 'obligate', 'extracellular', 'matrix', 'component', 'basement', 'membrane', 'region', 'many', 'mammalian', 'tissues', 'organs', 'skeletal', 'muscle', 'respiratory', 'system', 'medicine', 'genetic', 'cause', 'spectrum', 'muscular', 'dystrophies', 'myopathy', 'least', 'part', 'muscle', 'fiber', 'integrity', 'myoblasts', 'muscle', 'basement', 'membrane', 'collagen', 'myopathies', 'present', 'restrictive', 'respiratory', 'insufficiency', 'due', 'muscular', 'weakening', 'abundant', 'collagens', 'mammalian', 'lung', 'substantive', 'knowledge', 'gap', 'role', 'respiratory', 'system', 'development', 'function', 'few', 'studies', 'collagen', 'insufficiency', 'airway', 'epithelial', 'cell', 'survival', 'altered', 'lung', 'function', 'recent', 'work', 'collagen', 'genomic', 'risk', 'factor', 'chronic', 'lung', 'disease', 'premature', 'infants', 'motivation', 'role', 'collagen', 'lung', 'development', 'lung', 'epithelial', 'cell', 'biology', 'state', 'art', 'collagen', 'cell', 'developmental', 'biology', 'respiratory', 'system', 'essential', 'roles', 'normal', 'developmental', 'processes', 'airway', 'epithelial', 'cell', 'phenotype', 'intracellular', 'signaling']"
61,61,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101010616&origin=inward,Use of RNA-sequencing to detect abnormal transcription of the collagen Œ±-2 (VI) chain gene that can lead to Bethlem myopathy,"¬© This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License.Bethlem myopathy (BM) is an autosomal dominant or autosomal recessive disorder and is usually associated with mutations in the collagen VI genes. In the present study, the pathogenicity of a novel splice-site mutation was explored using RNA-sequencing in a family with suspected BM, and a myopathy panel was performed in the proband. The genetic status of all family members was confirmed using Sanger sequencing. clinical data and magnetic resonance imaging (MRI) features were also documented. In silico analysis was performed to predict the effects of the splice mutation. RNA-sequencing and reverse transcription (RT)-PcR were used to assess aberrant splicing. Immunocytochemistry was conducted to measure collagen VI protein levels within the gastrocnemius and in cultured skin fibroblasts. The results revealed that three patients in the family shared a similar classic BM presentation. MRI revealed distinct patterns of fatty infiltration in the lower extremities. A novel splicing mutation c.736-1G>c in the collagen Œ±-2 (VI) chain (COL6A2) gene was found in all three patients. In silico analysis predicted that the mutation would destroy the normal splice acceptor site. RNA-sequencing detected two abnormal splicing vari- ants adjacent to the mutation site, and RT-PcR confirmed the RNA-sequencing findings. Furthermore, a defect in the collagen protein within cultured fibroblasts was detected using immunocytochemistry. The mutation c.736-1G>c in the COL6A2 gene caused aberrant splicing and led to premature termination of protein translation. In conclusion, these findings may improve our knowledge of mutations of the COL6A2 gene associated with BM and demonstrated that RNA-sequencing can be a powerful tool for finding the underlying mechanism of a disease-causing mutations at a splice site.",0,0,scopus,"['particle swarm optimization (pso)', 'group members', 'open access', 'mutation strategy', 'correlation analysis', 'electronic publishing', 'distributed computer systems', 'differential evolution', 'evolutionary algorithms', 'mutation operators', 'mathematics', 'multicasts']",Ullrich congenital muscular dystrophy,"['sequencing', 'abnormal', 'transcription', 'collagen', 'chain', 'gene', 'myopathy']","['work', 'License', 'autosomal', 'dominant', 'autosomal', 'recessive', 'disorder', 'mutations', 'collagen', 'genes', 'present', 'study', 'pathogenicity', 'novel', 'splice', 'site', 'mutation', 'sequencing', 'family', 'myopathy', 'panel', 'proband', 'genetic', 'status', 'family', 'members', 'clinical', 'data', 'magnetic', 'resonance', 'imaging', 'features', 'silico', 'analysis', 'effects', 'splice', 'mutation', 'RNA', 'sequencing', 'reverse', 'transcription', 'RT)-PcR', 'aberrant', 'splicing', 'Immunocytochemistry', 'collagen', 'protein', 'levels', 'gastrocnemius', 'cultured', 'skin', 'fibroblasts', 'results', 'patients', 'family', 'similar', 'classic', 'presentation', 'distinct', 'patterns', 'fatty', 'infiltration', 'lower', 'extremities', 'novel', 'mutation', 'c.736', '1G', 'collagen', 'chain', 'gene', 'patients', 'silico', 'analysis', 'mutation', 'normal', 'splice', 'acceptor', 'site', 'RNA', 'sequencing', 'abnormal', 'vari-', 'ants', 'adjacent', 'mutation', 'site', 'findings', 'defect', 'collagen', 'protein', 'cultured', 'fibroblasts', 'immunocytochemistry', 'mutation', 'c.736', '1G', 'c', 'gene', 'aberrant', 'splicing', 'premature', 'termination', 'protein', 'translation', 'conclusion', 'findings', 'knowledge', 'mutations', 'gene', 'sequencing', 'powerful', 'tool', 'mechanism', 'disease', 'mutations', 'splice', 'site']"
62,62,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85098618388&origin=inward,Autophagy in the mesh of collagen VI,"¬© 2020 Elsevier B.V.Autophagy is a very versatile process through which the cell degrades damaged long-lived proteins, entire organelles, or pathogens, by engulfing them in characteristic double-membrane vesicles and conveying the cargo to lysosomes. It is a dynamic pathway tunable at multiple levels and responsive to nutrient and stress stimuli, also coming from the extracellular microenvironment and its remodeling. In the extracellular matrix, collagen type VI forms a distinctive set of beaded microfilaments that assemble into an intricate and multimodular meshwork of tightly linked proteins and surface receptors. When missing or defective, collagen VI triggers a series of pathological events in skeletal muscle and other tissues, with a remarkable impact on key cell processes, such as apoptosis and autophagy. In this review, we discuss the current knowledge about collagen VI regulation of autophagy in the different experimental models and human pathologies where it was studied, and provide some hints for future directions aimed at the fine dissection of this intriguing relationship, as well as its prospective translational impact for disease and therapy.",0,0,scopus,"['visual stimulus', 'tacit knowledge', 'mesh topologies', 'stochastic processes', 'mathematics', 'knowledge management', 'topology', 'knowledge based systems', 'standard model', 'correlation analysis', 'the standard model', 'brain computer interface', 'electronic document identification systems', 'explicit knowledge', 'probability', 'domain knowledge']",Ullrich congenital muscular dystrophy,"['mesh', 'collagen']","['versatile', 'process', 'cell', 'proteins', 'entire', 'organelles', 'pathogens', 'characteristic', 'double', 'membrane', 'vesicles', 'cargo', 'lysosomes', 'dynamic', 'pathway', 'tunable', 'multiple', 'levels', 'responsive', 'nutrient', 'stress', 'stimuli', 'extracellular', 'microenvironment', 'remodeling', 'extracellular', 'matrix', 'collagen', 'type', 'distinctive', 'set', 'beaded', 'microfilaments', 'intricate', 'multimodular', 'meshwork', 'proteins', 'surface', 'receptors', 'defective', 'collagen', 'series', 'pathological', 'events', 'skeletal', 'muscle', 'other', 'tissues', 'remarkable', 'impact', 'key', 'cell', 'processes', 'such', 'apoptosis', 'autophagy', 'review', 'current', 'knowledge', 'collagen', 'regulation', 'autophagy', 'different', 'experimental', 'models', 'human', 'pathologies', 'hints', 'future', 'directions', 'fine', 'dissection', 'intriguing', 'relationship', 'prospective', 'translational', 'impact', 'disease', 'therapy']"
63,63,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092049111&origin=inward,Sarcoma pathology and biology,"¬© Springer Nature Switzerland AG 2021.Pediatric sarcomas include a variety of histopathological patterns and diagnoses with a wide spectrum of underlying biologic mechanisms. Classic pediatric small round blue cell tumors, including alveolar rhabdomyosarcoma and Ewing sarcoma, have well-known, characteristic fusion transcripts (PAX3/PAX7-FOXO1 or EWSR1-FLI1, respectively). Unique gene rearrangements also characterize less common pediatric sarcomas, including synovial sarcoma, desmoplastic small round cell tumor, alveolar soft part sarcoma, and clear cell sarcoma. The presence of gene rearrangements led to the identification of new sarcoma subtypes, such as CIC-, BCOR- and NTRK-rearranged sarcomas. The fusion genes are typically strong oncogenic drivers, and tumors characterized by these rearrangements have few associated mutations identified on genomic sequencing. In addition, the addition of molecular pathological techniques to identify these gene rearrangements helps to refine the histopathological diagnosis of pediatric sarcomas. However, some of the most common pediatric sarcomas, embryonal rhabdomyosarcoma, and osteosarcoma lack these recurrent chromosomal rearrangements and instead demonstrate mutations in a variety of cancer-associated genes. This chapter provides an overview of the histopathology and pathobiology underlying the most common pediatric sarcomas.",0,0,scopus,"['fusion techniques', 'fusion reactions', 'fusion algorithms', 'data fusion', 'nuclear physics', 'multiple classifiers', 'frequency bands', 'fusion methods', 'classifier fusion', 'sensors', 'image fusion', 'antennas', 'biometrics']",Ullrich congenital muscular dystrophy,"['Sarcoma', 'pathology', 'biology']","['sarcomas', 'variety', 'histopathological', 'patterns', 'diagnoses', 'wide', 'spectrum', 'biologic', 'mechanisms', 'Classic', 'pediatric', 'small', 'round', 'blue', 'cell', 'tumors', 'alveolar', 'rhabdomyosarcoma', 'sarcoma', 'characteristic', 'fusion', 'transcripts', 'Unique', 'gene', 'rearrangements', 'common', 'pediatric', 'sarcomas', 'synovial', 'sarcoma', 'desmoplastic', 'small', 'round', 'cell', 'tumor', 'alveolar', 'soft', 'part', 'sarcoma', 'clear', 'cell', 'sarcoma', 'presence', 'gene', 'rearrangements', 'identification', 'new', 'sarcoma', 'subtypes', 'such', 'sarcomas', 'fusion', 'genes', 'strong', 'oncogenic', 'drivers', 'tumors', 'rearrangements', 'few', 'associated', 'mutations', 'genomic', 'sequencing', 'addition', 'addition', 'molecular', 'pathological', 'techniques', 'gene', 'rearrangements', 'histopathological', 'diagnosis', 'pediatric', 'sarcomas', 'common', 'pediatric', 'sarcomas', 'embryonal', 'rhabdomyosarcoma', 'recurrent', 'chromosomal', 'rearrangements', 'mutations', 'variety', 'cancer', 'genes', 'chapter', 'overview', 'histopathology', 'pathobiology', 'common', 'pediatric', 'sarcomas']"
64,64,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85083857365&origin=inward,Toddler with Isolated Motor Delay and Rickets,0,0,0,scopus,"['end to end delay', 'jitter', 'computer systems', 'ad hoc networks', 'bandwidth', 'propagation delays', 'network protocols', 'time delay', 'delay jitters', 'routing protocols']",Ullrich congenital muscular dystrophy,['Toddler'],[]
65,65,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099077593&origin=inward,"Modern views on the role of main components of stroma and tumor microenvironment in invasion, migration and metastasis","¬© 2020 Morion LLC. All rights reserved.The review presents modern ideas about tumor microenvironment, which most researchers recognize as the main ‚Äúplayer‚Äù in tumor cell invasion, cell migration and metastasis. The current data on the main components of the stroma and the microenvironment, which play the role of the driving force in tumor progression, are analyzed. In particular, the review highlights the issues of origin, biological traits, phenotypic plasticity, functional heterogeneity of activated fibroblasts - myofibroblasts and tumor-associated fibroblasts, which in recent years have received much attention. Such components of the extracellular matrix proteome as collagen and matrix metalloproteinases are discussed in detail. They are mostly produced by activated fibroblasts and, on the one hand, initiate the development of desmoplasia due to type I collagen and, on the other hand, promote degradation of extracellular matrix proteins due to metalloproteinases, which generally leads to tissue remodeling that promotes tumor progression. Possibilities of using the most important indicators of extracellular matrix remodeling as potential markers and targets of clinical strategy are discussed. Key Words: tumor microenvironment, extracellular matrix, activated fibroblasts, myofibroblasts, tumor-associated fibroblasts, collagen, matrix metalloproteinases, invasion, migration, metastasis, tumor progression.",0,0,scopus,"['digital rights', 'software architecture', 'multiple views', 'component', 'viewpoint', 'digital rights management', 'software', 'access control', 'multi-views', 'visualization', 'security systems', 'access rights']",Ullrich congenital muscular dystrophy,"['Modern', 'views', 'role', 'main', 'components', 'stroma', 'tumor', 'microenvironment', 'invasion', 'migration', 'metastasis']","['rights', 'review', 'modern', 'ideas', 'tumor', 'microenvironment', 'most', 'researchers', 'main', 'player', 'tumor', 'cell', 'invasion', 'cell', 'migration', 'metastasis', 'current', 'data', 'main', 'components', 'stroma', 'microenvironment', 'role', 'force', 'tumor', 'progression', 'particular', 'review', 'issues', 'origin', 'biological', 'traits', 'phenotypic', 'plasticity', 'functional', 'heterogeneity', 'fibroblasts', 'myofibroblasts', 'tumor', 'fibroblasts', 'recent', 'years', 'much', 'attention', 'Such', 'components', 'extracellular', 'matrix', 'proteome', 'collagen', 'matrix', 'metalloproteinases', 'detail', 'fibroblasts', 'hand', 'development', 'desmoplasia', 'due', 'type', 'collagen', 'other', 'hand', 'degradation', 'extracellular', 'matrix', 'proteins', 'due', 'metalloproteinases', 'tumor', 'progression', 'Possibilities', 'important', 'indicators', 'extracellular', 'matrix', 'remodeling', 'potential', 'markers', 'targets', 'clinical', 'strategy', 'Key', 'tumor', 'microenvironment', 'extracellular', 'matrix', 'fibroblasts', 'myofibroblasts', 'tumor', 'fibroblasts', 'collagen', 'matrix', 'metalloproteinases', 'invasion', 'migration', 'metastasis', 'tumor', 'progression']"
66,66,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85098935370&origin=inward,Analysis of copy number variation in dogs implicates genomic structural variation in the development of anterior cruciate ligament rupture,"Copyright: ¬© 2020 Binversie et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Anterior cruciate ligament (ACL) rupture is an important condition of the human knee. Second ruptures are common and societal costs are substantial. Canine cranial cruciate ligament (CCL) rupture closely models the human disease. CCL rupture is common in the Labrador Retriever (5.79% prevalence), ~100-fold more prevalent than in humans. Labrador Retriever CCL rupture is a polygenic complex disease, based on genome-wide association study (GWAS) of single nucleotide polymorphism (SNP) markers. Dissection of genetic variation in complex traits can be enhanced by studying structural variation, including copy number variants (CNVs). Dogs are an ideal model for CNV research because of reduced genetic variability within breeds and extensive phenotypic diversity across breeds. We studied the genetic etiology of CCL rupture by association analysis of CNV regions (CNVRs) using 110 case and 164 control Labrador Retrievers. CNVs were called from SNPs using three different programs (PennCNV, CNVPartition, and QuantiSNP). After quality control, CNV calls were combined to create CNVRs using ParseCNV and an association analysis was performed. We found no strong effect CNVRs but found 46 small effect (max(T) permutation P<0.05) CCL rupture associated CNVRs in 22 autosomes; 25 were deletions and 21 were duplications. Of the 46 CCL rupture associated CNVRs, we identified 39 unique regions. Thirty four were identified by a single calling algorithm, 3 were identified by two calling algorithms, and 2 were identified by all three algorithms. For 42 of the associated CNVRs, frequency in the population was <10% while 4 occurred at a frequency in the population ranging from 10‚Äì25%. Average CNVR length was 198,872bp and CNVRs covered 0.11 to 0.15% of the genome. All CNVRs were associated with case status. CNVRs did not overlap previous canine CCL rupture risk loci identified by GWAS. Associated CNVRs contained 152 annotated genes; 12 CNVRs did not have genes mapped to CanFam3.1. Using pathway analysis, a cluster of 19 homeobox domain transcript regulator genes was associated with CCL rupture (P = 6.6E-13). This gene cluster influences cranial-caudal body pattern formation during embryonic limb development. Clustered genes were found in 3 CNVRs on chromosome 14 (HoxA), 28 (NKX6-2), and 36 (HoxD). When analysis was limited to deletion CNVRs, the association was strengthened (P = 8.7E-16). This study suggests a component of the polygenic risk of CCL rupture in Labrador Retrievers is associated with small effect CNVs and may include aspects of stifle morphology regulated by homeobox domain transcript regulator genes.",0,0,scopus,"['signal processing', 'switching systems', 'component', 'software', 'adaptive algorithms', 'switching control', 'ranging', 'ultra-wideband (uwb)', 'open access', 'correlation analysis', 'electronic publishing', 'range finding', 'mathematics']",Ullrich congenital muscular dystrophy,"['Analysis', 'copy', 'number', 'variation', 'dogs', 'genomic', 'structural', 'variation', 'development', 'anterior', 'cruciate', 'ligament', 'rupture']","['Copyright', 'open', 'access', 'article', 'terms', 'unrestricted', 'use', 'distribution', 'reproduction', 'medium', 'original', 'author', 'source', 'Anterior', 'cruciate', 'ligament', 'rupture', 'important', 'condition', 'human', 'knee', 'Second', 'ruptures', 'common', 'societal', 'costs', 'substantial', 'Canine', 'cranial', 'cruciate', 'ligament', 'rupture', 'human', 'disease', 'CCL', 'rupture', 'common', '%', 'prevalence', 'prevalent', 'humans', 'rupture', 'polygenic', 'complex', 'disease', 'genome', 'wide', 'association', 'study', 'single', 'nucleotide', 'polymorphism', 'markers', 'Dissection', 'genetic', 'variation', 'complex', 'traits', 'structural', 'variation', 'copy', 'number', 'variants', 'Dogs', 'ideal', 'model', 'research', 'genetic', 'variability', 'breeds', 'extensive', 'phenotypic', 'diversity', 'breeds', 'genetic', 'etiology', 'rupture', 'association', 'analysis', 'regions', 'CNVRs', 'case', 'control', 'CNVs', 'SNPs', 'different', 'programs', 'PennCNV', 'quality', 'control', 'calls', 'CNVRs', 'ParseCNV', 'association', 'analysis', 'strong', 'effect', 'CNVRs', 'small', 'effect', 'permutation', 'rupture', 'CNVRs', 'autosomes', 'deletions', 'duplications', 'rupture', 'CNVRs', 'unique', 'regions', 'single', 'algorithm', 'algorithms', 'algorithms', 'CNVRs', 'frequency', 'population', '%', 'frequency', 'population', '%', 'Average', 'length', 'CNVRs', '%', 'genome', 'CNVRs', 'case', 'status', 'CNVRs', 'previous', 'canine', 'CCL', 'rupture', 'risk', 'loci', 'CNVRs', 'annotated', 'genes', 'CNVRs', 'genes', 'pathway', 'analysis', 'cluster', 'homeobox', 'domain', 'transcript', 'regulator', 'genes', 'rupture', 'P', 'gene', 'cluster', 'cranial', 'caudal', 'body', 'pattern', 'formation', 'embryonic', 'limb', 'development', 'genes', 'CNVRs', 'chromosome', 'analysis', 'deletion', 'CNVRs', 'association', 'P', 'study', 'component', 'polygenic', 'risk', 'rupture', 'small', 'effect', 'CNVs', 'aspects', 'stifle', 'morphology', 'homeobox', 'domain', 'transcript', 'regulator', 'genes']"
67,67,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096599011&origin=inward,Different histological patterns of type-V collagen levels confer a matrices-privileged tissue microenvironment for invasion in malignant tumors with prognostic value,"¬© 2020 The AuthorsPrevious studies have reported a close relationship between type V collagen (Col V) and tumor invasion and motility in both breast cancer (BC) and lung cancer (LC). The present work aims to determine whether the extracellular-matrix (ECM)-defined microenvironment influences patient clinical outcome and investigate to which extent histological patterns of Col V expression in malignant cells have a prognostic effect in patients. To that end, we examined the expression of Col V in the tissues of 174 primary tumors (MM, N = 82; LC, N = 41; and BC, N = 46) by immunohistochemistry. We found: (1) diffuse strong green birefringence in membrane and cytoplasm individualizing malignant cells in MM; (2) a focal and weak birefringence mainly in cytoplasmic membrane involving groups of malignant cells in LC and BC; (3) higher average H-score of Col V in MM than in LC and BC samples; (4) a direct correlation between Col V histologic pattern and TNM stage IV, status and median overall survival; (5) patients with LC in TNM stage I, and Col V ‚â§ 41.7 IOD/mm2 had a low risk of death and a median survival time more than 20 months; (6) patients with MM in TNM stage IV and Col V > 41.7 IOD/mm2 presented a high risk of death and a median survival time of just 20 months. These findings suggest that high levels of Col V individualizing malignant cells, as observed in MM, and low levels grouping malignant cells, as observed in LC and BC, confers different immune-privileged tissue microenvironment for tumor invasion with impact on prognosis of the patients.",0,0,scopus,"['light polarization', 'polarization state', 'fiber lasers', 'kaplan-meiers estimate', 'wavelength shift', 'second harmonic generation', 'correlation analysis', 'wavelength', 'correlation coefficient', 'fiber optic components', 'proportional hazards models', 'polarimeters', 'harmonic generation']",Ullrich congenital muscular dystrophy,"['Different', 'histological', 'patterns', 'type', 'V', 'collagen', 'levels', 'matrices', 'privileged', 'tissue', 'microenvironment', 'invasion', 'malignant', 'tumors', 'prognostic', 'value']","['studies', 'close', 'relationship', 'type', 'V', 'collagen', 'tumor', 'invasion', 'motility', 'breast', 'cancer', 'lung', 'cancer', 'present', 'work', 'extracellular', 'matrix', 'microenvironment', 'influences', 'patient', 'clinical', 'outcome', 'extent', 'histological', 'patterns', 'expression', 'malignant', 'cells', 'prognostic', 'effect', 'patients', 'end', 'expression', 'tissues', 'primary', 'tumors', 'immunohistochemistry', 'strong', 'green', 'birefringence', 'membrane', 'cytoplasm', 'malignant', 'cells', 'focal', 'weak', 'birefringence', 'cytoplasmic', 'membrane', 'groups', 'malignant', 'cells', 'higher', 'average', 'H', 'score', 'samples', 'direct', 'correlation', 'histologic', 'pattern', 'TNM', 'stage', 'status', 'median', 'overall', 'survival', 'patients', 'stage', 'low', 'risk', 'death', 'median', 'survival', 'time', 'more', 'months', 'patients', 'stage', 'high', 'risk', 'death', 'median', 'survival', 'time', 'months', 'findings', 'high', 'levels', 'malignant', 'cells', 'low', 'levels', 'malignant', 'cells', 'different', 'immune', 'privileged', 'tissue', 'microenvironment', 'tumor', 'invasion', 'impact', 'prognosis', 'patients']"
68,68,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85094881323&origin=inward,Congenital muscular dystrophy-associated inflammatory chemokines provide axes for effective recruitment of therapeutic adult stem cell into muscles,"¬© 2020, The Author(s).Background: Congenital muscular dystrophies (CMD) are a clinically and genetically heterogeneous group of neuromuscular disorders characterized by muscle weakness. The two most prevalent forms of CMD, collagen VI-related myopathies (COL6RM) and laminin Œ±2 deficient CMD type 1A (MDC1A), are both caused by deficiency or dysfunction of extracellular matrix proteins. Previously, we showed that an intramuscular transplantation of human adipose-derived stem cells (ADSC) into the muscle of the Col6a1‚àí/‚àí mice results in efficient stem cell engraftment, migration, long-term survival, and continuous production of the collagen VI protein, suggesting the feasibility of the systemic cellular therapy for COL6RM. In order for this therapeutic approach to work however, stem cells must be efficiently targeted to the entire body musculature. Thus, the main goal of this study is to test whether muscle homing of systemically transplanted ADSC can be enhanced by employing muscle-specific chemotactic signals originating from CMD-affected muscle tissue. Methods: Proteomic screens of chemotactic molecules were conducted in the skeletal muscles of COL6RM- and MDC1A-affected patients and CMD mouse models to define the inflammatory and immune activities, thus, providing potential markers of disease activity or treatment effect. Also using a pre-clinical animal model, recapitulating mild Ullrich congenital muscular dystrophy (UCMD), the therapeutic relevance of identified chemotactic pathways was investigated in vivo, providing a basis for future clinical investigations. Results: Comprehensive proteomic screens evaluating relevant human and mouse skeletal muscle biopsies offered chemotactic axes to enhance directional migration of systemically transplanted cells into CMD-affected muscles, including CCL5-CCR1/3/5, CCL2-CCR2, CXCL1/2-CXCR1,2, and CXCL7-CXCR2. Also, the specific populations of ADSC selected with an affinity for the chemokines being released by damaged muscle showed efficient migration to injured site and presented their therapeutic effect. Conclusions: Collectively, identified molecules provided insight into the mechanisms governing directional migration and intramuscular trafficking of systemically infused stem cells, thus, permitting broad and effective application of the therapeutic adult stem cells for CMD treatment.",0,0,scopus,"['cellular telephone systems', 'wireless networks', 'computer science', 'kaplan-meiers estimate', 'wireless', 'cellular radio systems', 'user interfaces', 'heterogeneous networks', 'bioinformatics', 'display devices', 'cellular', 'proportional hazards models']",Ullrich congenital muscular dystrophy,"['Congenital', 'muscular', 'dystrophy', 'inflammatory', 'chemokines', 'axes', 'effective', 'recruitment', 'therapeutic', 'adult', 'stem', 'cell', 'muscles']","['Congenital', 'muscular', 'dystrophies', 'heterogeneous', 'group', 'neuromuscular', 'disorders', 'muscle', 'weakness', 'prevalent', 'forms', 'collagen', 'myopathies', 'laminin', 'deficient', 'type', '1A', 'deficiency', 'dysfunction', 'extracellular', 'matrix', 'proteins', 'intramuscular', 'transplantation', 'human', 'adipose', 'stem', 'cells', 'muscle', 'mice', 'results', 'efficient', 'stem', 'cell', 'engraftment', 'migration', 'long', 'term', 'survival', 'continuous', 'production', 'collagen', 'protein', 'feasibility', 'systemic', 'cellular', 'therapy', 'order', 'therapeutic', 'approach', 'work', 'stem', 'cells', 'entire', 'body', 'musculature', 'main', 'goal', 'study', 'muscle', 'homing', 'muscle', 'specific', 'chemotactic', 'signals', 'muscle', 'tissue', 'Methods', 'Proteomic', 'screens', 'chemotactic', 'molecules', 'skeletal', 'muscles', 'patients', 'mouse', 'models', 'inflammatory', 'immune', 'activities', 'potential', 'markers', 'disease', 'activity', 'treatment', 'effect', 'pre', '-', 'clinical', 'animal', 'model', 'mild', 'congenital', 'muscular', 'dystrophy', 'therapeutic', 'relevance', 'chemotactic', 'pathways', 'vivo', 'basis', 'future', 'clinical', 'investigations', 'Results', 'Comprehensive', 'proteomic', 'screens', 'relevant', 'human', 'skeletal', 'muscle', 'biopsies', 'chemotactic', 'axes', 'directional', 'migration', 'cells', 'muscles', 'CCL2-CCR2', 'CXCL7-CXCR2', 'specific', 'populations', 'affinity', 'chemokines', 'damaged', 'muscle', 'efficient', 'migration', 'site', 'therapeutic', 'effect', 'Conclusions', 'molecules', 'insight', 'mechanisms', 'directional', 'migration', 'intramuscular', 'trafficking', 'stem', 'cells', 'broad', 'effective', 'application', 'therapeutic', 'adult', 'stem', 'cells', 'treatment']"
69,69,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092901715&origin=inward,Various haploinsufficiency mechanisms in Pitt-Hopkins syndrome,"¬© 2020Pitt-Hopkins syndrome is a rare neurodevelopment disorder caused by haploinsufficiency of the transcription factor 4 (TCF4). The main clinical symptoms of Pitt-Hopkins syndrome are severe development delay, intellectual disability, characteristic facial phenotype, and breathing abnormalities, including episodic hyperventilation. Different pathogenic variants can lead to Pitt-Hopkins syndrome. The most common are large deletions at 18q21 encompassing the TCF4 gene and frameshifting/nonsense single nucleotide variants. However, variants in noncoding regions can also lead to Pitt-Hopkins syndrome by disrupting the normal pre-mRNA splicing machinery. Here we describe three patients with Pitt-Hopkins syndrome caused by a large deletion in chromosome 18, a nonsense variant, and a novel variant located in intron 11 of TCF4 c.922+5G > A. Using RT-PCR analysis and minigene splicing assay we showed that this intronic variant leads to exon 11 skipping resulting in a formation of a premature stop codon. To our knowledge, this is the first functional annotation of a splicing variant in Pitt-Hopkins syndrome.",0,0,scopus,"['end to end delay', 'jitter', 'ad hoc networks', 'bandwidth', 'gesture recognition', 'facial expression', 'propagation delays', 'network protocols', 'face recognition', 'facial images', 'routing protocols']",Ullrich congenital muscular dystrophy,"['Various', 'haploinsufficiency', 'mechanisms', 'syndrome']","['syndrome', 'rare', 'neurodevelopment', 'disorder', 'haploinsufficiency', 'transcription', 'factor', 'main', 'clinical', 'symptoms', 'syndrome', 'severe', 'development', 'delay', 'intellectual', 'disability', 'characteristic', 'facial', 'phenotype', 'breathing', 'abnormalities', 'episodic', 'hyperventilation', 'Different', 'pathogenic', 'variants', 'syndrome', 'common', 'large', 'deletions', 'gene', 'frameshifting', 'nonsense', 'single', 'nucleotide', 'variants', 'variants', 'noncoding', 'regions', 'syndrome', 'normal', 'pre', '-', 'mRNA', 'machinery', 'patients', 'syndrome', 'large', 'deletion', 'chromosome', 'nonsense', 'variant', 'novel', 'variant', 'intron', 'c.922', 'G', 'A.', 'analysis', 'minigene', 'assay', 'intronic', 'variant', 'leads', 'formation', 'premature', 'stop', 'codon', 'knowledge', 'first', 'functional', 'annotation', 'splicing', 'variant', 'syndrome']"
70,70,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092710180&origin=inward,Modelling neuromuscular diseases in the age of precision medicine,"¬© 2020 by the authors. Licensee MDPI, Basel, Switzerland.Advances in knowledge resulting from the sequencing of the human genome, coupled with technological developments and a deeper understanding of disease mechanisms of pathogenesis are paving the way for a growing role of precision medicine in the treatment of a number of human conditions. The goal of precision medicine is to identify and deliver effective therapeutic approaches based on patients‚Äô genetic, environmental, and lifestyle factors. With the exception of cancer, neurological diseases provide the most promising opportunity to achieve treatment personalisation, mainly because of accelerated progress in gene discovery, deep clinical phenotyping, and biomarker availability. Developing reproducible, predictable and reliable disease models will be key to the rapid delivery of the anticipated benefits of precision medicine. Here we summarize the current state of the art of preclinical models for neuromuscular diseases, with particular focus on their use and limitations to predict safety and efficacy treatment outcomes in clinical trials.",0,0,scopus,"['tacit knowledge', 'stochastic processes', 'mathematics', 'knowledge based systems', 'standard model', 'correlation analysis', 'the standard model', 'electronic document identification systems', 'explicit knowledge', 'probability', 'domain knowledge']",Ullrich congenital muscular dystrophy,"['neuromuscular', 'diseases', 'age', 'precision', 'medicine']","['authors', 'Advances', 'knowledge', 'sequencing', 'human', 'genome', 'technological', 'developments', 'deeper', 'understanding', 'disease', 'mechanisms', 'pathogenesis', 'way', 'role', 'precision', 'medicine', 'treatment', 'number', 'human', 'conditions', 'goal', 'precision', 'medicine', 'effective', 'therapeutic', 'approaches', 'patients', 'genetic', 'environmental', 'lifestyle', 'factors', 'exception', 'cancer', 'neurological', 'diseases', 'promising', 'opportunity', 'treatment', 'personalisation', 'accelerated', 'progress', 'gene', 'discovery', 'deep', 'clinical', 'phenotyping', 'biomarker', 'availability', 'reproducible', 'predictable', 'reliable', 'disease', 'models', 'key', 'rapid', 'delivery', 'benefits', 'precision', 'medicine', 'current', 'state', 'art', 'preclinical', 'models', 'neuromuscular', 'diseases', 'particular', 'focus', 'use', 'limitations', 'safety', 'efficacy', 'treatment', 'outcomes', 'clinical', 'trials']"
71,71,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092557230&origin=inward,Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples,"¬© 2020, The Author(s).The COVID-19 pandemic has emerged as a global health emergency due to its association with severe pneumonia and relative high mortality. However, the molecular characteristics and pathological features underlying COVID-19 pneumonia remain largely unknown. To characterize molecular mechanisms underlying COVID-19 pathogenesis in the lung tissue using a proteomic approach, fresh lung tissues were obtained from newly deceased patients with COVID-19 pneumonia. After virus inactivation, a quantitative proteomic approach combined with bioinformatics analysis was used to detect proteomic changes in the SARS-CoV-2-infected lung tissues. We identified significant differentially expressed proteins involved in a variety of fundamental biological processes including cellular metabolism, blood coagulation, immune response, angiogenesis, and cell microenvironment regulation. Several inflammatory factors were upregulated, which was possibly caused by the activation of NF-Œ∫B signaling. Extensive dysregulation of the lung proteome in response to SARS-CoV-2 infection was discovered. Our results systematically outlined the molecular pathological features in terms of the lung response to SARS-CoV-2 infection, and provided the scientific basis for the therapeutic target that is urgently needed to control the COVID-19 pandemic.",0,0,scopus,"['cellular telephone systems', 'feature space', 'computer science', 'classification methods', 'rate control', 'wireless', 'cellular radio systems', 'security of data', 'h.264/avc', 'pattern recognition', 'mean absolute differences', 'bioinformatics', 'computer viruses', 'cellular']",Ullrich congenital muscular dystrophy,"['Pathological', 'features', 'COVID-19-associated', 'lung', 'injury', 'preliminary', 'proteomics', 'report', 'clinical', 'samples']","['pandemic', 'global', 'health', 'emergency', 'association', 'severe', 'pneumonia', 'relative', 'high', 'mortality', 'molecular', 'characteristics', 'pathological', 'features', 'pneumonia', 'unknown', 'molecular', 'mechanisms', 'pathogenesis', 'lung', 'tissue', 'proteomic', 'approach', 'fresh', 'lung', 'tissues', 'patients', 'pneumonia', 'virus', 'inactivation', 'quantitative', 'proteomic', 'approach', 'bioinformatics', 'analysis', 'proteomic', 'changes', 'lung', 'tissues', 'significant', 'proteins', 'variety', 'fundamental', 'biological', 'processes', 'cellular', 'metabolism', 'blood', 'coagulation', 'immune', 'response', 'angiogenesis', 'cell', 'microenvironment', 'regulation', 'Several', 'inflammatory', 'factors', 'activation', 'Œ∫B', 'Extensive', 'dysregulation', 'lung', 'proteome', 'response', 'infection', 'results', 'molecular', 'pathological', 'features', 'terms', 'lung', 'response', 'infection', 'scientific', 'basis', 'therapeutic', 'target', 'pandemic']"
72,72,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091687185&origin=inward,The first report of two homozygous sequence variants in FKRP and SELENON genes associated with syndromic congenital muscular dystrophy in Iran: Further expansion of the clinical phenotypes,"¬© 2020 John Wiley & Sons, Ltd.Background: Congenital muscular dystrophy (CMD) refers to hypotonia and delayed motor development that is manifested at or near the birth. Additional presentations have been observed in CMD syndromes. Methods: Thorough clinical examinations were performed on two unrelated Iranian families with typical symptoms of CMD and uncommon features such as intellectual disability and nephrolithiasis. The genomic DNA of probands were subjected to whole exome sequencing. Following the detection of candidate variants with a bioinformatic pipeline, the familial co-segregation analysis was carried out using polymerase chain reaction-based Sanger sequencing. Results: We identified a missense homozygous variant in the fukutin-related protein (FKRP) gene (c.968G>A, p.Arg323His) related to CMD-dystroglycanopathy type B5 (MDDGB5) and a frameshift homozygous variant in the selenoprotein N (SELENON) gene (c.1446delC, p.Asn483Thrfs*11) associated with congenital rigid-spine muscular dystrophy 1 (RSMD1), which were completely segregated with the phenotypes in the families. These variants were not found in either the 1000 Genomes Project or the Exome Aggregation Consortium. The present study provides the first report of these homozygous sequence variants in Iran. Moreover, our study was the first observation of nephrolithiasis in FKRP-related dystroglycanopathy and intellectual disability in SELENON-related myopathies. Based on in silico studies and molecular docking, these variations induced pathogenic effects on the proteins. Conclusions: Our findings extend the genetic database of Iranian patients with CMD and, in general, the phenotypical spectrum of syndromic CMD. It is recommended to consider these variants for a more accurate clinical interpretation, prenatal diagnosis and genetic counseling in families with a history of CMD, especially in those combined with cognitive impairments or renal dysfunctions.",0,0,scopus,"['computer systems', 'computer science', 'genetic database', 'database systems', 'disabilities', 'internet', 'frequency bands', 'user with disabilities', 'bioinformatics', 'antennas']",Ullrich congenital muscular dystrophy,"['first', 'report', 'homozygous', 'sequence', 'variants', 'genes', 'syndromic', 'congenital', 'muscular', 'dystrophy', 'Further', 'expansion', 'clinical', 'phenotypes']","['Background', 'Congenital', 'muscular', 'dystrophy', 'hypotonia', 'motor', 'development', 'birth', 'Additional', 'presentations', 'syndromes', 'Methods', 'Thorough', 'clinical', 'examinations', 'unrelated', 'Iranian', 'families', 'typical', 'symptoms', 'uncommon', 'features', 'such', 'intellectual', 'disability', 'nephrolithiasis', 'genomic', 'DNA', 'probands', 'whole', 'exome', 'sequencing', 'detection', 'candidate', 'variants', 'bioinformatic', 'pipeline', 'familial', 'co', '-', 'segregation', 'analysis', 'polymerase', 'chain', 'reaction', 'sequencing', 'Results', 'missense', 'homozygous', 'variant', 'protein', 'gene', 'A', 'p', 'Arg323His', 'dystroglycanopathy', 'type', 'frameshift', 'homozygous', 'variant', 'selenoprotein', 'gene', 'p', 'Asn483Thrfs*11', 'congenital', 'rigid', 'spine', 'muscular', 'dystrophy', 'phenotypes', 'families', 'variants', 'present', 'study', 'first', 'report', 'homozygous', 'sequence', 'variants', 'study', 'first', 'observation', 'nephrolithiasis', 'dystroglycanopathy', 'intellectual', 'disability', 'myopathies', 'silico', 'studies', 'molecular', 'docking', 'variations', 'pathogenic', 'effects', 'proteins', 'Conclusions', 'findings', 'genetic', 'database', 'Iranian', 'patients', 'general', 'phenotypical', 'spectrum', 'syndromic', 'variants', 'accurate', 'clinical', 'interpretation', 'prenatal', 'diagnosis', 'genetic', 'counseling', 'families', 'history', 'cognitive', 'impairments', 'renal', 'dysfunctions']"
73,73,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091393028&origin=inward,Monosodium Glutamate Induces Cytotoxicity in Rat Liver via Mitochondrial Permeability Transition Pore Opening,"¬© 2020, Springer Science+Business Media, LLC, part of Springer Nature.Monosodium glutamate (MSG) is a major food additive used as a flavor enhancer. A lot of controversies have been generated over the use of MSG. The present study therefore investigated whether MSG would induce cytotoxicity via the induction of mitochondrial permeability transition (mPT) pore opening. 36 male albino rats were used for this study. The rats were equally divided into six groups: group I is the control while group II, III, IV, V, and VI were orally treated with MSG (25, 50, 100, 200, and 400 mg/kg) daily for 28 days. The opening of the pore, cytochrome c release, mitochondrial ATPase activity, mitochondrial lipid peroxidation and hepatic DNA fragmentation were determined spectrophotometrically. Histological assessment of prostate and brain was carried out. The results show that MSG at concentrations ‚â§30 ¬µg/ml did not induce mPT pore opening while higher concentrations caused significant induction of pore opening. Also, at lower doses (25 and 50 mg/kg), MSG did not cause any significant induction of mPT pore opening while at higher doses, there were significant induction of pore opening. Similar trend of results was recorded for cytochrome c release, mitochondrial ATPase activity and lipid peroxidation. The histological results show that at low doses (25 and 50 mg/kg), no significant lesion was observed while higher doses caused benign prostatic hyperplasia (BPH) in the prostate and necrotic damage in the brain. MSG administration at low dose is tolerable while high doses induce cytotoxicity via mPT pore opening.",0,0,scopus,"['business activities', 'electronic commerce', 'information technology', 'social sciences', 'information systems', 'education', 'ebusiness', 'sociology', 'business process']",Ullrich congenital muscular dystrophy,['Opening'],"['Science+Business', 'part', 'glutamate', 'major', 'food', 'additive', 'flavor', 'enhancer', 'lot', 'controversies', 'use', 'present', 'study', 'cytotoxicity', 'induction', 'mitochondrial', 'permeability', 'transition', 'pore', 'opening', 'male', 'albino', 'rats', 'study', 'rats', 'groups', 'group', 'control', 'group', 'mg', 'kg', 'days', 'opening', 'pore', 'release', 'mitochondrial', 'activity', 'mitochondrial', 'lipid', 'peroxidation', 'hepatic', 'DNA', 'fragmentation', 'Histological', 'assessment', 'prostate', 'brain', 'results', 'concentrations', '¬µg', 'ml', 'pore', 'opening', 'higher', 'concentrations', 'significant', 'induction', 'pore', 'opening', 'lower', 'doses', 'mg', 'significant', 'induction', 'pore', 'opening', 'while', 'higher', 'doses', 'significant', 'induction', 'pore', 'opening', 'Similar', 'trend', 'results', 'cytochrome', 'release', 'mitochondrial', 'activity', 'lipid', 'peroxidation', 'histological', 'results', 'low', 'doses', 'mg', 'kg', 'significant', 'lesion', 'higher', 'doses', 'benign', 'prostatic', 'hyperplasia', 'prostate', 'necrotic', 'damage', 'brain', 'administration', 'low', 'dose', 'tolerable', 'high', 'doses', 'cytotoxicity', 'pore', 'opening']"
74,74,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090090617&origin=inward,FGF/FGFR signaling in health and disease,"¬© 2020, The Author(s).Growing evidences suggest that the fibroblast growth factor/FGF receptor (FGF/FGFR) signaling has crucial roles in a multitude of processes during embryonic development and adult homeostasis by regulating cellular lineage commitment, differentiation, proliferation, and apoptosis of various types of cells. In this review, we provide a comprehensive overview of the current understanding of FGF signaling and its roles in organ development, injury repair, and the pathophysiology of spectrum of diseases, which is a consequence of FGF signaling dysregulation, including cancers and chronic kidney disease (CKD). In this context, the agonists and antagonists for FGF-FGFRs might have therapeutic benefits in multiple systems.",0,0,scopus,"['cellular', 'spectrum sensing', 'cellular telephone systems', 'cost savings', 'wireless', 'frequency bands', 'cellular radio systems', 'channel capacity', 'cellular network', 'cognitive radio network', 'dynamic spectrum access', 'cellular system', 'antennas', 'dynamic spectrum', 'economics']",Ullrich congenital muscular dystrophy,"['health', 'disease']","['Author(s).Growing', 'evidences', 'fibroblast', 'growth', 'factor', 'receptor', 'crucial', 'roles', 'multitude', 'processes', 'embryonic', 'development', 'adult', 'homeostasis', 'cellular', 'lineage', 'commitment', 'differentiation', 'proliferation', 'apoptosis', 'various', 'types', 'cells', 'review', 'comprehensive', 'overview', 'current', 'understanding', 'roles', 'organ', 'development', 'injury', 'repair', 'pathophysiology', 'spectrum', 'diseases', 'consequence', 'dysregulation', 'cancers', 'chronic', 'kidney', 'disease', 'context', 'agonists', 'antagonists', 'therapeutic', 'benefits', 'multiple', 'systems']"
75,75,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089395981&origin=inward,Collagen VIŒ±2 chain deficiency causes trabecular bone loss by potentially promoting osteoclast differentiation through enhanced TNFŒ± signaling,"¬© 2020, The Author(s).Type VI collagen is well known for its role in muscular disorders, however its function in bone is still not well understood. To examine its role in bone we analyzed femoral and vertebral bone mass by micro-computed tomography analysis, which showed lower bone volume/total volume and trabecular number in Col6Œ±2-KO mice compared with WT. Dynamic histomorphometry showed no differences in trabecular bone formation between WT and Col6Œ±2-KO mice based on the mineral appositional rate, bone formation rate, and mineralizing perimeter. Femoral sections were assessed for the abundance of Tartrate Resistant Acid Phosphatase-positive osteoclasts, which revealed that mutant mice had more osteoclasts compared with WT mice, indicating that the primary effect of Col6a2 deficiency is on osteoclastogenesis. When bone marrow stromal cells (BMSCs) from WT and Col6Œ±2-KO mice were treated with rmTNFŒ± protein, the Col6Œ±2-KO cells expressed higher levels of TNFŒ± mRNA compared with WT cells. This was accompanied by higher levels of p-p65, a down-stream target of TNFŒ±, suggesting that BMSCs from Col6Œ±2-KO mice are highly sensitive to TNFŒ± signaling. Taken together, our data imply that Col6a2 deficiency causes trabecular bone loss by enhancing osteoclast differentiation through enhanced TNFŒ± signaling.",0,0,scopus,"['medical images', 'computerized tomography', 'x-ray computed tomography', 'data stream', 'image processing', 'optical tomography', 'database systems', 'data mining', 'micro-ct', 'image analysis', 'image reconstruction', 'data communication systems']",Ullrich congenital muscular dystrophy,"['chain', 'deficiency', 'trabecular', 'bone', 'loss', 'osteoclast', 'differentiation', 'TNFŒ±']","['collagen', 'known', 'role', 'muscular', 'disorders', 'function', 'bone', 'role', 'bone', 'femoral', 'vertebral', 'bone', 'mass', 'micro', 'computed', 'tomography', 'analysis', 'lower', 'bone', 'volume', 'total', 'volume', 'trabecular', 'number', 'Col6Œ±2-KO', 'mice', 'Dynamic', 'histomorphometry', 'differences', 'trabecular', 'bone', 'formation', 'mice', 'mineral', 'appositional', 'rate', 'bone', 'formation', 'rate', 'perimeter', 'Femoral', 'sections', 'abundance', 'positive', 'osteoclasts', 'mutant', 'mice', 'more', 'osteoclasts', 'mice', 'primary', 'effect', 'deficiency', 'osteoclastogenesis', 'bone', 'marrow', 'stromal', 'cells', 'Col6Œ±2-KO', 'mice', 'rmTNFŒ±', 'protein', 'cells', 'higher', 'levels', 'TNFŒ±', 'mRNA', 'cells', 'higher', 'levels', 'p', 'p65', 'down', 'stream', 'target', 'TNFŒ±', 'BMSCs', 'Col6Œ±2-KO', 'mice', 'sensitive', 'TNFŒ±', 'data', 'deficiency', 'trabecular', 'bone', 'loss', 'osteoclast', 'differentiation', 'TNFŒ±']"
76,76,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088947049&origin=inward,A Revisited Diagnosis of Collagen VI Related Muscular Dystrophy in a Patient with a Novel COL6A2 Variant and 21q223 Deletion,"¬© 2020 Georg Thieme Verlag KG Stuttgart ¬∑ New York.The genetic etiology of collagen VI related muscular dystrophies is heterogenous. Genomic deletions in one allele involving COL6A2 or both COL6A1 and COL6A2 unmasking a pathogenic variant in the second nondeleted allele have been described in the etiology. We aimed to report the clinical and molecular findings of a 13-year-old boy with ring chromosome 21 who presented to our clinic with easy fatigability, muscle weakness, and waddling gait. Phenotypic delineation along with chromosomal microarray analysis and DNA sequencing were performed. Affymetrix CytoScan Optima array platform and DNA sequencing revealed a 2,202 kb de novo deletion at 21q22.3, including COL6A1 and COL6A2, and a novel heterozygous variant at position c.2875G > A;p.(Glu959Lys) in COL6A2, respectively. Before his admission to our center, the patient was evaluated for hypotonia elsewhere when he was 15 months old. He was diagnosed with ring chromosome 21 on peripheral blood karyotype analysis; however, no further assessment was performed at that time. He had normal growth with mild dysmorphic facial features, distal laxity, gastrocnemius hypertrophy, proximal muscle weakness, increased lordotic posture with mild flexion contractures at the knees, and gait disturbance. Although the phenotype does not fit into classical Ullrich congenital muscular dystrophies, muscle magnetic resonance imaging (MRI) revealed a complementary pattern consistent with collagen VI related myopathies. Genetic testing confirmed the clinical diagnosis as well. This patient yet represents another example of the effect of large genomic deletions leading to recessive disorders through unmasking a pathogenic variant in the second nondeleted allele.",0,0,scopus,"['crossover operator', 'gesture recognition', 'facial expression', 'correlation analysis', 'genetic operators', 'evolutionary algorithms', 'face recognition', 'facial images', 'mathematics']",Ullrich congenital muscular dystrophy,"['Revisited', 'Novel', 'Deletion']","['genetic', 'etiology', 'collagen', 'muscular', 'dystrophies', 'heterogenous', 'Genomic', 'deletions', 'allele', 'COL6A2', 'COL6A1', 'COL6A2', 'pathogenic', 'variant', 'second', 'allele', 'etiology', 'clinical', 'molecular', 'findings', '13-year', 'old', 'boy', 'ring', 'chromosome', 'clinic', 'easy', 'fatigability', 'muscle', 'weakness', 'waddling', 'gait', 'delineation', 'chromosomal', 'microarray', 'analysis', 'DNA', 'sequencing', 'platform', 'DNA', 'sequencing', 'kb', 'novo', 'deletion', 'COL6A1', 'COL6A2', 'novel', 'heterozygous', 'variant', 'position', 'admission', 'center', 'patient', 'hypotonia', 'months', 'old', 'ring', 'chromosome', 'peripheral', 'blood', 'karyotype', 'analysis', 'further', 'assessment', 'time', 'normal', 'growth', 'mild', 'dysmorphic', 'facial', 'features', 'distal', 'laxity', 'gastrocnemius', 'hypertrophy', 'proximal', 'muscle', 'weakness', 'lordotic', 'posture', 'mild', 'flexion', 'contractures', 'knees', 'disturbance', 'phenotype', 'classical', 'congenital', 'muscular', 'dystrophies', 'muscle', 'magnetic', 'resonance', 'imaging', 'complementary', 'pattern', 'consistent', 'collagen', 'related', 'myopathies', 'Genetic', 'testing', 'clinical', 'diagnosis', 'patient', 'example', 'effect', 'large', 'genomic', 'deletions', 'recessive', 'disorders', 'pathogenic', 'variant', 'second', 'nondeleted', 'allele']"
77,77,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088782026&origin=inward,The Ehlers‚ÄìDanlos syndromes,"¬© 2020, Springer Nature Limited.The Ehlers‚ÄìDanlos syndromes (EDS) are a heterogeneous group of hereditary disorders of connective tissue, with common features including joint hypermobility, soft and hyperextensible skin, abnormal wound healing and easy bruising. Fourteen different types of EDS are recognized, of which the molecular cause is known for 13 types. These types are caused by variants in 20 different genes, the majority of which encode the fibrillar collagen types I, III and V, modifying or processing enzymes for those proteins, and enzymes that can modify glycosaminoglycan chains of proteoglycans. For the hypermobile type of EDS, the molecular underpinnings remain unknown. As connective tissue is ubiquitously distributed throughout the body, manifestations of the different types of EDS are present, to varying degrees, in virtually every organ system. This can make these disorders particularly challenging to diagnose and manage. Management consists of a care team responsible for surveillance of major and organ-specific complications (for example, arterial aneurysm and dissection), integrated physical medicine and rehabilitation. No specific medical or genetic therapies are available for any type of EDS.",0,0,scopus,"['feature space', 'wireless networks', 'classification methods', 'information technology', 'information management', 'database systems', 'security systems', 'pattern recognition', 'video surveillance', 'heterogeneous networks', 'sensors', 'surveillance applications']",Ullrich congenital muscular dystrophy,[],"['syndromes', 'heterogeneous', 'group', 'hereditary', 'disorders', 'connective', 'tissue', 'common', 'features', 'joint', 'hypermobility', 'soft', 'hyperextensible', 'skin', 'abnormal', 'wound', 'healing', 'easy', 'bruising', 'different', 'types', 'molecular', 'cause', 'types', 'types', 'variants', 'different', 'genes', 'majority', 'fibrillar', 'collagen', 'types', 'V', 'processing', 'enzymes', 'proteins', 'enzymes', 'glycosaminoglycan', 'chains', 'proteoglycans', 'hypermobile', 'type', 'molecular', 'underpinnings', 'unknown', 'connective', 'tissue', 'body', 'manifestations', 'different', 'types', 'present', 'degrees', 'organ', 'system', 'disorders', 'Management', 'care', 'team', 'responsible', 'surveillance', 'major', 'organ', 'specific', 'complications', 'example', 'arterial', 'aneurysm', 'dissection', 'physical', 'medicine', 'rehabilitation', 'specific', 'medical', 'genetic', 'therapies', 'available', 'type']"
78,78,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088381909&origin=inward,In vivo cell biological screening identifies an endocytic capture mechanism for T-tubule formation,"¬© 2020, The Author(s).The skeletal muscle T-tubule is a specialized membrane domain essential for coordinated muscle contraction. However, in the absence of genetically tractable systems the mechanisms involved in T-tubule formation are unknown. Here, we use the optically transparent and genetically tractable zebrafish system to probe T-tubule development in vivo. By combining live imaging of transgenic markers with three-dimensional electron microscopy, we derive a four-dimensional quantitative model for T-tubule formation. To elucidate the mechanisms involved in T-tubule formation in vivo, we develop a quantitative screen for proteins that associate with and modulate early T-tubule formation, including an overexpression screen of the entire zebrafish Rab protein family. We propose an endocytic capture model involving firstly, formation of dynamic endocytic tubules at transient nucleation sites on the sarcolemma, secondly, stabilization by myofibrils/sarcoplasmic reticulum and finally, delivery of membrane from the recycling endosome and Golgi complex.",0,0,scopus,"['computerized tomography', 'x-ray computed tomography', 'hierarchical system', 'hierarchical model', 'image display', 'imaging systems', 'image analysis', 'image reconstruction']",Ullrich congenital muscular dystrophy,"['vivo', 'cell', 'biological', 'screening', 'endocytic', 'capture', 'mechanism', 'T', 'tubule', 'formation']","['skeletal', 'muscle', 'T', 'tubule', 'specialized', 'membrane', 'domain', 'essential', 'coordinated', 'muscle', 'contraction', 'absence', 'tractable', 'systems', 'mechanisms', 'T', 'tubule', 'formation', 'unknown', 'transparent', 'tractable', 'zebrafish', 'system', 'T', 'tubule', 'development', 'vivo', 'live', 'imaging', 'transgenic', 'markers', 'dimensional', 'electron', 'microscopy', 'dimensional', 'quantitative', 'model', 'T', 'tubule', 'formation', 'mechanisms', 'T', 'tubule', 'formation', 'vivo', 'quantitative', 'screen', 'proteins', 'early', 'T', 'tubule', 'formation', 'overexpression', 'screen', 'entire', 'zebrafish', 'protein', 'family', 'endocytic', 'capture', 'model', 'formation', 'dynamic', 'endocytic', 'tubules', 'transient', 'nucleation', 'sites', 'sarcolemma', 'stabilization', 'myofibrils', 'sarcoplasmic', 'reticulum', 'delivery', 'membrane', 'recycling', 'endosome', 'complex']"
79,79,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85073991345&origin=inward,Influence of microRNAs and exosomes in muscle health and diseases,"¬© 2019, Springer Nature Switzerland AG.microRNAs are short, (18‚Äì22 nt) non-coding RNAs involved in important cellular processes due to their ability to regulate gene expression at the post-transcriptional level. Exosomes are small (50‚Äì200 nm) extracellular vesicles, naturally secreted from a variety of living cells and are believed to mediate cell‚Äìcell communication through multiple mechanisms, including uptake in destination cells. Circulating microRNAs and exosome-derived microRNAs can have key roles in regulating muscle cell development and differentiation. Several microRNAs are highly expressed in muscle and their regulation is important for myocyte homeostasis. Changes in muscle associated microRNA expression are associated with muscular diseases including muscular dystrophies, inflammatory myopathies, and congenital myopathies. In this review, we aim to highlight the biology of microRNAs and exosomes as well as their roles in muscle health and diseases. We also discuss the potential crosstalk between skeletal and cardiac muscle through exosomes and their contents.",0,0,scopus,"['cellular telephone systems', 'destination nodes', 'communication', 'ad hoc networks', 'wireless sensor networks', 'coding techniques', 'programming theory', 'network coding', 'image coding', 'wireless', 'cellular radio systems', 'coding scheme', 'cellular', 'routing protocols']",Ullrich congenital muscular dystrophy,"['Influence', 'microRNAs', 'exosomes', 'muscle', 'health', 'diseases']","['short', 'non', '-', 'coding', 'RNAs', 'important', 'cellular', 'processes', 'ability', 'gene', 'expression', 'post', '-', 'transcriptional', 'level', 'Exosomes', 'small', 'nm', 'extracellular', 'vesicles', 'variety', 'cells', 'cell', 'cell', 'communication', 'multiple', 'mechanisms', 'uptake', 'destination', 'cells', 'microRNAs', 'exosome', 'microRNAs', 'key', 'roles', 'muscle', 'cell', 'development', 'differentiation', 'Several', 'microRNAs', 'muscle', 'regulation', 'important', 'myocyte', 'homeostasis', 'Changes', 'muscle', 'expression', 'muscular', 'diseases', 'muscular', 'dystrophies', 'inflammatory', 'myopathies', 'congenital', 'myopathies', 'review', 'biology', 'microRNAs', 'exosomes', 'roles', 'muscle', 'health', 'diseases', 'potential', 'crosstalk', 'skeletal', 'cardiac', 'muscle', 'exosomes', 'contents']"
80,80,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096035745&origin=inward,"Fattening chips: Hypertrophy, feeding, and fasting of human white adipocytes: In vitro","¬© 2020 The Royal Society of Chemistry.Adipose is a distributed organ that performs vital endocrine and energy homeostatic functions. Hypertrophy of white adipocytes is a primary mode of both adaptive and maladaptive weight gain in animals and predicts metabolic syndrome independent of obesity. Due to the failure of conventional culture to recapitulate adipocyte hypertrophy, technology for production of adult-size adipocytes would enable applications such as in vitro testing of weight loss therapeutics. To model adaptive adipocyte hypertrophy in vitro, we designed and built fat-on-a-chip using fiber networks inspired by extracellular matrix in adipose tissue. Fiber networks extended the lifespan of differentiated adipocytes, enabling growth to adult sizes. By micropatterning preadipocytes in a native cytoarchitecture and by adjusting cell-to-cell spacing, rates of hypertrophy were controlled independent of culture time or differentiation efficiency. In vitro hypertrophy followed a nonlinear, nonexponential growth model similar to human development and elicited transcriptomic changes that increased overall similarity with primary tissue. Cells on the chip responded to simulated meals and starvation, which potentiated some adipocyte endocrine and metabolic functions. To test the utility of the platform for therapeutic development, transcriptional network analysis was performed, and retinoic acid receptors were identified as candidate drug targets. Regulation by retinoid signaling was suggested further by pharmacological modulation, where activation accelerated and inhibition slowed hypertrophy. Altogether, this work presents technology for mature adipocyte engineering, addresses the regulation of cell growth, and informs broader applications for synthetic adipose in pharmaceutical development, regenerative medicine, and cellular agriculture.",0,0,scopus,"['cellular telephone systems', 'network analysis', 'electric network analysis', 'optical fibers', 'wireless', 'engineering', 'cellular radio systems', 'network protocols', 'sensors', 'network architecture', 'cellular']",Ullrich congenital muscular dystrophy,"['chips', 'human', 'white', 'adipocytes', 'vitro']","['distributed', 'organ', 'vital', 'endocrine', 'energy', 'homeostatic', 'functions', 'white', 'adipocytes', 'primary', 'mode', 'adaptive', 'maladaptive', 'weight', 'gain', 'animals', 'metabolic', 'syndrome', 'independent', 'obesity', 'failure', 'conventional', 'culture', 'adipocyte', 'hypertrophy', 'technology', 'production', 'adult', 'size', 'adipocytes', 'applications', 'such', 'vitro', 'testing', 'weight', 'loss', 'therapeutics', 'adaptive', 'adipocyte', 'hypertrophy', 'vitro', 'fat', 'chip', 'fiber', 'networks', 'extracellular', 'matrix', 'adipose', 'tissue', 'Fiber', 'networks', 'lifespan', 'differentiated', 'adipocytes', 'growth', 'adult', 'sizes', 'preadipocytes', 'native', 'cytoarchitecture', 'cell', 'cell', 'spacing', 'rates', 'hypertrophy', 'independent', 'culture', 'time', 'differentiation', 'efficiency', 'hypertrophy', 'nonlinear', 'nonexponential', 'growth', 'model', 'similar', 'human', 'development', 'transcriptomic', 'changes', 'overall', 'similarity', 'primary', 'tissue', 'Cells', 'chip', 'simulated', 'meals', 'starvation', 'adipocyte', 'endocrine', 'metabolic', 'functions', 'utility', 'platform', 'therapeutic', 'development', 'transcriptional', 'network', 'analysis', 'retinoic', 'acid', 'receptors', 'candidate', 'drug', 'targets', 'Regulation', 'retinoid', 'signaling', 'pharmacological', 'modulation', 'activation', 'inhibition', 'hypertrophy', 'work', 'technology', 'mature', 'adipocyte', 'engineering', 'regulation', 'cell', 'growth', 'broader', 'applications', 'synthetic', 'adipose', 'pharmaceutical', 'development', 'regenerative', 'medicine', 'cellular', 'agriculture']"
81,81,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85096209015&origin=inward,Clinical and Genomic Evaluation of 207 Genetic Myopathies in the Indian Subcontinent,"¬© Copyright ¬© 2020 Chakravorty, Nallamilli, Khadilkar, Singla, Bhutada, Dastur, Gaitonde, Rufibach, Gloster and Hegde.Objective: Inherited myopathies comprise more than 200 different individually rare disease-subtypes, but when combined together they have a high prevalence of 1 in 6,000 individuals across the world. Our goal was to determine for the first time the clinical- and gene-variant spectrum of genetic myopathies in a substantial cohort study of the Indian subcontinent. Methods: In this cohort study, we performed the first large clinical exome sequencing (ES) study with phenotype correlation on 207 clinically well-characterized inherited myopathy-suspected patients from the Indian subcontinent with diverse ethnicities. Results: Clinical-correlation driven definitive molecular diagnosis was established in 49% (101 cases; 95% CI, 42‚Äì56%) of patients with the major contributing pathogenicity in either of three genes, GNE (28%; GNE-myopathy), DYSF (25%; Dysferlinopathy), and CAPN3 (19%; Calpainopathy). We identified 65 variant alleles comprising 37 unique variants in these three major genes. Seventy-eight percent of the DYSF patients were homozygous for the detected pathogenic variant, suggesting the need for carrier-testing for autosomal-recessive disorders like Dysferlinopathy that are common in India. We describe the observed clinical spectrum of myopathies including uncommon and rare subtypes in India: Sarcoglycanopathies (SGCA/B/D/G), Collagenopathy (COL6A1/2/3), Anoctaminopathy (ANO5), telethoninopathy (TCAP), Pompe-disease (GAA), Myoadenylate-deaminase-deficiency-myopathy (AMPD1), myotilinopathy (MYOT), laminopathy (LMNA), HSP40-proteinopathy (DNAJB6), Emery-Dreifuss-muscular-dystrophy (EMD), Filaminopathy (FLNC), TRIM32-proteinopathy (TRIM32), POMT1-proteinopathy (POMT1), and Merosin-deficiency-congenital-muscular-dystrophy-type-1 (LAMA2). Thirteen patients harbored pathogenic variants in >1 gene and had unusual clinical features suggesting a possible role of synergistic-heterozygosity/digenic-contribution to disease presentation and progression. Conclusions: Application of clinically correlated ES to myopathy diagnosis has improved our understanding of the clinical and genetic spectrum of different subtypes and their overlaps in Indian patients. This, in turn, will enhance the global gene-variant-disease databases by including data from developing countries/continents for more efficient clinically driven molecular diagnostics.",0,0,scopus,"['signal processing', 'spectrum sensing', 'computer systems', 'intrinsic mode functions', 'database systems', 'frequency bands', 'correlation analysis', 'cognitive radio network', 'correlation coefficient', 'dynamic spectrum access', 'antennas', 'dynamic spectrum']",Ullrich congenital muscular dystrophy,['Indian'],"['Objective', 'Inherited', 'myopathies', 'more', 'different', 'rare', 'disease', 'subtypes', 'high', 'prevalence', 'individuals', 'world', 'goal', 'first', 'time', 'clinical-', 'gene', 'variant', 'spectrum', 'genetic', 'myopathies', 'substantial', 'cohort', 'study', 'Indian', 'subcontinent', 'Methods', 'cohort', 'study', 'first', 'large', 'clinical', 'exome', 'sequencing', 'study', 'phenotype', 'correlation', 'myopathy', 'patients', 'Indian', 'subcontinent', 'diverse', 'ethnicities', 'Results', 'Clinical', 'correlation', 'definitive', 'molecular', 'diagnosis', '%', 'cases', '%', '%', 'patients', 'major', 'contributing', 'pathogenicity', 'genes', '%', 'GNE', '%', '%', 'variant', 'alleles', 'unique', 'variants', 'major', 'genes', 'percent', 'DYSF', 'patients', 'homozygous', 'pathogenic', 'variant', 'need', 'carrier', 'testing', 'autosomal', 'recessive', 'disorders', 'common', 'clinical', 'spectrum', 'myopathies', 'uncommon', 'rare', 'subtypes', 'B', 'G', 'telethoninopathy', 'Pompe', 'deaminase', 'deficiency', 'AMPD1', 'myotilinopathy', 'Emery', 'Dreifuss', 'muscular', 'dystrophy', 'deficiency', 'congenital', 'muscular', 'dystrophy', 'patients', 'pathogenic', 'variants', 'gene', 'unusual', 'clinical', 'features', 'possible', 'role', 'synergistic', 'heterozygosity', 'digenic', 'contribution', 'presentation', 'progression', 'Conclusions', 'Application', 'diagnosis', 'understanding', 'clinical', 'genetic', 'spectrum', 'different', 'subtypes', 'overlaps', 'Indian', 'patients', 'turn', 'global', 'gene', 'variant', 'disease', 'databases', 'data', 'countries', 'continents', 'efficient', 'molecular', 'diagnostics']"
82,82,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091793819&origin=inward,"247th ENMC International Workshop: Muscle magnetic resonance imaging - Implementing muscle MRI as a diagnostic tool for rare genetic myopathy cohorts. Hoofddorp, The Netherlands, September 2019",0,0,0,scopus,"['fiber lasers', 'photonic crystal fibers', 'higher-order modes']",Ullrich congenital muscular dystrophy,"['247th', 'Muscle', 'magnetic', 'resonance', 'muscle', 'diagnostic', 'tool', 'rare', 'genetic', 'myopathy', 'cohorts']",[]
83,83,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85095688959&origin=inward,Usher Syndrome: Genetics and Molecular Links of Hearing Loss and Directions for Therapy,"¬© Copyright ¬© 2020 Whatley, Francis, Ng, Khoh, Atlas, Dilley and Wong.Usher syndrome (USH) is an autosomal recessive (AR) disorder that permanently and severely affects the senses of hearing, vision, and balance. Three clinically distinct types of USH have been identified, decreasing in severity from Type 1 to 3, with symptoms of sensorineural hearing loss (SNHL), retinitis pigmentosa (RP), and vestibular dysfunction. There are currently nine confirmed and two suspected USH-causative genes, and a further three candidate loci have been mapped. The proteins encoded by these genes form complexes that play critical roles in the development and maintenance of cellular structures within the inner ear and retina, which have minimal capacity for repair or regeneration. In the cochlea, stereocilia are located on the apical surface of inner ear hair cells (HC) and are responsible for transducing mechanical stimuli from sound pressure waves into chemical signals. These signals are then detected by the auditory nerve fibers, transmitted to the brain and interpreted as sound. Disease-causing mutations in USH genes can destabilize the tip links that bind the stereocilia to each other, and cause defects in protein trafficking and stereocilia bundle morphology, thereby inhibiting mechanosensory transduction. This review summarizes the current knowledge on Usher syndrome with a particular emphasis on mutations in USH genes, USH protein structures, and functional analyses in animal models. Currently, there is no cure for USH. However, the genetic therapies that are rapidly developing will benefit from this compilation of detailed genetic information to identify the most effective strategies for restoring functional USH proteins.",0,0,scopus,"['direct links', 'cellular telephone systems', 'vision systems', 'relay channels', 'maintenance process', 'computer software maintenance', 'digital signal processors', 'cooperative communication', 'robots', 'wireless', 'cellular radio systems', 'mimo systems', 'computer vision', 'cellular', 'digital signals']",Ullrich congenital muscular dystrophy,[],"['Copyright', 'syndrome', 'autosomal', 'recessive', 'disorder', 'senses', 'hearing', 'vision', 'balance', 'types', 'severity', 'symptoms', 'sensorineural', 'hearing', 'loss', 'retinitis', 'pigmentosa', 'vestibular', 'dysfunction', 'USH', 'causative', 'genes', 'further', 'candidate', 'loci', 'proteins', 'genes', 'form', 'complexes', 'critical', 'roles', 'development', 'maintenance', 'cellular', 'structures', 'inner', 'ear', 'retina', 'minimal', 'capacity', 'repair', 'regeneration', 'cochlea', 'stereocilia', 'apical', 'surface', 'inner', 'ear', 'hair', 'cells', 'responsible', 'mechanical', 'stimuli', 'sound', 'pressure', 'waves', 'chemical', 'signals', 'signals', 'auditory', 'nerve', 'fibers', 'brain', 'sound', 'Disease', 'mutations', 'genes', 'tip', 'links', 'stereocilia', 'other', 'defects', 'protein', 'trafficking', 'stereocilia', 'bundle', 'morphology', 'mechanosensory', 'transduction', 'review', 'current', 'knowledge', 'syndrome', 'particular', 'emphasis', 'mutations', 'genes', 'protein', 'structures', 'functional', 'analyses', 'animal', 'models', 'cure', 'genetic', 'therapies', 'compilation', 'detailed', 'genetic', 'information', 'effective', 'strategies', 'functional', 'proteins']"
84,84,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85093689062&origin=inward,Reactive oxygen species and oxidative stress in the pathogenesis and progression of genetic diseases of the connective tissue,"¬© 2020 by the authors. Licensee MDPI, Basel, Switzerland.Connective tissue is known to provide structural and functional ‚Äúglue‚Äù properties to other tissues. It contains cellular and molecular components that are arranged in several dynamic organizations. Connective tissue is the focus of numerous genetic and nongenetic diseases. Genetic diseases of the connective tissue are minority or rare, but no less important than the nongenetic diseases. Here we review the impact of reactive oxygen species (ROS) and oxidative stress on the onset and/or progression of diseases that directly affect connective tissue and have a genetic origin. It is important to consider that ROS and oxidative stress are not synonymous, although they are often closely linked. In a normal range, ROS have a relevant physiological role, whose levels result from a fine balance between ROS producers and ROS scavenge enzymatic systems. However, pathology arises or worsens when such balance is lost, like when ROS production is abnormally and constantly high and/or when ROS scavenge (enzymatic) systems are impaired. These concepts apply to numerous diseases, and connective tissue is no exception. We have organized this review around the two basic structural molecular components of connective tissue: The ground substance and fibers (collagen and elastic fibers).",0,0,scopus,"['cellular telephone systems', 'component', 'software', 'optical fibers', 'wireless', 'cellular radio systems', 'sensors', 'cellular']",Ullrich congenital muscular dystrophy,"['Reactive', 'oxygen', 'species', 'oxidative', 'stress', 'pathogenesis', 'progression', 'genetic', 'diseases', 'connective', 'tissue']","['authors', 'Connective', 'tissue', 'structural', 'functional', '‚Äú', 'glue', 'properties', 'other', 'tissues', 'cellular', 'molecular', 'components', 'several', 'dynamic', 'organizations', 'Connective', 'tissue', 'focus', 'numerous', 'genetic', 'nongenetic', 'diseases', 'Genetic', 'diseases', 'connective', 'tissue', 'minority', 'rare', 'important', 'nongenetic', 'diseases', 'impact', 'reactive', 'oxygen', 'species', 'oxidative', 'stress', 'onset', 'progression', 'diseases', 'connective', 'tissue', 'genetic', 'origin', 'important', 'oxidative', 'stress', 'synonymous', 'normal', 'range', 'relevant', 'physiological', 'role', 'levels', 'fine', 'balance', 'producers', 'enzymatic', 'systems', 'pathology', 'worsens', 'such', 'balance', 'production', 'high', 'scavenge', 'enzymatic', 'systems', 'concepts', 'numerous', 'diseases', 'connective', 'tissue', 'exception', 'review', 'basic', 'structural', 'molecular', 'components', 'connective', 'tissue', 'ground', 'substance', 'fibers', 'collagen', 'elastic', 'fibers']"
85,85,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091775080&origin=inward,Biallelic mutations in Tenascin-X cause classical-like Ehlers-Danlos syndrome with slowly progressive muscular weakness,"¬© 2020 Elsevier B.V.Tenascin-X, is an extracellular matrix glycoprotein expressed in skin, muscle, tendons, and blood vessels with an anti-adhesive function. Biallelic Tenascin-X mutations cause classical-like Ehlers-Danlos syndrome. We report a 46-year-old woman with slowly progressive weakness of the lower limbs and myalgia from age 28 years. In the past she had Raynaud's phenomenon, multiple sprains and joint dislocations, conjunctival haemorrhages and a colonic perforation during colonoscopy. Neurologic examination showed moderate asymmetric proximal and axial muscular weakness, distal amyotrophy of 4 limbs, moderate skin hyperextensibility, and hypermobility of distal joints of fingers. Whole body Magnetic Resonance Imaging showed symmetric fatty infiltration of thigh and leg muscles, with predominant atrophy of thighs. Next Generation Sequencing revealed two pathogenic TNXB variants, g.32024681C>G, c.7826‚Äì1G>C, and g.32016181dup, c.9998dupA, p.(Asn3333Lysfs*35). Western Blot and immunofluorescence studies confirmed a marked Tenascin-X reduction in both patient's serum and muscle. Here we further detail the clinical and genetic spectrum of a patient with classical-like Ehlers-Danlos syndrome and prominent muscle involvement.",0,0,scopus,"['computerized tomography', 'x-ray computed tomography', 'fiber lasers', 'photonic crystal fibers', 'humanoid robot', 'imaging systems', 'frequency bands', 'anthropomorphic robots', 'higher-order modes', 'full body', 'antennas', 'image reconstruction']",Ullrich congenital muscular dystrophy,"['Biallelic', 'mutations', 'classical', 'like', 'syndrome', 'progressive', 'muscular', 'weakness']","['extracellular', 'matrix', 'glycoprotein', 'skin', 'muscle', 'tendons', 'blood', 'vessels', 'anti', '-', 'adhesive', 'function', 'mutations', 'classical', 'like', 'syndrome', '46-year', 'old', 'woman', 'progressive', 'weakness', 'lower', 'limbs', 'myalgia', 'age', 'years', 'past', 'phenomenon', 'multiple', 'sprains', 'joint', 'dislocations', 'conjunctival', 'haemorrhages', 'colonic', 'perforation', 'colonoscopy', 'Neurologic', 'examination', 'moderate', 'asymmetric', 'proximal', 'axial', 'muscular', 'weakness', 'distal', 'amyotrophy', 'limbs', 'moderate', 'skin', 'hyperextensibility', 'hypermobility', 'distal', 'joints', 'fingers', 'Whole', 'body', 'symmetric', 'fatty', 'infiltration', 'thigh', 'leg', 'muscles', 'predominant', 'atrophy', 'thighs', 'Next', 'pathogenic', 'variants', 'G', 'C', 'g.32016181dup', 'p.(Asn3333Lysfs*35', 'Western', 'immunofluorescence', 'studies', 'marked', 'reduction', 'patient', 'serum', 'muscle', 'clinical', 'genetic', 'spectrum', 'patient', 'classical', 'like', 'syndrome', 'prominent', 'muscle', 'involvement']"
86,86,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85091258305&origin=inward,The Common miRNA Signatures Associated with Mitochondrial Dysfunction in Different Muscular Dystrophies,"¬© 2020 American Society for Investigative PathologySecondary mitochondrial damage in skeletal muscles is a common feature of different neuromuscular disorders, which fall outside the mitochondrial cytopathies. The common cause of mitochondrial dysfunction and structural changes in skeletal muscle tissue remains to be discovered. Although they are associated with different clinical, genetic, and pathologic backgrounds, the pathomechanisms underlying neuromuscular disorders might be attributed to the complex interaction and cross talk between mitochondria and the associated miRNAs. This study aimed to identify the common miRNA signatures that are associated with mitochondrial damage in different muscular dystrophies (MDs; Duchenne muscular dystrophy, megaconial congenital muscular dystrophy, Ullrich congenital muscular dystrophy, and Œ±-dystroglycanopathy). The miRNome profiles of skeletal muscle biopsies acquired from four different MD groups and control individuals were analyzed by miRNA microarray. We identified 17 common up-regulated miRNAs in all of the tested MD groups. A specific bioinformatics approach identified 10 of these miRNAs to be specifically related to the mitochondrial pathways. Six miRNAs, miR-134-5p, miR-199a-5p, miR-382-5p, miR-409-3p, miR-497-5p, and miR-708-5p, were associated with the top four mitochondrial pathways and were thus selected as priority candidates for further validation by quantitative real-time PCR analysis. We demonstrate, for the first time, common up-regulated miRNAs that are associated with mitochondrial damage in different MD groups, therefore contributing to the pathophysiology. Our findings may open a new gate toward therapeutics.",0,0,scopus,"['damage detection', 'validation', 'interactive computer systems', 'computer science', 'local binary patterns', 'multi-modal interactions', 'structural damages', 'verification and validation', 'structural health monitoring', 'bioinformatics', 'content based retrieval']",Ullrich congenital muscular dystrophy,['Dystrophies'],"['mitochondrial', 'damage', 'skeletal', 'muscles', 'common', 'feature', 'different', 'neuromuscular', 'disorders', 'mitochondrial', 'cytopathies', 'common', 'cause', 'mitochondrial', 'dysfunction', 'structural', 'changes', 'skeletal', 'muscle', 'tissue', 'different', 'clinical', 'genetic', 'pathologic', 'backgrounds', 'pathomechanisms', 'neuromuscular', 'disorders', 'complex', 'interaction', 'cross', 'talk', 'mitochondria', 'associated', 'study', 'common', 'signatures', 'mitochondrial', 'damage', 'different', 'muscular', 'dystrophies', 'MDs', 'muscular', 'dystrophy', 'megaconial', 'congenital', 'muscular', 'dystrophy', 'congenital', 'muscular', 'dystrophy', 'Œ±', 'dystroglycanopathy', 'profiles', 'skeletal', 'muscle', 'biopsies', 'different', 'groups', 'control', 'individuals', 'common', 'groups', 'specific', 'bioinformatics', 'approach', 'mitochondrial', 'pathways', 'top', 'mitochondrial', 'pathways', 'priority', 'candidates', 'further', 'validation', 'quantitative', 'real', 'time', 'PCR', 'analysis', 'first', 'time', 'common', 'mitochondrial', 'damage', 'different', 'groups', 'pathophysiology', 'findings', 'new', 'gate', 'therapeutics']"
87,87,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088974829&origin=inward,"Collagen: quantification, biomechanics and role of minor subtypes in cartilage","¬© 2020, Springer Nature Limited.Collagen is a ubiquitous biomaterial in vertebrate animals. Although each of its 28 subtypes contributes to the functions of many different tissues in the body, most studies on collagen or collagenous tissues have focused on only one or two subtypes. With recent developments in analytical chemistry, especially mass spectrometry, substantial advances have been made towards quantifying the different collagen subtypes in various tissues; however, high-throughput and low-cost methods for collagen-subtype quantification do not yet exist. In this Review, we introduce the roles of collagen subtypes and crosslinks and describe modern assays that enable a deep understanding of tissue physiology and disease states. Using cartilage as a model tissue, we describe the roles of major and minor collagen subtypes in detail, discuss known and unknown structure‚Äìfunction relationships and show how tissue engineers may harness the functional characteristics of collagen to engineer robust neotissues.",0,0,scopus,"['pervasive', 'ubiquitous computing', 'pervasive environments', 'mobile computing', 'optical fibers', 'investments', 'engineers', 'user interfaces', 'pervasive computing', 'investment costs']",Ullrich congenital muscular dystrophy,"['Collagen', 'quantification', 'biomechanics', 'role', 'minor', 'subtypes', 'cartilage']","['ubiquitous', 'biomaterial', 'vertebrate', 'animals', 'subtypes', 'contributes', 'functions', 'many', 'different', 'tissues', 'body', 'most', 'studies', 'collagen', 'collagenous', 'tissues', 'subtypes', 'recent', 'developments', 'analytical', 'chemistry', 'mass', 'spectrometry', 'substantial', 'advances', 'different', 'collagen', 'subtypes', 'various', 'tissues', 'high', 'throughput', 'low', 'cost', 'methods', 'collagen', 'subtype', 'quantification', 'roles', 'collagen', 'subtypes', 'crosslinks', 'modern', 'assays', 'deep', 'understanding', 'tissue', 'physiology', 'disease', 'states', 'cartilage', 'model', 'tissue', 'roles', 'major', 'minor', 'collagen', 'subtypes', 'detail', 'known', 'unknown', 'structure', 'function', 'relationships', 'tissue', 'engineers', 'functional', 'characteristics', 'collagen', 'robust', 'neotissues']"
88,88,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85092601398&origin=inward,The Polyphenol Pterostilbene Ameliorates the Myopathic Phenotype of Collagen VI Deficient Mice via Autophagy Induction,"¬© Copyright ¬© 2020 Metti, Gambarotto, Chrisam, Baraldo, Braghetta, Blaauw and Bonaldo.The induction of autophagy, the catabolic pathway by which damaged or unnecessary cellular components are subjected to lysosome-mediated degradation and recycling, is impaired in Collagen VI (COL6) null mice and COL6-related myopathies. This autophagic impairment causes an accumulation of dysfunctional mitochondria, which in turn leads to myofiber degeneration. Our previous work showed that reactivation of autophagy in COL6-related myopathies is beneficial for muscle structure and function both in the animal model and in patients. Here we show that pterostilbene (Pt)‚Äîa non-toxic polyphenol, chemically similar to resveratrol but with a higher bioavailability and metabolic stability‚Äîstrongly promotes in vivo autophagic flux in the skeletal muscle of both wild-type and COL6 null mice. Reactivation of autophagy in COL6-deficient muscles was also paralleled by several beneficial effects, including significantly decreased incidence of spontaneous apoptosis, recovery of ultrastructural defects and muscle remodeling. These findings point at Pt as an effective autophagy-inducing nutraceutical for skeletal muscle with great potential in counteracting the major pathogenic hallmarks of COL6-related myopathies, a valuable feature that may be also beneficial in other muscle pathologies characterized by defective regulation of the autophagic machinery.",0,0,scopus,"['cellular telephone systems', 'component', 'software', 'hierarchical system', 'hierarchical model', 'asymptotic stability', 'wireless', 'cellular radio systems', 'channel capacity', 'lyapunov functions', 'cellular network', 'adaptive control systems', 'cellular system', 'cellular', 'global stability']",Ullrich congenital muscular dystrophy,[],"['Copyright', 'induction', 'autophagy', 'catabolic', 'pathway', 'unnecessary', 'cellular', 'components', 'lysosome', 'degradation', 'recycling', 'null', 'mice', 'COL6-related', 'myopathies', 'autophagic', 'impairment', 'accumulation', 'dysfunctional', 'mitochondria', 'turn', 'myofiber', 'degeneration', 'previous', 'work', 'reactivation', 'autophagy', 'COL6-related', 'myopathies', 'beneficial', 'muscle', 'structure', 'function', 'animal', 'model', 'patients', 'pterostilbene', 'non', '-', 'toxic', 'polyphenol', 'similar', 'higher', 'bioavailability', 'metabolic', 'stability', 'vivo', 'flux', 'skeletal', 'muscle', 'wild', 'type', 'null', 'mice', 'Reactivation', 'autophagy', 'muscles', 'several', 'beneficial', 'effects', 'incidence', 'spontaneous', 'apoptosis', 'recovery', 'ultrastructural', 'defects', 'muscle', 'remodeling', 'findings', 'effective', 'autophagy', 'nutraceutical', 'skeletal', 'muscle', 'great', 'potential', 'major', 'pathogenic', 'hallmarks', 'COL6-related', 'myopathies', 'valuable', 'feature', 'beneficial', 'other', 'muscle', 'pathologies', 'defective', 'regulation', 'autophagic', 'machinery']"
89,89,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086911698&origin=inward,Circulating Biomarkers in Muscular Dystrophies: Disease and Therapy Monitoring,"¬© 2020 The AuthorsMuscular dystrophies are a group of inherited disorders that primarily affect the muscle tissues. Across the muscular dystrophies, symptoms commonly compromise the quality of life in all areas of functioning. It is well noted that muscular dystrophies need reliable and measurable biomarkers that will monitor the progress of the disease and evaluate the potential therapeutic approaches. In this review, we analyze the current findings regarding the development of blood-based circulating biomarkers for different types of muscular dystrophies. We emphasize those muscular dystrophies that gained particular interest for the development of biomarkers, including Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy types 1 and 2, Ullrich congenital muscular dystrophy, congenital muscular dystrophy type 1A, Facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy types 2A, 2B, 2C, and 2D, recently renamed as limb-girdle muscular dystrophy R1 calpain3-related, R2 dysferlin-related, R5 Œ≥-sarcoglycan-related, and R3 Œ±-sarcoglycan-related. This review highlights the up-to-date progress in the development of biomarkers at the level of proteins, lipids, and metabolites, as well as microRNAs (miRNAs) that currently are the main potential biomarker candidates in muscular dystrophies. Muscular dystrophies are a family of inherited disorders. Apart from the need to develop therapeutic drugs, an increasing interest exists for the development of biomarkers. Koutsoulidou and Phylactou review the current findings related to the circulating biomarkers and their potential use as prognostic, monitoring, or pharmacodynamic biomarkers for muscular dystrophies.",0,0,scopus,"['two dimensional', 'image processing', 'coefficient of determination', 'correlation analysis', 'remote control', 'correlation coefficient', 'remote monitoring']",Ullrich congenital muscular dystrophy,[],"['dystrophies', 'group', 'disorders', 'muscle', 'tissues', 'muscular', 'dystrophies', 'symptoms', 'quality', 'life', 'areas', 'muscular', 'dystrophies', 'reliable', 'measurable', 'biomarkers', 'progress', 'disease', 'potential', 'therapeutic', 'approaches', 'review', 'current', 'findings', 'development', 'blood', 'biomarkers', 'different', 'types', 'muscular', 'dystrophies', 'muscular', 'dystrophies', 'particular', 'interest', 'development', 'biomarkers', 'muscular', 'dystrophy', 'muscular', 'dystrophy', 'myotonic', 'dystrophy', 'types', 'congenital', 'muscular', 'dystrophy', 'congenital', 'muscular', 'dystrophy', 'type', '1A', 'muscular', 'dystrophy', 'limb', 'girdle', 'muscular', 'dystrophy', 'types', '2B', '2C', '2D', 'limb', 'girdle', 'muscular', 'dystrophy', 'dysferlin', 'R5', 'Œ≥', 'R3', 'Œ±', 'review', 'up', 'date', 'progress', 'development', 'biomarkers', 'level', 'proteins', 'lipids', 'metabolites', 'main', 'potential', 'biomarker', 'candidates', 'muscular', 'dystrophies', 'Muscular', 'dystrophies', 'family', 'disorders', 'need', 'therapeutic', 'drugs', 'interest', 'development', 'biomarkers', 'current', 'findings', 'biomarkers', 'potential', 'use', 'prognostic', 'monitoring', 'pharmacodynamic', 'biomarkers', 'muscular', 'dystrophies']"
90,90,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090509608&origin=inward,Structure of a collagen VI Œ±3 chain VWA domain array: Adaptability and functional implications of myopathy causing mutations,"¬© 2020 Solomon-Degefa et al. Published under exclusive license by The American Society for Biochemistry and Molecular Biology, Inc.Collagen VI is a ubiquitous heterotrimeric protein of the extracellular matrix (ECM) that plays an essential role in the proper maintenance of skeletal muscle. Mutations in collagen VI lead to a spectrum of congenital myopathies, from the mild Bethlem myopathy to the severe Ullrich congenital muscular dystrophy. Collagen VI contains only a short triple helix and consists primarily of von Willebrand factor type A (VWA) domains, protein‚Äìprotein interaction modules found in a range of ECM proteins. Disease-causing mutations occur commonly in the VWA domains, and the second VWA domain of the a3 chain, the N2 domain, harbors several such mutations. Here, we investigate structure-function relationships of the N2 mutations to shed light on their possible myopathy mechanisms. We determined the X-ray crystal structure of N2, combined with monitoring secretion efficiency in cell culture of selected N2 single-domain mutants, finding that mutations located within the central core of the domain severely affect secretion efficiency. In longer Œ±3 chain constructs, spanning N6-N3, small-angle X-ray scattering demonstrates that the tandem VWA array has a modular architecture and samples multiple conformations in solution. Single-particle EM confirmed the presence of multiple conformations. Structural adaptability appears intrinsic to the VWA domain region of collagen VI Œ±3 and has implications for binding interactions and modulating stiffness within the ECM.",0,0,scopus,"['software architecture', 'computational efficiency', 'maintenance process', 'ecm proteins', 'computer software maintenance', 'architecture designs', 'theoretical computer science', 'direction of arrival', 'sub-arrays', 'electric discharge machining']",Ullrich congenital muscular dystrophy,"['Structure', 'collagen', 'Œ±3', 'chain', 'domain', 'array', 'Adaptability', 'functional', 'implications', 'myopathy', 'mutations']","['et', 'exclusive', 'license', 'ubiquitous', 'heterotrimeric', 'protein', 'extracellular', 'matrix', 'essential', 'role', 'proper', 'maintenance', 'skeletal', 'muscle', 'Mutations', 'collagen', 'lead', 'spectrum', 'congenital', 'myopathies', 'mild', 'myopathy', 'severe', 'congenital', 'muscular', 'dystrophy', 'short', 'triple', 'helix', 'factor', 'type', 'A', 'domains', 'protein', 'protein', 'interaction', 'modules', 'range', 'proteins', 'mutations', 'domains', 'second', 'domain', 'a3', 'chain', 'domain', 'harbors', 'several', 'such', 'mutations', 'structure', 'function', 'relationships', 'mutations', 'light', 'possible', 'myopathy', 'mechanisms', 'X', '-', 'ray', 'crystal', 'structure', 'secretion', 'efficiency', 'cell', 'culture', 'single', 'domain', 'mutants', 'mutations', 'central', 'core', 'domain', 'secretion', 'efficiency', 'longer', 'Œ±3', 'chain', 'constructs', 'N6-N3', 'small', 'angle', 'X', '-', 'ray', 'scattering', 'tandem', 'VWA', 'array', 'modular', 'architecture', 'multiple', 'conformations', 'solution', 'Single', 'particle', 'presence', 'multiple', 'conformations', 'Structural', 'adaptability', 'intrinsic', 'domain', 'region', 'collagen', 'implications', 'interactions', 'modulating', 'stiffness']"
91,91,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087081526&origin=inward,Exon-Skipping Oligonucleotides Restore Functional Collagen VI by Correcting a Common COL6A1 Mutation in Ullrich CMD,"¬© 2020 The Author(s)Collagen VI-related congenital muscular dystrophies (COL6-CMDs) are the second most common form of congenital muscular dystrophy. Currently, there is no effective treatment available. COL6-CMDs are caused by recessive or dominant mutations in one of the three genes encoding for the Œ± chains of collagen type VI (COL6A1, COL6A2, and COL6A3). One of the most common mutations in COL6-CMD patients is a de novo deep intronic c.930+189C > T mutation in COL6A1 gene. This mutation creates a cryptic donor splice site and induces incorporation of a novel in-frame pseudo-exon in the mature transcripts. In this study, we systematically evaluated the splice switching approach using antisense oligonucleotides (ASOs) to correct this mutation. Fifteen ASOs were designed using the RNA-tiling approach to target the misspliced pseudo-exon and its flanking sequences. The efficiency of ASOs was evaluated at RNA, protein, and structural levels in skin fibroblasts established from four patients carrying the c.930+189C > T mutation. We identified two additional lead ASO candidates that efficiently induce pseudo-exon exclusion from the mature transcripts, thus allowing for the restoration of a functional collagen VI microfibrillar matrix. Our findings provide further evidence for ASO exon skipping as a therapeutic approach for COL6-CMD patients carrying this common intronic mutation. ¬© 2020 The Author(s)COL6-related congenital muscular dystrophies are caused by mutations in COL6A genes leading to the reduction of collagen VI protein in extracellular matrix. Zhou and colleagues report an exon-skipping antisense approach to successfully correct a common deep intronic mutation and restore functional collagen VI protein in cultured skin fibroblasts from patients. Keywords: collagen VI, congenital muscular dystrophy, Ullrich muscular dystrophy, deep intronic mutation, exon skipping, antisense oligonucleotide, extra cellular matrix",0,0,scopus,"['cellular telephone systems', 'computational efficiency', 'structural frames', 'particle swarm optimization (pso)', 'theoretical computer science', 'wireless', 'frames', 'cellular radio systems', 'mutation strategy', 'differential evolution', 'evolutionary algorithms', 'mutation operators', 'cellular']",Ullrich congenital muscular dystrophy,[],"['congenital', 'muscular', 'dystrophies', 'COL6-CMDs', 'second', 'common', 'form', 'congenital', 'muscular', 'dystrophy', 'effective', 'treatment', 'available', 'COL6-CMDs', 'recessive', 'dominant', 'mutations', 'genes', 'Œ±', 'chains', 'collagen', 'type', 'COL6A1', 'COL6A2', 'common', 'mutations', 'COL6-CMD', 'patients', 'novo', 'deep', 'intronic', 'c.930', 'T', 'mutation', 'COL6A1', 'gene', 'mutation', 'cryptic', 'donor', 'splice', 'site', 'incorporation', 'novel', 'frame', 'pseudo', 'exon', 'mature', 'transcripts', 'study', 'splice', 'approach', 'antisense', 'oligonucleotides', 'mutation', 'ASOs', 'approach', 'misspliced', 'pseudo', 'exon', 'flanking', 'sequences', 'efficiency', 'protein', 'structural', 'levels', 'skin', 'fibroblasts', 'patients', 'c.930', 'T', 'mutation', 'additional', 'lead', 'candidates', 'pseudo', 'exon', 'exclusion', 'mature', 'transcripts', 'restoration', 'functional', 'collagen', 'microfibrillar', 'matrix', 'findings', 'further', 'evidence', 'exon', 'therapeutic', 'approach', 'COL6-CMD', 'patients', 'common', 'intronic', 'mutation', 'Author(s)COL6-related', 'congenital', 'muscular', 'dystrophies', 'mutations', 'genes', 'reduction', 'collagen', 'protein', 'extracellular', 'matrix', 'colleagues', 'exon', 'antisense', 'approach', 'common', 'deep', 'intronic', 'mutation', 'functional', 'collagen', 'protein', 'cultured', 'skin', 'fibroblasts', 'patients', 'Keywords', 'collagen', 'congenital', 'muscular', 'dystrophy', 'muscular', 'dystrophy', 'deep', 'intronic', 'mutation', 'exon', 'skipping', 'antisense', 'oligonucleotide', 'extra', 'cellular', 'matrix']"
92,92,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090755336&origin=inward,Targeting alternative splicing as a potential therapy for episodic ataxia type 2,"¬© 2020 by the authors.Episodic ataxia type 2 (EA2) is an autosomal dominant neurological disorder characterized by paroxysmal attacks of ataxia, vertigo, and nausea that usually last hours to days. It is caused by loss-of-function mutations in CACNA1A, the gene encoding the pore-forming Œ±1 subunit of P/Q-type voltage-gated Ca2+ channels. Although pharmacological treatments, such as acetazolamide and 4-aminopyridine, exist for EA2, they do not reduce or control the symptoms in all patients. CACNA1A is heavily spliced and some of the identified EA2 mutations are predicted to disrupt selective isoforms of this gene. Modulating splicing of CACNA1A may therefore represent a promising new strategy to develop improved EA2 therapies. Because RNA splicing is dysregulated in many other genetic diseases, several tools, such as antisense oligonucleotides, trans-splicing, and CRISPR-based strategies, have been developed for medical purposes. Here, we review splicing-based strategies used for genetic disorders, including those for Duchenne muscular dystrophy, spinal muscular dystrophy, and frontotemporal dementia with Parkinsonism linked to chromosome 17, and discuss their potential applicability to EA2.",0,0,scopus,"['dos attacks', 'episodic memory', 'autobiographical memory', 'semantic memory', 'computer crime', 'security issues', 'various attacks', 'learning', 'security attacks', 'network security', 'authentication', 'watermarking algorithms']",Ullrich congenital muscular dystrophy,"['alternative', 'splicing', 'potential', 'therapy', 'episodic', 'ataxia', 'type']","['authors', 'Episodic', 'ataxia', 'type', 'autosomal', 'dominant', 'neurological', 'disorder', 'paroxysmal', 'attacks', 'ataxia', 'vertigo', 'nausea', 'last', 'hours', 'days', 'loss', 'function', 'mutations', 'gene', 'pore', 'subunit', 'P', 'Q', 'type', 'voltage', 'Ca2', 'channels', 'pharmacological', 'treatments', 'such', 'symptoms', 'patients', 'EA2', 'mutations', 'selective', 'isoforms', 'gene', 'Modulating', 'splicing', 'promising', 'new', 'strategy', 'EA2', 'therapies', 'splicing', 'many', 'other', 'genetic', 'diseases', 'several', 'tools', 'such', 'antisense', 'oligonucleotides', 'trans', 'splicing', 'strategies', 'medical', 'purposes', 'strategies', 'genetic', 'disorders', 'muscular', 'dystrophy', 'spinal', 'muscular', 'dystrophy', 'frontotemporal', 'dementia', 'chromosome', 'potential', 'applicability']"
93,93,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088165368&origin=inward,Randomized trial of lung hyperinflation therapy in children with congenital muscular dystrophy,"¬© 2020 Wiley Periodicals LLCObjective: Respiratory compromise in congenital muscular dystrophy (CMD) occurs, in part, from chest wall contractures. Passive stretch with hyperinsufflation therapy could reduce related costo-vertebral joint contractures. We sought to examine the impact of hyperinsufflation use on lung function and quality of life in children with CMD. Study Design: We conducted a randomized controlled trial on hyperinsufflation therapy in children with CMD at two centers. An individualized hyperinsufflation regimen of 15 minutes twice daily using a cough assist device over a 12 months period was prescribed. We measured lung function, quality of life, and adherence. To demonstrate reproducibility, pulmonary function was measured twice on the same day. A mixed-effects regression model adjusting for confounders was used to assess the effects of hyperinsufflation. Results: We enrolled 34 participants in the study; 31 completed the trial (n = 17 treatment group and n = 14 controls). Participants in the treatment group demonstrated a relative gain in lung volume measured at 4 and 8 months, but not at 12 months. The control group required increases in the maximum insufflation pressures to achieve maximum lung volumes while the treatment group did not. Adherence was best early in the study, peaking at the first visit and decreasing at subsequent visits. Caregiver-reported quality of life was higher in the treatment group. Conclusion: Hyperinsufflation therapy is effective in increasing and sustaining lung volume over time. Adherence, however, was inconsistent and difficult to maintain. Further research should determine if improved adherence leads to sustained benefits of hyperinsufflation.",0,0,scopus,"['intelligent systems', 'software architecture', 'prototyping', 'architecture designs', 'software development', 'correlation analysis', 'portable device', 'systems design', 'regression model', 'intelligent control', 'portable equipment']",Ullrich congenital muscular dystrophy,"['trial', 'lung', 'hyperinflation', 'therapy', 'children', 'congenital', 'muscular', 'dystrophy']","['Respiratory', 'compromise', 'congenital', 'muscular', 'dystrophy', 'part', 'chest', 'wall', 'contractures', 'Passive', 'stretch', 'hyperinsufflation', 'therapy', 'related', 'costo', 'vertebral', 'joint', 'contractures', 'impact', 'hyperinsufflation', 'use', 'lung', 'function', 'quality', 'life', 'children', 'trial', 'hyperinsufflation', 'therapy', 'children', 'centers', 'individualized', 'hyperinsufflation', 'regimen', 'minutes', 'cough', 'assist', 'device', 'months', 'period', 'lung', 'function', 'quality', 'life', 'adherence', 'reproducibility', 'pulmonary', 'function', 'same', 'day', 'mixed', 'effects', 'regression', 'model', 'confounders', 'effects', 'hyperinsufflation', 'Results', 'participants', 'study', 'trial', 'treatment', 'group', 'controls', 'Participants', 'treatment', 'group', 'relative', 'gain', 'lung', 'volume', 'months', 'months', 'control', 'group', 'increases', 'maximum', 'insufflation', 'pressures', 'maximum', 'lung', 'volumes', 'treatment', 'group', 'Adherence', 'study', 'first', 'visit', 'subsequent', 'visits', 'quality', 'life', 'higher', 'treatment', 'group', 'Conclusion', 'Hyperinsufflation', 'therapy', 'effective', 'lung', 'volume', 'time', 'Adherence', 'inconsistent', 'difficult', 'Further', 'research', 'adherence', 'leads', 'sustained', 'benefits', 'hyperinsufflation']"
94,94,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086374128&origin=inward,Differential diagnosis of vacuolar myopathies in the NGS era,"¬© 2020 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology.Altered autophagy accompanied by abnormal autophagic (rimmed) vacuoles detectable by light and electron microscopy is a common denominator of many familial and sporadic non-inflammatory muscle diseases. Even in the era of next generation sequencing (NGS), late-onset vacuolar myopathies remain a diagnostic challenge. We identified 32 adult vacuolar myopathy patients from 30 unrelated families, studied their clinical, histopathological and ultrastructural characteristics and performed genetic testing in index patients and relatives using Sanger sequencing and NGS including whole exome sequencing (WES). We established a molecular genetic diagnosis in 17 patients. Pathogenic mutations were found in genes typically linked to vacuolar myopathy (GNE, LDB3/ZASP, MYOT, DES and GAA), but also in genes not regularly associated with severely altered autophagy (FKRP, DYSF, CAV3, COL6A2, GYG1 and TRIM32) and in the digenic facioscapulohumeral muscular dystrophy 2. Characteristic histopathological features including distinct patterns of myofibrillar disarray and evidence of exocytosis proved to be helpful to distinguish causes of vacuolar myopathies. Biopsy validated the pathogenicity of the novel mutations p.(Phe55*) and p.(Arg216*) in GYG1 and of the p.(Leu156Pro) TRIM32 mutation combined with compound heterozygous deletion of exon 2 of TRIM32 and expanded the phenotype of Ala93Thr-caveolinopathy and of limb-girdle muscular dystrophy 2i caused by FKRP mutation. In 15 patients no causal variants were detected by Sanger sequencing and NGS panel analysis. In 12 of these cases, WES was performed, but did not yield any definite mutation or likely candidate gene. In one of these patients with a family history of muscle weakness, the vacuolar myopathy was eventually linked to chloroquine therapy. Our study illustrates the wide phenotypic and genotypic heterogeneity of vacuolar myopathies and validates the role of histopathology in assessing the pathogenicity of novel mutations detected by NGS. In a sizable portion of vacuolar myopathy cases, it remains to be shown whether the cause is hereditary or degenerative.",0,0,scopus,"['feature space', 'particle swarm optimization (pso)', 'classification methods', 'system theory', 'mutation strategy', 'correlation analysis', 'system testing', 'pattern recognition', 'differential evolution', 'software engineering', 'evolutionary algorithms', 'mutation operators', 'mathematics']",Ullrich congenital muscular dystrophy,"['Differential', 'diagnosis', 'vacuolar', 'myopathies', 'era']","['behalf', 'Altered', 'autophagy', 'abnormal', 'autophagic', 'rimmed', 'vacuoles', 'detectable', 'light', 'electron', 'microscopy', 'common', 'denominator', 'many', 'familial', 'sporadic', 'non', '-', 'inflammatory', 'muscle', 'diseases', 'era', 'next', 'generation', 'sequencing', 'late', 'onset', 'vacuolar', 'myopathies', 'diagnostic', 'challenge', 'adult', 'vacuolar', 'myopathy', 'patients', 'unrelated', 'families', 'clinical', 'histopathological', 'ultrastructural', 'characteristics', 'genetic', 'testing', 'index', 'patients', 'relatives', 'sequencing', 'whole', 'exome', 'sequencing', 'molecular', 'genetic', 'diagnosis', 'patients', 'Pathogenic', 'mutations', 'genes', 'vacuolar', 'myopathy', 'genes', 'autophagy', 'TRIM32', 'digenic', 'facioscapulohumeral', 'muscular', 'dystrophy', 'Characteristic', 'histopathological', 'features', 'distinct', 'patterns', 'myofibrillar', 'disarray', 'evidence', 'exocytosis', 'helpful', 'causes', 'vacuolar', 'myopathies', 'pathogenicity', 'novel', 'mutations', 'p.(Phe55', 'p.(Leu156Pro', 'TRIM32', 'mutation', 'compound', 'heterozygous', 'deletion', 'exon', 'TRIM32', 'phenotype', 'limb', 'girdle', 'muscular', 'dystrophy', '2i', 'mutation', 'patients', 'causal', 'variants', 'sequencing', 'panel', 'analysis', 'cases', 'definite', 'mutation', 'likely', 'candidate', 'gene', 'patients', 'family', 'history', 'muscle', 'weakness', 'vacuolar', 'myopathy', 'therapy', 'study', 'wide', 'phenotypic', 'heterogeneity', 'vacuolar', 'myopathies', 'role', 'histopathology', 'pathogenicity', 'novel', 'mutations', 'sizable', 'portion', 'vacuolar', 'myopathy', 'cases', 'cause', 'hereditary', 'degenerative']"
95,95,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85086116212&origin=inward,Cardiac fibroblast diversity in health and disease,"¬© 2020 Elsevier B.V.The cardiac stroma plays essential roles in health and following cardiac damage. The major player of the stroma with respect to extracellular matrix deposition, maintenance and remodeling is the poorly defined fibroblast. It has long been recognized that there is considerable variability to the fibroblast phenotype. With the advent of new, high throughput analytical methods our understanding and appreciation of this heterogeneity has grown dramatically. This review aims to explore the diversity of cardiac fibroblasts and highlights new insights into the diverse nature of these cells and their progenitors as revealed by single cell sequencing and fate mapping studies. We propose that at least in part the observed heterogeneity is related to the existence of a differentiation cascade within stromal cells. Beyond in-organ heterogeneity, we also discuss how the stromal response to damage differs between non-regenerating organs such as the heart and regenerating organs such as skeletal muscle. In exploring possible causes for these differences, we outline that although fibrogenic cells from different organs overlap in many properties, they still possess organ-specific transcriptional signatures and differentiation biases that make them functionally distinct.",0,0,scopus,"['damage detection', 'gameplay', 'maintenance process', 'game design', 'computer software maintenance', 'structural damages', 'structural health monitoring', 'fingerprint', 'biometrics']",Ullrich congenital muscular dystrophy,"['Cardiac', 'fibroblast', 'diversity', 'health', 'disease']","['Elsevier', 'cardiac', 'stroma', 'essential', 'roles', 'health', 'cardiac', 'damage', 'major', 'player', 'stroma', 'respect', 'extracellular', 'matrix', 'deposition', 'maintenance', 'remodeling', 'fibroblast', 'considerable', 'variability', 'fibroblast', 'phenotype', 'advent', 'new', 'high', 'throughput', 'analytical', 'methods', 'understanding', 'appreciation', 'heterogeneity', 'review', 'diversity', 'cardiac', 'fibroblasts', 'new', 'insights', 'diverse', 'nature', 'cells', 'progenitors', 'single', 'cell', 'sequencing', 'fate', 'mapping', 'studies', 'least', 'part', 'observed', 'heterogeneity', 'existence', 'differentiation', 'cascade', 'stromal', 'cells', 'organ', 'heterogeneity', 'stromal', 'response', 'damage', 'differs', 'non', '-', 'regenerating', 'organs', 'such', 'heart', 'regenerating', 'organs', 'such', 'skeletal', 'muscle', 'possible', 'causes', 'differences', 'fibrogenic', 'cells', 'different', 'organs', 'many', 'properties', 'organ', 'specific', 'transcriptional', 'signatures', 'differentiation', 'biases', 'distinct']"
96,96,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085745155&origin=inward,Nox4 ‚Äì RyR1 ‚Äì Nox2: Regulators of micro-domain signaling in skeletal muscle,"¬© 2020The ability for skeletal muscle to perform optimally can be affected by the regulation of Ca2+ within the triadic junctional space at rest. Reactive oxygen species impact muscle performance due to changes in oxidative stress, damage and redox regulation of signaling cascades. The interplay between ROS and Ca2+ signaling at the triad of skeletal muscle is therefore important to understand as it can impact the performance of healthy and diseased muscle. Here, we aimed to examine how changes in Ca2+ and redox signaling within the junctional space micro-domain of the mouse skeletal muscle fibre alters the homeostasis of these complexes. The dystrophic mdx mouse model displays increased RyR1 Ca2+ leak and increased NAD(P)H Oxidase 2 ROS. These alterations make the mdx mouse an ideal model for understanding how ROS and Ca2+ handling impact each other. We hypothesised that elevated t-tubular Nox2 ROS increases RyR1 Ca2+ leak contributing to an increase in cytoplasmic Ca2+, which could then initiate protein degradation and impaired cellular functions such as autophagy and ER stress. We found that inhibiting Nox2 ROS did not decrease RyR1 Ca2+ leak observed in dystrophin-deficient skeletal muscle. Intriguingly, another NAD(P)H isoform, Nox4, is upregulated in mice unable to produce Nox2 ROS and when inhibited reduced RyR1 Ca2+ leak. Our findings support a model in which Nox4 ROS induces RyR1 Ca2+ leak and the increased junctional space [Ca2+] exacerbates Nox2 ROS; with the cumulative effect of disruption of downstream cellular processes that would ultimately contribute to reduced muscle or cellular performance.",0,0,scopus,"['cellular telephone systems', 'hierarchical system', 'hierarchical model', 'optical fibers', 'wireless', 'optical materials', 'cellular radio systems', 'channel capacity', 'sensors', 'cellular network', 'cellular system', 'cellular', 'optical fibre']",Ullrich congenital muscular dystrophy,"['RyR1', 'Nox2', 'Regulators', 'micro', '-', 'domain', 'skeletal', 'muscle']","['ability', 'skeletal', 'muscle', 'regulation', 'Ca2', 'triadic', 'junctional', 'space', 'rest', 'Reactive', 'oxygen', 'species', 'impact', 'muscle', 'performance', 'changes', 'oxidative', 'stress', 'damage', 'redox', 'regulation', 'cascades', 'interplay', 'Ca2', 'triad', 'skeletal', 'muscle', 'important', 'performance', 'healthy', 'diseased', 'muscle', 'changes', 'Ca2', 'redox', 'junctional', 'space', 'micro', '-', 'domain', 'mouse', 'skeletal', 'muscle', 'fibre', 'homeostasis', 'complexes', 'dystrophic', 'mdx', 'mouse', 'model', 'displays', 'RyR1', 'Ca2', 'leak', 'alterations', 'mdx', 'mouse', 'ideal', 'model', 'Ca2', 'handling', 'impact', 'other', 'elevated', 't', 'tubular', 'RyR1', 'Ca2', 'leak', 'increase', 'cytoplasmic', 'Ca2', 'protein', 'degradation', 'cellular', 'functions', 'such', 'autophagy', 'stress', 'RyR1', 'Ca2', 'leak', 'dystrophin', 'deficient', 'skeletal', 'muscle', 'isoform', 'mice', 'unable', 'RyR1', 'Ca2', 'leak', 'findings', 'model', 'RyR1', 'Ca2', 'leak', 'junctional', 'space', 'Ca2', 'cumulative', 'effect', 'disruption', 'downstream', 'cellular', 'processes', 'reduced', 'muscle', 'cellular', 'performance']"
97,97,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084408564&origin=inward,Coexistence of digenic mutations in the collagen VI genes (COL6A1 and COL6A3) leads to Bethlem myopathy,"¬© 2020 Elsevier B.V.Introduction: Bethlem myopathy is a kind of collagen VI related myopathy which affects proximal skeletal muscles and leads to gait disturbance and multiple joint contractures with an onset in the first two decades of life. Lung function impairment (respiratory muscle and diaphragmatic weakness, ventilatory restriction, hypoxaemia and hypercapnia) and respiratory failure are part of the clinical spectrum and can occur in ambulatory patients. Methodology: We carried out whole exome sequencing (WES) in combination with neuromuscular diseases-associated genes-filtering to detect the possible causative mutation(s) in a Korean family with Bethlem myopathy. An electrodiagnostic study showed myopathic pattern (normal nerve conduction study, and early recruitment and short amplitude muscle unit action potentials) in the proband. Results: Coexistence of digenic mutations in the collagen VI genes (COL6A1 and COL6A3) was identified by WES in the proband only: heterozygous missense mutations of the COL6A1 (NM_001848.2: c.823G > T, p.Gly275Trp; rs1556425467) and of the COL6A3 genes (NM_004369.3: c.9349G > A, p.Asp3117Asn; rs1226664855). COL6A3 mutation may be candidate as disease-associated variant, as far as it was found only in the proband harboring another heterozygous mutation in COL6A1 gene, previously reported as different pathogenic mutations (p.Gly275Arg and p.Gly275Glu) at the same codon in Bethlem myopathy. Conclusion: Our findings suggest that the coexistence of these digenic mutations is rare, but it may be used for the risk evaluation of individuals with a possible susceptibility to Bethlem myopathy. Taken together, genetic diagnosis using WES is a useful approach for the identification of pathogenic mutations associated with Bethlem myopathy.",0,0,scopus,"['particle swarm optimization (pso)', 'observability', 'disturbance rejection', 'frequency bands', 'mutation strategy', 'differential evolution', 'evolutionary algorithms', 'extended state observer', 'mutation operators', 'antennas', 'periodic disturbances']",Ullrich congenital muscular dystrophy,"['Coexistence', 'digenic', 'mutations', 'collagen', 'genes', 'COL6A1', 'myopathy']","['B.V.Introduction', 'myopathy', 'kind', 'collagen', 'myopathy', 'proximal', 'skeletal', 'muscles', 'disturbance', 'multiple', 'joint', 'contractures', 'onset', 'first', 'decades', 'life', 'Lung', 'function', 'impairment', 'respiratory', 'muscle', 'diaphragmatic', 'weakness', 'ventilatory', 'restriction', 'hypoxaemia', 'hypercapnia', 'respiratory', 'failure', 'part', 'clinical', 'spectrum', 'ambulatory', 'patients', 'Methodology', 'whole', 'exome', 'sequencing', 'combination', 'neuromuscular', 'diseases', 'genes', 'possible', 'causative', 'mutation(s', 'Korean', 'family', 'myopathy', 'electrodiagnostic', 'study', 'myopathic', 'pattern', 'normal', 'nerve', 'conduction', 'study', 'early', 'recruitment', 'short', 'amplitude', 'muscle', 'unit', 'action', 'potentials', 'proband', 'Results', 'Coexistence', 'digenic', 'mutations', 'collagen', 'genes', 'COL6A1', 'proband', 'heterozygous', 'missense', 'mutations', 'c.823', 'G', 'T', 'p', 'genes', 'NM_004369.3', 'G', 'A', 'p', 'Asp3117Asn', 'COL6A3', 'mutation', 'candidate', 'disease', 'variant', 'proband', 'heterozygous', 'mutation', 'COL6A1', 'gene', 'different', 'pathogenic', 'mutations', 'p', 'Gly275Arg', 'p', 'same', 'codon', 'myopathy', 'Conclusion', 'findings', 'coexistence', 'digenic', 'mutations', 'rare', 'risk', 'evaluation', 'individuals', 'possible', 'susceptibility', 'myopathy', 'genetic', 'diagnosis', 'useful', 'approach', 'identification', 'pathogenic', 'mutations', 'myopathy']"
98,98,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089942385&origin=inward,Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy,"¬© Copyright ¬© 2020 Vera, McConville, Kyba and Keller-Ross.Background: Sarcopenic obesity has been observed in people with neuromuscular impairment, and is linked to adverse health outcomes. It is unclear, however, if sarcopenic obesity develops in adults with facioscapulohumeral muscular dystrophy (FSHD). Methods: The purpose of this study was to determine if adults with FSHD meet criteria for sarcopenic obesity (appendicular lean mass index (ALMI) scores of < 7.26 or 5.45 kg/m2; % fat mass (FM) ‚â• 28 or 40% in men/women). Ten people with FSHD (50 ¬± 11 years, 2 females) and ten age/sex-matched controls (47 ¬± 13 years, 2 females) completed one visit, which included a full-body dual-energy x-ray absorptiometry (DXA) scan. Regional and whole body total mass, fat mass (FM), and lean mass (LM) were collected and body mass index (BMI) and sarcopenia measures were computed. Results: People with FSHD and controls had a similar whole body total mass (84.5 ¬± 12.9 vs. 81.8 ¬± 13.5 kg, respectively, p = 0.65). Though BMI was 2% lower in the FSHD group (p = 0.77), the % FM was 46% higher in FSHD, compared with controls (p < 0.01). In addition, ALM volume was 23% lower (p = 0.02) and ALMI was 27% lower in FSHD compared with controls (p < 0.01). Whole body LM trended to be lower in FSHD vs. controls (p = 0.05), and arm and leg LM were both lower in FSHD compared with controls (p < 0.05). Furthermore, the % LM was 18% lower in FSHD vs. controls (p < 0.01). FSHD participants exhibited greater total body FM (p < 0.01) and total leg FM (p < 0.01), but were similar in volume of total arm FM compared with controls (p = 0.09). Conclusion: Findings from this study suggest that people with FSHD, although similar in BMI and total body mass compared with controls, commonly meet the definition of sarcopenic obesity. Adults with co-existing FSHD and sarcopenic obesity may be at risk for significant impairments in quality of life, and encounter additional challenges in the management of FSHD manifestations.",0,0,scopus,"['application-layer multicast', 'communication channels (information theory)', 'humanoid robot', 'lean', 'software development', 'energy conservation', 'anthropomorphic robots', 'ray tracing', 'energy utilization', 'full body', 'multicasts']",Ullrich congenital muscular dystrophy,[],"['Copyright', 'Background', 'Sarcopenic', 'obesity', 'people', 'neuromuscular', 'impairment', 'adverse', 'health', 'outcomes', 'unclear', 'sarcopenic', 'obesity', 'adults', 'facioscapulohumeral', 'muscular', 'dystrophy', 'Methods', 'purpose', 'study', 'adults', 'FSHD', 'criteria', 'sarcopenic', 'obesity', 'appendicular', 'lean', 'mass', 'index', 'ALMI', 'scores', 'kg', 'm2', '%', 'fat', 'mass', '%', 'men', 'women', 'people', 'years', 'females', 'age', 'sex', 'controls', 'years', 'females', 'visit', 'full', 'body', 'dual', 'energy', 'x', 'ray', 'absorptiometry', 'scan', 'Regional', 'whole', 'body', 'total', 'mass', 'fat', 'mass', 'lean', 'mass', 'body', 'mass', 'index', 'sarcopenia', 'measures', 'Results', 'People', 'controls', 'similar', 'whole', 'body', 'total', 'mass', 'vs.', 'kg', '%', 'lower', 'FSHD', 'group', 'p', '%', '%', 'higher', 'controls', 'p', 'addition', 'volume', '%', 'lower', 'p', 'ALMI', '%', 'lower', 'controls', 'p', 'Whole', 'body', 'lower', 'controls', 'p', 'arm', 'leg', 'lower', 'controls', 'p', '%', '%', 'lower', 'controls', 'p', 'FSHD', 'participants', 'greater', 'total', 'body', 'total', 'leg', 'similar', 'volume', 'total', 'arm', 'controls', 'p', 'Conclusion', 'Findings', 'study', 'people', 'similar', 'total', 'body', 'mass', 'controls', 'definition', 'sarcopenic', 'obesity', 'Adults', 'co', '-', 'FSHD', 'sarcopenic', 'obesity', 'risk', 'significant', 'impairments', 'quality', 'life', 'additional', 'challenges', 'management', 'FSHD', 'manifestations']"
99,99,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089997151&origin=inward,Long Noncoding RNA (lncRNA) CTTN-IT1 Elevates Skeletal Muscle Satellite Cell Proliferation and Differentiation by Acting as ceRNA for YAP1 Through Absorbing miR-29a in Hu Sheep,"¬© Copyright ¬© 2020 Wu, Wang, Wang, Zhang, Chen, Lv, Li, Hussain and Sun.Characterizing the factors that regulate the growth and development of muscle is central to animal production. Skeletal muscle satellite cells (SMSCs) provide an important material for simulating the proliferation and differentiation of muscle cells. YAP1, which can promote muscle growth, is closely related to the proliferation of SMSCs in Hu sheep (Ovis aries). In addition, some miRNAs, such as miR-541-3p, miR-142-5p, and miR-29a, can play critical roles in muscle growth by specifically binding with their target mRNAs. Meanwhile, lncRNA can competitively bind these miRNAs and reduce the regulatory effect of miRNAs on their target genes and thus play critical roles themselves in muscle growth. However, the regulatory molecular mechanism of miRNA and lncRNA on SMSC proliferation through YAP1 remains unclear. Here, we characterized the regulatory network among YAP1 and its targeted miRNAs and lncRNAs in Hu sheep SMSCs. The potential ncRNAs that regulate YAP1 (miR-29a and CTTN-IT1) were predicted through multilevel bioinformatics analysis. Dual-luciferase assays, RT-qPCR, and western blots revealed that miR-29a can significantly reduce the mRNA and protein expression level by binding to a specific 3‚Ä≤-UTR of YAP1 (P < 0.05), while CTTN-IT1 can restore the expression of YAP1 through competitive binding to miR-29a. Furthermore, the mRNA and protein expression levels of MyoG, MyoD, and MyHC showed that miR-29a can inhibit the expression of genes related to the differentiation of SMSCs, and CTTN-IT1 can increase the expression of these same genes. Thus, miR-29a may inhibit the differentiation of SMSCs and CTTN-IT1 can restore this inhibition. The EdU staining assay indicated that excessive miR-29a can significantly reduce the proliferation ability of SMSCs (P < 0.05), while overexpression of CTTN-IT1 can significantly increase the proliferation of SMSCs (P < 0.01). CTTN-IT1 is a novel lncRNA that is a competing endogenous RNA (ceRNA) of miR-29a and can promote SMSC proliferation and differentiation by restoring the expression of YAP1 when it is inhibited by miR-29a in Hu sheep. Overall, our findings construct a CTTN-IT1-miR-29a-YAP1 regulatory network that will help contribute new insight into improving the muscle development of Hu sheep.",0,0,scopus,"['computer science', 'geostationary satellites', 'sms', 'network protocols', 'sms messages', 'network architecture', 'short message services', 'satellite system', 'bioinformatics', 'communication satellites']",Ullrich congenital muscular dystrophy,"['Noncoding', 'RNA', 'IT1', 'miR-29a', 'Sheep']","['Copyright', 'factors', 'growth', 'development', 'muscle', 'central', 'animal', 'production', 'Skeletal', 'muscle', 'satellite', 'cells', 'important', 'material', 'proliferation', 'differentiation', 'muscle', 'cells', 'muscle', 'growth', 'related', 'proliferation', 'sheep', 'aries', 'addition', 'such', 'miR-29a', 'critical', 'roles', 'muscle', 'growth', 'target', 'mRNAs', 'regulatory', 'effect', 'target', 'genes', 'critical', 'roles', 'muscle', 'growth', 'regulatory', 'molecular', 'mechanism', 'proliferation', 'unclear', 'regulatory', 'network', 'sheep', 'potential', 'miR-29a', 'multilevel', 'bioinformatics', 'analysis', 'Dual', 'luciferase', 'assays', 'western', 'blots', 'miR-29a', 'protein', 'expression', 'level', 'specific', 'P', 'expression', 'competitive', 'binding', 'miR-29a', 'protein', 'expression', 'levels', 'miR-29a', 'expression', 'genes', 'differentiation', 'expression', 'same', 'genes', 'miR-29a', 'differentiation', 'inhibition', 'staining', 'assay', 'excessive', 'miR-29a', 'proliferation', 'ability', 'P', 'overexpression', 'proliferation', 'P', 'novel', 'endogenous', 'miR-29a', 'proliferation', 'differentiation', 'expression', 'miR-29a', 'sheep', 'findings', 'regulatory', 'network', 'new', 'insight', 'muscle', 'development', 'sheep']"
100,100,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85090073157&origin=inward,Loss of supervillin causes myopathy with myofibrillar disorganization and autophagic vacuoles,"¬© The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.The muscle specific isoform of the supervillin protein (SV2), encoded by the SVIL gene, is a large sarcolemmal myosin II- and F-actin-binding protein. Supervillin (SV2) binds and co-localizes with costameric dystrophin and binds nebulin, potentially attaching the sarcolemma to myofibrillar Z-lines. Despite its important role in muscle cell physiology suggested by various in vitro studies, there are so far no reports of any human disease caused by SVIL mutations. We here report four patients from two unrelated, consanguineous families with a childhood/adolescence onset of a myopathy associated with homozygous loss-of-function mutations in SVIL. Wide neck, anteverted shoulders and prominent trapezius muscles together with variable contractures were characteristic features. All patients showed increased levels of serum creatine kinase but no or minor muscle weakness. Mild cardiac manifestations were observed. Muscle biopsies showed complete loss of large supervillin isoforms in muscle fibres by western blot and immunohistochemical analyses. Light and electron microscopic investigations revealed a structural myopathy with numerous lobulated muscle fibres and considerable myofibrillar alterations with a coarse and irregular intermyofibrillar network. Autophagic vacuoles, as well as frequent and extensive deposits of lipoproteins, including immature lipofuscin, were observed. Several sarcolemma-associated proteins, including dystrophin and sarcoglycans, were partially mis-localized. The results demonstrate the importance of the supervillin (SV2) protein for the structural integrity of muscle fibres in humans and show that recessive loss-of-function mutations in SVIL cause a distinctive and novel myopathy.",0,0,scopus,"['feature space', 'classification methods', 'optical fibers', 'optical materials', 'correlation analysis', 'pattern recognition', 'sensors', 'education', 'university', 'mathematics', 'optical fibre']",Ullrich congenital muscular dystrophy,"['Loss', 'supervillin', 'myopathy', 'myofibrillar', 'disorganization', 'autophagic', 'vacuoles']","['behalf', 'muscle', 'specific', 'isoform', 'supervillin', 'protein', 'gene', 'large', 'sarcolemmal', 'myosin', 'protein', 'co', '-', 'localizes', 'costameric', 'dystrophin', 'binds', 'nebulin', 'sarcolemma', 'myofibrillar', 'lines', 'important', 'role', 'muscle', 'cell', 'physiology', 'various', 'studies', 'reports', 'human', 'disease', 'mutations', 'patients', 'unrelated', 'consanguineous', 'families', 'childhood', 'adolescence', 'onset', 'myopathy', 'homozygous', 'loss', 'function', 'mutations', 'Wide', 'neck', 'anteverted', 'shoulders', 'prominent', 'trapezius', 'muscles', 'variable', 'contractures', 'characteristic', 'features', 'patients', 'increased', 'levels', 'serum', 'creatine', 'kinase', 'minor', 'muscle', 'weakness', 'Mild', 'cardiac', 'manifestations', 'Muscle', 'biopsies', 'complete', 'loss', 'large', 'supervillin', 'isoforms', 'muscle', 'fibres', 'western', 'blot', 'immunohistochemical', 'analyses', 'Light', 'microscopic', 'investigations', 'structural', 'myopathy', 'numerous', 'muscle', 'fibres', 'considerable', 'myofibrillar', 'alterations', 'coarse', 'irregular', 'intermyofibrillar', 'network', 'Autophagic', 'vacuoles', 'frequent', 'extensive', 'deposits', 'lipoproteins', 'immature', 'lipofuscin', 'Several', 'sarcolemma', 'proteins', 'sarcoglycans', 'mis', 'results', 'importance', 'supervillin', 'protein', 'structural', 'integrity', 'muscle', 'fibres', 'humans', 'recessive', 'loss', 'function', 'mutations', 'distinctive', 'novel', 'myopathy']"
101,101,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088493958&origin=inward,Thermal injury initiates pervasive fibrogenesis in skeletal muscle,"Copyright ¬© 2020 the American Physiological SocietySevere burn injury induces a myriad of deleterious effects to skeletal muscle, resulting in impaired function and delayed recovery. Following burn, catabolic signaling and myofiber atrophy are key fiber-intrinsic determinants of weakness; less well understood are alterations in the interstitial environment surrounding myofibers. Muscle quality, specifically alterations in the extracellular matrix (ECM), modulates force transmission and strength. We sought to determine the impact of severe thermal injury on adaptation to the muscle ECM and quantify muscle fibrotic burden. After a 30% total body surface area dorsal burn, spinotrapezius muscle was harvested from mice at 7 (7d, n = 5), 14 (14d, n = 4), and 21 days (21d, n = 4), and a sham control group was also examined (Sham, n = 4). Expression of transforming growth factor- (TGF), myostatin, and downstream effectors and proteases involved in fibrosis and collagen remodeling were measured by immunoblotting, and immunohistochemical and biochemical analyses assessed fibrogenic cell abundance and collagen deposition. Myostatin signaling increased progressively through 21 days postburn alongside fibrogenic/adipogenic progenitor cell expansion, with abundance peaking at 14 days postburn. Postburn, elevated expression of tissue inhibitor of matrix metalloproteinase 1 supported collagen remodeling resulting in a net accumulation of muscle collagen content. Collagen accumulation peaked at 14 days postburn but remained elevated through 21 days postburn, demonstrating minimal resolution of burn-induced fibrosis. These findings highlight a progressive upregulation of fibrogenic processes following burn injury, eliciting a fibrotic muscle phenotype that hinders regenerative capacity and is not resolved with 21 days of recovery.",0,0,scopus,"['pervasive', 'ubiquitous computing', 'pervasive environments', 'mobile computing', 'artificial intelligence', 'optical fibers', 'user interfaces', 'pervasive computing', 'sensors', 'ambient intelligence']",Ullrich congenital muscular dystrophy,"['Thermal', 'injury', 'pervasive', 'fibrogenesis', 'skeletal', 'muscle']","['Copyright', 'injury', 'myriad', 'deleterious', 'effects', 'skeletal', 'muscle', 'impaired', 'function', 'recovery', 'burn', 'catabolic', 'signaling', 'myofiber', 'atrophy', 'key', 'fiber', 'intrinsic', 'determinants', 'weakness', 'alterations', 'interstitial', 'environment', 'myofibers', 'Muscle', 'quality', 'alterations', 'extracellular', 'matrix', 'modulates', 'transmission', 'strength', 'impact', 'severe', 'thermal', 'injury', 'adaptation', 'muscle', 'muscle', 'fibrotic', 'burden', '%', 'total', 'body', 'surface', 'area', 'dorsal', 'burn', 'spinotrapezius', 'muscle', 'mice', '14d', 'days', '21d', 'sham', 'control', 'group', 'Expression', 'growth', 'factor-', 'myostatin', 'downstream', 'effectors', 'proteases', 'fibrosis', 'collagen', 'remodeling', 'immunohistochemical', 'biochemical', 'analyses', 'fibrogenic', 'cell', 'abundance', 'collagen', 'deposition', 'days', 'fibrogenic', 'adipogenic', 'progenitor', 'cell', 'expansion', 'abundance', 'days', 'postburn', 'Postburn', 'elevated', 'expression', 'tissue', 'inhibitor', 'matrix', 'metalloproteinase', 'collagen', 'remodeling', 'net', 'accumulation', 'muscle', 'collagen', 'content', 'Collagen', 'accumulation', 'days', 'postburn', 'days', 'postburn', 'minimal', 'resolution', 'burn', 'fibrosis', 'findings', 'progressive', 'upregulation', 'fibrogenic', 'processes', 'burn', 'injury', 'fibrotic', 'muscle', 'phenotype', 'regenerative', 'capacity', 'days', 'recovery']"
102,102,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084227036&origin=inward,Characteristic muscle signatures assessed by quantitative MRI in patients with Bethlem myopathy,"¬© 2020, Springer-Verlag GmbH Germany, part of Springer Nature.Using MRI, the main aim was to (1) map the pattern of muscle involvement by assessing fat fraction and (2) investigate frequency of target and sandwich signs in 42 muscles of patients with Bethlem myopathy (BM). Fifteen BM patients were included. Results were compared to findings in 8 healthy controls and 50 patients with four other types of muscular dystrophies. All muscles, except one, showed higher fat fraction in BM patients vs healthy controls (p < 0.05) with an overall proximal muscle affection, resembling a limb girdle-like pattern. In moderate patients, the specificity was 90% for the sandwich sign and 98% for the target sign. Sensitivity for both signs was 100%. Twelve BM patients had sandwich sign in other muscles than the vastus lateralis. Muscle strength correlated with fat fraction. Mean fat fraction in the psoas major was 39% in BM patients, which was considerably higher than in 3 of the 4 muscular dystrophy control diseases. The presence of signs in conjunction with severe affection of the psoas major muscle can serve as a diagnostic tool in BM. The high level of STIR lesions in muscles of BM patients warrants further investigations.",0,0,scopus,"['switching systems', 'variable frequency oscillators', 'control systems', 'computer systems', 'bandwidth', 'switching control', 'frequencies', 'output frequency', 'fingerprint', 'biometrics']",Ullrich congenital muscular dystrophy,"['Characteristic', 'muscle', 'signatures', 'quantitative', 'patients', 'myopathy']","['part', 'main', 'aim', 'pattern', 'muscle', 'involvement', 'fat', 'fraction', 'frequency', 'target', 'sandwich', 'signs', 'muscles', 'patients', 'patients', 'Results', 'findings', 'healthy', 'controls', 'patients', 'other', 'types', 'muscular', 'dystrophies', 'muscles', 'higher', 'fat', 'fraction', 'patients', 'healthy', 'controls', 'p', 'overall', 'proximal', 'muscle', 'affection', 'limb', 'girdle', 'like', 'pattern', 'moderate', 'patients', 'specificity', '%', 'sandwich', 'sign', '%', 'target', 'sign', 'Sensitivity', 'signs', '%', 'patients', 'sandwich', 'sign', 'other', 'muscles', 'vastus', 'lateralis', 'Muscle', 'strength', 'fat', 'fraction', 'fat', 'fraction', 'psoas', 'major', '%', 'patients', 'higher', 'muscular', 'dystrophy', 'control', 'diseases', 'presence', 'signs', 'conjunction', 'severe', 'affection', 'psoas', 'major', 'muscle', 'diagnostic', 'tool', 'high', 'level', 'lesions', 'muscles', 'patients', 'warrants', 'further', 'investigations']"
103,103,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85089433037&origin=inward,The Genetic Architecture of the Chickens Dropping Moisture by Genetic Parameter Estimation and Genome-Wide Association,"¬© Copyright ¬© 2020 Zhu, Zhang, Wen, Zhao, Chen, Jia, Wang, Lv, Yang, Guan, Ning and Qu.Dropping moisture (DM) refers to the water content of feces. High DM in chickens could be disadvantageous to pathogen control and fecal treatment in chicken farms. DM can be affected by environment, nutrition, disease, and genetics. In the present study, significant individual differences were presented in the DM of Rhode Island Red (RIR) chicken population, indicating that genetics could contribute to DM in the chickens. Subsequently, we estimated the genetic parameters of DM and conducted a genome-wide association study (GWAS) to find the potential genomic regions related to DM. The results showed that the heritability of DM ranged from 0.25 to 0.32. Furthermore, 11 significant loci on chromosome 7 were found to be associated with DM levels by the GWAS. The SNP rs15833816 within the COL6A3 gene was the most significant SNP related to DM. Hens carrying the G allele including GA and GG produced higher DM (P < 0.01) levels than those carrying the other genotype AA. Our results showed that DM is a medium-inheritable trait and that COL6A3 could be a potential candidate gene that regulates DM level in chickens.",0,0,scopus,"['signal processing', 'estimation method', 'numerical model', 'software architecture', 'architecture designs', 'object oriented programming', 'software engineering', 'sensors', 'maximum likelihood estimation', 'system architectures', 'network architecture', 'control system analysis', 'control parameters', 'embedded systems']",Ullrich congenital muscular dystrophy,[],"['Copyright', 'moisture', 'water', 'content', 'feces', 'High', 'chickens', 'disadvantageous', 'control', 'fecal', 'treatment', 'chicken', 'farms', 'environment', 'nutrition', 'disease', 'genetics', 'present', 'study', 'significant', 'individual', 'differences', 'chicken', 'population', 'genetics', 'chickens', 'genetic', 'parameters', 'genome', 'wide', 'association', 'study', 'potential', 'genomic', 'regions', 'results', 'heritability', 'significant', 'loci', 'chromosome', 'levels', 'gene', 'significant', 'Hens', 'G', 'allele', 'higher', 'P', 'levels', 'other', 'genotype', 'results', 'medium', 'inheritable', 'trait', 'potential', 'candidate', 'gene', 'level', 'chickens']"
104,104,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088781607&origin=inward,Innovative Therapeutic and Delivery Approaches Using Nanotechnology to Correct Splicing Defects Underlying Disease,"¬© Copyright ¬© 2020 Su√±√©-Pou, Limeres, Moreno-Castro, Hern√°ndez-Munain, Su√±√©-Negre, Cuestas and Su√±√©.Alternative splicing of pre-mRNA contributes strongly to the diversity of cell- and tissue-specific protein expression patterns. Global transcriptome analyses have suggested that >90% of human multiexon genes are alternatively spliced. Alterations in the splicing process cause missplicing events that lead to genetic diseases and pathologies, including various neurological disorders, cancers, and muscular dystrophies. In recent decades, research has helped to elucidate the mechanisms regulating alternative splicing and, in some cases, to reveal how dysregulation of these mechanisms leads to disease. The resulting knowledge has enabled the design of novel therapeutic strategies for correction of splicing-derived pathologies. In this review, we focus primarily on therapeutic approaches targeting splicing, and we highlight nanotechnology-based gene delivery applications that address the challenges and barriers facing nucleic acid-based therapeutics.",0,0,scopus,"['potential barriers', 'knowledge management', 'software development', 'explicit knowledge', 'intelligent systems', 'sustainable building', 'software architecture', 'intelligent buildings', 'architecture designs', 'systems design', 'intelligent control', 'tacit knowledge', 'nuclear physics', 'correlation analysis', 'mathematics', 'domain knowledge', 'electromagnetic wave attenuation', 'prototyping', 'knowledge based systems', 'correction method']",Ullrich congenital muscular dystrophy,"['Delivery', 'Defects']","['Copyright', 'Alternative', 'splicing', 'pre', '-', 'mRNA', 'diversity', 'cell-', 'tissue', 'specific', 'protein', 'expression', 'patterns', 'Global', 'transcriptome', 'analyses', '%', 'human', 'genes', 'Alterations', 'splicing', 'process', 'missplicing', 'events', 'genetic', 'diseases', 'pathologies', 'various', 'neurological', 'disorders', 'cancers', 'muscular', 'dystrophies', 'recent', 'decades', 'research', 'mechanisms', 'alternative', 'splicing', 'cases', 'dysregulation', 'mechanisms', 'disease', 'knowledge', 'design', 'novel', 'therapeutic', 'strategies', 'correction', 'splicing', 'pathologies', 'review', 'therapeutic', 'approaches', 'splicing', 'nanotechnology', 'gene', 'delivery', 'applications', 'challenges', 'barriers', 'nucleic', 'acid', 'therapeutics']"
105,105,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087417144&origin=inward,Physiopathology of the permeability transition pore: Molecular mechanisms in human pathology,"¬© 2020 by the authors.Mitochondrial permeability transition (MPT) is the sudden loss in the permeability of the inner mitochondrial membrane (IMM) to low-molecular-weight solutes. Due to osmotic forces, MPT is paralleled by a massive influx of water into the mitochondrial matrix, eventually leading to the structural collapse of the organelle. Thus, MPT can initiate outer-mitochondrial-membrane permeabilization (MOMP), promoting the activation of the apoptotic caspase cascade and caspase-independent cell-death mechanisms. The induction of MPT is mostly dependent on mitochondrial reactive oxygen species (ROS) and Ca2+, but is also dependent on the metabolic stage of the affected cell and signaling events. Therefore, since its discovery in the late 1970s, the role of MPT in human pathology has been heavily investigated. Here, we summarize the most significant findings corroborating a role for MPT in the etiology of a spectrum of human diseases, including diseases characterized by acute or chronic loss of adult cells and those characterized by neoplastic initiation.",0,0,scopus,"['target tracking', 'spectrum sensing', 'probability hypothesis density', 'data fusion', 'multi-target tracking', 'frequency bands', 'interacting multiple model', 'probability', 'cognitive radio network', 'antennas', 'dynamic spectrum access', 'dynamic spectrum']",Ullrich congenital muscular dystrophy,"['Physiopathology', 'permeability', 'transition', 'pore', 'Molecular', 'mechanisms', 'human', 'pathology']","['authors', 'Mitochondrial', 'permeability', 'transition', 'sudden', 'loss', 'permeability', 'inner', 'mitochondrial', 'membrane', 'low', 'molecular', 'weight', 'solutes', 'osmotic', 'forces', 'massive', 'influx', 'water', 'mitochondrial', 'matrix', 'structural', 'collapse', 'organelle', 'outer', 'mitochondrial', 'membrane', 'permeabilization', 'activation', 'apoptotic', 'caspase', 'cascade', 'caspase', 'independent', 'cell', 'death', 'mechanisms', 'induction', 'dependent', 'mitochondrial', 'reactive', 'oxygen', 'species', 'Ca2', 'dependent', 'metabolic', 'stage', 'affected', 'cell', 'events', 'discovery', 'late', '1970s', 'role', 'human', 'pathology', 'significant', 'findings', 'role', 'etiology', 'spectrum', 'human', 'diseases', 'diseases', 'acute', 'chronic', 'loss', 'adult', 'cells', 'neoplastic', 'initiation']"
106,106,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087174213&origin=inward,Nonsense suppression therapy: New hypothesis for the treatment of inherited bone marrow failure syndromes,"¬© 2020 by the authors. Licensee MDPI, Basel, Switzerland.Inherited bone marrow failure syndromes (IBMFS) are a group of cancer-prone genetic diseases characterized by hypocellular bone marrow with impairment in one or more hematopoietic lineages. The pathogenesis of IBMFS involves mutations in several genes which encode for proteins involved in DNA repair, telomere biology and ribosome biogenesis. The classical IBMFS include Shwachman‚ÄìDiamond syndrome (SDS), Diamond‚ÄìBlackfan anemia (DBA), Fanconi anemia (FA), dyskeratosis congenita (DC), and severe congenital neutropenia (SCN). IBMFS are associated with high risk of myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and solid tumors. Unfortunately, no specific pharmacological therapies have been highly effective for IBMFS. Hematopoietic stem cell transplantation provides a cure for aplastic or myeloid neoplastic complications. However, it does not affect the risk of solid tumors. Since approximately 28% of FA, 24% of SCN, 21% of DBA, 20% of SDS, and 17% of DC patients harbor nonsense mutations in the respective IBMFS-related genes, we discuss the use of the nonsense suppression therapy in these diseases. We recently described the beneficial effect of ataluren, a nonsense suppressor drug, in SDS bone marrow hematopoietic cells ex vivo. A similar approach could be therefore designed for treating other IBMFS. In this review we explain in detail the new generation of nonsense suppressor molecules and their mechanistic roles. Furthermore, we will discuss strengths and limitations of these molecules which are emerging from preclinical and clinical studies. Finally we discuss the state-of-the-art of preclinical and clinical therapeutic studies carried out for IBMFS.",0,0,scopus,"['node failure', 'wireless sensor networks', 'fault tolerance', 'epon', 'dba', 'sensor networks']",Ullrich congenital muscular dystrophy,"['Nonsense', 'suppression', 'therapy', 'New', 'hypothesis', 'treatment', 'bone', 'marrow', 'failure']","['authors', 'Inherited', 'bone', 'marrow', 'failure', 'syndromes', 'group', 'cancer', 'prone', 'genetic', 'diseases', 'hypocellular', 'bone', 'marrow', 'impairment', 'more', 'hematopoietic', 'lineages', 'pathogenesis', 'mutations', 'several', 'genes', 'proteins', 'DNA', 'repair', 'telomere', 'biology', 'ribosome', 'biogenesis', 'classical', 'syndrome', 'anemia', 'anemia', 'congenita', 'severe', 'congenital', 'neutropenia', 'high', 'risk', 'myelodysplastic', 'syndrome', 'acute', 'myeloid', 'leukemia', 'solid', 'tumors', 'specific', 'pharmacological', 'therapies', 'effective', 'Hematopoietic', 'stem', 'cell', 'transplantation', 'cure', 'aplastic', 'myeloid', 'neoplastic', 'complications', 'risk', 'solid', 'tumors', '%', '%', '%', 'DBA', '%', '%', 'patients', 'nonsense', 'mutations', 'respective', 'genes', 'use', 'nonsense', 'suppression', 'therapy', 'diseases', 'beneficial', 'effect', 'ataluren', 'nonsense', 'suppressor', 'drug', 'bone', 'marrow', 'hematopoietic', 'cells', 'vivo', 'similar', 'approach', 'other', 'review', 'detail', 'new', 'generation', 'nonsense', 'suppressor', 'molecules', 'mechanistic', 'roles', 'strengths', 'limitations', 'molecules', 'preclinical', 'clinical', 'studies', 'state', 'art', 'preclinical', 'clinical', 'therapeutic', 'studies']"
107,107,http://dx.doi.org/10.1155/2011/139194,Cyclosporine A in Ullrich Congenital Muscular Dystrophy: Long-Term Results,"Six individuals with Ullrich congenital muscular dystrophy (UCMD) and mutations in the genes-encoding collagen VI, aging 5‚Äì9, received 3‚Äì5‚Äâmg/kg of cyclosporine A (CsA) daily for 1 to 3.2 years. The primary outcome measure was the muscle strength evaluated with a myometer and expressed as megalimbs. The megalimbs score showed significant improvement (P=0.01) in 5 of the 6 patients. Motor function did not change. Respiratory function deteriorated in all. CsA treatment corrected mitochondrial dysfunction, increased muscle regeneration, and decreased the number of apoptotic nuclei. Results from this study demonstrate that long-term treatment with CsA ameliorates performance in the limbs, but not in the respiratory muscles of UCMD patients, and that it is well tolerated. These results suggest considering a trial of CsA or nonimmunosuppressive cyclosporins, that retains the PTP-desensitizing properties of CsA, as early as possible in UCMD patients when diaphragm is less compromised.",['Luciano Merlini'],0,doaj,[],Ullrich congenital muscular dystrophy,"['A', 'Long', 'Term', 'Results']","['individuals', 'congenital', 'muscular', 'dystrophy', 'mutations', 'genes', 'collagen', 'mg', 'kg', 'cyclosporine', 'years', 'primary', 'outcome', 'measure', 'muscle', 'strength', 'myometer', 'megalimbs', 'megalimbs', 'score', 'significant', 'improvement', 'P=0.01', 'patients', 'Motor', 'function', 'Respiratory', 'function', 'CsA', 'treatment', 'mitochondrial', 'dysfunction', 'muscle', 'regeneration', 'number', 'apoptotic', 'nuclei', 'Results', 'study', 'long', 'term', 'treatment', 'ameliorates', 'performance', 'limbs', 'respiratory', 'muscles', 'patients', 'results', 'trial', 'nonimmunosuppressive', 'cyclosporins', 'properties', 'possible', 'patients', 'diaphragm', 'compromised']"
108,108,http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=15;spage=1811;epage=1816;aulast=Fu,‚ÄúTarget‚Äù and ‚ÄúSandwich‚Äù Signs in Thigh Muscles have High Diagnostic Values for Collagen VI-related Myopathies,"Background: Collagen VI-related myopathies are autosomal dominant and recessive hereditary myopathies, mainly including Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM). Muscle magnetic resonance imaging (MRI) has been widely used to diagnosis muscular disorders. The purpose of this study was to evaluate the diagnostic value of thigh muscles MRI for collagen VI-related myopathies.
Methods: Eleven patients with collagen VI gene mutation-related myopathies were enrolled in this study. MRI of the thigh muscles was performed in all patients with collagen VI gene mutation-related myopathies and in 361 patients with other neuromuscular disorders (disease controls). T1-weighted images were used to assess fatty infiltration of the muscles using a modified Mercuri's scale. We assessed the sensitivity and specificity of the MRI features of collagen VI-related myopathies. The relationship between fatty infiltration of muscles and specific collagen VI gene mutations was also investigated.
Results: Eleven patients with collagen VI gene mutation-related myopathies included six UCMD patients and five BM patients. There was no significant difference between UCMD and BM patients in the fatty infiltration of each thigh muscle except sartorius (P = 0.033); therefore, we combined the UCMD and BM data. Mean fatty infiltration scores were 3.1 and 3.0 in adductor magnus and gluteus maximus, while the scores were 1.3, 1.3, and 1.5 in gracilis, adductor longus, and sartorius, respectively. A ‚Äútarget‚Äù sign in rectus femoris (RF) was present in seven cases, and a ‚Äúsandwich‚Äù sign in vastus lateralis (VL) was present in ten cases. The ‚Äútarget‚Äù and ‚Äúsandwich‚Äù signs had sensitivities of 63.6% and 90.9% and specificities of 97.3% and 96.9% for the diagnosis of collagen VI-related myopathies, respectively. Fatty infiltration scores were 2.0‚Äì3.0 in seven patients with mutations in the triple-helical domain, and 1.0‚Äì1.5 in three of four patients with mutations in the N- or C-domain of the collagen VI genes.
Conclusions: The ‚Äútarget‚Äù sign in RF and ‚Äúsandwich‚Äù sign in VL are common MRI features and are useful for the diagnosis of collagen VI-related myopathies. The severity of fatty infiltration of muscles may have a relationship with the mutation location of collagen VI gene.",['Jun Fu'],['Collagen VI-related Myopathies; Gene Mutation; Muscle Magnetic Resonance Imaging; Sensitivity; Specificity'],doaj,"['computerized tomography', 'x-ray computed tomography', 'particle swarm optimization (pso)', 'fiber lasers', 'imaging systems', 'mutation strategy', 'differential evolution', 'mutation operators', 'evolutionary algorithms', 'higher-order modes', 'photonic crystal fibers', 'image reconstruction']",Ullrich congenital muscular dystrophy,"['Signs', 'Diagnostic', 'Values']","['Background', 'myopathies', 'autosomal', 'dominant', 'recessive', 'hereditary', 'myopathies', 'congenital', 'muscular', 'dystrophy', 'Muscle', 'magnetic', 'resonance', 'imaging', 'muscular', 'disorders', 'purpose', 'study', 'diagnostic', 'value', 'thigh', 'muscles', 'collagen', 'myopathies', 'Methods', 'patients', 'collagen', 'gene', 'mutation', 'myopathies', 'study', 'MRI', 'thigh', 'muscles', 'patients', 'collagen', 'gene', 'mutation', 'myopathies', 'patients', 'other', 'neuromuscular', 'disorders', 'disease', 'controls', 'images', 'fatty', 'infiltration', 'muscles', 'scale', 'sensitivity', 'specificity', 'features', 'collagen', 'myopathies', 'relationship', 'fatty', 'infiltration', 'muscles', 'specific', 'collagen', 'gene', 'mutations', 'Results', 'patients', 'collagen', 'gene', 'mutation', 'myopathies', 'patients', 'patients', 'significant', 'difference', 'patients', 'fatty', 'infiltration', 'thigh', 'muscle', 'sartorius', 'P', 'data', 'fatty', 'infiltration', 'scores', 'adductor', 'magnus', 'maximus', 'scores', 'gracilis', 'adductor', 'longus', 'sartorius', 'target', 'sign', 'rectus', 'femoris', 'present', 'cases', 'sandwich', 'sign', 'vastus', 'lateralis', 'present', 'cases', 'target', 'sandwich', 'signs', 'sensitivities', '%', '%', 'specificities', '%', '%', 'diagnosis', 'collagen', 'myopathies', 'infiltration', 'scores', 'patients', 'mutations', 'triple', 'helical', 'domain', 'patients', 'mutations', 'domain', 'collagen', 'genes', 'Conclusions', 'target', 'sign', 'sandwich', 'sign', 'common', 'features', 'useful', 'diagnosis', 'collagen', 'myopathies', 'severity', 'fatty', 'infiltration', 'muscles', 'relationship', 'mutation', 'location', 'collagen', 'gene']"
109,109,http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00315/full,Nutritional status evaluation in patients affected by Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy,"Collagen VI mutations lead to disabling myopathies like Bethlem Myopathy (BM) and Ullrich Congenital Muscular Dystrophy (UCMD). We have investigated the nutritional and metabolic status of one UCMD and seven BM patients (5 female, 3 male, mean age 31 ¬± 9 years) in order to find a potential metabolic target for nutritional intervention. For this study, we used standard anthropometric tools, such as BMI evaluation and body circumference measurements. All results were compared to Dual Energy X ray Absorptiometry (DXA), considered the gold standard method. Energy intake of each patient was evaluated through longitudinal methods (7-day food diary) while Resting Energy Expenditure (REE) was predicted using specific equations and measured by indirect calorimetry. Clinical evaluation included general and nutritional blood and urine laboratory analyses and quantitative muscle strength measurement by hand-held dynamometry. BM and UCMD patients showed an altered body composition, characterized by low Free Fat Mass (FFM) and high Fat Mass (FM), allowing us to classify them as sarcopenic, and all but one as sarcopenic-obese. Another main result was the negative correlation between REE/FFM ratio (basal energy expenditure per kg of fat-free mass) and the severity of the disease, as defined by the muscle megascore (Correlation Coefficient -0.955, P value < 0.001). We postulate that the increase of the REE/FFM ratio in relation to the severity of the disease may be due to an altered and pathophysiological loss of energetic efficiency at the expense of skeletal muscle. We show that a specific metabolic disequilibrium is related to the severity of the disease, which may represent a target for a nutritional intervention in these patients.",['Silvia eToni'],"['Body Composition', 'Muscular Dystrophies', 'collagen VI', 'Nutritional assessment', 'basal energy expenditure']",doaj,"['numerical methods', 'computational efficiency', 'differential equations', 'theoretical computer science', 'energy conservation', 'handheld', 'correlation analysis', 'investments', 'correlation coefficient', 'energy utilization', 'capital investment', 'hand held computers']",Ullrich congenital muscular dystrophy,"['Nutritional', 'status', 'evaluation', 'patients']","['mutations', 'myopathies', 'nutritional', 'metabolic', 'status', 'patients', 'female', 'male', 'mean', 'age', 'years', 'order', 'potential', 'metabolic', 'target', 'nutritional', 'intervention', 'study', 'standard', 'anthropometric', 'tools', 'such', 'evaluation', 'body', 'circumference', 'measurements', 'results', 'ray', 'gold', 'standard', 'method', 'Energy', 'intake', 'patient', 'longitudinal', 'methods', 'food', 'diary', 'specific', 'equations', 'indirect', 'calorimetry', 'Clinical', 'evaluation', 'general', 'nutritional', 'blood', 'urine', 'laboratory', 'quantitative', 'muscle', 'strength', 'measurement', 'hand', 'dynamometry', 'patients', 'altered', 'body', 'composition', 'low', 'high', 'sarcopenic', 'sarcopenic', 'obese', 'main', 'result', 'negative', 'correlation', 'ratio', 'basal', 'energy', 'expenditure', 'kg', 'fat', 'free', 'mass', 'severity', 'disease', 'muscle', 'megascore', 'P', 'value', 'increase', 'ratio', 'relation', 'severity', 'disease', 'due', 'altered', 'pathophysiological', 'loss', 'energetic', 'efficiency', 'expense', 'skeletal', 'muscle', 'specific', 'metabolic', 'disequilibrium', 'severity', 'disease', 'target', 'nutritional', 'intervention', 'patients']"
110,110,http://www.annalsofian.org/article.asp?issn=0972-2327;year=2013;volume=16;issue=4;spage=712;epage=715;aulast=Saroja,"Bethlem myopathy: An autosomal dominant myopathy with flexion contractures, keloids, and follicular hyperkeratosis","Bethlem myopathy and Ullrich congenital muscular dystrophy form a spectrum of collagenopathies caused by genetic mutations encoding for any of the three subunits of collagen VI. Bethlem phenotype is relatively benign and is characterized by proximal dominant myopathy, keloids, contractures, distal hyperextensibility, and follicular hyperkeratosis. Three patients from a single family were diagnosed to have Bethlem myopathy based on European Neuromuscular Centre Bethlem Consortium criteria. Affected father and his both sons had slowly progressive proximal dominant weakness and recurrent falls from the first decade. Both children aged 18 and 20 years were ambulant at presentation. All had flexion contractures, keloids, and follicular hyperkeratosis without muscle hypertrophy. Creatinine kinase was mildly elevated and electromyography revealed myopathic features. Muscle imaging revealed severe involvement of glutei and vasti with ""central shadow"" in rectus femoris. Muscle biopsy in the father showed dystrophic changes with normal immmunostaining for collagen VI, sarcoglycans, and dysferlin.",['Aralikatte Onkarappa Saroja'],"['Bethlem myopathy', 'collagen VI', 'contractures', 'immunohistochemistry', 'keloids']",doaj,"['spectrum sensing', 'computerized tomography', 'x-ray computed tomography', 'feature space', 'classification methods', 'imaging systems', 'frequency bands', 'image reconstruction', 'pattern recognition', 'cognitive radio network', 'dynamic spectrum access', 'antennas', 'dynamic spectrum']",Ullrich congenital muscular dystrophy,"['myopathy', 'autosomal', 'dominant', 'myopathy', 'flexion', 'contractures', 'keloids', 'follicular', 'hyperkeratosis']","['myopathy', 'congenital', 'muscular', 'dystrophy', 'spectrum', 'collagenopathies', 'genetic', 'mutations', 'subunits', 'collagen', 'phenotype', 'benign', 'proximal', 'dominant', 'myopathy', 'keloids', 'contractures', 'distal', 'hyperextensibility', 'follicular', 'hyperkeratosis', 'patients', 'single', 'family', 'myopathy', 'criteria', 'Affected', 'father', 'sons', 'progressive', 'proximal', 'dominant', 'weakness', 'recurrent', 'first', 'decade', 'children', 'years', 'ambulant', 'presentation', 'flexion', 'contractures', 'keloids', 'follicular', 'hyperkeratosis', 'muscle', 'hypertrophy', 'Creatinine', 'kinase', 'elevated', 'electromyography', 'myopathic', 'features', 'Muscle', 'imaging', 'severe', 'involvement', 'glutei', 'central', 'shadow', 'rectus', 'femoris', 'Muscle', 'biopsy', 'father', 'dystrophic', 'changes', 'normal', 'collagen', 'sarcoglycans', 'dysferlin']"
111,111,http://europepmc.org/articles/PMC5731705?pdf=render,Transcriptome profiling identifies regulators of pathogenesis in collagen VI related muscular dystrophy.,"The collagen VI related muscular dystrophies (COL6-RD), Ullrich congenital muscular dystrophy (UCMD) and Bethlem myopathy (BM) are among the most common congenital muscular dystrophies and are characterized by distal joint laxity and a combination of distal and proximal joint contractures. Inheritance can be dominant negative (DN) or recessive depending on the type and location of the mutation. DN mutations allow incorporation of abnormal chains into secreted tetramers and are the most commonly identified mutation type in COL6-RD. Null alleles (nonsense, frameshift, and large deletions) do not allow incorporation of abnormal chains and act recessively. To better define the pathways disrupted by mutations in collagen VI, we have used a transcriptional profiling approach with RNA-Seq to identify differentially expressed genes in COL6-RD individuals from controls.RNA-Seq allows precise detection of all expressed transcripts in a sample and provides a tool for quantification of expression data on a genomic scale. We have used RNA-Seq to identify differentially expressed genes in cultured dermal fibroblasts from 13 COL6-RD individuals (8 dominant negative and 5 null) and 6 controls. To better assess the transcriptional changes induced by abnormal collagen VI in the extracellular matrix (ECM); we compared transcriptional profiles from subjects with DN mutations and subjects with null mutations to transcriptional profiles from controls.Differentially expressed transcripts between COL6-RD and control fibroblasts include upregulation of ECM components and downregulation of factors controlling matrix remodeling and repair. DN and null samples are differentiated by downregulation of genes involved with DNA replication and repair in null samples.Differentially expressed genes identified here may help identify new targets for development of therapies and biomarkers to assess the efficacy of treatments.",['Russell J Butterfield'],0,doaj,"['component', 'location based', 'software', 'particle swarm optimization (pso)', 'mutation strategy', 'differential evolution', 'evolutionary algorithms', 'mutation operators', 'location based services', 'detection algorithm', 'signal detection']",Ullrich congenital muscular dystrophy,"['Transcriptome', 'profiling', 'identifies', 'regulators', 'pathogenesis', 'collagen', 'muscular', 'dystrophy']","['collagen', 'muscular', 'dystrophies', 'congenital', 'muscular', 'dystrophy', 'common', 'congenital', 'muscular', 'dystrophies', 'distal', 'joint', 'laxity', 'combination', 'distal', 'proximal', 'joint', 'contractures', 'Inheritance', 'dominant', 'negative', 'recessive', 'type', 'location', 'mutation', 'DN', 'mutations', 'incorporation', 'abnormal', 'chains', 'secreted', 'tetramers', 'mutation', 'type', 'alleles', 'nonsense', 'large', 'deletions', 'incorporation', 'abnormal', 'chains', 'pathways', 'mutations', 'collagen', 'transcriptional', 'profiling', 'approach', 'genes', 'individuals', 'controls', 'precise', 'detection', 'transcripts', 'sample', 'tool', 'quantification', 'expression', 'data', 'genomic', 'scale', 'genes', 'cultured', 'dermal', 'fibroblasts', 'individuals', 'dominant', 'negative', 'null', 'controls', 'transcriptional', 'changes', 'abnormal', 'collagen', 'extracellular', 'matrix', 'transcriptional', 'profiles', 'subjects', 'DN', 'mutations', 'subjects', 'null', 'mutations', 'transcriptional', 'profiles', 'controls', 'transcripts', 'control', 'fibroblasts', 'upregulation', 'components', 'downregulation', 'factors', 'matrix', 'remodeling', 'repair', 'DN', 'null', 'samples', 'downregulation', 'genes', 'DNA', 'replication', 'repair', 'null', 'samples', 'genes', 'new', 'targets', 'development', 'therapies', 'biomarkers', 'efficacy', 'treatments']"
112,112,http://www.sciencedirect.com/science/article/pii/S2329050120301042,Circulating Biomarkers in Muscular Dystrophies: Disease and Therapy Monitoring,"Muscular dystrophies are a group of inherited disorders that primarily affect the muscle tissues. Across the muscular dystrophies, symptoms commonly compromise the quality of life in all areas of functioning. It is well noted that muscular dystrophies need reliable and measurable biomarkers that will monitor the progress of the disease and evaluate the potential therapeutic approaches. In this review, we analyze the current findings regarding the development of blood-based circulating biomarkers for different types of muscular dystrophies. We emphasize those muscular dystrophies that gained particular interest for the development of biomarkers, including Duchenne muscular dystrophy, Becker muscular dystrophy, myotonic dystrophy types 1 and 2, Ullrich congenital muscular dystrophy, congenital muscular dystrophy type 1A, Facioscapulohumeral muscular dystrophy, and limb-girdle muscular dystrophy types 2A, 2B, 2C, and 2D, recently renamed as limb-girdle muscular dystrophy R1 calpain3-related, R2 dysferlin-related, R5 Œ≥-sarcoglycan-related, and R3 Œ±-sarcoglycan-related. This review highlights the up-to-date progress in the development of biomarkers at the level of proteins, lipids, and metabolites, as well as microRNAs (miRNAs) that currently are the main potential biomarker candidates in muscular dystrophies.",['Andrie Koutsoulidou'],0,doaj,"['two dimensional', 'image processing', 'coefficient of determination', 'correlation analysis', 'remote control', 'correlation coefficient', 'remote monitoring']",Ullrich congenital muscular dystrophy,[],"['Muscular', 'dystrophies', 'group', 'disorders', 'muscle', 'tissues', 'muscular', 'dystrophies', 'symptoms', 'quality', 'life', 'areas', 'muscular', 'dystrophies', 'reliable', 'measurable', 'biomarkers', 'progress', 'disease', 'potential', 'therapeutic', 'approaches', 'review', 'current', 'findings', 'development', 'blood', 'biomarkers', 'different', 'types', 'muscular', 'dystrophies', 'muscular', 'dystrophies', 'particular', 'interest', 'development', 'biomarkers', 'muscular', 'dystrophy', 'muscular', 'dystrophy', 'myotonic', 'dystrophy', 'types', 'congenital', 'muscular', 'dystrophy', 'congenital', 'muscular', 'dystrophy', 'type', '1A', 'muscular', 'dystrophy', 'limb', 'girdle', 'muscular', 'dystrophy', 'types', '2B', '2C', '2D', 'limb', 'girdle', 'muscular', 'dystrophy', 'dysferlin', 'R5', 'Œ≥', 'R3', 'Œ±', 'review', 'up', 'date', 'progress', 'development', 'biomarkers', 'level', 'proteins', 'lipids', 'metabolites', 'main', 'potential', 'biomarker', 'candidates', 'muscular', 'dystrophies']"
113,113,http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2005000500014,Dystrophin-glycoproteins associated in congenital muscular dystrophy: immunohistochemical analysis of 59 Brazilian cases Complexo distrofina-glicoprote√≠nas associadas na distrofia muscular cong√™nita: an√°lise imuno-histoqu√≠mica em 59 casos,"The congenital muscular dystrophies (CMD) are heterogeneous muscular diseases with early and dystrophic pattern on muscle biopsy. Many different subtypes have been genetically identified and most phenotypes not yet identified belong to the merosin-positive (MP) CMD subgroup. OBJECTIVE: To analyze the immunohistochemical expression of the main proteins of the dystrophin-glycoproteins associated complex in muscle biopsy of patients with different CMD phenotypes, for investigating a possible correlation with clinical and histopathological data. METHOD: Fifty-nine patients with CMD had clinical, histopathological and immunohistochemical data evaluated: 32 had MP-CMD, 23 CMD with merosin deficiency (MD-CMD), one Ullrich phenotype and three Walker-Warburg disease. RESULTS: Dystrophin and dysferlin were normal in all; among the patients with MD-CMD, merosin deficiency was partial in nine who showed the same clinical severity as those with total deficiency; the reduced expression of a-sarcoglycan (SG) and alpha-dystroglycan (DG) showed statistically significant correlation with severe MD-CMD phenotype. CONCLUSION: There is a greater relationship between merosin and the former proteins; among MP-CMD patients, no remarkable immunohistochemical/phenotypical correlations were found, although the reduced expression of beta-DG had showed statistically significant correlation with severe phenotype and marked fibrosis on muscular biopsy.<br>A distrofia muscular cong√™nita (DMC) √© doen√ßa muscular heterog√™nea, de in√≠cio precoce e padr√£o histopatol√≥gico de distrofia. Diversos subtipos foram geneticamente identificados e os fen√≥tipos ainda n√£o identificados pertencem em geral ao subgrupo de DMC merosina-positiva (MP). OBJETIVO: Analisar a express√£o imuno-histoqu√≠mica das principais prote√≠nas do complexo distrofina-glicoprote√≠nas associadas na bi√≥psia muscular de pacientes com diferentes fen√≥tipos de DMC, a fim de investigar uma eventual correla√ß√£o com o quadro cl√≠nico e histopatol√≥gico. M√âTODO: Cinq√ºenta e nove pacientes com DMC foram avaliados clinicamente e sua bi√≥psia muscular, histopatologica e imuno-histoquimicamente: 32 eram MP, 23 merosina-deficiente (MD), um mostrava fen√≥tipo Ullrich e tr√™s s√≠ndrome de Walker-Warburg. RESULTADOS: Distrofina e disferlina foram normais em todos; nove pacientes MD apresentavam d√©ficit parcial de merosina, por√©m com a mesma gravidade cl√≠nica daqueles com defici√™ncia total. CONCLUS√ÉO: A hipoexpress√£o de a-sarcoglicana (SG) and alfa-distroglycan (DG) se correlacionou estatisticamente com o grave fen√≥tipo MD, assim indicando maior correla√ß√£o entre a merosina e as referidas prote√≠nas; entre os pacientes MP, apesar da hipoexpress√£o de beta-DG ter se correlacionado significativamente com fen√≥tipo e histopatologia mais grave, n√£o houve correla√ß√£o cl√≠nica/imuno-histoqu√≠mica valoriz√°vel.",['Lucio Gobbo Ferreira'],"['distrofia muscular cong√™nita', 'merosina', 'complexo distrofina', 'sarcoglicanas', 'distroglicanas', 'congenital muscular dystrophy', 'merosin', 'dystrophin-glycoproteins associated complex', 'sarcoglycan complex', 'dystroglycan complex']",doaj,"['wireless networks', 'integrated data', 'data integration', 'distributed antenna system', 'correlation analysis', 'das', 'heterogeneous networks', 'correlation coefficient', 'mathematics']",Ullrich congenital muscular dystrophy,"['glycoproteins', 'congenital', 'muscular', 'dystrophy', 'immunohistochemical', 'analysis', 'Brazilian', 'cases', 'distrofina', 'glicoprote√≠nas', 'associadas', 'muscular', 'cong√™nita', 'an√°lise', 'imuno', 'histoqu√≠mica', 'em', 'casos']","['congenital', 'muscular', 'dystrophies', 'heterogeneous', 'muscular', 'diseases', 'early', 'dystrophic', 'pattern', 'muscle', 'biopsy', 'Many', 'different', 'subtypes', 'most', 'phenotypes', 'merosin', 'positive', 'subgroup', 'immunohistochemical', 'expression', 'main', 'proteins', 'dystrophin', 'glycoproteins', 'complex', 'muscle', 'biopsy', 'patients', 'different', 'phenotypes', 'possible', 'correlation', 'clinical', 'histopathological', 'data', 'METHOD', 'patients', 'clinical', 'histopathological', 'immunohistochemical', 'data', 'merosin', 'deficiency', 'phenotype', 'disease', 'RESULTS', 'dysferlin', 'normal', 'patients', 'merosin', 'deficiency', 'partial', 'same', 'clinical', 'severity', 'total', 'deficiency', 'reduced', 'expression', 'sarcoglycan', 'alpha', 'dystroglycan', 'significant', 'correlation', 'severe', 'phenotype', 'CONCLUSION', 'greater', 'relationship', 'merosin', 'former', 'proteins', 'patients', 'remarkable', 'immunohistochemical', 'phenotypical', 'correlations', 'reduced', 'expression', 'beta', 'DG', 'significant', 'correlation', 'severe', 'phenotype', 'marked', 'fibrosis', 'muscular', 'distrofia', 'muscular', 'cong√™nita', 'muscular', 'heterog√™nea', 'precoce', 'padr√£o', 'histopatol√≥gico', 'distrofia', 'Diversos', 'subtipos', 'foram', 'geneticamente', 'fen√≥tipos', 'ainda', 'n√£o', 'identificados', 'pertencem', 'geral', 'merosina', 'positiva', 'OBJETIVO', 'express√£o', 'imuno', 'histoqu√≠mica', 'das', 'prote√≠nas', 'distrofina', 'glicoprote√≠nas', 'associadas', 'bi√≥psia', 'pacientes', 'com', 'diferentes', 'fen√≥tipos', 'fim', 'investigar', 'uma', 'eventual', 'correla√ß√£o', 'com', 'o', 'quadro', 'cl√≠nico', 'histopatol√≥gico', 'nove', 'pacientes', 'foram', 'avaliados', 'clinicamente', 'sua', 'bi√≥psia', 'muscular', 'histopatologica', 'e', 'imuno', 'histoquimicamente', 'eram', 'merosina', 'deficiente', 'mostrava', 'fen√≥tipo', 'tr√™s', 's√≠ndrome', 'disferlina', 'foram', 'todos', 'nove', 'pacientes', 'apresentavam', 'd√©ficit', 'parcial', 'por√©m', 'com', 'mesma', 'cl√≠nica', 'daqueles', 'com', 'defici√™ncia', 'total', 'CONCLUS√ÉO', 'hipoexpress√£o', 'sarcoglicana', 'alfa', 'distroglycan', 'correlacionou', 'estatisticamente', 'com', 'grave', 'fen√≥tipo', 'assim', 'indicando', 'maior', 'correla√ß√£o', 'merosina', 'e', 'prote√≠nas', 'apesar', 'beta', 'DG', 'correlacionado', 'significativamente', 'com', 'fen√≥tipo', 'e', 'histopatologia', 'mais', 'grave', 'n√£o', 'houve', 'correla√ß√£o', 'cl√≠nica', 'imuno', 'histoqu√≠mica', 'valoriz√°vel']"
114,114,http://dx.doi.org/10.1155/2013/152684,"Body Composition, Muscle Strength, and Physical Function of Patients with Bethlem Myopathy and Ullrich Congenital Muscular Dystrophy","Objective. To determine the contributions of body mass, adiposity, and muscularity to physical function and muscle strength in adult patients with Bethlem myopathy (BM) and Ullrich congenital muscular dystrophy (UCMD). Materials and Methods. Evaluation involved one UCMD and 7 BM patients. Body composition was determined by body mass index (BMI) and dual-energy-X-ray-absorptiometry (DXA), muscle strength by dynamometry, physical function by the distance walked in 6 minutes (6MWD), forced vital capacity (FVC) by a spirometer. Results. Six participants were of normal weight and 2 overweight based on BMI; all were sarcopenic based on appendicular fat free mass index (AFFMI); and 7 were sarcopenic obese based on AFFMI and % fat mass. Average muscle strength was reduced below 50% of normal. The 6MWD was in BM patients 30% less than normal. FVC was reduced in 4 of the BM patients. Muscle strength had a good correlation with the physical function variables. Correlation between muscle strength and BMI was poor; it was very high with AFFMI. AFFMI was the best single explicator of muscle strength and physical function. Conclusion. Muscle mass determined by DXA explains most of the variability of the measures of muscle strength and physical function in patients with BM and UCMD.",['Maria Teresa Miscione'],0,doaj,"['dynamic composition', 'mathematics', 'correlation analysis', 'web service composition', 'software engineering', 'correlation coefficient', 'automatic composition', 'service compositions', 'component composition']",Ullrich congenital muscular dystrophy,[],"['Objective', 'contributions', 'body', 'mass', 'adiposity', 'muscularity', 'physical', 'function', 'muscle', 'strength', 'adult', 'patients', 'congenital', 'muscular', 'dystrophy', 'Materials', 'Evaluation', 'patients', 'Body', 'composition', 'body', 'mass', 'index', 'dual', 'energy', 'X', 'ray', 'absorptiometry', 'muscle', 'strength', 'dynamometry', 'physical', 'function', 'distance', 'minutes', 'vital', 'capacity', 'spirometer', 'Results', 'participants', 'normal', 'weight', 'overweight', 'sarcopenic', 'appendicular', 'fat', 'free', 'mass', 'index', 'sarcopenic', 'obese', '%', 'fat', 'mass', 'Average', 'muscle', 'strength', '%', 'normal', 'patients', '%', 'less', 'normal', 'patients', 'Muscle', 'strength', 'good', 'correlation', 'physical', 'function', 'variables', 'Correlation', 'muscle', 'strength', 'poor', 'high', 'best', 'single', 'explicator', 'muscle', 'strength', 'physical', 'function', 'Conclusion', 'Muscle', 'mass', 'most', 'variability', 'measures', 'muscle', 'strength', 'physical', 'function', 'patients']"
115,115,http://journal.frontiersin.org/article/10.3389/fnagi.2017.00268/full,Differences in Adipose Tissue and Lean Mass Distribution in Patients with Collagen VI Related Myopathies Are Associated with Disease Severity and Physical Ability,"Mutations in human collagen VI genes cause a spectrum of musculoskeletal conditions in children and adults collectively termed collagen VI-related myopathies (COL6-RM) characterized by a varying degree of muscle weakness and joint contractures and which include Ullrich Congenital Muscular Dystrophy (UCMD) and Bethlem Myopathy (BM). Given that collagen VI is one of the most abundant extracellular matrix proteins in adipose tissue and its emerging role in energy metabolism we hypothesized that collagen VI deficiency might be associated with alterations in adipose tissue distribution and adipokines serum profile. We analyzed body composition by means of dual-energy X-ray absorptiometry in 30 pediatric and adult COL6-RM myopathy patients representing a range of severities (UCMD, intermediate-COL6-RM, and BM). We found a distinctive pattern of regional adipose tissue accumulation which was more evident in children at the most severe end of the spectrum. In particular, the accumulation of fat in the android region was a distinguishing feature of UCMD patients. In parallel, there was a decrease in lean mass compatible with a state of sarcopenia, particularly in ambulant children with an intermediate phenotype. All children and adult patients that were sarcopenic were also obese. These changes were significantly more pronounced in children with collagen VI deficiency than in children with Duchenne Muscular Dystrophy of the same ambulatory status. High molecular weight adiponectin and leptin were significantly increased in sera from children in the intermediate and BM group. Correlation analysis showed that the parameters of fat mass were negatively associated with motor function according to several validated outcome measures. In contrast, lean mass parameters correlated positively with physical performance and quality of life. Leptin and adiponectin circulating levels correlated positively with fat mass parameters and negatively with lean mass and thus may be relevant to the disease pathogenesis and as circulating markers. Taken together our results indicate that COL6-RM are characterized by specific changes in total fat mass and distribution which associate with disease severity, motor function, and quality of life and which are clinically meaningful and thus should be taken into consideration in the management of these patients.",['M. A. Rodr√≠guez'],"['myopathy', 'collagen VI', 'body composition', 'sarcopenia', 'obesity', 'adiponectin']",doaj,"['smart phones', 'android', 'mathematics', 'lean', 'software development', 'frequency bands', 'correlation analysis', 'correlation coefficient', 'antennas']",Ullrich congenital muscular dystrophy,['Differences'],"['Mutations', 'human', 'collagen', 'genes', 'spectrum', 'musculoskeletal', 'conditions', 'children', 'adults', 'collagen', 'myopathies', 'degree', 'muscle', 'weakness', 'joint', 'contractures', 'collagen', 'abundant', 'extracellular', 'matrix', 'proteins', 'adipose', 'tissue', 'role', 'energy', 'metabolism', 'collagen', 'deficiency', 'alterations', 'adipose', 'tissue', 'distribution', 'adipokines', 'profile', 'body', 'composition', 'means', 'dual', 'energy', 'X', '-', 'ray', 'absorptiometry', 'pediatric', 'adult', 'COL6-RM', 'myopathy', 'patients', 'range', 'severities', 'intermediate', 'distinctive', 'pattern', 'regional', 'adipose', 'tissue', 'accumulation', 'evident', 'children', 'severe', 'end', 'spectrum', 'particular', 'accumulation', 'fat', 'android', 'region', 'distinguishing', 'feature', 'patients', 'parallel', 'decrease', 'lean', 'mass', 'compatible', 'state', 'sarcopenia', 'ambulant', 'children', 'intermediate', 'phenotype', 'children', 'adult', 'patients', 'sarcopenic', 'obese', 'changes', 'pronounced', 'children', 'collagen', 'deficiency', 'children', 'same', 'ambulatory', 'status', 'High', 'molecular', 'weight', 'adiponectin', 'leptin', 'sera', 'children', 'intermediate', 'group', 'Correlation', 'analysis', 'parameters', 'fat', 'mass', 'motor', 'function', 'several', 'outcome', 'measures', 'contrast', 'lean', 'mass', 'parameters', 'physical', 'performance', 'quality', 'life', 'Leptin', 'adiponectin', 'levels', 'fat', 'mass', 'parameters', 'lean', 'mass', 'relevant', 'disease', 'pathogenesis', 'markers', 'results', 'specific', 'changes', 'total', 'fat', 'mass', 'distribution', 'disease', 'severity', 'motor', 'function', 'quality', 'life', 'meaningful', 'consideration', 'management', 'patients']"
116,116,http://www.sciencedirect.com/science/article/pii/S2162253117302160,Gapmer Antisense Oligonucleotides Suppress the Mutant Allele of COL6A3 and Restore Functional Protein in Ullrich Muscular Dystrophy,"Dominant-negative mutations in the genes that encode the three major Œ± chains of collagen type VI, COL6A1, COL6A2, and COL6A3, account for more than 50% of Ullrich congenital muscular dystrophy patients and nearly all Bethlem myopathy¬†patients. Gapmer antisense oligonucleotides (AONs) are usually used for gene silencing by stimulating RNA cleavage through the recruitment of an endogenous endonuclease known as RNase H to cleave the RNA strand of a DNA-RNA duplex. In this study, we exploited the application of the allele-specific silencing approach by gapmer AON as a potential¬†therapy for Collagen-VI-related congenital muscular dystrophy (COL6-CMD). A series of AONs were designed to selectively target an 18-nt heterozygous genomic deletion in exon 15 of COL6A3 at the mRNA and pre-mRNA level. We showed that gapmer AONs can selectively suppress the expression of mutant transcripts at both pre-mRNA and mRNA levels, and that the latter strategy had a far stronger efficiency than the former. More importantly, we found that silencing of the mutant transcripts by gapmer AONs increased the deposition of collagen VI protein into the extracellular matrix, thus restoring functional protein production. Our findings provide a clear proof of concept for AON allele-specific silencing as a therapeutic approach for COL6-CMD. Keywords: collagen VI, congenital muscular dystrophy, dominant mutations, antisense oligonucleotide therapy, gapmer, allele-specific silencing",['Elena Marrosu'],0,doaj,"['computational efficiency', 'formal proofs', 'theoretical computer science', 'formal verifications', 'formal logic']",Ullrich congenital muscular dystrophy,[],"['Dominant', 'negative', 'mutations', 'genes', 'major', 'Œ±', 'chains', 'collagen', 'type', 'COL6A2', 'more', '%', 'congenital', 'muscular', 'dystrophy', 'patients', 'myopathy', 'patients', 'Gapmer', 'antisense', 'AONs', 'gene', 'cleavage', 'recruitment', 'endogenous', 'endonuclease', 'strand', 'RNA', 'duplex', 'study', 'application', 'allele', 'specific', 'approach', 'gapmer', 'potential', 'therapy', 'congenital', 'muscular', 'dystrophy', 'series', 'heterozygous', 'genomic', 'deletion', 'exon', 'mRNA', 'pre', '-', 'mRNA', 'level', 'gapmer', 'AONs', 'expression', 'mutant', 'transcripts', 'pre', '-', 'levels', 'latter', 'strategy', 'stronger', 'efficiency', 'former', 'mutant', 'transcripts', 'gapmer', 'AONs', 'deposition', 'collagen', 'protein', 'extracellular', 'matrix', 'functional', 'protein', 'production', 'findings', 'clear', 'proof', 'concept', 'allele', 'specific', 'silencing', 'therapeutic', 'approach', 'COL6-CMD', 'Keywords', 'collagen', 'congenital', 'muscular', 'dystrophy', 'dominant', 'mutations', 'antisense', 'oligonucleotide', 'therapy', 'gapmer', 'allele', 'specific', 'silencing']"
117,117,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0014/722/A1/US20130014722A1.pdf,PISTON FOR AN INTERNAL COMBUSTION ENGINE AND METHOD FOR ITS PRODUCTION,"A piston for an internal combustion engine has a piston head that has a circumferential cooling channel as well as a combustion bowl having a circumferential bowl wall that makes a transition into a piston crown by way of a bowl edge region. The combustion bowl is formed at least in part by a piston base body and the bowl wall is formed at least in part from an insert. The insert is connected with the piston base body by means of beam welding. A lower weld seam is configured in the bowl wall, which seam encloses an acute angle with the piston center axis (M) and ends in the lower half of the cooling channel. An upper weld seam runs from the cooling channel ceiling to the piston crown and is disposed centered or radially offset toward the outside, with reference to the clear width of the cooling channel.","['SCHARP Rainer', 'KEMNITZ Peter', 'Ullrich Michael']",0,uspto,"['fading (radio)', 'formatting', 'engine pistons', 'engine cylinders', 'radio transmission', 'engineering', 'internal combustion', 'radio channels', 'insert', 'antennas', 'internal combustion engines', 'engine']",Ullrich congenital muscular dystrophy,"['PISTON', 'METHOD', 'PRODUCTION']","['piston', 'internal', 'combustion', 'engine', 'piston', 'head', 'circumferential', 'channel', 'combustion', 'bowl', 'circumferential', 'bowl', 'wall', 'transition', 'piston', 'crown', 'way', 'bowl', 'edge', 'region', 'combustion', 'bowl', 'least', 'part', 'piston', 'base', 'body', 'bowl', 'wall', 'least', 'part', 'insert', 'insert', 'piston', 'base', 'body', 'means', 'beam', 'welding', 'lower', 'weld', 'seam', 'bowl', 'wall', 'seam', 'acute', 'angle', 'piston', 'center', 'axis', 'lower', 'half', 'channel', 'upper', 'weld', 'seam', 'runs', 'channel', 'ceiling', 'piston', 'crown', 'outside', 'reference', 'clear', 'width', 'channel']"
118,118,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0016/023/A1/US20130016023A1.pdf,APPARATUS AND METHODS FOR PACKAGING ANTENNAS WITH INTEGRATED CIRCUIT CHIPS FOR MILLIMETER WAVE APPLICATIONS,"Apparatus and methods are provided for integrally packaging antennas with semiconductor IC (integrated circuit) chips to provide highly-integrated and high-performance radio/wireless communications systems for millimeter wave applications including, e.g., voice communication, data communication, and radar applications. For example, wireless communication modules are constructed with IC chips having receiver/transmitter/transceiver integrated circuits and planar antennas that are integrally constructed from BEOL (back end of line) metallization structures of the IC chip.","['Gaucher Brian P.', 'Liu Duixian', 'Pfeiffer Ullrich R.', 'Zwick Thomas M.']",0,uspto,"['global system for mobile communications', 'planar antennas', 'highly integrated', 'transceivers', 'wireless communication system', 'radar', 'signal receivers', 'wireless communications', 'slot antennas', 'signal processing', 'communication systems', 'signal to noise ratio', 'transmitters', 'communication channels (information theory)', 'computer network', 'computer hardware', 'radio', 'cellular telephone systems', 'communication', 'antennas', 'monolithic microwave integrated circuits', 'integrated circuits', 'wireless', 'wireless telecommunication systems']",Ullrich congenital muscular dystrophy,"['METHODS', 'PACKAGING', 'ANTENNAS', 'INTEGRATED', 'CIRCUIT', 'CHIPS', 'MILLIMETER', 'APPLICATIONS']","['Apparatus', 'methods', 'antennas', 'semiconductor', 'circuit', 'chips', 'high', 'performance', 'radio', 'wireless', 'communications', 'systems', 'millimeter', 'wave', 'applications', 'voice', 'communication', 'data', 'communication', 'radar', 'applications', 'example', 'wireless', 'communication', 'modules', 'chips', 'receiver', 'transmitter', 'transceiver', 'circuits', 'planar', 'antennas', 'end', 'line', 'metallization', 'structures', 'chip']"
119,119,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0017/584/A1/US20130017584A1.pdf,Enzymatic Hydroxylation of Aliphatic Hydrocarbon,"The invention relates to enzymatic methods for hydroxylation in position 2 or 3 of substituted or unsubstituted, linear or branched aliphatic hydrocarbons.","['Hofrichter Martin', 'Scheibner Katrin', 'Ullrich Ren√©', 'Kinne Matthias', 'Peter Sebastian', 'Lund Henrik', 'Kalum Lisbeth']",0,uspto,"['target tracking', 'robotics', 'target position']",Ullrich congenital muscular dystrophy,[],"['invention', 'enzymatic', 'methods', 'hydroxylation', 'position', 'unsubstituted', 'linear', 'aliphatic', 'hydrocarbons']"
120,120,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0023/917/A1/US20130023917A1.pdf,Surgical Tool Having A Programmable Rotary Module For Providing Haptic Feedback,"A surgical tool such as a grasper or a pair of surgical scissors includes a hinge portion that spans between a handle proximal portion and a distal working portion to communicate mechanical actions of the handle proximal portion to the distal working portion. A programmable rotary module is coupled to the hinge portion and includes a sensor, an actuator, and a controller. The sensor, actuator, and controller may be enclosed in a common housing. The sensor measures rotation of the distal working portion and the actuator generates haptic effects to the proximal handle portion. A controller is electrically connected to the sensor and to the actuator. The controller receives the rotation measurements from the sensor and, based upon the rotation measurements, outputs a control signal to the actuator relating to the generation of haptic effects. The haptic effects may include force sensations such as detents and barriers.","['Cruz Hernandez Juan Manuel', 'Gosline Andrew', 'Ullrich Christopher']",0,uspto,"['force feedback', 'haptic sensation', 'haptic interfaces', 'sensors', 'haptic feedbacks', 'haptics', 'remote control', 'computer hardware']",Ullrich congenital muscular dystrophy,[],"['surgical', 'tool', 'such', 'grasper', 'pair', 'surgical', 'scissors', 'hinge', 'portion', 'spans', 'handle', 'proximal', 'portion', 'distal', 'working', 'portion', 'mechanical', 'actions', 'handle', 'proximal', 'portion', 'distal', 'working', 'portion', 'programmable', 'rotary', 'module', 'hinge', 'portion', 'sensor', 'actuator', 'controller', 'sensor', 'actuator', 'controller', 'common', 'housing', 'sensor', 'rotation', 'distal', 'working', 'portion', 'actuator', 'haptic', 'effects', 'proximal', 'handle', 'portion', 'controller', 'sensor', 'actuator', 'controller', 'rotation', 'measurements', 'sensor', 'rotation', 'measurements', 'control', 'signal', 'actuator', 'generation', 'haptic', 'effects', 'haptic', 'effects', 'force', 'sensations', 'such', 'detents', 'barriers']"
121,121,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0024/798/A1/US20130024798A1.pdf,FITTING SYSTEM AND METHOD FOR FITTING A HEARING SYSTEM,The method for adjusting a hearing system to individual hearing needs and preferences of a specific hearing system user by means of a fitting system comprising a visual display comprises:,"['Schneider Philipp', 'Sigwanz Ullrich']",0,uspto,"['computer aided design', 'fiber optic sensors', 'splines', 'curve fitting', 'user interfaces', 'surface fitting', 'preference information', 'user preferences', 'mathematics', 'multi-objective optimisation']",Ullrich congenital muscular dystrophy,"['FITTING', 'SYSTEM', 'METHOD', 'HEARING', 'SYSTEM']","['method', 'hearing', 'system', 'individual', 'hearing', 'needs', 'preferences', 'specific', 'hearing', 'system', 'user', 'means', 'fitting', 'system', 'visual', 'display']"
122,122,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0025/355/A1/US20130025355A1.pdf,TEST WHEEL ARRANGEMENT,"There is proposed a test wheel arrangement () for testing a motor vehicle while the tyres are stationary, which test wheel arrangement () has a shaft section () which can be attached to a wheel hub () of a motor vehicle and on which a test wheel () is mounted to be freely rotatable.","['Inhoff Andreas', 'Hesse Ullrich', 'Zipp Walter']",0,uspto,"['vehicles', 'engineering']",Ullrich congenital muscular dystrophy,"['TEST', 'WHEEL', 'ARRANGEMENT']","['test', 'wheel', 'arrangement', 'motor', 'vehicle', 'tyres', 'stationary', 'wheel', 'arrangement', 'shaft', 'section', 'wheel', 'hub', 'motor', 'vehicle', 'test', 'wheel', 'rotatable']"
123,123,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0025/425/A1/US20130025425A1.pdf,CATCHER TANK ASSEMBLY OF WATERJET CUTTING SYSTEM,"A catcher tank assembly is provided for a waterjet cutting machine. The catcher tank assembly includes a catcher tank having a plurality of tank sections detachably coupleable together in a side-by-side manner to collectively define a catcher tank having a desired configuration. The catcher tank assembly further includes a workpiece support system detachably coupleable to an interior cavity of the catcher tank. The workpiece support system may include a plurality of workpiece support modules arrangeable in an array to support a workpiece platform of the waterjet cutting machine. The workpiece platform may be formed, for example, by a series of slats supported transversely to parallel rows of the workpiece support modules. Methods and systems which relate to or include the aforementioned catcher tank assembly are also provided.","['Knaupp Michael', 'Meyer Andreas', 'Craigen Steven J.', 'Mann Robert J.', 'Hashish Mohamed A.', 'Ullrich Eckhardt R.', 'Loofbourow Thomas R.']",0,uspto,"['machining centers', 'crystal whiskers', 'software frameworks', 'air holes', 'machining', 'computer aided manufacturing', 'computer programming', 'sub-arrays', 'direction of arrival', 'photonic crystal fibers']",Ullrich congenital muscular dystrophy,"['CUTTING', 'SYSTEM']","['catcher', 'tank', 'assembly', 'waterjet', 'machine', 'catcher', 'tank', 'assembly', 'catcher', 'tank', 'plurality', 'tank', 'sections', 'coupleable', 'side', 'side', 'manner', 'catcher', 'tank', 'configuration', 'catcher', 'tank', 'assembly', 'workpiece', 'support', 'system', 'coupleable', 'interior', 'cavity', 'catcher', 'tank', 'workpiece', 'support', 'system', 'plurality', 'workpiece', 'support', 'modules', 'arrangeable', 'array', 'workpiece', 'platform', 'waterjet', 'machine', 'workpiece', 'platform', 'example', 'series', 'slats', 'rows', 'workpiece', 'support', 'modules', 'Methods', 'systems', 'aforementioned', 'catcher', 'tank', 'assembly']"
124,124,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0038/433/A1/US20130038433A1.pdf,METHOD AND SYSTEM FOR LINE-OF-SIGHT-INDEPENDENT DATA TRANSMISSION,"In a method for line-of-sight-independent data transmission in a car-to-car or a car-to-infrastructure communication system, electromagnetic radiation having encoded data is transmitted from a transmitter located in a first vehicle or in a traffic infrastructure object, and a reflector system is provided for at least partially reflecting the transmitted electromagnetic radiation, wherein the reflector system is arranged so that the transmitted electromagnetic radiation arrives at a receiver located in a second vehicle or in the traffic infrastructure object. The reflected electromagnetic radiation having the encoded data can then be received by the receiver even when line-of-sight communication between the vehicles is impossible.",['Ullrich Christoph'],0,uspto,"['signal processing', 'communication systems', 'signal to noise ratio', 'transmitters', 'communication', 'communication channels (information theory)', 'electromagnetism', 'engineering', 'vehicles', 'transceivers', 'signal receivers', 'antennas', 'electromagnetic']",Ullrich congenital muscular dystrophy,"['METHOD', 'SYSTEM', 'LINE', 'SIGHT', 'TRANSMISSION']","['method', 'line', 'sight', 'independent', 'data', 'transmission', 'car', 'car', 'car', 'infrastructure', 'communication', 'system', 'electromagnetic', 'radiation', 'data', 'transmitter', 'first', 'vehicle', 'traffic', 'infrastructure', 'object', 'reflector', 'system', 'electromagnetic', 'radiation', 'reflector', 'system', 'transmitted', 'electromagnetic', 'radiation', 'receiver', 'second', 'vehicle', 'traffic', 'infrastructure', 'object', 'reflected', 'electromagnetic', 'radiation', 'data', 'receiver', 'line', 'sight', 'communication', 'vehicles', 'impossible']"
125,125,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130321/2013-12/US/2013/0067/814/A1/US20130067814A1.pdf,HYDROPONIC SYSTEM,"The invention relates to a hydroponic system and method. In various embodiments the hydroponic system and method includes modular plant containers in communication with a fluid reservoir and with one another. Such containers may be hung in vertical columns in window gardens. The containers may be made from low-impact or recycled materials, such as water bottles. The system includes a vertical fluid circuit and an air introduction assembly for supplying water, air and nutrients from the reservoir to the containers.","['Riley Britta', 'Ullrich Theodore Regan']",0,uspto,"['telecommunication networks', 'communication', 'communication protocols', 'viscous flow', 'computer network', 'non-newtonian fluids', 'communication networks', 'network protocols', 'wireless communications']",Ullrich congenital muscular dystrophy,['SYSTEM'],"['invention', 'hydroponic', 'system', 'method', 'various', 'embodiments', 'hydroponic', 'system', 'method', 'modular', 'plant', 'containers', 'communication', 'fluid', 'reservoir', 'Such', 'containers', 'vertical', 'columns', 'window', 'gardens', 'containers', 'low', 'impact', 'materials', 'such', 'water', 'bottles', 'system', 'vertical', 'fluid', 'circuit', 'air', 'introduction', 'assembly', 'water', 'air', 'nutrients', 'reservoir', 'containers']"
126,126,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130321/2013-12/US/2013/0068/764/A1/US20130068764A1.pdf,ECONOMICALLY IMPROVED PLASTIC BOTTLE AND PACKAGE SYSTEM,"A packing that includes a bottle and/or a bottle and box combination wherein the container has a handle portion and the box has a bottom opening utilized as a grip portion. The handle is pivotally mounted to the top of the container. In addition, the box includes an opening to permit access to the handle and the neck of the container.","['Kuhar Gene', 'Smith Brian', 'Shaver Rusty', 'Gamber Dan', 'Dygert Douglas', 'Ullrich Jeff', 'Guss Theodore']",0,uspto,"['positron annihilation spectroscopy', 'nuclear sciences', 'plastic bottles']",Ullrich congenital muscular dystrophy,"['ECONOMICALLY', 'IMPROVED', 'PLASTIC', 'BOTTLE', 'PACKAGE', 'SYSTEM']","['packing', 'bottle', 'bottle', 'box', 'combination', 'container', 'handle', 'portion', 'box', 'bottom', 'opening', 'grip', 'portion', 'handle', 'top', 'container', 'addition', 'box', 'opening', 'access', 'handle', 'neck', 'container']"
127,127,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130328/2013-13/US/2013/0078/450/A1/US20130078450A1.pdf,"METHOD FOR COLD GAS SPRAYING OF A LAYER HAVING A METAL MICROSTRUCTURE PHASE AND A MICROSTRUCTURE PHASE MADE OF PLASTIC, COMPONENT HAVING SUCH A LAYER, AND USE OF SAID COMPONENT","In a method for cold gas spraying a layer, coating particles are accelerated in a cold spraying nozzle. The particles have a plastic encapsulation. In said manner, the plastic is precipitated onto the substrate together with the metal material, thereby forming in particular layer compositions having good sliding properties, dirt repellent properties, or lubricating properties. The coating can be used as a bearing component of a sliding bearing, as a flow component, in particular as a rotor blade of wind power plants or body components of transportation vehicle, or as trim components of structures.","['Jensen Jens Dahl', 'Stier Oliver', 'Ullrich Raymond']",0,uspto,"['component', 'software', 'software architecture patterns', 'motion control', 'layered', 'engineering', 'vehicles', 'position control', 'manipulators', 'sensors', 'gear teeth', 'bevel gears']",Ullrich congenital muscular dystrophy,"['METHOD', 'COLD', 'GAS', 'METAL', 'MADE', 'COMPONENT', 'USE', 'COMPONENT']","['method', 'cold', 'gas', 'layer', 'coating', 'particles', 'cold', 'nozzle', 'particles', 'plastic', 'encapsulation', 'manner', 'plastic', 'substrate', 'metal', 'material', 'particular', 'layer', 'compositions', 'good', 'properties', 'dirt', 'repellent', 'properties', 'properties', 'coating', 'bearing', 'component', 'sliding', 'bearing', 'flow', 'component', 'particular', 'rotor', 'blade', 'wind', 'power', 'plants', 'body', 'components', 'transportation', 'vehicle', 'trim', 'components', 'structures']"
128,128,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130328/2013-13/US/2013/0078/685/A1/US20130078685A1.pdf,OZONOLYSIS OF UNSATURATED FATTY ACIDS AND DERIVATIVES THEREOF,"The invention relates to a method for the ozonolysis of unsaturated fatty acids and derivatives thereof, comprising a) ozonolysis of a fatty acid or of a derivative thereof in an organic phase comprising an organic solvent, and b) contacting the organic phase with an aqueous phase comprising catalase and preferably a buffer, where the fatty acid or the derivative thereof has a linear chain having at least eight carbon atoms, and the use of catalase for removing reactive oxygen species from a reaction mixture comprising ozonolysis products of an unsaturated fatty acid.","['ULLRICH Matthias', 'Hannen Peter', 'Roos Martin']",0,uspto,"['buffer storage', 'gaussians', 'gaussian distribution', 'bandwidth', 'microprocessor chips', 'telecommunication traffic', 'mass customization', 'customized products', 'parallel processing systems', 'data communication systems']",Ullrich congenital muscular dystrophy,"['DERIVATIVES', 'THEREOF']","['invention', 'method', 'ozonolysis', 'unsaturated', 'fatty', 'acids', 'derivatives', 'ozonolysis', 'fatty', 'acid', 'derivative', 'thereof', 'organic', 'phase', 'organic', 'solvent', 'organic', 'phase', 'aqueous', 'phase', 'comprising', 'catalase', 'buffer', 'fatty', 'acid', 'derivative', 'linear', 'chain', 'carbon', 'atoms', 'use', 'catalase', 'reactive', 'oxygen', 'species', 'reaction', 'mixture', 'comprising', 'ozonolysis', 'products', 'unsaturated', 'fatty', 'acid']"
129,129,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130404/2013-14/US/2013/0084/300/A1/US20130084300A1.pdf,DIAGNOSIS AND PREVENTION OF CANCER CELL INVASION,"The present invention relates to diagnostic and therapeutic methods in the field of malignant disorders. More particularly, the invention provides methods of determining the invasivity of malignant disorders and methods for reducing the invasivity of malignant disorders including the prevention or treatment of cancer cell invasion.","['ULLRICH Axel', 'Knyazev Pjotr', 'Knyazeva Tatjana', 'Cheburkin Yuri']",0,uspto,[],Ullrich congenital muscular dystrophy,"['CELL', 'INVASION']","['present', 'invention', 'diagnostic', 'therapeutic', 'methods', 'field', 'malignant', 'disorders', 'invention', 'methods', 'invasivity', 'malignant', 'disorders', 'methods', 'invasivity', 'malignant', 'disorders', 'prevention', 'treatment', 'cancer', 'cell', 'invasion']"
130,130,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130418/2013-16/US/2013/0092/409/A1/US20130092409A1.pdf,Hand-Held Power Tool with Mechanically Controlled Automatic On and Off Function,"A hand-held power tool includes a tool housing and a handle housing. The handle housing is movable relative to the tool housing. The hand-held power tool also includes an electric motor for driving the hand-held power tool. The electric motor is switched on and off by a relative movement of the handle housing relative to the tool housing. The hand-held power tool also includes a main electrical switch configured to apply an electrical voltage supply to the electric motor. The main electrical switch is switched by an actuating mechanism. The main electrical switch is actuatable with the aid of a movable component that is movable relative to the tool housing handily via the actuating mechanism, either directly or by the actuating mechanism.","['Ullrich Andre', 'Ruebsaamen Holger']",0,uspto,"['hand held computers', 'electric power', 'total power', 'component', 'software', 'energy harvesting', 'electricity', 'pumping (laser)', 'handheld', 'peak power', 'pulsed laser applications', 'power allocations', 'electrical energy']",Ullrich congenital muscular dystrophy,[],"['hand', 'power', 'tool', 'tool', 'housing', 'handle', 'housing', 'handle', 'housing', 'movable', 'relative', 'tool', 'housing', 'hand', 'power', 'tool', 'electric', 'motor', 'hand', 'power', 'tool', 'electric', 'motor', 'relative', 'movement', 'handle', 'housing', 'relative', 'tool', 'housing', 'hand', 'power', 'tool', 'main', 'electrical', 'switch', 'electrical', 'voltage', 'supply', 'electric', 'motor', 'main', 'electrical', 'switch', 'actuating', 'mechanism', 'main', 'electrical', 'switch', 'actuatable', 'aid', 'movable', 'component', 'movable', 'relative', 'tool', 'housing', 'actuating', 'mechanism', 'actuating', 'mechanism']"
131,131,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130502/2013-18/US/2013/0110/243/A1/US20130110243A1.pdf,MICROSTRUCTURED IMPLANT SURFACES,"An implantable device for treating disc degenerative disease and arthritis of the spine. The implant is sized for placement into an intravertebral disc space. The implant has a body with a predetermined, defined, repeating, three-dimensional pattern at least partially on at least one of its surfaces. The pattern is adapted to create a surface area of bone-contacting features that enhance in-growth and biological attachment to a biocompatible material. Also disclosed are process steps for making the implant.","['Patterson Chad', 'Schneider Jennifer', 'Ullrich Peter', 'Berg Mark']",0,uspto,"['feature space', 'microcavities', 'optoelectronic devices', 'classification methods', 'portable device', 'transparent optical networks', 'pattern recognition', 'portable equipment']",Ullrich congenital muscular dystrophy,['IMPLANT'],"['implantable', 'device', 'disc', 'degenerative', 'disease', 'arthritis', 'spine', 'implant', 'sized', 'placement', 'intravertebral', 'disc', 'space', 'implant', 'body', 'dimensional', 'pattern', 'least', 'surfaces', 'pattern', 'surface', 'area', 'bone', 'features', 'growth', 'biological', 'attachment', 'biocompatible', 'material', 'process', 'steps', 'implant']"
132,132,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130509/2013-19/US/2013/0115/662/A1/US20130115662A1.pdf,FUNGAL PEROXYGENASES AND METHODS OF APPLICATION,"The invention relates to polypeptides having peroxygenase activity and compositions comprising such polypeptides, their encoding polynucleotides, expression vectors and recombinant host cells comprising such polynucleotides or vectors, methods of producing the polypeptides, as well as methods of application and uses thereof, including a process for enzymatic, regioselective oxygenation of N-heterocycles of the general formula (I) to the corresponding N-oxides of the formula (II), by converting N-heterocycles of the formula (I) with a peroxidase polypeptide in the presence of at least one oxidizing agent in a one-stage reaction process.","['Pecyna Marek Jan', 'Ullrich Ren√©', 'Schnorr Kirk Matthew', 'Scheibner Karin', 'Kluge Martin Gunter', 'Hofrichter Martin']",0,uspto,"['noc', 'software agents', 'interfaces (computer)', 'intelligent agents', 'multiagent system', 'autonomous agents', 'network interface', 'agent based']",Ullrich congenital muscular dystrophy,"['FUNGAL', 'PEROXYGENASES', 'METHODS']","['invention', 'polypeptides', 'peroxygenase', 'activity', 'compositions', 'such', 'polypeptides', 'polynucleotides', 'expression', 'vectors', 'recombinant', 'host', 'cells', 'such', 'polynucleotides', 'vectors', 'methods', 'polypeptides', 'methods', 'application', 'process', 'enzymatic', 'regioselective', 'oxygenation', 'N', 'heterocycles', 'general', 'formula', 'I', 'corresponding', 'N', 'oxides', 'formula', 'N', 'heterocycles', 'formula', 'I', 'peroxidase', 'polypeptide', 'presence', 'agent', 'stage', 'reaction', 'process']"
133,133,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130516/2013-20/US/2013/0121/011/A1/US20130121011A1.pdf,VEHICLE LAMP WITH LIGHT-EMITTING DIODE AS LIGHT SOURCE,A vehicle lamp having a housing and an illumination unit arranged within the housing is provided. The illumination unit comprises at least one light-emitting diode as light source. The at least one light-emitting diode is thermally coupled to a cooling element. The cooling element has a surface region arranged within the housing. On the surface region a decorative element is arranged.,"['Langkabel Frank', 'Scheider Carina', 'Arkenbosch Patrick', 'Kozma Steve', 'Schneider Ingolf', 'Hochmuth Ullrich']",0,uspto,"['inertial confinement fusion', 'uniform illumination', 'engineering', 'illumination conditions', 'vehicles', 'face recognition', 'lighting conditions']",Ullrich congenital muscular dystrophy,"['EMITTING', 'DIODE', 'SOURCE']","['vehicle', 'lamp', 'housing', 'illumination', 'unit', 'housing', 'illumination', 'unit', 'light', 'diode', 'light', 'source', 'light', 'diode', 'element', 'element', 'surface', 'region', 'housing', 'surface', 'region', 'decorative', 'element']"
134,134,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130516/2013-20/US/2013/0122/791/A1/US20130122791A1.pdf,APPARATUS AND PROCESS FOR FORMATION OF LATERALLY DIRECTED FLUID JETS,"A processing apparatus is provided to process a workpiece. The processing apparatus can have a low-profile nozzle system capable of navigating through spaces in order to process target regions with relatively small clearances. A fluid jet outputted from the nozzle system is used to cut, mill, or otherwise process the target region of the workpiece.","['Hashish Mohamed', 'Craigen Steve', 'Schuman Bruce', 'Ullrich Eckhardt', 'Orova Jeno']",0,uspto,"['machining centers', 'viscous flow', 'computer aided manufacturing', 'machining', 'non-newtonian fluids']",Ullrich congenital muscular dystrophy,"['PROCESS', 'FORMATION', 'FLUID', 'JETS']","['processing', 'apparatus', 'workpiece', 'processing', 'apparatus', 'low', 'profile', 'nozzle', 'system', 'capable', 'spaces', 'order', 'regions', 'small', 'clearances', 'fluid', 'jet', 'nozzle', 'system', 'mill', 'process', 'target', 'region', 'workpiece']"
135,135,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130516/2013-20/US/2013/0123/925/A1/US20130123925A1.pdf,SELF-DEPLOYING LOCKING SCREW RETENTION DEVICE,A screw assembly and a spinal implant. The screw assembly includes a screw with a head and a shaft where a screw retention member is positioned beneath the head of the screw and substantially surrounds the shaft of the screw. The screw retention member is formed from a temperature-sensitive material. The screw retention member has a first contracted position adapted for inserting the screw through at least one hole in the spinal implant and a second expanded position adapted for retaining the screw within the at least one hole in the spinal implant. The screw retention member may be in the form of a coiled spring or a collar having a plurality of tabs.,"['Patterson Chad J.', 'Ullrich', 'JR. Peter F.']",0,uspto,"['target tracking', 'robotics', 'target position', 'portable device', 'portable equipment']",Ullrich congenital muscular dystrophy,"['LOCKING', 'SCREW', 'RETENTION', 'DEVICE']","['screw', 'assembly', 'spinal', 'implant', 'screw', 'assembly', 'screw', 'head', 'shaft', 'screw', 'retention', 'member', 'head', 'screw', 'shaft', 'screw', 'screw', 'retention', 'member', 'temperature', 'sensitive', 'material', 'screw', 'retention', 'member', 'first', 'position', 'screw', 'hole', 'spinal', 'implant', 'second', 'position', 'screw', 'hole', 'spinal', 'implant', 'screw', 'retention', 'member', 'form', 'spring', 'collar', 'plurality', 'tabs']"
136,136,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130523/2013-21/US/2013/0125/361/A1/US20130125361A1.pdf,"Assemblies, Systems and Methods for the Transportation and Display of Plants and Flowers","A system for efficient transportation and display of plants or flowers has been designed that contains two trays and a container. The first tray houses the plants or flowers. The second tray, in which the first tray nests, allows for easy movement of the first tray and the supply of water or nutrients. The container is designed to serve two functions, shipping and displaying.",['Ullrich Peter'],0,uspto,"['logistics', 'image display', 'freight transportation', 'correlation analysis', 'image analysis', 'display system', 'display devices']",Ullrich congenital muscular dystrophy,['Flowers'],"['system', 'efficient', 'transportation', 'display', 'plants', 'flowers', 'trays', 'container', 'first', 'tray', 'houses', 'plants', 'flowers', 'second', 'tray', 'first', 'tray', 'nests', 'easy', 'movement', 'first', 'tray', 'supply', 'water', 'nutrients', 'container', 'functions', 'shipping', 'displaying']"
137,137,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130523/2013-21/US/2013/0131/851/A1/US20130131851A1.pdf,SYSTEM AND METHOD FOR AUTOMATICALLY PRODUCING HAPTIC EVENTS FROM A DIGITAL AUDIO SIGNAL,"In an embodiment, a system and method for automatically converting a plurality of events in a plurality of channels in a structured representation sequence into haptic events. The method comprises calculating an event score for each event of the sequence in one or more channels. The method also comprises calculating a cumulative score based on the event scores in the one or more channels. The method includes selectively designating haptic events to the events based on the event scores in one or more selected channels, wherein the haptic events are output by a haptic actuator.","['ULLRICH Christopher J.', 'RANK Stephen D.']",0,uspto,"['force feedback', 'haptic sensation', 'virtual channels', 'control channels', 'fading (radio)', 'data channels', 'frequency division multiple access', 'feedback systems', 'physical channels', 'radio channels', 'audio', 'robotics', 'mobile devices', 'haptic interactions', 'radio transmission', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'audio signals', 'display devices', 'audio systems', 'haptic devices', 'virtual reality', 'signal analysis', 'audio acoustics', 'remote control', 'haptic display', 'antennas', 'tactile feedback', 'subchannels', 'digital audio', 'digital watermarking', 'user interfaces', 'haptics']",Ullrich congenital muscular dystrophy,"['SYSTEM', 'METHOD', 'EVENTS', 'AUDIO']","['embodiment', 'system', 'method', 'plurality', 'events', 'plurality', 'channels', 'structured', 'representation', 'sequence', 'haptic', 'events', 'method', 'event', 'score', 'event', 'sequence', 'more', 'channels', 'method', 'cumulative', 'score', 'event', 'scores', 'more', 'channels', 'method', 'haptic', 'events', 'events', 'event', 'scores', 'more', 'channels', 'haptic', 'events', 'haptic', 'actuator']"
138,138,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130606/2013-23/US/2013/0142/802/A1/US20130142802A1.pdf,ANTIBODY MOLECULES TO ONCOGENIC ISOFORMS OF FIBROBLAST GROWTH FACTOR RECEPTOR-2 AND USES THEREOF,"Antibody molecules that specifically bind to one or more isoforms expressed and/or associated with oncogenic phenotypes in a hyperproliferative cell (e.g., a cancerous or tumor cell) are disclosed. The isoform-binding antibody molecules can be used to treat, prevent and/or diagnose cancerous conditions and/or disorders. Methods of using the isoform-binding molecules to selectively detect oncogenic isoforms, to reduce the activity and/or induce the killing of a hyperproliferative cell expressing an oncogenic isoform in vitro, ex vivo or in vivo are also disclosed. Diagnostic and/or screening methods and kits for evaluating the function or expression of an oncogenic isoform are also disclosed.","['Chang Xiao-jia', 'Schwertschlag Ullrich S.', 'Turner Katherine Jane']",0,uspto,[],Ullrich congenital muscular dystrophy,"['ISOFORMS', 'GROWTH', 'THEREOF']","['Antibody', 'more', 'isoforms', 'oncogenic', 'phenotypes', 'hyperproliferative', 'cell', 'cancerous', 'tumor', 'cell', 'isoform', 'antibody', 'molecules', 'cancerous', 'conditions', 'disorders', 'Methods', 'isoform', 'molecules', 'oncogenic', 'isoforms', 'activity', 'killing', 'hyperproliferative', 'cell', 'oncogenic', 'isoform', 'vitro', 'vivo', 'vivo', 'Diagnostic', 'methods', 'kits', 'function', 'expression', 'oncogenic', 'isoform']"
139,139,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130606/2013-23/US/2013/0142/950/A1/US20130142950A1.pdf,METHOD FOR PRODUCING A LAYER BY MEANS OF COLD SPRAYING AND USE OF SUCH A LAYER,"The invention relates to a method for generating an abrasive wear-resistant layer () on a substrate (). According to the invention, said layer () consists of particles () of a ductile material, in particular Zn, wherein the parameters of the cold spraying process are set such that a comparatively loose laminate having pores () is formed by the spray particles (). Said laminate advantageously and surprisingly exhibits high resistance to abrasive wear (for example by a particle ()) because the layer () can avoid the attack by the particle () by plastic deformation and closure of the pores (), whereby abrasive removal of the layer is advantageously low. The invention further relates to a use of a cold gas-sprayed layer as a protective layer against abrasive wear.","['Arndt Axel', 'Doye Christian', 'Stier Oliver', 'Ullrich Raymond']",0,uspto,"['dos attacks', 'haptic interactions', 'denial of service attacks', 'software architecture patterns', 'computer crime', 'layered', 'network security', 'control system analysis', 'elastic deformation', 'control parameters']",Ullrich congenital muscular dystrophy,"['METHOD', 'COLD', 'SPRAYING', 'USE', 'LAYER']","['invention', 'method', 'abrasive', 'wear', 'resistant', 'layer', 'substrate', 'invention', 'layer', 'particles', 'ductile', 'material', 'particular', 'parameters', 'cold', 'spraying', 'process', 'such', 'loose', 'laminate', 'pores', 'spray', 'particles', 'laminate', 'high', 'resistance', 'abrasive', 'wear', 'example', 'particle', 'layer', 'attack', 'particle', 'plastic', 'deformation', 'closure', 'pores', 'abrasive', 'removal', 'layer', 'low', 'invention', 'use', 'cold', 'gas', 'layer', 'protective', 'layer', 'abrasive', 'wear']"
140,140,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130704/2013-27/US/2013/0167/691/A1/US20130167691A1.pdf,DRYWALL SCREWDRIVER,"A drywall screwdriver includes a housing, a screw-in depth limiting element, and a gearing unit. The drywall screwdriver further includes a coupling unit, an output spindle, an electric motor, and a battery receptacle region. The housing of the screwdriver has at least one hand grip region. An overall weight of the drywall screwdriver is less than 1.2 kg.","['Ullrich Andre', 'Ruebsaamen Holger']",0,uspto,"['electric power', 'energy harvesting', 'electricity', 'internal combustion engines', 'electrical energy', 'engine']",Ullrich congenital muscular dystrophy,['DRYWALL'],"['drywall', 'screwdriver', 'housing', 'screw', 'depth', 'element', 'unit', 'drywall', 'screwdriver', 'unit', 'output', 'spindle', 'electric', 'motor', 'battery', 'receptacle', 'region', 'housing', 'screwdriver', 'hand', 'grip', 'region', 'overall', 'weight', 'drywall', 'screwdriver', 'less', 'kg']"
141,141,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130704/2013-27/US/2013/0168/121/A1/US20130168121A1.pdf,Portable Power Tool,"A hand-power tool, in particular a drill and/or chiseling hammer, includes a transmission, a machine housing, and an inner housing arranged within the machine housing. The inner housing is provided for at least partially receiving at least one transmission element of the transmission. The at least one transmission element is supported jointly by the inner housing and by the machine housing.","['Ullrich Andre', 'Fehrle Siegfried', 'Bernhardt Thomas']",0,uspto,"['mobile devices', 'mobile telecommunication systems', 'total power', 'pumping (laser)', 'personal digital assistants', 'handheld', 'peak power', 'portable device', 'user interfaces', 'pulsed laser applications', 'power allocations', 'portable equipment', 'hand held computers']",Ullrich congenital muscular dystrophy,"['Portable', 'Power']","['hand', 'power', 'tool', 'particular', 'drill', 'hammer', 'transmission', 'machine', 'housing', 'inner', 'housing', 'machine', 'housing', 'inner', 'housing', 'least', 'transmission', 'element', 'transmission', 'transmission', 'element', 'inner', 'housing', 'machine', 'housing']"
142,142,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130704/2013-27/US/2013/0170/661/A1/US20130170661A1.pdf,METHOD FOR ADJUSTING A HEARING DEVICE AS WELL AS AN ARRANGEMENT FOR ADJUSTING A HEARING DEVICE,"A method for adjusting a hearing device () to individual needs of a hearing device user is disclosed. The hearing device () comprises an input transducer (), a signal processing unit () and an output transducer (), the signal processing unit () being operatively connected to the input transducer () as well as to the output transducer (), and the signal processing unit () defining an input/output behavior of the hearing device (). The method comprising the steps of operationally connecting the hearing device () to a fitting device () comprising a display unit (), displaying a hearing threshold level () of the hearing device user as a function of frequencies on the display unit (), displaying characteristics of a predefined sound sample () on the display unit (), and adjusting the input/output behavior such that at least a part of the predefined sound sample () lies above the hearing threshold level () at corresponding frequencies. An arrangement for adjusting a hearing device () is also disclosed.","['Sigwanz Ullrich', 'Baechler Patrick', 'Schneider Philipp', 'Schmitt Nicola']",0,uspto,"['signal processing', 'bandwidth', 'engineering', 'signal analysis', 'portable device', 'frequencies', 'portable equipment', 'digital signal processing']",Ullrich congenital muscular dystrophy,"['METHOD', 'A', 'HEARING', 'DEVICE', 'AS', 'ARRANGEMENT', 'A', 'HEARING', 'DEVICE']","['method', 'hearing', 'device', 'individual', 'needs', 'device', 'user', 'device', 'input', 'transducer', 'signal', 'processing', 'unit', 'output', 'transducer', 'signal', 'processing', 'unit', 'input', 'transducer', 'output', 'transducer', 'signal', 'processing', 'unit', 'input', 'output', 'behavior', 'hearing', 'device', 'method', 'steps', 'hearing', 'device', 'fitting', 'device', 'display', 'unit', 'hearing', 'threshold', 'level', 'device', 'user', 'function', 'frequencies', 'display', 'unit', 'characteristics', 'predefined', 'sound', 'sample', 'display', 'unit', 'input', 'output', 'behavior', 'such', 'least', 'part', 'predefined', 'sound', 'sample', 'hearing', 'threshold', 'level', 'frequencies', 'arrangement', 'hearing', 'device']"
143,143,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130718/2013-29/US/2013/0181/807/A1/US20130181807A1.pdf,CURRENT-SENSING RESISTOR,"The invention relates to a current-sensing resistor () for measuring an electric current, in particular also for measuring a battery current in a vehicle power supply, having a plate-shaped first connecting part () for introducing the electrical current to be measured, wherein the plate-shaped first connecting part () consists of an electrically conductive conductor material; a plate-shaped second connecting part () for conducting away the electrical current to be measured, wherein the plate-shaped second connecting part () consists of an electrically conductive conductor material; and a plate-shaped resistance element (), which is connected in the current path between the two connecting parts and through which the electrical current to be measured flows, wherein the resistance element () consists of a comparatively high-impedance resistance material. According to the invention an incision () is arranged in the plate-shaped first connecting part () and/or in the plate-shaped second connecting part () in order to reduce the temperature dependency of the measurement and to eliminate the influence of the plate-shaped connecting parts (usually copper or aluminum).",['Hetzler Ullrich'],0,uspto,"['microstrip antennas', 'insulating materials', 'conductive materials', 'electromagnetic wave scattering', 'vehicles', 'insulating layers', 'engineering', 'electric impedance', 'input impedance', 'electrically conductive']",Ullrich congenital muscular dystrophy,"['SENSING', 'RESISTOR']","['invention', 'current', 'resistor', 'electric', 'current', 'particular', 'battery', 'current', 'vehicle', 'power', 'supply', 'plate', 'first', 'part', 'electrical', 'current', 'plate', 'first', 'part', 'conductive', 'conductor', 'material', 'plate', 'second', 'part', 'electrical', 'current', 'plate', 'second', 'part', 'conductive', 'conductor', 'material', 'plate', 'resistance', 'element', 'current', 'path', 'parts', 'electrical', 'current', 'flows', 'resistance', 'element', 'high', 'impedance', 'resistance', 'material', 'invention', 'incision', 'plate', 'first', 'part', 'plate', 'second', 'part', 'order', 'temperature', 'dependency', 'measurement', 'influence', 'plate', 'parts', 'copper', 'aluminum']"
144,144,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130808/2013-32/US/2013/0199/815/A1/US20130199815A1.pdf,HAND POWER TOOL DEVICE,"A hand power tool device includes at least one drive unit, which has at least one drive shaft. The hand power tool device also includes at least one transmission unit which has at least one transmission element that is directly connected to the drive shaft. The hand power tool device also includes at least one cooling unit which has a fan element. The fan element is at least substantially directly connected to the at least one transmission element of the at least one transmission unit.","['Ullrich Andre', 'Ruebsaamen Holger']",0,uspto,"['total power', 'peak power', 'gear', 'portable device', 'pulsed laser applications', 'power allocations', 'gear teeth', 'portable equipment', 'pumping (laser)']",Ullrich congenital muscular dystrophy,"['POWER', 'TOOL', 'DEVICE']","['hand', 'power', 'tool', 'device', 'drive', 'unit', 'drive', 'shaft', 'hand', 'power', 'tool', 'device', 'transmission', 'unit', 'transmission', 'element', 'drive', 'shaft', 'hand', 'power', 'tool', 'device', 'unit', 'fan', 'element', 'fan', 'element', 'least', 'transmission', 'element', 'transmission', 'unit']"
145,145,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130808/2013-32/US/2013/0201/141/A1/US20130201141A1.pdf,Systems and Methods For Shifting Haptic Feedback Function Between Passive And Active Modes,"Systems and methods for shifting haptic feedback function between passive and active modes are disclosed. For example, one disclosed method includes receiving a first signal from a sensor, the first signal associated with a mode of interaction with a graphical user interface; receiving a second signal associated with an interaction with the graphical user interface; determining a haptic feedback effect based at least in part on the mode of interaction with the graphical user interface and the interaction with the graphical user interface; and generating a haptic signal configured to output the haptic feedback effect.","['Birnbaum David M.', 'Ullrich Christopher J.']",0,uspto,"['force feedback', 'haptic sensation', 'sleep mode', 'human computer interaction', 'graphic methods', 'feedback systems', 'sensors', 'graphical representations', 'robotics', 'mobile devices', 'haptic interfaces', 'haptic feedbacks', 'active mode', 'human engineering', 'display devices', 'computer hardware', 'haptic devices', 'graphical user interfaces', 'virtual reality', 'remote control', 'haptic display', 'tactile feedback', 'user interfaces', 'haptics']",Ullrich congenital muscular dystrophy,['Systems'],"['Systems', 'methods', 'haptic', 'feedback', 'function', 'passive', 'active', 'modes', 'example', 'method', 'first', 'signal', 'sensor', 'first', 'signal', 'mode', 'interaction', 'graphical', 'user', 'interface', 'second', 'signal', 'interaction', 'graphical', 'user', 'interface', 'haptic', 'feedback', 'effect', 'least', 'part', 'mode', 'interaction', 'graphical', 'user', 'interface', 'interaction', 'graphical', 'user', 'interface', 'haptic', 'signal', 'haptic', 'feedback', 'effect']"
146,146,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130808/2013-32/US/2013/0202/732/A1/US20130202732A1.pdf,TOOL CLOSING SYSTEM FOR PLASTIC BLOW MOLDING MACHINES,"A tool closing system for plastic blow molding machines comprises a drive base plate, a front mold clamping plate and a rear mold clamping plate positioned between the front clamping plate and the base plate. The base plate, front clamping plate, and rear clamping plate are shiftably arranged on guides which are mounted on a carriage. A drive device is fastened to the base plate and comprises an extensible and retractable drive rod which is articulated to the rear clamping plate for force transmission without bending moment. Two substantially C-shaped or U-shaped frame elements are arranged side by side in parallel with the guides. Each have a substantially horizontally extending central web and two substantially vertically extending webs. A respective one of the two vertical webs is articulated to the base plate and the other vertical web is articulated to the front clamping plate.","['Hennemann Ullrich', 'M√ºller Detlef', 'B√∂hm Andreas']",0,uspto,"['linguistics', 'world wide web', 'javascript', 'information technology', 'internet', 'user interfaces', 'web 2.0', 'web application', 'web page', 'parallel machine', 'parallel processing systems', 'ajax', 'web information', 'search engines']",Ullrich congenital muscular dystrophy,"['CLOSING', 'SYSTEM', 'PLASTIC', 'MACHINES']","['tool', 'closing', 'system', 'plastic', 'blow', 'molding', 'machines', 'drive', 'base', 'plate', 'front', 'mold', 'plate', 'rear', 'mold', 'plate', 'front', 'plate', 'base', 'plate', 'base', 'plate', 'front', 'plate', 'plate', 'guides', 'carriage', 'drive', 'device', 'base', 'plate', 'extensible', 'retractable', 'drive', 'rod', 'rear', 'plate', 'force', 'transmission', 'moment', 'C', 'shaped', 'frame', 'elements', 'side', 'side', 'parallel', 'guides', 'central', 'web', 'webs', 'respective', 'vertical', 'webs', 'base', 'plate', 'other', 'vertical', 'web', 'front', 'plate']"
147,147,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130815/2013-33/US/2013/0205/735/A1/US20130205735A1.pdf,MOWER WITH THUMB WHEEL THROTTLE CONTROL,A mower for cutting grass comprises a traction frame that is self-propelled over the ground by a power source carried on the traction frame. The mower includes a thumb wheel throttle control that progressively increases and decreases the power output of the power source as the thumb wheel is rotated in one direction or an opposite direction. The thumb wheel has a plurality of tabs that define grooves on an arcuate rim on the thumb wheel for receiving a thumb or index finger of one of the operator's hands.,"['Schmidt Gordon R.', 'Ullrich Helmut J.']",0,uspto,"['switching systems', 'control systems', 'computer systems', 'total power', 'structural frames', 'switching control', 'frames', 'peak power', 'pulsed laser applications', 'power allocations', 'pumping (laser)']",Ullrich congenital muscular dystrophy,"['THUMB', 'WHEEL', 'THROTTLE', 'CONTROL']","['mower', 'grass', 'traction', 'frame', 'self', 'ground', 'power', 'source', 'traction', 'frame', 'mower', 'thumb', 'wheel', 'throttle', 'control', 'power', 'output', 'power', 'source', 'thumb', 'wheel', 'direction', 'opposite', 'direction', 'thumb', 'wheel', 'plurality', 'tabs', 'grooves', 'arcuate', 'rim', 'thumb', 'wheel', 'thumb', 'index', 'finger', 'operator', 'hands']"
148,148,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130815/2013-33/US/2013/0207/904/A1/US20130207904A1.pdf,INTERACTIVITY MODEL FOR SHARED FEEDBACK ON MOBILE DEVICES,"A system that produces a dynamic haptic effect and generates a drive signal that includes a gesture signal and a real or virtual device sensor signal. The haptic effect is modified dynamically based on both the gesture signal and the real or virtual device sensor signal such as from an accelerometer or gyroscope, or by a signal created from processing data such as still images, video or sound. The haptic effect may optionally be modified dynamically by using the gesture signal and the real or virtual device sensor signal and a physical model, or may optionally be applied concurrently to multiple devices which are connected via a communication link. The haptic effect may optionally be encoded into a data file on a first device. The data file is then communicated to a second device and the haptic effect is read from the data file and applied to the second device.","['Short Jason', 'Devenish Ryan', 'Birnbaum David', 'Ullrich Chris']",0,uspto,"['force feedback', 'haptic sensation', 'mobile computing', 'accelerometers', 'virtual spaces', 'portable device', 'feedback systems', 'sensors', 'portable equipment', 'mobile devices', 'robotics', 'haptic interactions', 'gesture recognition', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'display devices', 'computer hardware', 'haptic devices', 'communication', 'gyroscopes', 'virtual reality', 'remote control', 'haptic display', 'tactile feedback', 'user interfaces', 'haptics', 'hand gesture']",Ullrich congenital muscular dystrophy,"['INTERACTIVITY', 'MODEL', 'DEVICES']","['system', 'dynamic', 'haptic', 'effect', 'drive', 'signal', 'gesture', 'signal', 'real', 'virtual', 'device', 'sensor', 'signal', 'haptic', 'effect', 'gesture', 'signal', 'real', 'virtual', 'device', 'sensor', 'signal', 'such', 'accelerometer', 'gyroscope', 'signal', 'data', 'such', 'images', 'video', 'sound', 'haptic', 'effect', 'gesture', 'signal', 'real', 'virtual', 'device', 'sensor', 'signal', 'physical', 'model', 'multiple', 'devices', 'communication', 'link', 'haptic', 'effect', 'data', 'file', 'first', 'device', 'data', 'file', 'second', 'device', 'haptic', 'effect', 'data', 'file', 'second', 'device']"
149,149,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130815/2013-33/US/2013/0207/917/A1/US20130207917A1.pdf,HIGH DEFINITION HAPTIC EFFECTS GENERATION USING PRIMITIVES,"A haptically enabled system receives a haptic effect primitive comprising a plurality of input parameters and receives an input from a sensor. The system generates a haptic effect signal from the haptic effect primitive, the haptic effect signal comprising a plurality of output parameters where at least one of the output parameters is varied based on the sensor input. The system then applies the haptic effect signal to an actuator.","['CRUZ-HERNANDEZ Juan Manuel', 'WU Liwen', 'ULLRICH Christopher J.']",0,uspto,"['force feedback', 'haptic sensation', 'feedback systems', 'sensors', 'robotics', 'mobile devices', 'haptic interactions', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'display devices', 'computer hardware', 'haptic devices', 'virtual reality', 'remote control', 'haptic display', 'tactile feedback', 'user interfaces', 'haptics', 'sensor data']",Ullrich congenital muscular dystrophy,"['HIGH', 'DEFINITION', 'GENERATION', 'PRIMITIVES']","['system', 'haptic', 'effect', 'primitive', 'plurality', 'input', 'parameters', 'input', 'sensor', 'system', 'haptic', 'effect', 'signal', 'haptic', 'effect', 'primitive', 'haptic', 'effect', 'signal', 'plurality', 'output', 'parameters', 'output', 'parameters', 'varied', 'sensor', 'input', 'system', 'haptic', 'effect', 'signal', 'actuator']"
150,150,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130815/2013-33/US/2013/0211/685/A1/US20130211685A1.pdf,"METHOD FOR OPERATING A BRAKE SYSTEM, BRAKE SYSTEMS IN WHICH THE METHOD IS CARRIED OUT AND MOTOR VEHICLES COMPRISING SAID BRAKE SYSTEMS","A method for the operation of a brake system having two brake circuits, with a recuperative brake, in particular an electrical generator, a master brake cylinder and a brake pedal simultaneously achieve optimized use of the regenerative braking and a constant braking experience for the driver with the highest safety requirements. When there is a braking demand by the driver with an associated desired braking torque and a first condition is met, at least one outlet valve is opened and brake fluid is conducted with an associated volume of brake fluid into at least one reservoir and the at least one outlet valve is then closed if a second condition is met. The first condition is met if a braking variable corresponding to the braking demand is not less than a specified minimum value. The second condition is met if the volume of brake fluid has flowed into the reservoirs.","['Ullrich Thorsten', 'Albrich von Albrichsfeld Christian', 'Karner J√ºrgen', 'F√ºhrer Jochen']",0,uspto,"['clutch', 'viscous flow', 'electric automobiles', 'vehicle suspensions', 'engineering', 'non-newtonian fluids', 'vehicles', 'clutches', 'regenerative braking', 'suspension system']",Ullrich congenital muscular dystrophy,"['METHOD', 'METHOD', 'COMPRISING', 'SYSTEMS']","['method', 'operation', 'brake', 'system', 'brake', 'circuits', 'recuperative', 'brake', 'particular', 'electrical', 'generator', 'master', 'brake', 'cylinder', 'brake', 'pedal', 'use', 'regenerative', 'braking', 'constant', 'braking', 'experience', 'driver', 'highest', 'safety', 'requirements', 'demand', 'driver', 'torque', 'first', 'condition', 'outlet', 'valve', 'brake', 'fluid', 'volume', 'brake', 'fluid', 'reservoir', 'outlet', 'valve', 'second', 'condition', 'first', 'condition', 'variable', 'corresponding', 'demand', 'less', 'minimum', 'value', 'second', 'condition', 'volume', 'brake', 'fluid', 'reservoirs']"
151,151,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130822/2013-34/US/2013/0213/399/A1/US20130213399A1.pdf,RESPIRATION SYSTEM,"A respiration system for noninvasive respiration includes a respiration drive, which is controlled by a control device, and includes a patient module () with electrodes for picking up electrode signals from the surface of the chest of a patient. The control device is set up to suppress ECG signals in the electrode signals in order to obtain electromyographic signals (EMG signals) representing the breathing effort and to control the respiration drive as a function of the EMG signals. Provisions are made for deriving ECG signals from the electrode signals before said ECG signals are suppressed and for making data representative of the ECG available for display.","['HANSMANN Hans-Ullrich', 'EGER Marcus', 'BACH Peter', 'VAN EYKERN Leenderd']",0,uspto,"['switching systems', 'signal processing', 'control systems', 'computer systems', 'switching control', 'digital signal processors', 'portable device', 'biomedical signal', 'portable equipment', 'digital signals']",Ullrich congenital muscular dystrophy,"['RESPIRATION', 'SYSTEM']","['respiration', 'system', 'noninvasive', 'respiration', 'respiration', 'drive', 'control', 'device', 'patient', 'module', 'electrodes', 'electrode', 'signals', 'surface', 'chest', 'patient', 'control', 'device', 'signals', 'electrode', 'signals', 'order', 'electromyographic', 'signals', 'signals', 'breathing', 'effort', 'respiration', 'drive', 'function', 'signals', 'Provisions', 'signals', 'electrode', 'signals', 'signals', 'data', 'representative', 'available', 'display']"
152,152,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130822/2013-34/US/2013/0218/292/A1/US20130218292A1.pdf,IMPLANT AND METHOD FOR PRODUCTION THEREOF,"A method for producing an implant and the implant itself, particularly an intraluminal endoprosthesis, wherein the implant is produced from a preferably hollow cylindrical semifinished article (), wherein the semifinished article contains magnesium or a magnesium alloy, the method comprising preparing the semifinished article (), and shaping the semifinished article at a temperature of between 250¬∞ C. and 550¬∞ C. using a tool, which has a metallic lubricant containing gallium and/or a gallium compound on at least a part of its surface that will come into contact with the semifinished article.","['Bayer Ullrich', 'Block Bernd', 'Becher Baerbel', 'Lootz Daniel']",0,uspto,"['electronic commerce', 'contracts', 'information technology', 'gallium compounds', 'semiconducting gallium']",Ullrich congenital muscular dystrophy,"['IMPLANT', 'METHOD', 'PRODUCTION', 'THEREOF']","['method', 'implant', 'implant', 'intraluminal', 'endoprosthesis', 'implant', 'hollow', 'cylindrical', 'article', 'article', 'magnesium', 'magnesium', 'alloy', 'method', 'comprising', 'article', 'article', 'temperature', 'tool', 'metallic', 'lubricant', 'gallium', 'gallium', 'compound', 'least', 'part', 'surface', 'contact', 'article']"
153,153,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130829/2013-35/US/2013/0222/310/A1/US20130222310A1.pdf,SYSTEM AND METHOD FOR DISPLAY OF MULTIPLE DATA CHANNELS ON A SINGLE HAPTIC DISPLAY,"A system that produces a haptic effect and generates a drive signal that includes at least two haptic effect signals each having a priority level. The haptic effect is a combination of the haptic effect signals and priority levels. The haptic effect may optionally be a combination of the two haptic effect signals if the priority levels are the same, otherwise only the haptic effect signal with the highest priority is used. The frequency of haptic notifications may also be used to generate a drive signal using foreground and background haptic effect channels depending on whether the frequency ratio exceeds a foreground haptic effect threshold.","['Birnbaum David', 'Ullrich Chris', 'Short Jason', 'Devenish Ryan']",0,uspto,"['force feedback', 'haptic sensation', 'control channels', 'data channels', 'feedback systems', 'robotics', 'mobile devices', 'haptic interactions', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'display devices', 'haptic devices', 'virtual reality', 'remote control', 'haptic display', 'tactile feedback', 'user interfaces', 'display system', 'haptics']",Ullrich congenital muscular dystrophy,"['SYSTEM', 'METHOD', 'DISPLAY', 'CHANNELS', 'SINGLE', 'HAPTIC', 'DISPLAY']","['system', 'haptic', 'effect', 'drive', 'signal', 'haptic', 'effect', 'priority', 'level', 'haptic', 'effect', 'combination', 'haptic', 'effect', 'signals', 'priority', 'levels', 'haptic', 'effect', 'combination', 'haptic', 'effect', 'signals', 'priority', 'levels', 'same', 'haptic', 'effect', 'signal', 'highest', 'priority', 'frequency', 'haptic', 'notifications', 'drive', 'signal', 'foreground', 'haptic', 'effect', 'channels', 'frequency', 'ratio', 'foreground', 'haptic', 'effect', 'threshold']"
154,154,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130829/2013-35/US/2013/0224/076/A1/US20130224076A1.pdf,MEDICAL DEVICE FOR TREATING A PATIENT,"A medical device () for treating a patient, with a device body (), at which at least one functional unit () to be operated manually by a treating person is arranged. The device () has a disinfection unit (), which is provided separately from the functional unit and comprises a housing () arranged at the device body () with a disinfection chamber () for receiving at least one hand of the treating person, a plasma generator () arranged in the disinfection chamber for generating an atmospheric plasma (P) disinfecting the hand of the treating person and a control unit () for actuating the plasma generator ().","['HANSMANN Hans-Ullrich', 'RIECKE Michael', 'SCHNAARS Henryk', 'KRETSCHMANN Hanno', 'KUMMERFELD Ryszard']",0,uspto,"['switching systems', 'control systems', 'computer systems', 'switching control', 'portable device', 'portable equipment']",Ullrich congenital muscular dystrophy,"['DEVICE', 'PATIENT']","['medical', 'device', 'patient', 'device', 'body', 'functional', 'unit', 'person', 'device', 'disinfection', 'unit', 'functional', 'unit', 'housing', 'device', 'body', 'disinfection', 'chamber', 'hand', 'person', 'plasma', 'generator', 'disinfection', 'chamber', 'atmospheric', 'plasma', 'P', 'hand', 'person', 'control', 'unit', 'plasma', 'generator']"
155,155,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130829/2013-35/US/2013/0226/073/A1/US20130226073A1.pdf,DEVICE FOR DISINFECTING WOUND TREATMENT,"A device () for disinfecting wound treatment is described, with a housing (), with a plasma generator () arranged in housing () for generating a disinfecting plasma, with a flow module () arranged in housing () for generating a gas stream, which forms a free jet () transporting the disinfecting plasma from housing (), and with a jet control unit () for affecting the free jet () in a planned manner by controlling the gas stream generated by flow module (). Means () has, furthermore, a guide apparatus () controllable via the jet control unit () for guiding the free jet ().","['KUMMERFELD Ryszard', 'HANSMANN Hans-Ullrich', 'KRETSCHMANN Hanno']",0,uspto,"['switching systems', 'stream data', 'control systems', 'computer systems', 'data stream', 'switching control', 'database systems', 'portable equipment', 'data mining', 'portable device', 'data communication systems']",Ullrich congenital muscular dystrophy,"['DEVICE', 'DISINFECTING', 'TREATMENT']","['device', 'wound', 'treatment', 'housing', 'plasma', 'generator', 'housing', 'plasma', 'flow', 'module', 'housing', 'gas', 'stream', 'free', 'jet', 'plasma', 'housing', 'jet', 'control', 'unit', 'free', 'jet', 'manner', 'gas', 'stream', 'flow', 'module', 'guide', 'apparatus', 'controllable', 'jet', 'control', 'unit', 'free', 'jet']"
156,156,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130912/2013-37/US/2013/0236/879/A1/US20130236879A1.pdf,"THREE-DIMENSIONAL, PREVASCULARIZED, ENGINEERED TISSUE CONSTRUCTS, METHODS OF MAKING AND METHODS OF USING THE TISSUE CONSTRUCTS","Embodiments of the present disclosure provide for three-dimensional (3D), prevascularized, engineered tissue constructs, 3D prevascularized engineered tissue models of cancer, and bioreactors and bioreactor arrays including the tissue constructs. The present disclosure also provides methods of making the tissue constructs, methods of using the tissue constructs, methods of drug discovery using the tissue constructs and/or cancer models, and the like.","['Berry Joel L.', 'Wick Timothy M.', 'Murphy-Ullrich Joanne', 'Penman Andrew D.', 'Cain Andrew W.']",0,uspto,"['stochastic processes', 'standard model', 'correlation analysis', 'the standard model', 'electronic document identification systems', 'mathematics', 'probability']",Ullrich congenital muscular dystrophy,"['METHODS', 'METHODS', 'CONSTRUCTS']","['Embodiments', 'present', 'disclosure', 'dimensional', '3D', 'engineered', 'tissue', 'constructs', '3D', 'tissue', 'models', 'cancer', 'bioreactors', 'bioreactor', 'tissue', 'constructs', 'present', 'disclosure', 'methods', 'tissue', 'constructs', 'methods', 'tissue', 'constructs', 'methods', 'drug', 'discovery', 'tissue', 'constructs', 'cancer', 'models', 'like']"
157,157,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130919/2013-38/US/2013/0245/080/A1/US20130245080A1.pdf,BENZOTHIAZOLONE COMPOUND,The present invention provides a compound of formula (I) in free form or in pharmaceutically acceptable salt form,"['CAO Jun', 'ERB Bernhard', 'FAIRHURST Robin Alec', 'GRANDEURY Arnaud', 'HATAKEYAMA Shinji', 'KOZICZAK-HOLBRO Magdalena', 'LAI Xinzhong', 'LUSTENBERGER Philipp', 'RIEBESEHL Bernd', 'TUFILLI Nicola', 'ULLRICH Thomas', 'WU Xiang', 'ZHOU Jianguang']",0,uspto,[],Ullrich congenital muscular dystrophy,['COMPOUND'],"['present', 'invention', 'compound', 'formula', 'I', 'free', 'form', 'acceptable', 'salt', 'form']"
158,158,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130926/2013-39/US/2013/0253/483/A1/US20130253483A1.pdf,Tool Having Multiple Feedback Devices,"Disclosed herein are systems and methods for managing how signals, which are sensed on a tool, are presented to an operator of the tool. According to one example of a method for managing signals, the method comprises allowing an operator to manipulate a tool having a plurality of output mechanisms mounted thereon. The method also includes sensing a property of an object located near or adjacent to a distal portion of the tool and processing the sensed property to obtain one or more output signals. Furthermore, the method includes applying the one or more output signals to one or more of the output mechanisms.","['Ramstein Christophe', 'Ullrich Christopher J.', 'Grant Danny A.']",0,uspto,"['feedback systems', 'computer systems', 'digital signals', 'digital signal processors']",Ullrich congenital muscular dystrophy,[],"['herein', 'systems', 'methods', 'signals', 'tool', 'operator', 'tool', 'example', 'method', 'signals', 'method', 'operator', 'tool', 'plurality', 'output', 'mechanisms', 'thereon', 'method', 'property', 'object', 'adjacent', 'distal', 'portion', 'tool', 'property', 'more', 'output', 'signals', 'method', 'more', 'output', 'signals', 'more', 'output', 'mechanisms']"
159,159,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131003/2013-40/US/2013/0255/515/A1/US20130255515A1.pdf,POSITIVE-WORKING LITHOGRAPHIC PRINTING PLATE PRECURSORS,"A positive-working multi-layer lithographic printing plate precursor has an inner imageable layer disposed over a substrate. This inner imageable layer comprises one or more first polymeric binders that are present in a total amount of at least 50 weight % and up to and including 97 weight %, based on total inner imageable layer dry weight. The precursor also has an ink-receptive outer imageable layer disposed over the inner imageable layer and this ink-receptive outer imageable layer comprises one or more second polymeric binders that are different than the first polymeric binder. Each of the one or more first polymeric binders has a weight average molecular weight of at least 200,000 and can also have a polydispersity of at least 4.","['Savariar-Hauck Celin', 'Hauck Gerhard', 'Ullrich Rene', 'Frank Dietmar']",0,uspto,"['layered', 'software architecture patterns']",Ullrich congenital muscular dystrophy,"['POSITIVE', 'WORKING', 'LITHOGRAPHIC', 'PRINTING', 'PLATE', 'PRECURSORS']","['positive', 'multi', '-', 'layer', 'lithographic', 'printing', 'plate', 'precursor', 'inner', 'imageable', 'layer', 'substrate', 'inner', 'imageable', 'layer', 'more', 'first', 'polymeric', 'binders', 'present', 'total', 'amount', 'weight', '%', 'weight', '%', 'total', 'inner', 'imageable', 'layer', 'dry', 'weight', 'precursor', 'ink', 'receptive', 'outer', 'imageable', 'layer', 'inner', 'imageable', 'layer', 'ink', 'receptive', 'outer', 'imageable', 'layer', 'second', 'polymeric', 'binders', 'different', 'first', 'polymeric', 'binder', 'more', 'first', 'polymeric', 'binders', 'weight', 'average', 'molecular', 'weight', 'polydispersity', 'least']"
160,160,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131003/2013-40/US/2013/0261/042/A1/US20130261042A1.pdf,LAUNDRY DETERGENT COMPOSITION COMPRISING WATER-SOLUBLE PHTHALOCYANINE COMPOUND,"The present invention relates to compositions having granules of phthalocyanine compounds, to a process for the preparation thereof, and to the use thereof in washing agent and additive formulations.","['STENGER Patrick Christopher', 'Moon Andrew Philip', 'Miracle Gregory Scot', 'Menge Ullrich', 'Schlingloff Gunther', 'Bachmann Frank', 'Lindenmaier Andreas']",0,uspto,"['dynamic composition', 'software agents', 'web service composition', 'software engineering', 'intelligent agents', 'multiagent system', 'automatic composition', 'service compositions', 'component composition']",Ullrich congenital muscular dystrophy,"['DETERGENT', 'COMPRISING', 'WATER']","['present', 'invention', 'compositions', 'granules', 'phthalocyanine', 'compounds', 'process', 'preparation', 'use', 'washing', 'agent', 'additive', 'formulations']"
161,161,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131017/2013-42/US/2013/0269/419/A1/US20130269419A1.pdf,SENSOR DEVICE FOR DETECTING A FLOW PROPERTY OF A FLUID MEDIUM,"A sensor device for detecting at least one flow property of a fluid medium. The sensor device includes at least one sensor housing, in which at least one electronic module having at least one flow sensor for detecting the flow property is accommodated. The electronic module is at least partially accommodated in at least one electronic space. Furthermore, at least one pressure sensor and at least one humidity sensor are accommodated inside the sensor housing. The pressure sensor and also the humidity sensor are at least partially accommodated in at least one sensor space, which is designed separately from the electronic space.","['Etherington Kurt', 'Schneider Norbert', 'Kaufmann Andreas', 'Beyrich Hans', 'Rittmann Michael', 'Dann Wolfgang', 'Konzelmann Uwe', 'Roehler Andreas', 'Ullrich Frank']",0,uspto,"['fiber optic sensors', 'infrared detectors', 'single sensor', 'infra-red sensor', 'sensors', 'temperature sensors', 'multi-sensor', 'sensor data', 'computer hardware']",Ullrich congenital muscular dystrophy,"['DEVICE', 'PROPERTY', 'FLUID', 'MEDIUM']","['sensor', 'device', 'flow', 'property', 'fluid', 'medium', 'sensor', 'device', 'sensor', 'housing', 'electronic', 'module', 'flow', 'sensor', 'flow', 'property', 'electronic', 'module', 'least', 'electronic', 'space', 'pressure', 'sensor', 'humidity', 'sensor', 'sensor', 'housing', 'pressure', 'sensor', 'humidity', 'sensor', 'least', 'sensor', 'space', 'electronic', 'space']"
162,162,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131024/2013-43/US/2013/0279/027/A1/US20130279027A1.pdf,COLOR-CORRECTED F-THETA OBJECTIVE FOR LASER MATERIAL PROCESSING,"An F-theta objective which is color-corrected for a wavelength range of 1065-1075 nm and is suitable for high laser outputs of more than 1 kW, having sixth individual lenses L-L, wherein the lenses are formed of at least two different materials.","['WUNDERLICH Joerg', 'KRUEGER Ullrich']",0,uspto,"['wavelength division multiplexing', 'two wavelength', 'fiber optic networks', 'pattern recognition', 'color images', 'color difference', 'color component', 'wavelength', 'color image processing']",Ullrich congenital muscular dystrophy,"['OBJECTIVE', 'LASER', 'MATERIAL', 'PROCESSING']","['theta', 'objective', 'color', 'wavelength', 'range', 'nm', 'suitable', 'high', 'laser', 'outputs', 'more', 'kW', 'sixth', 'individual', 'lenses', 'lenses', 'different', 'materials']"
163,163,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131024/2013-43/US/2013/0282/104/A1/US20130282104A1.pdf,IMPLANT AND METHOD FOR PRODUCING THE SAME,"A method for producing a semifinished part () for an implant, in particular for an intraluminal endoprosthesis, which comprises the following steps:","['Bayer Ullrich', 'Block Bernd', 'Lootz Daniel', 'Hannemann Jan', 'Venohr Nils']",0,uspto,[],Ullrich congenital muscular dystrophy,"['IMPLANT', 'METHOD', 'SAME']","['method', 'part', 'implant', 'particular', 'intraluminal', 'endoprosthesis', 'steps']"
164,164,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131024/2013-43/US/2013/0282/122/A1/US20130282122A1.pdf,INTERBODY SPINAL IMPLANT HAVING A ROUGHENED SURFACE TOPOGRAPHY ON ONE OR MORE INTERNAL SURFACES,"Interbody spinal implants comprise internal sidewalls having a roughened surface topography. The internal sidewalls may be those that surround a substantially hollow implant center, including the sidewalls of a vertical aperture and sidewalls of a transverse aperture. The roughened surface topography comprises macro, micro, and nano features that comprise an amplitude, a peak to valley height, and spacing.","['Ullrich', 'JR. Peter F.', 'Gemas Kevin W.', 'Patterson Chad J.', 'Schneider Jennifer M.']",0,uspto,"['machining centers', 'multimedia services', 'subsurface structures', 'ground penetrating radar systems', 'telecommunication equipment', 'insulating materials', 'optical testing', 'insulating layers', 'machined surface', 'optical surfaces', 'cutting forces']",Ullrich congenital muscular dystrophy,"['SPINAL', 'IMPLANT', 'ROUGHENED', 'SURFACE', 'MORE', 'INTERNAL', 'SURFACES']","['spinal', 'implants', 'internal', 'sidewalls', 'surface', 'topography', 'internal', 'sidewalls', 'hollow', 'implant', 'center', 'sidewalls', 'vertical', 'aperture', 'sidewalls', 'transverse', 'aperture', 'surface', 'topography', 'macro', 'micro', 'nano', 'amplitude', 'peak', 'height']"
165,165,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131031/2013-44/US/2013/0284/476/A1/US20130284476A1.pdf,HAND POWER TOOL,"A hand power tool includes at least one drive unit, at least one housing, and at least one switchover element. The at least one drive unit is configured to drive an insert tool. The at least one housing at least partially encloses the drive unit. The at least one switchover element is configured to switch over a drive direction of the at least one drive unit. The at least one switchover element includes at least one actuating face that has at least two switching positions. The at least one actuating face is at least partially configured such that, when in the at least two switching positions, the at least one actuating face is at least substantially flush with the at least one housing.","['Ullrich Andre', 'Ruebsaamen Holger']",0,uspto,"['frontal faces', 'face images', 'formatting', 'peak power', 'face features', 'face detection', 'pulsed laser applications', 'face recognition', 'facial images', 'insert', 'pumping (laser)']",Ullrich congenital muscular dystrophy,"['POWER', 'TOOL']","['hand', 'power', 'tool', 'drive', 'unit', 'housing', 'switchover', 'element', 'drive', 'unit', 'insert', 'tool', 'housing', 'least', 'drive', 'unit', 'switchover', 'element', 'drive', 'direction', 'drive', 'unit', 'switchover', 'element', 'actuating', 'face', 'switching', 'positions', 'actuating', 'face', 'least', 'such', 'switching', 'positions', 'actuating', 'face', 'least', 'flush', 'housing']"
166,166,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131107/2013-45/US/2013/0291/355/A1/US20130291355A1.pdf,DEVICE AND METHOD FOR PRODUCING A NONWOVEN COMPOSITE FABRIC,"The invention relates to a device for producing a nonwoven composite fabric. A nonwoven fabric layer is applied onto a support structure layer and connected to said layer by means of water jet needling. According to the invention, the following are provided:",['M√ºnstermann Ullrich'],0,uspto,"['portable device', 'layered', 'portable equipment', 'software architecture patterns']",Ullrich congenital muscular dystrophy,"['DEVICE', 'METHOD', 'NONWOVEN', 'COMPOSITE', 'FABRIC']","['invention', 'device', 'nonwoven', 'composite', 'fabric', 'nonwoven', 'fabric', 'layer', 'support', 'structure', 'layer', 'layer', 'means', 'water', 'jet', 'needling', 'invention']"
167,167,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131107/2013-45/US/2013/0292/357/A1/US20130292357A1.pdf,PROCESS OF FABRICATING IMPLANTS HAVING THREE DISTINCT SURFACES,"Processes of fabricating different surface topographies, which may include separate macro processing, micro processing, and nano processing steps, in order to produce an interbody spinal implant having at least three distinct surfaces including (1) at least one integration surface having a roughened surface topography including macro features, micro features, and nano features, without sharp teeth that risk damage to bone structures; (2) at least one graft contact surface having a coarse surface topography including micro features and nano features; and (3) at least one soft tissue surface having a substantially smooth surface including nano features.","['Ullrich', 'JR. Peter F.', 'Patterson Chad J.', 'Schneider Jennifer M.']",0,uspto,"['machining centers', 'damage detection', 'subsurface structures', 'feature space', 'ground penetrating radar systems', 'classification methods', 'optical testing', 'structural damages', 'pattern recognition', 'machined surface', 'optical surfaces', 'structural health monitoring', 'cutting forces']",Ullrich congenital muscular dystrophy,"['PROCESS', 'DISTINCT', 'SURFACES']","['Processes', 'different', 'surface', 'topographies', 'separate', 'macro', 'processing', 'micro', 'processing', 'nano', 'processing', 'steps', 'order', 'interbody', 'spinal', 'implant', 'distinct', 'surfaces', 'integration', 'surface', 'surface', 'topography', 'macro', 'features', 'micro', 'features', 'nano', 'features', 'sharp', 'teeth', 'damage', 'bone', 'structures', 'graft', 'contact', 'surface', 'coarse', 'surface', 'topography', 'micro', 'features', 'nano', 'features', 'soft', 'tissue', 'surface', 'smooth', 'surface', 'nano', 'features']"
168,168,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131107/2013-45/US/2013/0294/717/A1/US20130294717A1.pdf,Rolling Bearing for a Shaft,"A roller bearing for a shaft that has a cylindrical peripheral surface, the bearing including a race () to be fitted onto the shaft, and roller bodies () arranged to roll on the race (), the race () having a polygonal internal cross-section, so that it engages the peripheral surface of the shaft only in the vicinity of the center of each side () of the polygon.","['Schwarzbich J√∂rg', 'Ullrich Thomas']",0,uspto,"['roller bearings', 'rolling element bearing', 'bearing fault', 'rolling bearings', 'gear teeth', 'vibration signal', 'bevel gears']",Ullrich congenital muscular dystrophy,"['Bearing', 'Shaft']","['roller', 'bearing', 'shaft', 'cylindrical', 'peripheral', 'surface', 'bearing', 'race', 'shaft', 'roller', 'bodies', 'race', 'race', 'polygonal', 'internal', 'cross', '-', 'section', 'peripheral', 'surface', 'shaft', 'vicinity', 'center', 'side', 'polygon']"
169,169,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131107/2013-45/US/2013/0295/657/A1/US20130295657A1.pdf,Device and Method for the Detection of Particles,"The present invention relates to devices and methods for the qualitative and/or quantitative detection of particles. In particular, the invention relates to devices for the detection of particles, comprising a reaction chamber formed within a chamber body between a first surface and a second surface, wherein the second surface is located opposite to the first surface, and one or more displacers, wherein the distance between the first surface and the second surface is variable via the one or more displacers at least in one or more parts of the surface area of the first surface and/or second surface. The invention also relates to corresponding methods for the detection of particles.","['Ermantraut Eugen', 'Bickel Ralf', 'Schulz Torsten', 'Ullrich Thomas', 'Tuchscheerer Jens']",0,uspto,"['portable device', 'detection algorithm', 'portable equipment', 'signal detection']",Ullrich congenital muscular dystrophy,"['Device', 'Particles']","['present', 'invention', 'devices', 'methods', 'qualitative', 'quantitative', 'detection', 'particles', 'particular', 'invention', 'devices', 'detection', 'particles', 'reaction', 'chamber', 'chamber', 'body', 'first', 'surface', 'second', 'surface', 'second', 'surface', 'first', 'surface', 'more', 'displacers', 'distance', 'first', 'surface', 'second', 'surface', 'variable', 'more', 'displacers', 'least', 'more', 'parts', 'surface', 'area', 'first', 'surface', 'second', 'surface', 'invention', 'methods', 'detection', 'particles']"
170,170,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131107/2013-45/US/2013/0297/006/A1/US20130297006A1.pdf,IMPLANT WITH INCREASED CARBON CONTENT AT NEAR-SURFACE BOUNDARY LAYER,"Implant in the form of an intraluminal endoprosthesis, having a tubular body containing metallic material, optionally iron, whereby in at least a portion of the implant body the following are present in the structure of a near-surface boundary layer in comparison to the respective concentration in the remaining structure: an increased carbon content in a concentration of approximately 0.5% by weight to approximately 2% by weight; or an increased carbon and nitrogen content, wherein a concentration of carbon is approximately 0.5% by weight to approximately 7% by weight, and a concentration of nitrogen is approximately 0.5% by weight to approximately 17% by weight.","['Bayer Ullrich', 'Gerold Bodo']",0,uspto,"['numerical methods', 'multimedia services', 'world wide web', 'digital rights management', 'software architecture patterns', 'digital contents', 'layered', 'multimedia contents', 'web page', 'free surfaces']",Ullrich congenital muscular dystrophy,"['IMPLANT', 'INCREASED', 'CARBON', 'CONTENT']","['Implant', 'form', 'intraluminal', 'endoprosthesis', 'tubular', 'body', 'metallic', 'material', 'iron', 'least', 'portion', 'implant', 'body', 'present', 'structure', 'near', 'surface', 'boundary', 'layer', 'comparison', 'respective', 'concentration', 'structure', 'carbon', 'content', 'concentration', '%', 'weight', '%', 'weight', 'carbon', 'nitrogen', 'content', 'concentration', 'carbon', '%', 'weight', '%', 'weight', 'concentration', 'nitrogen', '%', 'weight', '%', 'weight']"
171,171,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131107/2013-45/US/2013/0297/179/A1/US20130297179A1.pdf,METHOD FOR MONITORING THE SIGNAL VALUE OF A VACUUM SENSOR,"A method for monitoring the signal value of a vacuum sensor of a vacuum system in a vehicle, wherein a vacuum generator and a brake booster are provided in the vacuum system, an upper error threshold (‚àíp_vac_errorthreshold) is calculated as a function of the operating states of the vacuum generator and of the brake booster, and wherein an error is identified when the signal value of the vacuum sensor exceeds the current value of the error threshold.","['Gruber Steffen', 'Peichl Thomas', 'Ross Scott F.', 'Ullrich Thorsten']",0,uspto,"['clutch', 'infrared detectors', 'single sensor', 'engineering', 'vehicles', 'infra-red sensor', 'clutches', 'sensors', 'multi-sensor', 'computer hardware']",Ullrich congenital muscular dystrophy,"['METHOD', 'VALUE', 'VACUUM', 'SENSOR']","['method', 'signal', 'value', 'vacuum', 'sensor', 'vacuum', 'system', 'vehicle', 'vacuum', 'generator', 'brake', 'booster', 'vacuum', 'system', 'upper', 'error', 'threshold', 'function', 'states', 'vacuum', 'generator', 'brake', 'booster', 'error', 'signal', 'value', 'vacuum', 'sensor', 'current', 'value', 'error', 'threshold']"
172,172,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131114/2013-46/US/2013/0298/616/A1/US20130298616A1.pdf,METHOD AND SYSTEM FOR OPERATING AN ELECTRONIC LOCK,"An interchangeable electronic lock includes an electronic access system to activate a motor which powers a gear assembly in the electronic lock. An optional manual bypass allows an operator to override the electronic access. When the lock is activated, the operator manually cranks a lock shaft to lock and unlock a storage unit. A controller selectively operates the motor to move the gear assembly in a linear direction. The gear assembly engages a first portion of a drive assembly with a second portion, to permit manual operation of the lock shaft to lock and unlock the storage unit. An optional modular chassis assembly includes a removable array of components for testing, maintenance and repair. The invention includes a system for operation of the electronic lock, a method of operating the electronic lock and software for operating the electronic lock.","['ULLRICH Theodore', 'McLEOD John', 'SABELLI Tonino', 'DIPIETRO Dean', 'GELARDI Pepin']",0,uspto,"['component', 'software', 'computer science', 'image retrieval', 'gear', 'planetary gears', 'gears', 'gear teeth']",Ullrich congenital muscular dystrophy,"['METHOD', 'SYSTEM', 'ELECTRONIC', 'LOCK']","['interchangeable', 'electronic', 'lock', 'electronic', 'access', 'system', 'motor', 'gear', 'assembly', 'electronic', 'lock', 'optional', 'manual', 'bypass', 'operator', 'electronic', 'access', 'lock', 'operator', 'lock', 'shaft', 'storage', 'unit', 'controller', 'motor', 'gear', 'assembly', 'linear', 'direction', 'gear', 'assembly', 'first', 'portion', 'drive', 'assembly', 'second', 'portion', 'manual', 'operation', 'lock', 'shaft', 'storage', 'unit', 'optional', 'modular', 'chassis', 'assembly', 'removable', 'array', 'components', 'testing', 'maintenance', 'repair', 'invention', 'system', 'operation', 'electronic', 'lock', 'method', 'electronic', 'lock', 'software', 'electronic', 'lock']"
173,173,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131114/2013-46/US/2013/0298/619/A1/US20130298619A1.pdf,INTERCHANGEABLE ELECTRONIC LOCK,"An electronic lock is interchangeable with mechanical locks in retrofit applications or as an OEM lock. The lock includes interchangeable modular components. The lock housing is interchangeable with other housings of different configurations to permit replacement of existing mechanical locks. The lock may also include interchangeable drivers for compatibility with other systems. The lock includes an electronic access system such as a programmable keypad or card reader to activate a motor which powers the electronic lock. An optional manual bypass allows an operator to override the electronic access, for example when the motor is inoperative. When the lock is activated, the operator manually cranks a lock shaft to lock and unlock a storage unit. An optional modular chassis assembly includes a removable array of components for testing, maintenance and repair.","['ULLRICH Theodore', 'McLEOD John', 'SABELLI Tonino', 'DIPIETRO Dean', 'GELARDI Pepin']",0,uspto,"['clock synchronization', 'component', 'software', 'maintenance process', 'critical sections', 'computer software maintenance', 'transactional memory', 'machine design', 'mechanical systems', 'direction of arrival', 'sub-arrays', 'mechanical clocks']",Ullrich congenital muscular dystrophy,"['ELECTRONIC', 'LOCK']","['electronic', 'lock', 'interchangeable', 'mechanical', 'locks', 'retrofit', 'applications', 'lock', 'lock', 'interchangeable', 'modular', 'components', 'lock', 'housing', 'interchangeable', 'other', 'housings', 'different', 'configurations', 'replacement', 'mechanical', 'locks', 'lock', 'interchangeable', 'drivers', 'compatibility', 'other', 'systems', 'lock', 'electronic', 'access', 'system', 'such', 'programmable', 'keypad', 'card', 'reader', 'motor', 'electronic', 'lock', 'optional', 'manual', 'bypass', 'operator', 'electronic', 'access', 'example', 'motor', 'inoperative', 'lock', 'operator', 'lock', 'shaft', 'storage', 'unit', 'optional', 'modular', 'chassis', 'assembly', 'removable', 'array', 'components', 'testing', 'maintenance', 'repair']"
174,174,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131114/2013-46/US/2013/0299/923/A1/US20130299923A1.pdf,FLEXIBLE STOP FOR AN ACCELERATION SENSOR,"A micromechanical acceleration sensor includes a seismic mass and a substrate that has a reference electrode. The seismic mass is deflectable in a direction perpendicular to the reference electrode, and the seismic mass has a flexible stop in the deflection direction. The flexible stop of the seismic mass includes an elastic layer.","['CLASSEN Johannes', 'REINMUTH Jochen', 'ULLRICH Guenther-Nino-Carlo']",0,uspto,"['acceleration sensors', 'single sensor', 'accelerometers', 'micro-mechanical', 'sensors', 'micromachined', 'micromachining', 'mems', 'multi-sensor', 'computer hardware', 'solid-state sensors']",Ullrich congenital muscular dystrophy,"['ACCELERATION', 'SENSOR']","['micromechanical', 'acceleration', 'sensor', 'seismic', 'mass', 'substrate', 'reference', 'electrode', 'seismic', 'mass', 'deflectable', 'direction', 'perpendicular', 'reference', 'electrode', 'seismic', 'mass', 'flexible', 'stop', 'deflection', 'direction', 'flexible', 'stop', 'seismic', 'mass', 'elastic', 'layer']"
175,175,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131114/2013-46/US/2013/0300/683/A1/US20130300683A1.pdf,INTERACTIVITY MODEL FOR SHARED FEEDBACK ON MOBILE DEVICES,"A system that produces a dynamic haptic effect and generates a drive signal that includes a gesture signal and a real or virtual device sensor signal. The haptic effect is modified dynamically based on both the gesture signal and the real or virtual device sensor signal such as from an accelerometer or gyroscope, or by a signal created from processing data such as still images, video or sound. The haptic effect may optionally be modified dynamically by using the gesture signal and the real or virtual device sensor signal and a physical model, or may optionally be applied concurrently to multiple devices which are connected via a communication link. The haptic effect may optionally be encoded into a data file on a first device. The data file is then communicated to a second device and the haptic effect is read from the data file and applied to the second device.","['Birnbaum David', 'Ullrich Chris', 'Short Jason', 'Devenish Ryan']",0,uspto,"['force feedback', 'haptic sensation', 'mobile computing', 'accelerometers', 'virtual spaces', 'portable device', 'feedback systems', 'sensors', 'portable equipment', 'mobile devices', 'robotics', 'haptic interactions', 'gesture recognition', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'display devices', 'computer hardware', 'haptic devices', 'communication', 'gyroscopes', 'virtual reality', 'remote control', 'haptic display', 'tactile feedback', 'user interfaces', 'haptics', 'hand gesture']",Ullrich congenital muscular dystrophy,"['INTERACTIVITY', 'MODEL', 'DEVICES']","['system', 'dynamic', 'haptic', 'effect', 'drive', 'signal', 'gesture', 'signal', 'real', 'virtual', 'device', 'sensor', 'signal', 'haptic', 'effect', 'gesture', 'signal', 'real', 'virtual', 'device', 'sensor', 'signal', 'such', 'accelerometer', 'gyroscope', 'signal', 'data', 'such', 'images', 'video', 'sound', 'haptic', 'effect', 'gesture', 'signal', 'real', 'virtual', 'device', 'sensor', 'signal', 'physical', 'model', 'multiple', 'devices', 'communication', 'link', 'haptic', 'effect', 'data', 'file', 'first', 'device', 'data', 'file', 'second', 'device', 'haptic', 'effect', 'data', 'file', 'second', 'device']"
176,176,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131114/2013-46/US/2013/0304/178/A1/US20130304178A1.pdf,IMPLANT AND METHOD FOR MANUFACTURING SAME,"The present invention relates to a method for manufacturing an implant, in particular an intraluminal endoprosthesis, having a body containing metallic material, preferably iron. For controlling the degradation of the implant the method includes the following steps: (a) providing a first part of the implant body; and (b) performing heat treatment which alters the carbon content and/or the boron content and/or the nitrogen content in the structure of a near-surface boundary layer in the first part of the implant body in such a way that strain on the lattice or a lattice transformation, optionally following a subsequent mechanical load, is achieved in the near-surface boundary layer. Such an implant is also described.","['Bayer Ullrich', 'Gerold Bodo']",0,uspto,"['numerical methods', 'multimedia services', 'world wide web', 'digital rights management', 'software architecture patterns', 'digital contents', 'layered', 'multimedia contents', 'web page', 'free surfaces']",Ullrich congenital muscular dystrophy,"['IMPLANT', 'METHOD', 'MANUFACTURING', 'SAME']","['present', 'invention', 'method', 'implant', 'particular', 'intraluminal', 'endoprosthesis', 'body', 'metallic', 'material', 'iron', 'degradation', 'implant', 'method', 'following', 'steps', 'first', 'part', 'implant', 'body', 'heat', 'treatment', 'carbon', 'content', 'boron', 'content', 'nitrogen', 'content', 'structure', 'near', 'surface', 'boundary', 'layer', 'first', 'part', 'implant', 'body', 'way', 'lattice', 'lattice', 'transformation', 'subsequent', 'mechanical', 'load', 'near', 'surface', 'boundary', 'layer', 'implant']"
177,177,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131114/2013-46/US/2013/0304/218/A1/US20130304218A1.pdf,PROCESS OF FABRICATING IMPLANTS HAVING INTERNAL FEATURES FOR GRAFT RETENTION AND LOAD TRANSFER BETWEEN IMPLANT AND VERTEBRAE,"Processes of fabricating at least one graft contact surface and other surface topographies on an interbody spinal implant, such as a solid-body or composite implant. The graft contact surface as one or more of the internal surfaces of the implant includes at least one ridge or groove, for example, which is designed to contact and promote retention and stabilization of bone growth-inducing materials placed within the internal openings of the implant body. In addition, the ridges or grooves may influence the biological processes to promote bone healing and fusion.","['Ullrich', 'JR. Peter F.', 'Schneider Jennifer M.', 'Patterson Chad J.']",0,uspto,"['electronic commerce', 'feature space', 'contracts', 'classification methods', 'information technology', 'transparent material', 'femtosecond laser', 'load transfer', 'fingerprint images', 'pattern recognition', 'finite element method', 'ultrafast lasers', 'orientation fields']",Ullrich congenital muscular dystrophy,"['PROCESS', 'INTERNAL', 'TRANSFER', 'IMPLANT', 'VERTEBRAE']","['Processes', 'graft', 'contact', 'surface', 'other', 'surface', 'topographies', 'interbody', 'spinal', 'implant', 'such', 'solid', 'body', 'composite', 'implant', 'graft', 'contact', 'surface', 'more', 'internal', 'surfaces', 'implant', 'ridge', 'groove', 'example', 'retention', 'stabilization', 'bone', 'growth', 'materials', 'internal', 'openings', 'implant', 'body', 'addition', 'ridges', 'grooves', 'biological', 'processes', 'bone', 'healing', 'fusion']"
178,178,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131121/2013-47/US/2013/0306/591/A1/US20130306591A1.pdf,PROCESS OF FABRICATING COMPOSITE IMPLANTS HAVING INTEGRATION SURFACES COMPOSED OF A REGULAR REPEATING PATTERN,"Processes of fabricating a roughened surface topography on a composite interbody spinal implant including a body having a top surface, a bottom surface, opposing lateral sides, and opposing anterior and posterior portions; a first integration plate affixed to the top surface of the body; and an optional second integration plate affixed to the bottom surface of the body. At least a portion of the first integration plate, optional second integration plate, or both has a roughened surface topography including macro features, micro features, and nano features, without sharp teeth that risk damage to bone structures, adapted to grip bone through friction, inhibit migration of the implant, and promote bone growth. The process steps may include separate and sequential macro processing, micro processing, and nano processing steps.","['Ullrich', 'JR. Peter F.', 'Patterson Chad J.', 'Schneider Jennifer M.']",0,uspto,"['machining centers', 'damage detection', 'subsurface structures', 'feature space', 'ground penetrating radar systems', 'classification methods', 'optical testing', 'structural damages', 'pattern recognition', 'machined surface', 'optical surfaces', 'structural health monitoring', 'cutting forces']",Ullrich congenital muscular dystrophy,"['PROCESS', 'COMPOSITE', 'IMPLANTS', 'INTEGRATION', 'SURFACES', 'REGULAR', 'REPEATING', 'PATTERN']","['Processes', 'surface', 'topography', 'composite', 'interbody', 'spinal', 'implant', 'body', 'top', 'surface', 'bottom', 'surface', 'lateral', 'sides', 'anterior', 'posterior', 'portions', 'first', 'integration', 'plate', 'top', 'surface', 'body', 'optional', 'second', 'integration', 'plate', 'bottom', 'surface', 'body', 'least', 'portion', 'first', 'integration', 'plate', 'optional', 'second', 'integration', 'plate', 'surface', 'topography', 'macro', 'features', 'micro', 'features', 'nano', 'features', 'sharp', 'teeth', 'damage', 'bone', 'structures', 'grip', 'bone', 'friction', 'inhibit', 'migration', 'implant', 'bone', 'growth', 'process', 'steps', 'separate', 'sequential', 'macro', 'processing', 'micro', 'processing', 'nano', 'processing', 'steps']"
179,179,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131121/2013-47/US/2013/0306/748/A1/US20130306748A1.pdf,FLUID JET RECEPTACLE WITH ROTATABLE INLET FEED COMPONENT AND RELATED FLUID JET CUTTING SYSTEM AND METHOD,A jet receiving receptacle is provided which is coupleable to a high pressure fluid jet system opposite a nozzle thereof to receive a fluid jet discharged from the nozzle after it acts on a workpiece. The jet receiving receptacle may include an inlet feed component having a tapered inlet that defines a jet receiving surface about a central axis to receive the fluid jet and direct the fluid jet downstream and toward the central axis. The jet receiving receptacle may further include a drive mechanism adapted to rotate the inlet feed component about the central axis such that impact of the fluid jet with the inlet feed component is distributed around the jet receiving surface. The drive mechanism may rotate the inlet feed component continuously or intermittently. Fluid jet cutting systems incorporating a jet receiving receptacle and related methods are also provided.,"['Hashish Mohamed A.', 'Craigen Steven J.', 'Schuman Bruce M.', 'Ullrich Eckhardt R.']",0,uspto,"['machining centers', 'component', 'software', 'viscous flow', 'microstrip antennas', 'microwaves', 'computer aided manufacturing', 'machining', 'non-newtonian fluids', 'microstripes']",Ullrich congenital muscular dystrophy,"['JET', 'JET', 'CUTTING', 'METHOD']","['jet', 'receiving', 'receptacle', 'coupleable', 'high', 'pressure', 'fluid', 'jet', 'system', 'nozzle', 'fluid', 'jet', 'nozzle', 'workpiece', 'jet', 'receiving', 'receptacle', 'inlet', 'feed', 'component', 'tapered', 'inlet', 'jet', 'surface', 'central', 'axis', 'fluid', 'jet', 'fluid', 'jet', 'downstream', 'central', 'axis', 'jet', 'receiving', 'receptacle', 'drive', 'mechanism', 'inlet', 'feed', 'component', 'central', 'axis', 'such', 'impact', 'fluid', 'jet', 'inlet', 'feed', 'component', 'jet', 'surface', 'drive', 'mechanism', 'inlet', 'feed', 'component', 'Fluid', 'jet', 'cutting', 'systems', 'jet', 'receiving', 'receptacle', 'related', 'methods']"
180,180,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131121/2013-47/US/2013/0309/674/A1/US20130309674A1.pdf,ANALYSIS OF THE METHYLATION PATTERN OF THE ALPHA-SYNUCLEIN GENE FROM DNA OF PERIPHERAL BLOOD MONOCYTES FOR DIAGNOSING PARKINSON'S DISEASE,"A method of using peripheral blood monocytes of a patient to at least one of diagnose and assess a risk of a patient of developing Parkinson's disease includes obtaining peripheral blood monocytes from the patient, and determining a methylation pattern of the SNCAregion of the SNCA gene of the DNA of the peripheral blood monocytes.","['Wuellner Ullrich', 'Schmitt Ina']",0,uspto,"['mathematics', 'correlation analysis']",Ullrich congenital muscular dystrophy,"['DNA', 'BLOOD', 'MONOCYTES', 'PARKINSON']","['method', 'peripheral', 'blood', 'monocytes', 'patient', 'diagnose', 'risk', 'patient', 'disease', 'peripheral', 'blood', 'monocytes', 'patient', 'methylation', 'pattern', 'gene', 'DNA', 'peripheral', 'blood', 'monocytes']"
181,181,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131121/2013-47/US/2013/0311/881/A1/US20130311881A1.pdf,Systems and Methods for Haptically Enabled Metadata,"Systems and methods for haptically enabled metadata are disclosed. One disclosed embodiment of a method comprises receiving, by an electronic device, an electronic list corresponding to a plurality of data items. The method further comprises analyzing, by the electronic device, metadata within the electronic list to determine a haptic effect associated with a first data item in the plurality of data items. The method further comprises generating a signal, the signal being generated when information corresponding to the first data item is initially displayed on a display associated with the electronic device, the signal configured to cause the haptic effect. The method further comprises outputting the signal.","['Birnbaum David', 'Bothsa Marcus Aurelius', 'Short Jason', 'Devenish Ryan', 'Ullrich Chris']",0,uspto,"['force feedback', 'haptic sensation', 'virtual reality', 'haptic interfaces', 'user interfaces', 'haptics', 'haptic feedbacks', 'remote control']",Ullrich congenital muscular dystrophy,['Systems'],"['Systems', 'methods', 'metadata', 'embodiment', 'method', 'electronic', 'device', 'electronic', 'list', 'plurality', 'data', 'items', 'method', 'electronic', 'device', 'metadata', 'electronic', 'list', 'haptic', 'effect', 'first', 'data', 'item', 'plurality', 'data', 'items', 'method', 'signal', 'signal', 'information', 'first', 'data', 'item', 'display', 'electronic', 'device', 'signal', 'haptic', 'effect', 'method', 'signal']"
182,182,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131205/2013-49/US/2013/0323/497/A1/US20130323497A1.pdf,FLAME RESISTANT LAMINATE,"A fire-resistant laminate is described, which distinguishes itself by its low heating value ‚â¶3 MJ/kg according to ISO 1716 and thanks to its special multilayer structure has excellent mechanical characteristics and a very good stability under changing climatic conditions (hot/humid/cold/dry). The laminate according to the invention comprises several mineral and glass non-woven fabrics with different functionalities and components. This includes high-filled non-woven fabrics, B-stage binders and other additives.","['Ullrich Gerald', 'Horvath Michael', 'Ketzer Michael', 'Gleich Klaus Friedrich']",0,uspto,"['cryptanalysis', 'block ciphers', 'component', 'asymptotic stability', 'software', 'machine design', 'cutting tools', 'linear matrix inequalities', 'mechanical systems', 'lyapunov functions', 'adaptive control systems', 'distinguishers', 'lead-free', 'hash functions', 'global stability']",Ullrich congenital muscular dystrophy,[],"['fire', 'resistant', 'laminate', 'low', 'heating', 'value', 'kg', 'thanks', 'special', 'multilayer', 'structure', 'excellent', 'mechanical', 'characteristics', 'good', 'stability', 'climatic', 'conditions', 'hot', 'humid', 'cold', 'dry', 'laminate', 'invention', 'several', 'mineral', 'glass', 'non', '-', 'fabrics', 'different', 'functionalities', 'components', 'non', '-', 'fabrics', 'B', 'stage', 'binders', 'other', 'additives']"
183,183,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131219/2013-51/US/2013/0336/986/A1/US20130336986A1.pdf,KINASES AS TARGETS FOR ANTI-DIABETIC THERAPY,"The present invention is related to compound capable of modulating the activity and/or expression of the protein kinases SCYL1, ADCK1, and GRK5, thereby enhancing the expression and/or release of insulin. The invention is further related to methods of identifying said compounds for the treatment of diseases of the carbohydrate metabolism. The invention is further related to methods of treatment of diseases of the carbohydrate metabolism, particularly diabetes mellitus type 2.","['Falcenberg Mathias', 'Ullrich Axel']",0,uspto,"['target tracking', 'multi-target tracking', 'multiple targets', 'multitarget']",Ullrich congenital muscular dystrophy,"['TARGETS', 'ANTI', '-', 'DIABETIC', 'THERAPY']","['present', 'invention', 'capable', 'activity', 'expression', 'protein', 'kinases', 'expression', 'release', 'insulin', 'invention', 'methods', 'identifying', 'compounds', 'treatment', 'diseases', 'carbohydrate', 'metabolism', 'invention', 'methods', 'treatment', 'diseases', 'carbohydrate', 'metabolism', 'mellitus', 'type']"
184,184,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20131219/2013-51/US/2013/0338/777/A1/US20130338777A1.pdf,INTERBODY SPINAL IMPLANT HAVNG A ROUGHENED SURFACE TOPOGRAPHY,"An interbody spinal implant including a body having a top surface, a bottom surface, opposing lateral sides, opposing anterior and posterior portions, a substantially hollow center, and a single vertical aperture. The single vertical aperture extends from the top surface to the bottom surface, has a size and shape predetermined to maximize the surface area of the top surface and the bottom surface available proximate the anterior and posterior portions while maximizing both radiographic visualization and access to the substantially hollow center, and defines a transverse rim. The body may be non-metallic and may form one component of a composite implant; the other component is a metal plate disposed on at least one of the top and bottom surfaces of the body.","['Bagga Charanpreet S.', 'Ullrich', 'JR. Peter F.']",0,uspto,"['subsurface structures', 'large aperture', 'component', 'ground penetrating radar systems', 'software', 'visualization', 'optical testing', 'human computer interaction', 'optical surfaces']",Ullrich congenital muscular dystrophy,"['IMPLANT', 'ROUGHENED', 'SURFACE', 'TOPOGRAPHY']","['interbody', 'spinal', 'implant', 'body', 'top', 'surface', 'bottom', 'surface', 'lateral', 'sides', 'anterior', 'posterior', 'portions', 'hollow', 'center', 'single', 'vertical', 'aperture', 'single', 'vertical', 'aperture', 'top', 'surface', 'bottom', 'surface', 'size', 'shape', 'surface', 'area', 'top', 'surface', 'bottom', 'surface', 'available', 'anterior', 'posterior', 'portions', 'radiographic', 'visualization', 'access', 'hollow', 'center', 'transverse', 'rim', 'body', 'non', '-', 'metallic', 'component', 'composite', 'implant', 'other', 'component', 'metal', 'plate', 'top', 'bottom', 'surfaces', 'body']"
185,185,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140102/2014-01/US/2014/0000/797/A1/US20140000797A1.pdf,Device For Bonding Textile Fibers By Means Of Hot Gases,"In a device for bonding web-shaped textile products by means of hot gases, in particular for bonding a nonwoven fabric that has thermally fusible fibers and/or filaments, comprising",['Munstermann Ullrich'],0,uspto,"['linguistics', 'world wide web', 'information technology', 'optical fibers', 'internet', 'portable device', 'sensors', 'search engines', 'web page', 'web information', 'portable equipment']",Ullrich congenital muscular dystrophy,"['Device', 'Textile', 'Fibers', 'Hot', 'Gases']","['device', 'web', 'textile', 'products', 'means', 'hot', 'gases', 'particular', 'nonwoven', 'fabric', 'fusible', 'fibers', 'filaments', 'comprising']"
186,186,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140116/2014-03/US/2014/0018/365/A1/US20140018365A1.pdf,PHARMACEUTICALLY ACTIVE COMPOUNDS AS AXL INHIBITORS,"The present invention relates to 1-nitrogen-heterocyclic-2-carboxamides and/or pharmaceutically acceptable salts thereof, the use of these derivatives as pharmaceutically active agents, especially for the treatment and/or prevention of Axl receptor tyrosine kinase subfamily induced disorders, including cancer and primary tumor metastases, and pharmaceutical compositions containing at least one of said 1-nitrogen-heterocyclic-2-carboxamide derivatives and/or pharmaceutically acceptable salts thereof.","['Schultz-Fademrecht Carsten', 'Klebl Bert', 'Choidas Axel', 'Koch Uwe', 'Eickhoff Jan', 'Wolf Alexander', 'Ullrich Axel']",0,uspto,"['artificial intelligence', 'software agents', 'intelligent agents', 'multiagent system', 'autonomous agents']",Ullrich congenital muscular dystrophy,['INHIBITORS'],"['present', 'invention', 'heterocyclic-2-carboxamides', 'acceptable', 'salts', 'use', 'derivatives', 'active', 'agents', 'treatment', 'prevention', 'receptor', 'tyrosine', 'kinase', 'induced', 'disorders', 'cancer', 'primary', 'tumor', 'metastases', 'pharmaceutical', 'compositions', 'heterocyclic-2-carboxamide', 'derivatives', 'acceptable', 'salts']"
187,187,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140116/2014-03/US/2014/0019/794/A1/US20140019794A1.pdf,Counter Based Clock Distribution in a Distributed System With Multiple Clock Domains Over a Switched Fabric,"System and method for synchronizing devices. A device reads a first counter coupled to and associated with a master clock and a second counter coupled to and associated with the device, where the device is one of one or more devices coupled to the master clock and each other via a switched fabric, where each device includes a respective clock, and is coupled to and associated with a respective second counter. Each of the first counter and the second counters is accessible by each of the one or more devices. The device determines a difference between the device's associated second counter and the first counter, and determines and stores a time reference for the device relative to the master clock based on the determined difference, where the time reference is useable to timestamp events or synchronize future events.","['Chandhoke Sundeep', 'Mohrmann Lee E.', 'Ullrich Adam C.', 'Greenstreet Rodney D.']",0,uspto,"['jitter', 'clock distribution', 'portable equipment', 'portable device', 'electric clocks', 'reference clock', 'distributed computer systems', 'clock signal', 'timing circuits', 'distributed systems']",Ullrich congenital muscular dystrophy,"['System', 'Domains', 'Switched']","['System', 'method', 'devices', 'device', 'first', 'counter', 'master', 'clock', 'second', 'counter', 'device', 'device', 'more', 'devices', 'master', 'clock', 'other', 'fabric', 'device', 'respective', 'clock', 'respective', 'second', 'counter', 'first', 'counter', 'second', 'counters', 'accessible', 'more', 'devices', 'device', 'difference', 'device', 'second', 'counter', 'first', 'counter', 'determines', 'stores', 'time', 'reference', 'device', 'relative', 'master', 'clock', 'determined', 'difference', 'time', 'reference', 'useable', 'timestamp', 'events', 'future', 'events']"
188,188,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140123/2014-04/US/2014/0024/295/A1/US20140024295A1.pdf,FLUID JET RECEIVING RECEPTACLES AND RELATED FLUID JET CUTTING SYSTEMS AND METHODS,"A jet receiving receptacle is provided which is coupleable to a high-pressure fluid jet system opposite a nozzle thereof to receive a fluid jet discharged from the nozzle after it acts on a workpiece. The jet receiving receptacle may include an elongated inlet alignable with a direction of travel of the nozzle to receive the fluid jet in a deflected state. The jet receiving receptacle may further include a jet deflection device positioned downstream of the elongated inlet to redirect at least a portion of the fluid jet and a jet rebound device located upstream of the jet deflection device to be impinged on by the redirected portion of the fluid jet. The jet deflection device and jet rebound device may form, in combination with a housing, a device to trap the fluid jet. Fluid jet cutting systems incorporating a jet receiving receptacle and related methods are also provided.","['Hashish Mohamed A.', 'Ullrich Eckhardt R.', 'Knaupp Michael', 'Craigen Steven J.', 'Brown Charles M.', 'Schuman Bruce M.']",0,uspto,"['machining centers', 'viscous flow', 'computer aided manufacturing', 'machining', 'non-newtonian fluids', 'portable device', 'portable equipment']",Ullrich congenital muscular dystrophy,"['FLUID', 'JET', 'JET', 'CUTTING', 'METHODS']","['jet', 'receiving', 'receptacle', 'coupleable', 'high', 'pressure', 'fluid', 'jet', 'system', 'nozzle', 'fluid', 'jet', 'nozzle', 'workpiece', 'jet', 'receiving', 'receptacle', 'elongated', 'inlet', 'alignable', 'direction', 'travel', 'nozzle', 'fluid', 'jet', 'deflected', 'state', 'jet', 'receiving', 'receptacle', 'jet', 'deflection', 'device', 'elongated', 'inlet', 'least', 'portion', 'fluid', 'jet', 'jet', 'rebound', 'device', 'upstream', 'jet', 'deflection', 'device', 'portion', 'fluid', 'jet', 'jet', 'deflection', 'device', 'jet', 'rebound', 'device', 'combination', 'housing', 'device', 'fluid', 'jet', 'Fluid', 'jet', 'cutting', 'systems', 'jet', 'receiving', 'receptacle', 'related', 'methods']"
189,189,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140130/2014-05/US/2014/0030/310/A1/US20140030310A1.pdf,IMPLANT AND METHOD FOR MANUFACTURING SAME,"The present invention relates to a method for manufacturing an implant, in particular an intraluminal endoprosthesis, having a body containing metallic material, preferably iron. The following manufacturing method is provided for promotion of the anti-inflammatory effect of the implant: (i) providing the body of the implant; (ii) producing an at least partially closed pore structure in a portion of the structure of the implant body close to the surface; and (iii) incorporating NOinto the cavities of the pore structure. Also described is an implant manufactured in this manner.","['Bayer Ullrich', 'Harder Claus', 'Burean Elisabeta']",0,uspto,"['crystal whiskers', 'flexible manufacturing systems', 'air holes', 'photonic crystal fibers', 'flexible manufacturing']",Ullrich congenital muscular dystrophy,"['IMPLANT', 'METHOD', 'MANUFACTURING', 'SAME']","['present', 'invention', 'method', 'implant', 'particular', 'intraluminal', 'endoprosthesis', 'body', 'metallic', 'material', 'iron', 'manufacturing', 'method', 'promotion', 'anti', '-', 'inflammatory', 'effect', 'implant', 'body', 'implant', 'least', 'pore', 'structure', 'portion', 'structure', 'implant', 'body', 'surface', 'cavities', 'pore', 'structure', 'implant', 'manner']"
190,190,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140130/2014-05/US/2014/0031/942/A1/US20140031942A1.pdf,ENDPLATE-PRESERVING SPINAL IMPLANT HAVING A ROUGHENED SURFACE TOPOGRAPHY,"An interbody spinal implant including a body having a top surface, a bottom surface, opposing lateral sides, opposing anterior and posterior portions, a substantially hollow center, and single vertical aperture, as well as an integration plate having a roughened surface topography on its top surface.","['Ullrich', 'JR. Peter F.', 'Patterson Chad J.']",0,uspto,"['machining centers', 'large aperture', 'subsurface structures', 'ground penetrating radar systems', 'optical testing', 'machined surface', 'optical surfaces', 'cutting forces']",Ullrich congenital muscular dystrophy,"['ENDPLATE', 'PRESERVING', 'SPINAL', 'IMPLANT', 'ROUGHENED', 'SURFACE', 'TOPOGRAPHY']","['interbody', 'spinal', 'implant', 'body', 'top', 'surface', 'bottom', 'surface', 'lateral', 'sides', 'anterior', 'posterior', 'portions', 'hollow', 'center', 'single', 'vertical', 'aperture', 'integration', 'plate', 'surface', 'topography', 'top', 'surface']"
191,191,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140213/2014-07/US/2014/0046/449/A1/US20140046449A1.pdf,SPINAL IMPLANT AND INTEGRATION PLATE FOR OPTIMIZING VERTEBRAL ENDPLATE CONTACT LOAD-BEARING EDGES,"An interbody spinal implant including a body and an integration plate having a top surface, a bottom surface, opposing lateral sides, opposing anterior and posterior portions, and a substantially hollow center in communication with a vertical aperture. The body is recessed in a way that portions of the integration plate protrude above the top and/or bottom surface of the body to enhance the resistance of the implant to expulsion from the intervertebral space.","['Ullrich', 'JR. Peter F.', 'Patterson Chad J.']",0,uspto,"['electronic commerce', 'communication', 'edge crossing', 'contracts', 'information technology', 'optimization', 'computer network', 'graph drawing', 'drawing (graphics)', 'wireless communications', 'mathematics']",Ullrich congenital muscular dystrophy,"['SPINAL', 'IMPLANT', 'INTEGRATION', 'PLATE', 'VERTEBRAL', 'ENDPLATE', 'EDGES']","['interbody', 'spinal', 'implant', 'body', 'integration', 'plate', 'top', 'surface', 'bottom', 'surface', 'lateral', 'sides', 'anterior', 'posterior', 'portions', 'hollow', 'center', 'communication', 'vertical', 'aperture', 'body', 'way', 'portions', 'integration', 'plate', 'protrude', 'top', 'bottom', 'surface', 'body', 'resistance', 'implant', 'expulsion', 'intervertebral', 'space']"
192,192,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140220/2014-08/US/2014/0048/435/A1/US20140048435A1.pdf,"Assemblies, Systems and Methods for the Transportation and Display of Plants and Flowers","A system for efficient transportation and display of plants or flowers has been designed that contains two or more trays and a container. The first tray and alternative tray house the plants or flowers. The second tray, in which the first tray and alternative tray nest, allows for easy movement of the first tray, the alternative tray and the supply of water or nutrients. The container is designed to serve two functions, shipping and displaying.",['Ullrich Peter'],0,uspto,"['logistics', 'image display', 'freight transportation', 'correlation analysis', 'image analysis', 'display system', 'display devices']",Ullrich congenital muscular dystrophy,['Flowers'],"['system', 'efficient', 'transportation', 'display', 'plants', 'flowers', 'more', 'trays', 'container', 'first', 'tray', 'alternative', 'tray', 'house', 'plants', 'flowers', 'second', 'tray', 'first', 'tray', 'alternative', 'tray', 'nest', 'easy', 'movement', 'first', 'tray', 'alternative', 'tray', 'supply', 'water', 'nutrients', 'container', 'functions', 'shipping', 'displaying']"
193,193,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140227/2014-09/US/2014/0055/358/A1/US20140055358A1.pdf,CONTEXT-DEPENDENT HAPTIC CONFIRMATION SYSTEM,"A haptic confirmation system is provided that produces a confirmation haptic effect in response to a user interaction with a user interface element, where the confirmation haptic effect is based on context metadata. The context metadata is mapped to one or more haptic parameters. A haptic signal is generated based on the one or more haptic parameters. The haptic signal is sent to an actuator configured to receive the haptic signal. The actuator utilized the haptic signal to generate the confirmation haptic effect.","['BIRNBAUM David', 'Ullrich Christopher J.', 'Bothsa Marcus Aurelius']",0,uspto,"['haptic devices', 'tactile feedback', 'robotics', 'force feedback', 'haptic interactions', 'haptic sensation', 'mobile devices', 'virtual reality', 'human computer interaction', 'haptic interfaces', 'user interfaces', 'feedback systems', 'haptics', 'haptic feedbacks', 'remote control', 'haptic display', 'human engineering', 'display devices']",Ullrich congenital muscular dystrophy,"['CONFIRMATION', 'SYSTEM']","['haptic', 'confirmation', 'system', 'confirmation', 'haptic', 'effect', 'response', 'user', 'interaction', 'user', 'interface', 'element', 'confirmation', 'haptic', 'effect', 'context', 'metadata', 'context', 'metadata', 'more', 'haptic', 'parameters', 'haptic', 'signal', 'more', 'haptic', 'parameters', 'haptic', 'signal', 'actuator', 'haptic', 'signal', 'actuator', 'haptic', 'signal', 'confirmation', 'haptic', 'effect']"
194,194,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140306/2014-10/US/2014/0060/537/A1/US20140060537A1.pdf,DEVICE FOR THE MECHANICAL RESPIRATION OF A PATIENT AND PROCESS FOR THE HYGIENIC PROCESSING THEREOF,"A device () for the mechanical respiration of a patient () has a gas delivery device (), which includes a flow module () for generating a gas stream (A), a gas outlet () and a gas inlet (). The device () includes a gas-carrying short-circuiting unit (), by which the gas outlet () and the gas inlet () can be coupled with one another to short-circuit the gas delivery device (), and a plasma generator () coupled into the short-circuited gas delivery device () for enriching the gas stream (A) generated in the short-circuited gas delivery device () with a disinfecting plasma.","['HANSMANN Hans-Ullrich', 'RIECKE Michael', 'SCHNAARS Henryk']",0,uspto,"['integrated circuit testing', 'stream data', 'data stream', 'flip flop circuits', 'electric network analysis', 'database systems', 'machine design', 'data mining', 'portable equipment', 'mechanical systems', 'portable device', 'logic design', 'data communication systems', 'logic gates']",Ullrich congenital muscular dystrophy,"['DEVICE', 'RESPIRATION', 'PROCESSING', 'THEREOF']","['device', 'mechanical', 'respiration', 'patient', 'gas', 'delivery', 'device', 'flow', 'module', 'gas', 'stream', 'A', 'gas', 'outlet', 'gas', 'inlet', 'device', 'gas', 'short', 'unit', 'gas', 'outlet', 'gas', 'inlet', 'short', 'circuit', 'gas', 'delivery', 'device', 'plasma', 'generator', 'gas', 'delivery', 'device', 'gas', 'stream', 'A', 'gas', 'delivery', 'device', 'plasma']"
195,195,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140306/2014-10/US/2014/0062/682/A1/US20140062682A1.pdf,SYSTEM FOR HAPTICALLY REPRESENTING SENSOR INPUT,A haptic representation system is provided that generates a haptic effect in response to sensor input. The sensor input is mapped to a haptic signal. The haptic signal is sent to an actuator configured to receive the haptic signal. The actuator utilizes the haptic signal to generate the haptic effect.,"['BIRNBAUM David', 'ULLRICH Christopher J.', 'GRANT Danny', 'MODARRES Ali', 'CRUZ-HERNANDEZ Juan Manuel']",0,uspto,"['force feedback', 'haptic sensation', 'virtual reality', 'haptic interfaces', 'user interfaces', 'sensors', 'haptics', 'haptic feedbacks', 'remote control', 'computer hardware']",Ullrich congenital muscular dystrophy,"['SYSTEM', 'HAPTICALLY', 'REPRESENTING', 'SENSOR', 'INPUT']","['haptic', 'representation', 'system', 'haptic', 'effect', 'response', 'input', 'sensor', 'input', 'haptic', 'signal', 'haptic', 'signal', 'actuator', 'haptic', 'signal', 'actuator', 'haptic', 'signal', 'haptic', 'effect']"
196,196,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140306/2014-10/US/2014/0062/809/A1/US20140062809A1.pdf,ANTENNA ARRAY IN A MOTOR VEHICLE,"An antenna array for a motor vehicle has at least one seal which is composed of a non-conductive material and has an antenna which is mounted in the region of a sealing face of the seal and has the purpose of receiving radio signals. A convertible roof or sun roof or some other metallic vehicle part which is part of the antenna array can be positioned against the sealing face during the operation of the antenna and removed again. The antenna forms, with the metallic vehicle part which bears against the seal, the slot antenna which is effective between at least two metal faces. On the other hand, in the state in which no vehicle part bears against the seal, the antenna forms a flat electrical reception monopole which extends at a distance from a metal face which forms the antenna ground.","['Jeschke Markus', 'Ullrich Christoph', 'Gerlemann Eckhard', 'Koehler Mareen']",0,uspto,"['antenna grounds', 'radio', 'signal to noise ratio', 'radio signals', 'microstrip antennas', 'monopole antennas', 'communication channels (information theory)', 'conductive materials', 'radio transmission', 'antenna arrays', 'radio broadcasting', 'radio waves', 'electromagnetic wave scattering', 'matrix algebra', 'slot antennas', 'monopole', 'antennas', 'wireless telecommunication systems']",Ullrich congenital muscular dystrophy,['VEHICLE'],"['antenna', 'array', 'motor', 'vehicle', 'seal', 'non', '-', 'conductive', 'material', 'antenna', 'region', 'face', 'seal', 'purpose', 'radio', 'signals', 'convertible', 'roof', 'sun', 'roof', 'other', 'metallic', 'vehicle', 'part', 'part', 'antenna', 'array', 'sealing', 'face', 'operation', 'antenna', 'antenna', 'forms', 'metallic', 'vehicle', 'part', 'seal', 'slot', 'antenna', 'effective', 'metal', 'faces', 'other', 'hand', 'state', 'vehicle', 'part', 'seal', 'antenna', 'flat', 'electrical', 'reception', 'monopole', 'distance', 'metal', 'face', 'antenna', 'ground']"
197,197,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140306/2014-10/US/2014/0064/516/A1/US20140064516A1.pdf,SOUND TO HAPTIC EFFECT CONVERSION SYSTEM USING MAPPING,"A haptic conversion system is provided that intercepts audio data, such as a digital audio signal, analyzes the audio data in frequency, and divides the analyzed audio data into one or more audio frequency regions, where each audio frequency region includes one or more audio sub-signals. The haptic conversion system further maps the one or more audio frequency regions to one or more haptic frequency regions, where each haptic frequency region includes one or more haptic signals. The haptic conversion system further maps the one or more haptic effects to one or more actuators. The haptic conversion system further sends the one or more haptic signals to one or more actuators, in order to generate one or more haptic effects.","['CRUZ-HERNANDEZ Juan Manuel', 'ULLRICH Christopher J.']",0,uspto,"['variable frequency oscillators', 'frequency dividers', 'audio stream', 'phase noise', 'audio data', 'digital audio', 'digital watermarking', 'haptic interfaces', 'signal analysis', 'audio acoustics', 'haptics', 'audio signals', 'audio', 'audio systems']",Ullrich congenital muscular dystrophy,"['SOUND', 'EFFECT', 'CONVERSION', 'MAPPING']","['haptic', 'conversion', 'system', 'intercepts', 'audio', 'data', 'such', 'digital', 'audio', 'signal', 'audio', 'data', 'frequency', 'analyzed', 'audio', 'data', 'more', 'audio', 'frequency', 'regions', 'audio', 'frequency', 'region', 'more', 'audio', 'sub', 'signals', 'haptic', 'conversion', 'system', 'more', 'audio', 'frequency', 'regions', 'haptic', 'frequency', 'regions', 'haptic', 'frequency', 'region', 'haptic', 'signals', 'haptic', 'conversion', 'system', 'haptic', 'effects', 'more', 'actuators', 'haptic', 'conversion', 'system', 'haptic', 'signals', 'more', 'actuators', 'order', 'haptic', 'effects']"
198,198,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140313/2014-11/US/2014/0070/103/A1/US20140070103A1.pdf,Terahertz Imager,A terahertz imager includes an array of pixel circuits. Each pixel circuit has an antenna and a detector. The detector is coupled to differential output terminals of the antenna. A frequency oscillator is configured to generate a frequency signal on an output line. The output line is coupled to an input terminal of the antenna of at least one of the pixel circuits.,"['Sherry Hani', 'Cathelin Andreia', 'Kaiser Andreas', 'Pfeiffer Ullrich', 'Grzyb Janusz', 'Zhao Yan']",0,uspto,"['field programmable gate arrays (fpga)', 'variable frequency oscillators', 'mobile telecommunication systems', 'mobile phones', 'output frequency', 'color images', 'mobile terminal', 'color component', 'antennas', 'logic gates', 'wireless telecommunication systems']",Ullrich congenital muscular dystrophy,[],"['terahertz', 'imager', 'array', 'pixel', 'circuits', 'pixel', 'circuit', 'antenna', 'detector', 'detector', 'output', 'terminals', 'antenna', 'frequency', 'oscillator', 'frequency', 'signal', 'output', 'line', 'output', 'line', 'input', 'terminal', 'antenna', 'pixel', 'circuits']"
199,199,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140313/2014-11/US/2014/0070/893/A1/US20140070893A1.pdf,High Frequency Oscillator,"A frequency oscillator includes a ring oscillator having N inverters coupled in series, where N is an odd integer equal to three or more. A first filter is coupled between an output node of a first of the inverters and an output line of the frequency oscillator. A second filter is coupled between an output node of a second of the inverters and the output line of the frequency oscillator.","['Sherry Hani', 'Kaiser Andreas', 'Pfeiffer Ullrich', 'Cathelin Andreia', 'Grzyb Janusz', 'Zhao Yan']",0,uspto,"['notch filters', 'variable frequency oscillators', 'oscillation frequency', 'bandwidth', 'frequency dividers', 'phase noise', 'fir filters', 'frequencies', 'output frequency']",Ullrich congenital muscular dystrophy,"['High', 'Oscillator']","['frequency', 'oscillator', 'ring', 'oscillator', 'inverters', 'series', 'N', 'odd', 'integer', 'equal', 'more', 'first', 'filter', 'output', 'node', 'first', 'inverters', 'output', 'line', 'frequency', 'oscillator', 'second', 'filter', 'output', 'node', 'second', 'inverters', 'output', 'line', 'frequency', 'oscillator']"
200,200,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140403/2014-14/US/2014/0091/914/A1/US20140091914A1.pdf,Systems And Methods For Mapping Message Contents To Virtual Physical Properties For Vibrotactile Messaging,"Systems and methods for mapping message contents to virtual physical properties for vibrotactile messaging are disclosed. For example, one disclosed method includes the steps of receiving a sensor signal from a sensor, the sensor configured to detect an interaction with a messaging device, determining a virtual physical property of a virtual message object based at least in part on the sensor signal, determining a haptic effect based at least in part on the virtual physical parameter; and generating a haptic signal configured to cause an actuator to output the haptic effect.","['Birnbaum David M.', 'Ullrich Christopher J.', 'Grant Danny']",0,uspto,"['mobile devices', 'mice (computer peripherals)', 'computer hardware', 'virtual spaces', 'virtual reality', 'vibrotactile', 'haptic interfaces', 'sensors', 'haptics', 'human engineering', 'tactile display']",Ullrich congenital muscular dystrophy,"['Systems', 'Properties', 'Messaging']","['Systems', 'methods', 'mapping', 'message', 'contents', 'virtual', 'physical', 'properties', 'vibrotactile', 'messaging', 'example', 'method', 'steps', 'sensor', 'signal', 'sensor', 'sensor', 'interaction', 'messaging', 'device', 'virtual', 'physical', 'property', 'virtual', 'message', 'object', 'least', 'part', 'sensor', 'signal', 'haptic', 'effect', 'least', 'part', 'virtual', 'physical', 'parameter', 'haptic', 'signal', 'actuator', 'haptic', 'effect']"
201,201,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140403/2014-14/US/2014/0094/921/A1/US20140094921A1.pdf,IMPLANTS WITH SELF-DEPLOYING ANCHORS,"A spinal implant having a top surface, a bottom surface, opposing lateral sides, and opposing anterior and posterior portions. At least one of the top surface and bottom surface has a roughened surface topography, without sharp teeth that risk damage to bone structures, adapted to grip bone through friction generated when the implant is placed between two vertebrae and to inhibit migration of the implant. At least one of the top surface and the bottom surface also includes at least one self-deploying anchor having an expulsion tab and a bone-engaging tip that causes the implant to resist expulsion once the expulsion tab is deployed.","['Patterson Chad J.', 'Ullrich', 'JR. Peter F.']",0,uspto,"['machining centers', 'anchor nodes', 'damage detection', 'subsurface structures', 'ground penetrating radar systems', 'optical testing', 'structural damages', 'localization algorithm', 'machined surface', 'optical surfaces', 'structural health monitoring', 'hybrid sensors', 'cutting forces']",Ullrich congenital muscular dystrophy,['ANCHORS'],"['spinal', 'implant', 'top', 'surface', 'bottom', 'surface', 'lateral', 'sides', 'anterior', 'posterior', 'portions', 'least', 'top', 'surface', 'bottom', 'surface', 'surface', 'topography', 'sharp', 'teeth', 'damage', 'bone', 'structures', 'grip', 'bone', 'friction', 'implant', 'vertebrae', 'migration', 'implant', 'least', 'top', 'surface', 'bottom', 'surface', 'self', 'anchor', 'expulsion', 'tab', 'bone', 'tip', 'implant', 'expulsion', 'expulsion', 'tab']"
202,202,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140410/2014-15/US/2014/0100/662/A1/US20140100662A1.pdf,EXPANDABLE SPINAL IMPLANT WITH EXPANSION WEDGE AND ANCHOR,"An interbody spinal implant system includes an implant having separate, but joined top and bottom portions, a socket for receiving an expansion wedge, an expansion wedge, and an anchor pin.","['Patterson Chad J.', 'Ullrich', 'JR. Peter F.']",0,uspto,[],Ullrich congenital muscular dystrophy,"['EXPANDABLE', 'SPINAL', 'IMPLANT', 'EXPANSION', 'WEDGE']","['interbody', 'spinal', 'implant', 'system', 'implant', 'separate', 'top', 'bottom', 'portions', 'socket', 'expansion', 'wedge', 'expansion', 'wedge', 'anchor', 'pin']"
203,203,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140417/2014-16/US/2014/0104/162/A1/US20140104162A1.pdf,Systems And Methods For Transmitting Haptic Messages,"Systems and methods for transmitting haptic messages are disclosed. For example, one disclosed method includes the steps of: receiving at least one sensor signal from at least one sensor of a mobile device, the at least one sensor signal associated with a movement of the mobile device, determining a message to be displayed in a user interface based at least in part on the at least one sensor signal, and causing the message to be displayed.","['Birnbaum David', 'Ullrich Chris', 'Rubin Peter', 'Ngo Phong David', 'Kopelow Leo']",0,uspto,"['mobile devices', 'mobile telecommunication systems', 'mobile computing', 'mobile phones', 'human computer interaction', 'haptic interfaces', 'user interfaces', 'sensors', 'haptics', 'mobile terminal', 'computer hardware']",Ullrich congenital muscular dystrophy,"['Systems', 'Haptic', 'Messages']","['Systems', 'methods', 'haptic', 'messages', 'example', 'method', 'steps', 'sensor', 'signal', 'sensor', 'mobile', 'device', 'sensor', 'signal', 'movement', 'mobile', 'device', 'message', 'user', 'interface', 'least', 'part', 'sensor', 'signal', 'message']"
204,204,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140417/2014-16/US/2014/0104/165/A1/US20140104165A1.pdf,SYSTEM AND METHOD FOR DISPLAY OF MULTIPLE DATA CHANNELS ON A SINGLE HAPTIC DISPLAY,"A system that produces a haptic effect and generates a drive signal that includes at least two haptic effect signals each having a priority level. The haptic effect is a combination of the haptic effect signals and priority levels. The haptic effect may optionally be a combination of the two haptic effect signals if the priority levels are the same, otherwise only the haptic effect signal with the highest priority is used. The frequency of haptic notifications may also be used to generate a drive signal using foreground and background haptic effect channels depending on whether the frequency ratio exceeds a foreground haptic effect threshold.","['Birnbaum David', 'Ullrich Chris', 'Short Jason', 'Devenish Ryan']",0,uspto,"['force feedback', 'haptic sensation', 'control channels', 'data channels', 'feedback systems', 'robotics', 'mobile devices', 'haptic interactions', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'display devices', 'haptic devices', 'virtual reality', 'remote control', 'haptic display', 'tactile feedback', 'user interfaces', 'display system', 'haptics']",Ullrich congenital muscular dystrophy,"['SYSTEM', 'METHOD', 'DISPLAY', 'CHANNELS', 'SINGLE', 'HAPTIC', 'DISPLAY']","['system', 'haptic', 'effect', 'drive', 'signal', 'haptic', 'effect', 'priority', 'level', 'haptic', 'effect', 'combination', 'haptic', 'effect', 'signals', 'priority', 'levels', 'haptic', 'effect', 'combination', 'haptic', 'effect', 'signals', 'priority', 'levels', 'same', 'haptic', 'effect', 'signal', 'highest', 'priority', 'frequency', 'haptic', 'notifications', 'drive', 'signal', 'foreground', 'haptic', 'effect', 'channels', 'frequency', 'ratio', 'foreground', 'haptic', 'effect', 'threshold']"
205,205,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140424/2014-17/US/2014/0110/994/A1/US20140110994A1.pdf,METHOD FOR OPERATING A BRAKING SYSTEM,"The invention relates to a method for operating a braking system, including a brake booster, which is divided into at least one vacuum chamber and at least one working chamber by at least one movable partition, wherein at least one vacuum chamber is connected, or can be connected, to a vacuum source for creating a vacuum, and further including at least one sensor, which detects at least one variable such as travel and/or angle and/or force of a brake pedal actuation and/or a brake pressure that is built up in at least one main brake cylinder connected to the brake booster in accordance with a brake pedal actuation. According to the invention, the remaining vacuum in at least one vacuum chamber is estimated on the basis of at least one of the detected variables by considering actuations already performed. The invention further relates to a braking system and to the use thereof.","['Gruber Steffen', 'Ullrich Thorsten', 'Ross Scott', 'Peichl Thomas']",0,uspto,"['clutch', 'infrared detectors', 'single sensor', 'vehicle suspensions', 'infra-red sensor', 'clutches', 'sensors', 'multi-sensor', 'computer hardware', 'suspension system']",Ullrich congenital muscular dystrophy,"['METHOD', 'BRAKING', 'SYSTEM']","['invention', 'method', 'system', 'brake', 'booster', 'vacuum', 'chamber', 'chamber', 'movable', 'partition', 'vacuum', 'chamber', 'vacuum', 'source', 'vacuum', 'sensor', 'variable', 'such', 'travel', 'angle', 'force', 'brake', 'pedal', 'actuation', 'brake', 'pressure', 'main', 'brake', 'cylinder', 'brake', 'booster', 'accordance', 'brake', 'pedal', 'actuation', 'invention', 'vacuum', 'vacuum', 'chamber', 'basis', 'detected', 'variables', 'actuations', 'invention', 'system', 'use']"
206,206,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140424/2014-17/US/2014/0113/049/A1/US20140113049A1.pdf,PROCESS FOR MAKING LOW-CALORIE CONFECTIONARY PRODUCT AND CONFECTIONARY PRODUCT,"The present invention relates to a process for producing a confectionery product comprising the step of admixing a structured liquid comprising a thermodynamically stable mixture of water, surfactant, co-surfactant and a non-aqueous component.","['Loeser Ulrich', 'Fischer Gunther', 'Paggios Konstantinos', 'Klemmer Hige F.M.', 'Schetzberg Sabine', 'Strey Reingard', 'Seyller Milena', 'Ullrich Frank']",0,uspto,"['computer aided design', 'product design', 'gaussians', 'component', 'gaussian distribution', 'software']",Ullrich congenital muscular dystrophy,"['PROCESS', 'PRODUCT', 'PRODUCT']","['present', 'invention', 'process', 'confectionery', 'product', 'step', 'structured', 'liquid', 'stable', 'mixture', 'water', 'surfactant', 'co', '-', 'surfactant', 'non', '-', 'aqueous', 'component']"
207,207,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140424/2014-17/US/2014/0114/421/A1/US20140114421A1.pdf,INTERBODY SPINAL IMPLANT HAVING A ROUGHENED SURFACE TOPOGRAPHY,"An interbody spinal implant including a body having a top surface, a bottom surface, opposing lateral sides, opposing anterior and posterior portions, a substantially hollow center, and a single vertical aperture. The single vertical aperture extends from the top surface to the bottom surface, has a size and shape predetermined to maximize the surface area of the top surface and the bottom surface available proximate the anterior and posterior portions while maximizing both radiographic visualization and access to the substantially hollow center, and defines a transverse rim.","['Ullrich', 'JR. Peter F.', 'Patterson Chad J.', 'Schneider Jennifer M.']",0,uspto,"['machining centers', 'subsurface structures', 'large aperture', 'ground penetrating radar systems', 'visualization', 'optical testing', 'human computer interaction', 'machined surface', 'optical surfaces', 'cutting forces']",Ullrich congenital muscular dystrophy,"['SPINAL', 'IMPLANT', 'ROUGHENED', 'SURFACE', 'TOPOGRAPHY']","['interbody', 'spinal', 'implant', 'body', 'top', 'surface', 'bottom', 'surface', 'lateral', 'sides', 'anterior', 'posterior', 'portions', 'hollow', 'center', 'single', 'vertical', 'aperture', 'single', 'vertical', 'aperture', 'top', 'surface', 'bottom', 'surface', 'size', 'shape', 'surface', 'area', 'top', 'surface', 'bottom', 'surface', 'available', 'anterior', 'posterior', 'portions', 'radiographic', 'visualization', 'access', 'hollow', 'center', 'transverse', 'rim']"
208,208,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140508/2014-19/US/2014/0125/467/A1/US20140125467A1.pdf,ENCODING DYNAMIC HAPTIC EFFECTS,"A system is provided that encodes one or more dynamic haptic effects. The system defines a dynamic haptic effect as including a plurality of key frames, where each key frame includes an interpolant value and a corresponding haptic effect. An interpolant value is a value that specifies where an interpolation occurs. The system generates a haptic effect file, and stores the dynamic haptic effect within the haptic effect file.","['DA COSTA Henry', 'AN Feng Tian', 'Ullrich Christopher J.']",0,uspto,"['force feedback', 'haptic sensation', 'feedback systems', 'robotics', 'mobile devices', 'haptic interactions', 'frames', 'haptic interfaces', 'haptic feedbacks', 'human engineering', 'display devices', 'haptic devices', 'key frames', 'virtual reality', 'visual communication', 'remote control', 'haptic display', 'tactile feedback', 'structural frames', 'user interfaces', 'haptics']",Ullrich congenital muscular dystrophy,"['ENCODING', 'DYNAMIC', 'HAPTIC', 'EFFECTS']","['system', 'encodes', 'dynamic', 'haptic', 'effects', 'system', 'dynamic', 'haptic', 'effect', 'plurality', 'key', 'frames', 'key', 'frame', 'interpolant', 'value', 'corresponding', 'haptic', 'effect', 'interpolant', 'value', 'value', 'interpolation', 'system', 'haptic', 'effect', 'file', 'dynamic', 'haptic', 'effect', 'haptic', 'effect', 'file']"
209,209,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140508/2014-19/US/2014/0125/490/A1/US20140125490A1.pdf,Electrical Powered Weight and Fullness Level System,"A collection apparatus weight and fullness level reporting system includes: an inlet; a removable collection bin receiving material placed into the collection apparatus; a compacting mechanism including a ram body, wherein the ram body travels between a home position located above the collection bin to a maximum travel position located inside the collection bin, wherein during each compaction cycle the ram body travels along a variable length of the compaction path; a fullness-reporting module that determines the height of the material in the collection bin; and a controller that determines the length of the compaction path the ram body travels during each compaction cycle based on the input received from the fullness reporting module, wherein at the end of each compaction cycle in which the material height is below a maximum height, the ram body is brought to rest at a height below the home position.","['Ullrich Julie Ann', 'Ullrich Thomas Albert']",0,uspto,"['target tracking', 'robotics', 'single path', 'multi path routing', 'target position', 'planar graph', 'routing algorithms', 'cycle', 'routing scheme', 'random access storage', 'random access memory', 'routing protocols']",Ullrich congenital muscular dystrophy,['Electrical'],"['collection', 'apparatus', 'weight', 'fullness', 'level', 'reporting', 'system', 'inlet', 'removable', 'collection', 'bin', 'material', 'collection', 'apparatus', 'mechanism', 'ram', 'body', 'ram', 'body', 'home', 'position', 'collection', 'bin', 'maximum', 'travel', 'position', 'collection', 'bin', 'compaction', 'cycle', 'ram', 'body', 'variable', 'length', 'compaction', 'path', 'fullness', 'reporting', 'module', 'height', 'material', 'collection', 'bin', 'controller', 'length', 'compaction', 'path', 'ram', 'body', 'compaction', 'cycle', 'input', 'fullness', 'reporting', 'module', 'end', 'compaction', 'cycle', 'material', 'height', 'maximum', 'height', 'ram', 'body', 'height', 'home', 'position']"
210,210,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140515/2014-20/US/2014/0135/569/A1/US20140135569A1.pdf,INCUBATOR WITH COATED INCUBATOR HOOD,"An incubator () includes an incubator hood () with two side walls (), a front wall (), a rear wall () and preferably an upper wall (), which have each inner and outer surfaces. One or more of the inner and/or outer surfaces of one or more of the walls () of the incubator hood are provided with a coating. The coating is electrically conductive and essentially optically transparent. The electrical conductivity of the coating is designed to heat the coated walls, similarly to a resistance heater, to a desired temperature by applying an electric voltage in order to prevent thereby water of condensation from forming. The coating is essentially scratch resistant.","['HANSMANN Hans-Ullrich', 'RIECKE Michael', 'SCHNAARS Henryk']",0,uspto,"['electric power', 'energy harvesting', 'electricity', 'conductive materials', 'electrically conductive', 'electrical energy']",Ullrich congenital muscular dystrophy,['COATED'],"['incubator', 'incubator', 'hood', 'side', 'walls', 'front', 'wall', 'rear', 'wall', 'upper', 'wall', 'inner', 'outer', 'surfaces', 'more', 'inner', 'outer', 'surfaces', 'more', 'walls', 'incubator', 'hood', 'coating', 'coating', 'conductive', 'transparent', 'electrical', 'conductivity', 'coating', 'coated', 'walls', 'resistance', 'heater', 'temperature', 'electric', 'voltage', 'order', 'water', 'condensation', 'coating', 'resistant']"
211,211,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140522/2014-21/US/2014/0137/405/A1/US20140137405A1.pdf,METHOD FOR THE PRODUCTION OF A PISTON FOR AN INTERNAL COMBUSTION ENGINE,"A method for producing piston for an internal combustion engine which has a piston head that has a circumferential cooling channel as well as a combustion bowl having a circumferential bowl wall that makes a transition into a piston crown by way of a bowl edge region. The combustion bowl is formed at least in part by a piston base body and the bowl wall is formed at least in part from an insert. The insert is connected with the piston base body by means of beam welding. A lower weld. seam is configured in the bowl wall, which seam encloses an acute angle with the piston center axis (M) and ends in the lower half of the cooling channel. An upper weld seam runs from the cooling channel ceiling to the piston crown and is disposed centered or radially offset toward the outside, with reference to the clear width of the cooling channel.","['SCHARP Rainer', 'KEMNITZ Peter', 'ULLRICH Michael']",0,uspto,"['fading (radio)', 'formatting', 'engine pistons', 'engine cylinders', 'radio transmission', 'engineering', 'internal combustion', 'radio channels', 'insert', 'antennas', 'internal combustion engines', 'engine']",Ullrich congenital muscular dystrophy,"['METHOD', 'PRODUCTION', 'PISTON']","['method', 'piston', 'internal', 'combustion', 'engine', 'piston', 'head', 'circumferential', 'channel', 'combustion', 'bowl', 'circumferential', 'bowl', 'wall', 'transition', 'piston', 'crown', 'way', 'bowl', 'edge', 'region', 'combustion', 'bowl', 'least', 'part', 'piston', 'base', 'body', 'bowl', 'wall', 'least', 'part', 'insert', 'insert', 'piston', 'base', 'body', 'means', 'beam', 'welding', 'lower', 'weld', 'seam', 'bowl', 'wall', 'seam', 'acute', 'angle', 'piston', 'center', 'axis', 'lower', 'half', 'channel', 'upper', 'weld', 'seam', 'runs', 'channel', 'ceiling', 'piston', 'crown', 'outside', 'reference', 'clear', 'width', 'channel']"
212,212,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140522/2014-21/US/2014/0138/174/A1/US20140138174A1.pdf,DRIVE DEVICE FOR AN ELECTRIC BICYCLE,"A drive device for an electric bicycle, contains a drive housing in which a hollow shaft is mounted, which is connected to a chain wheel of a chain transmission of an electric bicycle, a pedal crank shaft which is arranged coaxially with respect to the hollow shaft and is connected at both ends to pedal cranks, a first clutch which is shifted depending on the rotation direction and which is arranged between the hollow shaft and the pedal crank shaft, and an electric motor whose output is connected to the hollow shaft via a second clutch which is shifted depending on the rotation direction. The hollow shaft can be coupled to the pedal crank shaft in both rotation directions of the pedal crank shaft.","['Getta Udo', 'Noack Ullrich', 'Fleischmann Karl-Heinz']",0,uspto,"['clutch', 'electric power', 'energy harvesting', 'image retrieval', 'electricity', 'discrete cosine transforms', 'gear', 'portable device', 'clutches', 'gears', 'gear teeth', 'portable equipment', 'electrical energy']",Ullrich congenital muscular dystrophy,['DEVICE'],"['drive', 'device', 'electric', 'bicycle', 'drive', 'housing', 'hollow', 'shaft', 'chain', 'wheel', 'chain', 'transmission', 'electric', 'bicycle', 'pedal', 'crank', 'shaft', 'respect', 'hollow', 'shaft', 'ends', 'cranks', 'first', 'clutch', 'rotation', 'direction', 'hollow', 'shaft', 'pedal', 'crank', 'shaft', 'electric', 'motor', 'output', 'hollow', 'shaft', 'second', 'clutch', 'rotation', 'direction', 'hollow', 'shaft', 'pedal', 'crank', 'shaft', 'rotation', 'directions', 'pedal', 'crank', 'shaft']"
213,213,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140529/2014-22/US/2014/0144/163/A1/US20140144163A1.pdf,AIRCRAFT AIR CONDITIONING SYSTEM AND METHOD OF OPERATING AN AIRCRAFT AIR CONDITIONING SYSTEM,"An aircraft air conditioning system comprises an ambient supply line, an ambient air cooling device connected to the ambient air supply line and adapted to cool ambient air flowing through the ambient air supply line, an ambient air discharge line connected to the ambient air cooling device and being connectable to an aircraft cabin to supply ambient air cooled by the ambient air cooling device to the aircraft cabin, and a refrigerating apparatus. The refrigerating apparatus comprises a refrigerant circuit allowing the flow of a two-phase refrigerant therethrough and is designed to convert the two-phase refrigerant, upon flowing through the refrigerant circuit, from the liquid state of aggregation into the gaseous state of aggregation and thereafter again back from the gaseous state of aggregation into the liquid state of aggregation. The refrigerant circuit of the refrigerating apparatus is adapted to supply cooling energy to the ambient air cooling device.","['Klimpel Frank', 'Golle Steffen', 'Hesse Ullrich']",0,uspto,"['air conditioners', 'integrated circuit testing', 'field programmable gate arrays (fpga)', 'domestic appliances', 'flip flop circuits', 'electric network analysis', 'portable equipment', 'energy conservation', 'portable device', 'logic design', 'energy utilization', 'logic gates']",Ullrich congenital muscular dystrophy,"['CONDITIONING', 'AIRCRAFT', 'CONDITIONING', 'SYSTEM']","['aircraft', 'air', 'conditioning', 'system', 'ambient', 'supply', 'line', 'ambient', 'air', 'device', 'ambient', 'air', 'supply', 'line', 'cool', 'ambient', 'air', 'ambient', 'air', 'supply', 'line', 'ambient', 'air', 'discharge', 'line', 'ambient', 'air', 'device', 'connectable', 'aircraft', 'cabin', 'ambient', 'air', 'ambient', 'air', 'device', 'aircraft', 'cabin', 'apparatus', 'apparatus', 'refrigerant', 'circuit', 'flow', 'phase', 'refrigerant', 'therethrough', 'phase', 'refrigerant', 'refrigerant', 'circuit', 'liquid', 'state', 'aggregation', 'gaseous', 'state', 'aggregation', 'gaseous', 'state', 'aggregation', 'liquid', 'state', 'aggregation', 'refrigerant', 'circuit', 'apparatus', 'energy', 'ambient', 'air', 'device']"
214,214,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140605/2014-23/US/2014/0151/179/A1/US20140151179A1.pdf,Torque Limiting Clutch,"Apparatus directed to the art of disengaging an input from an output at predetermined torque values. A torque limiting clutch capable of use as a solid drive unit and a torque limited unit for which the torque disengagement value is selectable. The torque limiting clutch has an overload assembly and a torque drive mechanism which may comprise a plurality of drive pins. Additionally, the torque limiting clutch may comprise seals to discourage contaminants from entering the clutch.","['Greuel Billy', 'ULLRICH BRANDON', 'ALHO TIMOTHY']",0,uspto,"['clutch', 'image retrieval', 'motion control', 'discrete cosine transforms', 'gear', 'clutches', 'manipulators', 'torque control', 'gears', 'gear teeth']",Ullrich congenital muscular dystrophy,['Clutch'],"['art', 'input', 'output', 'predetermined', 'torque', 'values', 'torque', 'clutch', 'capable', 'use', 'solid', 'drive', 'unit', 'torque', 'limited', 'unit', 'torque', 'disengagement', 'value', 'selectable', 'torque', 'clutch', 'overload', 'assembly', 'torque', 'drive', 'mechanism', 'plurality', 'drive', 'pins', 'torque', 'clutch', 'seals', 'contaminants', 'clutch']"
215,215,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140605/2014-23/US/2014/0151/768/A1/US20140151768A1.pdf,TERAHERTZ IMAGER WITH DETECTION CIRCUIT,"A pixel circuit including: a differential detection circuit having first and second transistors coupled in series between differential output nodes of an antenna, the antenna being configured to be sensitive to terahertz radiation, and wherein: a first main conducting node of the first transistor is coupled to a first of the differential output nodes of the antenna; and a first main conducting node of the second transistor is coupled to a second of said differential output nodes of the antenna, wherein second main conducting nodes of the first and second transistors are formed by a common semiconductor region.","['Pfeiffer Ullrich', 'Sherry Hani', 'Cathelin Andreia']",0,uspto,"['ad hoc networks', 'wireless sensor networks', 'gateway nodes', 'phase shift keying', 'source nodes', 'wireless telecommunication systems', 'differential detection', 'signal receivers', 'gateways (computer networks)', 'rayleigh fading', 'antennas', 'detection algorithm', 'routing protocols', 'signal detection']",Ullrich congenital muscular dystrophy,"['TERAHERTZ', 'IMAGER', 'DETECTION', 'CIRCUIT']","['pixel', 'circuit', 'differential', 'detection', 'circuit', 'first', 'second', 'transistors', 'series', 'differential', 'output', 'nodes', 'antenna', 'antenna', 'sensitive', 'terahertz', 'radiation', 'first', 'main', 'conducting', 'node', 'first', 'transistor', 'first', 'differential', 'output', 'nodes', 'antenna', 'first', 'main', 'conducting', 'node', 'second', 'transistor', 'second', 'differential', 'output', 'nodes', 'antenna', 'second', 'main', 'nodes', 'first', 'second', 'transistors', 'common', 'semiconductor', 'region']"
216,216,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20140605/2014-23/US/2014/0152/313/A1/US20140152313A1.pdf,BATTERY SENSOR,"The invention relates to a battery sensor for a battery, in particular a motor vehicle battery, with a pole terminal () made out of an electrically conductive material for electric connection of the battery sensor () to a connecting contact of a battery, in particular to a ground contact of the battery, as well as with a low-ohm current-sense resistor for measuring a battery current with which the battery is discharged or charged. The battery sensor according to the invention further includes a plurality of tongues (-) arranged apart from the pole terminal () for mechanical mounting of the current-sense resistor () on the pole terminal (). (FIG. )",['HETZLER Ullrich'],0,uspto,"['single sensor', 'insulating materials', 'conductive materials', 'electromagnetic wave scattering', 'vehicles', 'insulating layers', 'engineering', 'sensors', 'multi-sensor', 'electrically conductive', 'computer hardware']",Ullrich congenital muscular dystrophy,"['BATTERY', 'SENSOR']","['invention', 'battery', 'sensor', 'battery', 'particular', 'motor', 'vehicle', 'battery', 'pole', 'terminal', 'conductive', 'material', 'electric', 'connection', 'battery', 'sensor', 'contact', 'battery', 'particular', 'ground', 'contact', 'battery', 'low', 'ohm', 'current', 'sense', 'resistor', 'battery', 'current', 'battery', 'battery', 'sensor', 'invention', 'plurality', 'tongues', 'pole', 'terminal', 'mechanical', 'mounting', 'current', 'sense', 'resistor', 'pole', 'terminal']"
217,217,https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=8759409,Physician-Level Aggregated Classifier for Genetic Muscle Disorders,"Muscle histopathology is the one of the most important diagnostic methods in the diagnosis of muscle diseases [1]. Nevertheless, it is a highly specialized field and only a limited number of experts are available in the world. Not surprisingly, significant number of cases are undiagnosed in underserved areas. We therefore intended to establish a computer-aided diagnostic system which should be helpful in this domain. This study aims to develop a multi-class classifier with deep learning for computer-aided muscle histopathological diagnosis. We chose five genetic muscle disease categories (dystrophinopathy, limb-girdle muscular dystrophy 2A (LGMD2A), limb-girdle muscular dystrophy 2B (LGMD2B), Ullrich congenital muscular dystrophy (UCMD), and Fukuyama-type congenital muscular dystrophy (FCMD)) as targets and aimed to distinguish between these diseases. We developed a new classifier, which we call the aggregated classifier, that improves the classification accuracy of existing classifiers to deal with histopathological images. The classifier achieved better classification accuracy than not only the existing classifier but also eight physicians who have been trained for muscle histopathology for variable duration. This result suggests that causative genes may possibly be precisely predicted only by hematoxylin-eosin (H&E) stained images without genetic testing.","['Yoshinori Kabeya', 'Toshiya Iwamori', 'Sho Yonezawa', 'Yusuke Takeuchi', 'Hiroki Nakano', 'Yuhe Nagisa', 'Mariko Okubo', 'Michio Inoue', 'Reitaro Tokumasu', 'Issei Ozawa', 'Atsushi Takano', 'Ichizo Nishino']","['Muscles', 'Diseases', 'Genetics', 'Training', 'Neural networks', 'Biomedical imaging']",ieeexplore,"['medical images', 'image processing', 'computer-aided diagnosis system', 'binary classification', 'neural networks', 'classifiers', 'multi-class classifier', 'computer aided diagnosis', 'machine learning', 'image analysis', 'learning', 'education', 'bioinformatics', 'deep learning', 'multi-class classification']",Ullrich congenital muscular dystrophy,[],"['Muscle', 'histopathology', 'important', 'diagnostic', 'methods', 'diagnosis', 'muscle', 'diseases', 'specialized', 'field', 'limited', 'number', 'experts', 'available', 'world', 'significant', 'number', 'cases', 'undiagnosed', 'underserved', 'areas', 'computer', 'diagnostic', 'system', 'helpful', 'domain', 'study', 'multi', '-', 'class', 'classifier', 'deep', 'learning', 'computer', 'muscle', 'histopathological', 'diagnosis', 'genetic', 'muscle', 'disease', 'categories', 'dystrophinopathy', 'limb', 'girdle', 'muscular', 'dystrophy', 'limb', 'girdle', 'muscular', 'dystrophy', 'congenital', 'muscular', 'dystrophy', 'type', 'congenital', 'muscular', 'dystrophy', 'targets', 'diseases', 'new', 'classifier', 'aggregated', 'classifier', 'classification', 'accuracy', 'classifiers', 'histopathological', 'images', 'classifier', 'better', 'classification', 'accuracy', 'classifier', 'physicians', 'muscle', 'histopathology', 'variable', 'duration', 'result', 'causative', 'genes', 'hematoxylin', 'images', 'genetic', 'testing']"
218,218,https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=9433942,Texture Analysis Of T1-Weighted Turbo Spin-Echo Mri For The Diagnosis And Follow-Up Of Collagen Vi-Related Myopathy,"Muscle texture analysis in Magnetic Resonance Imaging (MRI) has revealed a good correlation with typical histological changes resulting from neuromuscular disorders. In this research, we assess the effectiveness of several features in describing intramuscular texture alterations in cases of Collagen VI-related myopathy. A T1-weighted Turbo Spin-Echo MRI dataset was used $(\mathrm{N}_{subj}\,=26)$, consisting of thigh scans from subjects diagnosed with Ullrich Congenital Muscular Dystrophy or Bethlem Myopathy, with different severity levels, as well as healthy subjects. A total of 355 texture features were studied, including attributes derived from the Gray-Level Co-occurrence Matrix, the Run-Length Matrix, Wavelet and Gabor filters. The extracted features were ranked using the Support Vector Machine Recursive Feature Elimination (SVM-RFE) algorithm with Correlation Bias Reduction, prior to cross-validated classification with a Gaussian kernel SVM.","['Rafael Rodrigues', 'Marta G√≥mez-Garc√≠a de la Banda', 'Mickael Tordjman', 'David G√≥mez-Andr√©s', 'Susana Quijano-Roy', 'Robert-Yves Carlier', 'Antonio M. G. Pinheiro']","['Support vector machines', 'Correlation', 'Neuromuscular', 'Magnetic resonance imaging', 'Thigh', 'Feature extraction', 'Classification algorithms']",ieeexplore,"['svm', 'support vector', 'gaussians', 'gaussian distribution', 'classifiers', 'model checking', 'gabor filter', 'face recognition', 'gaussian kernels', 'spin', 'wavelet', 'support vector machine', 'wavelet transforms']",Ullrich congenital muscular dystrophy,['Up'],"['Muscle', 'texture', 'analysis', 'good', 'correlation', 'typical', 'histological', 'changes', 'neuromuscular', 'disorders', 'research', 'effectiveness', 'several', 'features', 'intramuscular', 'texture', 'alterations', 'cases', 'myopathy', 'T1-weighted', 'dataset', 'thigh', 'scans', 'subjects', 'different', 'severity', 'levels', 'healthy', 'subjects', 'total', 'texture', 'features', 'attributes', '-', 'occurrence', 'filters', 'features', 'Elimination', 'algorithm', 'cross', '-', 'validated', 'classification', 'Gaussian', 'kernel']"
219,219,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100443362&origin=inward,Understanding top managers‚Äô careers: How does career variety impact tenure on the board?,"¬© 2020 Elsevier LtdCareer variety has recently received attention in management literature in general, and top management literature in particular. While existing publications have predominantly linked career variety to individual adaptability, agility or competences, this paper focuses on the relationship between top managers‚Äô career variety and their tenure on the board. We rely on the boundaryless career approach and argue that there is a negative relationship between career variety and board tenure. Drawing on a sample of executive directors in UK FT 100 firms, we provide empirical evidence that increased career variety leads to shorter tenure on the board. We also reveal that this relationship is further strengthened with international educational experience. In addition, we show that in-house work experience mitigates the negative association between career variety and board tenure. We contribute to the literature on top managers‚Äô careers by unravelling the consequences that career variety during early and mid-stages of a career has on tenure on the board ‚Äì and hence on career stability in later stages of a career.",0,0,scopus,"['agile methods', 'numerical model', 'information technology', 'on-line education', 'information management', 'software development', 'database systems', 'empirical analysis', 'education', 'agile software development', 'online systems', 'distance education']",obsolete JMP syndrome,"['top', 'managers', 'careers', 'career', 'variety', 'impact', 'tenure', 'board']","['variety', 'attention', 'management', 'literature', 'general', 'top', 'management', 'literature', 'particular', 'publications', 'career', 'variety', 'individual', 'adaptability', 'agility', 'competences', 'paper', 'relationship', 'top', 'managers', 'career', 'variety', 'tenure', 'board', 'boundaryless', 'career', 'approach', 'negative', 'relationship', 'career', 'variety', 'board', 'tenure', 'sample', 'executive', 'directors', 'firms', 'empirical', 'evidence', 'career', 'variety', 'shorter', 'tenure', 'board', 'relationship', 'international', 'educational', 'experience', 'addition', 'house', 'work', 'experience', 'negative', 'association', 'career', 'variety', 'board', 'tenure', 'literature', 'top', 'managers', 'careers', 'consequences', 'career', 'variety', 'early', 'mid', '-', 'stages', 'career', 'tenure', 'board', 'career', 'stability', 'later', 'stages', 'career']"
220,220,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85045359748&origin=inward,Evolution science and ethics in the third millennium: Challenges and choices for humankind,"¬© Springer International Publishing AG 2018. All rights reserved.The book aims to revitalise the interdisciplinary debate about evolutionary ethics and substantiate the idea that evolution science can provide a rational and robust framework for understanding morality. It also traces pathways for knowledge-based choices to be made about directions for future long-term biological evolution and cultural development in view of adaptation to the expected, probable and possible future and the ecological sustainability of our planetary environment The authors discuss ethical challenges associated with the major biosocial sources of human variation: individual variation, inter-personal variation, inter-group variation, and inter-generational variation. This book approaches the long-term challenges of the human species in a holistic way. Researchers will find an extensive discussion of the key theoretical scientific aspects of the relationship between evolution and morality. Policy makers will find information that can help them better understand from where we are coming and inspire them to make choices and take actions in a longer-term perspective. The general public will find food for thoughts.",0,0,scopus,"['software architecture', 'viewpoint', 'social sciences', 'evolutionary process', 'evolutionary algorithms', 'education', 'design decisions', 'sociology', 'architectural knowledge']",obsolete JMP syndrome,"['Evolution', 'science', 'ethics', 'third', 'millennium', 'Challenges', 'choices', 'humankind']","['rights', 'book', 'interdisciplinary', 'debate', 'evolutionary', 'ethics', 'idea', 'evolution', 'science', 'rational', 'robust', 'framework', 'morality', 'pathways', 'knowledge', 'choices', 'directions', 'future', 'long', 'term', 'biological', 'evolution', 'cultural', 'development', 'view', 'adaptation', 'probable', 'possible', 'future', 'ecological', 'sustainability', 'planetary', 'environment', 'authors', 'ethical', 'challenges', 'major', 'biosocial', 'sources', 'human', 'variation', 'individual', 'variation', 'inter', '-', 'personal', 'variation', 'inter', '-', 'group', 'variation', 'inter', '-', 'generational', 'variation', 'book', 'long', 'term', 'challenges', 'human', 'species', 'holistic', 'way', 'Researchers', 'extensive', 'discussion', 'key', 'theoretical', 'scientific', 'aspects', 'relationship', 'evolution', 'morality', 'Policy', 'makers', 'information', 'choices', 'actions', 'longer', 'term', 'perspective', 'general', 'public', 'food', 'thoughts']"
221,221,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101522416&origin=inward,"Disease Entities, Negative Causes, Multifactoriality, and the Naturalness of Disease Classifications. Remarks on Some Philosophical Misperceptions of Medical Pathology","¬© 2018, Springer International Publishing AG, part of Springer Nature.In twentieth and twenty-first century medicine, the concept of disease entity has proven to be of key importance for pathology and the theory of diseases. Disease entities are kinds of complex clinical and etiopathogenetic processes that are triggered by specific primary causes and develop on anatomical, physiological, clinical and subjectively experienced levels. They are distinguished from healthy states of life by definite criteria of pathologicity. This paper sketches the prehistory as well as the central features of the current paradigm of disease entities. Since the 1970s, philosophical theories of disease tend to ignore or, at best, reject this concept. By examining the well-respected theories of H. Tristram Engelhardt, Jr. (The concepts of health and disease. In: Engelhardt HT, Spicker SF (eds) Evaluation and explanation in the biomedical sciences. Reidel, Dordrecht, pp 125‚Äì141, 1975 ff.), and Caroline Whitbeck (Philos Sci 44:619‚Äì637, 1977), it is shown that this defensive attitude results from a philosophical misconception of the concept. Engelhardt criticizes the concept of disease entity on account of historically obsolete, substantialistic or quasi-platonistic (essentialistic) interpretations of the concept. He erroneously assumes that explanations using this concept are inconsistent with explanations by laws of physiology. Caroline Whitbeck correctly refers to the modern, scientific version of the concept. But in her opinion, the concept ‚Äúcause of disease‚Äù is defined according to certain ‚Äúinstrumental interests‚Äù that may differ between subjects and is, thus, neither objective nor unique and unequivocal. Hence, the concept of disease entity is ambiguous and not suited for establishing a unique, unambiguous, and unequivocal natural classification of diseases. It is shown that Whitbeck‚Äôs objections rest upon misconceptions concerning the concept of ‚Äúprimary cause‚Äù resp. ‚Äúetiological factor‚Äù and of the so-called ‚Äúmulti-factorial‚Äù causation. By reference to a careful, medically and philosophically correct reconstruction of these concepts, it is shown that her objections do not apply.",0,0,scopus,"['hidden markov model (hmm)', 'computer systems', 'speech synthesis', 'hidden markov models (hmm)', 'hidden markov models', 'classification methods', 'social sciences', 'reconstruction', 'hidden markov models (hmms)', 'classification models', 'speech communication', 'synthesized speech', 'image reconstruction', 'sociology']",obsolete JMP syndrome,['Remarks'],"['part', 'twentieth', 'first', 'century', 'medicine', 'concept', 'disease', 'entity', 'key', 'importance', 'pathology', 'theory', 'diseases', 'entities', 'kinds', 'complex', 'clinical', 'etiopathogenetic', 'processes', 'specific', 'primary', 'causes', 'anatomical', 'physiological', 'clinical', 'experienced', 'levels', 'healthy', 'states', 'life', 'definite', 'criteria', 'pathologicity', 'paper', 'prehistory', 'central', 'features', 'current', 'paradigm', 'disease', 'entities', '1970s', 'philosophical', 'theories', 'disease', 'concept', 'theories', 'concepts', 'health', 'disease', 'eds', 'Evaluation', 'explanation', 'biomedical', 'sciences', 'ff', 'defensive', 'attitude', 'philosophical', 'misconception', 'concept', 'Engelhardt', 'concept', 'disease', 'entity', 'account', 'obsolete', 'substantialistic', 'quasi', '-', 'platonistic', 'essentialistic', 'interpretations', 'concept', 'explanations', 'concept', 'inconsistent', 'explanations', 'laws', 'physiology', 'modern', 'scientific', 'version', 'concept', 'opinion', 'concept', 'cause', 'disease', 'certain', 'instrumental', 'interests', 'subjects', 'objective', 'unique', 'unequivocal', 'concept', 'disease', 'entity', 'ambiguous', 'unique', 'unambiguous', 'unequivocal', 'natural', 'classification', 'diseases', 'objections', 'misconceptions', 'concept', 'primary', 'cause', 'resp', '‚Äú', 'etiological', 'factor', 'multi', '-', 'factorial', 'causation', 'reference', 'careful', 'correct', 'reconstruction', 'concepts', 'objections']"
222,222,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049612553&origin=inward,Speaking for the dead: Cadavers in biology and medicine,"¬© D. Gareth Jones 2000. All rights reserved.This was first published in 2000: This text explores issues surrounding the use of human cadavers and human tissues in science and medicine. This is an area of increasing significance in contemporary society, as more and more techniques become available for manipulating human genes and human material (including embryos, body organs and brain tissue). These issues are explored through case studies from contemporary society. Some of the most topical issues examined include plastination of human bodies as an art form, the use of biopsies from surgical operations, the ethics of using human DNA and stem cells in research, and the debate surrounding the transplantation of animal tissue and organs into humans.",0,0,scopus,"['information retrieval systems', 'digital rights', 'digital rights management', 'access control', 'text document', 'social sciences', 'security systems', 'text mining', 'access rights', 'sociology', 'rights management']",obsolete JMP syndrome,"['dead', 'Cadavers', 'biology', 'medicine']","['rights', 'text', 'issues', 'use', 'human', 'cadavers', 'human', 'tissues', 'science', 'medicine', 'area', 'significance', 'contemporary', 'society', 'more', 'more', 'techniques', 'available', 'human', 'genes', 'human', 'material', 'embryos', 'body', 'organs', 'brain', 'tissue', 'issues', 'case', 'studies', 'contemporary', 'society', 'topical', 'issues', 'plastination', 'human', 'bodies', 'art', 'form', 'use', 'biopsies', 'surgical', 'operations', 'ethics', 'human', 'DNA', 'stem', 'cells', 'research', 'debate', 'transplantation', 'animal', 'tissue', 'organs', 'humans']"
223,223,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84900118255&origin=inward,Speaking for the dead: The human body in biology and medicine,"Speaking for the Dead is an incisive examination of the highly topical and often controversial issues surrounding the use of human cadavers in scientific research. Fully revised and updated to include recent developments in this area, this new edition incorporates the repeated organ scandals in the UK, body parts scandals in the United States, and the abuses of bodies in China. The book provides new material on neuroimaging, neuroethics and Alzheimer's disease and the major ethical issues they raise for society, in addition to discussing plastination in the form of BodyWorlds types of exhibitions. As human anatomists and bioethicists, the authors offer a unique perspective on these issues, crossing the boundaries between clinical, medical, legal and ethical concerns. Their exploration of both historical and contemporary data results in a clear and comprehensive examination of issues at the forefront of bioethics. With its clear writing style and use of non-technical language Speaking for the Dead will be an essential book for all those interested in bioethics, an area which continues to increase in significance with the development of new techniques for the manipulation of human cadavers. As human anatomists and bioethicists, the authors offer a unique perspective on these issues, crossing the boundaries between clinical, medical, legal and ethical concerns. Their exploration of historical developments as well as their analyses of recent case studies result in a pertinent and comprehensive examination of issues at the forefront of bioethics. ¬© D. Gareth Jones and Maja I. Whitaker 2009. All rights reserved.",0,0,scopus,"['software architecture', 'computer systems', 'integrated data', 'viewpoint', 'data integration', 'correlation analysis', 'information systems', 'optimization problems', 'mathematics']",obsolete JMP syndrome,"['dead', 'human', 'body', 'biology', 'medicine']","['incisive', 'examination', 'topical', 'controversial', 'issues', 'use', 'human', 'cadavers', 'scientific', 'research', 'recent', 'developments', 'area', 'new', 'edition', 'organ', 'scandals', 'body', 'parts', 'scandals', 'abuses', 'bodies', 'book', 'new', 'material', 'neuroimaging', 'neuroethics', 'disease', 'major', 'ethical', 'issues', 'society', 'addition', 'plastination', 'form', 'types', 'exhibitions', 'human', 'anatomists', 'bioethicists', 'authors', 'unique', 'perspective', 'issues', 'boundaries', 'clinical', 'medical', 'legal', 'ethical', 'concerns', 'exploration', 'historical', 'contemporary', 'data', 'results', 'clear', 'comprehensive', 'examination', 'issues', 'forefront', 'bioethics', 'clear', 'writing', 'style', 'use', 'non', '-', 'technical', 'language', 'essential', 'book', 'interested', 'bioethics', 'area', 'significance', 'development', 'new', 'techniques', 'manipulation', 'human', 'cadavers', 'human', 'anatomists', 'bioethicists', 'authors', 'unique', 'perspective', 'issues', 'boundaries', 'clinical', 'medical', 'legal', 'ethical', 'concerns', 'exploration', 'historical', 'developments', 'analyses', 'recent', 'case', 'studies', 'pertinent', 'comprehensive', 'examination', 'issues', 'forefront', 'bioethics', 'rights']"
224,224,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84895329329&origin=inward,Abnormal skeletal phenotypes: From simple signs to complex diagnoses,"This book focuses on the radiographic changes of malformation syndromes and skeletal dysplasias. It is structured such that the reader can identify the radiographic changes and relate them to specific disease entities. The aim is to provide an essential, practical guideline to the recognition of the key radiographic signs for diagnosing malformation syndromes and skeletal dysplasias. The book is intended for radiologists, clinical and medical geneticists, and pediatricians. The material is divided into two parts. The first part is structured in a symptom-oriented form and describes approximately 200 radiographic signs, providing information about their incidence, anatomic location, diagnostic relevance, pathogenesis, and pattern of inheritance, if applicable. The second part presents about 100 syndromes and skeletal dysplasias and provides analytical information concerning symptoms, genetics, causes, radiographic appearance, and major differential diagnosis. ¬© Springer-Verlag Berlin Heidelberg, 2005. All rights are reserved.",0,0,scopus,"['user information', 'location based', 'object tracking', 'recognition algorithm', 'character recognition', 'recommender systems', 'face recognition', 'pattern recognition', 'object appearance', 'personal information', 'location based services']",obsolete Saldino-Noonan syndrome,"['Abnormal', 'skeletal', 'phenotypes', 'simple', 'signs', 'complex', 'diagnoses']","['book', 'radiographic', 'changes', 'malformation', 'syndromes', 'skeletal', 'dysplasias', 'such', 'reader', 'radiographic', 'changes', 'specific', 'disease', 'entities', 'aim', 'essential', 'practical', 'guideline', 'recognition', 'key', 'radiographic', 'signs', 'malformation', 'syndromes', 'skeletal', 'dysplasias', 'book', 'radiologists', 'clinical', 'medical', 'geneticists', 'pediatricians', 'material', 'parts', 'first', 'part', 'symptom', 'form', 'radiographic', 'signs', 'information', 'incidence', 'anatomic', 'location', 'diagnostic', 'relevance', 'pathogenesis', 'pattern', 'inheritance', 'applicable', 'second', 'part', 'syndromes', 'skeletal', 'dysplasias', 'analytical', 'information', 'symptoms', 'genetics', 'causes', 'radiographic', 'appearance', 'major', 'differential', 'diagnosis', 'rights']"
225,225,http://dialog.proquest.com/professional/docview/596761540?accountid=173210,AFP gene expression and antigenic protein localization in the cells of hepatocellular carcinoma and its surrounding tissues,"Using a double immunoenzymatic technique (PAP) and AFPcDNA-RNA in situ hybridization technique, we detected and analyzed the AFP gene expression and antigenic protein localization in hepatocellular carcinoma (HCC) and its surrounding tissues. The results demonstrated that AFP was truly synthesized again by some host liver cells around the cancer nodules. We considered that the cells which showed AFPmRNA positive hybridized signs might be a kind of preneoplastic cells. Their appearance might be related to injury caused by HBV infection and the inactivities of the inhibited gene on the AFP control mechanism. The substances secreted by the involved cancer cells, might be another causative factor for the excessive expression of the AFP in the liver cells near the cancer.","['Dai, Y M']","['Adolescent', 'Adult', 'Carcinoma, Hepatocellular', 'Child', 'Female', 'Gene Expression', 'Genes', 'Humans', 'Immunochemistry', 'Liver', 'Liver Neoplasms', 'Male', 'Middle Aged', 'RNA, Messenger', 'alpha-Fetoproteins']",ProQuest,"['target tracking', 'object tracking', 'localization system', 'wireless sensor networks', 'localization technique', 'localization algorithm', 'robot applications', 'sensor networks', 'object appearance', 'target localization']",liver carcinoma in situ,"['gene', 'expression', 'antigenic', 'protein', 'localization', 'cells', 'hepatocellular', 'carcinoma', 'tissues']","['double', 'immunoenzymatic', 'technique', 'RNA', 'situ', 'hybridization', 'technique', 'gene', 'expression', 'antigenic', 'protein', 'localization', 'hepatocellular', 'carcinoma', 'tissues', 'results', 'host', 'liver', 'cells', 'cancer', 'nodules', 'cells', 'positive', 'hybridized', 'signs', 'kind', 'preneoplastic', 'cells', 'appearance', 'injury', 'infection', 'inactivities', 'inhibited', 'gene', 'control', 'mechanism', 'substances', 'involved', 'cancer', 'cells', 'causative', 'factor', 'excessive', 'expression', 'liver', 'cells', 'cancer']"
226,226,http://dialog.proquest.com/professional/docview/596749331?accountid=173210,Detection of HBV DNA in hepatocellular carcinoma by in situ hybridization using a biotin-labelled probe,"Eight cases of hepatocellular carcinoma were hybridized in situ with a biotin-labelled HBV DNA probe on formalin fixed paraffin embedded sections. HBV DNA was detected in 218 cases both in cancer and pericancerous tissue of the liver, and both carcinomas were well differentiated. In three cases, HBV DNA was only present in pericancerous tissue and no HBV DNA could be identified in the remaining three cases. The positive rate of HBV DNA was 25% in tumor and 62.5% in the pericancerous area of liver. HBcAg was negative in all the eight tumors, nevertheless, HBsAg was present in one case. Both HBsAg and HBcAg were positive in the peri-cancerous tissue of liver in 6 out of 8 cases. In the remaining two, one was only HBsAg positive while the other was HBcAg positive. HBV DNA was identified mainly in the cytoplasm of tumor cells. In certain cells it was seen in the perinuclear cytoplasm or beneath the nuclear envelope. Only in a few cells, HBV DNA was distributed in the nuclei diffusely. Since HBV DNA was present both in the cytoplasm and nuclei, suggesting that HBV DNA was present in either integrated or free forms.","['Chen, M L']","['Adult', 'Aged', 'Blotting, Southern', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'DNA Probes', 'DNA, Viral', 'Hepatitis B virus', 'Humans', 'Liver Neoplasms', 'Liver Neoplasms', 'Male', 'Middle Aged', 'Nucleic Acid Hybridization']",ProQuest,"['embedded', 'embedded software', 'security of data', 'signal detection', 'malwares', 'malicious codes', 'computer viruses', 'detection algorithm', 'intrusion detection']",liver carcinoma in situ,"['Detection', 'hepatocellular', 'carcinoma', 'situ', 'hybridization', 'biotin', 'probe']","['cases', 'hepatocellular', 'carcinoma', 'situ', 'biotin', 'DNA', 'probe', 'formalin', 'paraffin', 'sections', 'cases', 'cancer', 'pericancerous', 'tissue', 'liver', 'carcinomas', 'differentiated', 'cases', 'present', 'pericancerous', 'tissue', 'DNA', 'cases', 'positive', 'rate', '%', 'tumor', '%', 'pericancerous', 'area', 'liver', 'negative', 'tumors', 'present', 'case', 'positive', 'peri', 'cancerous', 'tissue', 'liver', 'cases', 'positive', 'other', 'positive', 'cytoplasm', 'tumor', 'cells', 'certain', 'cells', 'perinuclear', 'cytoplasm', 'nuclear', 'envelope', 'few', 'cells', 'nuclei', 'present', 'cytoplasm', 'nuclei', 'present', 'free', 'forms']"
227,227,http://dialog.proquest.com/professional/docview/596242749?accountid=173210,Expression of c-myc oncogene in colorectal polyps as a biological marker for monitoring malignant potential,"The expression of oncogenes (c-myc, c-fos, c-Ki-ras, c-Ha-ras, and p53) was examined by Northern blot analysis using freshly isolated human colorectal and gastric cancers and noncancerous portions as the controls. Remarkably high levels of c-myc expression were found in colorectal cancers (eight of 11), but not in gastric cancers. High levels of c-myc expression were also detected in colorectal polyps and in metastatic liver tumors. In colorectal polyps, the transcript levels significantly correlated with the histologic malignancy and the size. In contrast, neither c-fos nor c-Ki-ras was overexpressed in colorectal and gastric cancers, and transcripts of c-Ha-ras and p53 were not evident in any tissue examined. In light of these observations the c-myc expression may be specifically associated with the evolution of colorectal cancer as well as progression and maintenance stages, hence may prove to be a useful marker to evaluate the malignant potential of colorectal polyps.","['Imaseki, H', 'Hayashi, H', 'Taira, M', 'Ito, Y', 'Tabata, Y', 'Onoda, S', 'Isono, K', 'Tatibana, M']","['Adenocarcinoma', 'Adenoma', 'Blotting, Northern', 'Carcinoma in Situ', 'Colonic Polyps', 'Colonic Polyps', 'Colorectal Neoplasms', 'Colorectal Neoplasms', 'Humans', 'Liver Neoplasms', 'Liver Neoplasms', 'Liver Neoplasms', 'Monitoring, Physiologic', 'Neoplasm Staging', 'Oncogenes', 'RNA, Neoplasm', 'Stomach Neoplasms', 'Stomach Neoplasms']",ProQuest,"['maintenance process', 'computer software maintenance', 'evolutionary process', 'correlation analysis', 'evolutionary algorithms', 'remote control', 'remote monitoring', 'mathematics']",liver carcinoma in situ,"['Expression', 'c', 'myc', 'oncogene', 'colorectal', 'polyps', 'biological', 'marker', 'malignant', 'potential']","['expression', 'oncogenes', 'c', 'myc', 'c', 'fos', 'c', 'Ki', 'Ha', 'ras', 'p53', 'Northern', 'blot', 'analysis', 'human', 'colorectal', 'gastric', 'cancers', 'noncancerous', 'portions', 'controls', 'high', 'levels', 'c', 'myc', 'expression', 'colorectal', 'cancers', 'gastric', 'cancers', 'High', 'levels', 'c', 'myc', 'expression', 'colorectal', 'polyps', 'metastatic', 'liver', 'tumors', 'colorectal', 'polyps', 'transcript', 'levels', 'histologic', 'malignancy', 'size', 'contrast', 'c', 'fos', 'c', 'Ki', 'overexpressed', 'colorectal', 'gastric', 'cancers', 'transcripts', 'c', 'Ha', 'ras', 'p53', 'evident', 'tissue', 'light', 'observations', 'c', 'myc', 'expression', 'evolution', 'colorectal', 'cancer', 'progression', 'maintenance', 'stages', 'useful', 'marker', 'malignant', 'potential', 'colorectal', 'polyps']"
228,228,http://dialog.proquest.com/professional/docview/596334060?accountid=173210,Serum and tissue positivity for hepatitis B virus markers in histopathologically proven glomerulonephropathies,"To assess the pathogenic significance of hepatitis B virus (HBV) in glomerulonephritis (GN), 98 patients with histopathologically proven glomerulonephropathies were screened for HBV markers, complement components and levels of circulating immune complexes (CICs); and renal biopsies from 31 of them were examined for the presence of hepatitis B surface antigen (HBsAg), and its location, by immunoperoxidase staining. The HBsAg positive rate in the patients (who came from a population with 10% HBsAg positivity) ranged from 51.9% in minimum change nephrotic syndrome (MCNS) to 81.8% in patients with proliferative glomerulonephritis (PGN). Whereas 24.5% of the cases were positive for HBsAg only, 10.2% had anti-HBcIgM with HBsAg, 13.3% had HBeAg with HBsAg and 9.2% had HBsAg, HBeAg and anti-HBcIgM. Complement component C3 levels were decreased in all groups of GN studied, but C4 levels varied. CIC levels were significantly increased (p less than 0.01) only in HBsAg-positive MCNS, focal glomerulosclerosis (FGS) and membranous glomerulonephritis (MGN). Of the 31 renal biopsies examined for the deposition of HBsAg, 4 (12.9%) were found to be positive for HBsAg in situ; 64.5% of biopsied patients were seropositive for HBsAg and 77.4% had CICs. All the four in-situ HBsAg-positive cases were seropositive for HBsAg, HBeAg and anti-HBcIgM with significantly high CIC levels (p less than 0.01). HBsAg deposition was intracytoplasmic in the mesangial cells of the glomeruli, in the glomerular basement membrane or in the tubules, or in a combination of these sites.","['Thyagarajan, S P', 'Thirunalasundari, T', 'Subramanian, S', 'Panchanadam, M', 'Nammalwar, B R', 'Prabha, V', 'Vijayakumar', 'Jayaraman, M']","['Biopsy', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Glomerulonephritis', 'Glomerulonephritis', 'Hepatitis B', 'Hepatitis B', 'Hepatitis B Core Antigens', 'Hepatitis B Surface Antigens', 'Hepatitis B e Antigens', 'Humans', 'Immunoenzyme Techniques', 'Kidney', 'Kidney', 'Liver Neoplasms', 'Liver Neoplasms']",ProQuest,"['location information', 'component', 'location based', 'ad hoc networks', 'wireless sensor networks', 'location based services', 'telecommunication equipment', 'software', 'security of data', 'malwares', 'malicious codes', 'sensor networks', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['positivity', 'hepatitis', 'virus', 'markers', 'glomerulonephropathies']","['pathogenic', 'significance', 'patients', 'glomerulonephropathies', 'markers', 'complement', 'components', 'levels', 'immune', 'complexes', 'CICs', 'renal', 'biopsies', 'presence', 'surface', 'antigen', 'location', 'immunoperoxidase', 'staining', 'positive', 'rate', 'patients', 'population', '%', 'positivity', '%', 'minimum', 'change', 'nephrotic', 'syndrome', '%', 'patients', 'proliferative', 'glomerulonephritis', '%', 'cases', 'positive', '%', 'anti', '-', '%', '%', 'anti', 'component', 'C3', 'levels', 'groups', 'C4', 'levels', 'levels', 'less', 'positive', 'focal', 'glomerulosclerosis', 'membranous', 'glomerulonephritis', 'renal', 'biopsies', 'deposition', '%', 'positive', 'situ', '%', 'biopsied', 'patients', 'seropositive', '%', 'CICs', 'situ', 'positive', 'cases', 'seropositive', 'anti', '-', 'high', 'levels', 'less', 'deposition', 'intracytoplasmic', 'mesangial', 'cells', 'glomeruli', 'glomerular', 'basement', 'membrane', 'tubules', 'combination', 'sites']"
229,229,http://dialog.proquest.com/professional/docview/596269072?accountid=173210,Two autopsy cases associated with a latent superficial carcinoma of esophagus,"To clarify the histogenesis of squamous cell carcinoma of esophagus, 307 esophagus resected from autopsied cases have been thoroughly examined. These specimens were dyed with Lugol solution and entirely blocked to study subserial sections. Among these specimens, two subclinically superficial squamous cell carcinomas were found. First case uncovered was that of a woman who had died of a carcinoma of uterus. Microscopic examination revealed a small carcinoma in situ, located in the cervical portion of the esophagus, though this lesion showed no associated dysplasia. The other case was that of an old man who had died of a massive hemorrhage from a gastric ulcer, associated with carcinomas of the lip, liver, and prostate. The esophageal lesion was an intramucosal carcinoma located in the mid esophagus that was encountered with moderate dysplasia. These examples are not only quite rare as being multiple primary carcinomas but they also suggest two possible types of cancer development of the esophagus: one that progresses from normal mucosa, and the other from dysplastic mucosa.","['Takiyama, W', 'Moriwaki, S', 'Mandai, K', 'Hara, K', 'Doihara, H', 'Takashima, S']","['Adult', 'Aged', 'Carcinoma in Situ', 'Carcinoma, Hepatocellular', 'Carcinoma, Squamous Cell', 'Esophageal Neoplasms', 'Esophagus', 'Female', 'Humans', 'Lip Neoplasms', 'Liver Neoplasms', 'Male', 'Mucous Membrane', 'Neoplasms, Multiple Primary', 'Prostatic Neoplasms', 'Uterine Neoplasms']",ProQuest,"['fuzzy sets', 'gaussian processes', 'latent variable', 'latent factor', 'correlation analysis', 'latent variable models', 'linear matrix inequalities', 'face recognition', 'illustrative examples', 'facial images', 'matrix factorizations', 'bayesian networks']",liver carcinoma in situ,"['autopsy', 'cases', 'latent', 'superficial', 'carcinoma', 'esophagus']","['histogenesis', 'squamous', 'cell', 'carcinoma', 'esophagus', 'esophagus', 'cases', 'specimens', 'solution', 'subserial', 'sections', 'specimens', 'superficial', 'squamous', 'cell', 'carcinomas', 'First', 'case', 'woman', 'carcinoma', 'uterus', 'Microscopic', 'examination', 'small', 'carcinoma', 'situ', 'cervical', 'portion', 'esophagus', 'lesion', 'associated', 'dysplasia', 'other', 'case', 'old', 'man', 'massive', 'hemorrhage', 'gastric', 'ulcer', 'carcinomas', 'lip', 'liver', 'prostate', 'esophageal', 'lesion', 'intramucosal', 'carcinoma', 'mid', 'esophagus', 'moderate', 'dysplasia', 'examples', 'rare', 'multiple', 'primary', 'carcinomas', 'possible', 'types', 'cancer', 'development', 'esophagus', 'one', 'normal', 'mucosa', 'other', 'dysplastic', 'mucosa']"
230,230,http://dialog.proquest.com/professional/docview/596461796?accountid=173210,"Studies on the gap junctional intercellular communication (GJIC) of human stomach carcinoma cells in comparison with normal cells and the effect of the tumor promoter, TPA","This work was conducted by using a rapid and simple technique, scrape-loading and dye transfer (SLDT) to study GJIC of human stomach carcinoma MGC-803 cells in comparison with normal WB rat liver cells, Chinese hamster V79 cells and a primary culture of chicken embryonic myoblasts. Cells were plated and grown overnight to confluency in 35 mm plastic dishes in appropriate media. Monolayered cells, after rinsing in PBS, were immersed in the mixed 0.05% Lucifer Yellow (MW 457.2) and 0.05% Rhodamine-Dextran (MW. 10,000) in PBS. Scrape loading was performed by utilization of a sharp knife. Cells were incubated in dye solution for an additional 3 min. at room temperature before rinsing with PBS and observation under fluorescent microscope. Cells competent in GJIC showed transfer of Lucifer Yellow from the injured border to interior cells while the high MW. Rhodamine-Dextran dye stayed in situ in the loaded cells. Cells incompetent in GJIC did not show dye transfer; both Lucifer Yellow and Rhodamine-Dtranex were retained in the original loaded cells of the injured border. The background cell monolayer away from the scrape line was dark indicating that none of the dye molecules could permeate through cell membrane in the conditions described. It was found that human stomach carcinoma MGC-803 cells lack GJIC; Chinese hamster V79 cells showed modest GJIC; WB rat liver cells and chick myoblasts showed marked GJIC. The tumor promoter, TPA(1-100 ng/ml), inhibits GJIC of the normal cells efficiently. An inhibitor of calmodulin, Trifluoperazine (TFP) (5-20 microM), evidently increased the GJIC of stomach carcinoma MGC-803 cells. Noteworthy is that TFP in the dosage range used in SLDT experiments showed inhibitory effect on cell growth and DNA synthesis of MGC-803 cells documented in parallel experiments. These results indicate that the lack of GJIC in MGC-803 cells correlates with their uncontrolled cell proliferation; the improvement of GJIC correlates with the inhibition of tumor cell proliferation. TPA inhibition of GJIC in normal cells in this work confirmed previous reports. Interestingly, it was found that when V79 cells were treated with TFP and then shifted to medium containing both TFP and TPA, GJIC was blocked. It is likely that TPA overcomes the effect of TFP on GJIC of MGC-803 cells. These results provide further evidence for the role of GJIC in carcinogenesis, specially the tumor promotion phase.","['Lin, Z X', 'Zhau, Y L', 'Han, Y L', 'Zhang, R F', 'Trosko, J E']","['Adenocarcinoma', 'Animals', 'Cell Communication', 'Cells, Cultured', 'Chick Embryo', 'Cricetinae', 'Humans', 'Intercellular Junctions', 'Rats', 'Stomach Neoplasms', 'Tetradecanoylphorbol Acetate', 'Trifluoperazine', 'Tumor Cells, Cultured']",ProQuest,"['telecommunication networks', 'communication', 'communication protocols', 'multimedia systems', 'digital media', 'computer network', 'communication networks', 'network protocols', 'wireless communications', 'digital storage']",liver carcinoma in situ,"['Studies', 'gap', 'junctional', 'intercellular', 'communication', 'human', 'stomach', 'carcinoma', 'cells', 'comparison', 'normal', 'cells', 'effect', 'tumor', 'promoter']","['work', 'rapid', 'simple', 'technique', 'scrape', 'loading', 'dye', 'transfer', 'GJIC', 'human', 'stomach', 'carcinoma', 'MGC-803', 'cells', 'comparison', 'normal', 'rat', 'liver', 'cells', 'Chinese', 'hamster', 'cells', 'primary', 'culture', 'chicken', 'embryonic', 'myoblasts', 'Cells', 'confluency', 'mm', 'plastic', 'dishes', 'appropriate', 'media', 'Monolayered', 'cells', 'mixed', '%', '%', 'loading', 'utilization', 'sharp', 'knife', 'Cells', 'dye', 'solution', 'additional', 'min', 'room', 'temperature', 'observation', 'fluorescent', 'microscope', 'Cells', 'competent', 'transfer', 'injured', 'border', 'interior', 'cells', 'high', 'dye', 'situ', 'loaded', 'cells', 'Cells', 'incompetent', 'dye', 'transfer', 'original', 'loaded', 'cells', 'injured', 'border', 'background', 'cell', 'monolayer', 'scrape', 'line', 'dark', 'none', 'dye', 'molecules', 'cell', 'membrane', 'conditions', 'human', 'stomach', 'carcinoma', 'MGC-803', 'cells', 'Chinese', 'hamster', 'cells', 'modest', 'rat', 'liver', 'cells', 'chick', 'myoblasts', 'tumor', 'promoter', 'TPA(1', 'ng', 'ml', 'normal', 'cells', 'inhibitor', 'calmodulin', 'TFP', 'GJIC', 'stomach', 'carcinoma', 'MGC-803', 'cells', 'TFP', 'dosage', 'range', 'experiments', 'inhibitory', 'effect', 'cell', 'growth', 'DNA', 'synthesis', 'MGC-803', 'cells', 'parallel', 'experiments', 'results', 'lack', 'MGC-803', 'cells', 'uncontrolled', 'cell', 'proliferation', 'improvement', 'inhibition', 'tumor', 'cell', 'proliferation', 'inhibition', 'normal', 'cells', 'work', 'previous', 'reports', 'cells', 'likely', 'effect', 'TFP', 'MGC-803', 'cells', 'results', 'further', 'evidence', 'role', 'carcinogenesis', 'tumor', 'promotion', 'phase']"
231,231,http://dialog.proquest.com/professional/docview/596106281?accountid=173210,Chromosomal assignment of woodchuck hepatitis virus (WHV) DNA integration sites in a woodchuck hepatocellular carcinoma-derived cell line (WH257GE10),The chromosomal sites of woodchuck hepatitis virus (WHV) DNA integration were identified in a woodchuck hepatocellular carcinoma-derived cell line (WH257GE10) by the in situ hybridization technique using 3H-labelled WHV whole genome (WHV 2) as a probe. The G-banded chromosome spreads from WH257GE10 were identified and diagrammed schematically according to their band patterns. WHV DNA was integrated into 2 sites: 33 region of the long arm of chromosome 6 (6q33) and 31 region of the long arm of chromosome 8 (8q31). Chromosomal sites of WHV DNA integration were stable during successive passage periods analyzed in vitro.,"['Mizuno, Y', 'Murakami, S', 'Matsushita, F', 'Unoura, M', 'Kobayashi, K', 'Migita, S', 'Hattori, N', 'Ohno, S']","['Animals', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Line', 'Chromosome Banding', 'Chromosome Deletion', 'Chromosome Mapping', 'DNA Probes', 'DNA, Viral', 'Genes, Viral', 'Hepatitis Viruses', 'Karyotyping', 'Kidney', 'Liver Neoplasms', 'Liver Neoplasms', 'Liver Neoplasms', 'Male', 'Marmota', 'Nucleic Acid Hybridization', 'Sciuridae']",ProQuest,"['crossover operator', 'frequency bands', 'security of data', 'genetic operators', 'malwares', 'malicious codes', 'evolutionary algorithms', 'antennas', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['Chromosomal', 'assignment', 'woodchuck', 'hepatitis', 'virus', 'DNA', 'integration', 'sites', 'woodchuck', 'hepatocellular', 'carcinoma', 'cell', 'line']","['chromosomal', 'sites', 'woodchuck', 'hepatitis', 'virus', 'DNA', 'integration', 'woodchuck', 'hepatocellular', 'carcinoma', 'cell', 'line', 'situ', 'hybridization', 'technique', '3H', 'whole', 'genome', 'probe', 'G', 'chromosome', 'spreads', 'band', 'patterns', 'sites', 'region', 'long', 'arm', 'chromosome', 'region', 'long', 'arm', 'chromosome', 'Chromosomal', 'sites', 'DNA', 'integration', 'stable', 'successive', 'passage', 'periods', 'vitro']"
232,232,http://dialog.proquest.com/professional/docview/596084403?accountid=173210,Choriocarcinoma and transitional cell carcinoma of the bladder--a case report and review of the clinical evolution of disease in reported cases,"The sixth reported case of choriocarcinoma associated with transitional cell carcinoma (TCC) of the bladder is described. A 67-year-old female presented with haematuria and was found to have a bladder tumour with both poorly differentiated TCC and trophoblastic elements. The tumour was confirmed as being limited to the bladder at laparotomy. The patient was treated with combination chemotherapy but, after an initial response, relapsed and died of disease. Postmortem examination revealed multiple metastatic choriocarcinoma and no TCC. A review of the clinical evolution in the reported cases suggests that transitional cell carcinoma is the cell of origin of these tumours by the process of progressive retrodifferentiation.","['Abratt, R P', 'Temple-Camp, C R', 'Pontin, A R']","['Aged', 'Brain Neoplasms', 'Carcinoma in Situ', 'Carcinoma, Transitional Cell', 'Choriocarcinoma', 'Choriocarcinoma', 'Esophageal Neoplasms', 'Female', 'Humans', 'Kidney Neoplasms', 'Liver Neoplasms', 'Lymphatic Metastasis', 'Neoplasms, Multiple Primary', 'Urinary Bladder Neoplasms', 'Uterine Neoplasms']",ProQuest,"['evolutionary algorithms', 'evolutionary process']",liver carcinoma in situ,"['transitional', 'cell', 'carcinoma', 'bladder', 'case', 'report', 'review', 'clinical', 'evolution', 'disease', 'cases']","['sixth', 'case', 'choriocarcinoma', 'transitional', 'cell', 'carcinoma', 'bladder', '67-year', 'old', 'female', 'haematuria', 'bladder', 'tumour', 'trophoblastic', 'elements', 'tumour', 'bladder', 'laparotomy', 'patient', 'combination', 'chemotherapy', 'initial', 'response', 'disease', 'Postmortem', 'examination', 'multiple', 'metastatic', 'choriocarcinoma', 'review', 'clinical', 'evolution', 'cases', 'transitional', 'cell', 'carcinoma', 'cell', 'origin', 'tumours', 'process', 'progressive', 'retrodifferentiation']"
233,233,http://dialog.proquest.com/professional/docview/596058515?accountid=173210,In vivo expression of two novel tumor-associated antigens and their use in immunolocalization of human hepatocellular carcinoma,"We are investigating the antigenic changes on the cell surface of human hepatocytes that distinguish the normal from the transformed phenotype using monoclonal antibodies. In vivo expression of antigens has been directly assessed by in situ radioimmunohistology. This technique allows one to determine the distribution and density of antigen expression at the individual cellular level on fresh hepatoma and adjacent uninvolved liver tissue. We have found two antigens recognized by monoclonal antibodies XF-8 and AF-20 that are uniformly present on 15/15 hepatocellular carcinomas tested thus far. Most if not all tumor cells highly express these antigens. Such antigens were not evident on adjacent normal liver and the XF-8 epitope was not found on other normal human tissues. AF-20 antigen distribution revealed low-level expression on a subpopulation of cells in the zona glomerulosa of the adrenal gland and on crypt cells of the small intestinal tract. We have studied the capability of radiolabeled XF-8 and AF-20 monoclonal antibodies when administered either alone or in combination to localize a hepatitis B virus-related hepatocellular carcinoma cell line (FOCUS) grown as subcutaneous tumors in nude mice. Biodistribution experiments demonstrated an excellent localization to tumor of 15 to 22% of the injected dose of 125I-labeled antibodies. Indeed, it was possible to enhance the delivery of 125I to the tumor cell surface by the use of XF-8 and AF-20 in combination. Nuclear imaging studies showed sharp visualization of tumor and demonstrate that these monoclonal antibodies have sufficient specificity and sensitivity to be strongly considered as immunotargeting agents.","['Takahashi, H', 'Ozturk, M', 'Wilson, B', 'Maki, A', 'Ozawa, K', 'Koizumi, M', 'Endo, K', 'Strauss, W', 'Shouval, D', 'Wands, J']","['Adenocarcinoma', 'Animals', 'Antibodies, Monoclonal', 'Antigens, Neoplasm', 'Antigens, Surface', 'Autoradiography', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Membrane', 'Humans', 'Liver Neoplasms', 'Liver Neoplasms', 'Liver Neoplasms', 'Mice', 'Mice, Nude', 'Neoplasm Transplantation', 'Tumor Cells, Cultured']",ProQuest,"['cellular telephone systems', 'artificial intelligence', 'wireless', 'cellular radio systems', 'visualization', 'human computer interaction', 'security of data', 'channel capacity', 'cellular network', 'multiagent system', 'cellular system', 'computer viruses', 'cellular']",liver carcinoma in situ,"['vivo', 'expression', 'novel', 'tumor', 'antigens', 'use', 'immunolocalization', 'human', 'hepatocellular', 'carcinoma']","['antigenic', 'changes', 'cell', 'surface', 'human', 'hepatocytes', 'normal', 'transformed', 'phenotype', 'monoclonal', 'antibodies', 'vivo', 'expression', 'antigens', 'situ', 'radioimmunohistology', 'technique', 'distribution', 'density', 'antigen', 'expression', 'individual', 'cellular', 'level', 'fresh', 'hepatoma', 'adjacent', 'uninvolved', 'liver', 'tissue', 'antigens', 'monoclonal', 'antibodies', 'present', 'hepatocellular', 'carcinomas', 'Most', 'tumor', 'antigens', 'Such', 'antigens', 'evident', 'adjacent', 'normal', 'liver', 'epitope', 'other', 'normal', 'human', 'tissues', 'antigen', 'distribution', 'low', 'level', 'expression', 'subpopulation', 'cells', 'zona', 'glomerulosa', 'adrenal', 'gland', 'crypt', 'cells', 'small', 'intestinal', 'tract', 'capability', 'radiolabeled', 'monoclonal', 'antibodies', 'alone', 'combination', 'hepatitis', 'virus', 'hepatocellular', 'carcinoma', 'cell', 'line', 'subcutaneous', 'tumors', 'nude', 'mice', 'Biodistribution', 'experiments', 'excellent', 'localization', 'tumor', '%', 'injected', 'dose', 'antibodies', 'possible', 'delivery', 'tumor', 'cell', 'surface', 'use', 'combination', 'Nuclear', 'imaging', 'studies', 'sharp', 'visualization', 'tumor', 'monoclonal', 'antibodies', 'sufficient', 'specificity', 'sensitivity', 'agents']"
234,234,http://dialog.proquest.com/professional/docview/596108683?accountid=173210,In situ localization of melanotransferrin (melanoma-associated antigen P97) in human liver. A light- and electronmicroscopic immunohistochemical study,"Using an indirect immunoperoxidase technique on frozen sections with the monoclonal antibody 96.5, we investigated the in situ distribution of melanotransferrin, a transferrin (Tf) and transferrin receptor (TfR) related glycoprotein, in human liver. Specimens included normal liver, liver in iron overload, hepatocellular carcinoma, angioma and foetal liver. On light microscopy, immunoreactivity was almost exclusively present on sinusoidal lining cells, apparently endothelial cells; the pattern was similar in normal and in iron-loaded liver. A gradient of more enhanced staining in acinar zone II and III was observed. The endothelial localization of the staining was supported by the positivity of the central vein endothelium and of the angiomas. Immunoelectron microscopy on three liver specimens showed positivity on sinusoidal endothelial cells but not on Ito and Kupffer cells. In addition, positivity on rough endoplasmic reticulum vesicles of some hepatocytes was also present. Four hepatocellular carcinomas showed an intense staining in tumour cells, 3 were weakly positive and 3 were negative. In the foetal livers, the central vein endothelium was positive from 21 weeks of gestation onward and additional positivity of zone III sinusoidal endothelial cells was present from 27 weeks on. The present results show that in the liver melanotransferrin has a localization different from Tf and the TfR. These latter molecules are predominantly localized in parenchymal cells. In addition, there does not appear to be a coordinate regulation secondary to iron storage, between melanotransferrin, Tf and the TfR. The observed gradient in the staining pattern in foetal and adult liver specimens further supports the heterogeneity of the endothelial cell population in the liver and suggests a developmental relationship between endothelial cells of sinusoids and central vein.","['Sciot, R', 'de Vos, R', 'van Eyken, P', 'van der Steen, K', 'Moerman, P', 'Desmet, V J']","['Adult', 'Antigens, Neoplasm', 'Carcinoma, Hepatocellular', 'Endothelium', 'Humans', 'Immunoenzyme Techniques', 'Iron', 'Kupffer Cells', 'Liver', 'Liver', 'Liver', 'Liver Neoplasms', 'Liver Neoplasms', 'Melanoma', 'Melanoma', 'Melanoma-Specific Antigens', 'Neoplasm Proteins', 'Reference Values', 'Skin Neoplasms']",ProQuest,"['target tracking', 'wireless sensor networks', 'localization technique', 'time-frequency distributions', 'time frequency analysis', 'time-frequency representations', 'localization algorithm', 'sensor networks', 'target localization']",liver carcinoma in situ,"['situ', 'localization', 'melanotransferrin', 'melanoma', 'antigen', 'human', 'liver', 'light-', 'immunohistochemical', 'study']","['indirect', 'immunoperoxidase', 'technique', 'frozen', 'sections', 'monoclonal', 'antibody', 'situ', 'distribution', 'melanotransferrin', 'transferrin', 'transferrin', 'receptor', 'glycoprotein', 'human', 'liver', 'normal', 'liver', 'liver', 'iron', 'overload', 'hepatocellular', 'carcinoma', 'angioma', 'foetal', 'liver', 'light', 'microscopy', 'immunoreactivity', 'present', 'sinusoidal', 'lining', 'cells', 'endothelial', 'cells', 'pattern', 'similar', 'normal', 'iron', 'liver', 'gradient', 'staining', 'acinar', 'zone', 'endothelial', 'localization', 'staining', 'positivity', 'central', 'vein', 'endothelium', 'angiomas', 'Immunoelectron', 'microscopy', 'liver', 'specimens', 'positivity', 'sinusoidal', 'endothelial', 'cells', 'cells', 'addition', 'positivity', 'rough', 'endoplasmic', 'reticulum', 'vesicles', 'hepatocytes', 'present', 'hepatocellular', 'carcinomas', 'intense', 'staining', 'tumour', 'cells', 'positive', 'negative', 'foetal', 'livers', 'central', 'vein', 'endothelium', 'positive', 'weeks', 'gestation', 'additional', 'positivity', 'zone', 'sinusoidal', 'endothelial', 'cells', 'present', 'weeks', 'present', 'results', 'liver', 'melanotransferrin', 'localization', 'different', 'TfR.', 'latter', 'molecules', 'parenchymal', 'cells', 'addition', 'coordinate', 'regulation', 'secondary', 'storage', 'melanotransferrin', 'TfR.', 'observed', 'gradient', 'staining', 'pattern', 'foetal', 'adult', 'liver', 'heterogeneity', 'endothelial', 'cell', 'population', 'liver', 'developmental', 'relationship', 'endothelial', 'cells', 'sinusoids', 'central', 'vein']"
235,235,http://dialog.proquest.com/professional/docview/596216813?accountid=173210,Expression of the preproenkephalin A gene in tumor cells and brain glioma: a northern and in situ hybridization study,"Preproenkephalin A (PPA) mRNA expression was studied by Northern blot and in situ hybridization in cell lines (rat glioma C6, rat hepatoma HTC, human neuroblastoma IMR32, mouse neuroblastoma NS20Y, rat fibroblast FR3T3, human bladder carcinoma EJ, human vulva carcinoma A431, myelocytic leukemia HL60, rat adrenal carcinoma Y1) and in brain tumours (implanted C6 cells). C6 glioma in cell culture, as well as in brain tumours, expressed high levels of PPA mRNA as compared to the caudate nucleus of the rat brain. EJ and FR3T3 cell lines also expressed the PPA mRNA, which was not detectable in A431, Y1, NS20Y, IMR32, HTC, HL60 cell lines as well as in the rat liver. This observation provides an interesting model to study the mechanisms by which the malignant transformation can induce in glial cells the derepression of a gene which is usually expressed in neurons or in neuron-like cells.","['Rost, N', 'Chaffanet, M', 'Nissou, M F', 'Chauvin, C', 'Foote, A M', 'Lain√©, M', 'Benabid, A L']","['Animals', 'Blotting, Northern', 'Brain Neoplasms', 'Cell Line', 'DNA Probes', 'Enkephalins', 'Female', 'Glioma', 'Protein Precursors', 'RNA, Messenger', 'Rats', 'Rats, Inbred Strains', 'Transcription, Genetic', 'Tumor Cells, Cultured']",ProQuest,"['hierarchical model', 'hierarchical system']",liver carcinoma in situ,"['Expression', 'preproenkephalin', 'gene', 'tumor', 'cells', 'brain', 'glioma', 'northern', 'situ', 'hybridization', 'study']","['mRNA', 'expression', 'Northern', 'blot', 'situ', 'hybridization', 'cell', 'lines', 'rat', 'glioma', 'C6', 'rat', 'hepatoma', 'human', 'neuroblastoma', 'mouse', 'neuroblastoma', 'NS20Y', 'rat', 'fibroblast', 'human', 'bladder', 'carcinoma', 'human', 'vulva', 'carcinoma', 'A431', 'myelocytic', 'leukemia', 'rat', 'adrenal', 'carcinoma', 'brain', 'tumours', 'cells', 'C6', 'glioma', 'cell', 'culture', 'brain', 'tumours', 'high', 'levels', 'mRNA', 'caudate', 'nucleus', 'rat', 'brain', 'cell', 'lines', 'mRNA', 'detectable', 'NS20Y', 'cell', 'lines', 'rat', 'liver', 'observation', 'interesting', 'model', 'mechanisms', 'malignant', 'transformation', 'glial', 'cells', 'derepression', 'gene', 'neurons', 'neuron', 'like', 'cells']"
236,236,http://dialog.proquest.com/professional/docview/595990964?accountid=173210,Inhibition of murine hepatic tumor growth by liposomes containing a lipophilic muramyl dipeptide,"We have investigated the ability of liposomes containing a lipophilic muramyl dipeptide, N-acetylmuramyl-L-alanyl-D-isoglutamine glycerol dipalmitate (MDP-GDP) to activate Kupffer cell tumoricidal activity in situ and to inhibit the growth of experimental hepatic micrometastases of tumor cell line H-59, a liver-homing variant of the Lewis lung carcinoma. Liposomes prepared from distearoylphosphatidylcholine/dimyristoylphosphatidylglycerol (DSPC/DMPG) and containing MDP-GDP (1 mumol and 2 micrograms, respectively) were efficiently taken up by the liver after i.v. administration. A single i.v. injection of DSPC/DMPG liposomes containing MDP-GDP was capable of inducing Kupffer cell tumoricidal activity against H-59 tumor cells as measured in vitro. Control liposomes or 100 micrograms free MDP were ineffective in inducing Kupffer cell tumoricidal activity in situ. Two treatment regimens were evaluated in vivo: firstly, C57BL/6 mice were injected with tumor cell line H-59 and subsequently treated with multiple injections of liposomal MDP-GDP. Secondly, treatment with liposomal MDP-GDP was initiated prior to tumor cell injection and continued after tumor cell injection. The ability of liposomes containing MDP-GDP to reduce the number of hepatic micrometastases using the first protocol was related to the tumor cell inoculum, significant inhibition being observed at lower liver tumor burdens (less than 25 tumor nodules). Pretreatment of the mice prior to tumor cell challenge followed by treatment afterwards greatly enhanced the efficacy of liposomal MDP-GDP and brought about a highly significant inhibition of the growth of experimental metastases even at high liver tumor burdens (greater than 50 nodules).","['Brodt, P', 'Blore, J', 'Phillips, N C', 'Munzer, J S', 'Rioux, J D']","['Acetylmuramyl-Alanyl-Isoglutamine', 'Acetylmuramyl-Alanyl-Isoglutamine', 'Animals', 'Cell Line', 'Female', 'Growth Inhibitors', 'Kupffer Cells', 'Liposomes', 'Liver Neoplasms, Experimental', 'Liver Neoplasms, Experimental', 'Liver Neoplasms, Experimental', 'Mice', 'Mice, Inbred C57BL', 'Phosphatidylcholines', 'Phosphatidylglycerols', 'Tissue Distribution', 'Triglycerides', 'Tumor Cells, Cultured']",ProQuest,"['value iteration', 'partially observable markov decision process', 'markov processes', 'mdp', 'optimal policies', 'markov decision processes', 'pomdp']",liver carcinoma in situ,"['Inhibition', 'murine', 'hepatic', 'tumor', 'growth', 'liposomes', 'lipophilic', 'muramyl', 'dipeptide']","['ability', 'liposomes', 'lipophilic', 'muramyl', 'dipeptide', 'N', 'acetylmuramyl', 'L', 'alanyl', 'D', 'isoglutamine', 'glycerol', 'dipalmitate', 'cell', 'tumoricidal', 'activity', 'situ', 'growth', 'experimental', 'hepatic', 'micrometastases', 'tumor', 'cell', 'line', 'liver', 'homing', 'variant', 'lung', 'carcinoma', 'Liposomes', 'distearoylphosphatidylcholine', 'dimyristoylphosphatidylglycerol', 'mumol', 'micrograms', 'liver', 'administration', 'single', 'injection', 'liposomes', 'capable', 'cell', 'tumoricidal', 'activity', 'tumor', 'cells', 'vitro', 'Control', 'liposomes', 'micrograms', 'free', 'ineffective', 'cell', 'tumoricidal', 'activity', 'situ', 'treatment', 'regimens', 'vivo', 'mice', 'tumor', 'cell', 'line', 'multiple', 'injections', 'liposomal', 'treatment', 'liposomal', 'tumor', 'cell', 'injection', 'tumor', 'cell', 'injection', 'ability', 'liposomes', 'number', 'hepatic', 'micrometastases', 'first', 'protocol', 'tumor', 'cell', 'inoculum', 'significant', 'inhibition', 'lower', 'liver', 'tumor', 'burdens', 'less', 'tumor', 'nodules', 'Pretreatment', 'mice', 'tumor', 'cell', 'challenge', 'treatment', 'efficacy', 'liposomal', 'significant', 'inhibition', 'growth', 'experimental', 'metastases', 'high', 'liver', 'tumor', 'burdens', 'greater', 'nodules']"
237,237,http://dialog.proquest.com/professional/docview/596739679?accountid=173210,"Morphology, distribution and its significance of intrahepatic HBV DNA in liver disease: a study by in situ hybridization","A biotin-labeled DNA probe specific for hepatitis B virus (HBV) nucleotide sequences was hybridized in situ to liver tissue of 129 cases with liver disease. It was found that HBV DNA was predominantly visualized in cytoplasm of hepatocytes in three patterns: cytoplasmic compact, discrete and inclusion pattern. Its distribution in parenchyma in the sections of specimens may be defined as lobular, focal and spotty. The detection of intrahepatic HBV DNA depended on two factors, at least in the present study: 1) liver disease activity; chronic active hepatitis (CAH) group had a significant higher prevalence (81%) as compared to cirrhosis, chronic lobular hepatitis (CLH), acute hepatitis and hepatocellular carcinoma (HCC) groups; 2) HBV infection state: HBV DNA was more easily detected in HBeAg positive or intrahepatic HBcAg positive patients than in single HBsAg positive or anti-HBc cases. The findings that hepatocytes expressing HBV DNA, particularly in focal distribution, were closely related to hepatic necrosis sites suggested that HBV replication might occur in conjunction with hepatic necrosis.","['Zhang, Y Y', 'Yan, P', 'Seng, H Q', 'Li, L', 'Hao, L J']","['DNA Replication', 'DNA, Viral', 'Hepatitis B', 'Hepatitis B', 'Hepatitis B Antibodies', 'Hepatitis B e Antigens', 'Hepatitis B virus', 'Hepatitis, Chronic', 'Hepatitis, Chronic', 'Humans', 'Liver Diseases', 'Nucleic Acid Hybridization']",ProQuest,"['data grid', 'peer-to-peer', 'fault tolerance', 'security of data', 'signal detection', 'malwares', 'malicious codes', 'replication strategies', 'computer viruses', 'detection algorithm', 'intrusion detection']",liver carcinoma in situ,"['distribution', 'significance', 'intrahepatic', 'liver', 'disease', 'study', 'situ', 'hybridization']","['biotin', 'DNA', 'probe', 'specific', 'hepatitis', 'nucleotide', 'sequences', 'situ', 'tissue', 'cases', 'liver', 'disease', 'cytoplasm', 'hepatocytes', 'patterns', 'cytoplasmic', 'compact', 'discrete', 'inclusion', 'pattern', 'distribution', 'parenchyma', 'sections', 'specimens', 'lobular', 'focal', 'spotty', 'detection', 'intrahepatic', 'factors', 'least', 'present', 'study', 'liver', 'disease', 'activity', 'chronic', 'active', 'hepatitis', 'group', 'significant', 'higher', 'prevalence', '%', 'cirrhosis', 'chronic', 'lobular', 'acute', 'hepatitis', 'hepatocellular', 'carcinoma', 'groups', 'infection', 'state', 'positive', 'intrahepatic', 'positive', 'patients', 'single', 'positive', 'anti', '-', 'HBc', 'cases', 'findings', 'focal', 'distribution', 'related', 'hepatic', 'necrosis', 'sites', 'replication', 'conjunction', 'hepatic', 'necrosis']"
238,238,http://dialog.proquest.com/professional/docview/596801721?accountid=173210,Surgery of benign liver tumors,"The most frequent benign liver tumors are hemangioma, focal nodular hyperplasia (FNH) and adenoma. It is essential for the diagnosis to differentiate these lesions from malignant tumors. While sonography, bolus-CT scan, chole-/bloodpool scintigraphy usually yield a safe diagnosis of hemangioma or FNH, adenomas do not show characteristic features. Operation is indicated for hemangioma of FNH only in case of tumor growth and/or symptoms. Operation for adenoma is as a rule indicated because of possible malignant transformation or uncertain differentiation from malignoma. Operative procedures include anatomical/atypical liver resection, ex situ resection or liver transplantation.","['Ringe, B', 'Mauz, S', 'Barg-Hock, H', 'Kotzerke, J', 'Pichlmayr, R']","['Adolescent', 'Adult', 'Carcinoma, Hepatocellular', 'Diagnosis, Differential', 'Female', 'Hemangioma, Cavernous', 'Hepatectomy', 'Humans', 'Hyperplasia', 'Liver', 'Liver Neoplasms', 'Male', 'Middle Aged', 'Precancerous Conditions']",ProQuest,"['medical images', 'multidetector computed tomography', 'computerized tomography', 'feature space', 'rule base', 'classification methods', 'knowledge based systems', 'ct image', 'fuzzy inference', 'pattern recognition', 'image quality', 'image segmentation']",liver carcinoma in situ,"['Surgery', 'benign', 'liver', 'tumors']","['frequent', 'benign', 'liver', 'tumors', 'hemangioma', 'focal', 'nodular', 'hyperplasia', 'adenoma', 'essential', 'diagnosis', 'lesions', 'malignant', 'tumors', 'sonography', 'bolus', 'CT', 'scan', 'chole-/bloodpool', 'scintigraphy', 'safe', 'diagnosis', 'hemangioma', 'FNH', 'adenomas', 'characteristic', 'features', 'Operation', 'hemangioma', 'case', 'tumor', 'growth', 'symptoms', 'Operation', 'adenoma', 'rule', 'possible', 'malignant', 'transformation', 'uncertain', 'differentiation', 'malignoma', 'Operative', 'procedures', 'anatomical', 'atypical', 'liver', 'resection', 'situ', 'resection', 'liver', 'transplantation']"
239,239,http://dialog.proquest.com/professional/docview/595887857?accountid=173210,"Human M2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma","Two overlapping clones, covering the entire coding sequence of human M2-type pyruvate kinase (PK) cDNA, were isolated and sequenced. Nucleotide sequencing results showed that they contained the 109-bp 5'-untranslated region, the 1593-bp coding region and the 585-bp 3'-untranslated region. Nucleotide sequence homology was 90% and 69% with rat M2-type and L-type PK cDNA, respectively. In situ hybridization using the human M2-type PK cDNA probe disclosed that the gene for M2-type PK is located at band q22 on chromosome 15. Northern blot analysis with RNA from human hepatoma demonstrated that M2-type PK was predominantly expressed in hepatoma cells, whereas L-type PK was preferentially expressed in the non-tumor portion of the liver.","['Tani, K', 'Yoshida, M C', 'Satoh, H', 'Mitamura, K', 'Noguchi, T', 'Tanaka, T', 'Fujii, H', 'Miwa, S']","['Amino Acid Sequence', 'Base Sequence', 'Blotting, Southern', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Chromosome Mapping', 'Chromosomes, Human, Pair 15', 'Cloning, Molecular', 'DNA, Recombinant', 'Genes', 'Humans', 'Isoenzymes', 'Liver Neoplasms', 'Liver Neoplasms', 'Molecular Sequence Data', 'Nucleic Acid Hybridization', 'Pyruvate Kinase', 'Restriction Mapping']",ProQuest,"['assignment problems', 'image coding', 'crossover operator', 'frequency bands', 'genetic operators', 'evolutionary algorithms', 'coding scheme', 'combinatorial optimization', 'antennas', 'network coding']",liver carcinoma in situ,"['Human', 'M2-type', 'kinase', 'cDNA', 'chromosomal', 'assignment', 'expression', 'hepatoma']","['clones', 'entire', 'coding', 'sequence', 'human', 'M2-type', 'pyruvate', 'Nucleotide', 'sequencing', 'results', 'region', 'region', 'region', 'Nucleotide', 'sequence', 'homology', '%', '%', 'rat', 'M2-type', 'L', 'type', 'situ', 'hybridization', 'human', 'M2-type', 'probe', 'gene', 'M2-type', 'band', 'q22', 'chromosome', 'Northern', 'blot', 'analysis', 'human', 'hepatoma', 'M2-type', 'hepatoma', 'cells', 'L', 'type', 'non', '-', 'tumor', 'portion', 'liver']"
240,240,http://dialog.proquest.com/professional/docview/595701733?accountid=173210,Regional mapping to 4q32.1 by in situ hybridization of a DNA domain rearranged in human liver cancer,"Recently, a unique cellular DNA segment, representing the normal allele counterpart of hepatitis B virus integration site, has been isolated. It has allowed the identification of a cellular domain in which rearrangements occur in approximately 10% of primary liver tumours. We here report on the assignment of this probe, D4S112, by in situ hybridization to band 4q32.1.","['Blanquet, V', 'Garreau, F', 'Chenivesse, X', 'Brechot, C', 'Turleau, C']","['Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cells, Cultured', 'Chromosome Banding', 'Chromosome Mapping', 'Chromosomes, Human, Pair 4', 'DNA, Viral', 'Gene Rearrangement', 'Hepatitis B virus', 'Humans', 'Karyotyping', 'Liver Neoplasms', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'Recombination, Genetic']",ProQuest,"['cellular telephone systems', 'assignment problems', 'wireless', 'cellular radio systems', 'security of data', 'genetic operators', 'malwares', 'malicious codes', 'evolutionary algorithms', 'cellular network', 'channel capacity', 'combinatorial optimization', 'cellular system', 'computer viruses', 'cellular', 'intrusion detection']",liver carcinoma in situ,"['Regional', 'mapping', 'situ', 'hybridization', 'DNA', 'domain', 'human', 'liver', 'cancer']","['unique', 'cellular', 'DNA', 'segment', 'normal', 'allele', 'counterpart', 'virus', 'integration', 'site', 'identification', 'cellular', 'domain', 'rearrangements', '%', 'primary', 'liver', 'tumours', 'assignment', 'probe', 'situ', 'hybridization']"
241,241,http://dialog.proquest.com/professional/docview/595531597?accountid=173210,Isolation and analysis of hepatoma nuclear proteins using monoclonal antibodies,"Monoclonal antibodies were prepared to nuclear nonhistone proteins from a 2-aminoacetyl fluorine-induced transplantable rat hepatocellular carcinoma. These antibodies recognized a total of six distinct antigens as revealed by molecular weight analysis. Studies of antigen specificity with respect to various tissues, tumors, cultured cells, and oncodevelopmental stages indicated that these nuclear species could be divided into two categories. Four antigens were classified as tumor related since they were significantly enriched in tumor tissue as compared to tissues of the normal adult rat. The remaining two antigens were detected only in tumors and transformed cells; one, only in certain hepatomas. Thus, these antigens were classified as tumor specific. As an initial step toward elucidating the function of these proteins, each antigen was isolated by immunoaffinity chromatography, radioiodinated in situ, and analyzed for the ability to bind DNA. Three antigens were positive for DNA binding, and one of these was selectively released from tumor nuclei with the transcriptionally active chromatin upon digestion with micrococcal nuclease. The implications of these results for the possible functional contribution of the six tumor antigens to transformation is discussed.","['Babin, J K', 'Anderson, J N']","['2-Acetylaminofluorene', 'Animals', 'Antibodies, Monoclonal', 'Antigens, Neoplasm', 'Chromatography, Affinity', 'Chromosomal Proteins, Non-Histone', 'Liver Neoplasms, Experimental', 'Liver Neoplasms, Experimental', 'Mice', 'Mice, Inbred BALB C', 'Nuclear Proteins', 'Rats', 'Rats, Inbred F344']",ProQuest,"['mathematics', 'correlation analysis']",liver carcinoma in situ,"['Isolation', 'analysis', 'hepatoma', 'nuclear', 'proteins', 'monoclonal', 'antibodies']","['Monoclonal', 'antibodies', 'prepared', 'nuclear', 'nonhistone', 'proteins', 'fluorine', 'transplantable', 'rat', 'hepatocellular', 'carcinoma', 'antibodies', 'total', 'distinct', 'antigens', 'molecular', 'weight', 'analysis', 'Studies', 'antigen', 'specificity', 'respect', 'various', 'tissues', 'tumors', 'cultured', 'cells', 'oncodevelopmental', 'stages', 'nuclear', 'species', 'categories', 'antigens', 'tumor', 'tumor', 'tissue', 'tissues', 'normal', 'adult', 'rat', 'antigens', 'tumors', 'cells', 'certain', 'hepatomas', 'antigens', 'tumor', 'specific', 'initial', 'step', 'function', 'proteins', 'antigen', 'immunoaffinity', 'chromatography', 'situ', 'ability', 'antigens', 'positive', 'DNA', 'binding', 'tumor', 'nuclei', 'active', 'chromatin', 'digestion', 'micrococcal', 'nuclease', 'implications', 'results', 'possible', 'functional', 'contribution', 'tumor', 'transformation']"
242,242,http://dialog.proquest.com/professional/docview/595569761?accountid=173210,Assignment of the human hap retinoic acid receptor RAR beta gene to the p24 band of chromosome 3,The human hap retinoic acid receptor RAR beta has been localized by in situ hybridization to the p24 band of chromosome 3.,"['Mattei, M G', 'de Th√©, H', 'Mattei, J F', 'Marchio, A', 'Tiollais, P', 'Dejean, A']","['Carcinoma, Hepatocellular', 'Carrier Proteins', 'Chromosome Banding', 'Chromosome Mapping', 'Chromosomes, Human, Pair 3', 'DNA', 'Genetic Markers', 'Hepatitis B virus', 'Humans', 'Karyotyping', 'Liver Neoplasms', 'Multigene Family', 'Nucleic Acid Hybridization', 'Receptors, Retinoic Acid', 'Tretinoin']",ProQuest,"['assignment problems', 'crossover operator', 'frequency bands', 'security of data', 'genetic operators', 'evolutionary algorithms', 'antennas', 'combinatorial optimization', 'computer viruses']",liver carcinoma in situ,"['Assignment', 'human', 'hap', 'retinoic', 'acid', 'receptor', 'RAR', 'beta', 'gene', 'p24', 'band', 'chromosome']","['human', 'hap', 'retinoic', 'acid', 'receptor', 'RAR', 'beta', 'situ', 'hybridization', 'p24', 'band', 'chromosome']"
243,243,http://dialog.proquest.com/professional/docview/595507987?accountid=173210,Analysis of alpha-fetoprotein gene expression in hepatocellular carcinoma and liver cirrhosis by in situ hybridization,The expression of the alpha-fetoprotein (AFP) gene in hepatocellular carcinoma (HCC) and liver cirrhosis by in situ hybridization analysis of AFP mRNA in cryostat and paraffin-embedded tissue sections was studied. In HCC sections the majority of tumor cells showed positive hybridization with a 3H-labeled AFP complementary DNA probe. The number of radioactive hybrid grains detected in HCC sections generally paralleled the level of serum AFP in the patient. In liver cirrhosis sections a small number of cells showed positive hybridization. These cells were dispersed in the tissue and morphologically indistinguishable from surrounding hepatocytes. Each of these cells contained a high level of hybridization signals to permit easy identification. In situ hybridization analysis of AFP mRNA may be of use in detecting preneoplastic cells in liver cirrhosis that cannot be defined on the morphologic and immunohistochemical basis.,"['Otsuru, A', 'Nagataki, S', 'Koji, T', 'Tamaoki, T']","['Carcinoma, Hepatocellular', 'Humans', 'Immunoenzyme Techniques', 'Liver Cirrhosis', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'Precancerous Conditions', 'RNA, Messenger', 'alpha-Fetoproteins', 'alpha-Fetoproteins']",ProQuest,"['carbides', 'cutting tools', 'digital signal processors', 'correlation analysis', 'optimization problems', 'mathematics', 'digital signals']",liver carcinoma in situ,"['Analysis', 'alpha', 'fetoprotein', 'gene', 'expression', 'hepatocellular', 'carcinoma', 'liver', 'cirrhosis', 'situ', 'hybridization']","['expression', 'alpha', 'fetoprotein', 'gene', 'hepatocellular', 'carcinoma', 'liver', 'cirrhosis', 'situ', 'hybridization', 'analysis', 'cryostat', 'paraffin', 'tissue', 'sections', 'sections', 'majority', 'tumor', 'cells', 'positive', 'hybridization', '3H', 'complementary', 'DNA', 'probe', 'number', 'radioactive', 'hybrid', 'grains', 'sections', 'level', 'serum', 'patient', 'liver', 'cirrhosis', 'sections', 'small', 'number', 'cells', 'positive', 'hybridization', 'cells', 'tissue', 'indistinguishable', 'hepatocytes', 'cells', 'high', 'level', 'hybridization', 'signals', 'easy', 'identification', 'situ', 'hybridization', 'analysis', 'use', 'preneoplastic', 'cells', 'liver', 'cirrhosis', 'morphologic', 'immunohistochemical', 'basis']"
244,244,http://dialog.proquest.com/professional/docview/595530370?accountid=173210,A lack of direct role of hepatitis B virus in the activation of ras and c-myc oncogenes in human hepatocellular carcinogenesis,"This study was performed to determine the relationship of the activation of ras and c-myc oncogenes in human hepatocellular carcinoma to the hepatitis B virus gene expression or the presence of hepatitis B virus DNA/RNA at the cellular level. This was done using immunocytochemical analysis with two different antibodies on serial sections. In addition, immunocytochemical assay for the detection of ras p21 or c-myc protein was performed in combination with in situ hybridization for hepatitis B virus DNA/RNA using 35S-labeled hepatitis B virus DNA as a probe. Investigation of a total of 14 paired human hepatocellular carcinoma and adjacent nontumorous hepatic tissues revealed enhanced expression of ras p21 in one human hepatocellular carcinoma whereas c-myc protein was found in one paired human hepatocellular carcinoma and nontumorous tissue of the same patient. Only a small proportion of human hepatocellular carcinoma cells or hepatocytes among a large number of cells on a given section showed enhanced expression, and the distribution of the oncogene product-expressing cells was focal. However, the cells overexpressing these oncogenes did not show hepatitis B surface antigen in the serial sections. Furthermore, the combined immunocytochemical and in situ hybridization assays revealed that human hepatocellular carcinoma cells overexpressing ras p21 did not show hepatitis B virus DNA/RNA, whereas some human hepatocellular carcinoma cells and nontumorous hepatocytes located away from the foci of oncogene-expressing cells gave positive signals. These findings suggest that continued expression of HBsAg or the presence of hepatitis B virus DNA/RNA in a given human hepatocellular carcinoma cell id not necessary for enhanced expression of ras or c-myc proteins.(ABSTRACT TRUNCATED AT 250 WORDS)","['Lee, H S', 'Rajagopalan, M S', 'Vyas, G N']","['Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'DNA, Viral', 'DNA, Viral', 'Gene Amplification', 'Gene Expression Regulation', 'Genes, ras', 'Hepatitis B Surface Antigens', 'Hepatitis B Surface Antigens', 'Hepatitis B virus', 'Hepatitis B virus', 'Humans', 'Immunohistochemistry', 'Liver', 'Liver Neoplasms', 'Liver Neoplasms', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'Oncogene Proteins, Viral', 'Oncogenes', 'RNA, Viral', 'RNA, Viral']",ProQuest,"['cellular telephone systems', 'intrusion detection', 'wireless', 'detection algorithm', 'cellular radio systems', 'security of data', 'malwares', 'channel capacity', 'malicious codes', 'cellular network', 'cellular system', 'computer viruses', 'cellular', 'signal detection']",liver carcinoma in situ,"['lack', 'direct', 'role', 'virus', 'activation', 'ras', 'c', 'myc', 'oncogenes', 'human', 'hepatocellular', 'carcinogenesis']","['study', 'relationship', 'activation', 'ras', 'c', 'myc', 'oncogenes', 'human', 'hepatocellular', 'carcinoma', 'virus', 'gene', 'expression', 'presence', 'virus', 'cellular', 'level', 'immunocytochemical', 'analysis', 'different', 'antibodies', 'serial', 'sections', 'addition', 'immunocytochemical', 'assay', 'detection', 'ras', 'p21', 'c', 'myc', 'protein', 'combination', 'situ', 'hybridization', 'virus', 'hepatitis', 'virus', 'DNA', 'probe', 'Investigation', 'total', 'human', 'hepatocellular', 'carcinoma', 'adjacent', 'nontumorous', 'hepatic', 'tissues', 'expression', 'ras', 'p21', 'human', 'hepatocellular', 'carcinoma', 'c', 'myc', 'protein', 'human', 'hepatocellular', 'carcinoma', 'nontumorous', 'tissue', 'same', 'patient', 'small', 'proportion', 'human', 'hepatocellular', 'carcinoma', 'cells', 'hepatocytes', 'large', 'number', 'cells', 'section', 'expression', 'distribution', 'oncogene', 'product', 'cells', 'focal', 'cells', 'oncogenes', 'hepatitis', 'surface', 'antigen', 'serial', 'sections', 'immunocytochemical', 'situ', 'hybridization', 'assays', 'human', 'hepatocellular', 'carcinoma', 'cells', 'ras', 'p21', 'virus', 'human', 'hepatocellular', 'carcinoma', 'cells', 'nontumorous', 'hepatocytes', 'foci', 'oncogene', 'cells', 'positive', 'signals', 'findings', 'expression', 'presence', 'virus', 'RNA', 'human', 'hepatocellular', 'carcinoma', 'cell', 'necessary', 'expression', 'ras', 'c', 'myc', 'proteins.(ABSTRACT', 'WORDS']"
245,245,http://dialog.proquest.com/professional/docview/595317089?accountid=173210,Relationship of intrahepatic bile duct hyperplasia to cholangiocellular carcinoma,"To investigate the relationship between intrahepatic bile duct hyperplasia and cholangiocellular carcinoma, 27 patients with cholangiocellular carcinoma (including biliary cystadenocarcinoma) and 303 controls were histologically examined. Livers with cholangiocellular carcinoma were closely associated with hyperplasia (100%), atypical hyperplasia (77.8%), and carcinoma in situ (51.9%). Transition from hyperplasia to atypical hyperplasia, and from atypical hyperplasia to carcinoma, was often observed. In the controls, hyperplasia was frequent in those older than 30 years of age, whereas carcinoma was frequent in patients from 50 to 80 years of age. Of the intrahepatic bile ducts examined, the large duct showed the highest incidence of hyperplasia, atypical hyperplasia, and carcinoma in situ. All 27 cases of cholangiocellular carcinoma originated in, or near, the hilus of the liver. These findings suggest that cholangiocellular carcinoma frequently develops from bile duct hyperplasia.","['Kurashina, M', 'Kozuka, S', 'Nakasima, N', 'Hirabayasi, N', 'Ito, M']","['Adenoma, Bile Duct', 'Adenoma, Bile Duct', 'Adult', 'Age Factors', 'Aged', 'Aged, 80 and over', 'Bile Duct Neoplasms', 'Bile Duct Neoplasms', 'Bile Ducts, Intrahepatic', 'Carcinoma in Situ', 'Humans', 'Hyperplasia', 'Japan', 'Middle Aged', 'Precancerous Conditions', 'Sex Factors']",ProQuest,[],liver carcinoma in situ,"['Relationship', 'intrahepatic', 'bile', 'duct', 'hyperplasia', 'cholangiocellular', 'carcinoma']","['relationship', 'intrahepatic', 'bile', 'duct', 'hyperplasia', 'cholangiocellular', 'carcinoma', 'patients', 'cholangiocellular', 'carcinoma', 'biliary', 'cystadenocarcinoma', 'controls', 'Livers', 'cholangiocellular', 'carcinoma', 'hyperplasia', '%', 'atypical', 'hyperplasia', '%', 'carcinoma', 'situ', '%', 'Transition', 'hyperplasia', 'atypical', 'hyperplasia', 'atypical', 'hyperplasia', 'carcinoma', 'controls', 'hyperplasia', 'frequent', 'older', 'years', 'age', 'carcinoma', 'frequent', 'patients', 'years', 'age', 'intrahepatic', 'bile', 'ducts', 'large', 'duct', 'highest', 'incidence', 'hyperplasia', 'atypical', 'hyperplasia', 'carcinoma', 'situ', 'cases', 'cholangiocellular', 'carcinoma', 'hilus', 'liver', 'findings', 'cholangiocellular', 'carcinoma', 'bile', 'duct', 'hyperplasia']"
246,246,http://dialog.proquest.com/professional/docview/595332848?accountid=173210,Dietary vitamin A and the risk of intraepithelial and invasive cervical neoplasia,"The risk of invasive and intraepithelial cervical neoplasia in relation to the frequency of intake of the major sources of preformed vitamin A (retinol) and beta-carotene in the Italian diet was analyzed in a study of 392 cases of invasive cancer compared with 392 age-matched controls hospitalized for acute conditions unrelated to any of the established or suspected risk factors for cervical cancer, and of 247 cases of cervical intraepithelial neoplasia compared with 247 controls found to have normal smears at the same screening clinics where cases had been identified. Women with invasive cancer consumed milk, green vegetables, and carrots less frequently, but no significant relation was noted for meat or liver. Consequently, estimated beta-carotene, but not retinol, intake was inversely and strongly related to the risk of invasive cervical cancer. Compared with women whose intake was over 150,000 international units (IU) per month, the relative risks were 3.0 for 100 to 149,999 and 4.7 for less than 100,000 IU. It was not possible to show that these relationships were incidental, since allowance for several identified potential distorting factors, including indicators of social status and the major risk factors for cervical cancer, did not materially modify the risk estimates. In contrast, no association emerged between any of the food items and vitamin A estimates considered and intraepithelial neoplasia. Thus, the results of this study can be interpreted in one of two ways: either some residual uncontrolled bias was responsible for the strong dietary correlates of invasive cervical cancer risk or beta-carotene (or any other correlate of a vegetable-rich diet) has effect on one of the later stages of the process of carcinogenesis, thus influencing the risk of invasive carcinoma but not of its precursors.","['La Vecchia, C', 'Decarli, A', 'Fasoli, M', 'Parazzini, F', 'Franceschi, S', 'Gentile, A', 'Negri, E']","['Adolescent', 'Adult', 'Age Factors', 'Aged', 'Carcinoma in Situ', 'Carcinoma in Situ', 'Carotenoids', 'Carotenoids', 'Diet', 'Diet Surveys', 'Female', 'Humans', 'Italy', 'Middle Aged', 'Risk Factors', 'Socioeconomic Factors', 'Uterine Cervical Neoplasms', 'Uterine Cervical Neoplasms', 'Vitamin A', 'Vitamin A Deficiency', 'beta Carotene']",ProQuest,"['estimation method', 'socioeconomic status', 'numerical model', 'variable frequency oscillators', 'bandwidth', 'social aspect', 'frequencies', 'output frequency', 'sociology']",liver carcinoma in situ,"['Dietary', 'vitamin', 'A', 'risk', 'intraepithelial', 'invasive', 'cervical', 'neoplasia']","['risk', 'invasive', 'intraepithelial', 'cervical', 'neoplasia', 'relation', 'frequency', 'intake', 'major', 'sources', 'vitamin', 'A', 'retinol', 'beta', 'carotene', 'Italian', 'diet', 'study', 'cases', 'invasive', 'cancer', 'age', 'controls', 'acute', 'conditions', 'unrelated', 'risk', 'factors', 'cervical', 'cancer', 'cases', 'cervical', 'intraepithelial', 'neoplasia', 'controls', 'normal', 'smears', 'same', 'screening', 'clinics', 'cases', 'Women', 'invasive', 'cancer', 'milk', 'green', 'vegetables', 'carrots', 'significant', 'relation', 'meat', 'liver', 'beta', 'carotene', 'retinol', 'intake', 'risk', 'invasive', 'cervical', 'cancer', 'women', 'intake', 'international', 'units', 'month', 'relative', 'risks', 'less', 'IU', 'possible', 'relationships', 'incidental', 'allowance', 'several', 'potential', 'factors', 'indicators', 'social', 'status', 'major', 'risk', 'factors', 'cervical', 'cancer', 'risk', 'estimates', 'contrast', 'association', 'food', 'items', 'vitamin', 'estimates', 'intraepithelial', 'neoplasia', 'results', 'study', 'ways', 'residual', 'uncontrolled', 'bias', 'responsible', 'strong', 'dietary', 'correlates', 'invasive', 'cervical', 'cancer', 'risk', 'beta', 'carotene', 'other', 'correlate', 'vegetable', 'rich', 'diet', 'effect', 'later', 'stages', 'process', 'carcinogenesis', 'risk', 'invasive', 'carcinoma', 'precursors']"
247,247,http://dialog.proquest.com/professional/docview/595612931?accountid=173210,Regional localization of the LCA oncogene to human chromosome region 2q14----q21,"A novel human oncogene, LCA, was assigned to region 2q14----q21 by in situ molecular hybridization. The present regional mapping substantiates the previous assignment that was performed by Southern blot analyses of DNAs from flow-sorted human chromosomes and human-mouse somatic cell hybrids.","['Tokino, T', 'Satoh, H', 'Yoshida, M C', 'Ochiya, T', 'Matsubara, K']","['Carcinoma, Hepatocellular', 'Chromosome Banding', 'Chromosome Mapping', 'Chromosomes, Human, Pair 2', 'DNA', 'DNA Probes', 'Humans', 'Karyotyping', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'Oncogenes']",ProQuest,"['target tracking', 'wireless sensor networks', 'crossover operator', 'localization technique', 'genetic operators', 'localization algorithm', 'evolutionary algorithms', 'sensor networks', 'target localization']",liver carcinoma in situ,"['Regional', 'localization', 'oncogene', 'human', 'chromosome', 'region', '---q21']","['novel', 'human', 'oncogene', 'region', 'situ', 'molecular', 'hybridization', 'present', 'regional', 'mapping', 'previous', 'assignment', 'Southern', 'blot', 'analyses', 'DNAs', 'flow', 'human', 'chromosomes', 'human', 'mouse', 'somatic', 'cell', 'hybrids']"
248,248,http://dialog.proquest.com/professional/docview/595856346?accountid=173210,Achievements of tumor surgery in tumors of the liver and bile ducts,"Tumor surgery in this field is no longer such a high risk as previously. Prolonged survival can be achieved by resection of hepatocellular carcinomas in non-cirrhotic livers (3-year survival 58%, n = 54 patients) and for colorectal liver metastases (3-year survival 44%, n = 124 patients). But surgery is rarely successful for the most frequent type of liver malignancy, the hepatocellular carcinoma in cirrhosis. Central bile duct carcinomas are now resected more frequently than in the past. Liver grafting seems indicated in special cases of liver and bile duct tumors. The future developments of operating on the in situ-perfused liver was discussed and the first operation on an ex situ-liver was demonstrated.","['Pichlmayr, R']","['Bile Duct Neoplasms', 'Gallbladder Neoplasms', 'Hepatectomy', 'Humans', 'Liver Neoplasms', 'Liver Neoplasms', 'Postoperative Complications', 'Prognosis']",ProQuest,"['kaplan-meiers estimate', 'polynomial approximation', 'approximation algorithms', 'fully polynomial time approximation schemes', 'proportional hazards models']",liver carcinoma in situ,"['Achievements', 'tumor', 'surgery', 'tumors', 'liver', 'bile', 'ducts']","['Tumor', 'surgery', 'field', 'high', 'risk', 'Prolonged', 'survival', 'resection', 'hepatocellular', 'carcinomas', 'non', '-', 'cirrhotic', 'livers', 'survival', '%', 'patients', 'colorectal', 'liver', 'metastases', 'survival', '%', 'patients', 'surgery', 'successful', 'frequent', 'type', 'liver', 'malignancy', 'hepatocellular', 'carcinoma', 'cirrhosis', 'Central', 'bile', 'duct', 'carcinomas', 'past', 'Liver', 'grafting', 'special', 'cases', 'liver', 'bile', 'duct', 'tumors', 'future', 'developments', 'situ', 'liver', 'first', 'operation', 'ex', 'situ', 'liver']"
249,249,http://dialog.proquest.com/professional/docview/595303286?accountid=173210,Inhibition of pancreatic and liver carcinogenesis in rats by retinoid- and selenium-supplemented diets,"Chemoprevention by a synthetic retinoid, selenium, and these agents in combination during the postinitiation stages of carcinogenesis induced in rats by azaserine was evaluated. Male Lewis rats were given three weekly injections of 30 mg/kg azaserine while being fed a purified diet. One week after completion of carcinogen treatment, groups of rats were switched to the purified diet supplemented with either a retinoid, N-(2-hydroxyethyl)retinamide, at a level of 0.5 or 1 mmol/kg diet, or with 5 ppm sodium selenite, or with a combination of retinoid and selenium. One year after the diet change, the incidence of pancreatic and other neoplasms was determined by autopsy and histologic study. The incidence of pancreatic carcinoma (including carcinoma-in-situ, CIS) among nonretinoid-treated controls was 68%. Since the dietary supplements were fed after completion of exposure to the carcinogen, the effects on both pancreatic and liver carcinogenesis were exerted during the postinitiation phase of carcinogenesis. As in previous studies, the retinoid inhibited the progression of pancreatic carcinogenesis in a dose-related fashion. Selenium alone had no effect. However, the combination of retinoid plus selenium was more effective than retinoid alone, although the increase in inhibition was not large. The retinoid was also found to inhibit liver carcinogenesis induced by azaserine. Selenium, either alone or in combination with retinoid, was ineffective. Finally, testicular atrophy, noted as a toxic effect of retinoids in other studies, was not observed in this work.","['Curphey, T J', 'Kuhlmann, E T', 'Roebuck, B D', 'Longnecker, D S']","['Animals', 'Azaserine', 'Drug Synergism', 'Food, Fortified', 'Liver Neoplasms, Experimental', 'Male', 'Pancreatic Neoplasms', 'Rats', 'Rats, Inbred Lew', 'Retinoids', 'Retinoids', 'Selenium', 'Selenium']",ProQuest,"['clustering algorithms', 'pulse position modulation', 'artificial intelligence', 'database systems', 'software agents', 'multiagent system', 'ppm', 'autonomous agents', 'real data sets']",liver carcinoma in situ,"['Inhibition', 'pancreatic', 'liver', 'carcinogenesis', 'rats', 'retinoid-', 'selenium', 'diets']","['Chemoprevention', 'synthetic', 'retinoid', 'selenium', 'agents', 'combination', 'postinitiation', 'stages', 'carcinogenesis', 'rats', 'azaserine', 'rats', 'weekly', 'injections', 'mg', 'azaserine', 'purified', 'diet', 'week', 'completion', 'carcinogen', 'treatment', 'groups', 'rats', 'purified', 'diet', 'retinoid', 'level', 'mmol', 'diet', 'ppm', 'sodium', 'selenite', 'combination', 'retinoid', 'selenium', 'year', 'diet', 'change', 'incidence', 'pancreatic', 'other', 'neoplasms', 'autopsy', 'histologic', 'study', 'incidence', 'pancreatic', 'carcinoma', 'carcinoma', 'situ', 'nonretinoid', 'controls', '%', 'dietary', 'supplements', 'completion', 'exposure', 'carcinogen', 'effects', 'pancreatic', 'liver', 'carcinogenesis', 'postinitiation', 'phase', 'carcinogenesis', 'previous', 'studies', 'retinoid', 'progression', 'pancreatic', 'carcinogenesis', 'dose', 'fashion', 'Selenium', 'effect', 'combination', 'retinoid', 'selenium', 'effective', 'increase', 'inhibition', 'large', 'retinoid', 'liver', 'carcinogenesis', 'azaserine', 'Selenium', 'combination', 'retinoid', 'ineffective', 'testicular', 'atrophy', 'toxic', 'effect', 'retinoids', 'other', 'studies', 'work']"
250,250,http://dialog.proquest.com/professional/docview/595969873?accountid=173210,Hepatitis B virus DNA detection by in situ hybridization in human hepatocellular carcinoma,0,"['Lee, D H', 'Lee, J D']","['Carcinoma, Hepatocellular', 'DNA, Viral', 'Hepatitis B virus', 'Humans', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'Proto-Oncogenes']",ProQuest,"['security of data', 'signal detection', 'malwares', 'malicious codes', 'computer viruses', 'detection algorithm', 'intrusion detection']",liver carcinoma in situ,"['virus', 'DNA', 'detection', 'situ', 'hybridization', 'human', 'hepatocellular', 'carcinoma']",[]
251,251,http://dialog.proquest.com/professional/docview/595523927?accountid=173210,Colonization of the rat liver by syngeneic tumor cells. An experimental approach by in vivo and in situ studies,"Syngeneic colon carcinoma cells and glioma cells were injected into the portal vein of BD IX rats. After various time periods the animals were sacrificed and the livers and lungs were fixed and prepared for histology. Atypical cells were observed in the liver 4 and 7 days after the injection of tumor cells, whereas distinct colonies of both colon carcinoma and glioma cells were demonstrated after 14 days. Lung metastases of both tumor cell types were seen after 14 and 30 days. Furthermore, injection of glioma and carcinoma cells into the tail vein gave detectable lung metastases after 7 and 4 days respectively. Intraperitoneal injection of tumor cells resulted in the accumulation of large tumor masses, particularly in the mesentery. By in situ perfusions of the liver with tumor cells included in the perfusion medium it was possible to establish that all the tumor cells were arrested in the course of 4 min. In contrast, normal rat leukocytes were not trapped in the liver, whereas trypsin-treated leukocytes were, suggesting the importance of trypsin-sensitive structures for binding to hepatic tissue. The binding of both glioma and carcinoma cells to the liver and the ensuing growth of tumor nodules in this organ indicate a lack of specificity on part of the malignant cell types for metastasis to the liver in the rat. Both tumor cell types colonized the first organ encountered after injection.","['Solberg, E', 'Gj√∏en, T', 'Seljelid, R', 'Kolset, S O']","['Animals', 'Carcinoma', 'Carcinoma', 'Carcinoma', 'Cell Line', 'Colonic Neoplasms', 'Colonic Neoplasms', 'Colonic Neoplasms', 'Glioma', 'Glioma', 'Glioma', 'Injections, Intravenous', 'Liver', 'Liver', 'Liver Neoplasms', 'Perfusion', 'Rats', 'Rats, Inbred Strains', 'Tumor Cells, Cultured', 'Tumor Cells, Cultured', 'Tumor Cells, Cultured', 'Tumor Stem Cell Assay']",ProQuest,[],liver carcinoma in situ,"['Colonization', 'rat', 'liver', 'syngeneic', 'tumor', 'cells', 'experimental', 'approach', 'vivo', 'situ', 'studies']","['Syngeneic', 'colon', 'carcinoma', 'cells', 'glioma', 'cells', 'portal', 'vein', 'rats', 'various', 'time', 'periods', 'animals', 'livers', 'lungs', 'histology', 'Atypical', 'cells', 'liver', 'days', 'injection', 'tumor', 'cells', 'distinct', 'colonies', 'colon', 'carcinoma', 'glioma', 'cells', 'days', 'metastases', 'tumor', 'cell', 'types', 'days', 'injection', 'glioma', 'carcinoma', 'cells', 'tail', 'vein', 'detectable', 'lung', 'metastases', 'days', 'Intraperitoneal', 'injection', 'tumor', 'cells', 'accumulation', 'large', 'tumor', 'masses', 'mesentery', 'situ', 'perfusions', 'liver', 'tumor', 'cells', 'perfusion', 'medium', 'possible', 'tumor', 'cells', 'course', 'min', 'contrast', 'normal', 'rat', 'leukocytes', 'liver', 'trypsin', 'leukocytes', 'importance', 'trypsin', 'sensitive', 'structures', 'hepatic', 'tissue', 'binding', 'glioma', 'carcinoma', 'cells', 'liver', 'growth', 'tumor', 'nodules', 'organ', 'lack', 'specificity', 'part', 'malignant', 'cell', 'types', 'metastasis', 'liver', 'rat', 'tumor', 'cell', 'types', 'first', 'organ', 'injection']"
252,252,http://dialog.proquest.com/professional/docview/595136811?accountid=173210,Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies,"In 110 consecutive, medicolegal autopsies of young and middle-aged women (range 20-54 years) the breasts were examined by an extensive histopathologic method and by correlative specimen radiography. Malignancy was found in 22 women (20%) of which only one was known to have had clinical invasive breast cancer (IBC). At autopsy 2 women had IBC (2%), the remaining in situ carcinoma (in situ BC) of microfocal type (18%), i.e. 15 (14%) intraductal carcinomas (DCIS), 4 (3%) lobular carcinoma in situ (LCIS) and one (1%) both DCIS and LCIS. Forty-five per cent of the women with malignancy had multicentric and 41% had bilateral lesions. Forty-five per cent of all histologically confirmed malignant lesions were identified by specimen radiography. Adenosis, benign epithelial hyperplasia, papilloma and duct ectasia were positively associated with malignancy. In addition malignancy was significantly more frequent among women aged more than 40 years, with late age at first full-term pregnancy, with alcohol abuse and with steatosis or cirrhosis of the liver. The results suggest that clinically occult in situ BC are frequent in young and middle-aged women.","['Nielsen, M', 'Thomsen, J L', 'Primdahl, S', 'Dyreborg, U', 'Andersen, J A']","['Adult', 'Alcoholism', 'Breast', 'Breast Diseases', 'Breast Diseases', 'Breast Neoplasms', 'Breast Neoplasms', 'Breast Neoplasms', 'Carcinoma in Situ', 'Carcinoma in Situ', 'Carcinoma, Intraductal, Noninfiltrating', 'Carcinoma, Intraductal, Noninfiltrating', 'Denmark', 'Female', 'Humans', 'Hyperplasia', 'Hyperplasia', 'Liver Diseases, Alcoholic', 'Middle Aged']",ProQuest,"['medical images', 'computerized tomography']",liver carcinoma in situ,"['Breast', 'cancer', 'atypia', 'young', 'middle', 'aged', 'women', 'study', 'medicolegal', 'autopsies']","['consecutive', 'medicolegal', 'autopsies', 'young', 'middle', 'aged', 'women', 'years', 'breasts', 'extensive', 'histopathologic', 'method', 'correlative', 'specimen', 'radiography', 'women', '%', 'clinical', 'invasive', 'breast', 'cancer', 'autopsy', 'women', '%', 'situ', 'carcinoma', 'situ', 'microfocal', 'type', '%', '%', 'intraductal', 'carcinomas', '%', 'lobular', 'carcinoma', 'situ', '%', 'cent', 'women', 'malignancy', 'multicentric', '%', 'bilateral', 'lesions', 'cent', 'malignant', 'lesions', 'specimen', 'radiography', 'Adenosis', 'benign', 'epithelial', 'hyperplasia', 'papilloma', 'duct', 'ectasia', 'malignancy', 'addition', 'malignancy', 'frequent', 'women', 'more', 'years', 'late', 'age', 'first', 'full', 'term', 'pregnancy', 'alcohol', 'abuse', 'steatosis', 'cirrhosis', 'liver', 'results', 'occult', 'situ', 'frequent', 'young', 'middle', 'aged', 'women']"
253,253,http://dialog.proquest.com/professional/docview/595121648?accountid=173210,Results of a 5 years prospective study of estriol succinate treatment in patients with climacteric complaints,"In a prospective study 911 patients were treated over a period of 5 years (M = 2.2) or a total of 2007 treatment years with estriol succinate oral (Synapause, 2-12 mg per day). The treatment was very effective in the removal of all typical climacteric complaints and of the atrophic genital changes caused by estrogen deficiency. Subjective side effects were seldom seen and without practical importance for the treatment. Objective, grave side effects were only few: one superficial phlebo-thrombosis, 2 cases of thrombophlebitis, one carcinoma in situ of the portio vaginalis uteri and 2 mammary cancers were seen. The carcinoma had probably no causal relationship to the treatment. Embolies, myocardial infarctions, cerebrovascular and liver-gall bladder complications did not occur during treatment. The rate of uterine bleedings was low. The incidence of all complications was not increased by estriol succinate; but was even lower than expected. Endometrial and ovarian cancers were not seen. Estriol succinate is accordingly a very effective and well tolerated preparation against climacteric complaints, exerting no significant side effects. It is remarkable that it does not proliferate the endometrium when given in one dose a day. Estriol succinate can therefore be characterized as the estrogen to be favoured for the treatment of postclimacteric women, who do not want to have uterine bleedings any longer.(ABSTRACT TRUNCATED AT 250 WORDS)","['Lauritzen, C']","['Blood Pressure', 'Body Weight', 'Climacteric', 'Estriol', 'Estriol', 'Female', 'Humans', 'Prospective Studies']",ProQuest,"['natural language processing', 'part of speech', 'subjective quality assessments', 'qos']",liver carcinoma in situ,"['Results', 'years', 'prospective', 'study', 'estriol', 'succinate', 'treatment', 'patients', 'climacteric', 'complaints']","['prospective', 'study', 'patients', 'period', 'years', 'M', 'total', 'treatment', 'years', 'estriol', 'succinate', 'oral', 'mg', 'day', 'treatment', 'effective', 'removal', 'typical', 'climacteric', 'complaints', 'atrophic', 'genital', 'changes', 'estrogen', 'deficiency', 'Subjective', 'side', 'effects', 'practical', 'importance', 'treatment', 'Objective', 'grave', 'side', 'effects', 'few', 'superficial', 'phlebo', 'thrombosis', 'cases', 'thrombophlebitis', 'carcinoma', 'situ', 'portio', 'vaginalis', 'uteri', 'mammary', 'cancers', 'carcinoma', 'causal', 'relationship', 'treatment', 'Embolies', 'myocardial', 'infarctions', 'cerebrovascular', 'liver', 'gall', 'bladder', 'complications', 'treatment', 'rate', 'uterine', 'bleedings', 'low', 'incidence', 'complications', 'estriol', 'succinate', 'lower', 'Endometrial', 'ovarian', 'cancers', 'succinate', 'effective', 'tolerated', 'preparation', 'climacteric', 'complaints', 'significant', 'side', 'effects', 'remarkable', 'endometrium', 'dose', 'day', 'succinate', 'estrogen', 'treatment', 'postclimacteric', 'women', 'uterine', 'bleedings', 'longer.(ABSTRACT', 'WORDS']"
254,254,http://dialog.proquest.com/professional/docview/595000896?accountid=173210,Management of endoscopically removed malignant colon polyps,"The medical records of 87 patients with 89 malignant colorectal polyps removed endoscopically between 1971 and 1983 were reviewed retrospectively. Fifty-five polyps contained carcinoma-in-situ. Four polyps had ""pseudo-invasion"" by displaced mucosal glands. Thirty polyps contained invasive carcinoma. No patients with carcinoma-in-situ or ""pseudo-invasion"" had either local residual disease or metastatic disease at the time of colectomy or which was detected during subsequent follow-up. Four patients (14%) with invasive cancer would have been inadequately treated by polypectomy alone, since one had residual disease at the polypectomy site, one had nodal metastases, one had liver metastases at the time of colectomy, and one subsequently developed liver metastases. Three histologic criteria correctly predicted all four cases where residual or recurrent disease was present: involvement of the polypectomy resection margin, lymphatic invasion within the polyp, and poorly differentiated histology. Polyp size, histology (villous adenoma, adenomatous polyp, or villo-adenomatous polyp), or anatomic location did not identify those patients who warranted further therapy. We conclude that polypectomy alone is adequate treatment for polyps containing carcinoma-in-situ. Polypectomy alone is also adequate treatment for most polyps containing invasive carcinoma. However, patients with lymphatic involvement within the polyp, poorly differentiated cancer, or resection margin involvement should probably undergo colectomy.","['Conte, C C', 'Welch, J P', 'Tennant, R', 'Forouhar, F', 'Lundy, J', 'Bloom, G P']","['Adult', 'Aged', 'Aged, 80 and over', 'Carcinoma in Situ', 'Colonic Polyps', 'Colonic Polyps', 'Colonoscopy', 'Female', 'Humans', 'Liver Neoplasms', 'Male', 'Middle Aged']",ProQuest,"['records management', 'health records', 'location information', 'location based', 'ad hoc networks', 'wireless sensor networks', 'information technology', 'information management', 'telecommunication equipment', 'database systems', 'sensor networks', 'location based services']",liver carcinoma in situ,"['Management', 'malignant', 'colon', 'polyps']","['medical', 'records', 'patients', 'malignant', 'colorectal', 'polyps', 'polyps', 'carcinoma', 'situ', 'polyps', 'pseudo', 'invasion', 'mucosal', 'glands', 'polyps', 'invasive', 'carcinoma', 'patients', 'carcinoma', 'situ', 'pseudo', 'invasion', 'local', 'residual', 'disease', 'metastatic', 'disease', 'time', 'colectomy', 'subsequent', 'follow', 'up', 'patients', '%', 'invasive', 'cancer', 'polypectomy', 'residual', 'disease', 'polypectomy', 'site', 'nodal', 'metastases', 'liver', 'metastases', 'time', 'colectomy', 'liver', 'metastases', 'histologic', 'criteria', 'cases', 'residual', 'recurrent', 'disease', 'present', 'involvement', 'polypectomy', 'resection', 'margin', 'lymphatic', 'invasion', 'polyp', 'histology', 'size', 'histology', 'villous', 'adenoma', 'adenomatous', 'polyp', 'villo', 'adenomatous', 'polyp', 'anatomic', 'location', 'patients', 'further', 'therapy', 'polypectomy', 'adequate', 'treatment', 'polyps', 'carcinoma', 'situ', 'adequate', 'treatment', 'most', 'polyps', 'invasive', 'carcinoma', 'patients', 'lymphatic', 'involvement', 'polyp', 'cancer', 'resection', 'margin', 'involvement', 'colectomy']"
255,255,http://dialog.proquest.com/professional/docview/594795694?accountid=173210,Pancreatic carcinogenicity of N-nitrosobis(2-oxopropyl)-amine in diabetic and non-diabetic Chinese hamsters,"To examine the role of diabetes in pancreatic cancer, 4 groups of Chinese hamsters--2 from genetically diabetic and 2 from non-diabetic lines--were treated with N-nitrosobis(2-oxo-propyl)amine (BOP) at different dose levels and intervals. In one group (referred to as the VA group), BOP was given weekly at a 5 mg/kg body wt. level for 18 or 23 weeks, whereas the other group (the EP group) received a weekly dose of 2.5 mg/kg body wt. for life. Except for diet and experimental design, all other laboratory conditions were similar in the two institutions. No VA hamster developed tumors. Three of 22 non-diabetic EP hamsters (but none of the diabetic hamsters) developed pancreatic hyperplastic and neoplastic lesions, comprising ductular cell adenomas (3 hamsters), carcinoma in situ (1 hamster), a well-differentiated adenocarcinoma (1 hamster), and a poorly differentiated adenocarcinoma (1 hamster) with regional lymph node metastases. In addition, over 50% of the EP hamsters had neoplasms for which the incidences and morphology did not vary between diabetic and non-diabetic groups or between the sexes. These were primarily of the liver (cholangiomas), lungs (adenomas) and skin (trichoepitheliomas, squamous cell carcinomas). The differing carcinogenic response of the two hamster groups to BOP apparently is not related to the total BOP dose, but rather to other factors, including the length of observation time.","['Bell, R H, Jr', 'Pour, P M']","['Animals', 'Blood Glucose', 'Body Weight', 'Carcinogens', 'Cricetinae', 'Cricetulus', 'Diabetes Mellitus, Experimental', 'Female', 'Liver Neoplasms, Experimental', 'Lung Neoplasms', 'Male', 'Nitrosamines', 'Pancreatic Neoplasms', 'Skin Neoplasms', 'Species Specificity']",ProQuest,"['intelligent systems', 'software architecture', 'destination nodes', 'ad hoc networks', 'wireless sensor networks', 'prototyping', 'wireless networks', 'intermediate node', 'architecture designs', 'software development', 'education', 'systems design', 'sensor networks', 'university', 'network coding', 'intelligent control', 'routing protocols']",liver carcinoma in situ,"['Pancreatic', 'carcinogenicity', 'nitrosobis(2-oxopropyl)-amine', 'diabetic', 'non', '-', 'diabetic', 'Chinese', 'hamsters']","['role', 'diabetes', 'pancreatic', 'cancer', 'groups', 'diabetic', 'non', '-', 'diabetic', 'lines', 'different', 'dose', 'levels', 'intervals', 'group', 'group', 'mg', 'body', 'wt', 'level', 'weeks', 'other', 'group', 'group', 'weekly', 'dose', 'mg', 'body', 'wt', 'life', 'diet', 'experimental', 'design', 'other', 'laboratory', 'conditions', 'similar', 'institutions', 'hamster', 'tumors', 'non', '-', 'diabetic', 'hamsters', 'none', 'diabetic', 'hamsters', 'pancreatic', 'hyperplastic', 'neoplastic', 'lesions', 'ductular', 'cell', 'adenomas', 'hamsters', 'carcinoma', 'situ', 'hamster', 'adenocarcinoma', 'hamster', 'differentiated', 'adenocarcinoma', 'hamster', 'regional', 'lymph', 'node', 'metastases', 'addition', '%', 'hamsters', 'neoplasms', 'incidences', 'morphology', 'diabetic', 'non', '-', 'diabetic', 'groups', 'sexes', 'liver', 'cholangiomas', 'lungs', 'adenomas', 'skin', 'trichoepitheliomas', 'squamous', 'cell', 'carcinomas', 'carcinogenic', 'response', 'hamster', 'groups', 'total', 'BOP', 'dose', 'other', 'factors', 'length', 'observation', 'time']"
256,256,http://dialog.proquest.com/professional/docview/595101905?accountid=173210,Cellular distribution and hormonal regulation of h-SBP in human hepatoma cells,"The cellular distribution of human Sex Steroid Binding Plasma Protein (h-SBP) was studied in human cells and tissues by indirect immunofluorescence. h-SBP was detected in the cytoplasm of hepatocytes, of prostate and epididymis epithelial cells and in endometrium. Sexual and non-sexual skin, intestine epithelium, striated muscle and some rodent organs were not labelled. The intracellular localization of h-SBP indicate that h-SBP could be taken up from the extracellular compartment or synthesized in situ in sex steroid target organs, where it may play a role in hormone uptake. The hormonal regulation of h-SBP secretion by a human hepatoma cell line, H5A, showed that tri-iodothyronine was more potent than estradiol or tamoxifen, which acted as estrogen agonist, in increasing secreted h-SBP and the combined effect of both thyroid and estrogen hormones resulted in an additive stimulation of h-SBP secretion. As shown by Northern blot analysis, oligonucleotides synthesized from the known sequence of h-SBP hybridized with a RNA of approximately 2 kb which was more represented in H5A cells than in normal human liver, and was increased 2-3 times after hormonal stimulation of the cells. The presence of a poly(A+)RNA coding for h-SBP in the human liver indicated the hepatic synthesis of this protein.","['Mercier-Bodard, C', 'Radanyi, C', 'Roux, C', 'Groyer, M T', 'Robel, P', 'Dadoune, J P', 'Petra, P H', 'Jolly, D J', 'Baulieu, E E']","['Animals', 'Carcinoma, Hepatocellular', 'Dexamethasone', 'Dihydrotestosterone', 'Endometrium', 'Epididymis', 'Female', 'Humans', 'Liver Neoplasms', 'Male', 'Mice', 'Muscles', 'Neoplasm Proteins', 'Organ Specificity', 'Phenolsulfonphthalein', 'Progesterone', 'Prostate', 'Rats', 'Sex Hormone-Binding Globulin', 'Skin', 'Tamoxifen', 'Tumor Cells, Cultured', 'Tumor Cells, Cultured', 'Viscera']",ProQuest,"['cellular', 'target tracking', 'cellular telephone systems', 'wireless sensor networks', 'localization technique', 'wireless', 'cellular radio systems', 'channel capacity', 'localization algorithm', 'cellular network', 'sensor networks', 'cellular system', 'target localization']",liver carcinoma in situ,"['Cellular', 'distribution', 'hormonal', 'regulation', 'human', 'hepatoma', 'cells']","['cellular', 'distribution', 'human', 'human', 'cells', 'tissues', 'indirect', 'immunofluorescence', 'cytoplasm', 'hepatocytes', 'prostate', 'epithelial', 'cells', 'endometrium', 'Sexual', 'non', '-', 'sexual', 'skin', 'intestine', 'epithelium', 'muscle', 'rodent', 'organs', 'intracellular', 'localization', 'extracellular', 'compartment', 'situ', 'sex', 'steroid', 'target', 'organs', 'role', 'hormone', 'uptake', 'hormonal', 'regulation', 'secretion', 'human', 'hepatoma', 'cell', 'line', 'tri', 'iodothyronine', 'potent', 'estradiol', 'tamoxifen', 'estrogen', 'agonist', 'secreted', 'combined', 'effect', 'thyroid', 'estrogen', 'hormones', 'additive', 'stimulation', 'secretion', 'Northern', 'blot', 'analysis', 'sequence', 'RNA', 'kb', 'represented', 'cells', 'normal', 'human', 'liver', 'times', 'hormonal', 'stimulation', 'cells', 'presence', 'human', 'liver', 'hepatic', 'synthesis', 'protein']"
257,257,http://dialog.proquest.com/professional/docview/594961732?accountid=173210,Gallbladder cancer as unexpected histologic diagnosis following cholecystectomy for cholelithiasis and cholecystitis,"Uncharacteristic symptoms, inadequate early diagnosis, and high malignancy are the major reasons why most of the patients with carcinoma of gallbladder are not admitted for clinical examination until metastasation had begun to involve the liver. So, the majority of authors who have made contributions to the literature are in agreement to the effect that the prognosis is extremely poor for patients with gallbladder carcinoma and that curative therapy is possible only in rare cases. There are only few reports on cases on whom operations could be performed in good time. Curable gallbladder carcinoma is more often than not an absolutely accidental finding obtained in the course of surgical treatment for cholelithiasis. Reported in this paper are four cases in which malignant lesions to mucosa were accidentally discovered by pathologists in histological examination of specimens obtained from cholecystectomy for cholecystolithiasis and cholecystitis. Problems involved in therapeutic action are discussed.","['Sons, H U', 'Dingels, W R', 'K√ºckelhaus, H G']","['Adenocarcinoma', 'Aged', 'Aged, 80 and over', 'Carcinoma in Situ', 'Carcinoma, Squamous Cell', 'Cholecystectomy', 'Cholecystitis', 'Cholecystitis', 'Cholelithiasis', 'Cholelithiasis', 'Female', 'Follow-Up Studies', 'Gallbladder', 'Gallbladder Neoplasms', 'Gallbladder Neoplasms', 'Humans', 'Male', 'Middle Aged', 'Neoplasms, Multiple Primary', 'Precancerous Conditions']",ProQuest,[],liver carcinoma in situ,"['Gallbladder', 'cancer', 'unexpected', 'histologic', 'diagnosis', 'cholecystectomy', 'cholelithiasis', 'cholecystitis']","['Uncharacteristic', 'symptoms', 'inadequate', 'early', 'diagnosis', 'high', 'malignancy', 'major', 'reasons', 'most', 'patients', 'carcinoma', 'gallbladder', 'clinical', 'examination', 'metastasation', 'liver', 'majority', 'authors', 'contributions', 'literature', 'agreement', 'effect', 'prognosis', 'poor', 'patients', 'gallbladder', 'carcinoma', 'curative', 'therapy', 'possible', 'rare', 'cases', 'few', 'reports', 'cases', 'operations', 'good', 'time', 'Curable', 'gallbladder', 'carcinoma', 'accidental', 'finding', 'course', 'surgical', 'treatment', 'cholelithiasis', 'paper', 'cases', 'malignant', 'lesions', 'mucosa', 'pathologists', 'histological', 'examination', 'specimens', 'cholecystectomy', 'cholecystolithiasis', 'cholecystitis', 'Problems', 'therapeutic', 'action']"
258,258,http://dialog.proquest.com/professional/docview/594496831?accountid=173210,Varying nuclear staining intensity of hepatitis B virus DNA in human hepatocellular carcinoma,"An in situ hybridization technique with biotinylated hepatitis B virus (HBV)-DNA probes was used to localize HBV-related DNA sequences in cells of human hepatocellular carcinoma (HCC). Formalin fixed, paraffin-embedded liver biopsies of 11 patients with HCC studied; nuclear HBV-DNA hybridization was observed in 7 of the patients. Sensitivity and specificity of the method were determined by examining appropriate controls. The number of cells exhibiting nuclear fluorescence and intensity of fluorescence varied from tumor to tumor. In two instances liver tissue adjacent to HCC exhibited nuclear staining. HBV-DNA nuclear staining did not correlate with tumor localization of HBsAg or HBcAg, nor with type or with differentiation of the tumor. The use of biotinylated HBV-DNA probes offers a powerful and reproducible technique to localize HBV-related DNA sequences even in formalin-fixed, paraffin-embedded tumor tissue, and also to compare the presence of HBV-DNA with that of viral antigens stained in parallel sections. The frequent localization of HBV-DNA in nuclei of HCC cells fortifies the important epidemiologic association between infection and HCC. The random cellular localization of HBV-DNA sequences in HCC suggests that HBV-DNA may be incorporated, or perhaps replicated, unequally in tumor cells.","['Brambilla, C', 'Tackney, C', 'Hirschman, S Z', 'Colombo, M', 'Dioguardi, M L', 'Donato, M F', 'Paronetto, F']","['Adult', 'Base Sequence', 'Carcinoma, Hepatocellular', 'Cell Nucleus', 'DNA, Viral', 'Hepatitis B Surface Antigens', 'Hepatitis B virus', 'Humans', 'Liver Neoplasms', 'Middle Aged', 'Nucleic Acid Hybridization', 'Staining and Labeling']",ProQuest,"['cellular', 'target tracking', 'cellular telephone systems', 'localization system', 'wireless sensor networks', 'localization technique', 'wireless', 'cellular radio systems', 'security of data', 'malwares', 'malicious codes', 'localization algorithm', 'robot applications', 'sensor networks', 'computer viruses', 'target localization', 'intrusion detection']",liver carcinoma in situ,"['nuclear', 'intensity', 'virus', 'DNA', 'human', 'hepatocellular', 'carcinoma']","['situ', 'hybridization', 'technique', 'biotinylated', 'hepatitis', 'virus', 'HBV)-DNA', 'probes', 'sequences', 'cells', 'human', 'hepatocellular', 'carcinoma', 'paraffin', 'liver', 'biopsies', 'patients', 'nuclear', 'hybridization', 'patients', 'Sensitivity', 'specificity', 'method', 'appropriate', 'controls', 'number', 'cells', 'nuclear', 'fluorescence', 'intensity', 'fluorescence', 'tumor', 'tumor', 'instances', 'liver', 'tissue', 'adjacent', 'nuclear', 'staining', 'nuclear', 'staining', 'tumor', 'localization', 'type', 'differentiation', 'tumor', 'use', 'biotinylated', 'probes', 'powerful', 'reproducible', 'technique', 'formalin', 'paraffin', 'tumor', 'tissue', 'presence', 'viral', 'antigens', 'parallel', 'sections', 'frequent', 'localization', 'nuclei', 'cells', 'fortifies', 'important', 'epidemiologic', 'association', 'infection', 'random', 'cellular', 'localization', 'sequences', 'tumor', 'cells']"
259,259,http://dialog.proquest.com/professional/docview/594380802?accountid=173210,Integration of hepatitis B virus DNA in chromosome-specific satellite sequences,We previously reported the cloning and detailed analysis of the integrated hepatitis B virus sequences in a human hepatoma cell line. We report here the integration of at least one of hepatitis B virus at human satellite DNA sequences. The majority of the cellular sequences identified by this satellite DNA were organized as a multimeric composition of a 0.6-kilobase EcoRI fragment. This clone hybridized in situ almost exclusively to the centromeric heterochromatin of chromosomes 1 and 16 and to a lower extent to chromosome 2 and to the heterochromatic region of the Y chromosome. The immediate flanking host sequence appeared as a hierarchy of repeating units which were almost identical to a previously reported human satellite III DNA sequence.,"['Shaul, Y', 'Garcia, P D', 'Schonberg, S', 'Rutter, W J']","['Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Line', 'Chromosomes, Human', 'Chromosomes, Human, 1-3', 'Chromosomes, Human, 16-18', 'DNA, Satellite', 'DNA, Viral', 'Hepatitis B virus', 'Humans', 'Liver Neoplasms', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'Recombination, Genetic', 'Repetitive Sequences, Nucleic Acid', 'Y Chromosome']",ProQuest,"['cellular telephone systems', 'wireless', 'geostationary satellites', 'cellular radio systems', 'security of data', 'genetic operators', 'evolutionary algorithms', 'satellite system', 'computer viruses', 'cellular', 'communication satellites']",liver carcinoma in situ,"['Integration', 'virus', 'DNA', 'chromosome', 'specific', 'satellite', 'sequences']","['cloning', 'detailed', 'analysis', 'hepatitis', 'virus', 'human', 'hepatoma', 'cell', 'line', 'integration', 'hepatitis', 'virus', 'human', 'satellite', 'DNA', 'majority', 'cellular', 'sequences', 'satellite', 'DNA', 'multimeric', 'composition', 'fragment', 'clone', 'situ', 'centromeric', 'heterochromatin', 'chromosomes', 'lower', 'extent', 'heterochromatic', 'region', 'chromosome', 'immediate', 'flanking', 'host', 'sequence', 'hierarchy', 'units', 'identical', 'human', 'satellite', 'DNA', 'sequence']"
260,260,http://dialog.proquest.com/professional/docview/594117275?accountid=173210,Cancer risks and the contraceptive pill. What is the evidence after nearly 25 years of use?,"The question of whether the steroidal components in oral contraceptives (OCs) may have an initiating or promotional influence on the development of cancer continues to be raised as a public health issue.  It is estimated that since the introduction of OCs nearly 25 years ago, more than 150 million women have used 1 or more types of the formulation and nearly 1 billion woman-years of exposure to the steroids have accumulated.  Contraceptive practice in Australia would indicate that about 25% of women of reproductive age are using OCs.  The debate about the OC's carcinogenic potential has recently been reopened with 2 reports in ""The Lancet"" of an association between the incidence of breast and cervical cancer and OC usage.  Biologically the relationship between the contraceptive steroids and cancer must continue to be regarded as the most important concern with the longterm use of OCs.  The demonstration of receptors to these steriods in these organs, in both normal and malignant tissues, further increases the speculation that the steroid hormones have a biological role in carcinogenesis in these target organs.  Theoretical reasons exist for the concern about carcinogenesis and contraceptive steroids.  This paper reviews the available evicence.  Data can be derived only from large-scale epidemiological research, by means of case-control or cohort studies.  No clear evidence exists that OCs cause or increase the chance of developing any cancer in the female genital tract and the breast.  In fact, OC offers a significant protection against the development of endometrial and ovarian cancer, especially to those women who have taken OCs for a long time.  The association between the risk of breast cancer and OC use is less certain, but factors such as the history of benign breast disease, a close relationship with breast cancer, or nulliparity -- previously considered to be important -- do not appear to contribute significantly to the risk.  The weight of evidence indicates that no increased risk of breast cancer exists, even in those younger women aged less than 25 years who decide to use OCs before their 1st full-term pregnancy.  There is some evidence that suggests that the risk of cervical neoplasia -- dysplasia, carcinoma-in-situ and invasive carcinoma -- may increase slightly in OC users but the actual part played by the patient's sexual history under these circumstances remains to be defined.  There is now strong evidence to implicate multiplicity of sexual partners and wart virus infection in carcinogenesis of the uterine cervix.  There does not appear to be an overall relationship between OCs and malignant melanoma.  Overall, the evidence is reassuring.  The low-dose combined OC can be considered safe, not only in terms of cardiovascular and thromboembolic risks, but also in relation to carcinogenesis.","['Khoo, S K']","['Adenoma', 'Adolescent', 'Adult', 'Aged', 'Australia', 'Breast Neoplasms', 'Contraceptives, Oral', 'Female', 'Humans', 'Liver Neoplasms', 'Maternal Age', 'Melanoma', 'Menarche', 'Menopause', 'Middle Aged', 'Neoplasms', 'Ovarian Neoplasms', 'Parity', 'Pituitary Neoplasms', 'Pregnancy', 'Risk', 'Sexual Behavior', 'Uterine Cervical Neoplasms', 'Uterine Neoplasms']",ProQuest,"['parity bits', 'perceived risk', 'electronic commerce', 'component', 'software', 'intelligent robots', 'security issues', 'security systems', 'information systems', 'demonstrations', 'wyner-ziv', 'distributed video coding', 'robot programming', 'security risks', 'turbo codes']",liver carcinoma in situ,"['Cancer', 'risks', 'contraceptive', 'pill', 'evidence', 'years', 'use']","['question', 'steroidal', 'components', 'oral', 'contraceptives', 'OCs', 'initiating', 'promotional', 'influence', 'development', 'cancer', 'public', 'health', 'issue', 'introduction', 'OCs', 'years', 'more', 'women', 'more', 'types', 'formulation', 'woman', 'years', 'exposure', 'steroids', 'Contraceptive', 'practice', '%', 'women', 'reproductive', 'age', 'OCs', 'debate', 'carcinogenic', 'potential', 'reports', 'association', 'incidence', 'breast', 'cervical', 'cancer', 'usage', 'relationship', 'contraceptive', 'steroids', 'cancer', 'important', 'concern', 'longterm', 'use', 'OCs', 'demonstration', 'receptors', 'steriods', 'organs', 'normal', 'malignant', 'tissues', 'speculation', 'steroid', 'hormones', 'biological', 'role', 'carcinogenesis', 'target', 'organs', 'Theoretical', 'reasons', 'concern', 'carcinogenesis', 'contraceptive', 'steroids', 'paper', 'available', 'evicence', 'large', 'scale', 'epidemiological', 'research', 'means', 'case', 'control', 'cohort', 'studies', 'clear', 'evidence', 'OCs', 'chance', 'cancer', 'female', 'genital', 'tract', 'breast', 'fact', 'significant', 'protection', 'development', 'endometrial', 'ovarian', 'cancer', 'women', 'OCs', 'long', 'time', 'association', 'risk', 'breast', 'cancer', 'OC', 'use', 'certain', 'factors', 'such', 'history', 'benign', 'breast', 'disease', 'close', 'relationship', 'breast', 'cancer', 'nulliparity', 'important', 'risk', 'weight', 'evidence', 'risk', 'breast', 'cancer', 'younger', 'women', 'less', 'years', 'OCs', '1st', 'full', 'term', 'pregnancy', 'evidence', 'risk', 'cervical', 'neoplasia', 'dysplasia', 'carcinoma', 'situ', 'invasive', 'carcinoma', 'users', 'actual', 'part', 'patient', 'sexual', 'history', 'circumstances', 'strong', 'evidence', 'multiplicity', 'sexual', 'partners', 'wart', 'virus', 'infection', 'carcinogenesis', 'uterine', 'cervix', 'overall', 'relationship', 'OCs', 'malignant', 'melanoma', 'evidence', 'low', 'dose', 'OC', 'safe', 'terms', 'cardiovascular', 'thromboembolic', 'risks', 'relation', 'carcinogenesis']"
261,261,http://dialog.proquest.com/professional/docview/594114262?accountid=173210,In vivo lactate production and utilization by Jensen sarcoma and Morris hepatoma 7288CTC,"These experiments were designed to determine the characteristics of lactic acid utilization and production in vivo in Jensen sarcoma and Morris hepatoma 7288CTC. Arteriovenous differences for lactic and pyruvic acids, glucose, and the ketone bodies were measured across ""tissue-isolated"" tumors growing in fed and fasted rats. Lactic acid was utilized (n = 18), produced (n = 24), or neither utilized nor produced (n = 1) by the tumors. Net tumor lactate production or utilization did not depend on the mean rate of glucose utilization which was the same in the lactate-utilizing and -producing tumors. For the lactic acid-utilizing tumors, the mean arterial whole blood lactate concentration entering the tumor was 3.47 +/- 0.39 mM, and the concentration in the tumor venous blood was 2.31 +/- 0.25 mM. For the lactic acid-producing tumors, the mean arterial lactic acid concentration was 1.29 +/- 0.10 mM, and the tumor venous blood concentration was 2.19 +/- 0.19 mM. Thus, both lactate-producing and lactate-utilizing tumors showed identical rates of glucose utilization and identical lactic acid concentrations in the venous blood leaving the tumors. Metabolite levels were also measured in tumors that were freeze clamped in situ immediately following collection of the arterial and tumor venous blood samples. The lactic acid content in the tumor mass (corrected for total tumor water) and the concentration in the tumor venous blood plasma were nearly identical, suggesting that the lactate concentrations in the tumor cells and tumor venous blood are at equilibrium. Transport of lactic acid between arterial plasma and tumor or between tumor and venous plasma was always down a concentration gradient; net lactate uptake and release in these tumors followed the law of mass action. High lactate concentrations were not observed in the Jensen sarcomas or in the venous blood leaving these tumors, and we were unable to confirm earlier studies indicating that Jensen sarcomas are consistently high net lactate producers in vivo.","['Sauer, L A', 'Dauchy, R T']","['Animals', 'Carcinoma 256, Walker', 'Female', 'Glucose', 'Glycine', 'Hydroxybutyrates', 'Lactates', 'Liver Neoplasms, Experimental', 'Male', 'Pyruvates', 'Rats', 'Sarcoma, Experimental']",ProQuest,"['nash equilibrium', 'multimedia services', 'world wide web', 'digital rights management', 'digital contents', 'multimedia contents', 'web page', 'game theory']",liver carcinoma in situ,"['vivo', 'production', 'utilization', 'sarcoma', 'hepatoma']","['experiments', 'characteristics', 'lactic', 'acid', 'utilization', 'production', 'vivo', 'sarcoma', 'hepatoma', 'Arteriovenous', 'differences', 'lactic', 'pyruvic', 'acids', 'glucose', 'ketone', 'bodies', 'tissue', 'tumors', 'fed', 'rats', 'Lactic', 'acid', 'tumors', 'Net', 'tumor', 'production', 'utilization', 'mean', 'rate', 'glucose', 'utilization', 'same', 'lactate', 'tumors', 'lactic', 'acid', 'tumors', 'mean', 'arterial', 'whole', 'blood', 'lactate', 'concentration', 'tumor', 'mM', 'concentration', 'tumor', 'venous', 'blood', 'lactic', 'acid', 'tumors', 'mean', 'arterial', 'lactic', 'acid', 'concentration', 'tumor', 'venous', 'blood', 'concentration', 'mM.', 'tumors', 'identical', 'rates', 'glucose', 'utilization', 'identical', 'lactic', 'acid', 'concentrations', 'venous', 'blood', 'tumors', 'Metabolite', 'levels', 'tumors', 'freeze', 'situ', 'collection', 'arterial', 'tumor', 'venous', 'blood', 'samples', 'lactic', 'acid', 'content', 'tumor', 'mass', 'total', 'tumor', 'water', 'concentration', 'tumor', 'venous', 'blood', 'plasma', 'identical', 'lactate', 'concentrations', 'tumor', 'cells', 'tumor', 'venous', 'blood', 'equilibrium', 'Transport', 'lactic', 'acid', 'arterial', 'plasma', 'tumor', 'tumor', 'venous', 'plasma', 'concentration', 'gradient', 'net', 'lactate', 'uptake', 'tumors', 'law', 'mass', 'action', 'High', 'lactate', 'concentrations', 'sarcomas', 'venous', 'blood', 'tumors', 'unable', 'earlier', 'studies', 'sarcomas', 'high', 'net', 'lactate', 'producers', 'vivo']"
262,262,http://dialog.proquest.com/professional/docview/594344849?accountid=173210,"Different sensitivity of two Walker 256 carcinoma lines to cyclophosphamide: correlation with drug distribution, biotransformation and macromolecule binding","Two closely related lines of the same Walker 256 carcinoma in Crl-CD/COBS rats, described as behaving differently as regards tumor growth and host reaction, show different chemotherapeutic sensitivity to cyclophosphamide (CPA). Line B, which induces early cachexia with marked anorexia, is only moderately sensitive to CPA, while line A, which causes mild anorexia and only terminal cachexia, shows marked responsiveness to CPA, cure being attained in 75% of animals treated with a single dose of 120 mg/kg and in 90-100% of those given 20 mg/kg every other day. Comparative studies in both tumor lines on the distribution of CPA in vivo and on its metabolism by the liver perfusion technique showed no appreciable differences between the two lines in the pharmacokinetics of the compound, but indicate a much greater metabolizing capacity of CPA in the Walker 256/A animals. In vitro metabolic and covalent binding studies confirm that the liver of the Walker 256/A group metabolizes and covalently binds twice as much CPA as the liver of the Walker 256/B group. Conversely to Walker B, microsomal preparations of the Walker tumor line A are able to metabolize CPA to intermediates which irreversibly bind to tissue macromolecules, suggesting an in situ activation of the compound in the sensitive Walker tumor.","['Donelli, M G', 'Guaitani, A', 'Torti, L', 'Damia, G', 'Corti, F', 'Bianchi, M', 'Tortoreto, M', 'Pantarotto, C', 'Bartosek, I']","['Animals', 'Biotransformation', 'Carcinoma 256, Walker', 'Carcinoma 256, Walker', 'Carcinoma 256, Walker', 'Cell Line', 'Chemotherapy, Cancer, Regional Perfusion', 'Chromatography, Gas', 'Cyclophosphamide', 'Cyclophosphamide', 'Cyclophosphamide', 'Kinetics', 'Liver', 'Microsomes, Liver', 'Neoplasm Invasiveness', 'Neoplasm Metastasis', 'Protein Binding', 'Rats', 'Rats, Inbred Strains', 'Tissue Distribution']",ProQuest,"['mobile telecommunication systems', 'noc', 'transmission capacities', 'ad hoc networks', 'mobile phones', 'correlation analysis', 'interfaces (computer)', 'correlation coefficient', 'mobile terminal', 'network interface', 'mathematics', 'multiplexing']",liver carcinoma in situ,"['Different', 'sensitivity', 'carcinoma', 'lines', 'correlation', 'drug', 'distribution', 'biotransformation', 'macromolecule', 'binding']","['related', 'lines', 'same', 'carcinoma', 'COBS', 'rats', 'regards', 'tumor', 'growth', 'host', 'reaction', 'different', 'chemotherapeutic', 'sensitivity', 'cyclophosphamide', 'Line', 'cachexia', 'anorexia', 'sensitive', 'CPA', 'line', 'mild', 'anorexia', 'only', 'terminal', 'cachexia', 'responsiveness', 'CPA', 'cure', 'being', '%', 'animals', 'single', 'dose', 'mg', 'kg', '%', 'mg', 'other', 'day', 'Comparative', 'studies', 'tumor', 'lines', 'distribution', 'CPA', 'vivo', 'metabolism', 'liver', 'perfusion', 'technique', 'appreciable', 'differences', 'lines', 'pharmacokinetics', 'compound', 'greater', 'metabolizing', 'capacity', 'CPA', 'animals', 'vitro', 'metabolic', 'covalent', 'binding', 'studies', 'liver', 'group', 'metabolizes', 'much', 'CPA', 'liver', 'group', 'microsomal', 'preparations', 'tumor', 'line', 'able', 'CPA', 'intermediates', 'macromolecules', 'situ', 'activation', 'compound', 'sensitive', 'tumor']"
263,263,http://dialog.proquest.com/professional/docview/594161065?accountid=173210,Intestinal-type adenocarcinoma of the gallbladder. A clinicopathologic study of seven cases,"Seven examples of a distinctive morphological variant of well-differentiated adenocarcinoma of the gallbladder with intestinal features are reported. Four tumors were composed predominantly of goblet cells and absorptive columnar cells, two of which had, in addition, a few Paneth cells and neuroendocrine cells. Three neoplasms closely resembled colonic carcinoma, and one of these also contained neuroendocrine cells. Serotonin-immunoreactive cells were demonstrated in three of the seven intestinal-type adenocarcinomas, two of which also had cells that stained for somatostatin pancreatic polypeptide and cholecystokinin. Four adenocarcinomas were associated with cholelithiasis, and three with intestinal metaplasia of the uninvolved mucosa. Despite the well-differentiated character of all neoplasms and the deceptively benign microscopic appearance of two of them, three patients died with extension to the liver and metastasis. Of the two survivors, one had carcinoma in situ and the other had a carcinoma that extended only to the muscle layer of the gallbladder. The various cell phenotypes found in these gallbladder adenocarcinomas can be explained on the basis of intestinal differentiation.","['Albores-Saavedra, J', 'Nadji, M', 'Henson, D E']","['Adenocarcinoma', 'Aged', 'Cell Differentiation', 'Female', 'Gallbladder Neoplasms', 'Humans', 'Intestines', 'Male', 'Middle Aged', 'Serotonin']",ProQuest,"['negative permittivity', 'fuzzy sets', 'feature space', 'object tracking', 'classification methods', 'linear matrix inequalities', 'pattern recognition', 'illustrative examples', 'metamaterials', 'refractometers', 'object appearance', 'negative refractive index']",liver carcinoma in situ,"['Intestinal', 'type', 'adenocarcinoma', 'gallbladder', 'clinicopathologic', 'study', 'cases']","['examples', 'distinctive', 'morphological', 'variant', 'adenocarcinoma', 'gallbladder', 'intestinal', 'features', 'tumors', 'goblet', 'cells', 'absorptive', 'columnar', 'cells', 'addition', 'few', 'cells', 'neuroendocrine', 'cells', 'neoplasms', 'colonic', 'carcinoma', 'neuroendocrine', 'cells', 'Serotonin', 'immunoreactive', 'cells', 'intestinal', 'type', 'adenocarcinomas', 'cells', 'somatostatin', 'pancreatic', 'polypeptide', 'cholecystokinin', 'adenocarcinomas', 'cholelithiasis', 'intestinal', 'metaplasia', 'uninvolved', 'mucosa', 'character', 'neoplasms', 'benign', 'microscopic', 'appearance', 'patients', 'extension', 'liver', 'metastasis', 'survivors', 'carcinoma', 'situ', 'other', 'carcinoma', 'muscle', 'layer', 'gallbladder', 'various', 'cell', 'phenotypes', 'gallbladder', 'adenocarcinomas', 'basis', 'intestinal', 'differentiation']"
264,264,http://dialog.proquest.com/professional/docview/594540030?accountid=173210,A curative surgical approach to gallbladder carcinoma in its early stages,"The study is based on 20 personal cases of gallbladder cancer and 254 similar cases from five surgical departments. The contradictory results obtained by surgery are explained by the special structure of the gallbladder wall and the bipolar connections with the liver and lymphatic ducts. Personal experience and literature reports evidence the possibility of cure for various stages: macroscopic lesions, while qualified as early stages are actually already advanced and necessitate extended liver resection with considerable lymph node dissections; the so-called early stage, detectable solely by histology, is harmful since the entire thickness of the mucosa is involved and always requires enlarged cholecystectomy to include the liver and lymph nodes. In this case good survival rates are possible; in situ pre-epithelial lesions diagnosed by cytology, are amenable to cure by simple cholecystectomy. Prevention rests on a wide range of indications for cholecystectomy (lithiasis, female sex, age over 50 years).","['Isman, H', 'Bourgeon, R']","['Adult', 'Female', 'Gallbladder Neoplasms', 'Gallbladder Neoplasms', 'Gallbladder Neoplasms', 'Humans', 'Male', 'Methods', 'Middle Aged', 'Neoplasm Staging']",ProQuest,"['cbr', 'destination nodes', 'ad hoc networks', 'wireless sensor networks', 'wireless networks', 'intermediate node', 'similar case', 'education', 'sensor networks', 'case based reasoning', 'university', 'network coding', 'case base', 'routing protocols']",liver carcinoma in situ,"['curative', 'surgical', 'approach', 'carcinoma', 'early', 'stages']","['study', 'personal', 'cases', 'gallbladder', 'cancer', 'similar', 'cases', 'surgical', 'departments', 'contradictory', 'results', 'surgery', 'special', 'structure', 'gallbladder', 'wall', 'bipolar', 'connections', 'liver', 'lymphatic', 'ducts', 'Personal', 'experience', 'literature', 'evidence', 'possibility', 'cure', 'various', 'stages', 'macroscopic', 'lesions', 'qualified', 'early', 'stages', 'advanced', 'necessitate', 'extended', 'liver', 'resection', 'considerable', 'lymph', 'node', 'dissections', 'early', 'stage', 'detectable', 'histology', 'harmful', 'entire', 'thickness', 'mucosa', 'enlarged', 'cholecystectomy', 'liver', 'lymph', 'nodes', 'case', 'good', 'survival', 'rates', 'possible', 'situ', 'pre', '-', 'epithelial', 'lesions', 'cytology', 'amenable', 'simple', 'cholecystectomy', 'Prevention', 'wide', 'range', 'indications', 'cholecystectomy', 'lithiasis', 'female', 'sex', 'age', 'years']"
265,265,http://dialog.proquest.com/professional/docview/594646246?accountid=173210,Pancreatic lesions induced by a single dose of N-nitrosobis(2-oxopropyl)amine and selection by resistance to cytotoxicity,"The experiments reported here were undertaken to ascertain whether the principle of the selection and rapid emergence of carcinogen-initiated cells based on their resistance to cytotoxicity demonstrated in rat liver is applicable to hamster pancreas. Hamsters injected with a single dose of 70 mg/kg body weight of the pancreatic carcinogen, N-nitrosobis(2-oxopropyl)amine, were subjected to pancreatic injury and regeneration induced by DL ethionine followed by methionine rescue while on a continuous daily regimen of 10 mg/kg body weight of N-nitroso-2,6-dimethylmorpholine by gavage. Randomly selected animals were killed weekly from the 4th week following the induction of regeneration through the 10th week. This carcinogenic schedule significantly decreased the time of emergence of cell injury, cell death, and proliferative, preneoplastic, and neoplastic lesions of the exocrine pancreas. Carcinoma in situ and invasive adenocarcinoma of pancreatic ducts appeared during the 7th and 8th week after induction of pancreatic regeneration, earlier than results obtained with multiple dose carcinogenesis experiments.","['Scarpelli, D G', 'Subbarao, V', 'Rao, M S']","['Animals', 'Cell Survival', 'Cricetinae', 'Drug Resistance', 'Male', 'Mesocricetus', 'Nitrosamines', 'Pancreas', 'Pancreas', 'Pancreatic Ducts', 'Pancreatic Ducts', 'Pancreatic Neoplasms', 'Pancreatic Neoplasms']",ProQuest,"['kaplan-meiers estimate', 'proportional hazards models']",liver carcinoma in situ,"['Pancreatic', 'lesions', 'single', 'dose', 'nitrosobis(2-oxopropyl)amine', 'selection', 'resistance', 'cytotoxicity']","['experiments', 'principle', 'selection', 'rapid', 'emergence', 'carcinogen', 'cells', 'resistance', 'cytotoxicity', 'rat', 'liver', 'applicable', 'hamster', 'pancreas', 'Hamsters', 'single', 'dose', 'mg', 'body', 'weight', 'pancreatic', 'carcinogen', 'pancreatic', 'injury', 'regeneration', 'ethionine', 'methionine', 'rescue', 'continuous', 'daily', 'regimen', 'mg', 'body', 'weight', 'gavage', 'animals', '4th', 'week', 'induction', 'regeneration', '10th', 'week', 'carcinogenic', 'schedule', 'time', 'emergence', 'cell', 'injury', 'cell', 'death', 'proliferative', 'preneoplastic', 'neoplastic', 'lesions', 'exocrine', 'pancreas', 'Carcinoma', 'situ', 'invasive', 'adenocarcinoma', 'pancreatic', 'ducts', '7th', '8th', 'week', 'induction', 'pancreatic', 'regeneration', 'results', 'multiple', 'dose', 'carcinogenesis', 'experiments']"
266,266,http://dialog.proquest.com/professional/docview/594649428?accountid=173210,The effects of intravesical and intradermal application of a new B.C.G. on the dog bladder,"Intravesical and intradermal application of B.C.G. (Bacillus Calmette Gu√©rin) has proven to be effective in the prophylaxis of recurrence of superficial bladder carcinoma after transurethral resection and in the treatment of carcinoma in situ (C.I.S.) in man. Different strains of B.C.G. have been used for this purpose. In this article a new strain of B.C.G. (B.C.G.-R.I.V.M.) has been tested to assess its toxicity. The effects of intravesical and intradermal application of B.C.G.-R.I.V.M. were studied on normal and on coagulated canine urothelium. In this study no general side effects of B.C.G.-R.I.V.M. were seen. Only minor local changes occurred in the bladder wall. Small granulomas were found in the suburothelial tissue. No granulomas or signs of active inflammation were observed in the pelvic lymphnodes, spleen and liver. Because B.C.G.-R.I.V.M. seemed to be a safe agent in the dog we have started to use it for prophylaxis in superficial bladder cancer in man.","['vd Meijden, A P', 'Steerenberg, P A', 'de Jong, W H', 'Bogman, M J', 'Feitz, W F', 'Hendriks, B T', 'Debruyne, F M', 'Ruitenberg, E J']","['Administration, Intravesical', 'Animals', 'BCG Vaccine', 'BCG Vaccine', 'Dogs', 'Female', 'Injections, Intradermal', 'Urinary Bladder']",ProQuest,"['software agents', 'intelligent agents', 'multiagent system', 'autonomous agents', 'agent based']",liver carcinoma in situ,"['effects', 'intravesical', 'intradermal', 'application', 'new', 'dog', 'bladder']","['Intravesical', 'intradermal', 'application', 'effective', 'prophylaxis', 'recurrence', 'superficial', 'bladder', 'carcinoma', 'transurethral', 'resection', 'treatment', 'carcinoma', 'situ', 'man', 'Different', 'strains', 'purpose', 'article', 'new', 'strain', 'B.C.G.-R.I.V.M.', 'toxicity', 'effects', 'intravesical', 'intradermal', 'application', 'B.C.G.-R.I.V.M.', 'normal', 'coagulated', 'canine', 'urothelium', 'study', 'general', 'side', 'effects', 'B.C.G.-R.I.V.M.', 'minor', 'local', 'changes', 'bladder', 'wall', 'Small', 'granulomas', 'suburothelial', 'tissue', 'granulomas', 'signs', 'active', 'inflammation', 'pelvic', 'lymphnodes', 'spleen', 'liver', 'B.C.G.-R.I.V.M.', 'safe', 'agent', 'dog', 'prophylaxis', 'superficial', 'bladder', 'cancer', 'man']"
267,267,http://dialog.proquest.com/professional/docview/593572620?accountid=173210,The PLC/PRF/5 human hepatoma cell line. I. Reevaluation of the karyotype,"The karyotype of the PLC/PRF/5 (Alexander) human hepatoma cell line was identified at passage +/- 110, prior to attempting in situ hybridization studies to determine the chromosomal localization of the hepatitis B virus (HBV) DNA integration sites. The karyotype was established by means of G-, Q-, and sequential C-banding techniques. Multiple consistent numerical and structural abnormalities were detected. These were compared with the original published unbanded karyotype of this cell line (at passage less than 25) and also with a previously published banded karyotype (at passages 60-90). Despite minor differences in the compared banded karyotypes (which are probably interpretational), the concordance in modal number and morphological karyotypic similarities over the course of 10 years indicate that this cell line is stable in vitro.","['Pinto, M R', 'Bey, E', 'Bernstein, R']","['Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Line', 'Chromosome Aberrations', 'Chromosome Banding', 'Genetic Markers', 'Humans', 'Karyotyping', 'Liver Neoplasms', 'Liver Neoplasms', 'Time Factors']",ProQuest,"['wireless sensor networks', 'microprocessor chips', 'crossover operator', 'genetic operators', 'localization algorithm', 'evolutionary algorithms', 'plc', 'programmable logic controllers']",liver carcinoma in situ,"['human', 'hepatoma', 'cell', 'line', 'Reevaluation', 'karyotype']","['karyotype', 'human', 'hepatoma', 'cell', 'line', 'passage', '/-', 'situ', 'hybridization', 'studies', 'chromosomal', 'localization', 'DNA', 'integration', 'sites', 'karyotype', 'means', 'sequential', 'C', 'techniques', 'consistent', 'numerical', 'structural', 'abnormalities', 'original', 'unbanded', 'karyotype', 'cell', 'line', 'passage', 'less', 'karyotype', 'passages', 'minor', 'differences', 'karyotypes', 'interpretational', 'concordance', 'modal', 'number', 'morphological', 'karyotypic', 'similarities', 'course', 'years', 'cell', 'line', 'stable']"
268,268,http://dialog.proquest.com/professional/docview/593569701?accountid=173210,The PLC/PRF/5 human hepatoma cell line. II. Chromosomal assignment of hepatitis B virus integration sites,"The chromosomal sites at which hepatitis B virus (HBV) DNA is integrated into the genome of the hepatocellular carcinoma (HCC) cell line, PLC/PRF/5 were investigated in an attempt to understand the mechanisms by which hepatitis B virus may induce malignant transformation. In situ hybridization of an HBV DNA probe to metaphase chromosomes of the PLC/PRF/5 cell line, followed by statistical analysis, identified three integration sites; these were 15q22-q23, 11q22, and 18q12. In particular, hybridization to chromosome #15, which is present in four copies in complete metaphases of this cell line, was highly significant (p much less than 0.0005).","['Bowcock, A M', 'Pinto, M R', 'Bey, E', 'Kuyl, J M', 'Dusheiko, G M', 'Bernstein, R']","['Adult', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Line', 'Cell Transformation, Neoplastic', 'Cell Transformation, Viral', 'Chromosome Banding', 'Chromosome Mapping', 'Chromosomes, Human, 13-15', 'Cloning, Molecular', 'DNA, Viral', 'Genetic Markers', 'Hepatitis B virus', 'Humans', 'Karyotyping', 'Liver Neoplasms', 'Liver Neoplasms', 'Male', 'Nucleic Acid Hybridization']",ProQuest,"['mathematics', 'correlation analysis', 'security of data', 'genetic operators', 'malwares', 'malicious codes', 'evolutionary algorithms', 'programmable logic controllers', 'plc', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['human', 'hepatoma', 'cell', 'line', 'Chromosomal', 'assignment', 'virus', 'integration', 'sites']","['chromosomal', 'sites', 'hepatitis', 'genome', 'hepatocellular', 'carcinoma', 'cell', 'line', 'attempt', 'mechanisms', 'hepatitis', 'virus', 'malignant', 'transformation', 'situ', 'hybridization', 'DNA', 'probe', 'chromosomes', 'cell', 'line', 'statistical', 'analysis', 'integration', 'sites', 'particular', 'hybridization', 'present', 'copies', 'complete', 'metaphases', 'cell', 'line', 'significant', 'less']"
269,269,http://dialog.proquest.com/professional/docview/593629128?accountid=173210,Hepatitis B virus DNA detected in formalin-fixed liver specimens and its relation to serologic markers and histopathologic features in chronic liver disease,"To examine the relationship of hepatitis B virus (HBV) DNA sequences in the liver with histopathologic features and antigenic markers, the authors determined the hepatocytic status of viral DNA by in situ hybridization in formalin-fixed liver sections using a biotinylated probe in 45 patients with various chronic liver diseases. The results were compared retrospectively with the HBV serologic markers and histopathologic features including the presence of ground-glass cells or Shikata staining positivity. The specificity of this in situ detection of HBV DNA has been proven excellent in a double-blind control study in 18 patients in whom liver HBV DNA was also determined by DNA extraction, gel electrophoresis, and the Southern blotting technique. In 41 patients, the findings of HBV DNA and serologic markers were concordant (17 positive and 24 negative). Twelve of the 20 HBV-DNA-positive patients were HBsAg-positive (6 with chronic hepatitis, 3 with cirrhosis, and 3 with hepatocellular carcinoma). Ground-glass cells or Shikata positivity were found in 10 of these 12 patients. HBV DNA sequences were found in the liver of all patients with chronic liver disease and serologic positivity for HBV infection. In liver with normal histologic features, HBV DNA was not demonstrable, despite the positive anti-HBc and anti-HBs. However, a positive HBV DNA was found in 3 serologically negative patients. In another patient the interpretation of findings was impossible because of severe hemosiderosis. From this study, it is concluded that in situ detection of HBV DNA in formalin-fixed liver sections has a clinical value and is suitable for routine use.","['Rijntjes, P J', 'Van Ditzhuijsen, T J', 'Van Loon, A M', 'Van Haelst, U J', 'Bronkhorst, F B', 'Yap, S H']","['Adolescent', 'Adult', 'Aged', 'Base Sequence', 'Child', 'Chronic Disease', 'DNA, Viral', 'False Positive Reactions', 'Female', 'Fixatives', 'Hepatitis B virus', 'Humans', 'Liver', 'Liver Diseases', 'Liver Diseases', 'Male', 'Middle Aged', 'Nucleic Acid Hybridization', 'Serologic Tests']",ProQuest,"['feature space', 'blind equalization', 'classification methods', 'security of data', 'signal detection', 'malwares', 'malicious codes', 'semi-blind', 'pattern recognition', 'orthogonal frequency division multiplexing', 'computer viruses', 'detection algorithm', 'blind source separation', 'intrusion detection']",liver carcinoma in situ,"['virus', 'DNA', 'formalin', 'liver', 'specimens', 'relation', 'serologic', 'markers', 'histopathologic', 'features', 'chronic', 'liver', 'disease']","['relationship', 'liver', 'histopathologic', 'features', 'antigenic', 'markers', 'authors', 'hepatocytic', 'status', 'viral', 'DNA', 'situ', 'hybridization', 'formalin', 'liver', 'sections', 'biotinylated', 'probe', 'patients', 'various', 'chronic', 'liver', 'diseases', 'results', 'serologic', 'markers', 'histopathologic', 'features', 'presence', 'ground', 'glass', 'cells', 'staining', 'positivity', 'specificity', 'situ', 'detection', 'excellent', 'double', 'blind', 'control', 'study', 'patients', 'liver', 'DNA', 'extraction', 'gel', 'electrophoresis', 'Southern', 'blotting', 'technique', 'patients', 'findings', 'serologic', 'markers', 'concordant', 'positive', 'negative', 'positive', 'patients', 'positive', 'chronic', 'hepatitis', 'cirrhosis', 'hepatocellular', 'carcinoma', 'Ground', 'glass', 'cells', 'positivity', 'patients', 'sequences', 'liver', 'patients', 'chronic', 'liver', 'disease', 'serologic', 'positivity', 'infection', 'liver', 'normal', 'histologic', 'features', 'demonstrable', 'positive', 'anti', '-', 'HBc', 'anti', '-', 'HBs', 'positive', 'negative', 'patients', 'patient', 'interpretation', 'findings', 'impossible', 'severe', 'hemosiderosis', 'study', 'situ', 'detection', 'formalin', 'liver', 'sections', 'clinical', 'value', 'suitable', 'routine', 'use']"
270,270,http://dialog.proquest.com/professional/docview/593593619?accountid=173210,Arterial thrombosis and embolism in malignancy,"In most reviews of arterial embolism or thrombosis the source of emboli or the cause of thrombosis can reasonably be established in over 90% of patients. Still about 10% remain without demonstrable cardiac or intraarterial sources. Although hypercoagulability induced by malignancy has been alluded to as a cause of unexplained intravascular thrombosis reports of arterial thromboembolism with such association are rare. Seven patients with unequivocal thromboembolism are presented. Two distinct clinical patterns are observed, one with in situ thrombosis of small arteries and the other with occlusion of large arteries causing limb ischemia or fatal organ infarction. The various pathogenetic mechanisms of arterial thrombosis or embolism in malignancy include sustained spasm of arteries, precipitation of cryoglobulins or other abnormal proteins in small arteries, direct tumor invasion of arteries, fragmentation and embolization of intracardiac or intraarterial metastases and spontaneous arterial thrombosis due to hypercoagulability. The hypercoagulable state can be recognized by the observation of shortened bleeding and clotting times, partial thromboplastin and prothrombin times, elevation of coagulation factors, platelets and yield stress index and resistance to anticoagulation. Patients presenting with arterial thromboembolic events with out demonstrable source should be investigated for malignancy. Conversely patients with malignancy should be searched for evidence of hypercoagulability in an attempt to prevent arterial thromboembolic complications.","['Pathanjali Sharma, P V', 'Babu, S C', 'Shah, P M', 'Seirafi, R', 'Clauss, R H']","['Adenocarcinoma', 'Aged', 'Blood Coagulation Disorders', 'Carcinoma', 'Embolism', 'Esophageal Neoplasms', 'Female', 'Humans', 'Liver Neoplasms', 'Male', 'Middle Aged', 'Ovarian Neoplasms', 'Pancreatic Neoplasms', 'Retroperitoneal Neoplasms', 'Thrombosis', 'Urinary Bladder Neoplasms']",ProQuest,"['clutter (information theory)', 'face images', 'object tracking', 'partial occlusions', 'clutter background', 'pose variation', 'object recognition', 'biometrics']",liver carcinoma in situ,"['Arterial', 'thrombosis', 'embolism', 'malignancy']","['most', 'reviews', 'arterial', 'embolism', 'thrombosis', 'source', 'emboli', 'cause', 'thrombosis', '%', 'patients', '%', 'demonstrable', 'cardiac', 'intraarterial', 'sources', 'hypercoagulability', 'malignancy', 'cause', 'unexplained', 'intravascular', 'thrombosis', 'reports', 'arterial', 'thromboembolism', 'such', 'association', 'rare', 'patients', 'unequivocal', 'thromboembolism', 'distinct', 'clinical', 'patterns', 'situ', 'thrombosis', 'small', 'arteries', 'other', 'occlusion', 'large', 'arteries', 'limb', 'ischemia', 'fatal', 'organ', 'infarction', 'various', 'pathogenetic', 'mechanisms', 'arterial', 'thrombosis', 'embolism', 'malignancy', 'sustained', 'spasm', 'arteries', 'precipitation', 'cryoglobulins', 'other', 'abnormal', 'proteins', 'small', 'arteries', 'direct', 'tumor', 'invasion', 'arteries', 'fragmentation', 'embolization', 'intracardiac', 'intraarterial', 'metastases', 'spontaneous', 'arterial', 'thrombosis', 'hypercoagulability', 'hypercoagulable', 'state', 'observation', 'shortened', 'bleeding', 'clotting', 'times', 'partial', 'thromboplastin', 'prothrombin', 'times', 'elevation', 'coagulation', 'factors', 'platelets', 'yield', 'stress', 'index', 'resistance', 'anticoagulation', 'Patients', 'arterial', 'thromboembolic', 'events', 'demonstrable', 'source', 'malignancy', 'patients', 'malignancy', 'evidence', 'hypercoagulability', 'attempt', 'arterial', 'thromboembolic', 'complications']"
271,271,http://dialog.proquest.com/professional/docview/593432990?accountid=173210,Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis,"Hepatobiliary carcinomas were found in eight patients with chronic ulcerative colitis (CUC) and primary sclerosing cholangitis (large-duct PSC; five cases) or ""pericholangitis"" (small-duct PSC; three cases). The tumors were extrahepatic in five cases and intrahepatic in two; in one case the neoplasm affected both liver and gallbladder. The tumors in seven patients were glandular and, sometimes, cystic and papillary; in the remaining patient a combined hepatocellular carcinoma and cholangiocarcinoma was found. The latter tumor seemed to arise from regenerative nodules in secondary biliary cirrhosis complicating PSC. The presence of carcinoma in situ in areas of fibrous cholangitis, the multicentric origin of the tumor, the presence of tumor-free large-duct PSC or small-duct PSC (pericholangitis) at a distance from the carcinomatous areas, and the documentation, in some cases, of long-standing inflammatory hepatobiliary disease prior to the discovery of the tumors would seem to confirm the clinical impression that carcinomas may develop in pre-existing PSC. The appearance of hepatobiliary carcinomas in patients with classic PSC and in patients with pericholangitis supports previous evidence indicating that cholangiographically diagnosed large-duct PSC and histologically diagnosed small-duct PSC (pericholangitis) are manifestations of a shared condition that could be named PSC syndrome. The findings of the present study indicate that the PSC syndrome predisposes patients for the development of bile duct carcinoma. Most patients with CUC and bile duct carcinoma seem to have PSC prior to the development of the hepatobiliary tumor.","['Wee, A', 'Ludwig, J', 'Coffey, R J, Jr', 'LaRusso, N F', 'Wiesner, R H']","['Adolescent', 'Adult', 'Autopsy', 'Bile Duct Neoplasms', 'Bile Duct Neoplasms', 'Biopsy', 'Carcinoma', 'Carcinoma', 'Cholangitis', 'Cholangitis', 'Chronic Disease', 'Colitis, Ulcerative', 'Colitis, Ulcerative', 'Female', 'Humans', 'Liver Neoplasms', 'Male', 'Middle Aged', 'Neoplasms, Multiple Primary']",ProQuest,"['program documentation', 'object tracking', 'appearance models', 'software engineering', 'face recognition', 'object appearance']",liver carcinoma in situ,"['Hepatobiliary', 'carcinoma', 'primary', 'sclerosing', 'cholangitis', 'ulcerative', 'colitis']","['Hepatobiliary', 'carcinomas', 'patients', 'chronic', 'ulcerative', 'colitis', 'primary', 'sclerosing', 'cholangitis', 'large', 'duct', 'cases', 'pericholangitis', 'small', 'duct', 'cases', 'tumors', 'extrahepatic', 'cases', 'intrahepatic', 'case', 'neoplasm', 'liver', 'gallbladder', 'tumors', 'patients', 'glandular', 'cystic', 'papillary', 'patient', 'hepatocellular', 'carcinoma', 'cholangiocarcinoma', 'latter', 'tumor', 'regenerative', 'nodules', 'secondary', 'biliary', 'cirrhosis', 'presence', 'carcinoma', 'situ', 'areas', 'fibrous', 'cholangitis', 'multicentric', 'origin', 'tumor', 'presence', 'tumor', 'free', 'large', 'duct', 'small', 'duct', 'distance', 'carcinomatous', 'areas', 'documentation', 'cases', 'inflammatory', 'hepatobiliary', 'disease', 'discovery', 'tumors', 'clinical', 'impression', 'carcinomas', 'pre', '-', 'appearance', 'hepatobiliary', 'carcinomas', 'patients', 'classic', 'patients', 'pericholangitis', 'previous', 'evidence', 'large', 'duct', 'PSC', 'small', 'duct', 'manifestations', 'condition', 'syndrome', 'findings', 'present', 'study', 'syndrome', 'predisposes', 'patients', 'development', 'bile', 'duct', 'carcinoma', 'Most', 'patients', 'bile', 'duct', 'carcinoma', 'development', 'hepatobiliary', 'tumor']"
272,272,http://dialog.proquest.com/professional/docview/593829437?accountid=173210,A case of double malignant neoplasms with posthepatitis aplastic anemia and Stevens-Johnson-like syndrome induced by drugs,0,"['Hosokawa, T', 'Itoga, T', 'Saburi, Y', 'Mizutani, R', 'Kanzaki, K']","['Anemia, Aplastic', 'Anti-Bacterial Agents', 'Carcinoma in Situ', 'Carcinoma, Squamous Cell', 'Chemical and Drug Induced Liver Injury', 'Female', 'Humans', 'Lymphoma', 'Middle Aged', 'Neoplasms, Multiple Primary', 'Stevens-Johnson Syndrome', 'Uterine Neoplasms']",ProQuest,"['artificial intelligence', 'software agents', 'intelligent agents', 'multiagent system', 'autonomous agents']",liver carcinoma in situ,"['case', 'double', 'malignant', 'neoplasms', 'posthepatitis', 'aplastic', 'anemia', 'like', 'syndrome', 'drugs']",[]
273,273,http://dialog.proquest.com/professional/docview/593371543?accountid=173210,Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries,"The numbers of second cancers among 182,040 women treated for cervical cancer that were reported to 15 cancer registries in 8 countries were compared to the numbers expected had the same risk prevailed as in the general population. A small 9% excess of second cancers (5,146 observed vs. 4,736 expected) occurred 1 or more years after treatment. Large radiation doses experienced by 82,616 women did not dramatically alter their risk of developing a second cancer; at most, about 162 of 3,324 second cancers (approximately equal to 5%) could be attributed to radiation. The relative risk (RR = 1.1) for developing cancer in organs close to the cervix that had received high radiation exposures--most notably, the bladder, rectum, uterine corpus, ovary, small intestine, bone, and connective tissue--and for developing multiple myeloma increased with time since treatment. No similar increase was seen for 99,424 women not treated with radiation. Only a slight excess of acute and non-lymphocytic leukemia was found among irradiated women (RR = 1.3), and substantially fewer cases were observed than expected on the basis of current radiation risk estimates. The small risk of leukemia may be associated with low doses of radiation absorbed by the bone marrow outside the pelvis, inasmuch as the marrow in the pelvis may have been destroyed or rendered inactive by very large radiotherapy exposures. There was little evidence of a radiation effect for cancers of the stomach, colon, liver, and gallbladder, for melanoma and other skin cancers, or for chronic lymphocytic leukemia despite substantial exposures. An excess of thyroid cancer possibly was related to the low dose received by this organ. Ovarian damage caused by radiation may have been responsible for a low breast cancer risk (RR = 0.7), which was evident even among postmenopausal women. A substantial excess of lung cancer (RR = 3.7) largely may be due to misclassification of metastases and the confounding influence of cigarette smoking. Women who were under 30 or over 50 years of age when irradiated were at greatest absolute risk for developing a second cancer. The RR, however, was higher among those under age 30 years at exposure (RR = 3.9) than among older women. The expression period for radiation-induced solid tumors appeared to continue to the end of life.","['Boice, J D, Jr', 'Day, N E', 'Andersen, A', 'Brinton, L A', 'Brown, R', 'Choi, N W', 'Clarke, E A', 'Coleman, M P', 'Curtis, R E', 'Flannery, J T']","['Abdominal Neoplasms', 'Adult', 'Age Factors', 'Aged', 'Carcinoma in Situ', 'Carcinoma in Situ', 'Epidemiologic Methods', 'Female', 'Head and Neck Neoplasms', 'Humans', 'International Cooperation', 'Leukemia', 'Lymphoma', 'Middle Aged', 'Neoplasm Invasiveness', 'Neoplasms, Multiple Primary', 'Neoplasms, Radiation-Induced', 'Radiotherapy Dosage', 'Registries', 'Risk', 'Statistics as Topic', 'Thoracic Neoplasms', 'Time Factors', 'Uterine Cervical Neoplasms', 'Uterine Cervical Neoplasms', 'Uterine Cervical Neoplasms', 'Uterine Cervical Neoplasms']",ProQuest,"['estimation method', 'numerical model', 'cooperative works', 'groupware', 'collaborative work', 'correlation analysis', 'collaborative activities', 'collaborative learning', 'human engineering', 'mathematics']",liver carcinoma in situ,"['Second', 'cancers', 'radiation', 'treatment', 'cervical', 'cancer', 'international', 'collaboration', 'cancer', 'registries']","['numbers', 'second', 'cancers', 'women', 'cervical', 'cancer', 'cancer', 'registries', 'countries', 'numbers', 'same', 'risk', 'general', 'population', 'small', '%', 'excess', 'second', 'cancers', 'more', 'years', 'treatment', 'Large', 'radiation', 'doses', 'women', 'risk', 'second', 'cancer', 'most', 'second', 'cancers', 'equal', '%', 'radiation', 'relative', 'risk', 'cancer', 'organs', 'cervix', 'high', 'radiation', 'exposures', 'bladder', 'rectum', 'uterine', 'corpus', 'ovary', 'small', 'intestine', 'bone', 'connective', 'tissue', 'multiple', 'myeloma', 'time', 'treatment', 'similar', 'increase', 'women', 'radiation', 'slight', 'excess', 'acute', 'non', '-', 'lymphocytic', 'leukemia', 'women', 'fewer', 'cases', 'basis', 'current', 'radiation', 'risk', 'estimates', 'small', 'risk', 'leukemia', 'low', 'doses', 'radiation', 'bone', 'marrow', 'pelvis', 'marrow', 'pelvis', 'inactive', 'large', 'radiotherapy', 'exposures', 'little', 'evidence', 'radiation', 'effect', 'cancers', 'stomach', 'colon', 'liver', 'gallbladder', 'melanoma', 'other', 'skin', 'cancers', 'chronic', 'lymphocytic', 'leukemia', 'substantial', 'exposures', 'excess', 'thyroid', 'cancer', 'low', 'dose', 'organ', 'Ovarian', 'damage', 'radiation', 'responsible', 'low', 'breast', 'cancer', 'risk', 'evident', 'postmenopausal', 'women', 'substantial', 'excess', 'lung', 'cancer', 'due', 'misclassification', 'metastases', 'influence', 'cigarette', 'smoking', 'Women', 'years', 'age', 'greatest', 'absolute', 'risk', 'second', 'cancer', 'higher', 'age', 'years', 'exposure', 'older', 'women', 'expression', 'period', 'radiation', 'solid', 'tumors', 'end', 'life']"
274,274,http://dialog.proquest.com/professional/docview/593235471?accountid=173210,Detection of messenger RNAs of alpha-fetoprotein and albumin in a human hepatoma cell line by in situ hybridization,"Detection of RNA transcripts within individual cells by in situ hybridization provides a powerful means for identifying specific cell types actively transcribing specific genes. We have applied this technique in order to analyze expression of the alpha-fetoprotein and albumin genes in a human hepatoma cell line, HuH-7. Using either 3H- or 35S-labeled human alpha-fetoprotein complementary DNA clone as a probe, we found that essentially all HuH-7 cells contained alpha-fetoprotein mRNA, although in various amounts. This correlated well with the presence of alpha-fetoprotein in all cells as detected by the peroxidase-antiperoxidase immunoenzyme method. The intracellular concentration of albumin, on the other hand, was below the level of detection by the peroxidase-antiperoxidase method. Consistent with this observation, we could not detect albumin mRNA with 3H-labeled albumin complementary DNA probes. However, the use of 35S-labeled probes having higher specific activities and higher efficiency of grain development resulted in the detection of albumin mRNA in a small percentage of HuH-7 cells. A variety of parameters involved in the in situ hybridization technique was examined to establish conditions suitable for demonstrating the presence of high- and low-copy numbers of mRNA in various cell and tissue preparations.","['Breborowicz, J', 'Tamaoki, T']","['Albumins', 'Carcinoma, Hepatocellular', 'Cell Line', 'Humans', 'Immunoenzyme Techniques', 'Liver Neoplasms', 'Nucleic Acid Hybridization', 'RNA, Messenger', 'alpha-Fetoproteins', 'alpha-Fetoproteins']",ProQuest,"['computational efficiency', 'theoretical computer science', 'correlation analysis', 'optimization problems', 'control system analysis', 'control parameters', 'detection algorithm', 'signal detection']",liver carcinoma in situ,"['Detection', 'messenger', 'RNAs', 'alpha', 'fetoprotein', 'albumin', 'human', 'hepatoma', 'cell', 'line', 'situ', 'hybridization']","['Detection', 'transcripts', 'individual', 'cells', 'situ', 'hybridization', 'powerful', 'means', 'specific', 'cell', 'types', 'specific', 'genes', 'technique', 'order', 'expression', 'alpha', 'fetoprotein', 'albumin', 'genes', 'human', 'hepatoma', 'cell', 'line', 'human', 'alpha', 'fetoprotein', 'complementary', 'DNA', 'clone', 'probe', 'HuH-7', 'cells', 'alpha', 'fetoprotein', 'various', 'amounts', 'presence', 'alpha', 'fetoprotein', 'cells', 'peroxidase', 'antiperoxidase', 'immunoenzyme', 'method', 'intracellular', 'concentration', 'albumin', 'other', 'hand', 'level', 'detection', 'peroxidase', 'antiperoxidase', 'method', 'Consistent', 'observation', 'albumin', 'mRNA', 'albumin', 'complementary', 'DNA', 'probes', 'use', 'probes', 'higher', 'specific', 'activities', 'higher', 'efficiency', 'grain', 'development', 'detection', 'albumin', 'small', 'percentage', 'cells', 'variety', 'parameters', 'situ', 'hybridization', 'technique', 'conditions', 'suitable', 'presence', 'high-', 'low', 'copy', 'numbers', 'mRNA', 'various', 'cell', 'tissue', 'preparations']"
275,275,http://dialog.proquest.com/professional/docview/593425197?accountid=173210,Chromosomal site of hepatitis B virus (HBV) integration in a human hepatocellular carcinoma-derived cell line,"The single site of integration of hepatitis B virus in the human hepatocellular carcinoma cell line Hep 3B 2-1/7 was found to segregate with human chromosome 12 in somatic cell hybrids. Analysis of metaphase spreads of Hep 3B 2-1/7 following in situ hybridization with pHBV revealed integration at 12q13----q14, a location that coincides with a fragile site, fra (12q13). The possible significance of this location to the development of hepatocellular carcinomas is discussed.","['Simon, D', 'Searls, D B', 'Cao, Y', 'Sun, K', 'Knowles, B B']","['Animals', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Line', 'Chromosomes, Human, 6-12 and X', 'Hepatitis B Surface Antigens', 'Hepatitis B virus', 'Humans', 'Hybrid Cells', 'Karyotyping', 'Liver Neoplasms', 'Liver Neoplasms', 'Liver Neoplasms, Experimental', 'Rats']",ProQuest,"['location information', 'location based', 'ad hoc networks', 'wireless sensor networks', 'location based services', 'telecommunication equipment', 'security of data', 'genetic operators', 'malwares', 'malicious codes', 'evolutionary algorithms', 'sensor networks', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['Chromosomal', 'site', 'integration', 'human', 'hepatocellular', 'carcinoma', 'cell', 'line']","['single', 'site', 'integration', 'virus', 'human', 'hepatocellular', 'carcinoma', 'cell', 'line', '3B', 'human', 'chromosome', 'somatic', 'cell', 'hybrids', 'Analysis', 'metaphase', 'spreads', '3B', 'situ', 'hybridization', 'integration', '---q14', 'location', 'fragile', 'site', 'fra', 'possible', 'significance', 'location', 'development', 'hepatocellular', 'carcinomas']"
276,276,http://dialog.proquest.com/professional/docview/594058689?accountid=173210,Increased liver chemiluminescence in tumor-bearing mice,"Spontaneous mouse liver chemiluminescence (109 +/- 6 cps/cm2) was increased in the early phase after tumor implantation in a distant position with respect to the liver. A 39% increased liver chemiluminescence was observed after 5 days of the injection of Ehrlich ascites tumor cells into the peritoneal cavity, and a 64% and a 46% increased liver chemiluminescence were measured after 8 and 14 days of the implantation of a fibrosarcoma and of an adenocarcinoma, respectively, in the leg. At the time of maximal stimulation of in vivo liver chemiluminescence by the distant tumors, cytosolic superoxide dismutase, catalase, and glutathione peroxidase activities were decreased by 18%, 38%, and 26% in the liver of mice bearing Ehrlich ascites tumors. The same three enzymatic activities were decreased by 21%, 19%, and 54% respectively, in the liver of fibrosarcoma-bearing mice. Total liver glutathione was decreased by 18% to 22% in the tumor-bearing animals. Hydroperoxide-initiated chemiluminescence was increased in the homogenates (105% and 45%) and mitochondria (64% and 34%) from the liver of mice bearing Ehrlich ascites tumors and fibrosarcomas, respectively, at the time of maximal in situ liver chemiluminescence. The hydroperoxide-initiated chemiluminescence of liver microsomes was decreased by 46% to 36% in the tumor-bearing animals at the same time. It is concluded that the liver of tumor-bearing animals is subjected, during the early phase after tumor implantation, to an oxidative stress with increased steady-state levels of peroxyl radicals, which are essentially responsible for the increased photoemission observed in vivo.","['Boveris, A', 'Llesuy, S F', 'Fraga, C G']","['Adenocarcinoma', 'Animals', 'Carcinoma, Ehrlich Tumor', 'Catalase', 'Female', 'Fibrosarcoma', 'Free Radicals', 'Glutathione', 'Glutathione Peroxidase', 'Liver', 'Luminescent Measurements', 'Mice', 'Mice, Inbred BALB C', 'Neoplasms, Experimental', 'Peroxides', 'Superoxide Dismutase', 'tert-Butylhydroperoxide']",ProQuest,"['real time systems', 'target tracking', 'robotics', 'crystal whiskers', 'target position', 'air holes', 'architecture types', 'cyber physical systems (cpss)', 'photonic crystal fibers']",liver carcinoma in situ,"['liver', 'chemiluminescence', 'tumor', 'mice']","['Spontaneous', 'mouse', 'liver', 'chemiluminescence', '/-', 'cps', 'cm2', 'early', 'phase', 'tumor', 'implantation', 'distant', 'position', 'respect', 'liver', '%', 'liver', 'chemiluminescence', 'days', 'injection', 'tumor', 'cells', 'peritoneal', 'cavity', '%', '%', 'liver', 'chemiluminescence', 'days', 'implantation', 'fibrosarcoma', 'adenocarcinoma', 'leg', 'time', 'maximal', 'stimulation', 'vivo', 'liver', 'chemiluminescence', 'distant', 'tumors', 'cytosolic', 'superoxide', 'dismutase', 'catalase', 'glutathione', 'peroxidase', 'activities', '%', '%', '%', 'liver', 'mice', 'tumors', 'same', 'enzymatic', 'activities', '%', '%', '%', 'liver', 'fibrosarcoma', 'mice', 'Total', 'liver', 'glutathione', '%', '%', 'tumor', 'animals', 'Hydroperoxide', 'chemiluminescence', 'homogenates', '%', '%', 'mitochondria', '%', '%', 'liver', 'mice', 'tumors', 'fibrosarcomas', 'time', 'maximal', 'situ', 'liver', 'chemiluminescence', 'hydroperoxide', 'chemiluminescence', 'liver', 'microsomes', '%', '%', 'tumor', 'animals', 'same', 'time', 'liver', 'tumor', 'animals', 'early', 'phase', 'tumor', 'implantation', 'oxidative', 'stress', 'steady', 'state', 'levels', 'peroxyl', 'radicals', 'responsible', 'photoemission', 'vivo']"
277,277,http://dialog.proquest.com/professional/docview/593258455?accountid=173210,Molecular cloning and characterization of the cDNA coding for hepatitis B virus surface antigen,Hepatitis B virus surface antigen (HBsAg) mRNA has been enriched from a hepatoma cell line (PLC/PRF/5) by specific polysome immunoprecipitation and used for cDNA cloning. A HBsAg cDNA clone was identified by in situ hybridization with a cloned viral probe. It was characterized by restriction endonuclease mapping and DNA sequence analysis. Molecular hybridization of PLC/PRF/5 cellular DNA and RNA to [32P]-labeled HBsAg cDNA revealed the integration of at least six copies of the hepatitis B virus (HBV) DNA into the host genome and expression of three DNA species containing HBsAg-specific sequences. The possible role of HBV in the oncogenesis of primary hepatocellular carcinoma is discussed.,"['He, B G', 'Melnick, J L', 'Siddiqui, A', 'Robinson, W S', 'Law, S W', 'Lai, E C']","['Carcinoma, Hepatocellular', 'Cell Line', 'Cloning, Molecular', 'DNA, Viral', 'Genes, Viral', 'Genetic Code', 'Hepatitis B Surface Antigens', 'Hepatitis B virus', 'Liver Neoplasms', 'Oncogenes', 'RNA, Messenger']",ProQuest,"['cellular telephone systems', 'microprocessor chips', 'wireless', 'cellular radio systems', 'security of data', 'malwares', 'programmable logic controllers', 'malicious codes', 'plc', 'computer viruses', 'cellular', 'intrusion detection']",liver carcinoma in situ,"['Molecular', 'cloning', 'characterization', 'hepatitis', 'virus', 'surface', 'antigen']","['virus', 'surface', 'antigen', 'hepatoma', 'cell', 'line', 'specific', 'polysome', 'immunoprecipitation', 'clone', 'situ', 'hybridization', 'viral', 'probe', 'restriction', 'endonuclease', 'mapping', 'DNA', 'sequence', 'analysis', 'Molecular', 'hybridization', 'cellular', 'DNA', 'integration', 'least', 'copies', 'DNA', 'host', 'genome', 'expression', 'DNA', 'species', 'specific', 'sequences', 'possible', 'role', 'oncogenesis', 'primary', 'hepatocellular', 'carcinoma']"
278,278,http://dialog.proquest.com/professional/docview/592849291?accountid=173210,Prolonged binding of a radiolabeled monoclonal antibody (B72.3) used for the in situ radioimmunodetection of human colon carcinoma xenografts,"Monoclonal antibody B72.3 binds to a glycoprotein complex with a molecular weight of 220,000 to 400,000. B72.3 reacts with approximately 50% of human mammary carcinomas and to 80% of the colon carcinomas tested but does not react appreciably with normal mammary tissue, with normal colon, or to a variety of normal adult human tissues tested using immunohistochemical techniques. B72.3 immunoglobulin G was purified and radiolabeled with 125I without significant loss in its reactivity to tumor extracts. The radiolabeled B72.3 immunoglobulin G was shown to efficiently localize human colon carcinoma xenografts in athymic mice. Tumor:tissue ratios of the localized antibody rose over the 7-day period studied, with tumor:liver, tumor:spleen, or tumor:kidney ratios of approximately 18:1 at Day 7 and a tumor:blood ratio of approximately 5:1 at Day 7. Tumor:muscle or tumor:brain ratios rose to over 100:1. The amount of radioactivity in the tumor increased for the first 2 days postinoculation of antibody and stayed constant over a 19-day period of study. Thus, there was no appreciable loss of radioiodine from the tumor over the study interval. No localization was seen in mice bearing a B72.3 antigen-negative human melanoma xenograft or with an isotype-identical control immunoglobulin G in mice bearing colon tumor xenografts. Gamma camera imaging with a pinhole collimator confirmed the ability of the radiolabeled antibody to detect the presence of colon carcinoma xenografts less than 0.5 cm in diameter over a 19-day period. The potential use of this system as a model for radioimmunotherapy will be discussed.","['Colcher, D', 'Keenan, A M', 'Larson, S M', 'Schlom, J']","['Animals', 'Antibodies, Monoclonal', 'Antigens, Neoplasm', 'Cell Line', 'Colonic Neoplasms', 'Colonic Neoplasms', 'Electrophoresis, Polyacrylamide Gel', 'Female', 'Glycoproteins', 'Humans', 'Iodine Radioisotopes', 'Mice', 'Mice, Nude', 'Neoplasm Transplantation', 'Radioimmunoassay', 'Radionuclide Imaging', 'Transplantation, Heterologous']",ProQuest,"['signal processing', 'target tracking', 'signal to noise ratio', 'wireless sensor networks', 'routing algorithms', 'correlation analysis', 'optimization problems', 'localization algorithm', 'sensor networks', 'target localization', 'time windows']",liver carcinoma in situ,"['binding', 'monoclonal', 'antibody', 'situ', 'radioimmunodetection', 'human', 'colon', 'carcinoma', 'xenografts']","['Monoclonal', 'antibody', 'glycoprotein', 'complex', 'molecular', 'weight', '%', 'human', 'mammary', 'carcinomas', '%', 'colon', 'carcinomas', 'normal', 'mammary', 'tissue', 'normal', 'colon', 'variety', 'normal', 'adult', 'human', 'tissues', 'immunohistochemical', 'techniques', 'B72.3', 'immunoglobulin', 'significant', 'loss', 'reactivity', 'tumor', 'extracts', 'radiolabeled', 'immunoglobulin', 'human', 'colon', 'carcinoma', 'xenografts', 'athymic', 'mice', 'Tumor', 'tissue', 'ratios', 'antibody', 'period', 'tumor', 'liver', 'tumor', 'spleen', 'tumor', 'kidney', 'ratios', 'Day', 'tumor', 'blood', 'ratio', 'Day', 'Tumor', 'muscle', 'tumor', 'brain', 'ratios', 'amount', 'radioactivity', 'tumor', 'first', 'days', 'postinoculation', 'antibody', 'constant', 'period', 'study', 'appreciable', 'loss', 'radioiodine', 'tumor', 'study', 'interval', 'localization', 'mice', 'antigen', 'negative', 'human', 'melanoma', 'xenograft', 'isotype', 'identical', 'control', 'immunoglobulin', 'G', 'mice', 'colon', 'tumor', 'xenografts', 'camera', 'pinhole', 'collimator', 'ability', 'radiolabeled', 'antibody', 'presence', 'colon', 'carcinoma', 'less', 'cm', 'diameter', 'period', 'potential', 'use', 'system', 'model', 'radioimmunotherapy']"
279,279,http://dialog.proquest.com/professional/docview/592833590?accountid=173210,Cholangiocellular carcinoma in polycystic kidney and liver disease,"Cholangiocellular carcinoma developed in two uremic patients with polycystic kidney and liver disease, who had been treated with intermittent hemodialysis for one and nine years. In one case, in situ transformation of the liver cyst epithelium into cholangiocellular carcinoma could be demonstrated. The incidence of cholangiocellular carcinoma in patients undergoing long-term dialysis for polycystic kidney and liver disease, however, has yet to be determined.","['Landais, P', 'Gr√ºnfeld, J P', 'Droz, D', 'Dr√ºeke, T', 'Albouze, G', 'Gogusev, J', 'Chauveau, D', 'Moynot, A']","['Adenoma, Bile Duct', 'Cell Transformation, Neoplastic', 'Cysts', 'Female', 'Humans', 'Kidney Failure, Chronic', 'Kidney Failure, Chronic', 'Liver Diseases', 'Liver Neoplasms', 'Male', 'Middle Aged', 'Polycystic Kidney Diseases', 'Renal Dialysis']",ProQuest,"['node failure', 'fault tolerance', 'sensor networks', 'wireless sensor networks']",liver carcinoma in situ,"['Cholangiocellular', 'carcinoma', 'polycystic', 'kidney', 'liver', 'disease']","['Cholangiocellular', 'carcinoma', 'uremic', 'patients', 'polycystic', 'kidney', 'liver', 'disease', 'intermittent', 'hemodialysis', 'years', 'case', 'situ', 'transformation', 'liver', 'cyst', 'epithelium', 'cholangiocellular', 'carcinoma', 'incidence', 'cholangiocellular', 'carcinoma', 'patients', 'long', 'term', 'dialysis', 'polycystic', 'kidney', 'liver', 'disease']"
280,280,http://dialog.proquest.com/professional/docview/593000709?accountid=173210,Fibronectin,0,"['Llena Puy, M C', 'Tres S√°nchez, A', 'Guill√©n Mart√≠nez, G']","['Amino Acid Sequence', 'Blood Coagulation', 'Carcinoma in Situ', 'Cell Adhesion', 'Cell Membrane', 'Connective Tissue Diseases', 'Fibronectins', 'Fibronectins', 'Humans', 'Liver Diseases', 'Molecular Weight', 'Neoplasms']",ProQuest,[],liver carcinoma in situ,['Fibronectin'],[]
281,281,http://dialog.proquest.com/professional/docview/592852512?accountid=173210,"A gene sequence expressed only in undifferentiated EC, EK cells and testes","A clone, EC1, has been isolated from a cDNA library prepared from 4-day embryoid bodies formed by suspension culture of PSMB EC cells. This clone has been used to screen a variety of RNA sources including adult tissues, embryonal carcinoma (EC), and endoderm cell lines. A 3-kb poly(A)+ RNA species was found to be present only in undifferentiated EC cells and adult mouse testes. This species was significantly reduced in testes of W/Wv mice compared with wild-type at this locus. Germ cells and their progeny are therefore implicated as the source of the RNA in testes. Hybrid-selected RNA from PSMB could be translated in vitro into a 35-kd protein, but no translatable message was evident in either PYS-2 (parietal), or PSA5-E (visceral) endoderm cell lines. DNA sequencing of the EC1 insert revealed that it is 744 bp in length, the 3' 460 bp of which are in open reading frame. Comparison with known sequences have shown no significant homology. EC1 subclones in M13 have been used to generate single-stranded probes for hybridisation to RNA in situ in tissue sections. Hybridisation of the strand complementary to RNA produces a signal limited to the central regions of embryoid bodies formed on suspension culture of embryo-derived EK cells coinciding with the presence of undifferentiated cells. Probing of a mouse genomic library and Southern blots of liver DNA with EC1 reveals that the gene is present as a single copy.","['Stacey, A J', 'Evans, M J']","['Amino Acid Sequence', 'Animals', 'Base Sequence', 'Cell Differentiation', 'DNA', 'Male', 'Mice', 'Mice, Inbred BALB C', 'Nucleic Acid Hybridization', 'Poly A', 'Protein Biosynthesis', 'RNA', 'RNA', 'RNA, Messenger', 'Teratoma', 'Testis']",ProQuest,"['structural frames', 'libraries', 'formatting', 'frames', 'sms', 'sms messages', 'short message services', 'education', 'insert']",liver carcinoma in situ,"['gene', 'sequence', 'undifferentiated', 'cells', 'testes']","['clone', 'library', 'embryoid', 'bodies', 'suspension', 'culture', 'cells', 'clone', 'variety', 'sources', 'adult', 'tissues', 'embryonal', 'carcinoma', 'endoderm', 'cell', 'lines', 'species', 'present', 'undifferentiated', 'cells', 'adult', 'mouse', 'testes', 'species', 'testes', 'mice', 'wild', 'type', 'locus', 'cells', 'progeny', 'source', 'testes', 'vitro', 'protein', 'translatable', 'message', 'evident', 'visceral', 'endoderm', 'cell', 'lines', 'DNA', 'sequencing', 'insert', 'bp', 'length', 'bp', 'open', 'reading', 'frame', 'Comparison', 'sequences', 'significant', 'homology', 'EC1', 'subclones', 'single', 'probes', 'hybridisation', 'situ', 'tissue', 'sections', 'Hybridisation', 'strand', 'complementary', 'signal', 'central', 'regions', 'embryoid', 'bodies', 'suspension', 'culture', 'embryo', 'cells', 'presence', 'undifferentiated', 'cells', 'mouse', 'genomic', 'library', 'Southern', 'blots', 'liver', 'gene', 'present', 'single', 'copy']"
282,282,http://dialog.proquest.com/professional/docview/592773465?accountid=173210,H+ stoichiometry of sites 1 + 2 of the respiratory chain of normal and tumor mitochondria,"The mechanistic stoichiometry for vectorial H+ ejection coupled to electron transport through energy-conserving segments 1 + 2 was determined on cyanide-inhibited mitochondria from rat liver, rat heart, and Ehrlich ascites tumor cells, and on rat liver mitoplasts with ferricyanide or ferricytochrome c as electron acceptors. K+ (+ valinomycin) and Ca2+ were employed as permeant cations. Three different methods were employed. In the first, known pulses of ferricyanide were added, and the total H+ ejected was determined with a glass electrode. Such measurements gave H+/2e-values exceeding 7.0 for both normal and tumor mitochondria with beta-hydroxybutyrate and other NAD-linked substrates; uptake of Ca2+ was also measured and gave the expected q+/2e-ratios. The second type of measurement was initiated by addition of ferricytochrome c to rat liver mitoplasts, with H+ ejection monitored with the glass electrode and ferricytochrome c reduction by dual-wavelength spectrophotometry; the H+/2e-ratios generally exceeded 7.0. In the third type of measurement, mixing and dilution artifacts were eliminated by oxidizing ferrocytochrome c in situ with a small amount of ferricyanide. H+/2e-ratios for rat liver mitoplasts oxidizing beta-hydroxybutyrate consistently approached or exceeded 7.5. Over 150 measurements made under a variety of conditions gave observed H+/2e-ejection ratios significantly exceeding 7.0, which correlated closely with H+/2e-measurements on sites 1 + 2 + 3, sites 2 + 3, and site 2. Factors leading to the deficit of the observed ratios from the integral value 8 for sites 1 + 2 were discussed.","['Villalobo, A', 'Alexandre, A', 'Lehninger, A L']","['Animals', 'Binding Sites', 'Calcium', 'Carcinoma, Ehrlich Tumor', 'Carcinoma, Ehrlich Tumor', 'Cations', 'Cytochrome c Group', 'Electron Transport', 'Ferricyanides', 'In Vitro Techniques', 'Mitochondria, Heart', 'Mitochondria, Liver', 'Protons', 'Rats']",ProQuest,"['signal processing', 'signal to noise ratio', 'wavelength division multiplexing', 'two wavelength', 'fiber optic networks', 'pulse width', 'energy-conserving', 'pulse train', 'energy conservation', 'pulsed laser applications', 'wavelength']",liver carcinoma in situ,"['H+', 'stoichiometry', 'sites', 'respiratory', 'chain', 'normal', 'tumor', 'mitochondria']","['mechanistic', 'stoichiometry', 'vectorial', 'ejection', 'transport', 'energy', 'segments', 'cyanide', 'mitochondria', 'rat', 'liver', 'rat', 'heart', 'tumor', 'cells', 'rat', 'liver', 'mitoplasts', 'ferricyanide', 'c', 'electron', 'acceptors', 'Ca2', 'permeant', 'cations', 'different', 'methods', 'first', 'pulses', 'ferricyanide', 'total', 'glass', 'electrode', 'Such', 'measurements', 'H+/2e', 'values', 'normal', 'tumor', 'mitochondria', 'beta', 'hydroxybutyrate', 'other', 'substrates', 'uptake', 'Ca2', 'ratios', 'second', 'type', 'measurement', 'addition', 'ferricytochrome', 'c', 'liver', 'mitoplasts', 'H+', 'ejection', 'glass', 'electrode', 'reduction', 'dual', 'wavelength', 'spectrophotometry', 'H+/2e', 'ratios', 'third', 'type', 'measurement', 'mixing', 'dilution', 'artifacts', 'c', 'situ', 'small', 'amount', 'ferricyanide', 'ratios', 'rat', 'liver', 'mitoplasts', 'beta', 'hydroxybutyrate', 'measurements', 'variety', 'conditions', 'H+/2e', 'ejection', 'ratios', 'H+/2e', 'measurements', 'sites', 'sites', 'site', 'Factors', 'deficit', 'observed', 'ratios', 'integral', 'value', 'sites']"
283,283,http://dialog.proquest.com/professional/docview/592783211?accountid=173210,In situ 125I-labelling of endosome proteins with lactoperoxidase conjugates,"Asialoorosomucoid was conjugated to lactoperoxidase and bound specifically to the asialoglycoprotein receptor on the human cell line Hep G2 at 4 degrees C. The bound conjugates incorporated 125I into cell surface proteins in the presence of H2O2. When Hep G2 cells were allowed to endocytose the prebound conjugates by warming to 37 degrees C for 10 min or were incubated for 1 h at 23 degrees C in the presence of conjugate, addition of 125I and H2O2 at 4 degrees C now resulted in labelling of endocytic vesicle proteins. The cell surface labelling pattern and the endosome labelling pattern were compared and found to be distinct. A major component labelled by the endocytosed asialoorosomucoid conjugate is shown to be the transferrin receptor. This protein and a component of 230 000 daltons are enriched in the endosome relative to the cell surface. The endocytosed lactoperoxidase conjugate was also visualised at the morphological level. Characteristic endosome tubules and vesicles contained electron-dense peroxidase reaction product as did cell surface coated pits. Selective capture of some cell surface proteins but not others by coated pits presumably gives rise to the distinct polypeptide composition of the endosome.","['Watts, C']","['Asialoglycoprotein Receptor', 'Asialoglycoproteins', 'Carcinoma, Hepatocellular', 'Cell Line', 'Cell Membrane', 'Coated Pits, Cell-Membrane', 'Endocytosis', 'Endosomes', 'Humans', 'Iodine Radioisotopes', 'Lactoperoxidase', 'Liver Neoplasms', 'Orosomucoid', 'Orosomucoid', 'Peroxidases', 'Receptors, Immunologic']",ProQuest,"['dynamic composition', 'computer aided design', 'product design', 'component', 'software', 'web service composition', 'software engineering', 'automatic composition', 'service compositions', 'component composition']",liver carcinoma in situ,"['situ', 'labelling', 'endosome', 'proteins', 'lactoperoxidase', 'conjugates']","['asialoglycoprotein', 'receptor', 'human', 'cell', 'line', 'degrees', 'bound', 'conjugates', 'cell', 'surface', 'proteins', 'presence', 'H2O2', 'cells', 'prebound', 'conjugates', 'degrees', 'C', 'min', 'h', 'degrees', 'C', 'presence', 'conjugate', 'addition', 'H2O2', 'degrees', 'labelling', 'endocytic', 'vesicle', 'proteins', 'cell', 'surface', 'labelling', 'pattern', 'endosome', 'labelling', 'pattern', 'distinct', 'major', 'component', 'asialoorosomucoid', 'conjugate', 'transferrin', 'receptor', 'protein', 'component', 'daltons', 'endosome', 'relative', 'cell', 'surface', 'endocytosed', 'lactoperoxidase', 'conjugate', 'morphological', 'level', 'Characteristic', 'endosome', 'tubules', 'vesicles', 'electron', 'dense', 'peroxidase', 'reaction', 'product', 'cell', 'surface', 'pits', 'Selective', 'capture', 'cell', 'surface', 'proteins', 'others', 'coated', 'pits', 'rise', 'distinct', 'polypeptide', 'composition', 'endosome']"
284,284,http://dialog.proquest.com/professional/docview/592865457?accountid=173210,Propagation and assay of hepatitis A virus in vitro,"Ten strains of hepatitis A virus (HAV) originating from far distant geographical locations were adapted to growth in PLC/PRF/5 (human hepatoma derived and/or MRC-5 (human embryonic lung) cells. In the course of primary adaptation some of these strains exhibited a predilection for distinct cultural conditions such as type of host cell and temperature of incubation. With progressive passage, variant viruses with quite different requirements could be selected; yet, it proved impossible to isolate a virus which replicated equally well in both types of cells and at both 32 and 37 degrees C without at least one preceding passage under the new conditions. Analysis of the virus/cell relationship of well adapted HAV strains revealed that the replication cycle of HAV extends over about 24 h. Moreover, replication evidently passes from a state of active production of infectious virus to a phase during which hepatitis A antigen (HAAg) is synthesized and terminates in the state of persistent infection with markedly reduced synthetic activity. In all three phases replication of HAV is non-cytolytic and the vast majority of both infectious virus and of HAAg remains cell associated. The observations concerning the growth characteristics of HAV were used to develop two rapid in vitro assay systems for HAV infectivity (fluorescent focus assay and in situ RIA). Finally, the conditions for large scale production of infectious HAV and of HAAg in a cell factory system were analysed.","['Siegl, G', 'deChastonay, J', 'Kronauer, G']","['Adaptation, Physiological', 'Antigens, Viral', 'Carcinoma, Hepatocellular', 'Cell Line', 'Embryo, Mammalian', 'Fluorescent Antibody Technique', 'Hepatovirus', 'Hepatovirus', 'Hepatovirus', 'Humans', 'Liver Neoplasms', 'Lung', 'Radioimmunoassay', 'Virus Cultivation', 'Virus Replication']",ProQuest,"['data grid', 'peer-to-peer', 'fault tolerance', 'planar graph', 'cycle', 'security of data', 'malwares', 'programmable logic controllers', 'malicious codes', 'replication strategies', 'plc', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['Propagation', 'assay', 'virus']","['strains', 'virus', 'distant', 'geographical', 'locations', 'growth', 'human', 'hepatoma', 'human', 'embryonic', 'lung', 'cells', 'course', 'primary', 'adaptation', 'strains', 'predilection', 'distinct', 'cultural', 'conditions', 'such', 'type', 'host', 'cell', 'temperature', 'incubation', 'progressive', 'passage', 'variant', 'viruses', 'different', 'requirements', 'impossible', 'virus', 'types', 'cells', 'degrees', 'C', 'passage', 'new', 'conditions', 'Analysis', 'virus', 'cell', 'relationship', 'strains', 'replication', 'cycle', 'h.', 'replication', 'state', 'active', 'production', 'infectious', 'virus', 'phase', 'antigen', 'terminates', 'state', 'persistent', 'infection', 'synthetic', 'activity', 'phases', 'replication', 'non', '-', 'cytolytic', 'vast', 'majority', 'infectious', 'virus', 'cell', 'observations', 'growth', 'characteristics', 'rapid', 'assay', 'systems', 'infectivity', 'fluorescent', 'focus', 'assay', 'situ', 'conditions', 'large', 'scale', 'production', 'infectious', 'HAAg', 'cell', 'factory', 'system']"
285,285,http://dialog.proquest.com/professional/docview/592594722?accountid=173210,Use of MAST suit in obstetrics and gynecology,0,"['Pearse, C S', 'Magrina, J F', 'Finley, B E']","['Adult', 'Carcinoma in Situ', 'Female', 'Gravity Suits', 'Hemorrhage', 'Hemorrhage', 'Humans', 'Liver Diseases', 'Postoperative Complications', 'Postoperative Complications', 'Postpartum Hemorrhage', 'Pregnancy', 'Pregnancy, Ectopic', 'Rupture, Spontaneous', 'Uterine Cervical Neoplasms']",ProQuest,[],liver carcinoma in situ,"['suit', 'obstetrics', 'gynecology']",[]
286,286,http://dialog.proquest.com/professional/docview/592602442?accountid=173210,Histological progression of hepatic neoplasia in rainbow trout (Salmo gairdneri),"The histological progression of hepatic neoplasia has not been as systematically studied in rainbow trout as it has been in rodents. Two putative preneoplastic lesions have been identified, the eosinophilic focus and the basophilic focus, but whether these correspond to similar lesions in rodent livers is not known. Preneoplastic liver lesions in rodents have been extensively characterized histochemically, but adaptation of these techniques to trout livers has not always been successful. Eosinophilic foci consist of hypertrophied cells, enlarged atypical nuclei, and dense glycogen-free cytoplasm. Mitotic figures are also occasionally seen. Usually, these foci have been infiltrated and at least partially destroyed by inflammatory cells, largely lymphocytes. In some liver sections, eosinophilic foci are intact and occasionally an eosinophilic-basophilic transformation can be seen. However, most often basophilic foci appear independently, surrounded by normal hepatocytes, with no indication of a prior eosinophilic stage. The cells of basophilic foci are similar to those of carcinomas: intensely basophilic, mitotically active, devoid of glycogen, and grouped into cords several cells in thickness. These nodules may appropriately be referred to as carcinomas in situ, because the only distinguishing characteristic is the size of the lesion. Attempts at differentiation between benign and malignant liver lesions appear arbitrary. We believe the best classification of the neoplastic liver lesion in trout is a hepatocellular carcinoma because the potential for malignant behavior always exists and, with sufficient time, can often be histologically demonstrated. We have also described our experience with the characteristics of other liver lesions associated with hepatocarcinogenesis.","['Hendricks, J D', 'Meyers, T R', 'Shelton, D W']","['Adenocarcinoma', 'Adenocarcinoma', 'Adenoma, Bile Duct', 'Adenoma, Bile Duct', 'Animals', 'Carcinogens', 'Liver Neoplasms', 'Liver Neoplasms', 'Neoplasm Metastasis', 'Neoplasm Transplantation', 'Salmonidae', 'Trout']",ProQuest,"['computer systems', 'parameter adaptation', 'classification methods', 'classification models', 'correlation analysis', 'optimization problems', 'differential evolution', 'supervised classification', 'image classification']",liver carcinoma in situ,"['Histological', 'progression', 'hepatic', 'neoplasia', 'rainbow', 'trout', 'gairdneri']","['histological', 'progression', 'hepatic', 'neoplasia', 'rainbow', 'trout', 'rodents', 'putative', 'preneoplastic', 'lesions', 'eosinophilic', 'focus', 'basophilic', 'focus', 'similar', 'lesions', 'rodent', 'livers', 'Preneoplastic', 'liver', 'lesions', 'rodents', 'adaptation', 'techniques', 'trout', 'livers', 'successful', 'Eosinophilic', 'foci', 'consist', 'hypertrophied', 'cells', 'atypical', 'nuclei', 'dense', 'glycogen', 'free', 'cytoplasm', 'Mitotic', 'figures', 'foci', 'least', 'inflammatory', 'cells', 'liver', 'sections', 'eosinophilic', 'foci', 'intact', 'eosinophilic', 'basophilic', 'transformation', 'foci', 'normal', 'hepatocytes', 'indication', 'prior', 'eosinophilic', 'stage', 'cells', 'basophilic', 'foci', 'similar', 'carcinomas', 'basophilic', 'active', 'devoid', 'glycogen', 'cords', 'several', 'cells', 'thickness', 'nodules', 'carcinomas', 'situ', 'only', 'characteristic', 'size', 'lesion', 'Attempts', 'differentiation', 'benign', 'malignant', 'liver', 'lesions', 'arbitrary', 'best', 'classification', 'neoplastic', 'liver', 'lesion', 'trout', 'hepatocellular', 'carcinoma', 'potential', 'malignant', 'behavior', 'sufficient', 'time', 'experience', 'characteristics', 'other', 'liver', 'lesions', 'hepatocarcinogenesis']"
287,287,http://dialog.proquest.com/professional/docview/592489309?accountid=173210,Carcinoma in situ of the gallbladder. A clinicopathologic study of 18 cases,"Eighteen cases of carcinoma in situ of the gallbladder collected over a 7-year period at the General Hospital of Mexico City are reported. All patients were females whose ages ranged from 26 to 83 years with a mean of 55. Their symptoms and signs were related to the presence of stones. Grossly, the in situ carcinomas could not be differentiated from chronic cholecystitis. In only one case was the diagnosis suspected on macroscopic examination. Thirteen lesions were located either in the fundus or body of the gallbladder. Histologically there were two types of in situ carcinoma--papillary (two cases) and nonpapillary (16 cases). Hyperplasia of the antral-type glands was associated with 12 cases and cholecystitis follicularis with four. The atypical changes began on the surface epithelium and extended into the epithelial invaginations and later into the antral-type glands. Four carcinomas in situ exhibited limited invasion into the underlying lamina propria or inner part of the muscle layer. In the 15 cases that were examined, immunoperoxidase stains revealed cytoplasmic staining for carcinoembryonic antigen (CEA). All patients we were able to follow (those who had only carcinoma in situ) are symptom-free after cholecystectomy. One of the four patients with microinvasion died 7 years after cholecystectomy with clinical evidence of liver metastasis.","['Albores-Saavedra, J', 'de Jesus Manrique, J', 'Angeles-Angeles, A', 'Henson, D E']","['Adult', 'Aged', 'Bile', 'Carcinoembryonic Antigen', 'Carcinoma in Situ', 'Carcinoma in Situ', 'Carcinoma, Papillary', 'Carcinoma, Papillary', 'Cholecystitis', 'Cholelithiasis', 'Chronic Disease', 'Diagnosis, Differential', 'Epithelium', 'Female', 'Gallbladder', 'Gallbladder Neoplasms', 'Gallbladder Neoplasms', 'Humans', 'Hyperplasia', 'Middle Aged']",ProQuest,"['layered', 'software architecture patterns']",liver carcinoma in situ,"['Carcinoma', 'situ', 'gallbladder', 'clinicopathologic', 'study', 'cases']","['cases', 'carcinoma', 'situ', 'gallbladder', 'period', 'patients', 'females', 'ages', 'years', 'mean', 'symptoms', 'signs', 'presence', 'stones', 'situ', 'carcinomas', 'chronic', 'cholecystitis', 'case', 'diagnosis', 'macroscopic', 'examination', 'lesions', 'fundus', 'body', 'gallbladder', 'types', 'situ', 'carcinoma', 'papillary', 'cases', 'nonpapillary', 'cases', 'antral', 'type', 'glands', 'cases', 'cholecystitis', 'atypical', 'changes', 'surface', 'epithelium', 'epithelial', 'invaginations', 'antral', 'type', 'glands', 'carcinomas', 'situ', 'limited', 'invasion', 'underlying', 'lamina', 'propria', 'inner', 'part', 'muscle', 'layer', 'cases', 'immunoperoxidase', 'stains', 'cytoplasmic', 'staining', 'carcinoembryonic', 'antigen', 'patients', 'able', 'carcinoma', 'situ', 'symptom', 'free', 'cholecystectomy', 'patients', 'microinvasion', 'years', 'cholecystectomy', 'clinical', 'evidence', 'liver', 'metastasis']"
288,288,http://dialog.proquest.com/professional/docview/592491170?accountid=173210,Isolation of mitochondria from ascites tumor cells permeabilized with digitonin,"A new, improved procedure for isolating mitochondria from ascites tumor cells is described. The unique feature of this technique is the use of digitonin to make the cells susceptible to disruption by Teflon pestle/glass vessel homogenization. The yield and respiratory control ratios of mitochondria isolated by this method from murine Ehrlich ascites tumor cells and rat AS30-D ascites hepatoma cells are significantly better than those obtained for mitochondria isolated by the commonly employed Nagarse method, which involves the use of proteolytic enzymes. Moreover, mitochondria isolated by this new procedure from three different lines of tumors exhibit respiratory control ratios with both adenosine diphosphate and a respiratory uncoupler comparable to those obtained with mitochondria present in situ within digitonin-permeabilized tumor cells.","['Moreadith, R W', 'Fiskum, G']","['Animals', 'Ascites', 'Carcinoma, Ehrlich Tumor', 'Cell Fractionation', 'Cell Membrane Permeability', 'Digitonin', 'Female', 'Liver Neoplasms, Experimental', 'Mice', 'Mice, Inbred C3H', 'Mitochondria', 'Neoplasms, Experimental', 'Oxygen Consumption', 'Rats', 'Rats, Inbred Strains']",ProQuest,"['switching systems', 'signal processing', 'signal to noise ratio', 'control systems', 'computer systems', 'switching control', 'local binary patterns', 'content based retrieval']",liver carcinoma in situ,"['Isolation', 'mitochondria', 'ascites', 'tumor', 'cells', 'digitonin']","['new', 'improved', 'procedure', 'mitochondria', 'ascites', 'tumor', 'cells', 'unique', 'feature', 'technique', 'use', 'digitonin', 'cells', 'susceptible', 'disruption', 'pestle', 'glass', 'vessel', 'homogenization', 'yield', 'respiratory', 'control', 'ratios', 'mitochondria', 'method', 'murine', 'tumor', 'cells', 'rat', 'AS30-D', 'hepatoma', 'cells', 'better', 'mitochondria', 'method', 'use', 'proteolytic', 'enzymes', 'mitochondria', 'new', 'procedure', 'different', 'lines', 'tumors', 'respiratory', 'control', 'ratios', 'adenosine', 'diphosphate', 'respiratory', 'uncoupler', 'comparable', 'mitochondria', 'present', 'situ', 'digitonin', 'tumor', 'cells']"
289,289,http://dialog.proquest.com/professional/docview/592335774?accountid=173210,A sequential study of methapyrilene hydrochloride-induced liver carcinogenesis in male F344 rats,"Methapyrilene hydrochloride [2-[2-(dimethylamino)-ethyl)-2-thenylamino)pyridine monohydrochloride (CAS: 135-23-9)]-induced hepatocarcinogenesis was studied in male F344/NCr rats by sequential histologic, histochemical, and biologic methods. Methapyrilene hydrochloride was administered in the feed to rats at a concentration of 1,000 ppm for periods up to 89 weeks. Groups of rats were killed after 5, 10, 15, 29, 40, or 73 weeks of ingesting the carcinogen. Another group was allowed to live out their life-span. Hepatocellular eosinophilic foci and adenomas were seen after 10 and 15 weeks, respectively. Basophilic foci and adenomas were found after 29 and 40 weeks, respectively. Hepatocellular carcinomas developed in 5 of 10 rats at week 40, in 3 of 5 rats at week 73, and in 19 of 19 rats that lived out their life-span. Carcinomas arose within adenomas or as small in situ carcinomas. The histologic types included trabecular, adenocarcinoma, mixed, and solid poorly differentiated hepatocellular carcinomas. Eleven of the mixed and solid poorly differentiated carcinomas metastasized to the lung. Solid poorly differentiated hepatocellular carcinomas grew upon transplantation to the mammary fat pad of weanling F344 rats. Cholangiocarcinomas were found in 7 of 19 rats only in the life-span group. Mucous cholangiofibrosis was seen in all rats after 15 weeks. With the use of Regaud's mitochondrial stain, an increased cellular density of mitochondria was seen in some hepatocytes of peripheral and central lobular areas and in some hepatocellular carcinoma cells, but not in cells in many of the adenomas and foci. Cellular alpha-fetoprotein was found by immunoperoxidase staining in portions of hepatocellular carcinomas, but not in foci, adenomas, and nonneoplastic areas. The majority of hepatocytes in foci, adenomas, and hepatocellular carcinomas contained gamma-glutamyl transpeptidase. The findings suggest that multiple pathways may be followed in the development of methapyrilene-induced liver cancer that are similar to those found in rats exposed to many other hepatic carcinogens.","['Ohshima, M', 'Ward, J M', 'Brennan, L M', 'Creasia, D A']","['Aminopyridines', 'Animals', 'Body Weight', 'Carcinogens', 'Liver', 'Liver', 'Liver Neoplasms', 'Liver Neoplasms', 'Liver Neoplasms, Experimental', 'Liver Neoplasms, Experimental', 'Male', 'Methapyrilene', 'Organ Size', 'Precancerous Conditions', 'Rats', 'Rats, Inbred F344', 'Time Factors']",ProQuest,"['cellular telephone systems', 'pulse position modulation', 'wireless', 'cellular radio systems', 'channel capacity', 'cellular network', 'ppm', 'cellular system', 'cellular']",liver carcinoma in situ,"['sequential', 'study', 'methapyrilene', 'hydrochloride', 'liver', 'carcinogenesis', 'male', 'F344', 'rats']","['Methapyrilene', 'monohydrochloride', 'hepatocarcinogenesis', 'male', 'rats', 'sequential', 'histologic', 'histochemical', 'biologic', 'methods', 'Methapyrilene', 'hydrochloride', 'feed', 'rats', 'concentration', 'ppm', 'periods', 'weeks', 'Groups', 'rats', 'weeks', 'carcinogen', 'group', 'life', 'span', 'Hepatocellular', 'eosinophilic', 'foci', 'adenomas', 'weeks', 'Basophilic', 'foci', 'adenomas', 'weeks', 'Hepatocellular', 'carcinomas', 'rats', 'week', 'rats', 'week', 'rats', 'life', 'span', 'Carcinomas', 'adenomas', 'small', 'situ', 'carcinomas', 'histologic', 'types', 'trabecular', 'adenocarcinoma', 'mixed', 'solid', 'hepatocellular', 'carcinomas', 'mixed', 'solid', 'carcinomas', 'lung', 'hepatocellular', 'carcinomas', 'transplantation', 'mammary', 'fat', 'pad', 'F344', 'rats', 'rats', 'life', 'span', 'group', 'Mucous', 'cholangiofibrosis', 'rats', 'weeks', 'use', 'mitochondrial', 'stain', 'cellular', 'density', 'mitochondria', 'hepatocytes', 'peripheral', 'central', 'lobular', 'areas', 'hepatocellular', 'carcinoma', 'cells', 'cells', 'many', 'adenomas', 'foci', 'Cellular', 'alpha', 'fetoprotein', 'immunoperoxidase', 'staining', 'portions', 'hepatocellular', 'carcinomas', 'foci', 'adenomas', 'nonneoplastic', 'areas', 'majority', 'hepatocytes', 'foci', 'adenomas', 'hepatocellular', 'carcinomas', 'gamma', 'glutamyl', 'transpeptidase', 'findings', 'multiple', 'pathways', 'development', 'methapyrilene', 'liver', 'cancer', 'similar', 'rats', 'many', 'other', 'hepatic', 'carcinogens']"
290,290,http://dialog.proquest.com/professional/docview/592352037?accountid=173210,Merkel cell carcinoma of the vulva,"The authors describe the clinical and histologic findings in a case of Merkel cell carcinoma of the vulva, which was associated with squamous cell carcinoma in situ and lichen sclerosus. Electron microscopy of the tumor revealed membrane-bound granules. At postmortem examination, metastases from this primary skin tumor were found in the pelvic lymph nodes, in paraortic lymph nodes, in the liver, and in vertebral bodies. The case is unusual because Merkel cell tumors are usually found on the face or the extremities and seldom metastasize widely.","['Bottles, K', 'Lacey, C G', 'Goldberg, J', 'Lanner-Cusin, K', 'Hom, J', 'Miller, T R']","['Aged', 'Carcinoma, Small Cell', 'Carcinoma, Small Cell', 'Carcinoma, Squamous Cell', 'Female', 'Humans', 'Lymphatic Metastasis', 'Mechanoreceptors', 'Neoplasms, Multiple Primary', 'Skin Neoplasms', 'Skin Neoplasms', 'Vulvar Neoplasms', 'Vulvar Neoplasms']",ProQuest,"['frontal faces', 'face images', 'ad hoc networks', 'wireless sensor networks', 'gateway nodes', 'source nodes', 'face features', 'face detection', 'face recognition', 'gateways (computer networks)', 'facial images', 'routing protocols']",liver carcinoma in situ,"['cell', 'carcinoma', 'vulva']","['authors', 'clinical', 'histologic', 'findings', 'case', 'cell', 'carcinoma', 'vulva', 'squamous', 'cell', 'carcinoma', 'situ', 'lichen', 'sclerosus', 'microscopy', 'tumor', 'membrane', 'granules', 'postmortem', 'examination', 'primary', 'skin', 'tumor', 'pelvic', 'lymph', 'nodes', 'paraortic', 'lymph', 'nodes', 'liver', 'vertebral', 'bodies', 'case', 'unusual', 'cell', 'tumors', 'face', 'extremities']"
291,291,http://dialog.proquest.com/professional/docview/592784822?accountid=173210,Natural killer cell activity in patients with abnormalities of the uterine cervix,"Peripheral blood lymphocytes from 105 patients with various degrees of cervical dysplasia (normal/mild, moderate and severe) up to carcinoma in situ were assayed for natural killer cell activity against K562 cells and Chang liver cells in vitro. No difference was found between the natural killer cell activities of any of the groups of patients studied. In addition, the K cell activity of the patients' lymphocytes was assayed in an antibody-dependent cellular cytotoxicity assay on Chang liver cells with anti-Chang cell antiserum. No difference was found between patient groups. There was no correlation between the presence of antibodies in the patients' serum to cytomegalovirus measured by anti-complement immunofluorescence and increased natural killer cell activity.","['Neill, W', 'Norval, M']","['Age Factors', 'Antibodies, Viral', 'Antibody-Dependent Cell Cytotoxicity', 'Carcinoma in Situ', 'Complement System Proteins', 'Cytomegalovirus', 'Cytotoxicity, Immunologic', 'Female', 'Humans', 'Killer Cells, Natural', 'Parity', 'Uterine Cervical Dysplasia', 'Uterine Cervical Neoplasms']",ProQuest,"['parity bits', 'cellular telephone systems', 'wireless', 'cellular radio systems', 'correlation analysis', 'channel capacity', 'wyner-ziv', 'cellular network', 'correlation coefficient', 'distributed video coding', 'cellular system', 'mathematics', 'cellular', 'turbo codes']",liver carcinoma in situ,"['Natural', 'killer', 'cell', 'activity', 'patients', 'abnormalities', 'uterine', 'cervix']","['Peripheral', 'blood', 'patients', 'various', 'degrees', 'cervical', 'dysplasia', 'normal', 'mild', 'moderate', 'severe', 'carcinoma', 'situ', 'natural', 'killer', 'cell', 'activity', 'cells', 'liver', 'cells', 'vitro', 'difference', 'natural', 'killer', 'cell', 'activities', 'groups', 'patients', 'addition', 'cell', 'activity', 'patients', 'lymphocytes', 'antibody', 'dependent', 'cellular', 'cytotoxicity', 'assay', 'liver', 'cells', 'anti', '-', 'cell', 'antiserum', 'difference', 'patient', 'groups', 'correlation', 'presence', 'antibodies', 'patients', 'serum', 'anti', '-', 'complement', 'immunofluorescence', 'natural', 'killer', 'cell', 'activity']"
292,292,http://dialog.proquest.com/professional/docview/593070356?accountid=173210,DNA methylation by N-nitrosomethylbenzylamine in target and non-target tissues of laboratory rodents. Comparison with carcinogenicity,"Following oral or systemic (subcutaneous) administration to rats,N-nitroso -methylbenzylamine (NMBzA) causes a high incidence of oesophageal tumours. Methylation of DNA purines by a single oral dose of [14C-methyl]-NMBzA was most extensive in the oesophagus, followed by liver, forestomach and lung. After a single intravenous injection, alkylation levels were also highest in oesophageal DNA, followed by liver, lung and forestomach. These differences in the extent of alkylation were found to correlate with the autoradiographic distribution of tissue-bound 14C-radioactivity in in-situ preparations of the upper gastrointestinal tract following oral exposure to [14C-methyl]-NMBzA. In mice, systemic administration of NMBzA leads to the development of forestomach and lung tumours; in this species, DNA methylation after intraperitoneal injection of NMBzA is highest in liver, followed by lung and forestomach. Administration of [14C-methyl]-NMBzA to mice in the drinking-water led to very high concentrations of alkylated DNA bases in both oesophagus and forestomach. This finding is in good agreement with carcinogenicity studies, which showed 100% carcinoma incidence at these sites. Autoradiographic studies indicate that in rats and mice the metabolism of NMBzA in the oesophagus is largely restricted to the mucosa, whereas in lung, bioactivation occurs predominantly in the bronchial epithelium. In autoradiographs from liver, tissue-bound radioactivity showed a patchy distribution, with predominant reaction in the centrilobular region. In Mongolian gerbils, methylation of lung DNA by a similar subcutaneous dose of [14C-methyl]-NMBzA was greater than in rats and mice, whereas in the remaining tissues, levels of methylated purines were comparatively low. Chronic subcutaneous administration of NMBzA to gerbils caused no tumour within an observation period of two years.","['Wiestler, O D', 'Uozumi, A', 'Kleihues, P']","['Animals', 'DNA', 'DNA, Neoplasm', 'Dimethylnitrosamine', 'Dimethylnitrosamine', 'Dimethylnitrosamine', 'Dimethylnitrosamine', 'Female', 'Inactivation, Metabolic', 'Male', 'Methylation', 'Mice', 'Neoplasms', 'Neoplasms', 'Organ Specificity', 'Rats', 'Rats, Inbred Strains']",ProQuest,[],liver carcinoma in situ,"['DNA', 'methylation', 'N', 'nitrosomethylbenzylamine', 'target', 'non', '-', 'target', 'tissues', 'laboratory', 'rodents', 'Comparison', 'carcinogenicity']","['oral', 'systemic', 'subcutaneous', 'administration', 'rats', 'N', 'nitroso', 'high', 'incidence', 'oesophageal', 'tumours', 'Methylation', 'DNA', 'purines', 'single', 'oral', 'dose', 'extensive', 'oesophagus', 'liver', 'forestomach', 'lung', 'single', 'intravenous', 'injection', 'alkylation', 'levels', 'highest', 'oesophageal', 'liver', 'lung', 'forestomach', 'differences', 'extent', 'alkylation', 'autoradiographic', 'distribution', 'tissue', 'radioactivity', 'situ', 'preparations', 'upper', 'gastrointestinal', 'tract', 'oral', 'exposure', 'methyl]-NMBzA.', 'mice', 'systemic', 'administration', 'development', 'forestomach', 'lung', 'tumours', 'species', 'DNA', 'methylation', 'intraperitoneal', 'injection', 'highest', 'liver', 'lung', 'forestomach', 'Administration', 'mice', 'drinking', 'water', 'high', 'concentrations', 'DNA', 'bases', 'oesophagus', 'forestomach', 'finding', 'good', 'agreement', 'carcinogenicity', 'studies', '%', 'carcinoma', 'incidence', 'sites', 'Autoradiographic', 'studies', 'rats', 'mice', 'metabolism', 'oesophagus', 'mucosa', 'lung', 'bioactivation', 'bronchial', 'epithelium', 'autoradiographs', 'liver', 'tissue', 'radioactivity', 'patchy', 'distribution', 'predominant', 'reaction', 'centrilobular', 'region', 'Mongolian', 'gerbils', 'methylation', 'lung', 'DNA', 'similar', 'subcutaneous', 'dose', 'greater', 'rats', 'mice', 'tissues', 'levels', 'methylated', 'purines', 'low', 'Chronic', 'subcutaneous', 'administration', 'gerbils', 'tumour', 'observation', 'period', 'years']"
293,293,http://dialog.proquest.com/professional/docview/591867448?accountid=173210,Enzymic detection of uracil in a cloned and sequenced deoxyribonucleic acid segment,"Uracil can occur in DNA either as a result of utilization of dUTP by DNA polymerases or from in situ deamination of cytosine. The latter results in transition mutations following the next round of replication. We describe a technique for the detection of uracil in DNA by a modification of the Maxam-Gilbert sequencing procedure. Reaction of end-labeled DNA with uracil-DNA glycosylase followed by 1 M piperidine results in scission products corresponding to locations of uracils. These are detected by autoradiography following electrophoresis through a sequencing gel. Comparison of these scission products with the DNA sequences elucidates the mechanism of origin of the DNA uracils. The technique was tested with a cloned human DNA sequence grown in a dut-,ung-strain of Escherichia coli, which incorporates uracil in place of thymine in its DNA, and by chemical deamination of cytosines in that sequence. The technique was expanded by use of alkaline and enzymic probes to investigate possible accumulation of uracil, base losses, and other modifications in human liver and brain DNA. No damaged DNA moieties were detected. This method is applicable to the study of any recoverable reiterated sequence by any enzyme preparation that can recognize modifications in DNA.","['Weiss, R B', 'Mineura, K', 'Henderson, E E', 'Duker, N J', 'deRiel, J K']","['Adolescent', 'Aged', 'Base Sequence', 'Carcinoma, Bronchogenic', 'Carcinoma, Small Cell', 'Cerebellum', 'Cloning, Molecular', 'DNA', 'DNA, Neoplasm', 'DNA-Directed DNA Polymerase', 'HeLa Cells', 'Humans', 'Liver', 'Male', 'Plasmids', 'Uracil']",ProQuest,"['data grid', 'design for testability', 'peer-to-peer', 'built-in self test', 'fault tolerance', 'mass customization', 'shift registers', 'customized products', 'software engineering', 'replication strategies', 'system under test', 'detection algorithm', 'circuit under test', 'signal detection']",liver carcinoma in situ,"['Enzymic', 'detection', 'uracil', 'deoxyribonucleic', 'acid', 'segment']","['DNA', 'result', 'utilization', 'polymerases', 'situ', 'deamination', 'cytosine', 'latter', 'results', 'transition', 'mutations', 'next', 'round', 'replication', 'technique', 'detection', 'uracil', 'DNA', 'modification', 'sequencing', 'procedure', 'Reaction', 'end', 'DNA', 'uracil', 'DNA', 'glycosylase', 'piperidine', 'results', 'scission', 'products', 'locations', 'uracils', 'autoradiography', 'electrophoresis', 'sequencing', 'gel', 'Comparison', 'scission', 'products', 'sequences', 'mechanism', 'origin', 'technique', 'human', 'DNA', 'sequence', 'dut-,ung', 'strain', 'coli', 'uracil', 'place', 'thymine', 'DNA', 'chemical', 'deamination', 'cytosines', 'sequence', 'technique', 'use', 'alkaline', 'enzymic', 'probes', 'possible', 'accumulation', 'uracil', 'base', 'losses', 'other', 'modifications', 'human', 'liver', 'brain', 'DNA', 'DNA', 'moieties', 'method', 'applicable', 'study', 'recoverable', 'sequence', 'enzyme', 'preparation', 'modifications', 'DNA']"
294,294,http://dialog.proquest.com/professional/docview/591616325?accountid=173210,Effects of four retinoids in N-nitrosobis(2-oxopropyl)amine-treated hamsters,"Four synthetic retinoids were evaluated with regard to chemo-prevention of pancreatic carcinomas in carcinogen-treated hamsters. Syrian golden hamsters were given two injections of N-nitrosobis(2-oxopropyl)amine (20 mg/kg) and then were fed retinoid-supplemented diets for 1 year. The incidence of pancreatic carcinomas was lower in six of eight retinoid-fed groups than in the control group, although the differences were not statistically significant. The lowest incidence was observed in groups fed N-(4-pivaloyloxyphenyl)retinamide and N-(2-hydroxypropyl)retinamide. Testicular atrophy with decreased spermatogenesis was noted in males fed N-(2-hydroxypropyl)retinamide, N-(3-hydroxypropyl)retinamide, and N-(2,3-dihydroxypropyl)retinamide.","['Longnecker, D S', 'Kuhlmann, E T', 'Curphey, T J']","['Adenocarcinoma', 'Animals', 'Body Weight', 'Carcinoma in Situ', 'Cricetinae', 'Diet', 'Female', 'Liver Neoplasms', 'Lung Neoplasms', 'Male', 'Mesocricetus', 'Neoplasms, Experimental', 'Neoplasms, Experimental', 'Nitrosamines', 'Organ Size', 'Pancreatic Neoplasms', 'Pancreatic Neoplasms', 'Sex Factors', 'Vitamin A']",ProQuest,"['switching systems', 'clustering algorithms', 'control systems', 'computer systems', 'switching control', 'database systems', 'real data sets']",liver carcinoma in situ,"['Effects', 'retinoids', 'nitrosobis(2-oxopropyl)amine', 'hamsters']","['synthetic', 'retinoids', 'regard', 'chemo', 'prevention', 'pancreatic', 'carcinomas', 'carcinogen', 'hamsters', 'Syrian', 'golden', 'hamsters', 'injections', 'N', 'nitrosobis(2-oxopropyl)amine', 'mg', 'kg', 'retinoid', 'diets', 'year', 'incidence', 'pancreatic', 'carcinomas', 'lower', 'retinoid', 'groups', 'control', 'group', 'differences', 'significant', 'lowest', 'incidence', 'groups', 'atrophy', 'decreased', 'spermatogenesis', 'males', 'N-(2,3-dihydroxypropyl)retinamide']"
295,295,http://dialog.proquest.com/professional/docview/591548093?accountid=173210,Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens,"Murine monoclonal antibodies, prepared against human metastatic mammary tumor cells, were used to demonstrate differential expression of several tumor-associated antigens (TAAs) among various mammary carcinomas and within a given tumor mass. Using the immunoperoxidase technique on serial sections of 39 human primary mammary carcinomas, a spectrum of antigenic phenotypes of TAAs was observed: 13% of the tumors reacted with all of a panel of four monoclonal antibodies; while 10% of the mammary tumors scored negative with all four antibodies. The remaining 30 tumors could be divided into several additional groups based on their differential reactivity with some, but not all, of the monoclonal antibodies. Furthermore, variation among mammary carcinomas was also observed in the cellular localization of antigens. Antigenic phenotypic diversity of mammary tumor cell populations within a given tumor mass was also observed; this was noted with respect to (a) antigenic expression in one area of a tumor mass and not another and (b) a ""patchwork"" effect in which antigens were expressed on cells immediately adjacent to cells which scored negative. Antigenic phenotypic diversity was also observed in established mammary tumor cell lines grown in vitro. A differential loss of some cell surface TAAs was observed as a function of continued cell passage; consistent with this finding, MCF-7 mammary tumor cell lines obtained from four sources could be differentiated from each other by their pattern of cell surface TAA expression. Single-cell clones derived from the MCF-7 mammary tumor cell line exhibited at least four distinct antigenic phenotypes; a change in cell surface phenotype of some of the clones was seen during subsequent passage. This definition of phenotypic variation and modulation of TAA expression among, and within, human mammary carcinomas has implications towards both the design and the outcome of studies involving the in situ immunodetection and therapy of breast cancer.","['Hand, P H', 'Nuti, M', 'Colcher, D', 'Schlom, J']","['Adenocarcinoma', 'Animals', 'Antibodies, Monoclonal', 'Antigens, Neoplasm', 'Breast Neoplasms', 'Cell Line', 'Female', 'Humans', 'Hybridomas', 'Liver Neoplasms', 'Liver Neoplasms', 'Lymphocytes', 'Mice', 'Plasmacytoma']",ProQuest,"['cellular', 'spectrum sensing', 'source codes', 'cellular telephone systems', 'optical fibers', 'wireless', 'clone detection', 'frequency bands', 'phase modulation', 'cellular radio systems', 'bit error rate', 'cognitive radio network', 'dynamic spectrum access', 'antennas', 'dynamic spectrum', 'code clone']",liver carcinoma in situ,"['Definition', 'antigenic', 'heterogeneity', 'modulation', 'human', 'mammary', 'carcinoma', 'cell', 'populations', 'monoclonal', 'antibodies', 'tumor', 'antigens']","['Murine', 'monoclonal', 'antibodies', 'human', 'metastatic', 'mammary', 'tumor', 'cells', 'differential', 'expression', 'several', 'tumor', 'antigens', 'TAAs', 'various', 'mammary', 'carcinomas', 'tumor', 'mass', 'immunoperoxidase', 'technique', 'serial', 'sections', 'human', 'primary', 'mammary', 'carcinomas', 'spectrum', 'antigenic', 'phenotypes', 'TAAs', '%', 'tumors', 'panel', 'monoclonal', 'antibodies', '%', 'mammary', 'tumors', 'negative', 'antibodies', 'tumors', 'several', 'additional', 'groups', 'differential', 'reactivity', 'monoclonal', 'antibodies', 'variation', 'mammary', 'carcinomas', 'cellular', 'localization', 'antigens', 'Antigenic', 'phenotypic', 'diversity', 'mammary', 'tumor', 'cell', 'populations', 'tumor', 'mass', 'respect', 'antigenic', 'expression', 'area', 'tumor', 'mass', 'patchwork', 'effect', 'antigens', 'cells', 'adjacent', 'cells', 'negative', 'Antigenic', 'phenotypic', 'diversity', 'mammary', 'tumor', 'cell', 'lines', 'vitro', 'differential', 'loss', 'cell', 'surface', 'TAAs', 'function', 'cell', 'passage', 'consistent', 'finding', 'mammary', 'tumor', 'cell', 'lines', 'sources', 'other', 'pattern', 'cell', 'surface', 'expression', 'Single', 'cell', 'clones', 'mammary', 'tumor', 'cell', 'line', 'least', 'distinct', 'antigenic', 'phenotypes', 'change', 'cell', 'surface', 'phenotype', 'clones', 'subsequent', 'passage', 'definition', 'phenotypic', 'variation', 'modulation', 'expression', 'human', 'mammary', 'carcinomas', 'implications', 'design', 'outcome', 'studies', 'situ', 'immunodetection', 'therapy', 'breast', 'cancer']"
296,296,http://dialog.proquest.com/professional/docview/591565539?accountid=173210,Synthesis of vimentin in a reticulocyte cell-free system programmed by poly(A)-rich RNA from several cell lines and rat liver,"Poly(A)-rich RNA has been isolated from Ehrlich ascites tumor (EAT) cells and translated in a rabbit reticulocyte cell-free system. The intermediate filament protein, vimentin, was found to be a major translation product. Fractionation of the poly(A)-rich RNA by sucrose gradient centrifugation showed that the vimentin mRNA had a sedimentation coefficient of about 18 S corresponding to a molecular size of about 2000 nucleotides. This means that it must possess significant non-coding regions. Vimentin synthesized in vitro was identical to native vimentin with regard to its precipitability with ammonium sulphate, extent of phosphorylation and susceptibility to digestion by the vimentin-specific, Ca2+-activated proteinase. Poly(A)-rich RNA was also isolated from a number of tissue-culture cells and rat liver, which contain varying amounts of vimentin in situ. It was found that the amount of vimentin synthesized by these RNA preparations in a rabbit reticulocyte cell-free system is proportional to the amount of vimentin detectable in situ, suggesting that the amount of cellular vimentin may be controlled at the level of transcription.","['McTavish, C F', 'Nelson, W J', 'Traub, P']","['Animals', 'Autoradiography', 'Carcinoma, Ehrlich Tumor', 'Cell-Free System', 'Cells, Cultured', 'Humans', 'Intermediate Filament Proteins', 'Liver', 'Poly A', 'RNA', 'RNA, Messenger', 'Rabbits', 'Rats', 'Reticulocytes', 'Vimentin']",ProQuest,"['computer aided design', 'machine translations', 'cellular telephone systems', 'product design', 'translation process', 'programming theory', 'coding techniques', 'network coding', 'image coding', 'wireless', 'cellular radio systems', 'coding scheme', 'cellular']",liver carcinoma in situ,"['vimentin', 'reticulocyte', 'cell', 'free', 'system', 'several', 'cell', 'lines', 'rat', 'liver']","['ascites', 'tumor', 'cells', 'rabbit', 'reticulocyte', 'cell', 'free', 'system', 'intermediate', 'filament', 'protein', 'vimentin', 'major', 'translation', 'product', 'Fractionation', 'sucrose', 'gradient', 'centrifugation', 'vimentin', 'sedimentation', 'coefficient', 'molecular', 'size', 'nucleotides', 'significant', 'non', '-', 'coding', 'regions', 'vitro', 'identical', 'vimentin', 'regard', 'precipitability', 'ammonium', 'sulphate', 'extent', 'phosphorylation', 'susceptibility', 'digestion', 'vimentin', 'specific', 'Ca2', 'proteinase', 'number', 'tissue', 'culture', 'cells', 'rat', 'liver', 'amounts', 'vimentin', 'situ', 'amount', 'vimentin', 'preparations', 'rabbit', 'reticulocyte', 'cell', 'free', 'system', 'proportional', 'amount', 'vimentin', 'detectable', 'situ', 'amount', 'cellular', 'vimentin', 'level', 'transcription']"
297,297,http://dialog.proquest.com/professional/docview/591640061?accountid=173210,Cytokeratin and nonhistone protein antigenic changes in rat liver during azo dye but not hepatotoxin feeding,"Chromosomal proteins from rat liver have been assessed immunologically for changes in specific cytokeratins or primary tumor nonhistone proteins during treatment with an azo dye hepatocarcinogen (3'-methyl-4-dimethylaminoazobenzene), (3'-Me-DAB) or the hepatotoxin alpha-naphthyl-iso-thiocyanate (alpha-NIT). Fisher rats were fed laboratory diets supplemented with either agent and sacrificed sequentially at various intervals. Chromosomal proteins from these livers were electrophoresed in the presence of sodium dodecyl sulfate, transferred to nitrocellulose sheets and reacted with rabbit antisera to Novikoff hepatoma cytokeratin or 3'-Me-DAB induced primary hepatoma dehistonized chromatin. Livers from carcinogen-fed animals exhibited distinct, sequential changes in antigenic nonhistone proteins until the immunological specificity characteristic of the hepatoma was achieved concomitant with the induction of neoplasia. No antigenic changes were observed to occur in hepatotoxin-fed animals. The rat carcinoma-specific cytokeratin antigens p39 and p49 in Novikoff hepatoma were observed to appear as early as three weeks after the start of carcinogen feeding and were present maximally in 23 week livers with in situ carcinoma. These cytokeratins were not detected in alpha-NIT-fed animals. Our results support the concept that the carcinogenic process can be related to temporal changes in the expression of cell-specific cytokeratins in addition to nonhistone chromosomal proteins. Furthermore, these data suggest the expression of these antigenic species to not be the direct result of changes in liver structure and cellular composition associated with carcinogen toxicity; rather, neoplastic transformation is apparently required.","['Schmidt, W N', 'Gronert, B J', 'McKusick, K B', 'Page, D L', 'Hnilica, L S']","['1-Naphthylisothiocyanate', 'Animals', 'Antigens', 'Chromosomal Proteins, Non-Histone', 'Keratins', 'Liver', 'Liver', 'Liver Neoplasms, Experimental', 'Male', 'Methyldimethylaminoazobenzene', 'Rats', 'Rats, Inbred F344', 'Rats, Inbred Strains', 'p-Dimethylaminoazobenzene']",ProQuest,"['digital video broadcasting (dvb)', 'cellular telephone systems', 'software agents', 'dvb-t', 'wireless', 'cellular radio systems', 'intelligent agents', 'multiagent system', 'autonomous agents', 'cellular', 'ofdm']",liver carcinoma in situ,"['nonhistone', 'protein', 'antigenic', 'changes', 'rat', 'liver', 'azo', 'dye']","['Chromosomal', 'proteins', 'rat', 'liver', 'changes', 'specific', 'cytokeratins', 'primary', 'tumor', 'nonhistone', 'proteins', 'treatment', 'azo', 'dye', 'hepatocarcinogen', 'hepatotoxin', 'alpha', 'naphthyl', 'iso', 'thiocyanate', 'alpha', 'Fisher', 'rats', 'laboratory', 'diets', 'agent', 'various', 'intervals', 'Chromosomal', 'proteins', 'livers', 'presence', 'sodium', 'dodecyl', 'sulfate', 'sheets', 'rabbit', 'antisera', 'hepatoma', 'cytokeratin', 'primary', 'hepatoma', 'chromatin', 'Livers', 'carcinogen', 'animals', 'distinct', 'sequential', 'changes', 'antigenic', 'nonhistone', 'proteins', 'immunological', 'specificity', 'characteristic', 'hepatoma', 'concomitant', 'induction', 'neoplasia', 'antigenic', 'changes', 'hepatotoxin', 'animals', 'rat', 'carcinoma', 'specific', 'cytokeratin', 'p39', 'p49', 'hepatoma', 'early', 'weeks', 'start', 'carcinogen', 'feeding', 'present', 'week', 'livers', 'situ', 'carcinoma', 'cytokeratins', 'alpha', 'NIT', 'animals', 'results', 'concept', 'carcinogenic', 'process', 'temporal', 'changes', 'expression', 'cell', 'specific', 'cytokeratins', 'addition', 'nonhistone', 'chromosomal', 'proteins', 'data', 'expression', 'antigenic', 'species', 'direct', 'result', 'changes', 'liver', 'structure', 'cellular', 'composition', 'carcinogen', 'toxicity', 'neoplastic', 'transformation']"
298,298,http://dialog.proquest.com/professional/docview/592152008?accountid=173210,Medroxyprogesterone acetate as a contraceptive for female drug addicts,"A study of 69 female drug addicts is presented who have been given depomedroxyprogesterone acetate (DMPA) as a contraceptive for 1 680 woman-months. No pregnancies were reported during the treatment period with DMPA. After stopping treatment, 60 pregnancies with 43 births were recorded, 12 with low birth weight. In 3 cases pregnancy ended with spontaneous abortion, and in 14 cases legal abortion were performed. During the study, regular liver function tests revealed no hepatotoxic effects from DMPA in this group of patients where one would expect a high frequency of a serum hepatitis. Neither coagulation nor blood pressure were affected. The most frequent side effect was amenorrhoea, which seems to be accepted well in this group. Metrorrhagia is often a reason for withdrawing the drug. A very high frequency of venereal or other gynaecological infection is presumably the explanation for the very high number of atypical inflammation cells found at vaginal cytological examination. In the series, two cases of carcinoma in situ have been demonstrated by cervical biopsy. Both cases are possibly related to these women's early sexual activity, very promiscuous life and to the poor environment of the drug addict.","['Mark, I']","['Adolescent', 'Adult', 'Chemical and Drug Induced Liver Injury', 'Contraceptive Agents, Female', 'Delayed-Action Preparations', 'Female', 'Humans', 'Medroxyprogesterone', 'Medroxyprogesterone', 'Medroxyprogesterone', 'Medroxyprogesterone Acetate', 'Substance-Related Disorders']",ProQuest,"['variable frequency oscillators', 'bandwidth', 'artificial intelligence', 'frequencies', 'test results', 'output frequency', 'multiagent system', 'autonomous agents', 'sensors']",liver carcinoma in situ,"['Medroxyprogesterone', 'contraceptive', 'female', 'drug', 'addicts']","['study', 'female', 'drug', 'addicts', 'depomedroxyprogesterone', 'acetate', 'contraceptive', 'woman', 'months', 'pregnancies', 'treatment', 'period', 'treatment', 'pregnancies', 'births', 'low', 'birth', 'weight', 'cases', 'pregnancy', 'spontaneous', 'abortion', 'cases', 'legal', 'abortion', 'study', 'regular', 'liver', 'function', 'tests', 'hepatotoxic', 'effects', 'group', 'patients', 'high', 'frequency', 'serum', 'hepatitis', 'coagulation', 'blood', 'pressure', 'frequent', 'side', 'effect', 'amenorrhoea', 'group', 'reason', 'drug', 'high', 'frequency', 'venereal', 'other', 'gynaecological', 'infection', 'explanation', 'high', 'number', 'atypical', 'inflammation', 'cells', 'vaginal', 'cytological', 'examination', 'series', 'cases', 'carcinoma', 'situ', 'cervical', 'biopsy', 'cases', 'related', 'women', 'early', 'sexual', 'activity', 'promiscuous', 'life', 'poor', 'environment', 'drug', 'addict']"
299,299,http://dialog.proquest.com/professional/docview/591454555?accountid=173210,Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 50-1982. Liver dysfunction after total colectomy for intestinal polyposis,0,0,"['Adenoma', 'Adenoma', 'Ampulla of Vater', 'Carcinoma in Situ', 'Carcinoma in Situ', 'Common Bile Duct Neoplasms', 'Common Bile Duct Neoplasms', 'Diagnosis, Differential', 'Female', 'Gardner Syndrome', 'Humans', 'Middle Aged']",ProQuest,[],liver carcinoma in situ,"['Case', 'records', 'Weekly', 'clinicopathological', 'exercises', 'Case', 'Liver', 'dysfunction', 'total', 'colectomy', 'intestinal', 'polyposis']",[]
300,300,http://dialog.proquest.com/professional/docview/591456828?accountid=173210,DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci,"The DNA content of cell nuclei of liver lesions induced in inbred male ACI rats by administration of 0.02% N-2-fluorenylacetamide (2-FAA) diet was measured with a microspectrophotometer in Feulgen-stained specimens. Altered liver foci of the eosinophilic, clear, and simple basophilic (toluidine blue weakly positive or negative) types had modal DNA values with a wider deviation (2C-10C) than the euploid pattern of normal hepatocytes (2C-6C). However, the DNA histograms of cells in hyperbasophilic (intensely toluidine blue-positive) foci were aneuploid (2C-18C) and resembled those of cells in hepatocellular carcinomas (2C-23C). Conversely, the modal DNA values of neoplastic nodules showed a narrower range (2C-12C). These results confirm that the hyperbasophilic foci may be a population similar to carcinoma in situ or may be a direct precursor lesion of hepatocellular carcinoma. In the livers from 4 humans, 3 of whom had a history of long-term use of some drugs, multiple hyperplastic foci resembling eosinophilic or clear cell foci in rats were identified. The modal DNA values of the cell nuclei in these foci showed a wider deviation (2C-10C) than in surrounding hepatocytes (2C-6C). In 2 patients, the lesions contained neoplasms and, therefore, hyperplastic foci in humans may be related to tumor development.","['Mori, H', 'Tanaka, T', 'Sugie, S', 'Takahashi, M', 'Williams, G M']","['2-Acetylaminofluorene', 'Animals', 'Cell Nucleus', 'DNA', 'Humans', 'Hyperplasia', 'Liver', 'Liver', 'Liver Neoplasms', 'Liver Neoplasms', 'Male', 'Rats', 'Rats, Inbred Strains']",ProQuest,"['multimedia services', 'boundary value problems', 'world wide web', 'digital rights management', 'image retrieval', 'digital contents', 'color histogram', 'graphic methods', 'multimedia contents', 'boundary values', 'web page', 'initial value problems', 'color image processing']",liver carcinoma in situ,"['DNA', 'content', 'liver', 'cell', 'nuclei', 'foci', 'neoplasms', 'rats', 'human', 'hyperplastic', 'foci']","['DNA', 'content', 'cell', 'nuclei', 'liver', 'lesions', 'male', 'rats', 'administration', '%', 'N-2-fluorenylacetamide', 'diet', 'microspectrophotometer', 'specimens', 'Altered', 'liver', 'foci', 'eosinophilic', 'clear', 'simple', 'basophilic', 'toluidine', 'blue', 'positive', 'negative', 'types', 'modal', 'DNA', 'values', 'wider', 'deviation', 'euploid', 'pattern', 'normal', 'hepatocytes', '2C-6C', 'DNA', 'histograms', 'cells', 'toluidine', 'blue', 'positive', 'foci', 'aneuploid', 'cells', 'hepatocellular', 'carcinomas', 'modal', 'DNA', 'values', 'neoplastic', 'nodules', 'narrower', 'range', 'results', 'hyperbasophilic', 'foci', 'population', 'similar', 'carcinoma', 'situ', 'direct', 'precursor', 'lesion', 'hepatocellular', 'carcinoma', 'livers', 'humans', 'history', 'long', 'term', 'use', 'drugs', 'multiple', 'hyperplastic', 'foci', 'eosinophilic', 'clear', 'cell', 'foci', 'rats', 'modal', 'DNA', 'values', 'cell', 'nuclei', 'foci', 'wider', 'deviation', 'hepatocytes', '2C-6C', 'patients', 'lesions', 'neoplasms', 'hyperplastic', 'foci', 'humans', 'tumor', 'development']"
301,301,http://dialog.proquest.com/professional/docview/591330079?accountid=173210,Tissue bile acids in patients with colon cancer and colonic polyps,"The purpose of this study was to determine whether in man unusual types of concentrations or bile acids were present in colonic polyps, colon carcinomas, or the adjacent, apparently normal tissue. Methods for the determination of soluble and tissue-bound bile acids were validated. Of 14 polyps analyzed, eight contained detectable levels of bile acid, predominantly chenodeoxycholic acid; no lithocholic acid was observed in either the tissue-bound or soluble bile acid fractions. Bile acids were found in four of nine samples of colon carcinoma; in one tumor, tissue-bound lithocholic acid was present. Bile acids were similarly found in seven of 10 samples of normal bowel taken adjacent to the carcinoma. In the soluble bile acid fraction, cholic acid was more abundant than chenodeoxycholic acid. There was no correlation between tissue histology and bile acid composition or concentration. Under the conditions used, this study did not disclose a relationship between tissue bile acids and colorectal histology.","['Gelb, A M', 'McSherry, C K', 'Sadowsky, J R', 'Mosbach, E H']","['Adenocarcinoma', 'Adenoma', 'Adult', 'Aged', 'Bile Acids and Salts', 'Biopsy', 'Carcinoma', 'Carcinoma in Situ', 'Chenodeoxycholic Acid', 'Colon', 'Colonic Neoplasms', 'Colonic Neoplasms', 'Female', 'Humans', 'Intestinal Polyps', 'Intestinal Polyps', 'Liver', 'Male', 'Middle Aged']",ProQuest,"['dynamic composition', 'mathematics', 'correlation analysis', 'web service composition', 'software engineering', 'correlation coefficient', 'automatic composition', 'service compositions', 'component composition']",liver carcinoma in situ,"['Tissue', 'bile', 'acids', 'patients', 'colon', 'cancer', 'colonic', 'polyps']","['purpose', 'study', 'man', 'unusual', 'types', 'concentrations', 'bile', 'acids', 'present', 'colonic', 'polyps', 'colon', 'carcinomas', 'adjacent', 'normal', 'tissue', 'Methods', 'determination', 'soluble', 'tissue', 'bile', 'acids', 'polyps', 'detectable', 'levels', 'bile', 'acid', 'chenodeoxycholic', 'acid', 'lithocholic', 'acid', 'tissue', 'soluble', 'bile', 'acid', 'fractions', 'Bile', 'acids', 'samples', 'colon', 'carcinoma', 'tumor', 'tissue', 'lithocholic', 'acid', 'present', 'Bile', 'acids', 'samples', 'normal', 'bowel', 'adjacent', 'carcinoma', 'soluble', 'bile', 'acid', 'fraction', 'cholic', 'acid', 'abundant', 'chenodeoxycholic', 'acid', 'correlation', 'tissue', 'histology', 'acid', 'composition', 'concentration', 'conditions', 'study', 'relationship', 'tissue', 'bile', 'acids', 'colorectal', 'histology']"
302,302,http://dialog.proquest.com/professional/docview/591308478?accountid=173210,Naturally occurring polypoid hyperplasia and papilloma in gallbladders of the fat sand rat (Psammomys obesus terraesanctae Thomas),"The gallbladders of 256 fat sand rats (131 males and 125 females) seven to 41 months old were studied histologically. None of the sand rats had been used in experimental procedures prior to death. Diffuse polypoid hyperplasia or papilloma of the gallbladder mucosa was found in 49 sand rats. Of these lesions, 45 were present in 126 sand rats in the second half of their lifespan. Neither concretions nor signs of chronic inflammation were seen. Signs of focal epithelial growth activity were seen in either form of lesion. Epithelial hyperplasia was excessive in two gallbladders, and one was diagnosed as carcinoma-in-situ. The papilloma in one sand rat revealed transition to adenocarcinoma, with penetration into the deep layers of the gallbladder. Preneoplastic nodules were found in the liver as frequently as reported previously, but they were unrelated to gallbladder lesions. The unusual high incidence of spontaneous epithelial proliferation in the gallbladder mucosa in sand rats of both sexes through several generations suggests this strain as a model in the experimental study of tumorigenesis in the gallbladder.","['Ungar, H', 'Adler, J H']","['Animals', 'Arvicolinae', 'Female', 'Gallbladder Diseases', 'Gallbladder Diseases', 'Gallbladder Neoplasms', 'Gallbladder Neoplasms', 'Hyperplasia', 'Hyperplasia', 'Male', 'Papilloma', 'Papilloma', 'Polyps', 'Polyps', 'Rodent Diseases']",ProQuest,"['software architecture patterns', 'hierarchical system', 'hierarchical model', 'wireless sensor networks', 'layered', 'life-times']",liver carcinoma in situ,"['polypoid', 'hyperplasia', 'papilloma', 'gallbladders', 'fat', 'sand', 'rat', 'obesus', 'terraesanctae']","['gallbladders', 'fat', 'sand', 'rats', 'males', 'females', 'months', 'old', 'None', 'sand', 'rats', 'experimental', 'procedures', 'death', 'polypoid', 'hyperplasia', 'papilloma', 'gallbladder', 'mucosa', 'sand', 'rats', 'lesions', 'present', 'sand', 'rats', 'second', 'half', 'lifespan', 'concretions', 'signs', 'chronic', 'inflammation', 'Signs', 'focal', 'epithelial', 'growth', 'activity', 'form', 'lesion', 'Epithelial', 'hyperplasia', 'excessive', 'gallbladders', 'carcinoma', 'situ', 'papilloma', 'sand', 'rat', 'transition', 'penetration', 'deep', 'layers', 'gallbladder', 'Preneoplastic', 'nodules', 'liver', 'unrelated', 'gallbladder', 'lesions', 'unusual', 'high', 'incidence', 'spontaneous', 'epithelial', 'proliferation', 'gallbladder', 'mucosa', 'sand', 'rats', 'sexes', 'several', 'generations', 'strain', 'model', 'experimental', 'study', 'tumorigenesis', 'gallbladder']"
303,303,http://dialog.proquest.com/professional/docview/591245536?accountid=173210,Inhibition of pancreatic carcinogenesis by retinoids in azaserine-treated rats,"Chemoprevention by retinoids of the progression of carcinomas induced in rats by azaserine was evaluated. Wistar/Lewis rats were given 15 weekly injections of azaserine, 10 mg/kg, while fed a chow diet; after the completion of carcinogen treatment, they were fed a chow diet supplemented with four different retinoids at the level of 0.5 to 2 mmol/kg diet for 1 year. The incidence of neoplasms was determined by autopsy and histological study. The incidence of pancreatic carcinoma among a male positive control group (azaserine treated, but not retinoid treated) was 42%. The incidence of pancreatic carcinoma among male rats treated with retinoids was: N-2-hydroxyethylretinamide, 6%; N-4-propionyloxyphenylretinamide, 17%; and retinylidene dimedone, 12%. The incidence in rats fed these three retinoids was significantly (p less than 0.05) below the control group incidence. Thus, these three retinoids appeared to be effective in inhibiting the progression of pancreatic carcinomas in the azaserine-induced model. A similar trend was demonstrated in females, but statistical significance was shown only in rats fed N-2-hydroxyethylretinamide. A fourth retinoid, N-4-carboxyphenylretinamide, was more toxic and less effective in chemoprevention. Since retinoids were fed after exposure to carcinogen, the effect was exerted during the postinitiation phase of carcinogenesis. The ratio of invasive pancreatic carcinomas to localized carcinomas (carcinoma in situ) was clearly higher among non-retinoid-treated rats than among those treated with retinoids. This is consistent with retarded progression in the retinoid-treated groups.","['Longnecker, D S', 'Curphey, T J', 'Kuhlmann, E T', 'Roebuck, B D']","['Animals', 'Azaserine', 'Female', 'Liver Neoplasms', 'Male', 'Neoplasm Metastasis', 'Neoplasms, Experimental', 'Pancreas', 'Pancreatic Neoplasms', 'Rats', 'Vitamin A', 'Vitamin A']",ProQuest,"['switching systems', 'control systems', 'computer systems', 'hierarchical system', 'hierarchical model', 'switching control', 'correlation analysis', 'statistical significance', 'mathematics']",liver carcinoma in situ,"['Inhibition', 'pancreatic', 'carcinogenesis', 'retinoids', 'azaserine', 'rats']","['Chemoprevention', 'retinoids', 'progression', 'carcinomas', 'rats', 'azaserine', 'rats', 'weekly', 'injections', 'azaserine', 'mg', 'kg', 'chow', 'diet', 'completion', 'carcinogen', 'treatment', 'chow', 'diet', 'different', 'retinoids', 'level', 'mmol', 'diet', 'year', 'incidence', 'neoplasms', 'autopsy', 'histological', 'study', 'incidence', 'pancreatic', 'carcinoma', 'male', 'positive', 'control', 'group', 'azaserine', 'retinoid', 'treated', '%', 'incidence', 'pancreatic', 'carcinoma', 'male', 'rats', 'retinoids', '%', '%', 'retinylidene', 'dimedone', '%', 'incidence', 'rats', 'retinoids', 'less', 'control', 'group', 'incidence', 'retinoids', 'effective', 'progression', 'pancreatic', 'carcinomas', 'azaserine', 'induced', 'model', 'similar', 'trend', 'females', 'statistical', 'significance', 'rats', 'fourth', 'retinoid', 'toxic', 'effective', 'chemoprevention', 'retinoids', 'exposure', 'carcinogen', 'effect', 'postinitiation', 'phase', 'carcinogenesis', 'ratio', 'invasive', 'pancreatic', 'carcinomas', 'carcinomas', 'carcinoma', 'situ', 'higher', 'non', '-', 'rats', 'retinoids', 'consistent', 'retarded', 'progression', 'groups']"
304,304,http://dialog.proquest.com/professional/docview/591137298?accountid=173210,A case of carcinoma of the gallbladder with unusual clinical course,"A case of carcinoma of the gallbladder with particular clinic course is described, stressing the problem of the precocious diagnosis of this kind of tumor. The insufficient knowledge about this argument, confirmed by conflicts of the studies about this, is denounced. Considering the far better prognosis when the diagnosis of cancer of the gallbladder is done in the stage ""in situ"", the AA. confirmed the importance of a careful anamnesis and, above all, of the histological examination on all the gallbladders removed for every cause.","['Bosco, L', 'Trompetto, M']","['Female', 'Gallbladder Neoplasms', 'Humans', 'Liver Neoplasms', 'Lung Neoplasms', 'Middle Aged', 'Respiratory Insufficiency']",ProQuest,"['tacit knowledge', 'explicit knowledge', 'combinatorial problems', 'combinatorial op-timization problem', 'combinatorial mathematics', 'knowledge management', 'polynomial approximation', 'optimization', 'knowledge based systems', 'approximation algorithms', 'combinatorial optimization', 'domain knowledge']",liver carcinoma in situ,"['case', 'carcinoma', 'gallbladder', 'unusual', 'clinical', 'course']","['case', 'carcinoma', 'gallbladder', 'particular', 'clinic', 'course', 'problem', 'precocious', 'diagnosis', 'kind', 'tumor', 'insufficient', 'knowledge', 'argument', 'conflicts', 'studies', 'better', 'prognosis', 'diagnosis', 'cancer', 'gallbladder', 'stage', 'situ', 'importance', 'careful', 'anamnesis', 'histological', 'examination', 'gallbladders', 'cause']"
305,305,http://dialog.proquest.com/professional/docview/590893709?accountid=173210,Metabolic fate of cell surface glycoproteins during immunoglobulin-induced internalization,"Goat antibodies directed against a subset of the externally oriented plasma membrane glycoproteins of hepatoma tissue culture (HTC) cells were used to follow the metabolic fate of the membrane antigens and the specifically bound immunoglobulin molecules in this cell type in cultures. Analyses of the immunoprecipitates from cells labeled in situ with neuraminidase and galactose oxidase, followed by reduction with tritiated sodium borohydride, indicate that about 40% of the galactose-labeled plasma membrane glycoproteins are recognized by the antiserum. Fluorescent microscopic analyses of cells treated with fluorescein-conjugated immunoglobulins and analyses of trypsin accessibility indicate that probably all of the antibodies bound to the cell surface are patched and internalized within about 4 hr when the cells are subsequently cultured at 37 degrees C in the presence of rabbit anti-goat immunoglobulins. At the same time, the antigens are also interiorized. Analyses of the cellular localization of the interiorized antigens and antibodies by cell fractionation on Percoll gradients show that the immunoglobulins to the cell surface antigens and the antigens themselves migrate to the same region of the Percoll gradient as lysosomal hydrolases. Although the antibodies bind to the cell surface glycoproteins and bring about patching and interiorization, there is no effect on the degradation of the plasma membrane antigens labeled via the galactose oxidase/borohydride reduction method. Furthermore, the iodinated antibodies directed against these membrane glycoproteins behave in their turnover properties like membrane antigens; the cell-bound specific immunoglobulins have the same half-life as the membrane glycoproteins. When the cells that had been reacted with the goat antibodies to membrane glycoprotein were cultured in the presence of rabbit anti-goat immunoglobulins, degradation of the former antibodies was effectively decreased. Similar results were obtained with concanavalin A and antibodies directed against this plant lectin.","['Baumann, H', 'Doyle, D']","['Animals', 'Antigen-Antibody Complex', 'Antigen-Antibody Reactions', 'Antigens, Surface', 'Carcinoma, Hepatocellular', 'Cell Line', 'Glycoproteins', 'Glycoproteins', 'Liver Neoplasms', 'Membrane Proteins', 'Membrane Proteins', 'Receptors, Antigen, B-Cell']",ProQuest,"['cellular telephone systems', 'wireless sensor networks', 'wireless', 'web accessibility', 'cellular radio systems', 'correlation analysis', 'user with disabilities', 'localization algorithm', 'cellular network', 'channel capacity', 'cellular system', 'mathematics', 'cellular']",liver carcinoma in situ,"['Metabolic', 'fate', 'cell', 'surface', 'glycoproteins', 'immunoglobulin', 'induced', 'internalization']","['antibodies', 'subset', 'plasma', 'membrane', 'glycoproteins', 'hepatoma', 'tissue', 'culture', 'cells', 'metabolic', 'fate', 'membrane', 'antigens', 'immunoglobulin', 'molecules', 'cell', 'type', 'cultures', 'Analyses', 'immunoprecipitates', 'cells', 'situ', 'neuraminidase', 'galactose', 'oxidase', 'reduction', 'tritiated', 'sodium', 'borohydride', '%', 'galactose', 'plasma', 'membrane', 'glycoproteins', 'antiserum', 'Fluorescent', 'microscopic', 'analyses', 'cells', 'fluorescein', 'immunoglobulins', 'analyses', 'trypsin', 'accessibility', 'antibodies', 'cell', 'surface', 'cells', 'degrees', 'C', 'presence', 'rabbit', 'anti', '-', 'goat', 'immunoglobulins', 'same', 'time', 'antigens', 'Analyses', 'cellular', 'localization', 'antigens', 'antibodies', 'cell', 'fractionation', 'gradients', 'immunoglobulins', 'cell', 'surface', 'antigens', 'antigens', 'same', 'region', 'gradient', 'lysosomal', 'hydrolases', 'antibodies', 'cell', 'surface', 'glycoproteins', 'interiorization', 'effect', 'degradation', 'plasma', 'membrane', 'antigens', 'galactose', 'oxidase', 'reduction', 'method', 'antibodies', 'membrane', 'glycoproteins', 'turnover', 'properties', 'membrane', 'antigens', 'cell', 'specific', 'immunoglobulins', 'same', 'half', 'life', 'membrane', 'glycoproteins', 'cells', 'goat', 'antibodies', 'membrane', 'glycoprotein', 'presence', 'rabbit', 'anti', '-', 'goat', 'immunoglobulins', 'degradation', 'former', 'antibodies', 'Similar', 'results', 'concanavalin', 'A', 'antibodies', 'plant', 'lectin']"
306,306,http://dialog.proquest.com/professional/docview/590796537?accountid=173210,Effect of epidermal chalones on induction and growth of tumors of the cervicovaginal epithelium of mice,"Tumors of the cervicovaginal epithelium were induced in BALB/c female mice with local application of dimethylbenzanthra cene. In the course of inducing tumors or after their appearance the mice were treated intravaginally with 55-81% ethanolic extract of the rat skin or liver (control) containing 1% chalones. The skin extract rather than liver one delays slightly the growth and incidence of cervical and vaginal tumours, and increases the survival of animals.","['Okulov, V B', 'Anisimov, V N', 'Chepik, O F', 'Azarova, M A']","['9,10-Dimethyl-1,2-benzanthracene', 'Adenocarcinoma', 'Animals', 'Antineoplastic Agents', 'Carcinoma in Situ', 'Carcinoma, Squamous Cell', 'Epidermis', 'Female', 'Growth Inhibitors', 'Growth Inhibitors', 'Liver', 'Mice', 'Neoplasms, Experimental', 'Neoplasms, Experimental', 'Rats', 'Uterine Cervical Neoplasms', 'Uterine Cervical Neoplasms', 'Vaginal Neoplasms', 'Vaginal Neoplasms']",ProQuest,"['queueing delays', 'computer systems', 'object tracking', 'artificial intelligence', 'propagation delays', 'network protocols', 'time delay', 'multiagent system', 'object appearance', 'queuing network']",liver carcinoma in situ,"['Effect', 'epidermal', 'chalones', 'induction', 'growth', 'tumors', 'cervicovaginal', 'epithelium', 'mice']","['Tumors', 'cervicovaginal', 'epithelium', 'female', 'mice', 'local', 'application', 'dimethylbenzanthra', 'course', 'tumors', 'appearance', 'mice', '%', 'ethanolic', 'extract', 'rat', 'skin', 'liver', 'control', '%', 'chalones', 'skin', 'extract', 'delays', 'growth', 'incidence', 'cervical', 'vaginal', 'tumours', 'survival', 'animals']"
307,307,http://dialog.proquest.com/professional/docview/590927989?accountid=173210,Radiation sensitivity of DNA molecules in situ in normal and neoplastic tissues of mice,"The sensitivity to radiation of DNA molecules in situ in various tissues was estimated by alkaline sucrose gradient centrifugation. The sensitivity of DNA in liver, thymus, spleen and cerebellum was found to be of the same order of magnitude. The oxygen enhancement ratios of DNA in spleen, thymus and cerebellum were all approximately three. Sensitivity of DNA molecules in the tumour was about half of that in normal tissues, probably because of its hypoxicity.","['Ono, T', 'Sakamoto, K', 'Okada, S']","['Adult', 'Animals', 'Carcinoma, Squamous Cell', 'Centrifugation, Density Gradient', 'DNA', 'DNA, Neoplasm', 'Humans', 'Sarcoma, Experimental']",ProQuest,"['signal processing', 'signal to noise ratio', 'image enhancement', 'enhancement techniques', 'speech enhancement']",liver carcinoma in situ,"['Radiation', 'sensitivity', 'DNA', 'molecules', 'situ', 'normal', 'neoplastic', 'tissues', 'mice']","['sensitivity', 'radiation', 'DNA', 'molecules', 'situ', 'various', 'tissues', 'alkaline', 'sucrose', 'gradient', 'centrifugation', 'sensitivity', 'DNA', 'liver', 'thymus', 'spleen', 'cerebellum', 'same', 'order', 'magnitude', 'oxygen', 'enhancement', 'ratios', 'DNA', 'spleen', 'thymus', 'cerebellum', 'Sensitivity', 'molecules', 'tumour', 'half', 'normal', 'tissues', 'hypoxicity']"
308,308,http://dialog.proquest.com/professional/docview/590921090?accountid=173210,Recent aspects of tumor invasiveness,0,"['Mareel, M M']","['Animals', 'Bone and Bones', 'Carcinoma in Situ', 'Cartilage', 'Cell Division', 'Cell Movement', 'Connective Tissue', 'Endothelium', 'Epithelium', 'Humans', 'Hydrolases', 'Liver', 'Muscles', 'Neoplasm Invasiveness', 'Neoplasm Metastasis', 'Nerve Tissue', 'Phagocytosis']",ProQuest,[],liver carcinoma in situ,"['Recent', 'aspects', 'tumor', 'invasiveness']",[]
309,309,http://dialog.proquest.com/professional/docview/590845814?accountid=173210,Clinical toxicology of estrogens,"This paper reviews both minor and major adverse reactions caused by estrogenic substances (natural and synthetic, steroidal and nonsteroidal) of which diethylstilbestrol is the prototype of nonsteroidal synthetic estrogen.  Minor side effects include nausea, breast tenderness, and excessive cervical secretions (most common), headache, and water and salt retention (less common and often eradicated by lowering estrogen dosage).  Vertigo, yeast infections, depression, and photosensitivity are other minor effects.  Major side effects are discussed in some detail.  Major effects include those on the endocrine system (e.g., feminization in boys and men and precocious puberty in girls); breast tumors; endometrial carcinoma; ovarian tumors; hypertension; thromboembolism; blood clotting excesses; various metabolic effects (including lipid metabolism and carbohydrate metabolism alterations); liver changes (bile alterations and neoplasms); porphyria; melanoma; and effects on a fetus in situ during maternal estrogen administration.  In general, lowering doses of estrogen should help eradicate or alleviate most of these effects.","['Westerholm, B']","['Adolescent', 'Adult', 'Blood Coagulation', 'Breast Neoplasms', 'Endocrine Glands', 'Estrogens', 'Female', 'Fetus', 'Humans', 'Hypertension', 'Liver', 'Liver Neoplasms', 'Male', 'Melanoma', 'Ovarian Neoplasms', 'Porphyrias', 'Pregnancy', 'Thromboembolism', 'Uterine Neoplasms']",ProQuest,"['database systems', 'real data sets', 'clustering algorithms']",liver carcinoma in situ,"['Clinical', 'toxicology', 'estrogens']","['paper', 'minor', 'major', 'adverse', 'reactions', 'estrogenic', 'substances', 'natural', 'synthetic', 'steroidal', 'nonsteroidal', 'diethylstilbestrol', 'prototype', 'nonsteroidal', 'synthetic', 'estrogen', 'Minor', 'side', 'effects', 'nausea', 'breast', 'tenderness', 'excessive', 'cervical', 'secretions', 'common', 'headache', 'water', 'salt', 'retention', 'common', 'estrogen', 'dosage', 'yeast', 'infections', 'depression', 'photosensitivity', 'other', 'minor', 'effects', 'Major', 'side', 'effects', 'detail', 'Major', 'effects', 'endocrine', 'system', 'feminization', 'boys', 'men', 'precocious', 'puberty', 'girls', 'breast', 'tumors', 'endometrial', 'carcinoma', 'ovarian', 'tumors', 'hypertension', 'thromboembolism', 'blood', 'clotting', 'excesses', 'various', 'metabolic', 'effects', 'lipid', 'metabolism', 'carbohydrate', 'metabolism', 'alterations', 'liver', 'changes', 'bile', 'alterations', 'neoplasms', 'porphyria', 'melanoma', 'effects', 'fetus', 'situ', 'maternal', 'estrogen', 'administration', 'general', 'doses', 'estrogen', 'most', 'effects']"
310,310,http://dialog.proquest.com/professional/docview/590730838?accountid=173210,First experimental demonstration of the carcinogenic effects of styrene oxide; long-term bioassays on Sprague-Dawley rats by oral administration,0,"['Maltoni, C', 'Failla, G', 'Kassapidis, G']","['Administration, Oral', 'Animals', 'Carcinoma in Situ', 'Dose-Response Relationship, Drug', 'Female', 'Liver Neoplasms', 'Male', 'Neoplasms, Experimental', 'Papilloma', 'Rats', 'Stomach Neoplasms', 'Styrenes', 'Time Factors']",ProQuest,"['intelligent robots', 'experimental demonstrations', 'demonstrations', 'robot programming', 'optical fiber communication']",liver carcinoma in situ,"['First', 'experimental', 'demonstration', 'carcinogenic', 'effects', 'styrene', 'oxide', 'long', 'term', 'bioassays', 'rats', 'oral', 'administration']",[]
311,311,http://dialog.proquest.com/professional/docview/590317783?accountid=173210,Tumorigenic aspects,"This report presents a review of tumors, except those of pituitary, that have been reported to occur in women taking combined oral contraceptive preparations. Pathologic features, both gross and microscopic, and differential diagnosis are emphasized. Particular attention is given to tumors of the liver: focal nodular hyperplasia (hepatic hamartoma) and liver cell adenoma (benign hepatoma). The characteristic features of these usually distinctive lesions are illustrated, and an attempt is made to evaluate the significance of each with respect to oral contraceptives. Tumorigenic aspects relating to the uterus and the breast are briefly discussed.","['Kirk, M E']","['Adenofibroma', 'Breast Diseases', 'Breast Neoplasms', 'Carcinoma in Situ', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Contraceptives, Oral', 'Contraceptives, Oral, Combined', 'Contraceptives, Oral, Synthetic', 'Female', 'Humans', 'Hyperplasia', 'Liver', 'Liver Neoplasms', 'Liver Neoplasms', 'Precancerous Conditions', 'Pregnancy', 'Uterine Cervical Dysplasia', 'Uterine Cervical Neoplasms', 'Vaginal Smears']",ProQuest,"['clustering algorithms', 'feature space', 'classification methods', 'database systems', 'pattern recognition', 'real data sets']",liver carcinoma in situ,"['Tumorigenic', 'aspects']","['report', 'review', 'tumors', 'pituitary', 'women', 'oral', 'contraceptive', 'preparations', 'gross', 'microscopic', 'differential', 'diagnosis', 'Particular', 'attention', 'tumors', 'liver', 'focal', 'nodular', 'hyperplasia', 'hepatic', 'hamartoma', 'liver', 'cell', 'adenoma', 'benign', 'hepatoma', 'characteristic', 'features', 'distinctive', 'lesions', 'attempt', 'significance', 'respect', 'oral', 'contraceptives', 'Tumorigenic', 'aspects', 'uterus', 'breast']"
312,312,http://dialog.proquest.com/professional/docview/589943134?accountid=173210,Oral contraception. Physiologic and pathologic effects,0,"['Andrews, W C']","['Adenoma', 'Breast Neoplasms', 'Carbohydrate Metabolism', 'Carcinoma', 'Carcinoma in Situ', 'Cerebrovascular Disorders', 'Contraceptives, Oral', 'Coronary Disease', 'Emotions', 'Female', 'Fertility', 'Headache', 'Humans', 'Hypertension', 'Liver Neoplasms', 'Ovarian Neoplasms', 'Thromboembolism', 'Uterine Cervical Neoplasms', 'Uterine Neoplasms']",ProQuest,"['robotics', 'computer aided instruction', 'emotion recognition', 'basic emotions', 'motion estimation', 'emotional expressions', 'facial expression', 'human emotion', 'affective state', 'affective computing', 'human motions', 'man machine systems']",liver carcinoma in situ,"['Oral', 'contraception', 'Physiologic', 'pathologic', 'effects']",[]
313,313,http://dialog.proquest.com/professional/docview/589877177?accountid=173210,Expression of hormonally induced tyrosine aminotransferase in host liver and Morris hepatoma No. 7777 during cofactor depletion,"Cytoplasmic tyrosine aminotransferase (L-tyrosine: 2-oxoglutarate aminotransferase, EC2.6.1.5) was partially purified from host liver and Morris hepatoma No. 7777 grown in pyridoxine depleted rats. The animals were sacrificed six hours following the intraperitoneal administration of hydrocortisone hemisuccinate. Enzyme preparations were subsequently resolved by electrophoresis on polyacrylamide gels. Enzyme activity was detected histochemically in situ on the gels. Six and at least three enzymatically active protein peaks were detected in host liver and the hepatoma, respectively, by this method.","['Shuler, J K', 'Tryfiates, G P']","['Animals', 'Carcinoma, Hepatocellular', 'Enzyme Induction', 'Hydrocortisone', 'Liver', 'Liver Neoplasms', 'Rats', 'Tyrosine Transaminase', 'Vitamin B 6 Deficiency']",ProQuest,"['network interface', 'noc', 'interfaces (computer)']",liver carcinoma in situ,"['Expression', 'tyrosine', 'aminotransferase', 'host', 'liver', 'hepatoma', 'cofactor', 'depletion']","['Cytoplasmic', 'tyrosine', 'aminotransferase', 'L', 'tyrosine', 'aminotransferase', 'host', 'liver', 'hepatoma', 'pyridoxine', 'rats', 'animals', 'hours', 'intraperitoneal', 'administration', 'hydrocortisone', 'hemisuccinate', 'Enzyme', 'preparations', 'electrophoresis', 'polyacrylamide', 'gels', 'Enzyme', 'activity', 'situ', 'gels', 'active', 'protein', 'peaks', 'host', 'liver', 'hepatoma', 'method']"
314,314,http://dialog.proquest.com/professional/docview/589513693?accountid=173210,Lipid dependence of mitochondrial monoamine oxidase from rat hepatoma 27 with the use of rat liver lipid exchange proteins,"The ability of liver lipid exchange proteins to introduce foreign phospholipids into intact mitochondria was used for a study of the lipid dependence of monoamine oxidase. Introduction of exogenous phosphatidylcholine into rat hepatoma mitochondria, in which both the monoamine oxidase activity and the phosphatidylcholine content are comparatively low, leads to considerable activation of the enzyme. The introduction of exogeneous phosphatidylserine, phosphatidylethanolamine and cardiolipin has no activating effect. This indicates that the decreased activity of monoamine oxidase in the hepatoma may be due to a low amount of phosphatidylcholine. The method described allows the study in situ of the lipid dependence of non-solubilized membrane-bound enzymes.","['Diatlovitskaia, E V', 'Valdnietse, A T', ""Bergel'son, L D""]","['Animals', 'Carcinoma, Hepatocellular', 'Carrier Proteins', 'Lipid Metabolism', 'Liver', 'Liver Neoplasms', 'Mitochondria', 'Monoamine Oxidase', 'Neoplasms, Experimental', 'Phospholipids', 'Phospholipids', 'Rats']",ProQuest,"['multimedia services', 'information dissemination', 'electronic data interchange', 'digital rights management', 'world wide web', 'data integration', 'digital contents', 'information exchanges', 'information management', 'data exchange', 'multimedia contents', 'web page']",liver carcinoma in situ,"['dependence', 'mitochondrial', 'monoamine', 'oxidase', 'rat', 'hepatoma', 'use', 'rat', 'liver', 'lipid', 'exchange', 'proteins']","['ability', 'liver', 'lipid', 'exchange', 'proteins', 'foreign', 'phospholipids', 'intact', 'mitochondria', 'study', 'lipid', 'dependence', 'monoamine', 'oxidase', 'Introduction', 'exogenous', 'phosphatidylcholine', 'rat', 'hepatoma', 'mitochondria', 'monoamine', 'oxidase', 'activity', 'phosphatidylcholine', 'content', 'low', 'considerable', 'activation', 'enzyme', 'introduction', 'exogeneous', 'phosphatidylserine', 'phosphatidylethanolamine', 'cardiolipin', 'effect', 'activity', 'monoamine', 'oxidase', 'hepatoma', 'due', 'low', 'amount', 'phosphatidylcholine', 'method', 'study', 'situ', 'lipid', 'dependence', 'non', '-', 'solubilized', 'membrane', 'enzymes']"
315,315,http://dialog.proquest.com/professional/docview/589177051?accountid=173210,Properties of the H-4-II-E tumor cell system. I. Growth and cell proliferation kinetics of an experimental hepatoma,"Growth and cell proliferation kinetics of hepatoma H-4-II-E and its tissue culture derivative have been studied to establish the characteristics of an in vivo--in vitro solid tumor model. The H-4-II-E line, originating from the Reuber H-35 hepatoma, can be maintained and studied either in cell culture or as a transplantable solid tumor in ACI male rats. In addition it allows for the in vitro assay of cell survival following treatment of animal tumors in situ. In vivo, hepatoma H-4-II-E is rapidly growing tumor with a mean doubling time of 49-2 hr. The cell cyle time is 39-1 hr with a cell loss factor of 0-32. Retrospective examination of tumor specimens obtained during the establishment of the H-4-II-E tumor system demonstrates that both structural as well as cell population changes have occurred. The biological characteristics of the primary tumor (H-35) and an early intermediate stage (H-35tc2) are compared with H-4-II-E and the histopathological, growth and cell kinetic changes are discussed.","['Evans, M J', 'Kovacs, C J']","['2-Acetylaminofluorene', 'Animals', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Division', 'Cell Line', 'Cell Survival', 'Disease Models, Animal', 'Kinetics', 'Liver Neoplasms', 'Male', 'Neoplasm Transplantation', 'Neoplasms, Experimental', 'Rats', 'Rats, Inbred ACI']",ProQuest,"['kinetic equations', 'hierarchical system', 'hierarchical model', 'kaplan-meiers estimate', 'standard model', 'asynchronous transfer mode', 'proportional hazards models', 'the standard model', 'electronic document identification systems', 'queueing theory', 'integral equations', 'probability', 'cell loss probability']",liver carcinoma in situ,"['Properties', 'H-4-II', 'E', 'tumor', 'cell', 'system', 'cell', 'proliferation', 'kinetics', 'experimental', 'hepatoma']","['Growth', 'cell', 'proliferation', 'kinetics', 'hepatoma', 'H-4-II', 'tissue', 'culture', 'derivative', 'characteristics', 'vivo', 'solid', 'tumor', 'model', 'H-4-II', 'E', 'line', 'hepatoma', 'cell', 'culture', 'transplantable', 'solid', 'tumor', 'male', 'rats', 'addition', 'assay', 'cell', 'survival', 'treatment', 'animal', 'tumors', 'situ', 'vivo', 'hepatoma', 'H-4-II', 'tumor', 'mean', 'time', 'hr', 'cell', 'cyle', 'time', 'hr', 'cell', 'loss', 'factor', 'Retrospective', 'examination', 'tumor', 'specimens', 'establishment', 'H-4-II', 'E', 'tumor', 'system', 'structural', 'cell', 'population', 'changes', 'biological', 'characteristics', 'primary', 'tumor', 'early', 'intermediate', 'stage', 'H-35tc2', 'H-4-II', 'E', 'histopathological', 'growth', 'cell', 'kinetic', 'changes']"
316,316,http://dialog.proquest.com/professional/docview/589751694?accountid=173210,Improvement of pancreatic cancer model by modified treatment with N-nitroso-bis (2-oxopropyl) amine,"Comparative studies were conducted in 2 groups of Syrian golden hamsters treated with N-nitroso-bis (2-oxopropyl)amine (BOP) weekly for life (group A) or weekly for 6 weeks (group B), and sacrificed at 2-week intervals. Pancreatic neoplasms developed as early as 8 weeks (group B) and 10 weeks (group A); however, in group B there were fewer, smaller lesions, well-differentiated morphologically. Liver neoplasms occurred only in group A, while gallbladder and kidney tumors were seen in both groups. A lower incidence of pulmonary adenomas was found in group B than in group A, which also had pulmonary carcinomas. The results indicate a further advance in the development of a pancreatic cancer model.","['Pour, P', 'Althoff, J', 'Kr√ºger, F W', 'Mohr, U']","['Adenocarcinoma', 'Animals', 'Body Weight', 'Carcinogens', 'Carcinoma in Situ', 'Carcinoma, Intraductal, Noninfiltrating', 'Cricetinae', 'Disease Models, Animal', 'Female', 'Lung Neoplasms', 'Male', 'Mesocricetus', 'Nitrosamines', 'Pancreatic Neoplasms', 'Time Factors']",ProQuest,"['stochastic processes', 'hierarchical system', 'hierarchical model', 'standard model', 'correlation analysis', 'the standard model', 'electronic document identification systems', 'mathematics', 'probability']",liver carcinoma in situ,"['Improvement', 'pancreatic', 'cancer', 'model', 'treatment', 'N', 'nitroso', 'bis', 'amine']","['Comparative', 'studies', 'groups', 'Syrian', 'golden', 'hamsters', 'N', 'nitroso', 'bis', 'weekly', 'life', 'group', 'weekly', 'weeks', 'group', 'intervals', 'Pancreatic', 'neoplasms', 'weeks', 'group', 'weeks', 'group', 'group', 'fewer', 'smaller', 'lesions', 'Liver', 'neoplasms', 'group', 'gallbladder', 'kidney', 'tumors', 'groups', 'lower', 'incidence', 'pulmonary', 'adenomas', 'group', 'group', 'pulmonary', 'carcinomas', 'results', 'further', 'advance', 'development', 'pancreatic', 'cancer', 'model']"
317,317,http://dialog.proquest.com/professional/docview/588861525?accountid=173210,"Increased guanylate cyclase activity and guanosine 3',5'-monophosphate content in ethionine-induced hepatomas","Ethionine-induced hepatomas are characterized by high adenylate cyclase activity and cyclic adenosine 3',5'-monophosphate content relative to those of surrounding liver or liver from pair-fed control rats. The present study examined the properties of the guanylate cyclase-cyclic guanosine 3',5'-monophosphate (cGMP) system of these tissues. cGMP levels of the ethionine-induced hepatomas, determined in both specimens quick-forzen in situ and after in vitro incubation of tissue slices, were approximately 2 times higher than those of surrounding liver or controls. Higher cGMP in the tumors was associated with an increase in whole homogenate, soluble, and particulate guanylate cyclase activities, as well as an increase in soluble cGMP-phosphodiesterase activity. 3-Isobutyl-1-methylxanthine, a potent inhibitor of cGMP-phosphodiesterase activity, potentiated the differences in cGMP between slices of the hepatomas and surrounding liver or control, suggesting that the higher steady-state cGMP content of the tumors reflected enhanced basal cGMP synthesis which was partially offset by increased nucleotide degradation. In the hepatomas, a greater proportion of the total guanylate cyclase activity was located in the particulate cell fraction (31%) as compared to the subcellular distribution of enzyme activity in either surrounding liver or controls (15% of total in the particulate fraction). Carbamylcholine, which increased cGMP 3-fold in surrounding liver and controls, failed to alter cGMP levels inslices of hepatoma. Further, the relative changes in both cGMP accumulation and guanylate cyclase activity of the tumors in response to NaN3, NH2OH, and NaNO2 were blunted compared to surrounding liver or controls, although in each instance a response was clearly evident. Ethionine-induced hepatomas are thus characterized by: (a) significant increases in cGMP content and in guanylate cyclase and cGMP-phosphodiesterase activities, (b) a change in the subcellular distribution of guanylate cyclase, and (c) altered responsiveness of the guanylate cyclase-cGMP system to several agonists.","['DeRubertis, F R', 'Craven, P']","['Adenylyl Cyclases', 'Animals', 'Azides', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Cell Division', 'Cyclic AMP', 'Cyclic GMP', 'Cyclic GMP', 'Ethionine', 'Guanylate Cyclase', 'Hydroxylamines', 'Liver Neoplasms', 'Liver Neoplasms', 'Male', 'Neoplasms, Experimental', 'Neoplasms, Experimental', 'Nitrates', 'Rats']",ProQuest,"['switching systems', 'multimedia services', 'control systems', 'computer systems', 'digital rights management', 'world wide web', 'digital contents', 'switching control', 'multimedia contents', 'web page']",liver carcinoma in situ,"['guanylate', 'cyclase', 'activity', 'guanosine', 'content', 'ethionine', 'hepatomas']","['Ethionine', 'hepatomas', 'high', 'adenylate', 'cyclase', 'activity', 'cyclic', 'adenosine', 'content', 'relative', 'liver', 'liver', 'pair', 'fed', 'control', 'rats', 'present', 'study', 'properties', 'guanylate', 'cyclase', 'cyclic', 'guanosine', 'system', 'tissues', 'levels', 'ethionine', 'hepatomas', 'specimens', 'quick', 'forzen', 'situ', 'vitro', 'incubation', 'tissue', 'slices', 'times', 'higher', 'liver', 'controls', 'Higher', 'tumors', 'increase', 'whole', 'homogenate', 'soluble', 'guanylate', 'cyclase', 'activities', 'increase', 'soluble', 'phosphodiesterase', 'activity', 'potent', 'inhibitor', 'phosphodiesterase', 'activity', 'differences', 'slices', 'hepatomas', 'liver', 'control', 'steady', 'state', 'content', 'tumors', 'basal', 'synthesis', 'nucleotide', 'degradation', 'hepatomas', 'greater', 'proportion', 'total', 'guanylate', 'cyclase', 'activity', 'particulate', 'cell', 'fraction', '%', 'subcellular', 'distribution', 'enzyme', 'activity', 'liver', 'controls', '%', 'total', 'particulate', 'fraction', 'Carbamylcholine', 'liver', 'controls', 'levels', 'inslices', 'hepatoma', 'relative', 'changes', 'accumulation', 'cyclase', 'activity', 'tumors', 'response', 'NaN3', 'NaNO2', 'liver', 'controls', 'instance', 'response', 'evident', 'Ethionine', 'hepatomas', 'significant', 'increases', 'content', 'guanylate', 'cyclase', 'phosphodiesterase', 'activities', 'change', 'subcellular', 'distribution', 'guanylate', 'cyclase', 'c', 'responsiveness', 'guanylate', 'cyclase', 'system', 'several', 'agonists']"
318,318,http://dialog.proquest.com/professional/docview/588805578?accountid=173210,"A study on Mallory bodies. Isolation, ultrastructure and preliminary biochemical characterization of Mallory bodies from livers of alcoholic cirrhosis and malignant hepatoma","Mallory bodies (MBs) were isolated from the livers of 8 alcoholic patients and a malignant hepatoma occurring in a non-alcoholic patient. MBs were isolated in large quantity and high purity. The isolates were devoid of liver cell organelles except in the case of malignant hepatoma where dense and membranous material resembling nuclear substances and endoplasmic reticulum were found. The ""nuclear"" material had continuity with MBs. Electron microscopic examination suggested the presence of a dense body and very fine filaments within in situ and isolated MBs in addition to the tubular structure of so-called MB fibers. Amino acid analysis indicated that the major component of MBs is a protein which does not contain unusual amino acids or any particular amino acid in a large quantity to characterize this protein. The isolated fractions were solubilized in 6 M guaindine hydrochloride by sonication or in 1% sodium dodecyl sulfate (SDS) with 2 mercaptoethanol and 8 M urea. The solubilized MB protein produced 3 peaks by Sephadex G 100 chromatography and at least five intense protein bands by SDS polyacrylamide gel electrophoresis. Serum sample and the fractions from control livers contained several protein bands which were similar to the major components of isolated MB protein. These morphological and biochemical findings suggest that MBs are not homogeneous protein, but they are probably complexes of various proteins and that some components of MBs are present in normal hepatocytes.","['Okamura, K']","['Aged', 'Alcoholism', 'Alcoholism', 'Amino Acids', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Humans', 'Inclusion Bodies', 'Inclusion Bodies', 'Liver', 'Liver', 'Liver Cirrhosis', 'Liver Cirrhosis', 'Liver Cirrhosis', 'Liver Neoplasms', 'Liver Neoplasms', 'Male', 'Neoplasm Proteins', 'Proteins']",ProQuest,"['sub-bands', 'discrete wavelet transform', 'component', 'software', 'image coding', 'hyper-spectral images', 'optical fibers', 'imaging systems', 'spectral band', 'frequency bands', 'sensors', 'antennas']",liver carcinoma in situ,"['study', 'bodies', 'Isolation', 'ultrastructure', 'preliminary', 'biochemical', 'characterization', 'bodies', 'livers', 'alcoholic', 'cirrhosis', 'malignant', 'hepatoma']","['Mallory', 'bodies', 'MBs', 'livers', 'alcoholic', 'patients', 'malignant', 'hepatoma', 'non', '-', 'alcoholic', 'patient', 'MBs', 'large', 'quantity', 'high', 'purity', 'isolates', 'devoid', 'liver', 'cell', 'organelles', 'case', 'malignant', 'hepatoma', 'dense', 'membranous', 'material', 'nuclear', 'substances', 'endoplasmic', 'reticulum', 'nuclear', 'material', 'continuity', 'MBs', 'microscopic', 'examination', 'presence', 'dense', 'body', 'fine', 'filaments', 'situ', 'isolated', 'MBs', 'addition', 'tubular', 'structure', 'MB', 'fibers', 'acid', 'analysis', 'major', 'component', 'MBs', 'protein', 'unusual', 'amino', 'acids', 'particular', 'amino', 'acid', 'large', 'quantity', 'protein', 'isolated', 'fractions', 'guaindine', 'hydrochloride', 'sonication', '%', 'sodium', 'dodecyl', 'sulfate', 'mercaptoethanol', 'M', 'urea', 'solubilized', 'protein', 'peaks', 'chromatography', 'least', 'intense', 'protein', 'bands', 'SDS', 'polyacrylamide', 'gel', 'electrophoresis', 'Serum', 'sample', 'fractions', 'control', 'livers', 'several', 'protein', 'bands', 'similar', 'major', 'components', 'isolated', 'protein', 'morphological', 'biochemical', 'findings', 'MBs', 'homogeneous', 'protein', 'complexes', 'various', 'proteins', 'components', 'MBs', 'present', 'normal', 'hepatocytes']"
319,319,http://dialog.proquest.com/professional/docview/588510622?accountid=173210,"The incidence, pathology and transplantation of hepatomas in CBA mice","Two hundred and seventy-five male CBA/Birmingham mice including 84 mice over 80 wk of age were autopsied at intervals over the whole range of their natural life span of about 2 1/2 yr. Body weight increased progressively up to 30 wk of age when a plateau value of 30-40 g was attained. Subsequent to 80 wk a slight, progressive decrease was observed. The thymus showed a profound increase in size from about 5 mg at birth to approximately 60 mg by the 3rd wk. Thereafter, the weight of the thymus decreased, rapidly at first, to reach 20-30 mg by 15 wk of age. The thymus weight then decreased more slowly to around 10 mg by the 80th wk. The spleen weight reached a plateau value of 50-60 mg by 4 wk and this was maintained until the 80th wk. In mice older than 80 wk varying degrees of splenomegaly were observed. Histologically, the areas of white pulp in these spleens were very prominent, suggestive of an on-going immune response. It was possible to associate this splenomegaly with the appearance of gross and microscopic evidence of hepatomas. No hepatomas were observed prior to 80 wk, but between 80 and 120 wk the incidence increased progressively; and all the mice whose age at autopsy exceeded 120 wk had hepatomas. Histologically the hepatomas showed marked nuclear plemorphism with occasional mitotic figures. Thrombi, areas of avascular necrosis and collections of inflammatory cells were observed. The tumour metastasised to the lung in 12% of cases. The doubling time of the hepatoma in situ  was estimated as 1-6 wk (range 1-3-1-8 wk). These hepatomas were transplantable and grew with a doubling of 2-25 wk in syngeneic adult recipients. To test if the more rapid progressive growth of the tumour in situ in old CBA mice might have resulted from a breakdown in ""immunological surveillance"" the same tumour was transplanted simultaneously to a group of young and old recipients. The tumour grew more slowly (doubling time, 2-5 wk) in the old recipients. This result would not appear to support the hypothesis of a prolonged breakdown of immunological surveillance as the cause of the progressive increase in the incidence and growth of these tumours in situ in old mice.","['Sharp, J G', 'Riches, A C', 'Littlewood, V', 'Thomas, D B']","['Age Factors', 'Animals', 'Body Weight', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Liver Neoplasms', 'Lung Neoplasms', 'Male', 'Mice', 'Mice, Inbred CBA', 'Neoplasm Metastasis', 'Neoplasm Transplantation', 'Neoplasms, Experimental', 'Organ Size', 'Spleen', 'Thymus Gland', 'Time Factors', 'Transplantation, Isogeneic']",ProQuest,"['persistent surveillance', 'object tracking', 'wireless sensor networks', 'security systems', 'wide area', 'video surveillance', 'sensors', 'life-times', 'object appearance', 'surveillance applications']",liver carcinoma in situ,"['incidence', 'pathology', 'transplantation', 'hepatomas', 'mice']","['male', 'mice', 'mice', 'wk', 'age', 'intervals', 'whole', 'range', 'natural', 'life', 'span', 'yr', 'Body', 'weight', 'wk', 'age', 'plateau', 'value', 'g', 'Subsequent', 'slight', 'progressive', 'decrease', 'thymus', 'profound', 'increase', 'size', 'mg', 'birth', 'mg', '3rd', 'wk', 'weight', 'thymus', 'mg', 'wk', 'age', 'thymus', 'weight', 'mg', '80th', 'wk', 'spleen', 'weight', 'plateau', 'value', 'mg', '80th', 'wk', 'mice', 'older', 'wk', 'degrees', 'splenomegaly', 'areas', 'white', 'pulp', 'spleens', 'prominent', 'suggestive', 'immune', 'response', 'possible', 'splenomegaly', 'appearance', 'gross', 'microscopic', 'evidence', 'hepatomas', 'hepatomas', 'wk', 'incidence', 'mice', 'age', 'wk', 'hepatomas', 'hepatomas', 'nuclear', 'plemorphism', 'occasional', 'mitotic', 'figures', 'areas', 'avascular', 'necrosis', 'collections', 'inflammatory', 'cells', 'tumour', 'lung', '%', 'cases', 'time', 'hepatoma', 'situ', 'wk', 'wk', 'hepatomas', 'transplantable', 'doubling', 'wk', 'syngeneic', 'adult', 'recipients', 'rapid', 'progressive', 'growth', 'tumour', 'situ', 'old', 'CBA', 'mice', 'breakdown', 'immunological', 'surveillance', 'same', 'tumour', 'group', 'young', 'old', 'recipients', 'tumour', 'time', 'wk', 'old', 'recipients', 'result', 'hypothesis', 'breakdown', 'immunological', 'surveillance', 'cause', 'progressive', 'increase', 'incidence', 'growth', 'tumours', 'situ', 'old', 'mice']"
320,320,http://dialog.proquest.com/professional/docview/588400929?accountid=173210,Diseases of the oral mucosa,"Lesions of the oral mucosa are numerous. The purpose of this article is to review the more common and most serious of them, to explore some basic-science aspects of their development and to discuss prevention and treatment.","['Scopp, I W', 'Valauri, A J']","['Adult', 'Carcinoma in Situ', 'Carcinoma, Squamous Cell', 'Cheek', 'Cheilitis', 'Cheilitis', 'Gingivitis', 'Gingivitis', 'Humans', 'Keratosis', 'Leukoplakia, Oral', 'Lichen Planus', 'Lichen Planus', 'Liver Cirrhosis', 'Male', 'Middle Aged', 'Mouth Diseases', 'Mouth Diseases', 'Mouth Diseases', 'Mouth Floor', 'Mouth Mucosa', 'Mouth Neoplasms', 'Mouth Neoplasms', 'Palatal Neoplasms', 'Stomatitis, Aphthous', 'Stomatitis, Aphthous', 'Stomatitis, Aphthous', 'Tongue Neoplasms']",ProQuest,"['social sciences', 'education', 'sociology']",liver carcinoma in situ,"['Diseases', 'oral', 'mucosa']","['Lesions', 'oral', 'mucosa', 'numerous', 'purpose', 'article', 'common', 'serious', 'basic', 'science', 'aspects', 'development', 'prevention', 'treatment']"
321,321,http://dialog.proquest.com/professional/docview/588231837?accountid=173210,Hepatic changes in young women ingesting contraceptive steroids. Hepatic hemorrhage and primary hepatic tumors,"Primary hepatic tumors developed in 13 young women who had been ingesting contraceptive steroids. Nine tumors were benign, and four malignant. Six tumors ruptured spontaneously and caused life-threatening hemorrhage. Benign tumors were successfully resected in eight women. One woman died during hepatic resection for malignant hepatoma; in two other cases of hepatocellular carcinoma, tumors were nonresectable. In two patients, the tumor was left in situ after neoplasm had been excluded by biopsy. The increase of such tumors in women of childbearing age warrants the suspicion that these contraceptive steroid hormones play an etiologic role.","['Mays, E T', 'Christopherson, W M', 'Mahr, M M', 'Williams, H C']","['Adult', 'Age Factors', 'Carcinoma, Hepatocellular', 'Contraceptives, Oral', 'Contraceptives, Oral, Synthetic', 'Female', 'Follow-Up Studies', 'Gastrointestinal Hemorrhage', 'Hemoperitoneum', 'Humans', 'Liver Neoplasms', 'Liver Neoplasms', 'Middle Aged']",ProQuest,"['database systems', 'real data sets', 'clustering algorithms']",liver carcinoma in situ,"['Hepatic', 'changes', 'young', 'women', 'contraceptive', 'steroids', 'Hepatic', 'hemorrhage', 'primary', 'hepatic', 'tumors']","['Primary', 'hepatic', 'tumors', 'young', 'women', 'contraceptive', 'steroids', 'tumors', 'benign', 'malignant', 'tumors', 'life', 'hemorrhage', 'Benign', 'tumors', 'women', 'woman', 'hepatic', 'resection', 'malignant', 'hepatoma', 'other', 'cases', 'hepatocellular', 'carcinoma', 'tumors', 'nonresectable', 'patients', 'tumor', 'situ', 'neoplasm', 'biopsy', 'increase', 'such', 'tumors', 'women', 'age', 'suspicion', 'steroid', 'hormones', 'etiologic', 'role']"
322,322,http://dialog.proquest.com/professional/docview/588171280?accountid=173210,Turnover of the plasma membrane proteins of hepatoma tissue culture cells,"The turnover of the plasma membrane proteins of hepatoma tissue culture cells was examined by three different methods--loss of polypeptides labeled in situ by lactoperoxidase-catalyzed iodination, loss of membrane polypeptides labeled with amino acid precursors, and loss from the membrane of fucose-labeled polypeptides. In both logarithmically growing and density-inhibited cells the proteins of the membrane are degraded with a half-life of about 100 hours. This is longer than the half-life of total cell protein, 50 to 60 hours, and longer than the doubling time of the cells, about 30 hours. Similar values for the rate of degradation of the membrane proteins were obtained by each of the three techniques. The same fucose-labeled polypeptides are present in the microsomal and the plasma membrane fractions of hepatoma tissue culture cells as analyzed by electrophoresis in dodecyl sulfate-acrylamide gels. But the fucose-labeled polypeptides were lost from the microsomal fraction at a faster rate than from the plasma membrane. Autoradiographic and double labeling techniques using 125I and 131I, or [3H]leucine and [14C]leucine were used to measure the relative rates of degradation of the proteins in the plasma membrane. All of the leucine-labeled polypeptides and the iodinated polypeptides had similar rates of degradation. These results support a model for the biogenesis of the plasma membrane in which the proteins are incorporated and removed in large structural units.","['Tweto, J', 'Doyle, D']","['Carcinoma, Hepatocellular', 'Cell Fractionation', 'Cell Line', 'Cell Membrane', 'Fucose', 'Glycoproteins', 'Iodoproteins', 'Kinetics', 'Liver Neoplasms', 'Microsomes', 'Neoplasm Proteins']",ProQuest,"['kinetic equations', 'boundary value problems', 'hierarchical system', 'hierarchical model', 'correlation analysis', 'optimization problems', 'boundary values', 'initial value problems', 'integral equations']",liver carcinoma in situ,"['Turnover', 'plasma', 'membrane', 'proteins', 'hepatoma', 'tissue', 'culture', 'cells']","['turnover', 'plasma', 'membrane', 'proteins', 'hepatoma', 'tissue', 'culture', 'cells', 'different', 'methods', 'loss', 'polypeptides', 'situ', 'lactoperoxidase', 'iodination', 'loss', 'membrane', 'polypeptides', 'amino', 'acid', 'precursors', 'loss', 'membrane', 'fucose', 'polypeptides', 'density', 'cells', 'proteins', 'membrane', 'half', 'life', 'hours', 'longer', 'half', 'life', 'total', 'cell', 'protein', 'hours', 'time', 'cells', 'hours', 'Similar', 'values', 'rate', 'degradation', 'membrane', 'proteins', 'techniques', 'same', 'fucose', 'polypeptides', 'present', 'microsomal', 'plasma', 'membrane', 'fractions', 'hepatoma', 'tissue', 'culture', 'cells', 'electrophoresis', 'dodecyl', 'sulfate', 'acrylamide', 'gels', 'fucose', 'polypeptides', 'microsomal', 'fraction', 'faster', 'rate', 'plasma', 'membrane', 'double', 'labeling', 'techniques', 'relative', 'rates', 'degradation', 'proteins', 'plasma', 'membrane', 'leucine', 'polypeptides', 'polypeptides', 'similar', 'rates', 'degradation', 'results', 'model', 'biogenesis', 'plasma', 'membrane', 'proteins', 'large', 'structural', 'units']"
323,323,http://dialog.proquest.com/professional/docview/588883779?accountid=173210,"Expression of hormonally induced tyrosine transaminase in normal, host liver and three Morris hepatomas","Cytoplasmic tyrosine transaminase (L-tyrosine: 2-oxoglutarate aminotransferase, EC 2.6.1.5) was partially purified from normal, host liver and three Morris hepatomas and subsequently resolved by electrophoresis on polyacrylamide gels. Enzyme activity was detected histochemically in situ on the gels. Seven enzymatically active forms were detected in normal liver. The presence of growing hepatomas altered significantly the expression of this enzyme. Only one, two and four activity peaks were detected in the host liver of animals with highly (most liver-like), well and poorly (least liver-like) differentiated hepatomas, respectively. Similarly, only one, four and six peaks were detected, respectively, in highly, well and poor differentiated hepatomas.","['Shuler, J K', 'Tryfiates, G P']","['Animals', 'Carcinoma, Hepatocellular', 'Carcinoma, Hepatocellular', 'Electrophoresis, Polyacrylamide Gel', 'Enzyme Induction', 'Female', 'Hydrocortisone', 'Isoenzymes', 'Liver', 'Liver Neoplasms', 'Liver Neoplasms', 'Neoplasms, Experimental', 'Rats', 'Rats, Inbred BUF', 'Tyrosine Transaminase', 'Tyrosine Transaminase']",ProQuest,"['network interface', 'noc', 'interfaces (computer)']",liver carcinoma in situ,"['Expression', 'tyrosine', 'transaminase', 'normal', 'host', 'liver', 'hepatomas']","['Cytoplasmic', 'tyrosine', 'transaminase', 'L', 'tyrosine', 'aminotransferase', 'normal', 'host', 'liver', 'hepatomas', 'electrophoresis', 'polyacrylamide', 'gels', 'Enzyme', 'activity', 'situ', 'gels', 'active', 'forms', 'normal', 'liver', 'presence', 'hepatomas', 'expression', 'enzyme', 'activity', 'peaks', 'host', 'liver', 'animals', 'liver', 'like', 'least', 'liver', 'like', 'differentiated', 'hepatomas', 'peaks', 'poor', 'differentiated', 'hepatomas']"
324,324,http://dialog.proquest.com/professional/docview/587994497?accountid=173210,CEA levels in patients with colorectal polyps,"Preoperative plasma CEA levels were measured in 93 selected patients with histologically defined colorectal adenomata removed at fibroptic colonoscopy in order to determine whether CEA levels are elevated in patients with colonic polyps, or vary with different histologic patterns. None of the patients had inflammatory bowel disease, previous history of carcinoma, or evidence of liver disease. Fifteen percent of the patients had elevated CEA levels (greater than or equal to 2.5 ng/ml; Hansen method), and two-thirds of these were between 2.5 and 4.0 ng/ml. Increased association of elevated CEA levels was noted with old age, villous adenomas (2- to 4-fold), and increased tumor size (greater than 2.3-cm diameter; 2-fold), but not with foci of dysplasia or carcinoma in situ as such. One-half (7/14) of the patients with elevated CEA levels showed the following: two patients had villous tumors with carcinoma in situ, one had a villous adenoma, two had mixed villous and tubular adenomas (with a high proportion of villous pattern), and two were subsequently shown to have carcinoma elsewhere in the colon. It is uncertain that the polyps were the source of the elevated circulating CEA levels; other factors including smoking and patient selection need to be considered. This preliminary study suggests that patients with colorectal adenomata and elevated circulating CEA may be at higher risk for the development of carcinoma. Further follow-up studies of the malignant potential of the polyp-bearing colon are essential.","['Doos, W G', 'Wolff, W I', 'Shinya, H', 'DeChabon, A', 'Stenger, R J', 'Gottlieb, L S', 'Zamcheck, N']","['Adenoma', 'Adenoma', 'Adult', 'Aged', 'Carcinoembryonic Antigen', 'Colonic Neoplasms', 'Colonic Neoplasms', 'Female', 'Follow-Up Studies', 'Humans', 'Intestinal Polyps', 'Intestinal Polyps', 'Male', 'Middle Aged', 'Rectal Neoplasms', 'Rectal Neoplasms']",ProQuest,[],liver carcinoma in situ,"['CEA', 'levels', 'patients', 'colorectal', 'polyps']","['Preoperative', 'plasma', 'CEA', 'levels', 'patients', 'colorectal', 'adenomata', 'fibroptic', 'colonoscopy', 'order', 'levels', 'patients', 'colonic', 'polyps', 'different', 'histologic', 'patterns', 'None', 'patients', 'inflammatory', 'bowel', 'disease', 'previous', 'history', 'carcinoma', 'evidence', 'liver', 'disease', 'percent', 'patients', 'levels', 'greater', 'equal', 'ng', 'ml', 'method', 'thirds', 'ng', 'ml', 'association', 'elevated', 'levels', 'old', 'age', 'villous', 'adenomas', 'tumor', 'size', 'greater', 'diameter', 'foci', 'dysplasia', 'carcinoma', 'situ', 'such', 'half', 'patients', 'elevated', 'levels', 'patients', 'villous', 'tumors', 'carcinoma', 'situ', 'villous', 'adenoma', 'villous', 'tubular', 'adenomas', 'high', 'proportion', 'villous', 'pattern', 'carcinoma', 'colon', 'uncertain', 'polyps', 'source', 'elevated', 'levels', 'other', 'factors', 'smoking', 'patient', 'selection', 'preliminary', 'study', 'patients', 'colorectal', 'adenomata', 'CEA', 'higher', 'risk', 'development', 'carcinoma', 'studies', 'malignant', 'potential', 'polyp', 'colon', 'essential']"
325,325,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107361865&origin=inward,Advances in 3D peptide hydrogel models in cancer research,"¬© 2021, The Author(s).In vitro cell culture models on monolayer surfaces (2D) have been widely adapted for identification of chemopreventive food compounds and food safety evaluation. However, the low correlation between 2D models and in vivo animal models has always been a concern; this gap is mainly caused by the lack of a three-dimensional (3D) extracellular microenvironment. In 2D models, cell behaviors and functionalities are altered, resulting in varied responses to external conditions (i.e., antioxidants) and hence leading to low predictability. Peptide hydrogel 3D scaffolding technologies, such as PGmatrix for cell culture, have been recently reported to grow organoid-like spheroids physiologically mimicking the 3D microenvironment that can be used as an in vitro 3D model for investigating cell activities, which is anticipated to improve the prediction rate. Thus, this review focuses on advances in 3D peptide hydrogels aiming to introduce 3D cell culture tools as in vitro 3D models for cancer-related research regarding food safety and nutraceuticals.",0,0,scopus,"['two dimensional', 'stochastic processes', 'image processing', 'mathematics', 'standard model', 'correlation analysis', 'the standard model', 'electronic document identification systems', 'three dimensional computer graphics', '3d modelling', 'probability']",liver carcinoma in situ,"['Advances', '3D', 'peptide', 'hydrogel', 'models', 'cancer', 'research']","['cell', 'culture', 'models', 'monolayer', 'surfaces', 'identification', 'chemopreventive', 'food', 'compounds', 'food', 'safety', 'evaluation', 'low', 'correlation', '2D', 'models', 'vivo', 'animal', 'models', 'concern', 'gap', 'lack', 'dimensional', '3D', 'extracellular', 'microenvironment', '2D', 'models', 'cell', 'behaviors', 'functionalities', 'varied', 'responses', 'external', 'conditions', 'antioxidants', 'low', 'predictability', 'Peptide', 'hydrogel', '3D', 'scaffolding', 'technologies', 'such', 'cell', 'culture', 'organoid', 'like', 'spheroids', '3D', 'microenvironment', 'vitro', '3D', 'model', 'cell', 'activities', 'prediction', 'rate', 'review', 'advances', '3D', 'peptide', 'hydrogels', '3D', 'cell', 'culture', 'tools', 'vitro', '3D', 'models', 'cancer', 'research', 'food', 'safety', 'nutraceuticals']"
326,326,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107360429&origin=inward,The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer,"¬© 2021, The Author(s).The development of triple-negative breast cancer (TNBC) is critically regulated by certain tumor-microenvironment-associated cells called mesenchymal stem/stromal cells (MSCs), which we and others have shown promote TNBC progression by activating pro-malignant signaling in neighboring cancer cells. Characterization of these cascades would better our understanding of TNBC biology and bring about therapeutics that eliminate the morbidity and mortality associated with advanced disease. Here, we focused on the emerging class of RNAs called long non-coding RNAs or lncRNAs and utilized a MSC-supported TNBC progression model to identify specific family members of functional relevance to TNBC pathogenesis. Indeed, although some have been described to play functional roles in TNBC, activities of lncRNAs as mediators of tumor-microenvironment-driven TNBC development remain to be fully explored. We report that MSCs stimulate robust expression of LINC01119 in TNBC cells, which in turn induces suppressor of cytokine signaling 5 (SOCS5), leading to accelerated cancer cell growth and tumorigenesis. We show that LINC01119 and SOCS5 exhibit tight correlation across multiple breast cancer gene sets and that they are highly enriched in TNBC patient cohorts. Importantly, we present evidence that the LINC01119-SOCS5 axis represents a powerful prognostic indicator of adverse outcomes in TNBC patients, and demonstrate that its repression severely impairs cancer cell growth. Altogether, our findings identify LINC01119 as a major driver of TNBC development and delineate critical non-coding RNA theranostics of potential translational utility in the management of advanced TNBC, a class of tumors in most need of effective and targeted therapy.",0,0,scopus,"['programming theory', 'source coding', 'hierarchical system', 'coding techniques', 'hierarchical model', 'image coding', 'channel coding', 'correlation analysis', 'coding scheme', 'data compression', 'correlation coefficient', 'network coding', 'signal encoding']",liver carcinoma in situ,"['LINC01119-SOCS5', 'axis', 'critical', 'theranostic', 'triple', 'negative', 'breast', 'cancer']","['development', 'triple', 'negative', 'breast', 'cancer', 'certain', 'tumor', 'microenvironment', 'cells', 'mesenchymal', 'stem', 'stromal', 'cells', 'others', 'promote', 'progression', 'pro', '-', 'malignant', 'signaling', 'cancer', 'cells', 'Characterization', 'cascades', 'understanding', 'biology', 'therapeutics', 'morbidity', 'mortality', 'advanced', 'disease', 'class', 'RNAs', 'long', 'non', '-', 'coding', 'RNAs', 'progression', 'model', 'specific', 'family', 'members', 'functional', 'relevance', 'pathogenesis', 'functional', 'roles', 'activities', 'mediators', 'tumor', 'microenvironment', 'development', 'MSCs', 'robust', 'expression', 'cells', 'turn', 'suppressor', 'cytokine', 'SOCS5', 'accelerated', 'cancer', 'cell', 'growth', 'tumorigenesis', 'exhibit', 'tight', 'correlation', 'multiple', 'breast', 'cancer', 'gene', 'sets', 'patient', 'cohorts', 'evidence', 'LINC01119-SOCS5', 'axis', 'powerful', 'prognostic', 'indicator', 'adverse', 'outcomes', 'patients', 'repression', 'cancer', 'cell', 'growth', 'findings', 'major', 'driver', 'development', 'critical', 'non', '-', 'coding', 'theranostics', 'potential', 'translational', 'utility', 'management', 'advanced', 'class', 'tumors', 'most', 'need', 'effective', 'therapy']"
327,327,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107322340&origin=inward,Nanomaterials for cancer therapy: current progress and perspectives,"¬© 2021, The Author(s).Cancer is a disease with complex pathological process. Current chemotherapy faces problems such as lack of specificity, cytotoxicity, induction of multi-drug resistance and stem-like cells growth. Nanomaterials are materials in the nanorange 1‚Äì100 nm which possess unique optical, magnetic, and electrical properties. Nanomaterials used in cancer therapy can be classified into several main categories. Targeting cancer cells, tumor microenvironment, and immune system, these nanomaterials have been modified for a wide range of cancer therapies to overcome toxicity and lack of specificity, enhance drug capacity as well as bioavailability. Although the number of studies has been increasing, the number of approved nano-drugs has not increased much over the years. To better improve clinical translation, further research is needed for targeted drug delivery by nano-carriers to reduce toxicity, enhance permeability and retention effects, and minimize the shielding effect of protein corona. This review summarizes novel nanomaterials fabricated in research and clinical use, discusses current limitations and obstacles that hinder the translation from research to clinical use, and provides suggestions for more efficient adoption of nanomaterials in cancer therapy.",0,0,scopus,"['moving obstacles', 'machine translations', 'signal to noise ratio', 'information theory', 'recommendation', 'transmission capacities', 'translation process', 'ad hoc networks', 'communication channels (information theory)', 'multiplexing', 'dynamic environments', 'recommender systems', 'path planning', 'channel capacity', 'robot programming', 'collision avoidance']",liver carcinoma in situ,"['Nanomaterials', 'cancer', 'therapy', 'current', 'progress', 'perspectives']","['Author(s).Cancer', 'disease', 'complex', 'pathological', 'process', 'Current', 'chemotherapy', 'problems', 'such', 'lack', 'specificity', 'cytotoxicity', 'induction', 'multi', '-', 'drug', 'resistance', 'stem', 'like', 'cells', 'growth', 'Nanomaterials', 'materials', 'nanorange', 'unique', 'optical', 'magnetic', 'electrical', 'properties', 'Nanomaterials', 'cancer', 'therapy', 'several', 'main', 'categories', 'cancer', 'cells', 'tumor', 'microenvironment', 'immune', 'system', 'nanomaterials', 'wide', 'range', 'cancer', 'therapies', 'toxicity', 'lack', 'specificity', 'drug', 'capacity', 'bioavailability', 'number', 'studies', 'number', 'nano', 'drugs', 'years', 'clinical', 'translation', 'further', 'research', 'drug', 'delivery', 'nano', 'carriers', 'toxicity', 'permeability', 'retention', 'effects', 'shielding', 'effect', 'protein', 'corona', 'review', 'novel', 'nanomaterials', 'research', 'clinical', 'use', 'current', 'limitations', 'obstacles', 'translation', 'research', 'clinical', 'use', 'suggestions', 'efficient', 'adoption', 'nanomaterials', 'cancer', 'therapy']"
328,328,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107126555&origin=inward,FLIM as a Promising Tool for Cancer Diagnosis and Treatment Monitoring,"¬© 2021, The Author(s).Fluorescence lifetime imaging microscopy (FLIM) has been rapidly developed over the past 30 years and widely applied in biomedical engineering. Recent progress in fluorophore-dyed probe design has widened the application prospects of fluorescence. Because fluorescence lifetime is sensitive to microenvironments and molecule alterations, FLIM is promising for the detection of pathological conditions. Current cancer-related FLIM applications can be divided into three main categories: (i) FLIM with autofluorescence molecules in or out of a cell, especially with reduced form of nicotinamide adenine dinucleotide, and flavin adenine dinucleotide for cellular metabolism research; (ii) FLIM with F√∂rster resonance energy transfer for monitoring protein interactions; and (iii) FLIM with fluorophore-dyed probes for specific aberration detection. Advancements in nanomaterial production and efficient calculation systems, as well as novel cancer biomarker discoveries, have promoted FLIM optimization, offering more opportunities for medical research and applications to cancer diagnosis and treatment monitoring. This review summarizes cutting-edge researches from 2015 to 2020 on cancer-related FLIM applications and the potential of FLIM for future cancer diagnosis methods and anti-cancer therapy development. We also highlight current challenges and provide perspectives for further investigation.[Figure not available: see fulltext.].",0,0,scopus,"['cellular telephone systems', 'wireless sensor networks', 'optimization', 'wireless', 'detection algorithm', 'engineering', 'cellular radio systems', 'life-times', 'mathematics', 'cellular', 'signal detection']",liver carcinoma in situ,[],"['lifetime', 'microscopy', 'past', 'years', 'biomedical', 'engineering', 'Recent', 'progress', 'probe', 'design', 'application', 'prospects', 'fluorescence', 'fluorescence', 'lifetime', 'sensitive', 'microenvironments', 'molecule', 'alterations', 'detection', 'pathological', 'conditions', 'Current', 'cancer', 'applications', 'main', 'categories', 'autofluorescence', 'molecules', 'cell', 'reduced', 'form', 'nicotinamide', 'adenine', 'dinucleotide', 'adenine', 'dinucleotide', 'cellular', 'metabolism', 'research', 'resonance', 'energy', 'transfer', 'protein', 'interactions', 'probes', 'specific', 'aberration', 'detection', 'Advancements', 'nanomaterial', 'production', 'efficient', 'calculation', 'systems', 'novel', 'cancer', 'biomarker', 'discoveries', 'optimization', 'more', 'opportunities', 'medical', 'research', 'applications', 'cancer', 'diagnosis', 'treatment', 'monitoring', 'review', 'edge', 'researches', 'cancer', 'applications', 'potential', 'future', 'cancer', 'diagnosis', 'methods', 'anti', '-', 'cancer', 'therapy', 'development', 'current', 'challenges', 'perspectives', 'further', 'available']"
329,329,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107014915&origin=inward,Breast cancer dormancy: need for clinically relevant models to address current gaps in knowledge,"¬© 2021, The Author(s).Breast cancer is the most commonly diagnosed cancer in the USA. Although advances in treatment over the past several decades have significantly improved the outlook for this disease, most women who are diagnosed with estrogen receptor positive disease remain at risk of metastatic relapse for the remainder of their life. The cellular source of late relapse in these patients is thought to be disseminated tumor cells that reactivate after a long period of dormancy. The biology of these dormant cells and their natural history over a patient‚Äôs lifetime is largely unclear. We posit that research on tumor dormancy has been significantly limited by the lack of clinically relevant models. This review will discuss existing dormancy models, gaps in biological understanding, and propose criteria for future models to enhance their clinical relevance.",0,0,scopus,"['cellular telephone systems', 'stochastic processes', 'mathematics', 'wireless sensor networks', 'wireless', 'standard model', 'cellular radio systems', 'correlation analysis', 'the standard model', 'life-times', 'electronic document identification systems', 'probability', 'cellular']",liver carcinoma in situ,"['Breast', 'cancer', 'dormancy', 'relevant', 'models', 'current', 'gaps', 'knowledge']","['Author(s).Breast', 'cancer', 'cancer', 'advances', 'treatment', 'past', 'several', 'decades', 'outlook', 'disease', 'most', 'women', 'estrogen', 'receptor', 'positive', 'disease', 'risk', 'metastatic', 'relapse', 'remainder', 'life', 'cellular', 'source', 'late', 'relapse', 'patients', 'tumor', 'cells', 'long', 'period', 'dormancy', 'biology', 'dormant', 'cells', 'natural', 'history', 'patient', 'lifetime', 'unclear', 'research', 'tumor', 'dormancy', 'lack', 'relevant', 'models', 'review', 'dormancy', 'models', 'gaps', 'biological', 'understanding', 'criteria', 'future', 'models', 'clinical', 'relevance']"
330,330,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106990889&origin=inward,Telomere biology disorders,"¬© 2021, The Author(s).Telomere biology disorders (TBD) are a heterogeneous group of diseases arising from germline mutations affecting genes involved in telomere maintenance. Telomeres are DNA-protein structures at chromosome ends that maintain chromosome stability; their length affects cell replicative potential and senescence. A constellation of bone marrow failure, pulmonary fibrosis, liver cirrhosis and premature greying is suggestive, however incomplete penetrance results in highly variable manifestations, with idiopathic pulmonary fibrosis as the most common presentation. Currently, the true extent of TBD burden is unknown as there is no established diagnostic criteria and the disorder often is unrecognised and underdiagnosed. There is no gold standard for measuring telomere length and not all TBD-related mutations have been identified. There is no specific cure and the only treatment is organ transplantation, which has poor outcomes. This review summarises the current literature and discusses gaps in understanding and areas of need in managing TBD.",0,0,scopus,"['asymptotic stability', 'wireless networks', 'maintenance process', 'computer software maintenance', 'crossover operator', 'genetic operators', 'lyapunov functions', 'evolutionary algorithms', 'heterogeneous networks', 'adaptive control systems', 'global stability']",liver carcinoma in situ,"['Telomere', 'biology', 'disorders']","['biology', 'disorders', 'heterogeneous', 'group', 'diseases', 'germline', 'mutations', 'genes', 'telomere', 'maintenance', 'Telomeres', 'protein', 'structures', 'chromosome', 'ends', 'chromosome', 'stability', 'length', 'cell', 'replicative', 'potential', 'senescence', 'constellation', 'bone', 'marrow', 'failure', 'pulmonary', 'fibrosis', 'liver', 'cirrhosis', 'premature', 'greying', 'suggestive', 'incomplete', 'penetrance', 'results', 'variable', 'manifestations', 'idiopathic', 'pulmonary', 'fibrosis', 'common', 'presentation', 'true', 'extent', 'burden', 'unknown', 'diagnostic', 'criteria', 'disorder', 'unrecognised', 'underdiagnosed', 'gold', 'standard', 'telomere', 'length', 'TBD', 'mutations', 'specific', 'cure', 'only', 'treatment', 'organ', 'transplantation', 'poor', 'outcomes', 'review', 'current', 'literature', 'gaps', 'understanding', 'areas', 'need']"
331,331,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106944464&origin=inward,TCONS_00230836 silencing restores stearic acid-induced Œ≤ cell dysfunction through alleviating endoplasmic reticulum stress rather than apoptosis,"¬© 2021, The Author(s).Background: Chronic exposure of pancreatic Œ≤ cells to high levels of stearic acid (C18:0) leads to impaired insulin secretion, which accelerates the progression of type 2 diabetes mellitus (T2DM). Recently, long noncoding RNAs (lncRNAs) were found to participate in saturated fatty acid-induced metabolism dysfunction. However, their contribution to stearic acid-induced Œ≤-cell dysfunction remains largely unknown. This study evaluated the possible role of the lncRNA TCONS_00230836 in stearic acid-stimulated lipotoxicity to Œ≤ cells. Method: Using high-throughput RNA-sequencing, TCONS_00230836 was screened out as being exclusively differentially expressed in stearic acid-treated mouse Œ≤-TC6 cells. Co-expression network was constructed to reveal the potential mRNAs targeted for lncRNA TCONS_00230836. Changes in this lncRNA‚Äôs and candidate mRNAs‚Äô levels were further assessed by real-time PCR in stearic acid-treated Œ≤-TC6 cells and islets of mice fed a high-stearic-acid diet (HSD). The localization of TCONS_00230836 was detected by fluorescent in situ hybridization. The endogenous lncRNA TCONS_00230836 in Œ≤-TC6 cells was abrogated by its Smart Silencer. Results: TCONS_00230836 was enriched in mouse islets and mainly localized in the cytoplasm. Its expression was significantly increased in stearic acid-treated Œ≤-TC6 cells and HSD-fed mouse islets. Knockdown of TCONS_00230836 significantly restored stearic acid-impaired glucose-stimulated insulin secretion through alleviating endoplasmic reticulum stress. However, stearic acid-induced Œ≤ cell apoptosis was not obviously recovered. Conclusion: Our findings suggest the involvement of TCONS_00230836 in stearic acid-induced Œ≤-cell dysfunction, which provides novel insight into stearic acid-induced lipotoxicity to Œ≤ cells. Anti-lncRNA TCONS_00230836 might be a new therapeutic strategy for alleviating stearic acid-induced Œ≤-cell dysfunction in the progression of T2DM.",0,0,scopus,"['target tracking', 'internet protocols', 'intelligent buildings', 'localization system', 'wireless sensor networks', 'network components', 'localization technique', 'smart homes', 'network protocols', 'program compilers', 'architecture types', 'localization algorithm', 'network architecture', 'internet of things', 'robot applications', 'sensor networks', 'target localization']",liver carcinoma in situ,"['TCONS_00230836', 'stearic', 'acid', 'cell', 'dysfunction', 'endoplasmic', 'reticulum', 'stress', 'apoptosis']","['Author(s).Background', 'Chronic', 'exposure', 'pancreatic', 'Œ≤', 'cells', 'high', 'levels', 'stearic', 'acid', 'C18:0', 'impaired', 'insulin', 'secretion', 'progression', 'type', 'diabetes', 'mellitus', 'noncoding', 'fatty', 'acid', 'metabolism', 'dysfunction', 'contribution', 'stearic', 'acid', 'cell', 'dysfunction', 'unknown', 'study', 'possible', 'role', 'stearic', 'acid', 'lipotoxicity', 'Œ≤', 'cells', 'high', 'throughput', 'stearic', 'acid', 'mouse', 'Œ≤', 'cells', 'Co', '-', 'expression', 'network', 'potential', 'mRNAs', 'Changes', 'candidate', 'levels', 'real', 'time', 'stearic', 'acid', 'cells', 'islets', 'mice', 'high', 'stearic', 'acid', 'diet', 'localization', 'fluorescent', 'situ', 'hybridization', 'endogenous', 'cells', 'Results', 'TCONS_00230836', 'mouse', 'islets', 'cytoplasm', 'expression', 'stearic', 'acid', 'cells', 'mouse', 'islets', 'stearic', 'acid', 'glucose', 'insulin', 'secretion', 'endoplasmic', 'reticulum', 'stress', 'stearic', 'acid', 'cell', 'apoptosis', 'Conclusion', 'findings', 'involvement', 'stearic', 'acid', 'cell', 'dysfunction', 'novel', 'insight', 'stearic', 'acid', 'lipotoxicity', 'Œ≤', 'cells', '-', 'lncRNA', 'TCONS_00230836', 'new', 'therapeutic', 'strategy', 'stearic', 'acid', 'cell', 'dysfunction', 'progression']"
332,332,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106879347&origin=inward,ADAMTS12 acts as a tumor microenvironment related cancer promoter in gastric cancer,"¬© 2021, The Author(s).The infiltration degree of immune and stromal cells has been shown clinically significant in tumor microenvironment (TME). However, the utility of stromal and immune components in Gastric cancer (GC) has not been investigated in detail. In the present study, ESTIMATE and CIBERSORT algorithms were applied to calculate the immune/stromal scores and the proportion of tumor-infiltrating immune cell (TIC) in GC cohort, including 415 cases from The Cancer Genome Atlas (TCGA) database. The differentially expressed genes (DEGs) were screened by Cox proportional hazard regression analysis and protein‚Äìprotein interaction (PPI) network construction. Then ADAMTS12 was regarded as one of the most predictive factors. Further analysis showed that ADAMTS12 expression was significantly higher in tumor samples and correlated with poor prognosis. Gene Set Enrichment Analysis (GSEA) indicated that in high ADAMTS12 expression group gene sets were mainly enriched in cancer and immune-related activities. In the low ADAMTS12 expression group, the genes were enriched in the oxidative phosphorylation pathway. CIBERSORT analysis for the proportion of TICs revealed that ADAMTS12 expression was positively correlated with Macrophages M0/M1/M2 and negatively correlated with T cells follicular helper. Therefore, ADAMTS12 might be a tumor promoter and responsible for TME status and tumor energy metabolic conversion.",0,0,scopus,"['computer systems', 'component', 'software', 'database systems', 'correlation analysis', 'regression model', 'mathematics', 'proportional hazards models']",liver carcinoma in situ,"['ADAMTS12', 'tumor', 'microenvironment', 'related', 'cancer', 'promoter', 'gastric', 'cancer']","['infiltration', 'degree', 'immune', 'stromal', 'cells', 'significant', 'tumor', 'microenvironment', 'utility', 'stromal', 'immune', 'components', 'Gastric', 'cancer', 'detail', 'present', 'study', 'algorithms', 'immune', 'stromal', 'scores', 'proportion', 'tumor', 'immune', 'cell', 'cohort', 'cases', 'database', 'genes', 'proportional', 'hazard', 'regression', 'analysis', 'protein', 'protein', 'interaction', 'network', 'construction', 'predictive', 'factors', 'Further', 'analysis', 'ADAMTS12', 'expression', 'higher', 'tumor', 'samples', 'poor', 'prognosis', 'high', 'ADAMTS12', 'expression', 'group', 'gene', 'sets', 'cancer', 'immune', 'activities', 'low', 'ADAMTS12', 'expression', 'group', 'genes', 'oxidative', 'phosphorylation', 'pathway', 'CIBERSORT', 'analysis', 'proportion', 'TICs', 'ADAMTS12', 'expression', 'cells', 'follicular', 'helper', 'tumor', 'promoter', 'responsible', 'status', 'tumor', 'energy', 'metabolic', 'conversion']"
333,333,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106694003&origin=inward,Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma,"¬© 2021, The Author(s).Background: Replication factor C (RFC) is closely related to tumor progression and metastasis. However, the functional significance of RFC2 in hepatocellular carcinoma remains unclear. Materials and methods: In order to solve this problem, the expression of RFC2 in liver cancer patients was analyzed through ONCOMINE, UALCAN, Human Protein Atlas. Survival analysis was conducted using Kaplan‚ÄìMeier plotter and GEPIA. GO and KEGG enrichment analyses were carried out. The protein‚Äìprotein interaction (PPI) network was performed through Metascape. Western blotting, cell counting kit-8 and transwell assay were used to detect the effect of RFC2 on cell proliferation and migration. Results: The transcription and protein level of RFC2 in HCC were overexpressed, which was significantly related to the clinical individual cancer stage and pathological tumor grade of HCC patients. In addition, in patients with liver cancer, higher RFC2 expression was found to be significantly correlated with shorter OS and DFS. Furthermore, the function of RFC2 in liver cancer was DNA replication, and its main mechanism was the phase transition of the cell cycle. Biological experiments demonstrated that knockdown of RFC2 reduced the proliferation and migration of HCC cells. Conclusion: RFC2 might promote the development of liver cancer, which might be achieved by regulating cell cycle and DNA replication. It could be used as a novel biomarker for the prognosis of liver cancer.",0,0,scopus,"['data grid', 'peer-to-peer', 'computer science', 'fault tolerance', 'planar graph', 'cycle', 'correlation analysis', 'replication strategies', 'mathematics', 'proportional hazards models', 'operating systems']",liver carcinoma in situ,"['unfavorable', 'progression', 'hepatocellular', 'carcinoma']","['Author(s).Background', 'Replication', 'factor', 'related', 'tumor', 'progression', 'metastasis', 'functional', 'significance', 'hepatocellular', 'carcinoma', 'unclear', 'Materials', 'methods', 'order', 'problem', 'expression', 'liver', 'cancer', 'patients', 'Survival', 'analysis', 'plotter', 'enrichment', 'analyses', 'protein', 'protein', 'interaction', 'network', 'Western', 'blotting', 'cell', 'counting', 'transwell', 'assay', 'effect', 'cell', 'proliferation', 'migration', 'Results', 'transcription', 'protein', 'level', 'overexpressed', 'clinical', 'individual', 'cancer', 'stage', 'pathological', 'tumor', 'grade', 'patients', 'addition', 'patients', 'liver', 'cancer', 'higher', 'expression', 'shorter', 'OS', 'function', 'liver', 'cancer', 'DNA', 'replication', 'main', 'mechanism', 'phase', 'transition', 'cell', 'cycle', 'Biological', 'experiments', 'knockdown', 'proliferation', 'migration', 'cells', 'Conclusion', 'development', 'liver', 'cancer', 'cell', 'cycle', 'DNA', 'replication', 'novel', 'biomarker', 'prognosis', 'liver', 'cancer']"
334,334,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106332219&origin=inward,Endocrine role of bone in the regulation of energy metabolism,"¬© 2021, The Author(s).Bone mainly functions as a supportive framework for the whole body and is the major regulator of calcium homeostasis and hematopoietic function. Recently, an increasing number of studies have characterized the significance of bone as an endocrine organ, suggesting that bone-derived factors regulate local bone metabolism and metabolic functions. In addition, these factors can regulate global energy homeostasis by altering insulin sensitivity, feeding behavior, and adipocyte commitment. These findings may provide a new pathological mechanism for related metabolic diseases or be used in the diagnosis, treatment, and prevention of metabolic diseases such as osteoporosis, obesity, and diabetes mellitus. In this review, we summarize the regulatory effect of bone and bone-derived factors on energy metabolism and discuss directions for future research.",0,0,scopus,"['formal framework', 'formal methods', 'software frameworks', 'humanoid robot', 'anthropomorphic robots', 'energy conservation', 'computer programming', 'energy utilization', 'full body']",liver carcinoma in situ,"['Endocrine', 'role', 'bone', 'regulation', 'energy', 'metabolism']","['functions', 'supportive', 'framework', 'whole', 'body', 'major', 'regulator', 'calcium', 'homeostasis', 'hematopoietic', 'function', 'number', 'studies', 'significance', 'bone', 'endocrine', 'organ', 'bone', 'factors', 'local', 'bone', 'metabolism', 'metabolic', 'functions', 'addition', 'factors', 'global', 'energy', 'homeostasis', 'insulin', 'sensitivity', 'behavior', 'adipocyte', 'commitment', 'findings', 'new', 'pathological', 'mechanism', 'related', 'metabolic', 'diseases', 'diagnosis', 'treatment', 'prevention', 'metabolic', 'diseases', 'such', 'osteoporosis', 'obesity', 'diabetes', 'mellitus', 'review', 'regulatory', 'effect', 'bone', 'bone', 'factors', 'energy', 'metabolism', 'directions', 'future', 'research']"
335,335,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106288532&origin=inward,Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity,"¬© 2021, The Author(s).Breast cancers exhibit intratumoral heterogeneity associated with disease progression and therapeutic resistance. To define the sources and the extent of heterogeneity, we performed an in-depth analysis of the genomic architecture of three chemoradiation-na√Øve breast cancers with well-defined clinical features including variable ER, PR, ERBB2 receptor expression and two distinct pathogenic BRCA2mut genotypes. The latter included a germ line carrier and a patient with a somatic variant. In each case we combined DNA content-based flow cytometry with whole exome sequencing and genome wide copy number variant (CNV) analysis of distinct populations sorted from multiple (4‚Äì18) mapped biopsies within the tumors and involved lymph nodes. Interrogating flow-sorted tumor populations from each biopsy provided an objective method to distinguish fixed and variable genomic lesions in each tumor. Notably we show that tumors exploit CNVs to fix mutations and deletions in distinct populations throughout each tumor. The identification of fixed genomic lesions that are shared or unique within each tumor, has broad implications for the study of tumor heterogeneity including the presence of tumor markers and therapeutic targets, and of candidate neoepitopes in breast and other solid tumors that can advance more effective treatment and clinical management of patients with disease.",0,0,scopus,"['content-based', 'software architecture', 'evolutionary computation', 'architecture designs', 'evolutionary programming', 'correlation analysis', 'evolutionary process', 'evolutionary algorithms', 'computer programming', 'mathematics', 'content based retrieval']",liver carcinoma in situ,"['Unique', 'evolutionary', 'trajectories', 'breast', 'cancers', 'distinct', 'genomic', 'spatial', 'heterogeneity']","['Author(s).Breast', 'cancers', 'intratumoral', 'heterogeneity', 'disease', 'progression', 'therapeutic', 'resistance', 'sources', 'extent', 'heterogeneity', 'depth', 'analysis', 'genomic', 'architecture', 'chemoradiation', 'na√Øve', 'breast', 'cancers', 'clinical', 'features', 'variable', 'receptor', 'expression', 'distinct', 'pathogenic', 'genotypes', 'latter', 'germ', 'line', 'carrier', 'patient', 'somatic', 'variant', 'case', 'DNA', 'content', 'flow', 'cytometry', 'whole', 'exome', 'sequencing', 'wide', 'copy', 'number', 'variant', 'analysis', 'distinct', 'populations', 'multiple', '4‚Äì18', 'biopsies', 'tumors', 'involved', 'lymph', 'nodes', 'flow', 'tumor', 'populations', 'biopsy', 'objective', 'method', 'variable', 'genomic', 'lesions', 'tumor', 'tumors', 'CNVs', 'mutations', 'deletions', 'distinct', 'populations', 'tumor', 'identification', 'genomic', 'lesions', 'unique', 'tumor', 'broad', 'implications', 'study', 'tumor', 'heterogeneity', 'presence', 'tumor', 'markers', 'therapeutic', 'targets', 'candidate', 'neoepitopes', 'breast', 'other', 'solid', 'tumors', 'more', 'effective', 'treatment', 'clinical', 'management', 'patients', 'disease']"
336,336,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106262315&origin=inward,X-ray fan beam coded aperture transmission and diffraction imaging for fast material analysis,"¬© 2021, The Author(s).X-ray transmission imaging has been used in a variety of applications for high-resolution measurements based on shape and density. Similarly, X-ray diffraction (XRD) imaging has been used widely for molecular structure-based identification of materials. Combining these X-ray methods has the potential to provide high-resolution material identification, exceeding the capabilities of either modality alone. However, XRD imaging methods have been limited in application by their long measurement times and poor spatial resolution, which has generally precluded combined, rapid measurements of X-ray transmission and diffraction. In this work, we present a novel X-ray fan beam coded aperture transmission and diffraction imaging system, developed using commercially available components, for rapid and accurate non-destructive imaging of industrial and biomedical specimens. The imaging system uses a 160 kV Bremsstrahlung X-ray source while achieving a spatial resolution of ‚âà 1 √ó 1 mm2 and a spectral accuracy of > 95% with only 15 s exposures per 150 mm fan beam slice. Applications of this technology are reported in geological imaging, pharmaceutical inspection, and medical diagnosis. The performance of the imaging system indicates improved material differentiation relative to transmission imaging alone at scan times suitable for a variety of industrial and biomedical applications.",0,0,scopus,"['computerized tomography', 'high spatial resolution', 'component', 'x-ray computed tomography', 'software', 'communication channels (information theory)', 'imaging systems', 'ray tracing', 'image resolution', 'image reconstruction']",liver carcinoma in situ,"['X', '-', 'ray', 'fan', 'beam', 'aperture', 'transmission', 'diffraction', 'fast', 'material', 'analysis']","['Author(s).X', 'ray', 'transmission', 'imaging', 'variety', 'applications', 'high', 'resolution', 'measurements', 'shape', 'density', 'X', '-', 'ray', 'diffraction', 'imaging', 'molecular', 'structure', 'identification', 'materials', 'X', '-', 'ray', 'methods', 'potential', 'high', 'resolution', 'material', 'identification', 'capabilities', 'modality', 'imaging', 'methods', 'application', 'long', 'measurement', 'times', 'poor', 'spatial', 'resolution', 'rapid', 'measurements', 'X', '-', 'ray', 'transmission', 'diffraction', 'work', 'novel', 'X', '-', 'ray', 'fan', 'beam', 'aperture', 'transmission', 'diffraction', 'imaging', 'system', 'available', 'components', 'rapid', 'accurate', 'non', '-', 'destructive', 'imaging', 'industrial', 'biomedical', 'specimens', 'system', '-', 'ray', 'source', 'spatial', 'resolution', '‚âà', 'mm2', 'spectral', 'accuracy', '%', 's', 'exposures', 'mm', 'fan', 'beam', 'slice', 'Applications', 'technology', 'geological', 'imaging', 'pharmaceutical', 'inspection', 'medical', 'diagnosis', 'performance', 'imaging', 'system', 'material', 'differentiation', 'relative', 'transmission', 'scan', 'times', 'suitable', 'variety', 'industrial', 'biomedical', 'applications']"
337,337,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106250860&origin=inward,Ipsilateral access portal venous embolization (PVE) for preoperative hypertrophy exhibits low complication rates in Clavien-Dindo and CIRSE scales,"¬© 2021, The Author(s).Background: Portal venous embolization (PVE) is a minimal invasive preoperative strategy that aims to increase future liver remnant (FLR) in order to facilitate extended hemihepatectomy. We analyzed our data retrospectively regarding complications and degree of hypertrophy (DH). Methods: 88 patients received PVE either by particles / coils (n = 77) or by glue / oil (n = 11), supported by 7 right hepatic vein embolizations (HVE) by coils or occluders. All complications were categorized by the Clavien- Dindo (CD) and the CIRSE classification. Results: In 88 patients (median age 68 years) there was one intervention with a biliary leak and subsequent drainage (complication grade 3 CD, CIRSE 3), two with prolonged hospital stay (grade 2 CD, grade 3 CIRSE) and 13 complications grade 1 CD, but no complications of grade 4 or higher neither in Clavien- Dindo nor in CIRSE classification. The median relative increase in FLR was 47% (SD 35%). The mean pre-intervention standardized FLR rose from 23% (SD 10%) to a post-intervention standardized FLR of 32% (SD 12%). The degree of hypertrophy (DH) was 9,3% (SD 5,2%) and the kinetic growth rate (KGR) per week was 2,06 (SD 1,84). Conclusion: PVE and, if necessary, additional sequential HVE were safe procedures with a low rate of complications and facilitated sufficient preoperative hypertrophy of the future liver remnant.",0,0,scopus,"['computer systems', 'coil', 'classification methods', 'automatic classification', 'classification models', 'supervised classification', 'image classification', 'chemical lasers']",liver carcinoma in situ,"['Ipsilateral', 'access', 'portal', 'venous', 'embolization', 'preoperative', 'hypertrophy', 'exhibits', 'low', 'complication', 'rates', 'scales']","['Author(s).Background', 'Portal', 'venous', 'embolization', 'minimal', 'invasive', 'preoperative', 'strategy', 'future', 'liver', 'remnant', 'order', 'extended', 'hemihepatectomy', 'data', 'complications', 'degree', 'hypertrophy', 'Methods', 'patients', 'particles', 'coils', 'glue', 'oil', 'right', 'hepatic', 'vein', 'embolizations', 'coils', 'occluders', 'complications', 'classification', 'Results', 'patients', 'median', 'age', 'years', 'intervention', 'biliary', 'leak', 'subsequent', 'drainage', 'complication', 'grade', 'CD', 'prolonged', 'hospital', 'stay', 'grade', 'CD', 'grade', 'complications', 'grade', 'CD', 'complications', 'grade', 'higher', 'classification', 'median', 'relative', 'increase', '%', 'SD', '%', 'mean', 'pre', '-', 'intervention', '%', 'SD', '%', 'post', '-', 'intervention', '%', 'SD', '%', 'degree', 'hypertrophy', '%', 'SD', '%', 'kinetic', 'growth', 'rate', 'week', 'Conclusion', 'necessary', 'additional', 'sequential', 'safe', 'procedures', 'low', 'rate', 'complications', 'sufficient', 'preoperative', 'hypertrophy', 'future', 'liver', 'remnant']"
338,338,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106213315&origin=inward,Longitudinal single-cell profiling reveals molecular heterogeneity and tumor-immune evolution in refractory mantle cell lymphoma,"¬© 2021, The Author(s).The mechanisms driving therapeutic resistance and poor outcomes of mantle cell lymphoma (MCL) are incompletely understood. We characterize the cellular and molecular heterogeneity within and across patients and delineate the dynamic evolution of tumor and immune cell compartments at single cell resolution in longitudinal specimens from ibrutinib-sensitive patients and non-responders. Temporal activation of multiple cancer hallmark pathways and acquisition of 17q are observed in a refractory MCL. Multi-platform validation is performed at genomic and cellular levels in PDX models and larger patient cohorts. We demonstrate that due to 17q gain, BIRC5/survivin expression is upregulated in resistant MCL tumor cells and targeting BIRC5 results in marked tumor inhibition in preclinical models. In addition, we discover notable differences in the tumor microenvironment including progressive dampening of CD8+ T cells and aberrant cell-to-cell communication networks in refractory MCLs. This study reveals diverse and dynamic tumor and immune programs underlying therapy resistance in MCL.",0,0,scopus,"['telecommunication networks', 'validation', 'cellular telephone systems', 'communication', 'computer network', 'wireless', 'cellular radio systems', 'evolutionary process', 'communication networks', 'verification and validation', 'evolutionary algorithms', 'cellular']",liver carcinoma in situ,"['Longitudinal', 'single', 'cell', 'profiling', 'molecular', 'heterogeneity', 'tumor', 'immune', 'evolution', 'refractory', 'mantle', 'cell', 'lymphoma']","['mechanisms', 'therapeutic', 'resistance', 'poor', 'outcomes', 'mantle', 'cell', 'lymphoma', 'cellular', 'molecular', 'heterogeneity', 'patients', 'dynamic', 'evolution', 'tumor', 'immune', 'cell', 'compartments', 'single', 'cell', 'resolution', 'longitudinal', 'specimens', 'ibrutinib', 'sensitive', 'patients', 'non', '-', 'responders', 'Temporal', 'activation', 'multiple', 'cancer', 'hallmark', 'pathways', 'acquisition', '17q', 'refractory', 'Multi', 'platform', 'validation', 'genomic', 'cellular', 'levels', 'models', 'larger', 'patient', 'cohorts', '17q', 'expression', 'resistant', 'tumor', 'cells', 'BIRC5', 'results', 'tumor', 'inhibition', 'preclinical', 'models', 'addition', 'notable', 'differences', 'tumor', 'microenvironment', 'progressive', 'dampening', 'T', 'cells', 'aberrant', 'cell', 'cell', 'communication', 'networks', 'refractory', 'MCLs', 'study', 'diverse', 'dynamic', 'tumor', 'immune', 'programs', 'therapy', 'resistance']"
339,339,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106191195&origin=inward,Development of a nomogram model to predict survival outcomes in patients with primary hepatic neuroendocrine tumors based on SEER database,"¬© 2021, The Author(s).Background: Primary hepatic neuroendocrine tumors (PH-NETs) are extremely rare and unknown. Because of its rarity, its prognosis features and influencing factors are not well established. Methods: Data of 140 patients with PH-NETs diagnosed in the SEER database from 1975 to 2016 were collected. The demographics and clinic-pathological features were described. By using propensity-score matching (PSM) analysis, three associated cohorts were selected to describe the malignancy of PH-NETs and univariate analysis was conducted. Then, multivariate Cox analyses were performed and a predicting nomograph was constructed. C-index, receiver operating characteristic (ROC) curve and calibration curves were used to evaluate the predictive value of nomogram. Results: The overall survival outcomes of PH-NETs were superior to hepatocellular carcinoma (HCC) with a mean survival time 30.64 vs 25.11 months (p = 0.052), but inferior to gastrointestinal tract neuroendocrine tumors in situ (GI-NETs in situ) with a mean survival time 30.64 vs 41.62 months (p = 0.017). With reference to gastrointestinal neuroendocrine tumors with liver metastasis (GI-NETs-LM), GI-NETs-LM had better outcomes in short time (1-year survival rate: 64.75% vs 56.43%) but was worse in long time (5-year survival rate: 8. 63% vs 18.57%). Multivariate Cox analyses showed that tumor grade and surgery were two independent factors for prognosis of the patients (p < 0.00). Tumor grade and surgery were used to construct the predicting nomogram. The C-index was 0.79 (95%CI = 0.75‚Äì0.83). The area under curve (AUC) values in ROC were 0.868 in 1-year and 0.917 in 3-year survival and the calibration curves showed good consistency. Conclusions: The overall prognosis PH-NETs is generally favorable, better than HCC and GI-NETs-LM in long term. Preoperative biopsy and complete pathological diagnosis were recommended. Radical surgical intervention including transplantation was the first choice in PH-NETs therapy.",0,0,scopus,"['computer systems', 'kaplan-meiers estimate', 'database systems', 'correlation analysis', 'curve fitting', 'matching algorithm', 'mathematics', 'image matching', 'proportional hazards models']",liver carcinoma in situ,"['Development', 'nomogram', 'model', 'survival', 'outcomes', 'patients', 'primary', 'hepatic', 'neuroendocrine', 'tumors', 'database']","['Primary', 'hepatic', 'neuroendocrine', 'tumors', 'NETs', 'rare', 'unknown', 'rarity', 'prognosis', 'features', 'factors', 'Methods', 'Data', 'patients', 'NETs', 'database', 'demographics', 'clinic', 'pathological', 'features', 'propensity', 'score', 'matching', 'analysis', 'cohorts', 'malignancy', 'NETs', 'univariate', 'analysis', 'multivariate', 'analyses', 'nomograph', 'C', 'index', 'receiver', 'characteristic', 'curve', 'calibration', 'curves', 'predictive', 'value', 'nomogram', 'Results', 'overall', 'survival', 'outcomes', 'superior', 'hepatocellular', 'carcinoma', 'mean', 'survival', 'time', 'months', 'p', 'inferior', 'gastrointestinal', 'tract', 'neuroendocrine', 'tumors', 'situ', 'NETs', 'situ', 'mean', 'survival', 'time', 'months', 'p', 'reference', 'gastrointestinal', 'neuroendocrine', 'tumors', 'liver', 'metastasis', 'better', 'outcomes', 'short', 'time', 'survival', 'rate', '%', '%', 'worse', 'long', 'time', 'survival', 'rate', '%', '%', 'analyses', 'tumor', 'grade', 'surgery', 'independent', 'factors', 'prognosis', 'patients', 'p', 'Tumor', 'grade', 'surgery', 'nomogram', 'index', 'area', 'curve', 'values', 'survival', 'calibration', 'curves', 'good', 'consistency', 'Conclusions', 'overall', 'prognosis', 'favorable', 'better', 'long', 'term', 'Preoperative', 'biopsy', 'complete', 'pathological', 'diagnosis', 'Radical', 'surgical', 'intervention', 'transplantation', 'first', 'choice', 'NETs', 'therapy']"
340,340,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106167125&origin=inward,Rescue radiofrequency ablation or percutaneous ethanol injection: a strategy for failed RALPPS stage-1 in patients with cirrhosis-related hepatocellular carcinoma,"¬© 2021, The Author(s).Background: The future liver remnant (FLR) faces a risk of poor growth in patients with cirrhosis-related hepatocellular carcinoma (HCC) after stage-1 radiofrequency-assisted ALPPS (RALPPS). The present study presents a strategy to trigger further FLR growth using supplementary radiofrequency ablation (RFA) and percutaneous ethanol injection (PEI). Methods: At RALPPS stage-1 the portal vein branch was ligated, followed by intraoperative RFA creating a coagulated avascular area between the FLR and the deportalized lobes. During the interstage period, patients not achieving sufficient liver size (‚â• 40%) within 2‚Äì3 weeks underwent additional percutaneous RFA/PEI of the deportalized lobes (rescue RFA/PEI) in an attempt to further stimulate FLR growth. Results: Seven patients underwent rescue RFA/PEI after RALPPS stage-1. In total five RFAs and eight PEIs were applied in these patients. The kinetic growth rate (KGR) was highest the first week after RALPPS stage-1 (10%, range ‚àí 1% to 15%), and then dropped to 1.5% (0‚Äì9%) in the second week (p < 0.05). With rescue RFA/PEI applied, KGR increased significantly to 4% (2‚Äì5%) compared with that before the rescue procedures (p < 0.05). Five patients proceeded to RALPPS stage-2. Two patients failed: In one patient the FLR remained at a constant level even after four rescue PEIs. The other patient developed metastasis. Except one patient died after RALPPS stage-2, no severe complications (Clavien-Dindo ‚â• IIIb) occurred among remaining six patients. Conclusions: Rescue RFA/PEI may provide an alternative to trigger further growth of the FLR in patients with cirrhosis-related HCC showing insufficient FLR after RALPPS stage-1. Trial registration Retrospectively registered.",0,0,scopus,"['integral equations', 'kinetic equations', 'rf-id tags', 'radio frequency (rf)']",liver carcinoma in situ,"['Rescue', 'radiofrequency', 'ablation', 'percutaneous', 'ethanol', 'injection', 'strategy', 'patients', 'cirrhosis', 'hepatocellular', 'carcinoma']","['Author(s).Background', 'future', 'liver', 'remnant', 'risk', 'poor', 'growth', 'patients', 'cirrhosis', 'hepatocellular', 'carcinoma', 'radiofrequency', 'present', 'study', 'strategy', 'further', 'growth', 'supplementary', 'radiofrequency', 'ablation', 'percutaneous', 'ethanol', 'injection', 'Methods', 'portal', 'vein', 'branch', 'intraoperative', 'RFA', 'coagulated', 'avascular', 'area', 'deportalized', 'lobes', 'interstage', 'period', 'patients', 'sufficient', 'liver', 'size', '%', 'weeks', 'additional', 'percutaneous', 'deportalized', 'lobes', 'rescue', 'attempt', 'growth', 'Results', 'patients', 'rescue', 'PEI', 'total', 'RFAs', 'PEIs', 'patients', 'kinetic', 'growth', 'rate', 'highest', 'first', 'week', '%', 'range', '%', '%', '%', '%', 'second', 'week', 'p', 'rescue', '%', '%', 'rescue', 'procedures', 'p', 'patients', 'patients', 'patient', 'constant', 'level', 'rescue', 'PEIs', 'other', 'patient', 'metastasis', 'patient', 'severe', 'complications', 'patients', 'Conclusions', 'Rescue', 'alternative', 'further', 'growth', 'patients', 'cirrhosis', 'insufficient', 'Trial', 'registration']"
341,341,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105989151&origin=inward,Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ,"¬© 2021, The Author(s).Background: The molecular biomarkers of breast ductal carcinoma in situ (DCIS) have important guiding significance for individualized precision treatment. This study was intended to explore the significance of radiomics based on ultrasound images to predict the expression of molecular biomarkers of mass type of DCIS. Methods: 116 patients with mass type of DCIS were included in this retrospective study. The radiomics features were extracted based on ultrasound images. According to the ratio of 7:3, the data sets of molecular biomarkers were split into training set and test set. The radiomics models were developed to predict the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), Ki67, p16, and p53 by using combination of multiple feature selection and classifiers. The predictive performance of the models were evaluated using the area under the curve (AUC) of the receiver operating curve. Results: The investigators extracted 5234 radiomics features from ultrasound images. 12, 23, 41, 51, 31 and 23 features were important for constructing the models. The radiomics scores were significantly (P < 0.05) in each molecular marker expression of mass type of DCIS. The radiomics models showed predictive performance with AUC greater than 0.7 in the training set and test set: ER (0.94 and 0.84), PR (0.90 and 0.78), HER2 (0.94 and 0.74), Ki67 (0.95 and 0.86), p16 (0.96 and 0.78), and p53 (0.95 and 0.74), respectively. Conclusion: Ultrasonic-based radiomics analysis provided a noninvasive preoperative method for predicting the expression of molecular markers of mass type of DCIS with good accuracy.",0,0,scopus,"['feature space', 'transmitters', 'computer-aided diagnosis system', 'classification methods', 'ultrasound images', 'classifiers', 'computer aided diagnosis', 'machine learning', 'pattern recognition', 'signal receivers', 'ultrasonic imaging', 'antennas']",liver carcinoma in situ,"['Preoperative', 'ultrasound', 'radiomics', 'analysis', 'expression', 'multiple', 'molecular', 'biomarkers', 'mass', 'type', 'breast', 'ductal', 'carcinoma', 'situ']","['Author(s).Background', 'molecular', 'biomarkers', 'breast', 'ductal', 'carcinoma', 'situ', 'important', 'guiding', 'significance', 'individualized', 'precision', 'treatment', 'study', 'significance', 'radiomics', 'ultrasound', 'images', 'expression', 'molecular', 'biomarkers', 'mass', 'type', 'Methods', 'patients', 'mass', 'type', 'retrospective', 'study', 'radiomics', 'features', 'ultrasound', 'images', 'ratio', 'data', 'sets', 'molecular', 'biomarkers', 'training', 'set', 'test', 'set', 'radiomics', 'models', 'expression', 'estrogen', 'receptor', 'progesterone', 'receptor', 'human', 'epidermal', 'growth', 'factor', 'receptor', 'p16', 'combination', 'multiple', 'feature', 'selection', 'classifiers', 'predictive', 'performance', 'models', 'area', 'curve', 'receiver', 'operating', 'curve', 'Results', 'investigators', 'radiomics', 'features', 'ultrasound', 'images', 'features', 'important', 'models', 'radiomics', 'scores', 'P', 'molecular', 'marker', 'expression', 'mass', 'type', 'radiomics', 'models', 'predictive', 'performance', 'greater', 'training', 'set', 'test', 'set', 'p16', 'p53', 'Conclusion', 'radiomics', 'analysis', 'noninvasive', 'preoperative', 'method', 'expression', 'molecular', 'markers', 'mass', 'type', 'good', 'accuracy']"
342,342,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105926046&origin=inward,Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients,"¬© 2021, The Author(s).B cell responses to tumor antigens occur early in breast tumors and may identify immunogenic drivers of tumorigenesis. Sixty-two candidate antigens were identified prior to palpable tumor development in TgMMTV-neu and C3(1)Tag transgenic mouse mammary tumor models. Five antigens (VPS35, ARPC2, SERBP1, KRT8, and PDIA6) were selected because their decreased expression decreased survival in human HER2 positive and triple negative cell lines in a siRNA screen. Vaccination with antigen-specific epitopes, conserved between mouse and human, inhibited tumor growth in both transgenic mouse models. Increased IgG autoantibodies to the antigens were elevated in serum from women with ductal carcinoma in situ (DCIS) and invasive breast cancer (IBC). The autoantibodies differentiated women with DCIS from control with AUC 0.93 (95% CI 0.88‚Äì0.98, p < 0.0001). The tumor antigens identified early in the development of breast cancer in mouse mammary tumor models were conserved in human disease, and potentially identify early diagnostic markers in human breast tumors.",0,0,scopus,"['stochastic processes', 'mathematics', 'image display', 'kaplan-meiers estimate', 'standard model', 'correlation analysis', 'image analysis', 'the standard model', 'electronic document identification systems', 'probability', 'proportional hazards models']",liver carcinoma in situ,"['Tumor', 'autoantibodies', 'mouse', 'breast', 'cancer', 'models', 'serum', 'breast', 'cancer', 'patients']","['cell', 'tumor', 'antigens', 'breast', 'tumors', 'immunogenic', 'drivers', 'tumorigenesis', 'candidate', 'antigens', 'palpable', 'tumor', 'development', 'C3(1)Tag', 'transgenic', 'mouse', 'mammary', 'tumor', 'models', 'antigens', 'VPS35', 'expression', 'survival', 'human', 'positive', 'triple', 'negative', 'cell', 'lines', 'screen', 'Vaccination', 'antigen', 'specific', 'epitopes', 'mouse', 'human', 'inhibited', 'tumor', 'growth', 'transgenic', 'mouse', 'models', 'IgG', 'autoantibodies', 'antigens', 'serum', 'women', 'ductal', 'carcinoma', 'situ', 'invasive', 'breast', 'cancer', 'autoantibodies', 'women', 'control', '%', 'p', 'tumor', 'development', 'breast', 'cancer', 'mouse', 'mammary', 'tumor', 'models', 'human', 'disease', 'early', 'diagnostic', 'markers', 'human', 'breast', 'tumors']"
343,343,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105841063&origin=inward,Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer,"¬© 2021, The Author(s).Background: Endocrine therapy remains the mainstay of treatment for estrogen receptor-positive (ER+) breast cancer. Constitutively active mutations in the ligand binding domain of ERŒ± render tumors resistant to endocrine agents. Breast cancers with the two most common ERŒ± mutations, Y537S and D538G, have low sensitivity to fulvestrant inhibition, a typical second-line endocrine therapy. Lasofoxifene is a selective estrogen receptor modulator with benefits on bone health and breast cancer prevention potential. This study investigated the anti-tumor activity of lasofoxifene in breast cancer xenografts expressing Y537S and D538G ERŒ± mutants. The combination of lasofoxifene with palbociclib, a CDK4/6 inhibitor, was also evaluated. Methods: Luciferase-GFP tagged MCF7 cells bearing wild-type, Y537S, or D538G ERŒ± were injected into the mammary ducts of NSG mice (MIND model), which were subsequently treated with lasofoxifene or fulvestrant as single agents or in combination with palbociclib. Tumor growth and metastasis were monitored with in vivo and ex vivo luminescence imaging, terminal tumor weight measurements, and histological analysis. Results: As a monotherapy, lasofoxifene was more effective than fulvestrant at inhibiting primary tumor growth and reducing metastases. Adding palbociclib improved the effectiveness of both lasofoxifene and fulvestrant for tumor suppression and metastasis prevention at four distal sites (lung, liver, bone, and brain), with the combination of lasofoxifene/palbociclib being generally more potent than that of fulvestrant/palbociclib. X-ray crystallography of the ERŒ± ligand binding domain (LBD) shows that lasofoxifene stabilizes an antagonist conformation of both wild-type and Y537S LBD. The ability of lasofoxifene to promote an antagonist conformation of Y537S, combined with its long half-life and bioavailability, likely contributes to the observed potent inhibition of primary tumor growth and metastasis of MCF7 Y537S cells. Conclusions: We report for the first time the anti-tumor activity of lasofoxifene in mouse models of endocrine therapy-resistant breast cancer. The results demonstrate the potential of using lasofoxifene as an effective therapy for women with advanced or metastatic ER+ breast cancers expressing the most common constitutively active ERŒ± mutations.",0,0,scopus,"['artificial intelligence', 'software agents', 'phase modulation', 'intelligent agents', 'multiagent system', 'autonomous agents', 'phase modulator']",liver carcinoma in situ,"['potential', 'treatment', 'therapy', 'resistant', 'positive', 'metastatic', 'breast', 'cancer']","['Author(s).Background', 'Endocrine', 'therapy', 'mainstay', 'treatment', 'estrogen', 'receptor', 'positive', 'breast', 'cancer', 'Constitutively', 'active', 'mutations', 'ligand', 'domain', 'ERŒ±', 'tumors', 'resistant', 'endocrine', 'agents', 'Breast', 'cancers', 'common', 'ERŒ±', 'mutations', 'Y537S', 'G', 'low', 'sensitivity', 'inhibition', 'typical', 'second', 'line', 'endocrine', 'therapy', 'selective', 'estrogen', 'receptor', 'modulator', 'benefits', 'bone', 'health', 'breast', 'cancer', 'prevention', 'potential', 'study', 'anti', '-', 'tumor', 'activity', 'lasofoxifene', 'breast', 'cancer', 'xenografts', 'Y537S', 'G', 'ERŒ±', 'mutants', 'combination', 'lasofoxifene', 'palbociclib', 'inhibitor', 'Methods', 'cells', 'wild', 'type', 'Y537S', 'D538', 'G', 'ERŒ±', 'mammary', 'ducts', 'mice', 'model', 'lasofoxifene', 'fulvestrant', 'single', 'agents', 'combination', 'palbociclib', 'Tumor', 'growth', 'metastasis', 'vivo', 'ex', 'vivo', 'luminescence', 'imaging', 'terminal', 'tumor', 'weight', 'measurements', 'histological', 'analysis', 'Results', 'monotherapy', 'lasofoxifene', 'effective', 'fulvestrant', 'primary', 'tumor', 'growth', 'metastases', 'palbociclib', 'effectiveness', 'lasofoxifene', 'fulvestrant', 'tumor', 'suppression', 'metastasis', 'prevention', 'distal', 'sites', 'lung', 'liver', 'bone', 'brain', 'combination', 'lasofoxifene', 'palbociclib', 'potent', 'fulvestrant', 'palbociclib', 'X', '-', 'ray', 'crystallography', 'ERŒ±', 'ligand', 'domain', 'lasofoxifene', 'antagonist', 'conformation', 'wild', 'type', 'Y537S', 'ability', 'lasofoxifene', 'antagonist', 'conformation', 'Y537S', 'long', 'half', 'life', 'bioavailability', 'likely', 'contributes', 'observed', 'potent', 'inhibition', 'primary', 'tumor', 'growth', 'metastasis', 'cells', 'Conclusions', 'first', 'time', 'anti', '-', 'tumor', 'activity', 'lasofoxifene', 'mouse', 'models', 'endocrine', 'therapy', 'resistant', 'breast', 'cancer', 'results', 'potential', 'lasofoxifene', 'effective', 'therapy', 'women', 'advanced', 'metastatic', 'breast', 'cancers', 'common', 'constitutively', 'active', 'ERŒ±', 'mutations']"
344,344,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105818137&origin=inward,"Role of lysosomes in physiological activities, diseases, and therapy","¬© 2021, The Author(s).Long known as digestive organelles, lysosomes have now emerged as multifaceted centers responsible for degradation, nutrient sensing, and immunity. Growing evidence also implicates role of lysosome-related mechanisms in pathologic process. In this review, we discuss physiological function of lysosomes and, more importantly, how the homeostasis of lysosomes is disrupted in several diseases, including atherosclerosis, neurodegenerative diseases, autoimmune disorders, pancreatitis, lysosomal storage disorders, and malignant tumors. In atherosclerosis and Gaucher disease, dysfunction of lysosomes changes cytokine secretion from macrophages, partially through inflammasome activation. In neurodegenerative diseases, defect autophagy facilitates accumulation of toxic protein and dysfunctional organelles leading to neuron death. Lysosomal dysfunction has been demonstrated in pathology of pancreatitis. Abnormal autophagy activation or inhibition has been revealed in autoimmune disorders. In tumor microenvironment, malignant phenotypes, including tumorigenesis, growth regulation, invasion, drug resistance, and radiotherapy resistance, of tumor cells and behaviors of tumor-associated macrophages, fibroblasts, dendritic cells, and T cells are also mediated by lysosomes. Based on these findings, a series of therapeutic methods targeting lysosomal proteins and processes have been developed from bench to bedside. In a word, present researches corroborate lysosomes to be pivotal organelles for understanding pathology of atherosclerosis, neurodegenerative diseases, autoimmune disorders, pancreatitis, and lysosomal storage disorders, and malignant tumors and developing novel therapeutic strategies.",0,0,scopus,"['computer systems', 'storage systems', 'storage management', 'information management', 'sensors', 'random access storage', 'digital storage', 'flash memory', 'storage devices', 'computer hardware', 'nonvolatile storage']",liver carcinoma in situ,"['Role', 'lysosomes', 'physiological', 'activities', 'diseases', 'therapy']","['digestive', 'organelles', 'lysosomes', 'centers', 'responsible', 'degradation', 'nutrient', 'sensing', 'immunity', 'evidence', 'role', 'lysosome', 'mechanisms', 'pathologic', 'process', 'review', 'physiological', 'function', 'lysosomes', 'homeostasis', 'lysosomes', 'several', 'diseases', 'atherosclerosis', 'neurodegenerative', 'diseases', 'autoimmune', 'disorders', 'pancreatitis', 'lysosomal', 'storage', 'disorders', 'malignant', 'tumors', 'atherosclerosis', 'disease', 'dysfunction', 'lysosomes', 'changes', 'cytokine', 'secretion', 'macrophages', 'inflammasome', 'activation', 'neurodegenerative', 'diseases', 'autophagy', 'accumulation', 'toxic', 'protein', 'dysfunctional', 'organelles', 'neuron', 'death', 'Lysosomal', 'dysfunction', 'pathology', 'pancreatitis', 'Abnormal', 'autophagy', 'activation', 'inhibition', 'autoimmune', 'disorders', 'tumor', 'microenvironment', 'malignant', 'phenotypes', 'tumorigenesis', 'growth', 'regulation', 'invasion', 'drug', 'resistance', 'resistance', 'tumor', 'cells', 'behaviors', 'tumor', 'macrophages', 'fibroblasts', 'dendritic', 'cells', 'T', 'cells', 'lysosomes', 'findings', 'series', 'therapeutic', 'methods', 'lysosomal', 'proteins', 'processes', 'bench', 'word', 'present', 'researches', 'lysosomes', 'pivotal', 'organelles', 'pathology', 'atherosclerosis', 'neurodegenerative', 'diseases', 'autoimmune', 'disorders', 'pancreatitis', 'lysosomal', 'storage', 'disorders', 'malignant', 'tumors', 'novel', 'therapeutic', 'strategies']"
345,345,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105796844&origin=inward,Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways,"¬© 2021, The Author(s).Background: The majority of pancreatic ductal adenocarcinomas (PDAC) are diagnosed at the metastatic stage, and standard therapies have limited activity with a dismal 5-year survival rate of only 8%. The liver and lung are the most common sites of PDAC metastasis, and each have been differentially associated with prognoses and responses to systemic therapies. A deeper understanding of the molecular and cellular landscape within the tumor microenvironment (TME) metastasis at these different sites is critical to informing future therapeutic strategies against metastatic PDAC. Results: By leveraging combined mass cytometry, immunohistochemistry, and RNA sequencing, we identify key regulatory pathways that distinguish the liver and lung TMEs in a preclinical mouse model of metastatic PDAC. We demonstrate that the lung TME generally exhibits higher levels of immune infiltration, immune activation, and pro-immune signaling pathways, whereas multiple immune-suppressive pathways are emphasized in the liver TME. We then perform further validation of these preclinical findings in paired human lung and liver metastatic samples using immunohistochemistry from PDAC rapid autopsy specimens. Finally, in silico validation with transfer learning between our mouse model and TCGA datasets further demonstrates that many of the site-associated features are detectable even in the context of different primary tumors. Conclusions: Determining the distinctive immune-suppressive features in multiple liver and lung TME datasets provides further insight into the tissue specificity of molecular and cellular pathways, suggesting a potential mechanism underlying the discordant clinical responses that are often observed in metastatic diseases.",0,0,scopus,"['validation', 'cellular telephone systems', 'hierarchical system', 'hierarchical model', 'wireless', 'cellular radio systems', 'verification and validation', 'channel capacity', 'learning', 'education', 'cellular network', 'validation process', 'cellular system', 'cellular']",liver carcinoma in situ,"['Multi', '-', 'omic', 'profiling', 'lung', 'liver', 'tumor', 'microenvironments', 'metastatic', 'pancreatic', 'cancer', 'site', 'specific', 'immune', 'regulatory', 'pathways']","['Author(s).Background', 'majority', 'pancreatic', 'ductal', 'adenocarcinomas', 'metastatic', 'stage', 'standard', 'therapies', 'activity', 'dismal', 'survival', 'rate', '%', 'liver', 'lung', 'common', 'sites', 'metastasis', 'prognoses', 'responses', 'systemic', 'therapies', 'deeper', 'understanding', 'molecular', 'cellular', 'landscape', 'tumor', 'microenvironment', 'metastasis', 'different', 'sites', 'critical', 'future', 'therapeutic', 'strategies', 'metastatic', 'Results', 'mass', 'cytometry', 'immunohistochemistry', 'sequencing', 'key', 'regulatory', 'pathways', 'liver', 'lung', 'TMEs', 'preclinical', 'mouse', 'model', 'metastatic', 'lung', 'higher', 'levels', 'immune', 'infiltration', 'immune', 'activation', 'pro', '-', 'immune', 'pathways', 'multiple', 'immune', 'suppressive', 'pathways', 'liver', 'further', 'validation', 'preclinical', 'findings', 'human', 'lung', 'liver', 'metastatic', 'samples', 'immunohistochemistry', 'rapid', 'autopsy', 'specimens', 'validation', 'transfer', 'mouse', 'model', 'TCGA', 'datasets', 'many', 'site', 'features', 'detectable', 'context', 'different', 'primary', 'tumors', 'Conclusions', 'distinctive', 'immune', 'suppressive', 'features', 'multiple', 'liver', 'lung', 'datasets', 'further', 'insight', 'tissue', 'specificity', 'molecular', 'cellular', 'pathways', 'potential', 'mechanism', 'discordant', 'clinical', 'responses', 'metastatic', 'diseases']"
346,346,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105792534&origin=inward,Rational construction of a reversible arylazo-based NIR probe for cycling hypoxia imaging in vivo,"¬© 2021, The Author(s).Reversible NIR luminescent probes with negligible photocytotoxicity are required for long-term tracking of cycling hypoxia in vivo. However, almost all of the reported organic fluorescent hypoxia probes reported until now were irreversible. Here we report a reversible arylazo-conjugated fluorescent probe (HDSF) for cycling hypoxia imaging. HDSF displays an off-on fluorescence switch at 705 nm in normoxia-hypoxia cycles. Mass spectroscopic and theoretical studies confirm that the reversible sensing behavior is attributed to the two electron-withdrawing trifluoromethyl groups, which stabilizes the reduction intermediate phenylhydrazine and blocks the further reductive decomposition. Cycling hypoxia monitoring in cells and zebrafish embryos is realized by HDSF using confocal imaging. Moreover, hypoxic solid tumors are visualized and the ischemia-reperfusion process in mice is monitored in real-time. This work provides an effective strategy to construct organic fluorescent probes for cycling hypoxia imaging and paves the way for the study of cycling hypoxia biology.",0,0,scopus,"['target tracking', 'focal plane arrays', 'computerized tomography', 'x-ray computed tomography', 'computer vision', 'swir', 'imaging systems', 'tracking system', 'detection and tracking', 'image reconstruction', 'semiconducting indium']",liver carcinoma in situ,"['Rational', 'construction', 'reversible', 'arylazo', 'probe', 'cycling', 'hypoxia', 'vivo']","['Author(s).Reversible', 'luminescent', 'probes', 'negligible', 'photocytotoxicity', 'long', 'term', 'tracking', 'cycling', 'hypoxia', 'vivo', 'organic', 'fluorescent', 'hypoxia', 'probes', 'irreversible', 'reversible', 'arylazo', 'fluorescent', 'probe', 'cycling', 'hypoxia', 'imaging', 'fluorescence', 'switch', 'nm', 'normoxia', 'hypoxia', 'cycles', 'Mass', 'spectroscopic', 'theoretical', 'studies', 'reversible', 'sensing', 'behavior', 'electron', 'trifluoromethyl', 'groups', 'reduction', 'intermediate', 'phenylhydrazine', 'further', 'reductive', 'decomposition', 'Cycling', 'hypoxia', 'monitoring', 'cells', 'zebrafish', 'embryos', 'confocal', 'imaging', 'hypoxic', 'solid', 'tumors', 'ischemia', 'reperfusion', 'process', 'mice', 'real', 'time', 'work', 'effective', 'strategy', 'organic', 'fluorescent', 'probes', 'cycling', 'hypoxia', 'imaging', 'way', 'study', 'cycling', 'hypoxia', 'biology']"
347,347,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105754599&origin=inward,A bibliometric review of oncolytic virus research as a novel approach for cancer therapy,"¬© 2021, The Author(s).Background: In recent years, oncolytic viruses (OVs) have drawn attention as a novel therapy to various types of cancers, both in clinical and preclinical cancer studies all around the world. Consequently, researchers have been actively working on enhancing cancer therapy since the early twentieth century. This study presents a systematic review of the literature on OVs, discusses underlying research clusters and, presents future directions of OVs research. Methods: A total of 1626 published articles related to OVs as cancer therapy were obtained from the Web of Science (WoS) database published between January 2000 and March 2020. Various aspects of OVs research, including the countries/territories, institutions, journals, authors, citations, research areas, and content analysis to find trending and emerging topics, were analysed using the bibliometrix package in the R-software. Results: In terms of the number of publications, the USA based researchers were the most productive (n = 611) followed by Chinese (n = 197), and Canadian (n = 153) researchers. The Molecular Therapy journal ranked first both in terms of the number of publications (n = 133) and local citations (n = 1384). The most prominent institution was Mayo Clinic from the USA (n = 117) followed by the University of Ottawa from Canada (n = 72), and the University of Helsinki from Finland (n = 63). The most impactful author was Bell J.C with the highest number of articles (n = 67) and total local citations (n = 885). The most impactful article was published in the Cell journal. In addition, the latest OVs research mainly builds on four research clusters. Conclusion: The domain of OVs research has increased at a rapid rate from 2000 to 2020. Based on the synthesis of reviewed studies, adenovirus, herpes simplex virus, reovirus, and Newcastle disease virus have shown potent anti-cancer activity. Developed countries such as the USA, Canada, the UK, and Finland were the most productive, hence, contributed most to this field. Further collaboration will help improve the clinical research translation of this therapy and bring benefits to cancer patients worldwide.",0,0,scopus,"['computer systems', 'software', 'computer science', 'database systems', 'security of data', 'malwares', 'malicious codes', 'education', 'university', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['bibliometric', 'review', 'oncolytic', 'virus', 'research', 'novel', 'approach', 'cancer', 'therapy']","['Author(s).Background', 'recent', 'years', 'oncolytic', 'viruses', 'OVs', 'attention', 'novel', 'therapy', 'various', 'types', 'cancers', 'clinical', 'preclinical', 'cancer', 'studies', 'world', 'researchers', 'cancer', 'therapy', 'early', 'twentieth', 'century', 'study', 'systematic', 'review', 'literature', 'OVs', 'research', 'clusters', 'future', 'directions', 'OVs', 'research', 'Methods', 'total', 'articles', 'OVs', 'cancer', 'therapy', 'Web', 'database', 'Various', 'aspects', 'OVs', 'research', 'countries', 'territories', 'institutions', 'journals', 'authors', 'citations', 'research', 'areas', 'content', 'analysis', 'trending', 'topics', 'bibliometrix', 'package', 'R', 'software', 'Results', 'terms', 'number', 'publications', 'researchers', 'productive', 'researchers', 'journal', 'terms', 'number', 'publications', 'local', 'citations', 'prominent', 'institution', 'impactful', 'author', 'highest', 'number', 'articles', 'total', 'local', 'citations', 'impactful', 'article', 'journal', 'addition', 'latest', 'OVs', 'research', 'research', 'clusters', 'Conclusion', 'domain', 'OVs', 'research', 'rapid', 'rate', 'synthesis', 'studies', 'adenovirus', 'simplex', 'virus', 'reovirus', 'disease', 'virus', 'potent', 'anti', '-', 'cancer', 'activity', 'countries', 'such', 'productive', 'field', 'Further', 'collaboration', 'clinical', 'research', 'translation', 'therapy', 'benefits', 'cancer', 'patients']"
348,348,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105747230&origin=inward,FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer,"¬© 2021, The Author(s).Most patients with triple negative breast cancer (TNBC) do not respond to anti-PD1/PDL1 immunotherapy, indicating the necessity to explore immune checkpoint targets. B7H3 is a highly glycosylated protein. However, the mechanisms of B7H3 glycosylation regulation and whether the sugar moiety contributes to immunosuppression are unclear. Here, we identify aberrant B7H3 glycosylation and show that N-glycosylation of B7H3 at NXT motif sites is responsible for its protein stability and immunosuppression in TNBC tumors. The fucosyltransferase FUT8 catalyzes B7H3 core fucosylation at N-glycans to maintain its high expression. Knockdown of FUT8 rescues glycosylated B7H3-mediated immunosuppressive function in TNBC cells. Abnormal B7H3 glycosylation mediated by FUT8 overexpression can be physiologically important and clinically relevant in patients with TNBC. Notably, the combination of core fucosylation inhibitor 2F-Fuc and anti-PDL1 results in enhanced therapeutic efficacy in B7H3-positive TNBC tumors. These findings suggest that targeting the FUT8-B7H3 axis might be a promising strategy for improving anti-tumor immune responses in patients with TNBC.",0,0,scopus,"['target tracking', 'asymptotic stability', 'multitarget', 'checkpointing', 'rollback recovery', 'multi-target tracking', 'fault tolerance', 'lyapunov functions', 'adaptive control systems', 'computer system recovery', 'multiple targets', 'global stability']",liver carcinoma in situ,"['aberrant', 'N', 'glycosylation', 'B7H3', 'immune', 'response', 'triple', 'negative', 'breast', 'cancer']","['patients', 'triple', 'negative', 'breast', 'cancer', 'anti', '-', 'immunotherapy', 'necessity', 'immune', 'checkpoint', 'targets', 'glycosylated', 'protein', 'mechanisms', 'B7H3', 'glycosylation', 'regulation', 'sugar', 'moiety', 'contributes', 'immunosuppression', 'unclear', 'aberrant', 'B7H3', 'glycosylation', 'N', 'glycosylation', 'B7H3', 'motif', 'sites', 'responsible', 'protein', 'stability', 'immunosuppression', 'tumors', 'fucosyltransferase', 'core', 'fucosylation', 'N', 'glycans', 'high', 'expression', 'rescues', 'immunosuppressive', 'function', 'cells', 'Abnormal', 'B7H3', 'glycosylation', 'overexpression', 'important', 'relevant', 'patients', 'combination', 'core', 'fucosylation', 'inhibitor', 'Fuc', 'anti', '-', 'PDL1', 'results', 'therapeutic', 'efficacy', 'B7H3-positive', 'tumors', 'findings', 'axis', 'promising', 'strategy', 'anti', '-', 'tumor', 'immune', 'responses', 'patients']"
349,349,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105716224&origin=inward,Plasma fibrinogen acts as a predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer: a retrospective study of 1004 Chinese breast cancer patients,"¬© 2021, The Author(s).Background: The aim of this study was to evaluate the relationship between pre-treatment plasma fibrinogen (Fib) level and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients and to assess the role of plasma Fib as a predictive factor. Methods: Data from 1004 consecutive patients with invasive breast cancer who received NAC and subsequent surgery were retrospectively analysed. Both univariate and multivariate analyses based on logistic regression model were performed to identify clinicopathological factors associated with pCR to NAC. Cox regression model was used to determine the correlation between clinical or pathological parameters and recurrence-free survival (RFS). The Kaplan-Meier method and the log-rank test were applied in the survival analysis. Results: The median value of Fib, rather than other plasma coagulation parameters, was significantly increased in non-pCR patients compared with pCR patients (P = 0.002). Based on the cut-off value estimated by the receiver operating characteristic (ROC) curve analysis, patients were divided into low or high Fib groups (Fib < 3.435 g/L or ‚â• 3.435 g/L). Low Fib levels were significantly associated with premenopausal or perimenopausal status (P < 0.001), tumour size ‚â§5 cm (P = 0.002), and positive hormone receptor status (P = 0.002). After adjusted for other clinicopathological factors in the multivariate logistic regression model, low Fib status was strongly associated with pCR to NAC (OR = 3.038, 95% CI 1.667‚Äì5.537, P < 0.001). Survival analysis showed that patients with low Fib levels exhibited better 3-year RFS compared with patients with high Fib levels in the tumour size>5 cm group (77.5% vs 58.4%, log-rank, P = 0.0168). Conclusions: This study demonstrates that low pre-treatment plasma Fib (Fib < 3.435 g/L) is an independent predictive factor for pCR to NAC in breast cancer patients. Moreover, T3-featured breast cancer patients with lower Fib level exhibit better RFS outcomes after NAC compared with high Fib status.",0,0,scopus,"['logistic regression models', 'median value', 'logistics', 'kaplan meier method', 'correlation analysis', 'median filter', 'regression model', 'logistic regression', 'proportional hazards models']",liver carcinoma in situ,"['fibrinogen', 'predictive', 'factor', 'pathological', 'complete', 'response', 'neoadjuvant', 'chemotherapy', 'breast', 'cancer', 'retrospective', 'study', 'Chinese', 'breast', 'cancer', 'patients']","['Author(s).Background', 'aim', 'study', 'relationship', 'pre', '-', 'treatment', 'plasma', 'fibrinogen', 'level', 'pathological', 'complete', 'response', 'pCR', 'neoadjuvant', 'chemotherapy', 'breast', 'cancer', 'patients', 'role', 'plasma', 'predictive', 'factor', 'Methods', 'Data', 'consecutive', 'patients', 'invasive', 'breast', 'cancer', 'subsequent', 'surgery', 'univariate', 'multivariate', 'analyses', 'logistic', 'regression', 'model', 'clinicopathological', 'factors', 'pCR', 'Cox', 'regression', 'model', 'correlation', 'clinical', 'pathological', 'parameters', 'recurrence', 'free', 'survival', 'method', 'log', 'rank', 'test', 'survival', 'analysis', 'Results', 'median', 'value', 'other', 'plasma', 'coagulation', 'parameters', 'non', '-', 'pCR', 'patients', 'pCR', 'patients', 'P', 'cut', 'value', 'receiver', 'operating', 'characteristic', 'curve', 'analysis', 'patients', 'low', 'high', 'groups', 'Fib', 'g', 'g', 'L', 'Low', 'levels', 'premenopausal', 'perimenopausal', 'status', 'P', 'tumour', 'size', 'P', 'positive', 'hormone', 'receptor', 'status', 'P', 'other', 'clinicopathological', 'factors', 'multivariate', 'logistic', 'regression', 'model', 'low', 'status', 'pCR', '=', '%', 'P', 'Survival', 'analysis', 'patients', 'low', 'levels', 'better', 'RFS', 'patients', 'high', 'levels', 'tumour', 'cm', 'group', '%', '%', 'log', 'rank', 'P', 'Conclusions', 'study', 'low', 'pre', '-', 'treatment', 'plasma', 'Fib', 'g', 'L', 'independent', 'predictive', 'factor', 'pCR', 'breast', 'cancer', 'patients', 'breast', 'cancer', 'patients', 'lower', 'level', 'exhibit', 'better', 'RFS', 'outcomes', 'high', 'status']"
350,350,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105603547&origin=inward,Biomechanical regulation of breast cancer metastasis and progression,"¬© 2021, The Author(s).Physical activity has been consistently linked to decreased incidence of breast cancer and a substantial increase in the length of survival of patients with breast cancer. However, the understanding of how applied physical forces directly regulate breast cancer remains limited. We investigated the role of mechanical forces in altering the chemoresistance, proliferation and metastasis of breast cancer cells. We found that applied mechanical tension can dramatically alter gene expression in breast cancer cells, leading to decreased proliferation, increased resistance to chemotherapeutic treatment and enhanced adhesion to inflamed endothelial cells and collagen I under fluidic shear stress. A mechanistic analysis of the pathways involved in these effects supported a complex signaling network that included Abl1, Lck, Jak2 and PI3K to regulate pro-survival signaling and enhancement of adhesion under flow. Studies using mouse xenograft models demonstrated reduced proliferation of breast cancer cells with orthotopic implantation and increased metastasis to the skull when the cancer cells were treated with mechanical load. Using high throughput mechanobiological screens we identified pathways that could be targeted to reduce the effects of load on metastasis and found that the effects of mechanical load on bone colonization could be reduced through treatment with a PI3KŒ≥ inhibitor.",0,0,scopus,"['kaplan-meiers estimate', 'machine design', 'microfabricated', 'correlation analysis', 'mechanical systems', 'microfabrication', 'network protocols', 'network architecture', 'mathematics', 'proportional hazards models', 'solid-state sensors']",liver carcinoma in situ,"['Biomechanical', 'regulation', 'breast', 'cancer', 'metastasis', 'progression']","['Author(s).Physical', 'activity', 'incidence', 'breast', 'cancer', 'substantial', 'increase', 'length', 'survival', 'patients', 'breast', 'cancer', 'understanding', 'physical', 'forces', 'breast', 'cancer', 'limited', 'role', 'mechanical', 'forces', 'chemoresistance', 'proliferation', 'metastasis', 'breast', 'cancer', 'cells', 'mechanical', 'tension', 'gene', 'expression', 'breast', 'cancer', 'cells', 'proliferation', 'resistance', 'chemotherapeutic', 'treatment', 'enhanced', 'adhesion', 'endothelial', 'cells', 'collagen', 'fluidic', 'shear', 'stress', 'mechanistic', 'analysis', 'pathways', 'effects', 'complex', 'network', 'pro', '-', 'survival', 'signaling', 'enhancement', 'adhesion', 'flow', 'Studies', 'mouse', 'xenograft', 'models', 'reduced', 'proliferation', 'breast', 'cancer', 'cells', 'orthotopic', 'implantation', 'metastasis', 'skull', 'cancer', 'cells', 'mechanical', 'load', 'high', 'throughput', 'mechanobiological', 'screens', 'pathways', 'effects', 'load', 'metastasis', 'effects', 'mechanical', 'load', 'bone', 'colonization', 'treatment', 'inhibitor']"
351,351,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105566803&origin=inward,Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors,"¬© 2021, The Author(s).Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and has demonstrated clinical activity in gastric/gastroesophageal junction (G/GEJ) patients with elevated tumoral expression of DKK1. Here we report on the validation of a DKK1 RNAscope chromogenic in situ hybridization assay to assess DKK1 expression in G/GEJ tumor tissue. To reduce pathologist time, potential pathologist variability from manual scoring and support pathologist decision making, a digital image analysis algorithm that identifies tumor cells and quantifies the DKK1 signal was developed. Following CLIA guidelines the DKK1 RNAscope chromogenic in situ hybridization assay and digital image analysis algorithm were successfully validated for sensitivity, specificity, accuracy, and precision. The DKK1 RNAscope assay in conjunction with the digital image analysis solution is acceptable for prospective screening of G/GEJ adenocarcinoma patients. The work described here will further advance the companion diagnostic development of our DKK1 RNAscope assay and could generally be used as a guide for the validation of RNAscope assays with digital image quantification.",0,0,scopus,"['validation', 'computer vision', 'image processing', 'digital image', 'image analysis', 'verification and validation', 'pattern recognition', 'image quality', 'color images', 'reference image', 'image matching', 'color image processing']",liver carcinoma in situ,"['Validation', 'RNAscope', 'chromogenic', 'situ', 'hybridization', 'assay', 'gastric', 'junction', 'adenocarcinoma', 'tumors']","['Author(s).Dickkopf-1', 'secreted', 'modulator', 'tumors', 'poor', 'clinical', 'outcomes', 'humanized', 'monoclonal', 'therapeutic', 'antibody', 'high', 'affinity', 'clinical', 'activity', 'gastric', 'gastroesophageal', 'junction', 'patients', 'elevated', 'tumoral', 'expression', 'validation', 'RNAscope', 'chromogenic', 'situ', 'hybridization', 'assay', 'expression', 'tumor', 'tissue', 'pathologist', 'time', 'potential', 'pathologist', 'variability', 'manual', 'scoring', 'pathologist', 'decision', 'making', 'digital', 'image', 'analysis', 'algorithm', 'identifies', 'tumor', 'cells', 'signal', 'RNAscope', 'chromogenic', 'situ', 'hybridization', 'assay', 'digital', 'image', 'analysis', 'algorithm', 'sensitivity', 'specificity', 'accuracy', 'precision', 'RNAscope', 'conjunction', 'digital', 'image', 'analysis', 'solution', 'acceptable', 'prospective', 'screening', 'adenocarcinoma', 'patients', 'work', 'companion', 'diagnostic', 'development', 'RNAscope', 'assay', 'guide', 'validation', 'RNAscope', 'assays', 'digital', 'image', 'quantification']"
352,352,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105434400&origin=inward,Regulation of amyloid-Œ≤ levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells,"¬© 2021, The Author(s).In this study, we set out to identify regulators of intact amyloid-Œ≤40/42 (AŒ≤) levels in A549 (p53 wild-type) and H1299 (p53-null) lung cancer cell media. Higher AŒ≤ levels were detected in the media of A549 than H1299 cells without or with treatment with 4-methylumbelliferone (4-MU) and/or the anti-CD44 antibody (5F12). Using inhibitors, we found that PI3K, AKT, and NFŒ∫B are likely involved in regulating AŒ≤ levels in the media. However, increased AŒ≤ levels that more closely resembled those found upon 4-MU co-treatment resulted from MMP2/9 inhibition, suggesting that MMP2/9 maybe the main contributors to regulation of AŒ≤ levels in the media. Differences in AŒ≤ levels might be accounted for, in part, by p53 since blocking p53 function in A549 cells resulted in decreased AŒ≤ levels, increased MMP2/9 levels, increased PI3K/AKT activities and the phospho/total NFŒ∫B ratio. Using siRNA targeted against MMP2 or MMP9, we found increased AŒ≤ levels in the media, however, MMP2 knockdown led to AŒ≤ levels closely mimicking those detected by co-treatment with 4-MU. Cell viability or apoptosis upon treatment with either MMP2 or MMP9 siRNA along with AŒ≤ immunodepletion, showed that MMP2 is the predominant regulator of the cytotoxic effects induced by AŒ≤ in lung cancer cells.",0,0,scopus,"['multimedia services', 'multimedia systems', 'digital rights management', 'audio-visual', 'digital media', 'digital contents', 'multimedia contents', 'audio acoustics', 'face recognition', 'media streaming', 'digital storage', 'streaming media']",liver carcinoma in situ,"['Regulation', 'amyloid', 'Œ≤', 'levels', 'matrix', 'metalloproteinase-2/9', 'media', 'lung', 'cancer', 'cells']","['Author(s).In', 'study', 'regulators', 'intact', 'amyloid', 'AŒ≤', 'levels', 'A549', 'wild', 'type', 'lung', 'cancer', 'cell', 'media', 'Higher', 'levels', 'media', 'A549', 'cells', 'treatment', 'anti', '-', 'antibody', 'inhibitors', 'levels', 'media', 'levels', 'co', '-', 'treatment', 'inhibition', 'main', 'contributors', 'regulation', 'levels', 'media', 'Differences', 'levels', 'part', 'p53', 'p53', 'function', 'A549', 'cells', 'levels', 'levels', 'activities', 'phospho', 'total', 'ratio', 'siRNA', 'levels', 'media', 'levels', 'co', '-', 'treatment', 'viability', 'apoptosis', 'treatment', 'immunodepletion', 'predominant', 'regulator', 'cytotoxic', 'effects', 'lung', 'cancer', 'cells']"
353,353,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105384784&origin=inward,Prospective investigation of polyomavirus infection and the risk of adult glioma,"¬© 2021, The Author(s).Glioma is an aggressive primary tumor of the brain with a poorly understood etiology. We studied the association of 4 human polyomaviruses (HPyV)‚ÄîJC virus (JCV), BK virus (BKV), human polyomavirus 6 (HPyV6), and Merkel cell polyomavirus (MCPyV) with glioma risk within the Cancer Prevention Study II in the US (CPS-II) and the Janus Serum Bank in Norway. Cohort participants subsequently diagnosed with glioma from the CPS-II (n = 37) and Janus Serum Bank (n = 323), a median of 6.9 and 15.4 years after blood collection, respectively, were matched to individual controls on age, sex, and date of blood draw. Serum antibodies to the major viral capsid protein (VP1) were used to establish infection history for each polyomavirus. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using conditional logistic regression. In the Janus Serum Bank, MCPyV infection was associated with a higher risk of glioma overall (OR: 1.56; 95% CI 1.10, 2.19). A modest, nonsignificant positive association with MCPyV infection was also observed in CPS-II (OR: 1.29; 95% CI 0.54, 3.08). In both cohorts, glioma risk was not significantly related to infection with JCV, BKV or HPyV6. The present study suggests that MCPyV infection may increase glioma risk.",0,0,scopus,"['real time systems', 'computer viruses', 'logistics', 'security of data', 'correlation analysis', 'malwares', 'architecture types', 'malicious codes', 'cyber physical systems (cpss)', 'logistic regression', 'intrusion detection']",liver carcinoma in situ,"['Prospective', 'investigation', 'polyomavirus', 'infection', 'risk', 'adult', 'glioma']","['aggressive', 'primary', 'tumor', 'brain', 'etiology', 'association', 'human', 'polyomaviruses', 'virus', 'virus', 'human', 'polyomavirus', 'cell', 'polyomavirus', 'glioma', 'risk', 'Cohort', 'participants', 'glioma', 'median', 'years', 'blood', 'collection', 'individual', 'controls', 'age', 'sex', 'date', 'blood', 'draw', 'Serum', 'antibodies', 'major', 'viral', 'capsid', 'protein', 'infection', 'history', 'polyomavirus', 'Odds', 'ratios', '%', 'confidence', 'intervals', 'conditional', 'logistic', 'regression', 'infection', 'higher', 'risk', 'glioma', '%', 'modest', 'nonsignificant', 'positive', 'association', 'infection', '%', 'cohorts', 'glioma', 'risk', 'infection', 'present', 'study', 'infection', 'glioma', 'risk']"
354,354,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105220693&origin=inward,N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies,"¬© 2021, The Author(s).The N6-methyladenosine (m6A) modification is a dynamic and reversible epigenetic modification, which is co-transcriptionally deposited by a methyltransferase complex, removed by a demethylase, and recognized by reader proteins. Mechanistically, m6A modification regulates the expression levels of mRNA and nocoding RNA by modulating the fate of modified RNA molecules, such as RNA splicing, nuclear transport, translation, and stability. Several studies have shown that m6A modification is dysregulated in the progression of multiple diseases, especially human tumors. We emphasized that the dysregulation of m6A modification affects different signal transduction pathways and involves in the biological processes underlying tumor cell proliferation, apoptosis, invasion and migration, and metabolic reprogramming, and discuss the effects on different cancer treatment.",0,0,scopus,"['local stability', 'machine translations', 'stability criteria', 'control system stability', 'asymptotic stability', 'translation process', 'global stability', 'numerical example', 'linear matrix inequalities', 'asymptotical stability', 'lyapunov functions', 'adaptive control systems', 'delay control systems', 'sufficient conditions', 'lyapunov stability theorem', 'global asymptotic stability']",liver carcinoma in situ,"['N6-methyladenosine', 'dependent', 'signalling', 'cancer', 'progression', 'insights', 'cancer', 'therapies']","['N6-methyladenosine', 'modification', 'dynamic', 'reversible', 'epigenetic', 'modification', 'co', 'methyltransferase', 'complex', 'demethylase', 'reader', 'proteins', 'modification', 'expression', 'levels', 'mRNA', 'fate', 'molecules', 'such', 'splicing', 'nuclear', 'transport', 'translation', 'stability', 'Several', 'studies', 'm6A', 'modification', 'progression', 'multiple', 'diseases', 'human', 'tumors', 'dysregulation', 'm6A', 'modification', 'different', 'signal', 'transduction', 'pathways', 'biological', 'processes', 'tumor', 'cell', 'proliferation', 'apoptosis', 'invasion', 'migration', 'metabolic', 'reprogramming', 'effects', 'different', 'cancer', 'treatment']"
355,355,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105112551&origin=inward,The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation,"¬© 2021, The Author(s).Background: Prostate cancer occurs through multiple steps until advanced metastasis. Signaling pathways studies can result in the identification of targets to interrupt cancer progression. Glypicans are cell surface proteoglycans linked to the membrane through glycosylphosphatidylinositol. Their interaction with specific ligands has been reported to trigger diverse signaling, including Wnt. In this study, prostate cancer cell lines PC-3, DU-145, and LNCaP were compared to normal prostate RWPE-1 cell line to investigate glypican family members and the activation of the Wnt signaling pathway. Results: Glypican-1 (GPC1) was highly expressed in all the examined cell lines, except for LNCaP, which expressed glypican-5 (GPC5). The subcellular localization of GPC1 was detected on the cell surface of RWPE-1, PC-3, and DU-145 cell lines, while GPC5 suggested cytoplasm localization in LNCaP cells. Besides glypican, flow cytometry analysis in these prostate cell lines confirmed the expression of Wnt-3a and unphosphorylated Œ≤-catenin. The co-immunoprecipitation assay revealed increased levels of binding between Wnt-3a and glypicans in cancer cells, suggesting a relationship between these proteoglycans in this pathway. A marked increase in nuclear Œ≤-catenin was observed in tumor cells. However, only PC-3 cells demonstrated activation of canonical Wnt signaling, according to the TOPFLASH assay. Conclusions: GPC1 was the majorly expressed gene in all the studied cell lines, except for LNCaP, which expressed GPC5. We assessed by co-immunoprecipitation that these GPCs could interact with Wnt-3a. However, even though nuclear Œ≤-catenin was found increased in the prostate cancer cells (i.e., PC-3, DU-145 and LNCaP), activation of Wnt pathway was only found in PC-3 cells. In these PC-3 cells, GPC1 and Wnt-3a revealed high levels of colocalization, as assessed by confocal microscopy studies. This suggests a localization at the cellular surface, where Frizzled receptor is required for downstream activation. The interaction of Wnt-3a with GPCs in DU-145 and LNCaP cells, which occurs in absence of Wnt signaling activation, requires further studies. Once non-TCF-LEF proteins can also bind Œ≤-catenin, another signaling pathway may be involved in these cells with regulatory function.",0,0,scopus,"['cellular', 'target tracking', 'cellular telephone systems', 'localization system', 'wireless sensor networks', 'localization technique', 'wireless', 'cellular radio systems', 'localization algorithm', 'robot applications', 'sensor networks', 'target localization']",liver carcinoma in situ,"['Glypican', 'proteoglycans', 'intrinsic', 'interactions', 'human', 'prostate', 'cancer', 'cells', 'cascade', 'activation']","['Author(s).Background', 'Prostate', 'cancer', 'multiple', 'steps', 'advanced', 'metastasis', 'pathways', 'studies', 'identification', 'targets', 'cancer', 'progression', 'Glypicans', 'cell', 'surface', 'proteoglycans', 'membrane', 'glycosylphosphatidylinositol', 'interaction', 'specific', 'ligands', 'diverse', 'signaling', 'study', 'prostate', 'cancer', 'cell', 'lines', 'DU-145', 'normal', 'prostate', 'cell', 'line', 'glypican', 'family', 'members', 'activation', 'pathway', 'Results', 'cell', 'lines', 'subcellular', 'localization', 'cell', 'surface', 'DU-145', 'cell', 'lines', 'cytoplasm', 'localization', 'cells', 'glypican', 'cytometry', 'analysis', 'prostate', 'cell', 'lines', 'expression', 'unphosphorylated', 'Œ≤', 'catenin', 'co', '-', 'immunoprecipitation', 'assay', 'increased', 'levels', 'glypicans', 'cancer', 'cells', 'relationship', 'proteoglycans', 'pathway', 'marked', 'increase', 'nuclear', 'Œ≤', 'catenin', 'tumor', 'cells', 'cells', 'activation', 'canonical', 'assay', 'Conclusions', 'gene', 'cell', 'lines', 'co', '-', 'immunoprecipitation', 'GPCs', 'nuclear', 'Œ≤', 'catenin', 'prostate', 'cancer', 'cells', 'DU-145', 'activation', 'pathway', 'cells', 'cells', 'high', 'levels', 'colocalization', 'confocal', 'microscopy', 'studies', 'localization', 'cellular', 'surface', 'receptor', 'downstream', 'activation', 'interaction', 'GPCs', 'DU-145', 'cells', 'absence', 'activation', 'further', 'studies', 'non', '-', 'proteins', 'Œ≤', 'catenin', 'pathway', 'cells', 'regulatory', 'function']"
356,356,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85105042398&origin=inward,miRNA activity inferred from single cell mRNA expression,"¬© 2021, The Author(s).High throughput single-cell RNA sequencing (scRNAseq) can provide mRNA expression profiles for thousands of cells. However, miRNAs cannot currently be studied at the same scale. By exploiting that miRNAs bind well-defined sequence motifs and typically down-regulate target genes, we show that motif enrichment analysis can be used to derive miRNA activity estimates from scRNAseq data. Motif enrichment analyses have traditionally been used to derive binding motifs for regulatory factors, such as miRNAs or transcription factors, that have an effect on gene expression. Here we reverse its use. By starting from the miRNA seed site, we derive a measure of activity for miRNAs in single cells. We first establish the approach on a comprehensive set of bulk TCGA cancer samples (n = 9679), with paired mRNA and miRNA expression profiles, where many miRNAs show a strong correlation with measured expression. By downsampling we show that the method can be used to estimate miRNA activity in sparse data comparable to scRNAseq experiments. We then analyze a human and a mouse scRNAseq data set, and show that for several miRNA candidates, including liver specific miR-122 and muscle specific miR-1 and miR-133a, we obtain activity measures supported by the literature. The methods are implemented and made available in the miReact software. Our results demonstrate that miRNA activities can be estimated at the single cell level. This allows insights into the dynamics of miRNA activity across a range of fields where scRNAseq is applied.",0,0,scopus,"['sparse representation', 'software', 'integrated data', 'computer science', 'data integration', 'signal reconstruction', 'correlation analysis', 'approximation algorithms', 'correlation coefficient', 'mathematics', 'sparse approximations']",liver carcinoma in situ,"['miRNA', 'activity', 'single', 'cell', 'mRNA', 'expression']","['throughput', 'single', 'cell', 'RNA', 'sequencing', 'scRNAseq', 'expression', 'profiles', 'thousands', 'cells', 'same', 'scale', 'sequence', 'motifs', 'target', 'genes', 'motif', 'enrichment', 'analysis', 'miRNA', 'activity', 'estimates', 'scRNAseq', 'data', 'Motif', 'enrichment', 'analyses', 'motifs', 'regulatory', 'factors', 'such', 'transcription', 'factors', 'effect', 'gene', 'expression', 'use', 'seed', 'site', 'measure', 'activity', 'single', 'cells', 'approach', 'comprehensive', 'set', 'bulk', 'TCGA', 'cancer', 'samples', 'expression', 'profiles', 'many', 'strong', 'correlation', 'measured', 'expression', 'method', 'activity', 'sparse', 'data', 'comparable', 'experiments', 'human', 'mouse', 'scRNAseq', 'data', 'several', 'candidates', 'liver', 'specific', 'muscle', 'specific', 'miR-1', 'miR-133a', 'activity', 'measures', 'literature', 'methods', 'available', 'software', 'results', 'activities', 'single', 'cell', 'level', 'insights', 'dynamics', 'activity', 'range', 'fields', 'scRNAseq']"
357,357,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104772075&origin=inward,Extracellular matrix and its therapeutic potential for cancer treatment,"¬© 2021, The Author(s).The extracellular matrix (ECM) is one of the major components of tumors that plays multiple crucial roles, including mechanical support, modulation of the microenvironment, and a source of signaling molecules. The quantity and cross-linking status of ECM components are major factors determining tissue stiffness. During tumorigenesis, the interplay between cancer cells and the tumor microenvironment (TME) often results in the stiffness of the ECM, leading to aberrant mechanotransduction and further malignant transformation. Therefore, a comprehensive understanding of ECM dysregulation in the TME would contribute to the discovery of promising therapeutic targets for cancer treatment. Herein, we summarized the knowledge concerning the following: (1) major ECM constituents and their functions in both normal and malignant conditions; (2) the interplay between cancer cells and the ECM in the TME; (3) key receptors for mechanotransduction and their alteration during carcinogenesis; and (4) the current therapeutic strategies targeting aberrant ECM for cancer treatment.",0,0,scopus,"['target tracking', 'component', 'software', 'multitarget', 'multi-target tracking', 'optical fibers', 'machine design', 'phase modulation', 'mechanical systems', 'bit error rate', 'multiple targets']",liver carcinoma in situ,"['Extracellular', 'matrix', 'therapeutic', 'potential', 'cancer', 'treatment']","['extracellular', 'matrix', 'major', 'components', 'tumors', 'multiple', 'crucial', 'roles', 'mechanical', 'support', 'modulation', 'microenvironment', 'source', 'molecules', 'quantity', 'cross', '-', 'linking', 'status', 'components', 'major', 'factors', 'tissue', 'stiffness', 'tumorigenesis', 'interplay', 'cancer', 'cells', 'tumor', 'microenvironment', 'stiffness', 'aberrant', 'mechanotransduction', 'further', 'malignant', 'transformation', 'comprehensive', 'understanding', 'dysregulation', 'discovery', 'therapeutic', 'targets', 'cancer', 'treatment', 'knowledge', 'major', 'constituents', 'functions', 'normal', 'malignant', 'conditions', 'interplay', 'cancer', 'cells', 'TME', 'key', 'receptors', 'mechanotransduction', 'alteration', 'carcinogenesis', 'current', 'therapeutic', 'strategies', 'aberrant', 'cancer', 'treatment']"
358,358,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104740749&origin=inward,Clinicopathologic features of metastatic small cell carcinoma of the prostate to the liver: a series of four cases,"¬© 2021, The Author(s).Background: Small cell neuroendocrine carcinoma of the prostate (SCNECP) is a rare, aggressive subtype of prostate carcinoma. Most SCNECP arise from conventional prostate adenocarcinoma (CPAC) treated with androgen deprivation therapy (ADT). Case presentations: We identified four cases of CPAC treated with ADT, which evolved to SCNECP with liver metastasis. The average interval between the diagnosis of CPAC and SCNECP was 102 months (range: 12 to 168). Histologically, the tumors showed nests of cells with high nuclear:cytoplasmic ratios, granular chromatin, and frequent mitoses. All cases were synaptophysin, chromogranin, and AE1/AE3 positive, with a Ki-67 labeling index ‚â•70%. NKX3.1 was negative in all but one case and TTF-1 was positive in half. Weak ERG positivity by IHC was seen in one case which also demonstrated the TMPRSS2-ERG gene rearrangement; all other cases were negative for ERG by IHC. Serum prostate specific antigen (PSA) levels were normal to near-normal in all. The median interval between the diagnosis of SCNECP and death was 3.25 months (range: 0.75 to 26). Conclusions: Our case series highlights the importance of considering a prostate primary, even in the setting of normal PSA levels and loss of prostate markers, when diagnosing neuroendocrine carcinoma in the liver. Further, we emphasize the significance of diagnosing SCNECP that metastasizes to the liver, as it portends a particularly dismal prognosis.",0,0,scopus,"['signal processing', 'signal to noise ratio', 'feature space', 'classification methods', 'routing algorithms', 'pattern recognition', 'time windows']",liver carcinoma in situ,"['Clinicopathologic', 'features', 'metastatic', 'small', 'cell', 'carcinoma', 'prostate', 'liver', 'series', 'cases']","['Author(s).Background', 'Small', 'cell', 'neuroendocrine', 'carcinoma', 'prostate', 'SCNECP', 'rare', 'aggressive', 'subtype', 'prostate', 'carcinoma', 'Most', 'SCNECP', 'conventional', 'prostate', 'adenocarcinoma', 'androgen', 'deprivation', 'therapy', 'Case', 'presentations', 'cases', 'liver', 'metastasis', 'average', 'interval', 'diagnosis', 'SCNECP', 'months', 'range', 'tumors', 'nests', 'cells', 'high', 'nuclear', 'cytoplasmic', 'ratios', 'granular', 'chromatin', 'frequent', 'mitoses', 'cases', 'synaptophysin', 'chromogranin', 'positive', 'labeling', 'index', '%', 'negative', 'case', 'positive', 'half', 'Weak', 'positivity', 'case', 'gene', 'rearrangement', 'other', 'cases', 'negative', 'Serum', 'specific', 'antigen', 'levels', 'normal', 'normal', 'median', 'interval', 'diagnosis', 'SCNECP', 'death', 'months', 'range', 'Conclusions', 'case', 'series', 'importance', 'prostate', 'primary', 'setting', 'normal', 'levels', 'loss', 'prostate', 'markers', 'neuroendocrine', 'carcinoma', 'liver', 'significance', 'SCNECP', 'liver', 'dismal', 'prognosis']"
359,359,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104730219&origin=inward,Identification of an immune-related signature indicating the dedifferentiation of thyroid cells,"¬© 2021, The Author(s).Background: Immune cells account for a large proportion of the tumour microenvironment in anaplastic thyroid carcinomas (ATCs). However, the expression pattern of immune-related genes (IRGs) in ATCs is unclear. Our study aimed to identify an immune-related signature indicating the dedifferentiation of thyroid cells. Methods: We compared the differences in thyroid differentiation score (TDS), infiltration of immune cells and enriched pathways between ATCs and papillary thyroid carcinomas (PTCs) or normal thyroid tissues in the Gene Expression Omnibus database. Univariate and multivariable Cox analyses were used to screen prognosis-associated IRGs in The Cancer Genome Atlas database. After constructing a risk score, we investigated its predictive value for differentiation and survival by applying receiver operating characteristic and Kaplan‚ÄìMeier curves. We further explored its associations with important immune checkpoint molecules, infiltrating immune cells and response to immunotherapy. Results: Compared with PTCs or normal thyroid tissues, ATCs exhibited lower TDS values and higher enrichment of immune cells and activation of the inflammatory response. The quantitative analyses and immunohistochemical staining validated that most ATC cell lines and ATC tissues had higher expression of MMP9 and lower expression of SDC2 than normal thyroid samples and PTC. Higher risk scores indicates dedifferentiation and a worse prognosis. Additionally, the risk score was positively correlated with the immune checkpoint molecules PDL1, CTLA4, IDO1, and HAVCR2 and infiltration of multiple immune cells. Importantly, we found that the samples with higher risk scores tended to have a better response to immunotherapy than those with lower scores. Conclusion: Our findings indicate that the risk score may not only contribute to the determination of differentiation and prognosis of thyroid carcinomas but also help the prediction of immune cells infiltration and immunotherapy response.",0,0,scopus,"['computer systems', 'clustering algorithms', 'checkpointing', 'database systems', 'cryptography', 'fuzzy c-means', 'fuzzy systems', 'digital signature', 'computer system recovery', 'fingerprint', 'biometrics']",liver carcinoma in situ,"['Identification', 'immune', 'signature', 'dedifferentiation', 'thyroid', 'cells']","['cells', 'large', 'proportion', 'tumour', 'microenvironment', 'anaplastic', 'thyroid', 'carcinomas', 'expression', 'pattern', 'immune', 'genes', 'unclear', 'study', 'immune', 'signature', 'dedifferentiation', 'thyroid', 'cells', 'Methods', 'differences', 'thyroid', 'differentiation', 'score', 'infiltration', 'immune', 'cells', 'pathways', 'ATCs', 'papillary', 'thyroid', 'carcinomas', 'normal', 'thyroid', 'tissues', 'database', 'Univariate', 'multivariable', 'analyses', 'prognosis', 'IRGs', 'database', 'risk', 'score', 'predictive', 'value', 'differentiation', 'survival', 'receiver', 'characteristic', 'curves', 'associations', 'important', 'immune', 'checkpoint', 'molecules', 'immune', 'cells', 'response', 'Results', 'normal', 'thyroid', 'tissues', 'ATCs', 'lower', 'values', 'higher', 'enrichment', 'immune', 'cells', 'activation', 'inflammatory', 'response', 'quantitative', 'analyses', 'immunohistochemical', 'staining', 'most', 'cell', 'lines', 'tissues', 'higher', 'expression', 'lower', 'expression', 'normal', 'thyroid', 'samples', 'PTC', 'Higher', 'risk', 'scores', 'dedifferentiation', 'worse', 'prognosis', 'risk', 'score', 'immune', 'checkpoint', 'molecules', 'infiltration', 'multiple', 'immune', 'cells', 'samples', 'higher', 'risk', 'scores', 'better', 'response', 'lower', 'scores', 'Conclusion', 'findings', 'risk', 'score', 'determination', 'differentiation', 'prognosis', 'thyroid', 'carcinomas', 'prediction', 'immune', 'cells', 'infiltration', 'immunotherapy', 'response']"
360,360,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104670980&origin=inward,Key proteins of invadopodia are overexpressed in oral squamous cell carcinoma suggesting an important role of MT1-MMP in the tumoral progression,"¬© 2021, The Author(s).Background: Oral squamous cell carcinoma (OSCC) is the most relevant malignant neoplasm among all head and neck tumours due to its high prevalence and unfavourable prognosis. Tumour invasion and metastasis that affect prognosis are result of a set of complex events that cells with invasive potential use to spread to other regions. These cells use several mechanisms to invade tissues, including a type of finger-like membrane protrusion called invadopodia. This study aims to investigate the immunoexpression of invaopodia related-proteins TKs5, cortactin, TKs4 and MT1-MMP in OSCC and correlate it to clinicopathological data. Methods: An immunohistochemical evaluation of fifty cases of OSCCs and 20 cases of oral mucosa (OM) were assessed. The expression of invadopodia proteins were analysed in comparison to normal tissue (OM) and correlated to different clinical-stage and histological grade of OSCC. Results: TKs5, cortactin, TKs4 and MT1-MMP were significantly overexpressed in OSCC when compared to OM (p < 0.0001). Among tumour stages, TKs5 showed a statistical difference in immunolabelling between stage I and III (p = 0.026). Cortactin immunolabelling was statistically higher in grade I than in grade II and III. No differences were seen on TKs4 expression based on tumour staging or grading. MT1-MMP was higher expressed and showed statistical difference between stages I and III and grades I compared to II and III. Conclusions: The invadopodia related-proteins were found to be overexpressed in OSCC when compared to OM, suggesting invadopodia formation and activity. Besides overexpressed in OSCC, cortactin, TKs4 and TKs5 showed no or ambiguous differences in protein expression when compared among clinical-stages or histological grades groups. Conversely, the expression of MT1-MMP increased in advanced stages and less differentiated tumours, suggesting MT1-MMP expression as a promising prognostic marker in OSCC.",0,0,scopus,"['integrated data', 'data integration', 'statistical methods', 'correlation analysis', 'mathematics']",liver carcinoma in situ,"['Key', 'proteins', 'invadopodia', 'oral', 'squamous', 'cell', 'carcinoma', 'important', 'role', 'tumoral', 'progression']","['Author(s).Background', 'Oral', 'squamous', 'cell', 'carcinoma', 'relevant', 'malignant', 'neoplasm', 'head', 'neck', 'tumours', 'due', 'high', 'prevalence', 'unfavourable', 'prognosis', 'Tumour', 'invasion', 'metastasis', 'prognosis', 'result', 'set', 'complex', 'events', 'cells', 'invasive', 'potential', 'use', 'other', 'regions', 'cells', 'several', 'mechanisms', 'tissues', 'type', 'finger', 'like', 'membrane', 'protrusion', 'invadopodia', 'study', 'immunoexpression', 'invaopodia', 'proteins', 'cortactin', 'clinicopathological', 'data', 'Methods', 'immunohistochemical', 'evaluation', 'cases', 'OSCCs', 'cases', 'oral', 'mucosa', 'expression', 'invadopodia', 'proteins', 'comparison', 'normal', 'tissue', 'different', 'clinical', 'stage', 'histological', 'grade', 'Results', 'cortactin', 'p', 'tumour', 'stages', 'statistical', 'difference', 'stage', 'p', 'Cortactin', 'immunolabelling', 'higher', 'grade', 'grade', 'differences', 'expression', 'tumour', 'grading', 'higher', 'statistical', 'difference', 'stages', 'grades', 'Conclusions', 'invadopodia', 'proteins', 'invadopodia', 'formation', 'activity', 'overexpressed', 'cortactin', 'ambiguous', 'differences', 'protein', 'expression', 'clinical', 'stages', 'histological', 'grades', 'groups', 'expression', 'advanced', 'stages', 'differentiated', 'tumours', 'expression', 'promising', 'prognostic', 'marker']"
361,361,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104655295&origin=inward,Novel insights into the m<sup>6</sup>A-RNA methyltransferase METTL3 in cancer,"¬© 2021, The Author(s).N6-methyladenosine (m6A) is a prevalent internal RNA modification in higher eukaryotic cells. As the pivotal m6A regulator, RNA methyltransferase-like 3 (METTL3) is responsible for methyl group transfer in the progression of m6A modification. This epigenetic regulation contributes to the structure and functional regulation of RNA and further promotes tumorigenesis and tumor progression. Accumulating evidence has illustrated the pivotal roles of METTL3 in a variety of human cancers. Here, we systemically summarize the interaction between METTL3 and RNAs, and illustrate the multiple functions of METTL3 in human cancer. METLL3 is aberrantly expressed in a variety of tumors. Elevation of METTL3 is usually associated with rapid progression and poor prognosis of tumors. On the other hand, METTL3 may also function as a tumor suppressor in several cancers. Based on the tumor-promoting effect of METTL3, the possibility of applying METTL3 inhibitors is further discussed, which is expected to provide novel insights into antitumor therapy.",0,0,scopus,"['interactive computer systems', 'multi-modal interactions']",liver carcinoma in situ,"['Novel', 'insights', 'm', 'A', 'RNA', 'methyltransferase', 'cancer']","['Author(s).N6-methyladenosine', 'prevalent', 'internal', 'modification', 'higher', 'eukaryotic', 'cells', 'pivotal', 'm6A', 'regulator', 'methyltransferase', 'like', 'responsible', 'methyl', 'group', 'transfer', 'progression', 'm6A', 'modification', 'epigenetic', 'regulation', 'structure', 'functional', 'regulation', 'further', 'tumorigenesis', 'tumor', 'progression', 'evidence', 'pivotal', 'roles', 'METTL3', 'variety', 'human', 'cancers', 'interaction', 'METTL3', 'RNAs', 'multiple', 'functions', 'METTL3', 'human', 'cancer', 'METLL3', 'variety', 'tumors', 'Elevation', 'rapid', 'progression', 'poor', 'prognosis', 'tumors', 'other', 'hand', 'METTL3', 'tumor', 'suppressor', 'several', 'cancers', 'tumor', 'effect', 'possibility', 'METTL3', 'inhibitors', 'novel', 'insights', 'antitumor', 'therapy']"
362,362,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104598922&origin=inward,Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma,"¬© 2021, The Author(s).Background: Due to the difficulties in early diagnosing and treating hepatocellular carcinoma (HCC), prognoses for patients remained poor in the past decade. In this study, we established a screening model to discover novel prognostic biomarkers in HCC patients. Methods: Candidate biomarkers were screened by liquid chromatography with tandem mass spectrometry (LC-MS/MS) analyses of five HCC normal (N)/tumor (T) paired tissues and preliminarily verified them through several in silico database analyses. Expression levels and functional roles of candidate biomarkers were respectively evaluated by immunohistochemical staining in N/T paired tissue (n = 120) and MTS, colony formation, and transwell migration/invasion assays in HCC cell lines. Associations of clinicopathological features and prognoses with candidate biomarkers in HCC patients were analyzed from GEO and TCGA datasets and our recruited cohort. Results: We found that the transmembrane P24 trafficking protein 9 (TMED9) protein was elevated in HCC tissues according to a global proteomic analysis. Higher messenger (m)RNA and protein levels of TMED9 were observed in HCC tissues compared to normal liver tissues or pre-neoplastic lesions. The TMED9 mRNA expression level was significantly associated with an advanced stage and a poor prognosis of overall survival (OS, p = 0.00084) in HCC patients. Moreover, the TMED9 protein expression level was positively correlated with vascular invasion (p = 0.026), OS (p = 0.044), and disease-free survival (p = 0.015) in our recruited Taiwanese cohort. In vitro, manipulation of TMED9 expression in HCC cells significantly affected cell migratory, invasive, proliferative, and colony-forming abilities. Conclusions: Ours is the first work to identify an oncogenic role of TMED9 in HCC cells and may provide insights into the application of TMED9 as a novel predictor of clinical outcomes and a potential therapeutic target in patients with HCC.",0,0,scopus,"['computer systems', 'computer science', 'kaplan-meiers estimate', 'database systems', 'correlation analysis', 'bioinformatics', 'mathematics', 'proportional hazards models', 'operating systems']",liver carcinoma in situ,"['Proteomics', 'identification', 'vascular', 'invasion', 'poor', 'prognoses', 'patients', 'hepatocellular', 'carcinoma']","['Author(s).Background', 'difficulties', 'early', 'hepatocellular', 'carcinoma', 'patients', 'poor', 'past', 'decade', 'study', 'screening', 'model', 'novel', 'prognostic', 'biomarkers', 'patients', 'Methods', 'biomarkers', 'liquid', 'chromatography', 'tandem', 'mass', 'spectrometry', 'normal', 'tissues', 'several', 'silico', 'database', 'analyses', 'Expression', 'levels', 'functional', 'roles', 'candidate', 'biomarkers', 'immunohistochemical', 'staining', 'tissue', 'colony', 'formation', 'migration', 'invasion', 'assays', 'cell', 'lines', 'Associations', 'clinicopathological', 'features', 'prognoses', 'candidate', 'biomarkers', 'patients', 'TCGA', 'datasets', 'cohort', 'Results', 'transmembrane', 'trafficking', 'protein', 'protein', 'tissues', 'global', 'proteomic', 'analysis', 'Higher', 'messenger', 'protein', 'levels', 'tissues', 'normal', 'liver', 'tissues', 'pre', '-', 'neoplastic', 'lesions', 'expression', 'level', 'advanced', 'stage', 'poor', 'prognosis', 'overall', 'survival', 'p', 'patients', 'protein', 'expression', 'level', 'vascular', 'invasion', 'p', 'p', 'disease', 'free', 'survival', 'p', 'Taiwanese', 'cohort', 'vitro', 'manipulation', 'expression', 'cells', 'cell', 'migratory', 'invasive', 'proliferative', 'colony', 'abilities', 'Conclusions', 'first', 'work', 'oncogenic', 'role', 'cells', 'insights', 'application', 'novel', 'predictor', 'clinical', 'outcomes', 'potential', 'therapeutic', 'target', 'patients']"
363,363,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104590387&origin=inward,Expression of CCL2/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression,"¬© 2021, The Author(s).Ductal carcinoma in situ (DCIS) is the most common type of pre-invasive breast cancer diagnosed in women. Because the majority of DCIS cases are unlikely to progress to invasive breast cancer, many women are over-treated for DCIS. By understanding the molecular basis of early stage breast cancer progression, we may identify better prognostic factors and design treatments tailored specifically to the predicted outcome of DCIS. Chemokines are small soluble molecules with complex roles in inflammation and cancer progression. Previously, we demonstrated that CCL2/CCR2 chemokine signaling in breast cancer cell lines regulated growth and invasion through p42/44MAPK and SMAD3 dependent mechanisms. Here, we sought to determine the clinical and functional relevance of CCL2/CCR2 signaling proteins to DCIS progression. Through immunostaining analysis of DCIS and IDC tissues, we show that expression of CCL2, CCR2, phospho-SMAD3 and phospho-p42/44MAPK correlate with IDC. Using PDX models and an immortalized hDCIS.01 breast epithelial cell line, we show that breast epithelial cells with high CCR2 and high CCL2 levels form invasive breast lesions that express phospho-SMAD3 and phospho-p42/44MAPK. These studies demonstrate that increased CCL2/CCR2 signaling in breast tissues is associated with DCIS progression, and could be a signature to predict the likelihood of DCIS progression to IDC.",0,0,scopus,"['software development', 'electronic document identification systems', 'probability', 'intelligent systems', 'software architecture', 'stochastic processes', 'conditional probabilities', 'architecture designs', 'cryptography', 'standard model', 'systems design', 'posterior probability', 'intelligent control', 'biometrics', 'correlation analysis', 'speech recognition', 'digital signature', 'mathematics', 'prototyping', 'the standard model', 'fingerprint', 'probability distributions']",liver carcinoma in situ,"['Expression', 'proteins', 'breast', 'carcinoma', 'cells', 'invasive', 'progression']","['Author(s).Ductal', 'carcinoma', 'situ', 'common', 'type', 'pre', '-', 'invasive', 'breast', 'cancer', 'women', 'majority', 'DCIS', 'cases', 'unlikely', 'invasive', 'breast', 'cancer', 'many', 'women', 'molecular', 'basis', 'early', 'stage', 'breast', 'cancer', 'progression', 'better', 'prognostic', 'factors', 'design', 'treatments', 'outcome', 'Chemokines', 'small', 'soluble', 'molecules', 'complex', 'roles', 'inflammation', 'cancer', 'progression', 'chemokine', 'breast', 'cancer', 'cell', 'lines', 'growth', 'invasion', 'dependent', 'mechanisms', 'clinical', 'functional', 'relevance', 'proteins', 'DCIS', 'progression', 'analysis', 'tissues', 'expression', 'phospho', 'SMAD3', 'phospho', 'p42/44MAPK', 'correlate', 'models', 'immortalized', 'breast', 'epithelial', 'cell', 'line', 'breast', 'epithelial', 'cells', 'high', 'high', 'CCL2', 'levels', 'invasive', 'breast', 'lesions', 'phospho', 'SMAD3', 'phospho', 'p42/44MAPK', 'studies', 'breast', 'tissues', 'DCIS', 'progression', 'signature', 'likelihood', 'DCIS', 'progression']"
364,364,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104466019&origin=inward,Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer,"¬© 2021, The Author(s).Background: Currently, over half of breast cancer cases are unrelated to known risk factors, highlighting the importance of discovering other cancer-promoting factors. Since crosstalk between gut microbes and host immunity contributes to many diseases, we hypothesized that similar interactions could occur between the recently described breast microbiome and local immune responses to influence breast cancer pathogenesis. Methods: Using 16S rRNA gene sequencing, we characterized the microbiome of human breast tissue in a total of 221 patients with breast cancer, 18 individuals predisposed to breast cancer, and 69 controls. We performed bioinformatic analyses using a DADA2-based pipeline and applied linear models with White‚Äôs t or Kruskal‚ÄìWallis H-tests with Benjamini‚ÄìHochberg multiple testing correction to identify taxonomic groups associated with prognostic clinicopathologic features. We then used network analysis based on Spearman coefficients to correlate specific bacterial taxa with immunological data from NanoString gene expression and 65-plex cytokine assays. Results: Multiple bacterial genera exhibited significant differences in relative abundance when stratifying by breast tissue type (tumor, tumor adjacent normal, high-risk, healthy control), cancer stage, grade, histologic subtype, receptor status, lymphovascular invasion, or node-positive status, even after adjusting for confounding variables. Microbiome‚Äìimmune networks within the breast tended to be bacteria-centric, with sparse structure in tumors and more interconnected structure in benign tissues. Notably, Anaerococcus, Caulobacter, and Streptococcus, which were major bacterial hubs in benign tissue networks, were absent from cancer-associated tissue networks. In addition, Propionibacterium and Staphylococcus, which were depleted in tumors, showed negative associations with oncogenic immune features; Streptococcus and Propionibacterium also correlated positively with T-cell activation-related genes. Conclusions: This study, the largest to date comparing healthy versus cancer-associated breast microbiomes using fresh-frozen surgical specimens and immune correlates, provides insight into microbial profiles that correspond with prognostic clinicopathologic features in breast cancer. It additionally presents evidence for local microbial‚Äìimmune interplay in breast cancer that merits further investigation and has preventative, diagnostic, and therapeutic potential.",0,0,scopus,"['sparse representation', 'linear models', 'network analysis', 'computer science', 'electric network analysis', 'signal reconstruction', 'correlation analysis', 'network protocols', 'approximation algorithms', 'network architecture', 'bioinformatics', 'sparse approximations']",liver carcinoma in situ,"['Human', 'breast', 'microbiome', 'correlates', 'prognostic', 'features', 'immunological', 'signatures', 'breast', 'cancer']","['Author(s).Background', 'half', 'breast', 'cancer', 'cases', 'unrelated', 'risk', 'factors', 'importance', 'other', 'cancer', 'factors', 'crosstalk', 'gut', 'microbes', 'host', 'immunity', 'contributes', 'many', 'diseases', 'similar', 'interactions', 'breast', 'microbiome', 'local', 'immune', 'responses', 'breast', 'cancer', 'pathogenesis', 'Methods', 'gene', 'sequencing', 'microbiome', 'human', 'breast', 'tissue', 'total', 'patients', 'breast', 'cancer', 'individuals', 'breast', 'cancer', 'controls', 'bioinformatic', 'analyses', 'DADA2-based', 'pipeline', 'linear', 'models', 'tests', 'multiple', 'testing', 'correction', 'taxonomic', 'groups', 'prognostic', 'clinicopathologic', 'features', 'network', 'analysis', 'coefficients', 'specific', 'bacterial', 'taxa', 'immunological', 'data', 'gene', 'expression', '65-plex', 'cytokine', 'assays', 'Results', 'bacterial', 'genera', 'significant', 'differences', 'relative', 'abundance', 'breast', 'tissue', 'type', 'tumor', 'tumor', 'adjacent', 'normal', 'high', 'risk', 'healthy', 'control', 'cancer', 'stage', 'grade', 'histologic', 'subtype', 'receptor', 'status', 'lymphovascular', 'invasion', 'node', 'positive', 'status', 'variables', 'Microbiome', 'immune', 'networks', 'breast', 'bacteria', 'centric', 'sparse', 'structure', 'tumors', 'interconnected', 'structure', 'benign', 'tissues', 'major', 'bacterial', 'hubs', 'benign', 'tissue', 'networks', 'absent', 'cancer', 'tissue', 'networks', 'addition', 'tumors', 'negative', 'associations', 'oncogenic', 'immune', 'features', 'cell', 'activation', 'genes', 'Conclusions', 'study', 'largest', 'date', 'healthy', 'cancer', 'breast', 'fresh', 'frozen', 'surgical', 'specimens', 'immune', 'correlates', 'insight', 'microbial', 'profiles', 'prognostic', 'clinicopathologic', 'features', 'breast', 'cancer', 'evidence', 'local', 'microbial', 'immune', 'interplay', 'breast', 'cancer', 'further', 'investigation', 'preventative', 'diagnostic', 'therapeutic', 'potential']"
365,365,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104447052&origin=inward,Circular RNA hsa_circ_0003288 induces EMT and invasion by regulating hsa_circ_0003288/miR-145/PD-L1 axis in hepatocellular carcinoma,"¬© 2021, The Author(s).Background: Epithelial-mesenchymal transition (EMT) has been associated with wound healing, tumorigenesis, and metastasis. Circular RNAs (circRNAs) are functional non-coding RNAs involved in multiple human cancers. However, whether and how circRNAs contribute to the EMT in hepatocellular carcinomas (HCC) remains to be deciphered. In this study, we investigated the regulation and function of hsa_circ_0003288 on programmed death-1 ligand 1 (PD-L1) during EMT and HCC invasiveness. Methods: Hsa_circ_0003288 expression was measured by real-time quantitative reverse transcriptase PCR (qRT-PCR). Luciferase reporter assays, RNA pull-down assay and fluorescence in situ hybridization (FISH) were used to determine the correlation between hsa_circ_0003288 and miR-145 and between miR-145 and PD-L1. Furthermore, ectopic overexpression and siRNA-mediated downregulation of hsa_circ_0003288, transwell assays, and in vivo studies were used to determine the function of hsa_circ_0003288 on the EMT and invasiveness of L02 and HCC cells. Results: miR-145 directly targeted the PD-L1 3‚Ä≤-untranslated region (UTR) region, and hsa_circ_0003288 acted as a miR-145 sponge to regulate PD-L1 expression. Overexpression of hsa_circ_0003288 increased PD-L1 levels and promoted EMT, migration, and invasiveness of L02 cells. These observations were reversed after knockdown of hsa_circ_0003288 in HepG2 and Huh7 cells. Overexpression of PD-L1 rescued EMT, migration, and invasiveness of HepG2 and Huh7 cells after knockdown of hsa_circ_0003288. Furthermore, hsa_circ_0003288 knockdown reduced EMT in in vivo studies. Hsa_circ_0003288/PD-L1 axis was found to mediate the metastatic phenotypes via the PI3K/Akt pathway in HCC. Additionally, expression levels of hsa_circ_0003288 were increased and positively correlated with PD-L1 expression in HCC tissues. Conclusion: Our findings demonstrated that hsa_circ_0003288 promoted EMT and invasion of HCC via the hsa_circ_0003288/miR-145/PD-L1 axis through the PI3K/Akt pathway. Targeting hsa_circ_0003288 may be a therapeutic strategy for the treatment of HCC.",0,0,scopus,"['programming theory', 'source coding', 'coding techniques', 'image coding', 'correlation analysis', 'channel coding', 'coding scheme', 'data compression', 'correlation coefficient', 'mathematics', 'network coding', 'signal encoding']",liver carcinoma in situ,"['Circular', 'invasion', 'axis', 'hepatocellular', 'carcinoma']","['Epithelial', 'mesenchymal', 'transition', 'wound', 'healing', 'tumorigenesis', 'metastasis', 'Circular', 'RNAs', 'circRNAs', 'functional', 'non', '-', 'coding', 'RNAs', 'multiple', 'human', 'cancers', 'hepatocellular', 'carcinomas', 'study', 'regulation', 'function', 'ligand', 'invasiveness', 'Methods', 'expression', 'real', 'time', 'quantitative', 'reverse', 'transcriptase', 'Luciferase', 'reporter', 'assays', 'pull', 'down', 'assay', 'fluorescence', 'situ', 'hybridization', 'correlation', 'ectopic', 'overexpression', 'downregulation', 'transwell', 'assays', 'vivo', 'studies', 'function', 'hsa_circ_0003288', 'invasiveness', 'cells', 'Results', 'region', 'region', 'sponge', 'expression', 'Overexpression', 'levels', 'migration', 'invasiveness', 'cells', 'observations', 'knockdown', 'cells', 'Overexpression', 'migration', 'invasiveness', 'cells', 'knockdown', 'vivo', 'studies', 'Hsa_circ_0003288/PD', 'axis', 'metastatic', 'phenotypes', 'pathway', 'expression', 'levels', 'expression', 'tissues', 'Conclusion', 'findings', 'hsa_circ_0003288', 'invasion', 'axis', 'pathway', 'hsa_circ_0003288', 'therapeutic', 'strategy', 'treatment']"
366,366,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104426549&origin=inward,Nanoparticle-mediated synergistic chemoimmunotherapy for tailoring cancer therapy: recent advances and perspectives,"¬© 2021, The Author(s).Nowadays, a potent challenge in cancer treatment is considered the lack of efficacious strategy, which has not been able to significantly reduce mortality. Chemoimmunotherapy (CIT) as a promising approach in both for the first-line and relapsed therapy demonstrated particular benefit from two key gating strategies, including chemotherapy and immunotherapy to cancer therapy; therefore, the discernment of their participation and role of potential synergies in CIT approach is determinant. In this study, in addition to balancing the pros and cons of CIT with the challenges of each of two main strategies, the recent advances in the cancer CIT have been discussed. Additionally, immunotherapeutic strategies and the immunomodulation effect induced by chemotherapy, which boosts CIT have been brought up. Finally, harnessing and development of the nanoparticles, which mediated CIT have expatiated in detail.[Figure not available: see fulltext.]",0,0,scopus,[],liver carcinoma in situ,"['Nanoparticle', 'synergistic', 'chemoimmunotherapy', 'cancer', 'therapy', 'recent', 'advances', 'perspectives']","['potent', 'challenge', 'cancer', 'treatment', 'lack', 'efficacious', 'strategy', 'able', 'mortality', 'promising', 'approach', 'first', 'line', 'therapy', 'particular', 'benefit', 'key', 'gating', 'strategies', 'chemotherapy', 'cancer', 'therapy', 'discernment', 'participation', 'role', 'potential', 'synergies', 'approach', 'determinant', 'study', 'addition', 'pros', 'cons', 'challenges', 'main', 'strategies', 'recent', 'advances', 'cancer', 'immunotherapeutic', 'strategies', 'immunomodulation', 'effect', 'chemotherapy', 'harnessing', 'development', 'nanoparticles', 'available', 'fulltext']"
367,367,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104342558&origin=inward,Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches,"¬© 2021, The Author(s).Hepatocellular carcinoma (HCC) is the second leading cause of death due to cancer. Although there are different treatment options, these strategies are not efficient in terms of restricting the tumor cell‚Äôs proliferation and metastasis. The liver tumor microenvironment contains the non-parenchymal cells with supportive or inhibitory effects on the cancerous phenotype of HCC. Several signaling pathways are dis-regulated in HCC and cause uncontrolled cell propagation, metastasis, and recurrence of liver carcinoma cells. Recent studies have established new approaches for the prevention and treatment of HCC using small molecules. Small molecules are compounds with a low molecular weight that usually inhibit the specific targets in signal transduction pathways. These components can induce cell cycle arrest, apoptosis, block metastasis, and tumor growth. Devising strategies for simultaneously targeting HCC and the non-parenchymal population of the tumor could lead to more relevant research outcomes. These strategies may open new avenues for the treatment of HCC with minimal cytotoxic effects on healthy cells. This study provides the latest findings on critical signaling pathways governing HCC behavior and using small molecules in the control of HCC both in vitro and in vivo models.",0,0,scopus,"['switching systems', 'target tracking', 'component', 'software', 'multitarget', 'planar graph', 'switching control', 'multi-target tracking', 'cycle', 'multiple targets']",liver carcinoma in situ,"['Critical', 'signaling', 'pathways', 'hepatocellular', 'carcinoma', 'behavior', 'small', 'molecule', 'approaches']","['Author(s).Hepatocellular', 'carcinoma', 'second', 'cause', 'death', 'cancer', 'different', 'treatment', 'options', 'strategies', 'efficient', 'terms', 'tumor', 'cell', 'proliferation', 'metastasis', 'liver', 'tumor', 'microenvironment', 'non', '-', 'parenchymal', 'cells', 'supportive', 'inhibitory', 'effects', 'cancerous', 'phenotype', 'Several', 'pathways', 'regulated', 'uncontrolled', 'cell', 'propagation', 'metastasis', 'recurrence', 'liver', 'carcinoma', 'cells', 'Recent', 'studies', 'new', 'approaches', 'prevention', 'treatment', 'small', 'molecules', 'Small', 'molecules', 'compounds', 'low', 'molecular', 'weight', 'specific', 'targets', 'signal', 'transduction', 'pathways', 'components', 'cell', 'cycle', 'arrest', 'apoptosis', 'block', 'metastasis', 'tumor', 'growth', 'Devising', 'strategies', 'non', '-', 'parenchymal', 'population', 'tumor', 'relevant', 'research', 'outcomes', 'strategies', 'new', 'avenues', 'treatment', 'minimal', 'cytotoxic', 'effects', 'healthy', 'cells', 'study', 'latest', 'findings', 'critical', 'signaling', 'pathways', 'behavior', 'small', 'molecules', 'control', 'vitro', 'vivo', 'models']"
368,368,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104269921&origin=inward,Perioperative risk factors for survival outcomes in elective colorectal cancer surgery: a retrospective cohort study,"¬© 2021, The Author(s).Background: Surgical resection remains the best option for long-term survival in colorectal cancer (CRC); however, surgery can lead to tumor cell release into the circulation. Previous studies have also shown that surgery can affect cancer cell growth. The role of perioperative factors influencing long-term survival in patients presenting for CRC surgery remains to be investigated. Methods: This retrospective single‚Äìcenter cohort study was conducted to collect the clinical data of patients who underwent elective laparoscopic resection for CRC from January 2014 to December 2015, namely clinical manifestations, pathological results, and perioperative characteristics. Survival was estimated using the Kaplan‚ÄìMeier log-rank test. Univariable and multivariable Cox regression models were used to compare hazard ratios (HR) for death. Results: A total of 234 patients were eligible for analysis. In the multivariable Cox model, tumor-node-metastasis (TNM) stage (stage IV: HR 30.63, 95% confidence interval (CI): 3.85‚Äì243.65; P = 0.001), lymphovascular invasion (yes: HR 2.07, 95% CI 1.09‚Äì3.92; P = 0.027), inhalational anesthesia with isoflurane (HR 1.96, 95% CI 1.19‚Äì3.21; P = 0.008), and Klintrup‚ÄìMakinen (KM) inflammatory cell infiltration grade (low-grade inflammation: HR 2.03, 95% CI 1.20‚Äì3.43; P = 0.008) were independent risk factors affecting 5-year overall survival after laparoscopic resection for CRC. Conclusions: TNM stage, lymphovascular invasion, isoflurane, and KM grade were independent risk factors affecting CRC prognosis. Sevoflurane and high-grade inflammation may be associated with improved survival in CRC patients undergoing resection.",0,0,scopus,"['computer systems', 'integrated data', 'data integration', 'kaplan-meiers estimate', 'correlation analysis', 'time delay', 'regression model', 'proportional hazards models']",liver carcinoma in situ,"['Perioperative', 'risk', 'factors', 'survival', 'outcomes', 'elective', 'colorectal', 'cancer', 'surgery', 'retrospective', 'cohort', 'study']","['Author(s).Background', 'Surgical', 'resection', 'best', 'option', 'long', 'term', 'survival', 'colorectal', 'cancer', 'surgery', 'tumor', 'cell', 'release', 'circulation', 'Previous', 'studies', 'surgery', 'cancer', 'cell', 'growth', 'role', 'perioperative', 'factors', 'long', 'term', 'survival', 'patients', 'CRC', 'surgery', 'Methods', 'retrospective', 'single', 'center', 'cohort', 'study', 'clinical', 'data', 'patients', 'elective', 'laparoscopic', 'resection', 'CRC', 'clinical', 'manifestations', 'pathological', 'results', 'perioperative', 'characteristics', 'log', 'rank', 'test', 'Univariable', 'multivariable', 'regression', 'models', 'hazard', 'ratios', 'death', 'Results', 'total', 'patients', 'eligible', 'analysis', 'multivariable', 'model', 'tumor', 'node', 'metastasis', 'stage', 'stage', '%', 'confidence', 'interval', 'P', '=', 'lymphovascular', 'invasion', 'HR', '%', 'P', 'inhalational', 'anesthesia', 'isoflurane', 'HR', '%', 'P', 'inflammatory', 'cell', 'infiltration', 'grade', 'low', 'grade', 'inflammation', 'HR', '%', 'P', 'independent', 'risk', 'factors', 'overall', 'survival', 'laparoscopic', 'resection', 'CRC', 'Conclusions', 'TNM', 'stage', 'lymphovascular', 'invasion', 'isoflurane', 'grade', 'independent', 'risk', 'factors', 'CRC', 'prognosis', 'Sevoflurane', 'high', 'grade', 'inflammation', 'improved', 'survival', 'CRC', 'patients', 'resection']"
369,369,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85104068509&origin=inward,Whole-exome sequencing reveals the etiology of the rare primary hepatic mucoepidermoid carcinoma,"¬© 2021, The Author(s).Background: Primary hepatic mucoepidermoid carcinoma (HMEC) is extremely rare and the molecular etiology is still unknown. The CRTC1-MAML2 fusion gene was previously detected in a primary HMEC, which is often associated with MEC of salivary gland in the literature. Methods: A 64-year-old male was diagnosed with HMEC based on malignant squamous cells and mucus-secreting cells in immunohistochemical examination. Fluorescence in situ hybridization (FISH) was used to detect the CRTC1-MAML2 fusion gene in HMEC. Whole-exome sequencing and Sanger sequencing were used to reveal the molecular characteristics of HMEC and analysis was performed with public data. Pedigree investigation was performed to identify susceptibility genes. Results: Hematoxylin‚Äìeosin staining and immunohistochemistry revealed that the tumor cells were composed of malignant epidermoid malignant cells and mucous cells, indicating a diagnosis of HMEC. The CRTC1-MAML2 fusion gene was not detected in the primary HMEC, and somatic mutations in GNAS, KMT2C and ELF3 genes were identified by sequencing. Analyses of public data revealed somatic GNAS alterations in 2.1% hepatobiliary tumors and relation with parasite infection. Heterozygous germline mutations of FANCA, FANCI, FANCJ/BRIP1 and FAN1 genes were also identified. Pedigree investigation verified that mutation of Fanconi‚Äôs anemia susceptibility genes were present in the pedigree. Conclusions: Here we provide the first evidence of the molecular etiology of a rare HMEC associated with germline Fanconi‚Äôs anemia gene mutations and somatic GNAS R201H mutation.",0,0,scopus,"['fusion techniques', 'fusion reactions', 'particle swarm optimization (pso)', 'data fusion', 'nuclear physics', 'correlation analysis', 'fusion methods', 'image fusion', 'sensors', 'evolutionary algorithms', 'mutation operators', 'mathematics', 'biometrics']",liver carcinoma in situ,"['Whole', 'exome', 'sequencing', 'etiology', 'rare', 'primary', 'hepatic', 'mucoepidermoid', 'carcinoma']","['Primary', 'hepatic', 'mucoepidermoid', 'carcinoma', 'rare', 'molecular', 'etiology', 'unknown', 'fusion', 'gene', 'primary', 'salivary', 'gland', 'literature', 'Methods', '64-year', 'old', 'male', 'malignant', 'squamous', 'cells', 'mucus', 'cells', 'immunohistochemical', 'examination', 'Fluorescence', 'situ', 'hybridization', 'CRTC1-MAML2', 'fusion', 'gene', 'Whole', 'exome', 'sequencing', 'sequencing', 'molecular', 'characteristics', 'analysis', 'public', 'data', 'Pedigree', 'investigation', 'susceptibility', 'genes', 'Results', 'staining', 'immunohistochemistry', 'tumor', 'cells', 'malignant', 'epidermoid', 'malignant', 'cells', 'mucous', 'cells', 'diagnosis', 'fusion', 'gene', 'primary', 'somatic', 'mutations', 'genes', 'Analyses', 'public', 'data', 'somatic', 'alterations', '%', 'hepatobiliary', 'tumors', 'relation', 'parasite', 'infection', 'Heterozygous', 'germline', 'mutations', 'BRIP1', 'genes', 'Pedigree', 'investigation', 'mutation', 'anemia', 'susceptibility', 'genes', 'present', 'pedigree', 'Conclusions', 'first', 'evidence', 'molecular', 'etiology', 'rare', 'germline', 'anemia', 'gene', 'mutations', 'somatic', 'mutation']"
370,370,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103885612&origin=inward,Targeting neddylation E2s: a novel therapeutic strategy in cancer,"¬© 2021, The Author(s).Ubiquitin-conjugating enzyme E2 M (UBE2M) and ubiquitin-conjugating enzyme E2 F (UBE2F) are the two NEDD8-conjugating enzymes of the neddylation pathway that take part in posttranslational modification and change the activity of target proteins. The activity of E2 enzymes requires both a 26-residue N-terminal docking peptide and a conserved E2 catalytic core domain, which is the basis for the transfer of neural precursor cell-expressed developmentally downregulated 8 (NEDD8). By recruiting E3 ligases and targeting cullin and non-cullin substrates, UBE2M and UBE2F play diverse biological roles. Currently, there are several inhibitors that target the UBE2M-defective in cullin neddylation protein 1 (DCN1) interaction to treat cancer. As described above, this review provides insights into the mechanism of UBE2M and UBE2F and emphasizes these two E2 enzymes as appealing therapeutic targets for the treatment of cancers.",0,0,scopus,"['target tracking', 'mobile telecommunication systems', 'interactive computer systems', 'multitarget', 'multi-target tracking', 'mobile phones', 'multi-modal interactions', 'mobile terminal', 'multiple targets']",liver carcinoma in situ,"['neddylation', 'novel', 'therapeutic', 'strategy', 'cancer']","['enzyme', 'enzyme', 'NEDD8-conjugating', 'enzymes', 'neddylation', 'pathway', 'part', 'posttranslational', 'modification', 'activity', 'target', 'proteins', 'activity', 'enzymes', '26-residue', 'N', 'terminal', 'docking', 'peptide', 'conserved', 'catalytic', 'core', 'domain', 'basis', 'transfer', 'neural', 'precursor', 'cell', 'NEDD8', 'ligases', 'cullin', 'non', '-', 'cullin', 'substrates', 'diverse', 'biological', 'roles', 'several', 'inhibitors', 'defective', 'cullin', 'neddylation', 'protein', 'interaction', 'cancer', 'review', 'insights', 'mechanism', 'E2', 'enzymes', 'therapeutic', 'targets', 'treatment', 'cancers']"
371,371,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103824081&origin=inward,The m<sup>6</sup>A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis,"¬© 2021, The Author(s).The m6A RNA methylation is the most prevalent internal modification in mammalian mRNAs which plays critical biological roles by regulating vital cellular processes. Dysregulations of the m6A modification due to aberrant expression of its regulatory proteins are frequently observed in many pathological conditions, particularly in cancer. Normal cells undergo malignant transformation via activation or modulation of different oncogenic signaling pathways through complex mechanisms. Accumulating evidence showing regulation of oncogenic signaling pathways at the epitranscriptomic level has added an extra layer of the complexity. In particular, recent studies demonstrated that, in many types of cancers various oncogenic signaling pathways are modulated by the m6A modification in the target mRNAs as well as noncoding RNA transcripts. m6A modifications in these RNA molecules control their fate and metabolism by regulating their stability, translation or subcellular localizations. In this review we discussed recent exciting studies on oncogenic signaling pathways that are modulated by the m6A RNA modification and/or their regulators in cancer and provided perspectives for further studies. The regulation of oncogenic signaling pathways by the m6A modification and its regulators also render them as potential druggable targets for the treatment of cancer.",0,0,scopus,"['local stability', 'asymptotic stability', 'multitarget', 'numerical example', 'asymptotical stability', 'lyapunov functions', 'channel capacity', 'adaptive control systems', 'cellular', 'optical fibers', 'layered', 'linear matrix inequalities', 'delay control systems', 'multiple targets', 'cellular telephone systems', 'multi-target tracking', 'bit error rate', 'lyapunov stability theorem', 'global asymptotic stability', 'target tracking', 'machine translations', 'sufficient conditions', 'stability criteria', 'control system stability', 'translation process', 'software architecture patterns', 'wireless', 'phase modulation', 'cellular radio systems', 'cellular network', 'cellular system', 'global stability']",liver carcinoma in situ,"['m', 'methylation', 'regulates', 'oncogenic', 'pathways', 'cell', 'malignant', 'transformation', 'carcinogenesis']","['methylation', 'prevalent', 'internal', 'modification', 'mammalian', 'critical', 'biological', 'roles', 'vital', 'cellular', 'processes', 'Dysregulations', 'modification', 'aberrant', 'expression', 'regulatory', 'proteins', 'many', 'pathological', 'conditions', 'cancer', 'Normal', 'cells', 'malignant', 'transformation', 'activation', 'modulation', 'different', 'oncogenic', 'pathways', 'complex', 'mechanisms', 'evidence', 'regulation', 'oncogenic', 'pathways', 'epitranscriptomic', 'level', 'extra', 'layer', 'complexity', 'particular', 'recent', 'studies', 'many', 'types', 'cancers', 'various', 'oncogenic', 'pathways', 'm6A', 'modification', 'target', 'transcripts', 'm6A', 'modifications', 'molecules', 'fate', 'metabolism', 'stability', 'translation', 'subcellular', 'localizations', 'review', 'recent', 'exciting', 'studies', 'oncogenic', 'pathways', 'modification', 'regulators', 'cancer', 'perspectives', 'further', 'studies', 'regulation', 'oncogenic', 'pathways', 'm6A', 'modification', 'regulators', 'potential', 'druggable', 'targets', 'treatment', 'cancer']"
372,372,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103808022&origin=inward,A KRAS-responsive long non-coding RNA controls microRNA processing,"¬© 2021, The Author(s).Wild-type KRAS (KRASWT) amplification has been shown to be a secondary means of KRAS activation in cancer and associated with poor survival. Nevertheless, the precise role of KRASWT overexpression in lung cancer progression is largely unexplored. Here, we identify and characterize a KRAS-responsive lncRNA, KIMAT1 (ENSG00000228709) and show that it correlates with KRAS levels both in cell lines and in lung cancer specimens. Mechanistically, KIMAT1 is a MYC target and drives lung tumorigenesis by promoting the processing of oncogenic microRNAs (miRNAs) through DHX9 and NPM1 stabilization while halting the biogenesis of miRNAs with tumor suppressor function via MYC-dependent silencing of p21, a component of the Microprocessor Complex. KIMAT1 knockdown suppresses not only KRAS expression but also KRAS downstream signaling, thereby arresting lung cancer growth in vitro and in vivo. Taken together, this study uncovers a role for KIMAT1 in maintaining a positive feedback loop that sustains KRAS signaling during lung cancer progression and provides a proof of principle that interfering with KIMAT1 could be a strategy to hamper KRAS-induced tumorigenesis.",0,0,scopus,"['programming theory', 'component', 'microcontrollers', 'software', 'coding techniques', 'microprocessor chips', 'image coding', 'microprocessor', 'coding scheme', 'network coding', 'embedded systems']",liver carcinoma in situ,"['responsive', 'long', 'non', '-', 'coding', 'microRNA', 'processing']","['type', 'amplification', 'secondary', 'means', 'activation', 'cancer', 'poor', 'survival', 'precise', 'role', 'overexpression', 'lung', 'cancer', 'progression', 'unexplored', 'responsive', 'levels', 'cell', 'lines', 'lung', 'cancer', 'specimens', 'target', 'lung', 'tumorigenesis', 'processing', 'oncogenic', 'microRNAs', 'stabilization', 'biogenesis', 'tumor', 'suppressor', 'function', 'dependent', 'silencing', 'p21', 'component', 'KIMAT1', 'expression', 'downstream', 'lung', 'cancer', 'growth', 'vitro', 'vivo', 'study', 'role', 'positive', 'feedback', 'loop', 'lung', 'cancer', 'progression', 'proof', 'principle', 'strategy', 'tumorigenesis']"
373,373,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103807682&origin=inward,The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling,"¬© 2021, The Author(s).Ovarian cancer is characterized by dysbiosis, referred to as oncobiosis in neoplastic diseases. In ovarian cancer, oncobiosis was identified in numerous compartments, including the tumor tissue itself, the upper and lower female genital tract, serum, peritoneum, and the intestines. Colonization was linked to Gram-negative bacteria with high inflammatory potential. Local inflammation probably participates in the initiation and continuation of carcinogenesis. Furthermore, local bacterial colonies in the peritoneum may facilitate metastasis formation in ovarian cancer. Vaginal infections (e.g. Neisseria gonorrhoeae or Chlamydia trachomatis) increase the risk of developing ovarian cancer. Bacterial metabolites, produced by the healthy eubiome or the oncobiome, may exert autocrine, paracrine, and hormone-like effects, as was evidenced in breast cancer or pancreas adenocarcinoma. We discuss the possible involvement of lipopolysaccharides, lysophosphatides and tryptophan metabolites, as well as, short-chain fatty acids, secondary bile acids and polyamines in the carcinogenesis of ovarian cancer. We discuss the applicability of nutrients, antibiotics, and probiotics to harness the microbiome and support ovarian cancer therapy. The oncobiome and the most likely bacterial metabolites play vital roles in mediating the effectiveness of chemotherapy. Finally, we discuss the potential of oncobiotic changes as biomarkers for the diagnosis of ovarian cancer and microbial metabolites as possible adjuvant agents in therapy.",0,0,scopus,"['artificial intelligence', 'software agents', 'intelligent agents', 'multiagent system', 'autonomous agents']",liver carcinoma in situ,"['role', 'microbiome', 'ovarian', 'cancer', 'mechanistic', 'insights', 'oncobiosis', 'bacterial', 'metabolite']","['Author(s).Ovarian', 'cancer', 'dysbiosis', 'oncobiosis', 'neoplastic', 'diseases', 'ovarian', 'cancer', 'oncobiosis', 'numerous', 'compartments', 'tumor', 'upper', 'lower', 'female', 'genital', 'tract', 'serum', 'peritoneum', 'intestines', 'Colonization', 'negative', 'bacteria', 'high', 'inflammatory', 'potential', 'Local', 'inflammation', 'initiation', 'continuation', 'carcinogenesis', 'local', 'bacterial', 'colonies', 'peritoneum', 'metastasis', 'formation', 'ovarian', 'cancer', 'Vaginal', 'infections', 'e.g.', 'gonorrhoeae', 'trachomatis', 'risk', 'ovarian', 'cancer', 'Bacterial', 'metabolites', 'healthy', 'eubiome', 'oncobiome', 'autocrine', 'paracrine', 'hormone', 'like', 'effects', 'breast', 'cancer', 'pancreas', 'adenocarcinoma', 'possible', 'involvement', 'lipopolysaccharides', 'lysophosphatides', 'metabolites', 'short', 'chain', 'fatty', 'acids', 'secondary', 'bile', 'acids', 'polyamines', 'carcinogenesis', 'ovarian', 'cancer', 'applicability', 'nutrients', 'antibiotics', 'probiotics', 'microbiome', 'ovarian', 'cancer', 'therapy', 'oncobiome', 'likely', 'bacterial', 'metabolites', 'vital', 'roles', 'effectiveness', 'chemotherapy', 'potential', 'oncobiotic', 'changes', 'biomarkers', 'diagnosis', 'ovarian', 'cancer', 'microbial', 'metabolites', 'possible', 'adjuvant', 'agents', 'therapy']"
374,374,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103807229&origin=inward,Src is essential for the endosomal delivery of the FGFR4 signaling complex in hepatocellular carcinoma,"¬© 2021, The Author(s).Background: Hepatocytes usually express fibroblast growth factor receptor 4 (FGFR4), but not its ligand, fibroblast growth factor 19 (FGF19). A subtype of hepatocellular carcinoma (HCC) expresses FGF19, which activates the FGFR4 signaling pathway that induces cell proliferation. FGFR4 inhibitors that target this mechanism are under clinical development for the treatment of HCCs with FGF19 amplification or FGFR4 overexpression. Src plays an essential role in the FGFR1 and FGFR2 signaling pathways. However, it is yet to be understood whether Src has any role in the FGF19-FGFR4 pathway in HCCs. In this study, we aimed to elucidate the role of Src in the FGF19-FGFR4 axis in HCC. Methods: 3 HCC cell lines expressing both FGF19 and FGFR4 were selected. The expression of each protein was suppressed by siRNA treatment, and the activity-regulating relationship between FGFR4 and Src was investigated by westernblot. Co-immunoprecipitation was performed using the FGFR4 antibody to identify the endosomal complex formation and receptor endocytosis. The intracellular migration pathways of the endosomal complex were observed by immuno-fluorescence and nuclear co-immunoprecipitation. Dasatinib and BLU9931 were used for cytotoxicity comparison. Results: FGFR4 modulates the activity of Src and Src modulates the expression of FGFR4, showing a mutual regulatory relationship. FGFR4 activated by FGF19 formed an endosomal complex with Src and STAT3 and moved to the nucleus. However, when Src was suppressed, the formation of the endosomal complex was not observed. FGFR4 was released from the complex transferred into the nucleus and the binding of Src and STAT3 was maintained. Dasatinib showed cytotoxic results comparable to BLU9931. The results of our study demonstrated that Src is essential for the nuclear transport of STAT3, as it induces the endosomal delivery of FGFR4 in FGF19-expressing HCC cell lines. Conclusions: We found that Src is essential for the endosomal delivery of the FGFR4 signaling complex in HCC. Our findings provide a scientific rationale for repurposing Src inhibitors for the treatment of HCCs in which the FGFR4 pathway is activated.",0,0,scopus,[],liver carcinoma in situ,"['essential', 'endosomal', 'delivery', 'complex', 'hepatocellular', 'carcinoma']","['Author(s).Background', 'Hepatocytes', 'fibroblast', 'growth', 'factor', 'receptor', 'ligand', 'fibroblast', 'growth', 'factor', 'subtype', 'hepatocellular', 'carcinoma', 'pathway', 'cell', 'proliferation', 'inhibitors', 'mechanism', 'clinical', 'development', 'treatment', 'amplification', 'overexpression', 'essential', 'role', 'pathways', 'role', 'FGF19-FGFR4', 'pathway', 'study', 'role', 'FGF19-FGFR4', 'axis', 'Methods', 'cell', 'lines', 'expression', 'protein', 'treatment', 'activity', 'relationship', 'westernblot', 'Co', '-', 'immunoprecipitation', 'antibody', 'endosomal', 'complex', 'formation', 'receptor', 'endocytosis', 'intracellular', 'migration', 'pathways', 'endosomal', 'complex', 'immuno', 'fluorescence', 'nuclear', 'co', '-', 'immunoprecipitation', 'cytotoxicity', 'comparison', 'Results', 'activity', 'expression', 'mutual', 'regulatory', 'relationship', 'FGFR4', 'endosomal', 'complex', 'nucleus', 'formation', 'endosomal', 'complex', 'complex', 'nucleus', 'binding', 'cytotoxic', 'results', 'comparable', 'results', 'study', 'essential', 'nuclear', 'transport', 'endosomal', 'delivery', 'cell', 'lines', 'Conclusions', 'essential', 'endosomal', 'delivery', 'complex', 'findings', 'scientific', 'rationale', 'inhibitors', 'treatment', 'HCCs', 'pathway']"
375,375,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103682561&origin=inward,Efficacy of the association liver partition and portal vein ligation for staged hepatectomy for the treatment of solitary huge hepatocellular carcinoma: a retrospective single-center study,"¬© 2021, The Author(s).Background: The feasibility of association liver partition and portal vein ligation for staged hepatectomy (ALPPS) for solitary huge hepatocellular carcinoma (HCC, maximal diameter ‚â• 10 cm) remains uncertain. This study aims to evaluate the safety and the efficacy of ALPPS for patients with solitary huge HCC. Methods: Twenty patients with solitary huge HCC who received ALPPS during January 2017 and December 2019 were retrospectively analyzed. The oncological characteristics of contemporaneous patients who underwent one-stage resection and transcatheter arterial chemoembolization (TACE) were compared using propensity score matching (PSM). Results: All patients underwent complete two-staged ALPPS. The median future liver remnant from the ALPPS-I stage to the ALPPS-II stage increased by 64.5% (range = 22.3‚Äì221.9%) with a median interval of 18 days (range = 10‚Äì54 days). The 90-day mortality rate after the ALPPS-II stage was 5%. The 1- and 3-year overall survival (OS) rates were 70.0% and 57.4%, respectively, whereas the 1- and 3-year progression-free survival (PFS) rates were 60.0% and 43.0%, respectively. In the one-to-one PSM analysis, the long-term survival of patients who received ALPPS was significantly better than those who received TACE (OS, P = 0.007; PFS, P = 0.011) but comparable with those who underwent one-stage resection (OS, P = 0.463; PFS, P = 0.786). Conclusion: The surgical outcomes of ALPPS were superior to those of TACE and similar to those of one-stage resection. ALPPS is a safe and effective treatment strategy for patients with unresectable solitary huge HCC.",0,0,scopus,"['computer science', 'time windows', 'kaplan-meiers estimate', 'routing algorithms', 'correlation analysis', 'mathematics', 'proportional hazards models', 'operating systems']",liver carcinoma in situ,"['Efficacy', 'association', 'liver', 'partition', 'portal', 'vein', 'ligation', 'hepatectomy', 'treatment', 'solitary', 'huge', 'hepatocellular', 'carcinoma', 'retrospective', 'single', 'center', 'study']","['Author(s).Background', 'feasibility', 'association', 'liver', 'partition', 'portal', 'vein', 'ligation', 'hepatectomy', 'solitary', 'huge', 'hepatocellular', 'carcinoma', 'maximal', 'diameter', 'cm', 'uncertain', 'study', 'safety', 'efficacy', 'patients', 'solitary', 'huge', 'Methods', 'patients', 'solitary', 'huge', 'oncological', 'characteristics', 'contemporaneous', 'patients', 'stage', 'resection', 'transcatheter', 'arterial', 'chemoembolization', 'propensity', 'score', 'Results', 'patients', 'complete', 'median', 'future', 'liver', 'remnant', 'stage', '%', 'range', '%', 'median', 'interval', 'days', 'range', 'days', 'mortality', 'rate', 'stage', '%', 'overall', 'survival', 'rates', '%', '%', 'progression', 'free', 'survival', 'rates', '%', '%', 'PSM', 'analysis', 'long', 'term', 'survival', 'patients', 'better', 'P', 'P', '=', 'comparable', 'stage', 'resection', 'P', 'P', 'Conclusion', 'surgical', 'outcomes', 'superior', 'similar', 'stage', 'resection', 'safe', 'effective', 'treatment', 'strategy', 'patients', 'unresectable', 'solitary', 'huge']"
376,376,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103674533&origin=inward,Activation of NF-Œ∫B signaling via cytosolic mitochondrial RNA sensing in kerotocytes with mitochondrial DNA common deletion,"¬© 2021, The Author(s).Scar formation as a result of corneal wound healing is a leading cause of blindness. It is a challenge to understand why scar formation is more likely to occur in the central part of the cornea as compared to the peripheral part. The purpose of this study was to unravel the underlying mechanisms. We applied RNA-seq to uncover the differences of expression profile in keratocytes in the central/peripheral part of the cornea. The relative quantity of mitochondrial RNA was measured by multiplex qPCR. The characterization of mitochondrial RNA in the cytoplasm was confirmed by immunofluoresence microscope and biochemical approach. Gene expression was analyzed by western blot and RT qPCR. We demonstrate that the occurrence of mitochondrial DNA common deletion is greater in keratocytes from the central cornea as compared to those of the peripheral part. The keratocytes with CD have elevated oxidative stress levels, which leads to the leakage of mitochondrial double-stranded RNA into the cytoplasm. The cytoplasmic mitochondrial double-stranded RNA is sensed by MDA5, which induces NF-Œ∫B activation. The NF-Œ∫B activation thereafter induces fibrosis-like extracellular matrix expressions and IL-8 mRNA transcription. These results provide a novel explanation of the different clinical outcome in different regions of the cornea during wound healing.",0,0,scopus,"['signal to noise ratio', 'demultiplexing', 'wavelength division multiplexing', 'demultiplexers', 'fiber optic networks', 'communication channels (information theory)', 'optical fibers', 'frequency division multiplexing', 'multiplexing equipment', 'time division multiplexing', 'multiplexing']",liver carcinoma in situ,"['Activation', 'cytosolic', 'mitochondrial', 'kerotocytes', 'mitochondrial', 'DNA', 'common', 'deletion']","['formation', 'result', 'corneal', 'wound', 'healing', 'leading', 'cause', 'blindness', 'challenge', 'scar', 'formation', 'likely', 'central', 'part', 'cornea', 'peripheral', 'part', 'purpose', 'study', 'mechanisms', 'differences', 'expression', 'profile', 'keratocytes', 'central', 'peripheral', 'part', 'cornea', 'relative', 'quantity', 'mitochondrial', 'multiplex', 'characterization', 'mitochondrial', 'cytoplasm', 'immunofluoresence', 'microscope', 'biochemical', 'approach', 'Gene', 'expression', 'western', 'blot', 'occurrence', 'mitochondrial', 'common', 'deletion', 'greater', 'keratocytes', 'central', 'cornea', 'peripheral', 'part', 'keratocytes', 'oxidative', 'stress', 'levels', 'leakage', 'mitochondrial', 'double', 'stranded', 'cytoplasm', 'cytoplasmic', 'mitochondrial', 'double', 'stranded', 'activation', 'activation', 'fibrosis', 'like', 'extracellular', 'matrix', 'expressions', 'transcription', 'results', 'novel', 'explanation', 'different', 'clinical', 'outcome', 'different', 'regions', 'cornea', 'wound', 'healing']"
377,377,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103600758&origin=inward,Pyroptosis: mechanisms and diseases,"¬© 2021, The Author(s).Currently, pyroptosis has received more and more attention because of its association with innate immunity and disease. The research scope of pyroptosis has expanded with the discovery of the gasdermin family. A great deal of evidence shows that pyroptosis can affect the development of tumors. The relationship between pyroptosis and tumors is diverse in different tissues and genetic backgrounds. In this review, we provide basic knowledge of pyroptosis, explain the relationship between pyroptosis and tumors, and focus on the significance of pyroptosis in tumor treatment. In addition, we further summarize the possibility of pyroptosis as a potential tumor treatment strategy and describe the side effects of radiotherapy and chemotherapy caused by pyroptosis. In brief, pyroptosis is a double-edged sword for tumors. The rational use of this dual effect will help us further explore the formation and development of tumors, and provide ideas for patients to develop new drugs based on pyroptosis.",0,0,scopus,"['tacit knowledge', 'knowledge management', 'knowledge based systems', 'explicit knowledge', 'domain knowledge']",liver carcinoma in situ,"['Pyroptosis', 'mechanisms', 'diseases']","['pyroptosis', 'more', 'more', 'attention', 'association', 'innate', 'immunity', 'disease', 'research', 'scope', 'pyroptosis', 'discovery', 'gasdermin', 'family', 'great', 'deal', 'evidence', 'pyroptosis', 'development', 'tumors', 'relationship', 'pyroptosis', 'tumors', 'diverse', 'different', 'tissues', 'genetic', 'backgrounds', 'review', 'basic', 'knowledge', 'pyroptosis', 'relationship', 'pyroptosis', 'tumors', 'significance', 'pyroptosis', 'tumor', 'treatment', 'addition', 'possibility', 'pyroptosis', 'potential', 'tumor', 'treatment', 'strategy', 'side', 'effects', 'radiotherapy', 'chemotherapy', 'pyroptosis', 'brief', 'pyroptosis', 'edged', 'sword', 'tumors', 'rational', 'use', 'dual', 'effect', 'formation', 'development', 'tumors', 'ideas', 'patients', 'new', 'drugs', 'pyroptosis']"
378,378,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103544945&origin=inward,Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy,"¬© 2021, The Author(s).Background: The inflammation indexes in blood routine play an essential role in evaluating the prognosis of patients with hepatocellular carcinoma, but the effect on early recurrence has not been clarified. The study aimed to investigate the risk factors of early recurrence (within 2 years) and recurrence-free survival after curative hepatectomy and explore the role of inflammatory indexes in predicting early recurrence. Methods: The baseline data of 161 patients with hepatocellular carcinoma were analyzed retrospectively. The optimal cut-off value of the inflammatory index was determined according to the Youden index. Its predictive performance was compared by the area under the receiver operating characteristic curve. Logistic and Cox regression analyses were used to determine the risk factors of early recurrence and recurrence-free survival. Results: The area under the curve of monocyte to lymphocyte ratio (MLR) for predicting early recurrence was 0.700, which was better than systemic inflammatory response index (SIRI), neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR) and systemic immune-inflammatory index (SII). MLR, tumour size, tumour differentiation and BCLC stage are all risk factors for early recurrence and recurrence-free survival of HCC. Combining the above four risk factors to construct a joint index, the area under the curve for predicting early recurrence was 0.829, which was better than single MLR, tumour size, tumour differentiation and BCLC stage. Furthermore, with the increase of risk factors, the recurrence-free survival of patients is worse. Conclusion: The combination of MLR and clinical risk factors is helpful for clinicians to identify high-risk patients with early recurrence and carry out active postoperative adjuvant therapy to improve the prognosis of patients.",0,0,scopus,"['b spline curve', 'logistics', 'kaplan-meiers estimate', 'correlation analysis', 'curve fitting', 'control point', 'mathematics', 'proportional hazards models']",liver carcinoma in situ,"['Inflammatory', 'indexes', 'preoperative', 'blood', 'routine', 'early', 'recurrence', 'hepatocellular', 'carcinoma', 'curative', 'hepatectomy']","['Author(s).Background', 'inflammation', 'indexes', 'blood', 'routine', 'essential', 'role', 'prognosis', 'patients', 'hepatocellular', 'carcinoma', 'effect', 'early', 'recurrence', 'study', 'risk', 'factors', 'early', 'recurrence', 'years', 'recurrence', 'free', 'survival', 'curative', 'hepatectomy', 'role', 'inflammatory', 'indexes', 'early', 'recurrence', 'Methods', 'baseline', 'data', 'patients', 'hepatocellular', 'carcinoma', 'optimal', 'cut', 'value', 'inflammatory', 'index', 'index', 'predictive', 'performance', 'area', 'receiver', 'characteristic', 'curve', 'regression', 'analyses', 'risk', 'factors', 'early', 'recurrence', 'recurrence', 'free', 'survival', 'Results', 'area', 'curve', 'monocyte', 'lymphocyte', 'ratio', 'early', 'recurrence', 'better', 'systemic', 'inflammatory', 'response', 'index', 'neutrophil', 'lymphocyte', 'ratio', 'platelet', 'ratio', 'systemic', 'immune', 'inflammatory', 'index', 'tumour', 'size', 'tumour', 'differentiation', 'BCLC', 'stage', 'risk', 'factors', 'early', 'recurrence', 'recurrence', 'free', 'survival', 'above', 'risk', 'factors', 'joint', 'index', 'area', 'curve', 'early', 'recurrence', 'better', 'single', 'tumour', 'size', 'tumour', 'differentiation', 'stage', 'increase', 'risk', 'factors', 'recurrence', 'free', 'survival', 'patients', 'worse', 'Conclusion', 'combination', 'clinical', 'risk', 'factors', 'helpful', 'clinicians', 'high', 'risk', 'patients', 'early', 'recurrence', 'active', 'postoperative', 'adjuvant', 'therapy', 'prognosis', 'patients']"
379,379,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103527949&origin=inward,Diquafosol tetrasodium elicits total cholesterol release from rabbit meibomian gland cells via P2Y<inf>2</inf> purinergic receptor signalling,"¬© 2021, The Author(s).Diquafosol tetrasodium (DQS), a purinergic P2Y2 receptor agonist, stimulates secretion of both water and mucins from the conjunctiva into tears. Hence, DQS-containing eye drops have been approved as a therapeutic option for dry eye disease in some Asian countries, including Japan. Recent clinical reports state that instilling DQS-containing eye drops significantly increases the lipid layer thickness in tears. Therefore, we examined this compound‚Äôs direct actions on holocrine lipid-secreting meibomian gland cells and their function. Isolated meibomian gland cells (meibocytes) were procured from rabbits and cultivated in serum-free culture medium. Differentiated meibocytes with pioglitazone were used for the subsequent experiments. Intracellular Ca2+ signalling of the cells was dramatically elevated with DQS addition in a dose-dependent manner. This DQS-induced elevation was almost completely cancelled by the coexistence of the selective P2Y2 receptor antagonist AR-C118925XX. DQS treatment also facilitated total cholesterol (TC) release from cells into the medium. This effect of DQS on TC was suppressed significantly by the intracellular Ca2+ chelator BAPTA-AM as well as by AR-C118925XX. DNA fragmentation analysis revealed that DQS may have enhanced the apoptotic DNA fragmentation caused spontaneously by cells. Thus, DQS could stimulate meibocytes to release lipids through the P2Y2 receptor and possibly facilitate holocrine cell maturation.",0,0,scopus,"['action sequences', 'human actions', 'software architecture patterns', 'layered', 'correlation analysis', 'mathematics']",liver carcinoma in situ,"['tetrasodium', 'total', 'cholesterol', 'release', 'rabbit', 'meibomian', 'gland', 'cells', 'purinergic', 'receptor']","['tetrasodium', 'purinergic', 'P2Y2', 'receptor', 'agonist', 'secretion', 'water', 'mucins', 'conjunctiva', 'tears', 'eye', 'drops', 'therapeutic', 'option', 'dry', 'eye', 'disease', 'Asian', 'countries', 'Recent', 'clinical', 'reports', 'state', 'eye', 'drops', 'lipid', 'layer', 'thickness', 'tears', 'compound', 'direct', 'actions', 'holocrine', 'lipid', 'meibomian', 'gland', 'cells', 'function', 'Isolated', 'meibomian', 'gland', 'cells', 'meibocytes', 'rabbits', 'free', 'culture', 'medium', 'Differentiated', 'meibocytes', 'pioglitazone', 'subsequent', 'experiments', 'Intracellular', 'Ca2', 'signalling', 'cells', 'addition', 'dose', 'dependent', 'manner', 'elevation', 'coexistence', 'selective', 'P2Y2', 'receptor', 'antagonist', 'DQS', 'treatment', 'total', 'cholesterol', 'release', 'cells', 'medium', 'effect', 'intracellular', 'Ca2', 'chelator', 'DNA', 'fragmentation', 'analysis', 'apoptotic', 'DNA', 'fragmentation', 'cells', 'meibocytes', 'lipids', 'P2Y2', 'receptor', 'holocrine', 'cell', 'maturation']"
380,380,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103410150&origin=inward,Targeting macrophages in cancer immunotherapy,"¬© 2021, The Author(s).Immunotherapy is regarded as the most promising treatment for cancers. Various cancer immunotherapies, including adoptive cellular immunotherapy, tumor vaccines, antibodies, immune checkpoint inhibitors, and small-molecule inhibitors, have achieved certain successes. In this review, we summarize the role of macrophages in current immunotherapies and the advantages of targeting macrophages. To better understand and make better use of this type of cell, their development and differentiation characteristics, categories, typical markers, and functions were collated at the beginning of the review. Therapeutic strategies based on or combined with macrophages have the potential to improve the treatment efficacy of cancer therapies.",0,0,scopus,"['cellular telephone systems', 'checkpointing', 'fault tolerance', 'rollback recovery', 'wireless', 'cellular radio systems', 'channel capacity', 'cellular network', 'cellular system', 'computer system recovery', 'cellular']",liver carcinoma in situ,"['macrophages', 'cancer', 'immunotherapy']","['promising', 'treatment', 'cancers', 'Various', 'cancer', 'immunotherapies', 'adoptive', 'cellular', 'immunotherapy', 'tumor', 'vaccines', 'antibodies', 'immune', 'checkpoint', 'inhibitors', 'small', 'molecule', 'inhibitors', 'certain', 'successes', 'review', 'role', 'macrophages', 'current', 'immunotherapies', 'advantages', 'macrophages', 'better', 'use', 'type', 'cell', 'development', 'differentiation', 'characteristics', 'categories', 'typical', 'markers', 'functions', 'beginning', 'review', 'Therapeutic', 'strategies', 'macrophages', 'potential', 'treatment', 'efficacy', 'cancer', 'therapies']"
381,381,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103355296&origin=inward,"Global analysis of expression, maturation and subcellular localization of mouse liver transcriptome identifies novel sex-biased and TCPOBOP-responsive long non-coding RNAs","¬© 2021, The Author(s).Background: While nuclear transcription and RNA processing and localization are well established for protein coding genes (PCGs), these processes are poorly understood for long non-coding (lnc)RNAs. Here, we characterize global patterns of transcript expression, maturation and localization for mouse liver RNA, including more than 15,000 lncRNAs. PolyA-selected liver RNA was isolated and sequenced from four subcellular fractions (chromatin, nucleoplasm, total nucleus, and cytoplasm), and from the chromatin-bound fraction without polyA selection. Results: Transcript processing, determined from normalized intronic to exonic sequence read density ratios, progressively increased for PCG transcripts in going from the chromatin-bound fraction to the nucleoplasm and then on to the cytoplasm. Transcript maturation was similar for lncRNAs in the chromatin fraction, but was significantly lower in the nucleoplasm and cytoplasm. LncRNA transcripts were 11-fold more likely to be significantly enriched in the nucleus than cytoplasm, and 100-fold more likely to be significantly chromatin-bound than nucleoplasmic. Sequencing chromatin-bound RNA greatly increased the sensitivity for detecting lowly expressed lncRNAs and enabled us to discover and localize hundreds of novel regulated liver lncRNAs, including lncRNAs showing sex-biased expression or responsiveness to TCPOBOP a xenobiotic agonist ligand of constitutive androstane receptor (Nr1i3). Conclusions: Integration of our findings with prior studies and lncRNA annotations identified candidate regulatory lncRNAs for a variety of hepatic functions based on gene co-localization within topologically associating domains or transcription divergent or antisense to PCGs associated with pathways linked to hepatic physiology and disease.",0,0,scopus,"['target tracking', 'localization system', 'wireless sensor networks', 'image coding', 'localization technique', 'network coding', 'localization algorithm', 'coding scheme', 'robot applications', 'sensor networks', 'target localization']",liver carcinoma in situ,"['Global', 'analysis', 'expression', 'maturation', 'subcellular', 'localization', 'mouse', 'liver', 'transcriptome', 'identifies', 'novel', 'sex', 'TCPOBOP', 'responsive', 'long', 'non', '-', 'coding', 'RNAs']","['Author(s).Background', 'nuclear', 'transcription', 'RNA', 'processing', 'localization', 'protein', 'genes', 'processes', 'long', 'non', '-', 'coding', 'global', 'patterns', 'transcript', 'expression', 'maturation', 'localization', 'mouse', 'liver', 'more', 'liver', 'subcellular', 'fractions', 'chromatin', 'nucleoplasm', 'total', 'nucleus', 'cytoplasm', 'chromatin', 'fraction', 'selection', 'Results', 'processing', 'intronic', 'sequence', 'density', 'ratios', 'transcripts', 'chromatin', 'fraction', 'nucleoplasm', 'cytoplasm', 'maturation', 'similar', 'chromatin', 'fraction', 'lower', 'nucleoplasm', 'cytoplasm', 'LncRNA', 'transcripts', '11-fold', 'likely', 'nucleus', 'cytoplasm', 'likely', 'chromatin', 'nucleoplasmic', 'chromatin', 'sensitivity', 'hundreds', 'novel', 'liver', 'sex', 'expression', 'responsiveness', 'xenobiotic', 'agonist', 'ligand', 'constitutive', 'androstane', 'receptor', 'Conclusions', 'Integration', 'findings', 'prior', 'studies', 'annotations', 'candidate', 'regulatory', 'variety', 'hepatic', 'functions', 'gene', 'co', '-', 'localization', 'domains', 'transcription', 'divergent', 'antisense', 'PCGs', 'pathways', 'hepatic', 'physiology', 'disease']"
382,382,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103350148&origin=inward,Delivery of cancer therapies by synthetic and bio-inspired nanovectors,"¬© 2021, The Author(s).Background: As a complement to the clinical development of new anticancer molecules, innovations in therapeutic vectorization aim at solving issues related to tumor specificity and associated toxicities. Nanomedicine is a rapidly evolving field that offers various solutions to increase clinical efficacy and safety. Main: Here are presented the recent advances for different types of nanovectors of chemical and biological nature, to identify the best suited for translational research projects. These nanovectors include different types of chemically engineered nanoparticles that now come in many different flavors of ‚Äòsmart‚Äô drug delivery systems. Alternatives with enhanced biocompatibility and a better adaptability to new types of therapeutic molecules are the cell-derived extracellular vesicles and micro-organism-derived oncolytic viruses, virus-like particles and bacterial minicells. In the first part of the review, we describe their main physical, chemical and biological properties and their potential for personalized modifications. The second part focuses on presenting the recent literature on the use of the different families of nanovectors to deliver anticancer molecules for chemotherapy, radiotherapy, nucleic acid-based therapy, modulation of the tumor microenvironment and immunotherapy. Conclusion: This review will help the readers to better appreciate the complexity of available nanovectors and to identify the most fitting ‚Äútype‚Äù for efficient and specific delivery of diverse anticancer therapies.",0,0,scopus,"['clustering algorithms', 'database systems', 'parallelizations', 'technology innovation', 'engineering research', 'security of data', 'program compilers', 'worms', 'computer worms', 'computer viruses', 'real data sets', 'automatic parallelization']",liver carcinoma in situ,"['Delivery', 'cancer', 'therapies', 'synthetic', 'bio', 'nanovectors']","['Author(s).Background', 'complement', 'clinical', 'development', 'new', 'anticancer', 'molecules', 'innovations', 'therapeutic', 'vectorization', 'aim', 'issues', 'tumor', 'specificity', 'toxicities', 'Nanomedicine', 'field', 'various', 'solutions', 'clinical', 'efficacy', 'safety', 'Main', 'recent', 'advances', 'different', 'types', 'nanovectors', 'chemical', 'biological', 'nature', 'suited', 'translational', 'research', 'projects', 'nanovectors', 'different', 'types', 'nanoparticles', 'many', 'different', 'flavors', 'smart', 'drug', 'delivery', 'systems', 'Alternatives', 'biocompatibility', 'better', 'adaptability', 'new', 'types', 'therapeutic', 'molecules', 'cell', 'extracellular', 'vesicles', 'micro', 'organism', 'oncolytic', 'viruses', 'virus', 'like', 'particles', 'bacterial', 'minicells', 'first', 'part', 'review', 'main', 'physical', 'chemical', 'biological', 'properties', 'potential', 'personalized', 'modifications', 'second', 'part', 'recent', 'literature', 'use', 'different', 'families', 'nanovectors', 'anticancer', 'molecules', 'chemotherapy', 'radiotherapy', 'nucleic', 'acid', 'therapy', 'modulation', 'tumor', 'microenvironment', 'immunotherapy', 'Conclusion', 'review', 'readers', 'complexity', 'available', 'nanovectors', 'fitting', '‚Äú', 'type', 'efficient', 'specific', 'delivery', 'diverse', 'anticancer', 'therapies']"
383,383,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103347406&origin=inward,Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy,"¬© 2021, The Author(s).Background: Epigenetic alterations are known contributors to cancer development and aggressiveness. Additional to alterations in cancer cells, aberrant epigenetic marks are present in cells of the tumor microenvironment, including lymphocytes and tumor-associated macrophages, which are often overlooked but known to be a contributing factor to a favorable environment for tumor growth. Therefore, the main aim of this review is to give an overview of the epigenetic alterations affecting immune cells in the tumor microenvironment to provoke an immunosuppressive function and contribute to cancer development. Moreover, immunotherapy is briefly discussed in the context of epigenetics, describing both its combination with epigenetic drugs and the need for epigenetic biomarkers to predict response to immune checkpoint blockage. Main body: Combining both topics, epigenetic machinery plays a central role in generating an immunosuppressive environment for cancer growth, which creates a barrier for immunotherapy to be successful. Furthermore, epigenetic-directed compounds may not only affect cancer cells but also immune cells in the tumor microenvironment, which could be beneficial for the clinical response to immunotherapy. Conclusion: Thus, modulating epigenetics in combination with immunotherapy might be a promising therapeutic option to improve the success of this therapy. Further studies are necessary to (1) understand in depth the impact of the epigenetic machinery in the tumor microenvironment; (2) how the epigenetic machinery can be modulated according to tumor type to increase response to immunotherapy and (3) find reliable biomarkers for a better selection of patients eligible to immunotherapy.",0,0,scopus,"['fault tolerance', 'checkpointing', 'rollback recovery', 'visualization tools', 'visualization', 'computer system recovery']",liver carcinoma in situ,"['tumor', 'microenvironment', 'epigenetic', 'tools', 'cancer', 'immunotherapy']","['Epigenetic', 'alterations', 'contributors', 'cancer', 'development', 'aggressiveness', 'Additional', 'alterations', 'cancer', 'cells', 'aberrant', 'epigenetic', 'marks', 'present', 'cells', 'tumor', 'microenvironment', 'lymphocytes', 'tumor', 'macrophages', 'factor', 'favorable', 'environment', 'tumor', 'growth', 'main', 'aim', 'review', 'overview', 'epigenetic', 'alterations', 'immune', 'cells', 'tumor', 'microenvironment', 'immunosuppressive', 'function', 'cancer', 'development', 'immunotherapy', 'context', 'epigenetics', 'combination', 'epigenetic', 'drugs', 'need', 'epigenetic', 'biomarkers', 'response', 'immune', 'checkpoint', 'blockage', 'Main', 'body', 'topics', 'epigenetic', 'machinery', 'central', 'role', 'immunosuppressive', 'environment', 'cancer', 'growth', 'barrier', 'immunotherapy', 'successful', 'epigenetic', 'compounds', 'cancer', 'cells', 'immune', 'cells', 'tumor', 'microenvironment', 'beneficial', 'clinical', 'response', 'Conclusion', 'epigenetics', 'combination', 'immunotherapy', 'promising', 'therapeutic', 'option', 'success', 'therapy', 'Further', 'studies', 'necessary', 'depth', 'impact', 'epigenetic', 'machinery', 'tumor', 'microenvironment', 'epigenetic', 'machinery', 'tumor', 'type', 'response', 'reliable', 'biomarkers', 'better', 'selection', 'patients', 'eligible']"
384,384,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103346227&origin=inward,Regulation of autophagy by microRNAs in human breast cancer,"¬© 2021, The Author(s).Breast cancer is the most common solid cancer that affects female population globally. MicroRNAs (miRNAs) are short non-coding RNAs that can regulate post-transcriptional modification of multiple downstream genes. Autophagy is a conserved cellular catabolic activity that aims to provide nutrients and degrade un-usable macromolecules in mammalian cells. A number of in vitro, in vivo and clinical studies have reported that some miRNAs could modulate autophagy activity in human breast cancer cells, and these would influence human breast cancer progression and treatment response. Therefore, this review was aimed to discuss the roles of autophagy-regulating miRNAs in influencing breast cancer development and treatment response. The review would first introduce autophagy types and process, followed by the discussion of the roles of different miRNAs in modulating autophagy in human breast cancer, and to explore how would this miRNA-autophagy regulatory process affect the disease progression or treatment response. Lastly, the potential applications and challenges of utilizing autophagy-regulating miRNAs as breast cancer biomarkers and novel therapeutic agents would be discussed.",0,0,scopus,"['cellular telephone systems', 'programming theory', 'source coding', 'coding techniques', 'network coding', 'image coding', 'artificial intelligence', 'wireless', 'cellular radio systems', 'channel coding', 'coding scheme', 'multiagent system', 'data compression', 'cellular', 'signal encoding']",liver carcinoma in situ,"['Regulation', 'autophagy', 'human', 'breast', 'cancer']","['Author(s).Breast', 'cancer', 'common', 'solid', 'cancer', 'female', 'population', 'short', 'non', '-', 'coding', 'RNAs', 'post', '-', 'transcriptional', 'modification', 'multiple', 'downstream', 'genes', 'conserved', 'cellular', 'catabolic', 'activity', 'nutrients', 'un', 'usable', 'macromolecules', 'mammalian', 'cells', 'number', 'vivo', 'clinical', 'studies', 'autophagy', 'activity', 'human', 'breast', 'cancer', 'cells', 'human', 'breast', 'cancer', 'progression', 'treatment', 'response', 'review', 'roles', 'autophagy', 'breast', 'cancer', 'development', 'treatment', 'response', 'review', 'autophagy', 'types', 'process', 'discussion', 'roles', 'different', 'modulating', 'autophagy', 'human', 'breast', 'cancer', 'autophagy', 'regulatory', 'process', 'disease', 'progression', 'treatment', 'response', 'potential', 'applications', 'challenges', 'autophagy', 'breast', 'cancer', 'biomarkers', 'novel', 'therapeutic', 'agents']"
385,385,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103190353&origin=inward,Elastin-specific MRI of extracellular matrix-remodelling following hepatic radiofrequency-ablation in a VX2 liver tumor model,"¬© 2021, The Author(s).Hepatic radiofrequency ablation (RFA) induces a drastic alteration of the biomechanical environment in the peritumoral liver tissue. The resulting increase in matrix stiffness has been shown to significantly influence carcinogenesis and cancer progression after focal RF ablation. To investigate the potential of an elastin-specific MR agent (ESMA) for the assessment of extracellular matrix (ECM) remodeling in the periablational rim following RFA in a VX2 rabbit liver tumor-model, twelve New-Zealand-White-rabbits were implanted in the left liver lobe with VX2 tumor chunks from donor animals. RFA of tumors was performed using a perfused RF needle-applicator with a mean tip temperature of 70 ¬∞C. Animals were randomized into four groups for MR imaging and scanned at four different time points following RFA (week 0 [baseline], week 1, week 2 and week 3 after RFA), followed by sacrifice and histopathological analysis. ESMA-enhanced MR imaging was used to assess ECM remodeling. Gadobutrol was used as a third-space control agent. Molecular MR imaging using an elastin-specific probe demonstrated a progressive increase in contrast-to-noise ratio (CNR) (week 3: ESMA: 28.1 ¬± 6.0; gadobutrol: 3.5 ¬± 2.0), enabling non-invasive imaging of the peritumoral zone with high spatial-resolution, and accurate assessment of elastin deposition in the periablational rim. In vivo CNR correlated with ex vivo histomorphometry (ElasticaVanGiesson-stain, y = 1.2x ‚àí 1.8, R2 = 0.89, p < 0.05) and gadolinium concentrations at inductively coupled mass spectroscopy (ICP-MS, y = 0.04x + 1.2, R2 = 0.95, p < 0.05). Laser-ICP-MS confirmed colocalization of elastin-specific probe with elastic fibers. Following thermal ablation, molecular imaging using an elastin-specific MR probe is feasible and provides a quantifiable biomarker for the assessment of the ablation-induced remodeling of the ECM in the periablational rim.",0,0,scopus,"['signal processing', 'signal to noise ratio', 'rf-id tags', 'high spatial resolution', 'software agents', 'radio frequency (rf)', 'imaging systems', 'intelligent agents', 'multiagent system', 'image resolution', 'image reconstruction']",liver carcinoma in situ,"['specific', 'extracellular', 'matrix', 'remodelling', 'hepatic', 'radiofrequency', 'ablation', 'VX2', 'liver', 'tumor', 'model']","['Author(s).Hepatic', 'radiofrequency', 'ablation', 'drastic', 'alteration', 'biomechanical', 'environment', 'peritumoral', 'liver', 'tissue', 'increase', 'matrix', 'stiffness', 'carcinogenesis', 'cancer', 'progression', 'focal', 'RF', 'ablation', 'potential', 'elastin', 'specific', 'agent', 'assessment', 'extracellular', 'matrix', 'periablational', 'rim', 'RFA', 'VX2', 'rabbit', 'liver', 'tumor', 'model', 'rabbits', 'left', 'liver', 'lobe', 'VX2', 'tumor', 'donor', 'animals', 'RFA', 'tumors', 'RF', 'needle', 'applicator', 'mean', 'tip', 'temperature', 'C', 'Animals', 'groups', 'different', 'time', 'points', 'week', 'baseline', 'week', 'week', 'week', 'sacrifice', 'histopathological', 'analysis', 'ESMA', 'imaging', 'remodeling', 'third', 'space', 'control', 'agent', 'elastin', 'specific', 'probe', 'progressive', 'increase', 'contrast', 'noise', 'ratio', 'week', 'ESMA', 'gadobutrol', 'non', '-', 'invasive', 'imaging', 'peritumoral', 'zone', 'high', 'spatial', 'resolution', 'accurate', 'assessment', 'elastin', 'deposition', 'periablational', 'rim', 'vivo', 'ex', 'vivo', 'histomorphometry', 'p', 'gadolinium', 'concentrations', 'mass', 'spectroscopy', '=', 'p', 'Laser', 'colocalization', 'elastin', 'specific', 'probe', 'elastic', 'fibers', 'thermal', 'ablation', 'molecular', 'imaging', 'elastin', 'specific', 'probe', 'feasible', 'quantifiable', 'biomarker', 'assessment', 'ablation', 'remodeling', 'periablational', 'rim']"
386,386,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85103179584&origin=inward,Standardization of esophageal adenocarcinoma in vitro model and its applicability for model drug testing,"¬© 2021, The Author(s).FLO-1 cell line represents an important tool in esophageal adenocarcinoma (EAC) research as a verified and authentic cell line to study the disease pathophysiology and antitumor drug screenings. Since in vitro characteristics of cells depend on the microenvironment and culturing conditions, we performed a thorough characterization of the FLO-1 cell line under different culturing conditions with the aim of (1) examining the effect of serum-free growth medium and air‚Äìliquid interface (A‚ÄìL) culturing, which better reflect physiological conditions in vivo and (2) investigating the differentiation potential of FLO-1 cells to mimic the properties of the in vivo esophageal epithelium. Our study shows that the composition of the media influenced the morphological, ultrastructural and molecular characteristics of FLO-1 cells, such as the expression of junctional proteins. Importantly, FLO-1 cells formed spheres at the A‚ÄìL interface, recapitulating key elements of tumors in the esophageal tube, i.e., direct contact with the gas phase and three-dimensional architecture. On the other hand, FLO-1 models exhibited high permeability to model drugs and zero permeability markers, and low transepithelial resistance, and therefore poorly mimicked normal esophageal epithelium. In conclusion, the identified effect of culture conditions on the characteristics of FLO-1 cells should be considered for standardization, data reproducibility and validity of the in vitro EAC model. Moreover, the sphere-forming ability of FLO-1 cells at the A‚ÄìL interface should be considered in EAC tumor biology and anticancer drug studies as a reliable and straightforward model with the potential to increase the predictive efficiency of the current in vitro approaches.",0,0,scopus,"['software architecture', 'computational efficiency', 'hierarchical system', 'hierarchical model', 'architecture designs', 'theoretical computer science', 'user-computer interface', 'human computer interaction', 'user interfaces']",liver carcinoma in situ,"['Standardization', 'esophageal', 'adenocarcinoma', 'model', 'applicability', 'model', 'drug', 'testing']","['cell', 'line', 'important', 'tool', 'esophageal', 'adenocarcinoma', 'research', 'verified', 'authentic', 'cell', 'line', 'disease', 'pathophysiology', 'antitumor', 'drug', 'screenings', 'characteristics', 'cells', 'microenvironment', 'culturing', 'conditions', 'thorough', 'characterization', 'cell', 'line', 'different', 'culturing', 'conditions', 'aim', 'effect', 'free', 'growth', 'medium', 'air', 'liquid', 'interface', 'L', 'culturing', 'physiological', 'conditions', 'vivo', 'differentiation', 'potential', 'cells', 'properties', 'vivo', 'epithelium', 'study', 'composition', 'media', 'morphological', 'ultrastructural', 'molecular', 'characteristics', 'cells', 'such', 'expression', 'junctional', 'proteins', 'cells', 'spheres', 'L', 'interface', 'key', 'elements', 'tumors', 'esophageal', 'tube', 'direct', 'contact', 'gas', 'phase', 'dimensional', 'architecture', 'other', 'hand', 'models', 'high', 'permeability', 'drugs', 'permeability', 'markers', 'low', 'transepithelial', 'resistance', 'normal', 'esophageal', 'epithelium', 'conclusion', 'effect', 'culture', 'conditions', 'characteristics', 'cells', 'standardization', 'data', 'reproducibility', 'validity', 'model', 'sphere', 'ability', 'cells', 'L', 'interface', 'tumor', 'biology', 'anticancer', 'drug', 'studies', 'reliable', 'straightforward', 'model', 'potential', 'predictive', 'efficiency', 'current', 'approaches']"
387,387,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102897943&origin=inward,Terahertz refractive index-based morphological dilation for breast carcinoma delineation,"¬© 2021, The Author(s).This paper reports investigations led on the combination of the refractive index and morphological dilation to enhance performances towards breast tumour margin delineation during conserving surgeries. The refractive index map of invasive ductal and lobular carcinomas were constructed from an inverse electromagnetic problem. Morphological dilation combined with refractive index thresholding was conducted to classify the tissue regions as malignant or benign. A histology routine was conducted to evaluate the performances of various dilation geometries associated with different thresholds. It was found that the combination of a wide structuring element and high refractive index was improving the correctness of tissue classification in comparison to other configurations or without dilation. The method reports a sensitivity of around 80% and a specificity of 82% for the best case. These results indicate that combining the fundamental optical properties of tissues denoted by their refractive index with morphological dilation may open routes to define supporting procedures during breast-conserving surgeries.",0,0,scopus,"['morphological operator', 'structuring element', 'surface testing', 'mathematical morphology', 'signal processing', 'thresholding', 'method of moments', 'fiber lasers', 'electromagnetism', 'morphological filters', 'aspherics', 'electromagnetic problems', 'refractometers', 'morphological operations', 'fiber optic components', 'transmittance', 'electromagnetic', 'high refractive index', 'morphological filtering', 'wavelength shift', 'light transmission', 'electromagnets', 'image segmentation', 'wavelength']",liver carcinoma in situ,"['Terahertz', 'refractive', 'index', 'morphological', 'dilation', 'breast', 'carcinoma', 'delineation']","['paper', 'investigations', 'combination', 'refractive', 'index', 'morphological', 'dilation', 'performances', 'breast', 'tumour', 'margin', 'delineation', 'surgeries', 'refractive', 'index', 'map', 'invasive', 'ductal', 'lobular', 'carcinomas', 'inverse', 'electromagnetic', 'problem', 'Morphological', 'dilation', 'refractive', 'index', 'thresholding', 'tissue', 'regions', 'malignant', 'benign', 'histology', 'routine', 'performances', 'various', 'dilation', 'geometries', 'different', 'thresholds', 'combination', 'wide', 'structuring', 'element', 'high', 'refractive', 'index', 'correctness', 'tissue', 'classification', 'comparison', 'other', 'configurations', 'dilation', 'method', 'sensitivity', '%', 'specificity', '%', 'best', 'case', 'results', 'fundamental', 'optical', 'properties', 'tissues', 'refractive', 'index', 'morphological', 'dilation', 'routes', 'procedures', 'breast', 'surgeries']"
388,388,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102766991&origin=inward,Double rarity: malignant masquerade biliary stricture in a situs inversus totalis patient,"¬© 2021, The Author(s).Background: Situs inversus totalis is a rare anatomical variation of both the thoracic and the abdominal organs. Common bile duct strictures can be caused by malignant and benign diseases as well. 7‚Äì18% of the latter ones are 'malignant masquerade‚Äô cases, as pre-operative differentiation is difficult. Case presentation: We present the case of a 68y male patient with known situs inversus totalis and a recent onset of obstructive jaundice caused by a malignant behaving common bile duct stricture. Technically difficult endoscopic retrograde cholangiopancreatography, brush cytology, magnetic resonance cholangiopancreatography, endoscopic ultrasound, and percutaneous transhepatic drainage with stent implantation were performed for proper diagnosis. Cholecystectomy, common bile duct resection with hilar lymphadenectomy, and hepatico-jejunostomy have been performed following multidisciplinary consultation. The final histology report did not confirm any clear malignancy, the patient is doing well. Conclusion: In situs inversus patients, both diagnostic and therapeutic procedures can lead to various difficulties. Benign biliary strictures are frequently misdiagnosed preoperatively as cholangiocellular carcinoma. Surgery is usually unavoidable, involving a significant risk of complications. The co-existence of these two difficult diagnostic and therapeutic features made our case challenging.",0,0,scopus,"['medical images', 'cbr', 'feature space', 'fiber lasers', 'classification methods', 'ultrasound images', 'pattern recognition', 'higher-order modes', 'ultrasonic imaging', 'photonic crystal fibers', 'case base', 'case representation']",liver carcinoma in situ,"['Double', 'rarity', 'malignant', 'masquerade', 'biliary', 'stricture', 'situs', 'inversus', 'totalis', 'patient']","['inversus', 'totalis', 'rare', 'anatomical', 'variation', 'thoracic', 'abdominal', 'organs', 'Common', 'bile', 'duct', 'strictures', 'malignant', 'benign', 'diseases', '7‚Äì18', '%', 'latter', 'ones', 'malignant', 'masquerade', 'cases', 'pre', '-', 'operative', 'differentiation', 'difficult', 'Case', 'presentation', 'case', '68y', 'male', 'patient', 'situs', 'inversus', 'totalis', 'recent', 'onset', 'obstructive', 'jaundice', 'malignant', 'common', 'bile', 'duct', 'stricture', 'difficult', 'endoscopic', 'retrograde', 'cholangiopancreatography', 'brush', 'cytology', 'magnetic', 'resonance', 'cholangiopancreatography', 'endoscopic', 'ultrasound', 'percutaneous', 'transhepatic', 'drainage', 'stent', 'implantation', 'proper', 'diagnosis', 'Cholecystectomy', 'common', 'bile', 'duct', 'resection', 'hilar', 'lymphadenectomy', 'hepatico', 'jejunostomy', 'multidisciplinary', 'consultation', 'final', 'histology', 'report', 'clear', 'malignancy', 'patient', 'Conclusion', 'situs', 'inversus', 'patients', 'diagnostic', 'therapeutic', 'procedures', 'various', 'difficulties', 'Benign', 'biliary', 'strictures', 'cholangiocellular', 'carcinoma', 'Surgery', 'unavoidable', 'significant', 'risk', 'complications', 'co', '-', 'existence', 'difficult', 'diagnostic', 'therapeutic', 'features', 'case']"
389,389,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102735473&origin=inward,"Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties","¬© 2021, The Author(s).Biomaterials have had an increasingly important role in recent decades, in biomedical device design and the development of tissue engineering solutions for cell delivery, drug delivery, device integration, tissue replacement, and more. There is an increasing trend in tissue engineering to use natural substrates, such as macromolecules native to plants and animals to improve the biocompatibility and biodegradability of delivered materials. At the same time, these materials have favourable mechanical properties and often considered to be biologically inert. More importantly, these macromolecules possess innate functions and properties due to their unique chemical composition and structure, which increase their bioactivity and therapeutic potential in a wide range of applications. While much focus has been on integrating these materials into these devices via a spectrum of cross-linking mechanisms, little attention is drawn to residual bioactivity that is often hampered during isolation, purification, and production processes. Herein, we discuss methods of initial material characterisation to determine innate bioactivity, means of material processing including cross-linking, decellularisation, and purification techniques and finally, a biological assessment of retained bioactivity of a final product. This review aims to address considerations for biomaterials design from natural polymers, through the optimisation and preservation of bioactive components that maximise the inherent bioactive potency of the substrate to promote tissue regeneration.",0,0,scopus,"['intelligent systems', 'opinion mining', 'electronic commerce', 'component', 'software', 'engineering', 'portable device', 'evolutionary algorithms', 'sales', 'systems design', 'intelligent control', 'product reviews', 'portable equipment', 'multi-objective optimisation']",liver carcinoma in situ,"['Bioactive', 'potential', 'natural', 'biomaterials', 'identification', 'retention', 'assessment', 'biological', 'properties']","['Author(s).Biomaterials', 'important', 'role', 'recent', 'decades', 'biomedical', 'device', 'design', 'development', 'tissue', 'engineering', 'solutions', 'cell', 'delivery', 'drug', 'delivery', 'device', 'integration', 'tissue', 'replacement', 'more', 'trend', 'tissue', 'engineering', 'natural', 'substrates', 'such', 'macromolecules', 'native', 'plants', 'animals', 'biocompatibility', 'biodegradability', 'materials', 'same', 'time', 'materials', 'favourable', 'mechanical', 'properties', 'inert', 'macromolecules', 'innate', 'functions', 'properties', 'due', 'unique', 'chemical', 'composition', 'structure', 'bioactivity', 'therapeutic', 'potential', 'wide', 'range', 'applications', 'much', 'focus', 'materials', 'devices', 'spectrum', 'cross', '-', 'linking', 'mechanisms', 'little', 'attention', 'residual', 'bioactivity', 'isolation', 'purification', 'production', 'processes', 'methods', 'initial', 'material', 'characterisation', 'innate', 'bioactivity', 'material', 'processing', 'cross', '-', 'linking', 'decellularisation', 'purification', 'techniques', 'biological', 'assessment', 'retained', 'bioactivity', 'final', 'product', 'review', 'considerations', 'biomaterials', 'design', 'natural', 'polymers', 'optimisation', 'preservation', 'bioactive', 'components', 'inherent', 'bioactive', 'potency', 'substrate', 'tissue', 'regeneration']"
390,390,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102708183&origin=inward,O-GlcNAcylation homeostasis controlled by calcium influx channels regulates multiple myeloma dissemination,"¬© 2021, The Author(s).Background: Multiple myeloma (MM) cell motility is a critical step during MM dissemination throughout the body, but how it is regulated remains largely unknown. As hypercalcemia is an important clinical feature of MM, high calcium (Ca2+) and altered Ca2+ signaling could be a key contributing factor to the pathological process. Methods: Bioinformatics analyses were employed to assess the clinical significance of Ca2+ influx channels in clinical specimens of smoldering and symptomatic MM. Functional and regulatory roles of influx channels and downstream signaling in MM cell migration and invasion were conducted and experimental MM dissemination was examined in a xenograft mouse model using in vivo live imaging and engraftment analysis. Results: Inhibition of TRPM7, ORAI1, and STIM1 influx channels, which are highly expressed in MM patients, and subsequent blockage of Ca2+ influx by CRISPR/Cas9 and small molecule inhibitors, effectively inhibit MM cell migration and invasion, and attenuate the experimental MM dissemination. Mechanistic studies reveal a nutrient sensor O-GlcNAcylation as a downstream regulator of Ca2+ influx that specifically targets cell adhesion molecules. Hyper-O-GlcNAcylation following the inhibition of Ca2+ influx channels induces integrin Œ±4 and integrin Œ≤7 downregulation via ubiquitin-proteasomal degradation and represses the aggressive MM phenotype. Conclusions: Our findings unveil a novel regulatory mechanism of MM cell motility via Ca2+ influx/O-GlcNAcylation axis that directly targets integrin Œ±4 and integrin Œ≤7, providing mechanistic insights into the pathogenesis and progression of MM and demonstrating potential predictive biomarkers and therapeutic targets for advanced MM.",0,0,scopus,"['virtual channels', 'control channels', 'computer science', 'subchannels', 'data channels', 'frequency division multiple access', 'sensors', 'physical channels', 'bioinformatics', 'computer hardware']",liver carcinoma in situ,"['GlcNAcylation', 'homeostasis', 'calcium', 'influx', 'channels', 'multiple', 'myeloma', 'dissemination']","['myeloma', 'cell', 'motility', 'critical', 'step', 'dissemination', 'body', 'remains', 'unknown', 'hypercalcemia', 'important', 'clinical', 'feature', 'high', 'calcium', 'Ca2', 'Ca2', 'signaling', 'key', 'contributing', 'factor', 'pathological', 'process', 'Methods', 'Bioinformatics', 'analyses', 'clinical', 'significance', 'Ca2', 'influx', 'channels', 'clinical', 'specimens', 'symptomatic', 'Functional', 'regulatory', 'roles', 'influx', 'channels', 'downstream', 'cell', 'migration', 'invasion', 'experimental', 'dissemination', 'xenograft', 'mouse', 'model', 'vivo', 'imaging', 'engraftment', 'analysis', 'Results', 'Inhibition', 'ORAI1', 'influx', 'channels', 'patients', 'subsequent', 'blockage', 'Ca2', 'influx', 'small', 'molecule', 'inhibitors', 'cell', 'migration', 'invasion', 'experimental', 'dissemination', 'Mechanistic', 'studies', 'nutrient', 'sensor', 'O', 'GlcNAcylation', 'downstream', 'regulator', 'Ca2', 'cell', 'adhesion', 'molecules', 'GlcNAcylation', 'inhibition', 'Ca2', 'influx', 'channels', 'induces', 'downregulation', 'ubiquitin', 'proteasomal', 'degradation', 'aggressive', 'phenotype', 'Conclusions', 'findings', 'novel', 'regulatory', 'mechanism', 'cell', 'motility', 'Ca2', 'influx', 'O', 'GlcNAcylation', 'axis', 'integrin', 'mechanistic', 'insights', 'pathogenesis', 'progression', 'potential', 'predictive', 'biomarkers', 'therapeutic', 'targets', 'advanced']"
391,391,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102689543&origin=inward,Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition,"¬© 2021, The Author(s).Non-secretory multiple myeloma (NSMM) constitutes a distinct entity of multiple myeloma characterized by the absence of detectable monoclonal protein and rarely an absence of free light chains in the serum and urine. Given its rarity, the genomic landscape, clinical course, and prognosis of NSSM are not well characterized. Here, we report a case of a patient with relapsed and refractory NSMM with brain metastasis harboring a TFG-ALK fusion showing a dramatic and durable (over two years) response to commercially available anaplastic lymphoma kinase (ALK) inhibitors. The case emphasizes the beneficial role of molecular profiling in this target-poor disease.",0,0,scopus,"['fusion techniques', 'fusion reactions', 'fusion algorithms', 'data fusion', 'nuclear physics', 'multiple classifiers', 'fusion methods', 'classifier fusion', 'sensors', 'image fusion', 'biometrics']",liver carcinoma in situ,"['Non', '-', 'secretory', 'multiple', 'myeloma', 'unusual', 'fusion', 'dramatic', 'response', 'inhibition']","['Author(s).Non', 'secretory', 'multiple', 'myeloma', 'distinct', 'entity', 'multiple', 'myeloma', 'absence', 'detectable', 'monoclonal', 'protein', 'absence', 'free', 'light', 'chains', 'serum', 'urine', 'rarity', 'genomic', 'landscape', 'clinical', 'course', 'prognosis', 'case', 'patient', 'relapsed', 'refractory', 'brain', 'metastasis', 'fusion', 'dramatic', 'durable', 'years', 'response', 'available', 'anaplastic', 'lymphoma', 'kinase', 'inhibitors', 'case', 'beneficial', 'role', 'molecular', 'profiling', 'target', 'poor', 'disease']"
392,392,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102688496&origin=inward,Fibronectin as a multiregulatory molecule crucial in tumor matrisome: from structural and functional features to clinical practice in oncology,"¬© 2021, The Author(s).Deciphering extracellular matrix (ECM) composition and architecture may represent a novel approach to identify diagnostic and therapeutic targets in cancer. Among the ECM components, fibronectin and its fibrillary assembly represent the scaffold to build up the entire ECM structure, deeply affecting its features. Herein we focus on this extraordinary protein starting from its complex structure and defining its role in cancer as prognostic and theranostic marker.",0,0,scopus,"['dynamic composition', 'software architecture', 'feature space', 'component', 'software', 'classification methods', 'architecture designs', 'web service composition', 'pattern recognition', 'service compositions', 'automatic composition']",liver carcinoma in situ,"['Fibronectin', 'multiregulatory', 'molecule', 'crucial', 'tumor', 'matrisome', 'structural', 'functional', 'features', 'clinical', 'practice', 'oncology']","['extracellular', 'matrix', 'composition', 'architecture', 'novel', 'approach', 'diagnostic', 'therapeutic', 'targets', 'cancer', 'components', 'fibronectin', 'fibrillary', 'assembly', 'scaffold', 'entire', 'structure', 'features', 'extraordinary', 'protein', 'complex', 'structure', 'role', 'cancer', 'prognostic', 'theranostic', 'marker']"
393,393,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102660861&origin=inward,Recent Advancements in Nanomedicine for ‚ÄòCold‚Äô Tumor Immunotherapy,"¬© 2021, The Author(s).Although current anticancer immunotherapies using immune checkpoint inhibitors (ICIs) have been reported with a high clinical success rate, numerous patients still bear ‚Äòcold‚Äô tumors with insufficient T cell infiltration and low immunogenicity, responding poorly to ICI therapy. Considering the advancements in precision medicine, in-depth mechanism studies on the tumor immune microenvironment (TIME) among cold tumors are required to improve the treatment for these patients. Nanomedicine has emerged as a promising drug delivery system in anticancer immunotherapy, activates immune function, modulates the TIME, and has been applied in combination with other anticancer therapeutic strategies. This review initially summarizes the mechanisms underlying immunosuppressive TIME in cold tumors and addresses the recent advancements in nanotechnology for cold TIME reversal-based therapies, as well as a brief talk about the feasibility of clinical translation.[Figure not available: see fulltext.]",0,0,scopus,"['checkpointing', 'fault tolerance', 'rollback recovery', 'mai', 'frequency division multiplexing', 'signal interference', 'ofdm systems', 'intercell interference', 'radio interference', 'carrier frequency offsets', 'bit error rate', 'multiple access interference', 'computer system recovery', 'intercarrier interference']",liver carcinoma in situ,"['Recent', '‚Äô']","['current', 'anticancer', 'immunotherapies', 'immune', 'checkpoint', 'inhibitors', 'high', 'clinical', 'success', 'rate', 'numerous', 'patients', 'cold', 'tumors', 'insufficient', 'cell', 'infiltration', 'low', 'immunogenicity', 'therapy', 'advancements', 'precision', 'medicine', 'depth', 'mechanism', 'studies', 'tumor', 'immune', 'microenvironment', 'cold', 'tumors', 'treatment', 'patients', 'promising', 'drug', 'delivery', 'system', 'anticancer', 'immunotherapy', 'immune', 'function', 'combination', 'other', 'anticancer', 'therapeutic', 'strategies', 'review', 'mechanisms', 'immunosuppressive', 'cold', 'tumors', 'recent', 'advancements', 'nanotechnology', 'cold', 'reversal', 'therapies', 'brief', 'talk', 'feasibility', 'clinical', 'available', 'fulltext']"
394,394,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102598800&origin=inward,PLA1A expression as a diagnostic marker of BRAF-mutant metastasis in melanoma cancer,"¬© 2021, The Author(s).BRAF and NRAS are the most reported mutations associated to melanomagenesis. The lack of accurate diagnostic markers in response to therapeutic treatment in BRAF/NRAS-driven melanomagenesis is one of the main challenges in melanoma personalized therapy. In order to assess the diagnostic value of phosphatidylserine-specific phospholipase A1-alpha (PLA1A), a potent lysophospholipid mediating the production of lysophosphatidylserine, PLA1A mRNA and serum levels were compared in subjects with malignant melanoma (n = 18), primary melanoma (n = 13), and healthy subjects (n = 10). Additionally, the correlation between histopathological subtypes of BRAF/NRAS-mutated melanoma and PLA1A was analyzed. PLA1A expression was significantly increased during melanogenesis and positively correlated to disease severity and histopathological markers of metastatic melanoma. PLA1A mRNA and serum levels were significantly higher in patients with BRAF-mutated melanoma compared to the patients with NRAS-mutated melanoma. Notably, PLA1A can be used as a diagnostic marker for an efficient discrimination between na√Øve melanoma samples and advanced melanoma samples (sensitivity 91%, specificity 57%, and AUC 0.99), as well as BRAF-mutated melanoma samples (sensitivity 62%, specificity 61%, and AUC 0.75). Our findings suggest that PLA1A can be considered as a potential diagnostic marker for advanced and BRAF-mutated melanoma.",0,0,scopus,"['mathematics', 'correlation coefficient', 'correlation analysis']",liver carcinoma in situ,"['PLA1A', 'expression', 'diagnostic', 'marker', 'mutant', 'metastasis', 'melanoma', 'cancer']","['reported', 'mutations', 'melanomagenesis', 'lack', 'accurate', 'diagnostic', 'markers', 'response', 'therapeutic', 'treatment', 'melanomagenesis', 'main', 'challenges', 'melanoma', 'therapy', 'order', 'diagnostic', 'value', 'phosphatidylserine', 'specific', 'phospholipase', 'A1-alpha', 'potent', 'lysophospholipid', 'production', 'lysophosphatidylserine', 'PLA1A', 'mRNA', 'serum', 'levels', 'subjects', 'malignant', 'melanoma', 'primary', 'melanoma', 'healthy', 'subjects', 'correlation', 'histopathological', 'subtypes', 'melanoma', 'PLA1A', 'expression', 'melanogenesis', 'severity', 'histopathological', 'markers', 'metastatic', 'melanoma', 'PLA1A', 'mRNA', 'serum', 'levels', 'higher', 'patients', 'melanoma', 'patients', 'melanoma', 'diagnostic', 'marker', 'efficient', 'discrimination', 'na√Øve', 'melanoma', 'samples', 'advanced', 'melanoma', 'samples', 'sensitivity', '%', 'specificity', '%', 'melanoma', 'samples', 'sensitivity', '%', 'specificity', '%', 'findings', 'PLA1A', 'potential', 'diagnostic', 'marker', 'advanced', 'melanoma']"
395,395,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102519848&origin=inward,Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer,"¬© 2021, The Author(s).Tyrosine kinase inhibitors were found to be clinically effective for treatment of patients with certain subsets of cancers carrying somatic mutations in receptor tyrosine kinases. However, the duration of clinical response is often limited, and patients ultimately develop drug resistance. Here, we use single-cell RNA sequencing to demonstrate the existence of multiple cancer cell subpopulations within cell lines, xenograft tumors and patient tumors. These subpopulations exhibit epigenetic changes and differential therapeutic sensitivity. Recurrently overrepresented ontologies in genes that are differentially expressed between drug tolerant cell populations and drug sensitive cells include epithelial-to-mesenchymal transition, epithelium development, vesicle mediated transport, drug metabolism and cholesterol homeostasis. We show analysis of identified markers using the LINCS database to predict and functionally validate small molecules that target selected drug tolerant cell populations. In combination with EGFR inhibitors, crizotinib inhibits the emergence of a defined subset of EGFR inhibitor-tolerant clones. In this study, we describe the spectrum of changes associated with drug tolerance and inhibition of specific tolerant cell subpopulations with combination agents.",0,0,scopus,"['computer systems', 'domain ontologies', 'artificial intelligence', 'database systems', 'frequency bands', 'ontology', 'multiagent system', 'antennas', 'semantics']",liver carcinoma in situ,"['Single', 'cell', 'transcriptional', 'changes', 'drug', 'tolerance', 'response', 'combination', 'therapies', 'cancer']","['Author(s).Tyrosine', 'kinase', 'inhibitors', 'effective', 'treatment', 'patients', 'certain', 'subsets', 'cancers', 'somatic', 'mutations', 'receptor', 'tyrosine', 'kinases', 'duration', 'clinical', 'response', 'limited', 'patients', 'drug', 'resistance', 'single', 'cell', 'RNA', 'existence', 'multiple', 'cancer', 'cell', 'subpopulations', 'cell', 'lines', 'xenograft', 'tumors', 'patient', 'tumors', 'subpopulations', 'epigenetic', 'changes', 'differential', 'therapeutic', 'sensitivity', 'ontologies', 'genes', 'drug', 'tolerant', 'cell', 'populations', 'drug', 'sensitive', 'cells', 'epithelial', 'mesenchymal', 'transition', 'epithelium', 'development', 'vesicle', 'transport', 'drug', 'metabolism', 'cholesterol', 'homeostasis', 'analysis', 'markers', 'LINCS', 'database', 'small', 'molecules', 'drug', 'tolerant', 'cell', 'populations', 'combination', 'inhibitors', 'crizotinib', 'emergence', 'subset', 'inhibitor', 'tolerant', 'clones', 'study', 'spectrum', 'changes', 'drug', 'tolerance', 'inhibition', 'specific', 'tolerant', 'cell', 'subpopulations', 'combination', 'agents']"
396,396,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102290512&origin=inward,Comprehensive analysis of ceRNA networks reveals prognostic lncRNAs related to immune infiltration in colorectal cancer,"¬© 2021, The Author(s).Background: Competing endogenous RNA (ceRNA) represents a class of RNAs (e.g., long noncoding RNAs [lncRNAs]) with microRNA (miRNA) binding sites, which can competitively bind miRNA and inhibit its regulation of target genes. Increasing evidence has underscored the involvement of dysregulated ceRNA networks in the occurrence and progression of colorectal cancer (CRC). The purpose of this study was to construct a ceRNA network related to the prognosis of CRC and further explore the potential mechanisms that affect this prognosis. Methods: RNA-Seq and miRNA-Seq data from The Cancer Genome Atlas (TCGA) were used to identify differentially expressed lncRNAs (DElncRNAs), microRNAs (DEmiRNAs), and mRNAs (DEmRNAs), and a prognosis-related ceRNA network was constructed based on DElncRNA survival analysis. Subsequently, pathway enrichment, Pearson correlation, and Gene Set Enrichment Analysis (GSEA) were performed to determine the function of the genes in the ceRNA network. Gene Expression Profiling Interactive Analysis (GEPIA) and immunohistochemistry (IHC) were also used to validate differential gene expression. Finally, the correlation between lncRNA and immune cell infiltration in the tumor microenvironment was evaluated based on the CIBERSORT algorithm. Results: A prognostic ceRNA network was constructed with eleven key survival-related DElncRNAs (MIR4435-2HG, NKILA, AFAP1-AS1, ELFN1-AS1, AC005520.2, AC245884.8, AL354836.1, AL355987.4, AL591845.1, LINC02038, and AC104823.1), 54 DEmiRNAs, and 308 DEmRNAs. The MIR4435-2HG- and ELFN1-AS1-associated ceRNA subnetworks affected and regulated the expression of the COL5A2, LOX, OSBPL3, PLAU, VCAN, SRM, and E2F1 target genes and were found to be related to prognosis and tumor-infiltrating immune cell types. Conclusions: MIR4435-2HG and ELFN1-AS1 are associated with prognosis and tumor-infiltrating immune cell types and could represent potential prognostic biomarkers or therapeutic targets in colorectal carcinoma.",0,0,scopus,"['network components', 'correlation analysis', 'pearson correlation', 'program compilers', 'network protocols', 'network architecture', 'correlation coefficient', 'mathematics', 'correlation methods']",liver carcinoma in situ,"['Comprehensive', 'analysis', 'networks', 'prognostic', 'immune', 'infiltration', 'colorectal', 'cancer']","['Author(s).Background', 'endogenous', 'class', 'RNAs', 'noncoding', 'sites', 'miRNA', 'regulation', 'target', 'genes', 'evidence', 'involvement', 'dysregulated', 'networks', 'occurrence', 'progression', 'colorectal', 'cancer', 'purpose', 'study', 'network', 'prognosis', 'CRC', 'potential', 'mechanisms', 'prognosis', 'Methods', 'data', 'DEmiRNAs', 'prognosis', 'network', 'survival', 'analysis', 'pathway', 'enrichment', 'correlation', 'function', 'genes', 'network', 'immunohistochemistry', 'differential', 'gene', 'expression', 'correlation', 'immune', 'cell', 'infiltration', 'tumor', 'microenvironment', 'algorithm', 'Results', 'prognostic', 'network', 'key', 'survival', 'DElncRNAs', 'DEmiRNAs', '2HG-', 'subnetworks', 'expression', 'E2F1', 'target', 'genes', 'prognosis', 'tumor', 'immune', 'cell', 'types', 'Conclusions', 'prognosis', 'tumor', 'immune', 'cell', 'types', 'potential', 'prognostic', 'biomarkers', 'therapeutic', 'targets', 'colorectal', 'carcinoma']"
397,397,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102200211&origin=inward,Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?,"¬© 2021, The Author(s).With the development of machine learning (ML) algorithms, a growing number of predictive models have been established for predicting the therapeutic outcome of patients with hepatocellular carcinoma (HCC) after various treatment modalities. By using the different combinations of clinical and radiological variables, ML algorithms can simulate human learning to detect hidden patterns within the data and play a critical role in artificial intelligence techniques. Compared to traditional statistical methods, ML methods have greater predictive effects. ML algorithms are widely applied in nearly all steps of model establishment, such as imaging feature extraction, predictive factor classification, and model development. Therefore, this review presents the literature pertaining to ML algorithms and aims to summarize the strengths and limitations of ML, as well as its potential value in prognostic prediction, after various treatment modalities for HCC.",0,0,scopus,"['classification methods', 'video coding', 'signal processing', 'computational efficiency', 'macro block', 'computer science', 'artificial intelligence', 'signal distortion', 'classification models', 'correlation analysis', 'coding efficiency', 'optimization problems', 'learning', 'education', 'prediction modes', 'mathematics', 'bit rates', 'adaptive algorithms', 'efficient algorithm', 'statistical methods', 'machine learning', 'h.264/avc']",liver carcinoma in situ,"['Current', 'updates', 'machine', 'prediction', 'therapeutic', 'outcome', 'hepatocellular', 'carcinoma']","['development', 'machine', 'learning', 'algorithms', 'number', 'predictive', 'models', 'therapeutic', 'outcome', 'patients', 'hepatocellular', 'carcinoma', 'various', 'treatment', 'modalities', 'different', 'combinations', 'clinical', 'radiological', 'variables', 'algorithms', 'human', 'learning', 'hidden', 'patterns', 'data', 'critical', 'role', 'artificial', 'intelligence', 'techniques', 'traditional', 'statistical', 'methods', 'methods', 'greater', 'predictive', 'effects', 'ML', 'algorithms', 'steps', 'model', 'establishment', 'such', 'feature', 'extraction', 'predictive', 'factor', 'classification', 'model', 'development', 'review', 'literature', 'algorithms', 'strengths', 'limitations', 'potential', 'value', 'prognostic', 'prediction', 'various', 'treatment', 'modalities']"
398,398,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102168325&origin=inward,"Deciphering the effects of kosmotrope and chaotrope salts during aqueous two phase extraction (ATPE) of polyphenolic compounds and glycoalkaloids from the leaves of a nutraceutical plant, Solanum retroflexum, with the aid of UPLC-QTOF-MS","¬© 2021, The Author(s).Solanum plants (Solanaceae) are renowned source of nutraceuticals and have widely been explored for their phytochemical constituents. This work investigated the effects of kosmotropic and chaotropic salts on the number of phytochemicals extracted from the leaves of a nutraceutical plant, Solanum retroflexum, and analyzed on the ultra-performance liquid chromatography hyphenated to a quadrupole time of flight mass spectrometer (UPLC-QTOF-MS) detector. Here, a total of 20 different compounds were putatively characterized. The majority of the identified compounds were polyphenols and glycoalkaloids. Another compound, caffeoyl malate was identified for the first time in this plant. Glycoalkaloids such as solanelagnin, solamargine, solasonine, Œ≤-solanine (I) and Œ≤-solanine (II) were found to be extracted by almost all the salts used herein. Kosmotrope salts, overall, were more efficient in extracting polar compounds with 4 more polyphenolic compounds extracted compared to the chaotropes. Chaotropes were generally more selective for the extraction of less polar compounds (glycoalkaloids) with 3 more extracted than the kosmotropes. The chaotrope and the kosmotrope that extracted the most metabolites were NaCl and Na2SO4, respectively, with 12 metabolites extracted for each salt. This work demonstrated that a comprehensive metabolome of S. retroflexum, more than what was previously reported on the same plant, can be achieved by application of kosmotropes and chaotropes as extractants with the aid of the Aqueous Two Phase Extraction approach. The best-performing salts, Na2SO4 or NaCl, could potentially be applied on a commercial scale, to meet the ever-growing demand of the studied metabolites. The Aqueous Two Phase Extraction technique was found to be efficient in simultaneous extraction of multiple metabolites which can be applied in metabolomics.",0,0,scopus,"['semiconductor quantum wires', 'customer demands', 'flight control systems', 'natural language processing', 'data mining', 'information retrieval', 'flight test', 'information extraction', 'information analysis', 'sales', 'molecular beams', 'detection algorithm', 'signal detection']",liver carcinoma in situ,"['effects', 'kosmotrope', 'chaotrope', 'salts', 'aqueous', 'phase', 'extraction', 'polyphenolic', 'compounds', 'glycoalkaloids', 'leaves', 'nutraceutical', 'plant', 'retroflexum', 'aid']","['plants', 'renowned', 'source', 'nutraceuticals', 'phytochemical', 'constituents', 'work', 'effects', 'kosmotropic', 'chaotropic', 'salts', 'number', 'phytochemicals', 'leaves', 'nutraceutical', 'plant', 'Solanum', 'retroflexum', 'ultra', '-', 'performance', 'liquid', 'chromatography', 'quadrupole', 'time', 'flight', 'mass', 'spectrometer', 'detector', 'total', 'different', 'compounds', 'majority', 'compounds', 'polyphenols', 'glycoalkaloids', 'compound', 'caffeoyl', 'malate', 'first', 'time', 'plant', 'Glycoalkaloids', 'such', 'solanelagnin', 'solamargine', 'solasonine', 'solanine', 'I', 'salts', 'herein', 'salts', 'efficient', 'polar', 'compounds', 'more', 'polyphenolic', 'compounds', 'chaotropes', 'Chaotropes', 'selective', 'extraction', 'less', 'polar', 'compounds', 'glycoalkaloids', 'extracted', 'kosmotropes', 'chaotrope', 'kosmotrope', 'most', 'metabolites', 'metabolites', 'salt', 'work', 'comprehensive', 'metabolome', 'retroflexum', 'more', 'same', 'plant', 'application', 'kosmotropes', 'chaotropes', 'extractants', 'aid', 'approach', 'salts', 'commercial', 'scale', 'demand', 'metabolites', 'Aqueous', 'technique', 'efficient', 'simultaneous', 'extraction', 'multiple', 'metabolites', 'metabolomics']"
399,399,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102068782&origin=inward,3D bioprinting of hepatocytes: core‚Äìshell structured co-cultures with fibroblasts for enhanced functionality,"¬© 2021, The Author(s).With the aim of understanding and recapitulating cellular interactions of hepatocytes in their physiological microenvironment and to generate an artificial 3D in vitro model, a co-culture system using 3D extrusion bioprinting was developed. A bioink based on alginate and methylcellulose (algMC) was first shown to be suitable for bioprinting of hepatocytes; the addition of Matrigel to algMC enhanced proliferation and morphology of them in monophasic scaffolds. Towards a more complex system that allows studying cellular interactions, we applied core‚Äìshell bioprinting to establish tailored 3D co-culture models for hepatocytes. The bioinks were specifically functionalized with natural matrix components (based on human plasma, fibrin or Matrigel) and used to co-print fibroblasts and hepatocytes in a spatially defined, coaxial manner. Fibroblasts acted as supportive cells for co-cultured hepatocytes, stimulating the expression of certain biomarkers of hepatocytes like albumin. Furthermore, matrix functionalization positively influenced both cell types in their respective compartments by enhancing their adhesion, viability, proliferation and function. In conclusion, we established a functional co-culture model with independently tunable compartments for different cell types via core‚Äìshell bioprinting. This provides the basis for more complex in vitro models allowing co-cultivation of hepatocytes with other liver-specific cell types to closely resemble the liver microenvironment.",0,0,scopus,"['cellular telephone systems', 'component', 'software', 'hierarchical system', 'hierarchical model', 'wireless', 'standard model', 'cellular radio systems', 'channel capacity', 'the standard model', 'cellular network', 'electronic document identification systems', 'cellular system', 'cellular']",liver carcinoma in situ,"['3D', 'bioprinting', 'hepatocytes', 'core', 'shell', 'structured', 'co', '-', 'cultures', 'fibroblasts', 'functionality']","['aim', 'understanding', 'cellular', 'interactions', 'hepatocytes', 'physiological', 'microenvironment', 'artificial', '3D', 'vitro', 'model', 'co', '-', 'culture', 'system', '3D', 'extrusion', 'bioprinting', 'bioink', 'alginate', 'methylcellulose', 'algMC', 'suitable', 'bioprinting', 'hepatocytes', 'addition', 'proliferation', 'morphology', 'monophasic', 'scaffolds', 'complex', 'system', 'cellular', 'interactions', 'core', 'shell', 'bioprinting', '3D', 'co', '-', 'culture', 'models', 'hepatocytes', 'bioinks', 'natural', 'matrix', 'components', 'human', 'plasma', 'fibrin', '-', 'print', 'fibroblasts', 'hepatocytes', 'coaxial', 'manner', 'Fibroblasts', 'supportive', 'cells', 'co', '-', 'cultured', 'hepatocytes', 'expression', 'certain', 'biomarkers', 'hepatocytes', 'albumin', 'matrix', 'functionalization', 'cell', 'types', 'respective', 'compartments', 'adhesion', 'viability', 'proliferation', 'function', 'conclusion', 'functional', 'co', '-', 'culture', 'model', 'tunable', 'compartments', 'different', 'cell', 'types', 'core', 'shell', 'bioprinting', 'basis', 'more', 'complex', 'models', 'co', '-', 'cultivation', 'hepatocytes', 'other', 'liver', 'specific', 'cell', 'types', 'liver', 'microenvironment']"
400,400,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85102030168&origin=inward,Multizonal anogenital neoplasia in women: a cohort analysis,"¬© 2021, The Author(s).Background: There is currently a lack of information on full anogenital evaluation of women with a previous history of anogenital neoplasia. Methods: Retrospective analysis of the Homerton Anogenital Neoplasia Service records from January 2012 to March 2017, to identify all new referrals of women with previous anogenital neoplasia, who had had at least one complete examination of all anogenital sites. Multizonal anogenital disease (MZD) was defined as the presence of high-grade squamous intraepithelial lesions (HSIL)/carcinoma concurrently at two or more of the following sites/zones: perianus, anal canal, vulva, vagina or cervix. Results: 253 women were included, mean age was 47 (SD=15) years and median duration of follow-up was 12 (IQR=21) months. Fifty-six women (22%) were diagnosed with MZD at first assessment and/or during follow-up. Current smokers (RR=1.84, 95% CI 1.21‚Äì2.79, p=0.004) and women on immunodulators/immunosuppressive drugs (RR=2.57, 95% CI 1.72-3.86, p<0.001) had an increased risk for MZD. The risk was lower for women without a previous history of anogenital high-grade lesions/cancer compared to those with this history (RR=0.06, 95% CI 0.01-0.45, p=0.006). Conclusions: Multizonal assessment was important to diagnose occult areas of disease and should be especially considered in current smokers, pharmacologically immunocompromised and those with a previous history of anogenital HSIL/cancer.",0,0,scopus,"['user information', 'telecommunication services', 'information technology', 'routing algorithms', 'recommender systems', 'correlation analysis', 'network management', 'quality of service', 'personal information', 'mathematics', 'service management', 'time windows']",liver carcinoma in situ,"['Multizonal', 'anogenital', 'neoplasia', 'women', 'cohort', 'analysis']","['Author(s).Background', 'lack', 'information', 'full', 'anogenital', 'evaluation', 'women', 'previous', 'history', 'anogenital', 'neoplasia', 'Methods', 'Retrospective', 'analysis', 'new', 'referrals', 'women', 'previous', 'anogenital', 'neoplasia', 'complete', 'examination', 'anogenital', 'sites', 'Multizonal', 'anogenital', 'disease', 'presence', 'high', 'grade', 'squamous', 'intraepithelial', 'lesions', 'more', 'sites', 'zones', 'perianus', 'anal', 'canal', 'vulva', 'vagina', 'cervix', 'Results', 'women', 'mean', 'age', 'SD=15', 'years', 'median', 'duration', 'follow', 'up', 'months', 'women', '%', 'first', 'assessment', 'up', 'Current', 'smokers', '%', 'women', 'immunodulators', 'immunosuppressive', 'drugs', '%', 'p<0.001', 'risk', 'risk', 'lower', 'women', 'previous', 'history', 'anogenital', 'high', 'grade', 'lesions', 'cancer', 'history', '%', 'Conclusions', 'Multizonal', 'assessment', 'important', 'occult', 'areas', 'disease', 'current', 'smokers', 'previous', 'history', 'anogenital', 'cancer']"
401,401,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101962435&origin=inward,mRNA in cancer immunotherapy: beyond a source of antigen,"¬© 2021, The Author(s).mRNA therapeutics have become the focus of molecular medicine research. Various mRNA applications have reached major milestones at high speed in the immuno-oncology field. This can be attributed to the knowledge that mRNA is one of nature‚Äôs core building blocks carrying important information and can be considered as a powerful vector for delivery of therapeutic proteins to the patient. For a long time, the major focus in the use of in vitro transcribed mRNA was on development of cancer vaccines, using mRNA encoding tumor antigens to modify dendritic cells ex vivo. However, the versatility of mRNA and its many advantages have paved the path beyond this application. In addition, due to smart design of both the structural properties of the mRNA molecule as well as pharmaceutical formulations that improve its in vivo stability and selective targeting, the therapeutic potential of mRNA can be considered as endless. As a consequence, many novel immunotherapeutic strategies focus on the use of mRNA beyond its use as the source of tumor antigens. This review aims to summarize the state-of-the-art on these applications and to provide a rationale for their clinical application.",0,0,scopus,"['local stability', 'asymptotic stability', 'bandwidth', 'telecommunication systems', 'knowledge management', 'numerical example', 'software development', 'programming languages', 'smart homes', 'asymptotical stability', 'lyapunov functions', 'adaptive control systems', 'explicit knowledge', 'personal information', 'intelligent systems', 'software architecture', 'internet protocols', 'intelligent buildings', 'multi path routing', 'architecture designs', 'linear matrix inequalities', 'architecture types', 'internet of things', 'systems design', 'delay control systems', 'intelligent control', 'primary path', 'routing protocols', 'tacit knowledge', 'user information', 'routing algorithms', 'routing scheme', 'recommender systems', 'high bandwidth', 'domain knowledge', 'lyapunov stability theorem', 'global asymptotic stability', 'sufficient conditions', 'single path', 'control system stability', 'stability criteria', 'prototyping', 'knowledge based systems', 'backup path', 'solution methods', 'global stability']",liver carcinoma in situ,"['mRNA', 'cancer', 'immunotherapy', 'source', 'antigen']","['therapeutics', 'focus', 'molecular', 'medicine', 'research', 'Various', 'applications', 'major', 'milestones', 'high', 'speed', 'immuno', 'oncology', 'field', 'knowledge', 'nature', 'core', 'building', 'blocks', 'important', 'information', 'powerful', 'vector', 'delivery', 'therapeutic', 'proteins', 'patient', 'long', 'time', 'major', 'focus', 'use', 'development', 'cancer', 'vaccines', 'mRNA', 'tumor', 'dendritic', 'cells', 'vivo', 'versatility', 'many', 'advantages', 'path', 'application', 'addition', 'due', 'smart', 'design', 'structural', 'properties', 'molecule', 'pharmaceutical', 'formulations', 'vivo', 'stability', 'selective', 'targeting', 'therapeutic', 'potential', 'mRNA', 'endless', 'consequence', 'many', 'novel', 'immunotherapeutic', 'strategies', 'use', 'mRNA', 'use', 'source', 'tumor', 'review', 'state', 'art', 'applications', 'rationale', 'clinical', 'application']"
402,402,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101942483&origin=inward,"M√©n√©trier-like disease in a Pointer with concurrent granulomatous gastritis, helicobacteriosis and leishmaniosis: a case report","¬© 2021, The Author(s).Background: M√©n√©trier-like disease is a rare hypertrophic canine gastropathy, reported in only seven dogs. Clinical signs are vomiting, anorexia and weight loss. Macroscopically, giant cerebriform gastric mucosal folds are typically seen in the corpus and fundus of the stomach. Histopathologically, fundic mucous cell hyperplasia and loss of parietal and chief cells are typical. Case presentation: A nine-year-old spayed female Pointer had a history of intermittent vomiting, marked weight loss and hypoalbuminaemia. A gastroduodenoscopy was performed three times within three months with macroscopic changes remaining the same. The gastric mucosa of the corpus, fundus and proximal antrum was markedly irregular, with cerebriform mucosal folds. In the first gastric biopsies, histopathology revealed a moderate granulomatous gastritis, with a severe manifestation of Helicobacter-like organisms. Treatment for Helicobacter spp. decreased the vomiting slightly. The dog was diagnosed with concurrent leishmaniosis; the conventional anti-Leishmania treatment decreased the vomiting moderately, the hypoalbuminaemia resolved and the dog gained weight back to a normal body condition. Granulomatous gastritis was not present in the gastric biopsies after these treatments. The dog increased vomiting when palliative treatment (maropitant citrate, ondansetron and esomeprazole) was discontinued, and thus, full-thickness biopsies of the stomach were taken and M√©n√©trier-like disease was diagnosed. The affected area was too large to be surgically removed; thus, palliative treatment was reinstated. The dog remained clinically well 39 months after the first clinical presentation. Conclusions: This is the first report of M√©n√©trier-like disease in a dog with a simultaneous manifestation of granulomatous gastritis, helicobacteriosis and leishmaniosis. The clinical signs decreased after treatment of helicobacteriosis and leishmaniosis, but vomiting remained probably as a sign of M√©n√©trier-like disease. Treatment options for dogs are surgical removal of the abnormal area or palliative treatment. In humans, promising results for a cure have been shown with cetuximab treatment, a human monoclonal antibody, but no canine antibody is commercially available yet. The dog here was doing well 39 months after first presentation, which is the longest reported survival time for M√©n√©trier-like disease with only palliative treatment in dogs. Full-thickness biopsies are preferred in macroscopic hypertrophic lesions of the stomach for better assessment of M√©n√©trier-like disease.",0,0,scopus,"['cbr', 'kaplan-meiers estimate', 'proportional hazards models', 'case base', 'case representation']",liver carcinoma in situ,"['like', 'disease', 'concurrent', 'granulomatous', 'gastritis', 'helicobacteriosis', 'leishmaniosis', 'case', 'report']","['like', 'disease', 'rare', 'hypertrophic', 'canine', 'gastropathy', 'dogs', 'Clinical', 'signs', 'anorexia', 'weight', 'loss', 'giant', 'cerebriform', 'gastric', 'mucosal', 'folds', 'corpus', 'fundus', 'stomach', 'fundic', 'mucous', 'cell', 'hyperplasia', 'loss', 'parietal', 'chief', 'cells', 'typical', 'Case', 'presentation', 'year', 'old', 'female', 'history', 'intermittent', 'vomiting', 'weight', 'loss', 'hypoalbuminaemia', 'gastroduodenoscopy', 'times', 'months', 'macroscopic', 'changes', 'same', 'gastric', 'mucosa', 'corpus', 'fundus', 'proximal', 'antrum', 'irregular', 'cerebriform', 'mucosal', 'folds', 'first', 'gastric', 'biopsies', 'histopathology', 'moderate', 'granulomatous', 'gastritis', 'severe', 'manifestation', 'Helicobacter', 'like', 'organisms', 'Treatment', 'spp', 'vomiting', 'dog', 'concurrent', 'leishmaniosis', 'conventional', 'anti', '-', 'Leishmania', 'treatment', 'vomiting', 'hypoalbuminaemia', 'dog', 'weight', 'normal', 'body', 'condition', 'Granulomatous', 'gastritis', 'present', 'gastric', 'biopsies', 'treatments', 'dog', 'vomiting', 'palliative', 'treatment', 'maropitant', 'citrate', 'ondansetron', 'esomeprazole', 'full', 'thickness', 'biopsies', 'stomach', 'like', 'disease', 'affected', 'area', 'large', 'palliative', 'treatment', 'dog', 'months', 'first', 'clinical', 'presentation', 'Conclusions', 'first', 'report', 'like', 'disease', 'dog', 'simultaneous', 'manifestation', 'granulomatous', 'gastritis', 'helicobacteriosis', 'leishmaniosis', 'clinical', 'signs', 'treatment', 'helicobacteriosis', 'leishmaniosis', 'vomiting', 'sign', 'like', 'disease', 'Treatment', 'options', 'dogs', 'surgical', 'removal', 'abnormal', 'area', 'palliative', 'treatment', 'humans', 'results', 'cure', 'cetuximab', 'treatment', 'human', 'monoclonal', 'antibody', 'canine', 'antibody', 'available', 'dog', 'months', 'first', 'presentation', 'longest', 'survival', 'time', 'like', 'disease', 'only', 'palliative', 'treatment', 'dogs', 'Full', 'thickness', 'biopsies', 'macroscopic', 'hypertrophic', 'lesions', 'stomach', 'better', 'assessment', 'like', 'disease']"
403,403,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101940698&origin=inward,Ivermectin converts cold tumors hot and synergizes with immune checkpoint blockade for treatment of breast cancer,"¬© 2021, The Author(s).We show that treatment with the FDA-approved anti-parasitic drug ivermectin induces immunogenic cancer cell death (ICD) and robust T cell infiltration into breast tumors. As an allosteric modulator of the ATP/P2X4/P2X7 axis which operates in both cancer and immune cells, ivermectin also selectively targets immunosuppressive populations including myeloid cells and Tregs, resulting in enhanced Teff/Tregs ratio. While neither agent alone showed efficacy in vivo, combination therapy with ivermectin and checkpoint inhibitor anti-PD1 antibody achieved synergy in limiting tumor growth (p = 0.03) and promoted complete responses (p < 0.01), also leading to immunity against contralateral re-challenge with demonstrated anti-tumor immune responses. Going beyond primary tumors, this combination achieved significant reduction in relapse after neoadjuvant (p = 0.03) and adjuvant treatment (p < 0.001), and potential cures in metastatic disease (p < 0.001). Statistical modeling confirmed bona fide synergistic activity in both the adjuvant (p = 0.007) and metastatic settings (p < 0.001). Ivermectin has dual immunomodulatory and ICD-inducing effects in breast cancer, converting cold tumors hot, thus represents a rational mechanistic partner with checkpoint blockade.",0,0,scopus,"['checkpointing', 'fault tolerance', 'rollback recovery', 'software agents', 'statistical methods', 'correlation analysis', 'intelligent agents', 'multiagent system', 'computer system recovery']",liver carcinoma in situ,"['Ivermectin', 'converts', 'cold', 'tumors', 'hot', 'immune', 'checkpoint', 'blockade', 'treatment', 'breast', 'cancer']","['Author(s).We', 'treatment', 'anti', '-', 'parasitic', 'drug', 'ivermectin', 'induces', 'immunogenic', 'cancer', 'cell', 'death', 'robust', 'cell', 'infiltration', 'breast', 'tumors', 'allosteric', 'modulator', 'axis', 'cancer', 'immune', 'cells', 'ivermectin', 'immunosuppressive', 'populations', 'myeloid', 'cells', 'ratio', 'agent', 'efficacy', 'vivo', 'combination', 'therapy', 'ivermectin', 'checkpoint', 'inhibitor', 'anti', '-', 'PD1', 'antibody', 'synergy', 'tumor', 'growth', 'p', 'complete', 'responses', 'p', 'immunity', 'contralateral', 're', '-', 'challenge', 'anti', '-', 'tumor', 'immune', 'responses', 'primary', 'tumors', 'combination', 'significant', 'reduction', 'relapse', 'neoadjuvant', 'p', 'adjuvant', 'treatment', 'p', 'potential', 'cures', 'metastatic', 'disease', 'p', 'Statistical', 'modeling', 'bona', 'fide', 'synergistic', 'activity', 'adjuvant', 'p', 'metastatic', 'settings', 'p', 'dual', 'immunomodulatory', 'effects', 'breast', 'cancer', 'cold', 'tumors', 'hot', 'rational', 'mechanistic', 'partner', 'checkpoint', 'blockade']"
404,404,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101923697&origin=inward,Comprehensive analysis of the transcriptome‚Äêwide m<sup>6</sup>A methylome in invasive malignant pleomorphic adenoma,"¬© 2021, The Author(s).Background: Invasive malignant pleomorphic adenoma (IMPA) is a highly invasive parotid gland tumor and lacks effective therapy. N6-Methyladenosine (m6A) is the most prevalent post-transcriptional modification of mRNAs in eukaryotes and plays an important role in the pathogenesis of multiple tumors. However, the significance of m6A-modified mRNAs in IMPA has not been elucidated to date. Hence, in this study, we attempted to profile the effect of IMPA in terms of m6A methylation in mRNA. Methods: Methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-seq) and RNA sequencing (RNA-seq) were utilized to acquire the first transcriptome-wide profiling of the m6A methylome map in IMPA followed by bioinformatics analysis. Results: In this study, we obtained m6A methylation maps of IMPA samples and normal adjacent tissues through MeRIP-seq. In total, 25,490 m6A peaks associated with 13,735 genes were detected in the IMPA group, whereas 33,930 m6A peaks associated with 18,063 genes were detected in the control group. Peaks were primarily enriched within coding regions and near stop codons with AAACC and GGAC motifs. Moreover, functional enrichment analysis demonstrated that m6A-containing genes were significantly enriched in cancer and metabolism relevant pathways. Furthermore, we identified a relationship between the m6A methylome and the RNA transcriptome, indicating a mechanism by which m6A modulates gene expression. Conclusions: Our study is the first to provide comprehensive and transcriptome-wide profiles to determine the potential roles played by m6A methylation in IMPA. These results may open new avenues for in-depth research elucidating the m6A topology of IMPA and the molecular mechanisms governing the formation and progression of IMPA.",0,0,scopus,"['switching systems', 'network topology', 'computer science', 'switching control', 'topology', 'computer network', 'correlation analysis', 'bioinformatics', 'mathematics']",liver carcinoma in situ,"['Comprehensive', 'analysis', 'm', 'methylome', 'invasive', 'malignant', 'pleomorphic', 'adenoma']","['Author(s).Background', 'Invasive', 'malignant', 'pleomorphic', 'adenoma', 'invasive', 'parotid', 'gland', 'tumor', 'effective', 'therapy', 'prevalent', 'post', '-', 'transcriptional', 'modification', 'eukaryotes', 'important', 'role', 'pathogenesis', 'multiple', 'tumors', 'significance', 'm6A', 'date', 'study', 'effect', 'terms', 'm6A', 'methylation', 'Methods', 'immunoprecipitation', 'next', 'generation', 'sequencing', 'sequencing', 'RNA', 'first', 'transcriptome', 'wide', 'profiling', 'methylome', 'map', 'bioinformatics', 'analysis', 'Results', 'study', 'methylation', 'maps', 'samples', 'normal', 'adjacent', 'tissues', 'total', 'm6A', 'peaks', 'genes', 'group', 'm6A', 'peaks', 'genes', 'control', 'group', 'Peaks', 'regions', 'stop', 'codons', 'motifs', 'functional', 'enrichment', 'analysis', 'm6A', 'genes', 'cancer', 'metabolism', 'relevant', 'pathways', 'relationship', 'm6A', 'methylome', 'transcriptome', 'mechanism', 'm6A', 'modulates', 'gene', 'expression', 'Conclusions', 'study', 'first', 'comprehensive', 'transcriptome', 'wide', 'profiles', 'potential', 'roles', 'm6A', 'methylation', 'results', 'new', 'avenues', 'depth', 'research', 'topology', 'molecular', 'mechanisms', 'formation', 'progression']"
405,405,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101872836&origin=inward,Cancer-associated fibroblasts promote the survival of irradiated nasopharyngeal carcinoma cells via the NF-Œ∫B pathway,"¬© 2021, The Author(s).Background: Irradiation has emerged as a valid tool for nasopharyngeal carcinoma (NPC) in situ treatment; however, NPC derived from tissues treated with irradiation is a main cause cancer-related death. The purpose of this study is to uncover the underlying mechanism regarding tumor growth after irradiation and provided potential therapeutic strategy. Methods: Fibroblasts were extracted from fresh NPC tissue and normal nasopharyngeal mucosa. Immunohistochemistry was conducted to measure the expression of Œ±-SMA and FAP. Cytokines were detected by protein array chip and identified by real-time PCR. CCK-8 assay was used to detect cell proliferation. Radiation-resistant (IRR) 5-8F cell line was established and colony assay was performed to evaluate tumor cell growth after irradiation. Signaling pathways were acquired via gene set enrichment analysis (GSEA). Comet assay and Œ≥-H2AX foci assay were used to measure DNA damage level. Protein expression was detected by western blot assay. In vivo experiment was performed subcutaneously. Results: We found that radiation-resistant NPC tissues were constantly infiltrated with a greater number of cancer-associated fibroblasts (CAFs) compared to radiosensitive NPC tissues. Further research revealed that CAFs induced the formation of radioresistance and promoted NPC cell survival following irradiation via the IL-8/NF-Œ∫B pathway to reduce irradiation-induced DNA damage. Treatment with Tranilast, a CAF inhibitor, restricted the survival of CAF-induced NPC cells and attenuated the of radioresistance properties. Conclusions: Together, these data demonstrate that CAFs can promote the survival of irradiated NPC cells via the NF-Œ∫B pathway and induce radioresistance that can be interrupted by Tranilast, suggesting the potential value of Tranilast in sensitizing NPC cells to irradiation.",0,0,scopus,"['damage detection', 'kaplan-meiers estimate', 'electric power supplies to apparatus', 'structural damages', 'direction of arrival', 'sub-arrays', 'asic', 'structural health monitoring', 'fluences', 'laser damage', 'proportional hazards models']",liver carcinoma in situ,"['Cancer', 'fibroblasts', 'survival', 'nasopharyngeal', 'carcinoma', 'cells', 'pathway']","['Irradiation', 'valid', 'tool', 'nasopharyngeal', 'carcinoma', 'situ', 'treatment', 'tissues', 'irradiation', 'main', 'cause', 'cancer', 'death', 'purpose', 'study', 'mechanism', 'tumor', 'growth', 'irradiation', 'potential', 'therapeutic', 'strategy', 'Methods', 'Fibroblasts', 'fresh', 'tissue', 'normal', 'nasopharyngeal', 'mucosa', 'expression', 'Œ±', 'SMA', 'Cytokines', 'protein', 'array', 'chip', 'real', 'time', 'CCK-8', 'assay', 'cell', 'proliferation', 'Radiation', 'resistant', '8F', 'cell', 'line', 'colony', 'assay', 'tumor', 'cell', 'growth', 'irradiation', 'pathways', 'gene', 'enrichment', 'analysis', 'Comet', 'assay', 'foci', 'assay', 'DNA', 'damage', 'level', 'Protein', 'expression', 'western', 'blot', 'assay', 'vivo', 'experiment', 'Results', 'radiation', 'resistant', 'tissues', 'greater', 'number', 'cancer', 'fibroblasts', 'radiosensitive', 'tissues', 'Further', 'research', 'formation', 'radioresistance', 'cell', 'survival', 'irradiation', 'IL-8/NF', 'Œ∫B', 'pathway', 'irradiation', 'DNA', 'damage', 'Treatment', 'inhibitor', 'survival', 'cells', 'radioresistance', 'properties', 'Conclusions', 'data', 'CAFs', 'survival', 'cells', 'pathway', 'radioresistance', 'potential', 'value', 'cells', 'irradiation']"
406,406,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101864759&origin=inward,Cancer Immunoprevention: Current Status and Future Directions,"¬© 2021, L. Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.Cancer is one of the most serious diseases affecting health and the second leading cause of death worldwide. Despite the development of various therapeutic modalities to deal with cancer, limited improvement in overall survival of patients has been yielded. Since there is no certain cure for cancer, detection of premalignant lesions, and prevention of their progression are vital to the decline of high morbidity and mortality of cancer. Among approaches to cancer prevention, immunoprevention has gained further attention in recent years. Deep understanding of the tumor/immune system interplay and successful prevention of virally-induced malignancies by vaccines have paved the way toward broadening cancer immunoprevention application. The identification of tumor antigens in premalignant lesions was the turning point in cancer immunoprevention that led to designing preventive vaccines for various malignancies including multiple myeloma, colorectal, and breast cancer. In addition to vaccines, immune checkpoint inhibitors are also being tested for the prevention of oral squamous cell carcinoma (SCC), and imiquimod which is an established drug for the prevention of skin SCC, is a non-specific immunomodulator. Herein, to provide a bench-to-bedside understanding of cancer immunoprevention, we will review the role of the immune system in suppression and promotion of tumors, immunoprevention of virally-induced cancers, identification of tumor antigens in premalignant lesions, and clinical advances of cancer immunoprevention.",0,0,scopus,"['checkpointing', 'fault tolerance', 'kaplan-meiers estimate', 'rollback recovery', 'education', 'university', 'computer system recovery', 'detection algorithm', 'proportional hazards models', 'signal detection']",liver carcinoma in situ,['Directions'],"['serious', 'diseases', 'health', 'second', 'cause', 'death', 'development', 'various', 'therapeutic', 'modalities', 'cancer', 'limited', 'improvement', 'overall', 'survival', 'patients', 'certain', 'cure', 'cancer', 'detection', 'premalignant', 'lesions', 'prevention', 'progression', 'vital', 'decline', 'high', 'morbidity', 'mortality', 'cancer', 'approaches', 'cancer', 'prevention', 'immunoprevention', 'further', 'attention', 'recent', 'years', 'Deep', 'understanding', 'tumor', 'immune', 'system', 'interplay', 'successful', 'prevention', 'malignancies', 'vaccines', 'way', 'cancer', 'immunoprevention', 'application', 'identification', 'tumor', 'premalignant', 'lesions', 'turning', 'point', 'cancer', 'immunoprevention', 'preventive', 'vaccines', 'various', 'malignancies', 'multiple', 'myeloma', 'colorectal', 'breast', 'cancer', 'addition', 'vaccines', 'immune', 'checkpoint', 'inhibitors', 'prevention', 'oral', 'squamous', 'cell', 'carcinoma', 'imiquimod', 'drug', 'prevention', 'skin', 'non', '-', 'specific', 'immunomodulator', 'bench', 'bedside', 'understanding', 'cancer', 'immunoprevention', 'role', 'immune', 'system', 'suppression', 'promotion', 'tumors', 'immunoprevention', 'cancers', 'identification', 'tumor', 'premalignant', 'lesions', 'clinical', 'advances', 'cancer', 'immunoprevention']"
407,407,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101864756&origin=inward,Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development,"¬© 2021, The Author(s).Background: Although mRNA vaccines have been effective against multiple cancers, their efficacy against pancreatic adenocarcinoma (PAAD) remains undefined. Accumulating evidence suggests that immunotyping can indicate the comprehensive immune status in tumors and their immune microenvironment, which is closely associated with therapeutic response and vaccination potential. The aim of this study was to identify potent antigens in PAAD for mRNA vaccine development, and further distinguish immune subtypes of PAAD to construct an immune landscape for selecting suitable patients for vaccination. Methods: Gene expression profiles and clinical information of 239 PAAD datasets were extracted from ICGC, and RNA-Seq data of 103 samples were retrieved from TCGA. GEPIA was used to calculate differential expression levels and prognostic indices, cBioPortal program was used to compare genetic alterations, and TIMER was used to explore correlation between genes and immune infiltrating cells. Consensus cluster was used for consistency matrix construction and data clustering, DAVID was used for functional annotation, and graph learning-based dimensional reduction was used to depict immune landscape. Results: Six overexpressed and mutated tumor antigens associated with poor prognosis and infiltration of antigen presenting cells were identified in PAAD, including ADAM9, EFNB2, MET, TMOD3, TPX2, and WNT7A. Furthermore, five immune subtypes (IS1-IS5) and nine immune gene modules of PAAD were identified that were consistent in both patient cohorts. The immune subtypes showed distinct molecular, cellular and clinical characteristics. IS1 and IS2 exhibited immune-activated phenotypes and correlated to better survival compared to the other subtypes. IS4 and IS5 tumors were immunologically cold and associated with higher tumor mutation burden. Immunogenic cell death modulators, immune checkpoints, and CA125 and CA199, were also differentially expressed among the five immune subtypes. Finally, the immune landscape of PAAD showed a high degree of heterogeneity between individual patients. Conclusions: ADAM9, EFNB2, MET, TMOD3, TPX2, and WNT7A are potent antigens for developing anti-PAAD mRNA vaccine, and patients with IS4 and IS5 tumors are suitable for vaccination.",0,0,scopus,"['clustering algorithms', 'cellular telephone systems', 'particle swarm optimization (pso)', 'cluster analysis', 'data clustering', 'data mining', 'clustering methods', 'wireless', 'cellular radio systems', 'evolutionary algorithms', 'learning', 'education', 'mutation operators', 'cellular']",liver carcinoma in situ,"['Identification', 'tumor', 'immune', 'subtypes', 'pancreatic', 'adenocarcinoma', 'vaccine', 'development']","['Author(s).Background', 'vaccines', 'effective', 'multiple', 'cancers', 'efficacy', 'pancreatic', 'adenocarcinoma', 'undefined', 'evidence', 'comprehensive', 'immune', 'status', 'tumors', 'immune', 'microenvironment', 'therapeutic', 'response', 'vaccination', 'potential', 'aim', 'study', 'potent', 'antigens', 'vaccine', 'development', 'immune', 'subtypes', 'immune', 'landscape', 'suitable', 'patients', 'vaccination', 'Methods', 'Gene', 'expression', 'profiles', 'clinical', 'information', 'PAAD', 'datasets', 'data', 'samples', 'differential', 'expression', 'levels', 'prognostic', 'indices', 'cBioPortal', 'program', 'genetic', 'alterations', 'correlation', 'genes', 'immune', 'cells', 'Consensus', 'cluster', 'consistency', 'matrix', 'construction', 'data', 'clustering', 'functional', 'annotation', 'graph', 'learning', 'dimensional', 'reduction', 'immune', 'landscape', 'Results', 'overexpressed', 'mutated', 'tumor', 'poor', 'prognosis', 'infiltration', 'antigen', 'cells', 'ADAM9', 'immune', 'subtypes', 'IS1-IS5', 'immune', 'gene', 'modules', 'consistent', 'patient', 'cohorts', 'immune', 'subtypes', 'distinct', 'molecular', 'cellular', 'clinical', 'characteristics', 'IS1', 'immune', 'phenotypes', 'better', 'survival', 'other', 'subtypes', 'IS4', 'tumors', 'cold', 'higher', 'tumor', 'mutation', 'burden', 'Immunogenic', 'cell', 'death', 'modulators', 'immune', 'checkpoints', 'CA199', 'immune', 'subtypes', 'immune', 'landscape', 'high', 'degree', 'heterogeneity', 'individual', 'patients', 'Conclusions', 'WNT7A', 'potent', 'antigens', 'anti', '-', 'PAAD', 'vaccine', 'patients', 'tumors', 'suitable', 'vaccination']"
408,408,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101817800&origin=inward,Effect of oxidative stress and calcium deregulation on FAM26F (CALHM6) expression during hepatitis B virus infection,"¬© 2021, The Author(s).Background: Family with sequence similarity 26, member F (FAM26F) is an important innate immunity modulator playing a significant role in diverse immune responses, however, the association of FAM26F expression with HBV infection is not yet known. Thus, the current study aims to explore the differential expression of FAM26F in vitro in HepAD38 and HepG2 cell lines upon HBV infection, and in vivo in HBV infected individuals. The effects of antioxidant and calcium inhibitors on the regulation of FAM26F expression were also evaluated. The expression of FAM26F was simultaneously determined with well-established HBV infection markers: IRF3, and IFN-Œ≤. Methods: The expression of FAM26F and marker genes was analyzed through Real-time qPCR and western blot. Results: Our results indicate that the differential expression of FAM26F followed the same trend as that of IRF3 and IFN-Œ≤. The in vitro study revealed that, in both HBV infected cell lines, FAM26F expression was significantly down-regulated as compared to uninfected control cells. Treatment of cells with N-acetyl-L-cysteine (NAC), EGTA-AM, BAPTA-AM, and Ru360 significantly upregulated the expression of FAM26F in both the cell lines. Moreover, in in vivo study, FAM26F expression was significantly downregulated in all HBV infected groups as compared to controls (p = 0.0007). The expression was higher in the HBV recovered cases, probably due to the decrease in infection and increase in the immunity of these individuals. Conclusion: Our study is the first to show the association of FAM26F with HBV infection. It is proposed that FAM26F expression could be an early predictive marker for HBV infection, and thus is worthy of further investigation.",0,0,scopus,"['switching systems', 'semantic similarity', 'delta sigma modulator', 'control systems', 'computer systems', 'switching control', 'natural language processing', 'phase modulation', 'security of data', 'malwares', 'malicious codes', 'ontology', 'computer viruses', 'delta sigma modulation', 'phase modulator', 'intrusion detection']",liver carcinoma in situ,"['Effect', 'oxidative', 'stress', 'calcium', 'deregulation', 'CALHM6', 'expression', 'virus', 'infection']","['Family', 'sequence', 'similarity', 'member', 'important', 'innate', 'immunity', 'modulator', 'significant', 'role', 'diverse', 'immune', 'responses', 'association', 'FAM26F', 'expression', 'infection', 'current', 'study', 'differential', 'expression', 'vitro', 'cell', 'lines', 'infection', 'vivo', 'infected', 'individuals', 'effects', 'antioxidant', 'calcium', 'inhibitors', 'regulation', 'FAM26F', 'expression', 'expression', 'determined', 'infection', 'markers', 'Methods', 'expression', 'marker', 'genes', 'Real', 'time', 'qPCR', 'western', 'blot', 'Results', 'results', 'differential', 'expression', 'same', 'trend', 'vitro', 'study', 'cell', 'lines', 'FAM26F', 'expression', 'regulated', 'uninfected', 'control', 'cells', 'Treatment', 'cells', 'N', 'acetyl', 'L', 'cysteine', 'expression', 'cell', 'lines', 'vivo', 'study', 'FAM26F', 'expression', 'groups', 'controls', 'p', 'expression', 'higher', 'cases', 'due', 'decrease', 'infection', 'increase', 'immunity', 'individuals', 'Conclusion', 'study', 'first', 'association', 'infection', 'FAM26F', 'expression', 'early', 'predictive', 'marker', 'infection', 'worthy', 'further', 'investigation']"
409,409,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101794624&origin=inward,Assessment of the embolization effect of temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) nanogels in the rabbit renal artery by CT perfusion and confirmed by macroscopic examination,"¬© 2021, The Author(s).Transcatheter embolization is an important treatment method in clinical therapy, and vascular embolization material plays a key role in embolization. The temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) (PIB) nanogel is a novel embolic agent. To evaluate the feasibility of the nanogel as a blood vessel embolization agent, we aimed to assess the effect of embolization with PIB nanogels in the rabbit renal artery by non-invasive computed tomography (CT) perfusion, macroscopic and histological examination. Ten healthy adult Japanese rabbits were used to implement RAE of PIB nanogels in their right kidneys. CT perfusion scans were performed pre- and post-treatment at various time-points (1, 4, 8, and 12 weeks). Two rabbits were euthanized and histologically examined at each time-point, and the remaining rabbits were euthanized at 12 weeks after embolization. The RAE efficacy of the nanogels was further confirmed by macroscopic and histological examination. The renal volume and renal blood flow (BF) of the right kidney were significantly decreased post-treatment compared with those pre-treatment (volume: pre, 9278 ¬± 1736 mm3; post 1 week, 5155 ¬± 979 mm3, P < 0.0001; post 4 weeks, 3952 ¬± 846 mm3, P < 0.0001; post 8 weeks, 3226 ¬± 556 mm3, P < 0.0001; post 12 weeks, 2064 ¬± 507 mm3, P < 0.0001. BF: pre, 530.81 ¬± 51.50 ml/min/100 ml; post 1 week, 0 ml/min/100 ml, P < 0.0001; post 4 weeks, 0 ml/min/100 ml, P < 0.0001; post 8 weeks, 0 ml/min/100 ml, P < 0.0001; post 12 weeks, 0 ml/min/100 ml, P < 0.0001). No revascularization or collateral circulation was observed on histological examination during this period, and PIB nanogels were dispersed in all levels of the renal arteries. Twelve weeks after embolization, CT perfusion showed no BF in the right renal artery and renal tissue, a finding that was consistent with histological examination showing complete embolization of the right renal artery with a lack of formation of collateral vessels. The effect of embolization on PIB was adequate, with good dispersion and permanency, and could be evaluated by non-invasive and quantitative CT perfusion.",0,0,scopus,"['medical images', 'computerized tomography', 'software agents', 'ct image', 'intelligent agents', 'multiagent system', 'autonomous agents', 'image segmentation']",liver carcinoma in situ,"['Assessment', 'embolization', 'effect', 'temperature', 'sensitive', 'isopropylacrylamide', 'co', '-', 'butyl', 'methylacrylate', 'rabbit', 'renal', 'artery', 'perfusion', 'macroscopic', 'examination']","['embolization', 'important', 'treatment', 'method', 'clinical', 'therapy', 'vascular', 'embolization', 'material', 'key', 'role', 'embolization', 'temperature', 'sensitive', 'isopropylacrylamide', 'co', '-', 'butyl', 'methylacrylate', 'nanogel', 'novel', 'embolic', 'agent', 'feasibility', 'nanogel', 'blood', 'vessel', 'embolization', 'agent', 'effect', 'embolization', 'nanogels', 'rabbit', 'renal', 'artery', 'non', '-', 'invasive', 'tomography', 'perfusion', 'macroscopic', 'histological', 'examination', 'healthy', 'adult', 'Japanese', 'rabbits', 'nanogels', 'right', 'kidneys', 'perfusion', 'scans', 'pre-', 'post', '-', 'treatment', 'various', 'time', 'points', 'weeks', 'rabbits', 'time', 'point', 'rabbits', 'weeks', 'embolization', 'efficacy', 'nanogels', 'macroscopic', 'histological', 'examination', 'renal', 'volume', 'renal', 'blood', 'flow', 'right', 'kidney', 'post', '-', 'treatment', 'pre', '-', 'treatment', 'volume', 'mm3', 'post', 'week', 'mm3', 'P', 'weeks', 'mm3', 'P', 'weeks', 'mm3', 'P', 'weeks', 'mm3', 'P', 'ml', 'ml', 'post', 'week', 'ml', 'ml', 'P', 'weeks', 'ml', 'ml', 'P', 'weeks', 'ml', 'ml', 'P', 'weeks', 'ml', 'ml', 'P', 'revascularization', 'collateral', 'circulation', 'histological', 'examination', 'period', 'nanogels', 'levels', 'renal', 'arteries', 'weeks', 'embolization', 'perfusion', 'BF', 'right', 'renal', 'artery', 'renal', 'tissue', 'finding', 'consistent', 'histological', 'examination', 'complete', 'embolization', 'right', 'renal', 'artery', 'lack', 'formation', 'collateral', 'vessels', 'effect', 'embolization', 'adequate', 'good', 'dispersion', 'permanency', 'non', '-', 'invasive', 'quantitative', 'perfusion']"
410,410,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101781366&origin=inward,SOX9-transactived long non-coding RNA NEAT1 promotes the self-renewal of liver cancer stem cells through PKA/Hippo signaling,0,0,0,scopus,"['programming theory', 'source coding', 'coding techniques', 'image coding', 'channel coding', 'coding scheme', 'data compression', 'network coding', 'signal encoding']",liver carcinoma in situ,"['long', 'non', '-', 'coding', 'self', 'renewal', 'liver', 'cancer', 'stem', 'cells']",[]
411,411,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101709904&origin=inward,Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection,"¬© 2021, The Author(s).Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide is a major public health concern. Cancer patients are considered a vulnerable population to SARS-CoV-2 infection and may develop several COVID-19 symptoms. The heightened immunocompromised state, prolonged chronic pro-inflammatory milieu coupled with comorbid conditions are shared in both disease conditions and may influence patient outcome. Although ovarian cancer (OC) and COVID-19 are diseases of entirely different primary organs, both diseases share similar molecular and cellular characteristics in their microenvironment suggesting a potential cooperativity leading to poor outcome. In COVID-19 related cases, hospitalizations and deaths worldwide are lower in women than in males; however, comorbidities associated with OC may increase the COVID-19 risk in women. The women at the age of 50-60 years are at greater risk of developing OC as well as SARS-CoV-2 infection. Increased levels of gonadotropin and androgen, dysregulated renin-angiotensin-aldosterone system (RAAS), hyper-coagulation and chronic inflammation are common conditions observed among OC and severe cases of COVID-19. The upregulation of common inflammatory cytokines and chemokines such as tumor necrosis factor Œ± (TNF-Œ±), interleukin (IL)-1Œ≤, IL-2, IL-6, IL-10, interferon-Œ≥-inducible protein 10 (IP-10), granulocyte colony-stimulating factor (G-CSF), monocyte chemoattractant protein-1 (MCP-1), macrophage colony-stimulating factor (M-CSF), among others in the sera of COVID-19 and OC subjects suggests potentially similar mechanism(s) involved in the hyper-inflammatory condition observed in both disease states. Thus, it is conceivable that the pathogenesis of OC may significantly contribute to the potential infection by SARS-CoV-2. Our understanding of the influence and mechanisms of SARS-CoV-2 infection on OC is at an early stage and in this article, we review the underlying pathogenesis presented by various comorbidities of OC and correlate their influence on SARS-CoV-2 infection.",0,0,scopus,"['cellular telephone systems', 'computer crime', 'rate control', 'security issues', 'wireless', 'cellular radio systems', 'malicious attack', 'various attacks', 'h.264/avc', 'security attacks', 'network security', 'mean absolute differences', 'authentication', 'cellular', 'watermarking algorithms']",liver carcinoma in situ,"['Comorbidities', 'inflammation', 'ovarian', 'cancer', 'influence', 'infection']","['disease', 'novel', 'severe', 'acute', 'respiratory', 'syndrome', 'coronavirus', 'major', 'public', 'health', 'concern', 'Cancer', 'patients', 'vulnerable', 'population', 'infection', 'several', 'symptoms', 'heightened', 'state', 'chronic', 'pro', '-', 'inflammatory', 'milieu', 'comorbid', 'conditions', 'disease', 'conditions', 'patient', 'outcome', 'ovarian', 'cancer', 'diseases', 'different', 'primary', 'organs', 'diseases', 'similar', 'molecular', 'cellular', 'characteristics', 'microenvironment', 'potential', 'cooperativity', 'poor', 'outcome', 'COVID-19', 'cases', 'hospitalizations', 'deaths', 'lower', 'women', 'males', 'comorbidities', 'risk', 'women', 'women', 'age', 'years', 'greater', 'risk', 'infection', 'Increased', 'levels', 'gonadotropin', 'androgen', 'renin', 'angiotensin', 'aldosterone', 'system', 'hyper', 'coagulation', 'chronic', 'inflammation', 'common', 'conditions', 'severe', 'cases', 'upregulation', 'common', 'inflammatory', 'cytokines', 'chemokines', 'such', 'tumor', 'necrosis', 'factor', 'interferon', 'Œ≥', 'inducible', 'protein', 'granulocyte', 'colony', 'factor', 'G', 'monocyte', 'chemoattractant', 'macrophage', 'colony', 'factor', 'others', 'sera', 'subjects', 'similar', 'hyper', 'inflammatory', 'condition', 'disease', 'states', 'conceivable', 'pathogenesis', 'potential', 'infection', 'understanding', 'influence', 'mechanisms', 'infection', 'early', 'stage', 'article', 'pathogenesis', 'various', 'comorbidities', 'OC', 'influence', 'infection']"
412,412,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101477386&origin=inward,"Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agents","¬© 2021, The Author(s).Cancer stem cells (CSCs) show a self-renewal capacity and differentiation potential that contribute to tumor progression and therapy resistance. However, the underlying processes are still unclear. Elucidation of the key hallmarks and resistance mechanisms of CSCs may help improve patient outcomes and reduce relapse by altering therapeutic regimens. Here, we reviewed the identification of CSCs, the intrinsic and extrinsic mechanisms of therapy resistance in CSCs, the signaling pathways of CSCs that mediate treatment failure, and potential CSC-targeting agents in various tumors from the clinical perspective. Targeting the mechanisms and pathways described here might contribute to further drug discovery and therapy.",0,0,scopus,"['transmission capacities', 'ad hoc networks', 'artificial intelligence', 'software agents', 'intelligent agents', 'multiagent system', 'autonomous agents', 'multiplexing']",liver carcinoma in situ,"['cancer', 'stem', 'cells', 'therapy', 'resistance', 'mechanism', 'prospective', 'agents']","['stem', 'cells', 'self', 'renewal', 'capacity', 'differentiation', 'potential', 'tumor', 'progression', 'therapy', 'resistance', 'processes', 'unclear', 'Elucidation', 'key', 'hallmarks', 'resistance', 'mechanisms', 'CSCs', 'patient', 'outcomes', 'relapse', 'therapeutic', 'regimens', 'identification', 'CSCs', 'intrinsic', 'extrinsic', 'mechanisms', 'therapy', 'resistance', 'pathways', 'CSCs', 'mediate', 'treatment', 'failure', 'potential', 'agents', 'various', 'tumors', 'clinical', 'perspective', 'mechanisms', 'pathways', 'further', 'drug', 'discovery', 'therapy']"
413,413,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101387258&origin=inward,Alternative splicing and cancer: a systematic review,"¬© 2021, The Author(s).The abnormal regulation of alternative splicing is usually accompanied by the occurrence and development of tumors, which would produce multiple different isoforms and diversify protein expression. The aim of the present study was to conduct a systematic review in order to describe the regulatory mechanisms of alternative splicing, as well as its functions in tumor cells, from proliferation and apoptosis to invasion and metastasis, and from angiogenesis to metabolism. The abnormal splicing events contributed to tumor progression as oncogenic drivers and/or bystander factors. The alterations in splicing factors detected in tumors and other mis-splicing events (i.e., long non-coding and circular RNAs) in tumorigenesis were also included. The findings of recent therapeutic approaches targeting splicing catalysis and splicing regulatory proteins to modulate pathogenically spliced events (including tumor-specific neo-antigens for cancer immunotherapy) were introduced. The emerging RNA-based strategies for the treatment of cancer with abnormally alternative splicing isoforms were also discussed. However, further studies are still required to address the association between alternative splicing and cancer in more detail.",0,0,scopus,[],liver carcinoma in situ,"['Alternative', 'splicing', 'cancer', 'systematic', 'review']","['abnormal', 'regulation', 'alternative', 'splicing', 'occurrence', 'development', 'tumors', 'multiple', 'different', 'isoforms', 'protein', 'expression', 'aim', 'present', 'study', 'systematic', 'review', 'order', 'regulatory', 'mechanisms', 'alternative', 'splicing', 'functions', 'tumor', 'cells', 'proliferation', 'apoptosis', 'invasion', 'metastasis', 'angiogenesis', 'metabolism', 'abnormal', 'splicing', 'events', 'tumor', 'progression', 'oncogenic', 'drivers', 'bystander', 'factors', 'alterations', 'factors', 'tumors', 'other', 'mis', 'events', 'long', 'non', '-', 'coding', 'circular', 'RNAs', 'tumorigenesis', 'findings', 'recent', 'therapeutic', 'approaches', 'catalysis', 'regulatory', 'proteins', 'events', 'tumor', 'specific', 'antigens', 'cancer', 'immunotherapy', 'RNA', 'strategies', 'treatment', 'cancer', 'alternative', 'splicing', 'isoforms', 'further', 'studies', 'association', 'alternative', 'splicing', 'cancer', 'more', 'detail']"
414,414,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101260623&origin=inward,Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy,"¬© 2021, The Author(s).Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer immunity, which may result in immune checkpoint blockade therapy being ineffective, in addition to other novel immunotherapies in cancer patients. In the present review, we discuss the deficiencies of current cancer immunotherapies. More importantly, we highlight the critical role of tumor immune microenvironment regulators in tumor immune surveillance, immunological evasion, and the potential for their further translation into clinical practice. Based on their general targetability in clinical therapy, we believe that tumor immune microenvironment regulators are promising cancer immunotherapeutic targets. Targeting the tumor immune microenvironment, alone or in combination with immune checkpoint-targeting drugs, might benefit cancer patients in the future.",0,0,scopus,"['persistent surveillance', 'checkpointing', 'fault tolerance', 'rollback recovery', 'security systems', 'wide area', 'video surveillance', 'sensors', 'surveillance applications', 'computer system recovery']",liver carcinoma in situ,"['Advantages', 'tumor', 'immune', 'microenvironment', 'immune', 'checkpoint', 'cancer', 'immunotherapy']","['Author(s).Despite', 'great', 'success', 'cancer', 'immunotherapy', 'immune', 'checkpoint', 'drugs', 'popular', 'weapon', 'armory', 'cancer', 'therapy', 'evidence', 'tumor', 'immune', 'microenvironment', 'critical', 'role', 'anti', '-', 'cancer', 'immunity', 'immune', 'checkpoint', 'blockade', 'therapy', 'ineffective', 'addition', 'other', 'novel', 'immunotherapies', 'cancer', 'patients', 'present', 'review', 'deficiencies', 'current', 'cancer', 'immunotherapies', 'critical', 'role', 'tumor', 'immune', 'microenvironment', 'regulators', 'tumor', 'immune', 'surveillance', 'immunological', 'evasion', 'potential', 'further', 'translation', 'clinical', 'practice', 'general', 'targetability', 'clinical', 'therapy', 'tumor', 'immune', 'microenvironment', 'regulators', 'cancer', 'immunotherapeutic', 'targets', 'tumor', 'immune', 'microenvironment', 'alone', 'combination', 'immune', 'checkpoint', 'drugs', 'cancer', 'patients', 'future']"
415,415,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85101063041&origin=inward,Inhibition of androgen/AR signaling inhibits diethylnitrosamine (DEN) induced tumour initiation and remodels liver immune cell networks,"¬© 2021, The Author(s).A promotional role for androgen receptor (AR) signaling in hepatocellular carcinogenesis is emerging. In pre-clinical models, including diethylnitrosamine- (DEN-) induced hepatocellular carcinoma (HCC), anti-androgen therapies delay hepatocarcinogenesis. However, pharmacologic anti-androgen therapy in advanced HCC patients fails, suggesting that AR plays a role in HCC onset. This study aims to characterize AR expression and function throughout DEN-induced liver inflammation and carcinogenesis and evaluate the efficacy of prophylactic AR antagonism to prevent hepatocarcinogenesis. We demonstrate that pharmacologic AR antagonism with enzalutamide inhibits hepatocellular carcinogenesis. With enzalutamide treatment, we observe decreased CYP2E1 expression, reducing DEN-induced hepatocyte death and DNA ethyl-adducts. AR protein expression analyses show that DEN causes an initial upregulation of AR in portal fibroblasts and leukocytes, but not hepatocytes, suggesting that hepatocyte-autonomous AR signaling is not essential for DEN-induced carcinogenesis. Ablating androgen signaling by surgical castration reduced pre-carcinogen Kupffer cell populations but did not alter DEN-mediated immune cell recruitment nor AR expression. In this study, we identified that anti-androgen interventions modulate mutagenic DNA adducts, tumour initiation, and immune cell composition. Additionally, we find that AR expression in hepatocytes is not present during nor required for early DEN-mediated carcinogenesis.",0,0,scopus,"['telecommunication networks', 'communication', 'mesh network', 'computer network', 'standard model', 'propagation delays', 'communication networks', 'network protocols', 'network architecture', 'the standard model', 'electronic document identification systems', 'wireless mesh networks (wmn)']",liver carcinoma in situ,"['Inhibition', 'androgen', 'signaling', 'diethylnitrosamine', 'tumour', 'initiation', 'liver', 'immune', 'cell', 'networks']","['promotional', 'role', 'androgen', 'receptor', 'hepatocellular', 'carcinogenesis', 'pre', '-', 'clinical', 'models', 'hepatocellular', 'carcinoma', 'anti', '-', 'androgen', 'therapies', 'delay', 'hepatocarcinogenesis', 'pharmacologic', 'anti', '-', 'androgen', 'therapy', 'advanced', 'patients', 'role', 'onset', 'study', 'expression', 'function', 'liver', 'inflammation', 'carcinogenesis', 'efficacy', 'prophylactic', 'antagonism', 'hepatocarcinogenesis', 'antagonism', 'enzalutamide', 'hepatocellular', 'carcinogenesis', 'enzalutamide', 'treatment', 'CYP2E1', 'expression', 'hepatocyte', 'death', 'DNA', 'adducts', 'protein', 'expression', 'initial', 'upregulation', 'portal', 'fibroblasts', 'leukocytes', 'hepatocytes', 'hepatocyte', 'autonomous', 'AR', 'signaling', 'essential', 'carcinogenesis', 'androgen', 'surgical', 'castration', 'pre', '-', 'carcinogen', 'cell', 'populations', 'immune', 'cell', 'recruitment', 'expression', 'study', 'anti', '-', 'androgen', 'interventions', 'mutagenic', 'DNA', 'adducts', 'tumour', 'initiation', 'immune', 'cell', 'composition', 'expression', 'hepatocytes', 'present', 'early', 'carcinogenesis']"
416,416,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100912059&origin=inward,mRNA vaccine: a potential therapeutic strategy,"¬© 2021, The Author(s).mRNA vaccines have tremendous potential to fight against cancer and viral diseases due to superiorities in safety, efficacy and industrial production. In recent decades, we have witnessed the development of different kinds of mRNAs by sequence optimization to overcome the disadvantage of excessive mRNA immunogenicity, instability and inefficiency. Based on the immunological study, mRNA vaccines are coupled with immunologic adjuvant and various delivery strategies. Except for sequence optimization, the assistance of mRNA-delivering strategies is another method to stabilize mRNAs and improve their efficacy. The understanding of increasing the antigen reactiveness gains insight into mRNA-induced innate immunity and adaptive immunity without antibody-dependent enhancement activity. Therefore, to address the problem, scientists further exploited carrier-based mRNA vaccines (lipid-based delivery, polymer-based delivery, peptide-based delivery, virus-like replicon particle and cationic nanoemulsion), naked mRNA vaccines and dendritic cells-based mRNA vaccines. The article will discuss the molecular biology of mRNA vaccines and underlying anti-virus and anti-tumor mechanisms, with an introduction of their immunological phenomena, delivery strategies, their importance on Corona Virus Disease 2019 (COVID-19) and related clinical trials against cancer and viral diseases. Finally, we will discuss the challenge of mRNA vaccines against bacterial and parasitic diseases.",0,0,scopus,"['mathematics', 'optimization', 'correlation analysis', 'security of data', 'optimization problems', 'malwares', 'malicious codes', 'evolutionary algorithms', 'computer viruses', 'multi-objective optimisation', 'intrusion detection']",liver carcinoma in situ,"['mRNA', 'vaccine', 'potential', 'therapeutic', 'strategy']","['vaccines', 'tremendous', 'potential', 'cancer', 'viral', 'diseases', 'due', 'superiorities', 'safety', 'efficacy', 'industrial', 'production', 'recent', 'decades', 'development', 'different', 'kinds', 'sequence', 'optimization', 'disadvantage', 'excessive', 'immunogenicity', 'instability', 'inefficiency', 'immunological', 'study', 'vaccines', 'immunologic', 'adjuvant', 'various', 'delivery', 'strategies', 'sequence', 'optimization', 'assistance', 'strategies', 'method', 'efficacy', 'understanding', 'antigen', 'reactiveness', 'gains', 'insight', 'innate', 'immunity', 'adaptive', 'immunity', 'antibody', 'dependent', 'enhancement', 'activity', 'problem', 'scientists', 'carrier', 'vaccines', 'lipid', 'delivery', 'polymer', 'delivery', 'peptide', 'delivery', 'virus', 'like', 'replicon', 'particle', 'nanoemulsion', 'naked', 'vaccines', 'dendritic', 'cells', 'vaccines', 'article', 'molecular', 'biology', 'vaccines', 'anti', '-', 'virus', 'anti', '-', 'tumor', 'mechanisms', 'introduction', 'immunological', 'phenomena', 'delivery', 'strategies', 'importance', 'clinical', 'trials', 'cancer', 'viral', 'diseases', 'challenge', 'vaccines', 'bacterial', 'parasitic', 'diseases']"
417,417,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100895186&origin=inward,VŒ≥9VŒ¥2 T cells strengthen cisplatin inhibition activity against breast cancer MDA-MB-231 cells by disrupting mitochondrial function and cell ultrastructure,"¬© 2021, The Author(s).Background: Breast cancer ranks second of new cases and fifth of death in 2018 worldwide. Cis-platinum (CDDP) has been used as a chemotherapy to treat breast cancer for years. However, CDDP can adversely disrupt immune function of host. Thus, development of new protocol that can minimize side effect and meanwhile elevate clinical efficacy of CDDP will eventually benefit cancer patients. Since VŒ≥9VŒ¥2 T cells can up-regulate immune function of cancer patients, therefore, our hypothesis is that introduction of VŒ≥9VŒ¥2 T cells could potentiate CDDP efficacy against breast cancer. Methods: We used breast cancer cell line MDA-MB-231 as model cell to test our hypothesis. The cancer cell viability in vitro in the context of different dose of CDDP was analyzed by flow cytometry. The cytoskeleton alteration was visualized by confocal microscopy, and the ultrastructure of cell membrane was observed by atomic force microscopy. The mitochondrial function of MDA-MB-231 cells was detected as well by flow cytometry. Results: Comparing to either VŒ≥9VŒ¥2 T cells or CDDP alone, VŒ≥9VŒ¥2 T cells plus CDDP could more strikingly induce MDA-MB-231 cell membrane ultrastructure disruption and cytoskeleton disorder, and more significantly enhance the inhibition of CDDP on proliferation of MDA-MB-231 cells. At the same time, VŒ≥9VŒ¥2 T cells strengthened CDDP-induced mitochondrial dysfunction of cancer cells. Conclusion: This work revealed that VŒ≥9VŒ¥2 T cells could synergistically enhance the inhibition activity of CDDP against breast cancer cells. Meanwhile, this in vitro proof-of-concept study implied the clinical prospect of the combining application of VŒ≥9VŒ¥2 T cells and CDDP in breast cancer therapy.",0,0,scopus,"['noc', 'communication', 'communication protocols', 'formal proofs', 'hierarchical model', 'hierarchical system', 'interfaces (computer)', 'network protocols', 'transport protocols', 'network interface', 'transmission control protocol', 'data communication systems', 'formal verifications', 'formal logic']",liver carcinoma in situ,"['cells', 'cisplatin', 'inhibition', 'activity', 'breast', 'cancer', 'MB-231', 'cells', 'mitochondrial', 'function', 'cell', 'ultrastructure']","['Breast', 'cancer', 'second', 'new', 'cases', 'fifth', 'death', 'Cis', 'platinum', 'chemotherapy', 'breast', 'cancer', 'years', 'immune', 'function', 'host', 'development', 'new', 'protocol', 'side', 'effect', 'clinical', 'efficacy', 'cancer', 'patients', 'VŒ≥9VŒ¥2', 'cells', 'immune', 'function', 'cancer', 'patients', 'hypothesis', 'introduction', 'VŒ≥9VŒ¥2', 'cells', 'efficacy', 'breast', 'cancer', 'Methods', 'breast', 'cancer', 'cell', 'line', 'MB-231', 'model', 'cell', 'hypothesis', 'cancer', 'cell', 'viability', 'vitro', 'context', 'different', 'dose', 'flow', 'cytometry', 'cytoskeleton', 'alteration', 'confocal', 'microscopy', 'ultrastructure', 'cell', 'membrane', 'atomic', 'force', 'microscopy', 'mitochondrial', 'function', 'MB-231', 'cells', 'flow', 'cytometry', 'Results', 'cells', 'CDDP', 'VŒ≥9VŒ¥2', 'cells', 'MB-231', 'cell', 'membrane', 'ultrastructure', 'disruption', 'cytoskeleton', 'disorder', 'inhibition', 'proliferation', 'MB-231', 'cells', 'same', 'time', 'VŒ≥9VŒ¥2', 'cells', 'mitochondrial', 'dysfunction', 'cancer', 'cells', 'Conclusion', 'work', 'VŒ≥9VŒ¥2', 'cells', 'inhibition', 'activity', 'breast', 'cancer', 'cells', 'proof', 'concept', 'study', 'clinical', 'prospect', 'application', 'VŒ≥9VŒ¥2', 'cells', 'CDDP', 'breast', 'cancer', 'therapy']"
418,418,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100872091&origin=inward,The biological function of m6A reader YTHDF2 and its role in human disease,"¬© 2021, The Author(s).N6-methyladenosine (m6A) modification is a dynamic and reversible post-transcriptional modification and the most prevalent internal RNA modification in eukaryotic cells. YT521-B homology domain family 2 (YTHDF2) is a member of m6A ‚Äúreaders‚Äù and its role in human diseases remains unclear. Accumulating evidence suggests that YTHDF2 is greatly implicated in many aspects of human cancers and non-cancers through various mechanisms. YTHDF2 takes a great part in multiple biological processes, such as migration, invasion, metastasis, proliferation, apoptosis, cell cycle, cell viability, cell adhesion, differentiation and inflammation, in both human cancers and non-cancers. Additionally, YTHDF2 influences various aspects of RNA metabolism, including mRNA decay and pre-ribosomal RNA (pre-rRNA) processing. Moreover, emerging researches indicate that YTHDF2 predicts the prognosis of different cancers. Herein, we focus on concluding YTHDF2-associated mechanisms and potential biological functions in kinds of cancers and non-cancers, and its prospects as a prognostic biomarker.",0,0,scopus,"['planar graph', 'cycle']",liver carcinoma in situ,"['biological', 'function', 'm6A', 'reader', 'role', 'human', 'disease']","['Author(s).N6-methyladenosine', 'modification', 'dynamic', 'reversible', 'post', '-', 'transcriptional', 'modification', 'prevalent', 'internal', 'modification', 'eukaryotic', 'cells', 'homology', 'domain', 'family', 'member', 'readers', 'role', 'human', 'diseases', 'unclear', 'evidence', 'many', 'aspects', 'human', 'cancers', 'non', '-', 'cancers', 'various', 'mechanisms', 'great', 'part', 'multiple', 'biological', 'processes', 'such', 'migration', 'invasion', 'metastasis', 'proliferation', 'apoptosis', 'cell', 'cycle', 'cell', 'viability', 'cell', 'adhesion', 'differentiation', 'inflammation', 'human', 'cancers', 'non', '-', 'cancers', 'various', 'aspects', 'metabolism', 'pre', '-', 'ribosomal', 'processing', 'researches', 'prognosis', 'different', 'cancers', 'YTHDF2-associated', 'mechanisms', 'potential', 'biological', 'functions', 'kinds', 'cancers', 'non', '-', 'cancers', 'prospects', 'prognostic', 'biomarker']"
419,419,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100823350&origin=inward,MUTYH is associated with hepatocarcinogenesis in a non-alcoholic steatohepatitis mouse model,"¬© 2021, The Author(s).Non-alcoholic steatohepatitis (NASH)-related HCC is associated with oxidative stress. However, the mechanisms underlying the development of NASH-related HCC is unclear. MUTYH is one of the enzymes that is involved in repair of oxidative DNA damage. The aim of this study was to investigate the association between MUTYH and NASH-related hepatocarcinogenesis. MUTYH wild-type (Mutyh+/+), heterozygous (Mutyh+/‚àí), and MUTYH-null (Mutyh‚àí/‚àí) mice were fed a high-fat high-cholesterol (HFHC) diet or HFHC + high iron diet (20 mice per group) for 9 months. Five of 20 Mutyh‚àí/‚àí mice fed an HFHC + high iron diet developed liver tumors, and they developed more liver tumors than other groups (especially vs. Mutyh+/+ fed an HFHC diet, P = 0.0168). Immunohistochemical analysis revealed significantly higher accumulation of oxidative stress markers in mice fed an HFHC + high iron diet. The gene expression profiles in the non-tumorous hepatic tissues were compared between wild-type mice that developed no liver tumors and MUTYH-null mice that developed liver tumors. Gene Set Enrichment Analysis identified the involvement of the Wnt/Œ≤-catenin signaling pathway and increased expression of c-Myc in MUTYH-null liver. These findings suggest that MUTYH deficiency is associated with hepatocarcinogenesis in patients with NASH with hepatic iron accumulation.",0,0,scopus,"['damage detection', 'hierarchical system', 'hierarchical model', 'correlation analysis', 'structural damages', 'structural health monitoring', 'mathematics']",liver carcinoma in situ,"['hepatocarcinogenesis', 'non', '-', 'alcoholic', 'steatohepatitis', 'mouse', 'model']","['alcoholic', 'steatohepatitis', 'NASH)-related', 'oxidative', 'stress', 'mechanisms', 'development', 'unclear', 'enzymes', 'repair', 'oxidative', 'DNA', 'damage', 'aim', 'study', 'association', 'hepatocarcinogenesis', 'wild', 'type', 'heterozygous', 'mice', 'high', 'fat', 'high', 'cholesterol', 'diet', 'high', 'iron', 'diet', 'mice', 'group', 'months', 'mice', 'high', 'iron', 'diet', 'liver', 'tumors', 'more', 'liver', 'tumors', 'other', 'groups', 'diet', 'P', 'Immunohistochemical', 'analysis', 'higher', 'accumulation', 'oxidative', 'stress', 'markers', 'mice', 'high', 'iron', 'diet', 'gene', 'expression', 'profiles', 'non', '-', 'tumorous', 'hepatic', 'tissues', 'wild', 'type', 'mice', 'liver', 'tumors', 'null', 'mice', 'liver', 'tumors', 'involvement', 'Œ≤', 'catenin', 'pathway', 'expression', 'c', 'Myc', 'null', 'liver', 'findings', 'deficiency', 'hepatocarcinogenesis', 'patients', 'hepatic', 'iron', 'accumulation']"
420,420,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100572758&origin=inward,"The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure","¬© 2021, The Author(s).Background: Heart failure (HF) is a clinical syndrome characterized by left ventricular dysfunction or elevated intracardiac pressures. Research supports that microRNAs (miRs) participate in HF by regulating targeted genes. Hence, the current study set out to study the role of HDAC3-medaited miR-18a in HF by targeting ADRB3. Methods: Firstly, HF mouse models were established by ligation of the left coronary artery at the lower edge of the left atrial appendage, and HF cell models were generated in the cardiomyocytes, followed by ectopic expression and silencing experiments. Numerous parameters including left ventricular posterior wall dimension (LVPWD), interventricular septal dimension (IVSD), left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD), left ventricular ejection fraction (LVEF), left ventricular fractional shortening (LVFS), left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LEVDP), heart rate (HR), left ventricular pressure rise rate (+ dp/dt) and left ventricular pressure drop rate (-dp/dt) were measured in the mice. In addition, apoptosis in the mice was detected by means of TUNEL staining, while RT-qPCR and Western blot analysis were performed to detect miR-18a, HDAC3, ADRB3, cMyb, MMP-9, Collagen 1 and TGF-Œ≤1 expression patterns. Dual luciferase reporter assay validated the targeting relationship between ADRB3 and miR-18a. Cardiomyocyte apoptosis was determined by means of flow cytometry. Results: HDAC3 and ADRB3 were up-regulated and miR-18a was down-regulated in HF mice and cardiomyocytes. In addition, HDAC3 could reduce the miR-18a expression, and ADRB3 was negatively-targeted by miR-18a. After down-regulation of HDAC3 or ADRB3 or over-expression of miR-18a, IVSD, LVEDD, LVESD and LEVDP were found to be decreased but LVPWD, LVEF, LVFS, LVSP, + dp/dt, and ‚àídp/dt were all increased in the HF mice, whereas fibrosis, hypertrophy and apoptosis of HF cardiomyocytes were declined. Conclusion: Collectively, our findings indicate that HDAC3 silencing confers protection against HF by inhibiting miR-18a-targeted ADRB3.",0,0,scopus,"['node failure', 'field programmable gate arrays (fpga)', 'vlsi circuits', 'stochastic processes', 'mathematics', 'wireless sensor networks', 'fault tolerance', 'standard model', 'correlation analysis', 'parallel processing systems', 'research support', 'systolic arrays', 'sensor networks', 'electronic document identification systems', 'the standard model', 'education', 'probability']",liver carcinoma in situ,"['crosstalk', 'progression', 'heart', 'failure']","['Heart', 'failure', 'clinical', 'syndrome', 'ventricular', 'dysfunction', 'intracardiac', 'pressures', 'Research', 'miRs', 'genes', 'current', 'study', 'role', 'HDAC3-medaited', 'miR-18a', 'Methods', 'mouse', 'models', 'ligation', 'left', 'coronary', 'artery', 'lower', 'edge', 'left', 'atrial', 'appendage', 'cell', 'models', 'cardiomyocytes', 'ectopic', 'expression', 'experiments', 'Numerous', 'parameters', 'ventricular', 'posterior', 'wall', 'dimension', 'interventricular', 'septal', 'dimension', 'ventricular', 'end', 'diastolic', 'diameter', 'ventricular', 'end', 'systolic', 'diameter', 'ventricular', 'ejection', 'fraction', 'ventricular', 'fractional', 'shortening', 'ventricular', 'systolic', 'pressure', 'ventricular', 'end', 'diastolic', 'pressure', 'heart', 'rate', 'ventricular', 'pressure', 'rise', 'rate', 'dt', 'ventricular', 'pressure', 'drop', 'rate', '-dp', 'dt', 'mice', 'addition', 'apoptosis', 'mice', 'means', 'TUNEL', 'staining', 'Western', 'blot', 'analysis', 'miR-18a', 'Œ≤1', 'expression', 'patterns', 'Dual', 'luciferase', 'reporter', 'assay', 'relationship', 'miR-18a', 'apoptosis', 'means', 'flow', 'cytometry', 'Results', 'miR-18a', 'regulated', 'mice', 'cardiomyocytes', 'addition', 'miR-18a', 'expression', 'miR-18a', 'regulation', 'expression', 'miR-18a', 'dt', 'mice', 'fibrosis', 'hypertrophy', 'apoptosis', 'cardiomyocytes', 'Conclusion', 'findings', 'confers', 'protection', 'miR-18a']"
421,421,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100560839&origin=inward,pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma,"¬© 2021, The Author(s).A limitation of current anticancer nanocarriers is the contradiction between multiple functions and favorable biocompatibility. Thus, we aimed to develop a compatible drug delivery system loaded with paclitaxel (PTX) for hepatocellular carcinoma (HCC) therapy. A basic backbone, PTX-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) PHBV nanoparticle (PHBV-PTX-NPs), was prepared by emulsion solvent evaporation. As a gatekeeper, the pH-sensitive coating was formed by self-polymerization of dopamine (PDA). The HCC-targeted arginine-glycine-aspartic acid (RGD)-peptide and PDA-coated nanoparticles (NPs) were combined through the Michael addition. Subsequently, the physicochemical properties of RGD-PDA-PHBV-PTX-NPs were characterized by dynamic light scattering-autosizer, transmission electron microscope, fourier transform infrared spectroscopy, differential scanning calorimetry, thermogravimetry and X-ray spectroscopy. As expected, the RGD-PDA-PHBV-PTX-NPs showed robust anticancer efficacy in a xenograft mouse model. More importantly, they exhibited lower toxicity than PTX to normal hepatocytes and mouse in vitro and in vivo, respectively. Taken together, these results indicate that the RGD-PDA-PHBV-PTX-NPs are potentially beneficial for easing conflict between multifunction and biocompatible characters of nanocarriers. [Figure not available: see fulltext.].",0,0,scopus,"['signal processing', 'smart phones', 'mobile telecommunication systems', 'metropolitan area networks', 'mobile devices', 'metro networks', 'fiber optic networks', 'optical fibers', 'telephone sets', 'personal digital assistants', 'optical materials', 'engineering', 'vehicles', 'user interfaces', 'fourier transforms', 'light propagation']",liver carcinoma in situ,"['pH', 'responsive', 'delivery', 'vehicle', 'polydopamine', 'paclitaxel', 'poly', 'co-3-hydroxyvalerate', 'nanoparticles', 'therapy', 'hepatocellular', 'carcinoma']","['Author(s).A', 'limitation', 'current', 'anticancer', 'nanocarriers', 'contradiction', 'multiple', 'functions', 'favorable', 'biocompatibility', 'compatible', 'drug', 'delivery', 'system', 'paclitaxel', 'hepatocellular', 'carcinoma', 'therapy', 'basic', 'backbone', 'poly', 'co-3-hydroxyvalerate', 'PHBV', 'nanoparticle', 'PHBV', 'emulsion', 'solvent', 'evaporation', 'gatekeeper', 'pH', 'sensitive', 'coating', 'self', 'polymerization', 'dopamine', 'arginine', 'glycine', 'aspartic', 'acid', 'RGD)-peptide', 'nanoparticles', 'NPs', 'addition', 'physicochemical', 'properties', 'dynamic', 'light', 'scattering', 'transmission', 'electron', 'microscope', 'fourier', 'infrared', 'spectroscopy', 'differential', 'scanning', 'calorimetry', 'thermogravimetry', 'X', '-', 'ray', 'spectroscopy', 'robust', 'anticancer', 'efficacy', 'xenograft', 'mouse', 'model', 'lower', 'toxicity', 'normal', 'hepatocytes', 'mouse', 'vitro', 'vivo', 'results', 'NPs', 'beneficial', 'conflict', 'multifunction', 'biocompatible', 'characters', 'nanocarriers', 'Figure', 'available']"
422,422,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100318828&origin=inward,Real-time monitoring of liver fibrosis through embedded sensors in a microphysiological system,"¬© 2021, The Author(s).Hepatic fibrosis is a foreshadowing of future adverse events like liver cirrhosis, liver failure, and cancer. Hepatic stellate cell activation is the main event of liver fibrosis, which results in excessive extracellular matrix deposition and hepatic parenchyma's disintegration. Several biochemical and molecular assays have been introduced for in vitro study of the hepatic fibrosis progression. However, they do not forecast real-time events happening to the in vitro models. Trans-epithelial electrical resistance (TEER) is used in cell culture science to measure cell monolayer barrier integrity. Herein, we explored TEER measurement's utility for monitoring fibrosis development in a dynamic cell culture microphysiological system. Immortal HepG2 cells and fibroblasts were co-cultured, and transforming growth factor Œ≤1 (TGF-Œ≤1) was used as a fibrosis stimulus to create a liver fibrosis-on-chip model. A glass chip-based embedded TEER and reactive oxygen species (ROS) sensors were employed to gauge the effect of TGF-Œ≤1 within the microphysiological system, which promotes a positive feedback response in fibrosis development. Furthermore, albumin, Urea, CYP450 measurements, and immunofluorescent microscopy were performed to correlate the following data with embedded sensors responses. We found that chip embedded electrochemical sensors could be used as a potential substitute for conventional end-point assays for studying fibrosis in microphysiological systems.",0,0,scopus,"['embedded', 'computer hardware', 'sensing systems', 'social sciences', 'wireless telecommunication systems', 'sensors', 'wireless sensor', 'embedded software', 'sensor data', 'sociology']",liver carcinoma in situ,"['Real', 'time', 'monitoring', 'liver', 'fibrosis', 'sensors', 'microphysiological', 'system']","['Author(s).Hepatic', 'fibrosis', 'foreshadowing', 'future', 'adverse', 'events', 'liver', 'cirrhosis', 'liver', 'failure', 'cancer', 'Hepatic', 'stellate', 'cell', 'activation', 'main', 'event', 'liver', 'fibrosis', 'excessive', 'extracellular', 'matrix', 'deposition', 'hepatic', 'parenchyma', 'disintegration', 'Several', 'biochemical', 'molecular', 'assays', 'study', 'hepatic', 'fibrosis', 'progression', 'real', 'time', 'events', 'models', 'Trans', '-', 'epithelial', 'electrical', 'resistance', 'cell', 'culture', 'science', 'cell', 'monolayer', 'barrier', 'integrity', 'measurement', 'utility', 'fibrosis', 'development', 'dynamic', 'cell', 'culture', 'microphysiological', 'system', 'cells', 'fibroblasts', '-', 'cultured', 'growth', 'factor', 'Œ≤1', 'fibrosis', 'stimulus', 'liver', 'fibrosis', 'chip', 'model', 'glass', 'chip', 'reactive', 'oxygen', 'species', 'sensors', 'effect', 'microphysiological', 'system', 'positive', 'feedback', 'response', 'fibrosis', 'development', 'albumin', 'measurements', 'immunofluorescent', 'microscopy', 'data', 'sensors', 'responses', 'chip', 'electrochemical', 'sensors', 'potential', 'substitute', 'conventional', 'end', 'point', 'assays', 'fibrosis', 'microphysiological', 'systems']"
423,423,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100253789&origin=inward,Noni fruit‚Äôs water spot appearance on the second day of harvest: a trade-off between resistance and energy,"¬© 2021, The Author(s).Background: Noni (Morinda citrifolia Linn.) is a tropical tree that bears climacteric fruit. Previous observations and research have shown that the second day (2 d) after harvest is the most important demarcation point when the fruit has the same appearance as the freshly picked fruit (0 d); however, they are beginning to become water spot appearance. We performed a conjoint analysis of metabolome and transcriptome data for noni fruit of 0 d and 2 d to reveal what happened to the fruit at the molecular level. Genes and metabolites were annotated to KEGG pathways and the co-annotated KEGG pathways were used as a statistical analysis. Results: We found 25 pathways that were significantly altered at both metabolic and transcriptional levels, including a total of 285 differentially expressed genes (DEGs) and 11 differential metabolites through an integrative analysis of transcriptomics and metabolomics. The energy metabolism and pathways originating from phenylalanine were disturbed the most. The upregulated resistance metabolites and genes implied the increase of resistance and energy consumption in the postharvest noni fruit. Most genes involved in glycolysis were downregulated, further limiting the available energy. This lack of energy led noni fruit to water spot appearance, a prelude to softening. The metabolites and genes related to the resistance and energy interacted and restricted each other to keep noni fruit seemingly hard within two days after harvest, but actually the softening was already unstoppable. Conclusions: This study provides a new insight into the relationship between the metabolites and genes of noni fruit, as well as a foundation for further clarification of the post-ripening mechanism in noni fruit. [Figure not available: see fulltext.]",0,0,scopus,"['commerce', 'trade', 'object tracking', 'energy conservation', 'correlation analysis', 'appearance models', 'face recognition', 'energy utilization', 'object appearance', 'mathematics']",liver carcinoma in situ,"['Noni', 'fruit', 'water', 'spot', 'appearance', 'second', 'day', 'harvest', 'trade', 'off', 'resistance', 'energy']","['Author(s).Background', 'citrifolia', 'tropical', 'tree', 'climacteric', 'fruit', 'Previous', 'observations', 'research', 'second', 'day', 'harvest', 'important', 'demarcation', 'point', 'fruit', 'same', 'appearance', 'fruit', 'd', 'water', 'spot', 'appearance', 'conjoint', 'analysis', 'metabolome', 'transcriptome', 'data', 'noni', 'fruit', 'd', 'd', 'fruit', 'molecular', 'level', 'Genes', 'metabolites', 'pathways', 'co', '-', 'annotated', 'pathways', 'statistical', 'analysis', 'Results', 'pathways', 'metabolic', 'transcriptional', 'levels', 'total', 'genes', 'differential', 'metabolites', 'integrative', 'analysis', 'transcriptomics', 'metabolomics', 'energy', 'metabolism', 'pathways', 'phenylalanine', 'upregulated', 'resistance', 'metabolites', 'genes', 'increase', 'resistance', 'energy', 'consumption', 'postharvest', 'noni', 'fruit', 'Most', 'genes', 'glycolysis', 'available', 'energy', 'lack', 'energy', 'noni', 'fruit', 'water', 'spot', 'appearance', 'prelude', 'softening', 'metabolites', 'genes', 'resistance', 'energy', 'other', 'noni', 'fruit', 'days', 'harvest', 'softening', 'unstoppable', 'Conclusions', 'study', 'new', 'insight', 'relationship', 'metabolites', 'genes', 'noni', 'fruit', 'foundation', 'further', 'clarification', 'post', '-', 'ripening', 'mechanism', 'noni', 'fruit', 'Figure', 'available', 'fulltext']"
424,424,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100241890&origin=inward,Circulatory shear stress induces molecular changes and side population enrichment in primary tumor-derived lung cancer cells with higher metastatic potential,"¬© 2021, The Author(s).Cancer is a leading cause of death and disease worldwide. However, while the survival for patients with primary cancers is improving, the ability to prevent metastatic cancer has not. Once patients develop metastases, their prognosis is dismal. A critical step in metastasis is the transit of cancer cells in the circulatory system. In this hostile microenvironment, variations in pressure and flow can change cellular behavior. However, the effects that circulation has on cancer cells and the metastatic process remain unclear. To further understand this process, we engineered a closed-loop fluidic system to analyze molecular changes induced by variations in flow rate and pressure on primary tumor-derived lung adenocarcinoma cells. We found that cancer cells overexpress epithelial-to-mesenchymal transition markers TWIST1 and SNAI2, as well as stem-like marker CD44 (but not CD133, SOX2 and/or NANOG). Moreover, these cells display a fourfold increased percentage of side population cells and have an increased propensity for migration. In vivo, surviving circulatory cells lead to decreased survival in rodents. These results suggest that cancer cells that express a specific circulatory transition phenotype and are enriched in side population cells are able to survive prolonged circulatory stress and lead to increased metastatic disease and shorter survival.",0,0,scopus,"['cellular telephone systems', 'kaplan-meiers estimate', 'wireless', 'microfabricated', 'cellular radio systems', 'microfabrication', 'channel capacity', 'cellular network', 'cellular system', 'cellular', 'proportional hazards models', 'solid-state sensors']",liver carcinoma in situ,"['Circulatory', 'shear', 'stress', 'molecular', 'changes', 'side', 'population', 'enrichment', 'primary', 'tumor', 'lung', 'cancer', 'cells', 'higher', 'metastatic', 'potential']","['Author(s).Cancer', 'leading', 'cause', 'death', 'disease', 'survival', 'patients', 'primary', 'cancers', 'ability', 'metastatic', 'cancer', 'patients', 'metastases', 'prognosis', 'dismal', 'critical', 'step', 'metastasis', 'transit', 'cancer', 'cells', 'circulatory', 'system', 'hostile', 'microenvironment', 'variations', 'pressure', 'flow', 'cellular', 'behavior', 'effects', 'circulation', 'cancer', 'cells', 'metastatic', 'process', 'unclear', 'process', 'closed', 'loop', 'fluidic', 'system', 'molecular', 'changes', 'variations', 'flow', 'rate', 'pressure', 'primary', 'tumor', 'lung', 'adenocarcinoma', 'cells', 'cancer', 'cells', 'epithelial', 'mesenchymal', 'transition', 'markers', 'TWIST1', 'stem', 'like', 'marker', 'cells', 'percentage', 'side', 'population', 'cells', 'propensity', 'migration', 'vivo', 'circulatory', 'cells', 'survival', 'rodents', 'results', 'cancer', 'cells', 'specific', 'circulatory', 'transition', 'phenotype', 'side', 'population', 'cells', 'able', 'circulatory', 'stress', 'metastatic', 'disease', 'shorter', 'survival']"
425,425,http://dx.doi.org/10.1080/2162402X.2018.1424673,In situ delivery of allogeneic natural killer cell (NK) combined with Cetuximab in liver metastases of gastrointestinal carcinoma: A phase I clinical trial,"Despite successful introduction of NK-based cellular therapy in the treatment of myeloid leukemia, the potential use of NK alloreactivity in solid malignancies is still elusive. We performed a phase I clinical trial to assess the safety and efficacy of in situ delivery of allogeneic NK cells combined with cetuximab in liver metastasis of gastrointestinal origin. The conditioning chemotherapy was administrated before the allogeneic NK cells injection via hepatic artery. Three escalating doses were tested (3.106, 8.106 and 12.106 NK cells/kg) following by a high-dose interleukin-2 (IL-2). Cetuximab was administered intravenously every week for 7 weeks. Nine patients with liver metastases of colorectal or pancreatic cancers were included, three per dose level. Hepatic artery injection was successfully performed in all patients with no report of dose-limiting toxicity. Two patients had febrile aplasia requiring a short-term antibiotherapy. Grade 3/4 anemia and thrombopenia were also observed related to the chemotherapy. Objective clinical responses were documented in 3 patients and among them 2 occurred in patients injected with cell products harboring two KIR ligand mismatches and one in a patient with one KIR ligand mismatch. Immune monitoring revealed that most patients presented an increase but transient of IL-15 and IL-7 cytokines levels one week after chemotherapy. Furthermore, a high expansion of FoxP3+regulatory T cells and PD-1+ T cells was observed in all patients, related to IL-2 administration. Our results demonstrated that combining allogeneic NK cells transfer via intra-hepatic artery, cetuximab and a high-dose IL-2 is feasible, well tolerated and may result in clinical responses.",['O. Adotevi'],"['adoptive cell transfer', 'cetuximab', 'intrahepatic infusion', 'nk cell']",doaj,"['cellular telephone systems', 'remote monitoring', 'wireless', 'mass customization', 'customized products', 'cellular radio systems', 'channel capacity', 'cellular network', 'remote control', 'cellular system', 'cellular']",liver carcinoma in situ,"['situ', 'delivery', 'allogeneic', 'natural', 'killer', 'cell', 'liver', 'metastases', 'gastrointestinal', 'carcinoma', 'phase', 'clinical', 'trial']","['successful', 'introduction', 'cellular', 'therapy', 'treatment', 'myeloid', 'leukemia', 'potential', 'use', 'alloreactivity', 'solid', 'malignancies', 'elusive', 'phase', 'clinical', 'trial', 'safety', 'efficacy', 'situ', 'delivery', 'allogeneic', 'cells', 'cetuximab', 'liver', 'metastasis', 'gastrointestinal', 'origin', 'conditioning', 'chemotherapy', 'allogeneic', 'cells', 'injection', 'hepatic', 'artery', 'escalating', 'doses', 'cells', 'kg', 'high', 'dose', 'week', 'weeks', 'patients', 'liver', 'metastases', 'colorectal', 'pancreatic', 'cancers', 'dose', 'level', 'Hepatic', 'artery', 'injection', 'patients', 'report', 'dose', 'toxicity', 'patients', 'febrile', 'aplasia', 'short', 'term', 'antibiotherapy', 'anemia', 'thrombopenia', 'chemotherapy', 'Objective', 'clinical', 'responses', 'patients', 'patients', 'cell', 'products', 'ligand', 'mismatches', 'patient', 'ligand', 'mismatch', 'monitoring', 'most', 'patients', 'increase', 'transient', 'cytokines', 'levels', 'week', 'chemotherapy', 'high', 'expansion', 'cells', 'T', 'cells', 'patients', 'administration', 'results', 'allogeneic', 'cells', 'transfer', 'intra', '-', 'hepatic', 'artery', 'cetuximab', 'high', 'dose', 'feasible', 'tolerated', 'clinical', 'responses']"
426,426,http://europepmc.org/articles/PMC3485291?pdf=render,"In vivo and in vitro suppression of hepatocellular carcinoma by EF24, a curcumin analog.","The synthetic compound 3,5-bis(2-flurobenzylidene)piperidin-4-one (EF24) is a potent analog of curcumin that exhibits enhanced biological activity and bioavailability without increasing toxicity. EF24 exerts antitumor activity by arresting the cell cycle and inducing apoptosis, suppressing many types of cancer cells in vitro. The antiproliferative and antiangiogenic properties of EF24 provide theoretical support for its development and application to liver cancers. We investigated the in vitro and in vivo activities of EF24 on liver cancer to better understand its therapeutic effects and mechanisms. EF24 induced significant apoptosis and G2/M-phase cell cycle arrest in mouse liver cancer cell lines, Hepa1-6 and H22. The expression levels of G2/M cell cycle regulating factors, cyclin B1 and Cdc2, were significantly decreased, pp53, p53, and p21 were significantly increased in EF24-treated cells. In addition, EF24 treatment significantly reduced Bcl-2 concomitant with an increase in Bax, enhanced the release of cytochrome c from the mitochondria into the cytosol, resulting in an upregulation of cleaved-caspase-3, which promoted poly (ADP-ribose) polymerase cleavage. EF24-treated cells also displayed decreases in phosphorylated Akt, phosphorylated extracellular signal-regulated kinase and vascular endothelial growth factor. Our in vitro protein expression data were confirmed in vivo using a subcutaneous hepatocellular carcinoma (HCC) tumor model. This mouse HCC model confirmed that total body weight was unchanged following EF24 treatment, although tumor weight was significantly decreased. Using an orthotopic HCC model, EF24 significantly reduced the liver/body weight ratio and relative tumor areas compared to the control group. In situ detection of apoptotic cells and quantification of Ki-67, a biomarker of cell proliferation, all indicated significant tumor suppression with EF24 treatment. These results suggest that EF24 exhibits anti-tumor activity on liver cancer cells via mitochondria-dependent apoptosis and inducing cell cycle arrest coupled with antiangiogenesis. The demonstrated activities of EF24 support its further evaluation as a treatment for human liver cancers.",['Haitao Liu'],0,doaj,"['clustering algorithms', 'hierarchical system', 'hierarchical model', 'planar graph', 'database systems', 'cycle', 'analog signals', 'real data sets', 'detection algorithm', 'digital signals', 'signal detection']",liver carcinoma in situ,"['vivo', 'suppression', 'hepatocellular', 'carcinoma', 'curcumin', 'analog']","['synthetic', 'compound', 'potent', 'analog', 'curcumin', 'biological', 'activity', 'bioavailability', 'toxicity', 'activity', 'cell', 'cycle', 'apoptosis', 'many', 'types', 'cancer', 'cells', 'vitro', 'antiproliferative', 'antiangiogenic', 'properties', 'EF24', 'theoretical', 'support', 'development', 'application', 'liver', 'cancers', 'vitro', 'vivo', 'activities', 'liver', 'cancer', 'therapeutic', 'effects', 'mechanisms', 'EF24', 'significant', 'apoptosis', 'G2/M', 'phase', 'cell', 'cycle', 'arrest', 'mouse', 'liver', 'cancer', 'cell', 'lines', 'expression', 'levels', 'cell', 'cycle', 'regulating', 'factors', 'cyclin', 'B1', 'pp53', 'p53', 'p21', 'cells', 'addition', 'treatment', 'Bcl-2', 'concomitant', 'increase', 'release', 'c', 'mitochondria', 'cytosol', 'upregulation', 'poly', 'polymerase', 'cleavage', 'cells', 'decreases', 'extracellular', 'signal', 'regulated', 'kinase', 'vascular', 'endothelial', 'growth', 'factor', 'protein', 'expression', 'data', 'vivo', 'subcutaneous', 'hepatocellular', 'carcinoma', 'tumor', 'model', 'mouse', 'model', 'total', 'body', 'weight', 'unchanged', 'treatment', 'tumor', 'weight', 'orthotopic', 'model', 'liver', 'body', 'weight', 'ratio', 'relative', 'tumor', 'areas', 'control', 'group', 'situ', 'detection', 'apoptotic', 'cells', 'quantification', 'biomarker', 'cell', 'proliferation', 'significant', 'tumor', 'suppression', 'treatment', 'results', 'anti', '-', 'tumor', 'activity', 'liver', 'cancer', 'cells', 'mitochondria', 'dependent', 'apoptosis', 'cell', 'cycle', 'arrest', 'antiangiogenesis', 'demonstrated', 'activities', 'further', 'evaluation', 'treatment', 'human', 'liver', 'cancers']"
427,427,http://www.scopemed.org/fulltextpdf.php?mno=43160,"Bone marrow micrometastasis detected by flow cytometry is associated  bone, bone marrow, lung macrometastasis in breast cancer","Purpose: The aim of the present study was to analyze deposits in bone marrow for determining  micrometastases in breast cancer patients by flow cytometry. And its correlation of  prognostic factors and macrometastasis at the first diagnosis.
Material and Methods: Bone marrow samples were obtained from 52 breast cancer patients and 16 control patients via aspiration from the iliac spine at the time of first diagnosis after the surgery. Epithelial cells were identified with anti-cytokeratin monoclonal antibody, and double-staining with propidium iodide and CD45using flow cytometry. 
Results: In all, 2 (12.5%) of the 16 control patients and 11 (21%) of the 52 breast cancer patients had cytokeratin-18 positive cells in their bone marrow. A relationship between the presence of occult metastatic cells in bone marrow, and the presence/absence of lymph node metastases, tumor size, stage, menopausal status, hormone receptor status, histological grade, c-erb-B2 expression, tumor subtype, lymphovascular invasion, Ductal carcinoma in situ (DCIS) component, and gender was not observed. Significant positive relationships were observed between bone marrow micrometastasis, and age, and bone, bone marrow, lung, and liver metastases. 
Conclusion: Bone marrow micrometastasis was associated with age, bone, bone marrow, lung, and liver metastases at the time of diagnosis.. [Cukurova Med J 2014; 39(2.000): 305-314]",['Mustafa Salih Akin'],['Bone marrow; breast cancer; cytokeratin; flow cytometry; metastasis'],doaj,"['switching systems', 'control systems', 'computer systems', 'component', 'software', 'switching control', 'correlation analysis', 'correlation coefficient', 'mathematics']",liver carcinoma in situ,"['Bone', 'marrow', 'micrometastasis', 'flow', 'cytometry', 'bone', 'bone', 'marrow', 'lung', 'macrometastasis', 'breast', 'cancer']","['Purpose', 'aim', 'present', 'study', 'deposits', 'bone', 'marrow', 'micrometastases', 'breast', 'cancer', 'patients', 'flow', 'cytometry', 'correlation', 'prognostic', 'factors', 'macrometastasis', 'first', 'diagnosis', 'Bone', 'marrow', 'samples', 'breast', 'cancer', 'patients', 'control', 'patients', 'aspiration', 'iliac', 'spine', 'time', 'first', 'diagnosis', 'surgery', 'Epithelial', 'cells', 'anti', '-', 'cytokeratin', 'monoclonal', 'antibody', 'double', 'staining', 'propidium', 'flow', 'cytometry', 'Results', '%', 'control', 'patients', '%', 'breast', 'cancer', 'patients', 'cytokeratin-18', 'positive', 'cells', 'bone', 'marrow', 'relationship', 'presence', 'occult', 'metastatic', 'cells', 'bone', 'marrow', 'presence', 'absence', 'lymph', 'node', 'metastases', 'tumor', 'size', 'stage', 'menopausal', 'status', 'hormone', 'receptor', 'status', 'histological', 'grade', 'c', 'erb', 'B2', 'expression', 'tumor', 'subtype', 'lymphovascular', 'invasion', 'carcinoma', 'situ', 'component', 'gender', 'Significant', 'positive', 'relationships', 'bone', 'marrow', 'micrometastasis', 'age', 'bone', 'bone', 'marrow', 'lung', 'liver', 'metastases', 'Conclusion', 'Bone', 'marrow', 'micrometastasis', 'age', 'bone', 'bone', 'marrow', 'lung', 'liver', 'metastases', 'time', 'diagnosis']"
428,428,http://www.lcgdbzz.org/qk_content.asp?id=9531,Expression features and clinical significance of the microRNA-888 gene family in hepatocellular carcinoma,"ObjectiveTo investigate the expression features and clinical significance of the microRNA-888 (miRNA-888) gene family members in hepatocellular carcinoma (HCC). MethodsA total of 72 patients with pathologically confirmed HCC who were treated in The First Affiliated Hospital of Hunan University of Chinese Medicine from January 2012 to December 2017 were enrolled, and 72 liver tissue samples collected from healthy volunteers were enrolled as normal control group. Quantitative real-time PCR and in situ hybridization were used to measure the expression of miRNA-888 family members (miRNA-888, miRNA-891a, miRNA-891b, miRNA-892a, and miRNA-892b) in HCC tissue, and the association of the expression of miRNA-888, miRNA-891b, and miRNA-892a with the clinicopathological features of HCC was analyzed. The t-test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. ResultsHCC tissue had significantly higher expression of miRNA-888, miRNA-891b, and miRNA-892a than normal liver tissue (miRNA-888: 2.53¬±0.75 vs 0.46¬±0.08, t=14.02, PÔºú0.001; miRNA-891b: 2.26¬±0.38 vs 1.19¬±0.21, t=7.75, PÔºú0.001; miRNA-892a: 5.44¬±1.01 vs 1.06¬±0.30, t=35.27, PÔºú0ÓÄê001). According to the results of in situ hybridization, the miRNAs of miRNA-888, miRNA-891b, and miRNA-892a were mainly located in the cell nucleus of HCC tissue, and there were significant differences in the expression of these miRNAs between HCC tissue and normal tissue (miRNA-888: 3.91¬±0.92 vs 1.21¬±0.42, t=22.65, PÔºú0.001; miRNA-891b: 2.92¬±0.76 vs 0.83¬±0.21, t=22ÓÄê92, PÔºú0ÓÄê001; miRNA-892a: 3.81¬±0.99 vs 1.30¬±0.32, t=20.47, PÔºú0ÓÄê001). There were significant differences in the expression of miRNA-888 and miRNA-891b between the patients with different histological grades and clinical stages (œá2=6.25, 4.44, 4.76, and 6.05, all PÔºú0.05), and there was a significantly higher expression of miRNA-892a in stage III/IV tumors (œá2=8.50, PÔºú0.001). ConclusionThere are significant increases in the expression of miRNA-888, miRNA-891b, and miRNA-892a in HCC tissue, and such increases are closely associated with the malignancy of HCC. ",['HUANG Xiangjun'],0,doaj,"['feature space', 'continuous data', 'integrated data', 'classification methods', 'data integration', 'data mining', 'group members', 'pattern recognition', 'distributed computer systems', 'education', 'university', 'multicasts']",liver carcinoma in situ,"['Expression', 'features', 'clinical', 'significance', 'gene', 'family', 'hepatocellular', 'carcinoma']","['expression', 'features', 'clinical', 'significance', 'gene', 'family', 'members', 'hepatocellular', 'carcinoma', 'MethodsA', 'total', 'patients', 'liver', 'tissue', 'samples', 'healthy', 'volunteers', 'normal', 'control', 'group', 'Quantitative', 'real', 'time', 'situ', 'hybridization', 'expression', 'miRNA-888', 'family', 'members', 'miRNA-888', 'tissue', 'association', 'expression', 'miRNA-888', 'clinicopathological', 'features', 't', 'test', 'comparison', 'continuous', 'data', 'groups', 'chi', 'square', 'test', 'comparison', 'categorical', 'data', 'groups', 'ResultsHCC', 'tissue', 'higher', 'expression', 'miRNA-888', 'normal', 'liver', 'tissue', 'miRNA-888', '0.46¬±0.08', 't=14.02', 'PÔºú0.001', 't=7.75', 't=35.27', 'results', 'situ', 'hybridization', 'miRNA-888', 'cell', 'nucleus', 'tissue', 'significant', 'differences', 'expression', 'tissue', 'normal', 'tissue', 'miRNA-888', 't=22.65', 'PÔºú0.001', '0.83¬±0.21', 't=22\ue01092', 't=20.47', 'significant', 'differences', 'expression', 'miRNA-888', 'patients', 'different', 'histological', 'grades', 'clinical', 'stages', 'higher', 'expression', 'stage', 'tumors', 'significant', 'increases', 'expression', 'miRNA-888', 'tissue', 'such', 'increases', 'malignancy']"
429,429,https://www.mdpi.com/1999-4915/11/10/969,A Novel Hepadnavirus is Associated with Chronic Hepatitis and Hepatocellular Carcinoma in Cats,"In 2015, over 850,000 people died from chronic hepatitis and hepatocellular carcinoma (HCC) caused by hepatitis B virus (HBV). A novel hepatitis B-like virus has recently been identified in domestic cats. The pathogenic potential of domestic cat hepadnavirus (DCH), for which 6.5% to 10.8% of pet cats are viremic, is unknown. We evaluated stored formalin-fixed, paraffin-embedded biopsies of diseased and normal feline liver for the presence of DCH using PCR and in situ hybridization (ISH). DCH was detected in 43% (6/14) of chronic hepatitis cases and 28% (8/29) of HCCs, whereas cholangitis (<i>n</i> = 6), biliary carcinoma (<i>n</i> = 18) and normal liver (<i>n</i> = 15) all tested negative for DCH. Furthermore, in DCH-associated cases, the histologic features of inflammation and neoplasia, and the viral distribution on ISH were strikingly similar to those seen with HBV-associated disease. Several histological features common in human HBV-associated hepatitis, including piecemeal necrosis and apoptotic bodies, were identified in DCH-positive cases of chronic hepatitis. In two cases of HCC examined, the proliferation index in regions that were ISH-positive was higher than in ISH-negative regions. The intracellular distribution of virus in both hepatitis and HCC demonstrated that viral nucleic acid is present in both nuclear and cytoplasmic forms. Collectively, these findings demonstrate a compelling association between DCH and some cases of chronic hepatitis and hepatocellular carcinoma in the cat that mirrors features of HBV-associated hepatopathies. Future investigations of viral epidemiology and natural history are needed to establish the impact of DCH on feline health.",['Patricia  A. Pesavento'],"['feline', 'cancer', 'viral', 'cat', 'hbv', 'hcc', 'disease', 'oncogenesis', 'pathology', '<i>orthohepadnavirus</i>', 'hepatology']",doaj,"['feature space', 'classification methods', 'spect imaging', 'security of data', 'malwares', 'malicious codes', 'pattern recognition', 'single photon emission computed tomography', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,['Cats'],"['people', 'chronic', 'hepatitis', 'hepatocellular', 'carcinoma', 'novel', 'hepatitis', 'like', 'virus', 'domestic', 'cats', 'pathogenic', 'potential', 'domestic', 'cat', 'hepadnavirus', '%', '%', 'pet', 'cats', 'viremic', 'unknown', 'formalin', 'paraffin', 'biopsies', 'diseased', 'normal', 'feline', 'liver', 'presence', 'situ', 'hybridization', '%', 'chronic', 'hepatitis', 'cases', '%', 'HCCs', 'cholangitis', 'n</i', 'biliary', 'carcinoma', 'n</i', 'normal', 'liver', 'n</i', 'negative', 'cases', 'histologic', 'features', 'inflammation', 'neoplasia', 'viral', 'distribution', 'similar', 'disease', 'Several', 'histological', 'features', 'common', 'human', 'hepatitis', 'piecemeal', 'necrosis', 'apoptotic', 'bodies', 'positive', 'cases', 'chronic', 'hepatitis', 'cases', 'proliferation', 'index', 'regions', 'positive', 'higher', 'negative', 'regions', 'intracellular', 'distribution', 'virus', 'hepatitis', 'viral', 'nucleic', 'acid', 'present', 'nuclear', 'cytoplasmic', 'forms', 'findings', 'compelling', 'association', 'cases', 'chronic', 'hepatitis', 'hepatocellular', 'carcinoma', 'cat', 'features', 'hepatopathies', 'Future', 'investigations', 'viral', 'epidemiology', 'natural', 'history', 'impact', 'feline', 'health']"
430,430,http://dx.doi.org/10.1080/2162402X.2019.1571388,Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma,"As a major cellular component in tumor microenvironment, the distribution, frequency, and prognostic significance of infiltrating B cell subsets in hepatocellular carcinoma (HCC) remain controversial. Using tyramide signal amplification (TSA) based fluorescent multiplexed immunohistochemistry in situ, we evaluated the distribution and frequency of B cell subsets in two independent HCC cohorts (n¬†=¬†619). The results were further confirmed by flow cytometry. Correlations of B cell subsets with clinicopathologic features and patient prognosis were analyzed. Five B cell subsets were defined by multiplexed immunohistochemistry and each subset was clearly separated by t-SNE dimension reduction analysis. Notably, the densities of all B cell subsets were significantly decreased in the tumor. The frequency of plasma cells within B cells was most abundant in the tumor. In training cohort (n¬†=¬†258), high densities of tumor-infiltrating CD20+ B cells, naive B cells, IgM+ memory B cells, CD27‚àí isotype-switched memory B cells, and plasma cells were associated with superior survival. Multivariate analysis further identified CD20+ B cells, naive B cells, and CD27‚àí isotype-switched memory B cells as independent prognosticators for survival. Unsupervised cluster analysis confirmed increased B cell subsets harbored superior survival. In addition, high density of B cells was correlated with smaller tumor size and well differentiation. The results were validated in the independent cohort of 361 HCC patients. Intratumor infiltration of B cells is significantly impaired during HCC progression. High densities of tumor-infiltrating B cells imply a better clinical outcome. Therapies designed to target B cells may be a novel strategy in HCC.",['Zhao Zhang'],"['liver cancer', 'tumor microenvironment (tme)', 'b cell subsets', 'tyramide signal amplification (tsa)', 'prognosis']",doaj,"['cellular telephone systems', 'component', 'software', 'bandwidth', 'cluster analysis', 'wireless', 'cellular radio systems', 'machine learning', 'frequencies', 'random access storage', 'random access memory', 'cellular']",liver carcinoma in situ,"['Landscape', 'cells', 'clinical', 'significance', 'human', 'hepatocellular', 'carcinoma']","['major', 'cellular', 'component', 'tumor', 'microenvironment', 'distribution', 'frequency', 'prognostic', 'significance', 'B', 'cell', 'subsets', 'hepatocellular', 'carcinoma', 'controversial', 'tyramide', 'signal', 'amplification', 'fluorescent', 'multiplexed', 'immunohistochemistry', 'situ', 'distribution', 'frequency', 'B', 'cell', 'subsets', 'independent', 'cohorts', 'results', 'flow', 'cytometry', 'Correlations', 'B', 'cell', 'subsets', 'clinicopathologic', 'features', 'patient', 'prognosis', 'B', 'cell', 'subsets', 'multiplexed', 'immunohistochemistry', 'subset', 't', 'SNE', 'dimension', 'reduction', 'analysis', 'densities', 'B', 'cell', 'subsets', 'tumor', 'frequency', 'plasma', 'cells', 'B', 'cells', 'abundant', 'tumor', 'training', 'cohort', 'high', 'densities', 'tumor', 'cells', 'naive', 'cells', 'memory', 'cells', 'isotype', 'memory', 'B', 'cells', 'plasma', 'cells', 'superior', 'survival', 'Multivariate', 'analysis', 'cells', 'naive', 'cells', 'isotype', 'memory', 'B', 'cells', 'independent', 'prognosticators', 'survival', 'Unsupervised', 'cluster', 'analysis', 'B', 'cell', 'subsets', 'superior', 'survival', 'addition', 'high', 'density', 'B', 'cells', 'smaller', 'tumor', 'size', 'well', 'differentiation', 'results', 'independent', 'cohort', 'patients', 'infiltration', 'B', 'cells', 'progression', 'High', 'densities', 'tumor', 'B', 'cells', 'better', 'clinical', 'outcome', 'Therapies', 'B', 'cells', 'novel', 'strategy']"
431,431,http://www.eurjmedres.com/content/16/3/101,Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetence,"<p>Abstract</p> <p>Objectives</p> <p>To estimate the cancer risk of HIV-infected patients in the HAART era with respect to a general reference population and to determine risk factors for malignancy.</p> <p>Methods</p> <p>Long term (1996-2009) cancer incidence of the Bonn single centre HIV cohort was compared to the incidence of the reference population of Saarland using standardized incidence ratios (SIR). Poisson regression analysis was used to identify predictors of cancer risk.</p> <p>Results</p> <p>1,476 patients entered the cohort, enabling 8,772 person years of observation. 121 tumours in 114 patients, 7 in-situ and 114 invasive cancers, were identified. Malignancies associated with infectious agents such as Kaposi sarcoma (SIRs: male: 5,683; female: 277), non-Hodgkin lymphoma (SIRs male: 35; female: 18), anal cancer (SIRs male: 88; female: 115) as well a cervical carcinoma (SIR female: 4) and Hodgkin's disease (SIR male: 39) and liver cancer (SIR male: 18) were substantially more frequent in HIV-infected patients than in the general population (p < 0.001, each), whereas all other types of cancer were not increased. Poisson regression identified HAART (incidence rate ratio IRR (95% CI): 0.28 (0.19-0.41), p < 0.001), CD4 count (IRR per 100 cells/Œºl increase: 0.66 (0.57-0.76), p < 0.001), hepatitis B (IRR: 2.15 (1.10-4.20), p = 0.046) and age (IRR per 10 year increase: 1.23 (1.03 - 1.46), p = 0.023) as independent predictors for the occurrence of any type of cancer.</p> <p>Conclusions</p> <p>HAART and preserved CD4 cells preferentially reduce the risk of malignancies associated with oncogenic infections.</p> ",['Vogel M'],"['Lymphoma', 'Carcinoma', 'HIV', 'CD4-T cells', 'HAART']",doaj,"['logistic regression models', 'arrival process', 'mathematics', 'correlation analysis', 'regression model', 'logistic regression', 'queuing network']",liver carcinoma in situ,"['Cancer', 'risk', 'individuals', 'oncogenic', 'infections', 'state', 'immunocompetence']","['Abstract</p', 'Objectives</p', 'cancer', 'risk', 'patients', 'era', 'respect', 'general', 'reference', 'population', 'risk', 'factors', 'Long', 'term', 'cancer', 'incidence', 'single', 'centre', 'cohort', 'incidence', 'reference', 'population', 'standardized', 'incidence', 'ratios', 'Poisson', 'regression', 'analysis', 'predictors', 'cancer', 'risk.</p', 'patients', 'cohort', 'person', 'years', 'observation', 'tumours', 'patients', 'situ', 'invasive', 'cancers', 'Malignancies', 'infectious', 'agents', 'such', 'sarcoma', 'SIRs', 'male', 'female', 'non', '-', 'Hodgkin', 'lymphoma', 'SIRs', 'male', 'female', 'anal', 'cancer', 'SIRs', 'male', 'female', 'cervical', 'carcinoma', 'female', 'disease', 'male', 'liver', 'cancer', 'male', 'frequent', 'patients', 'general', 'population', 'p', 'other', 'types', 'cancer', 'Poisson', 'regression', 'incidence', 'rate', 'ratio', '%', 'CD4', 'count', 'cells', 'Œºl', 'increase', 'age', 'year', 'increase', 'independent', 'predictors', 'occurrence', 'type', 'Conclusions</p', 'CD4', 'cells', 'risk', 'malignancies', 'oncogenic']"
432,432,https://www.dovepress.com/preparation-synergism-and-biocompatibility-of-in-situ-liquid-crystals--peer-reviewed-fulltext-article-IJN,"Preparation, Synergism, and Biocompatibility of in situ Liquid Crystals Loaded with Sinomenine and 5-Fluorouracil for Treatment of Liver Cancer","Jiaojiao Cao,1,* Jie Huang,1,* Shuangying Gui,1,2 Xiaoqin Chu1,2 1Department of Pharmaceutics, Anhui University of Chinese Medicine, Hefei, 230012, People&rsquo;s Republic of China; 2Institute of Pharmaceutics, Anhui Academy of Chinese Medicine, Hefei, 230012, People&rsquo;s Republic of China*These authors contributed equally to this workCorrespondence: Xiaoqin ChuMaster Instructor Tel +86 13856929921Fax +86 551-68129028Email chuxq420@163.comPurpose: Transarterial chemoembolization is the preferred treatment for patients with middle and advanced-stage hepatocellular carcinoma (HCC); however, most hepatic artery embolization agents have various disadvantages. The purpose of this study was to evaluate phytantriol-based liquid crystal injections for potential use in treatment of HCC.Methods: Using sinomenine (SN) and 5-fluorouracil (5-FU) as model drugs, three precursor in situ liquid crystal injections based on phytantriol (P1, P2, and P3) were prepared, and their in vitro biocompatibility, anticancer activity, and drug release investigated, to evaluate their feasibility for use in treatment of HCC. The properties of the precursor injections and subsequent cubic liquid crystal gels were observed by visual and polarizing microscopy, in an in vitro gelation experiment. Biocompatibility was evaluated by in vitro hemolysis, histocompatibility, and cytotoxicity assays.Results: Precursor injections were colorless liquids that formed transparent cubic liquid crystal gels on addition of excess water. The three precursor injections all caused slight hemolysis, without agglutination, and were mildly cytotoxic. Histocompatibility experiments showed that P1 had good histocompatibility, while P2 and P3 resulted in strong inflammatory responses, which subsequently resolved spontaneously. In vitro anti-cancer testing showed that SN and 5-FU inhibited HepG2 cells in a time- and concentration-dependent manner and had synergistic effects. Further, in vitro release assays indicated that all three preparations had sustained release effects, with cumulative release of &gt; 80% within 48 h.Conclusion: These results indicate that SN and 5-FU have synergistic inhibitory effects on HepG2 cells, which has not previously been reported. Moreover, we describe a biocompatible precursor injection, useful as a drug carrier for the treatment of liver cancer, which can achieve targeting, sustained release, synergistic chemotherapy, and embolization. These data indicate that precursor injections containing SN and 5-FU have great potential for use in therapy for liver cancer.Keywords: carcinoma, hepatocellular, drug carriers, delayed-action preparations, chemoembolization, therapeutic, SN, 5-FU",['Cao J'],"['biocompatibility', 'liver cancer', 'sn', '5-fu']",doaj,"['spatial light modulators', 'artificial intelligence', 'optical data processing', 'graphical user interfaces', 'user interfaces', 'light modulation', 'education', 'multiagent system', 'nonlinear optics', 'non-linear optical properties', 'university']",liver carcinoma in situ,"['Preparation', 'Biocompatibility', 'situ']","['Shuangying', 'China*These', 'authors', 'workCorrespondence', '+86', 'Transarterial', 'chemoembolization', 'preferred', 'treatment', 'patients', 'middle', 'advanced', 'stage', 'hepatocellular', 'carcinoma', 'hepatic', 'artery', 'embolization', 'agents', 'various', 'disadvantages', 'purpose', 'study', 'phytantriol', 'liquid', 'crystal', 'injections', 'potential', 'use', 'treatment', 'sinomenine', 'model', 'drugs', 'precursor', 'situ', 'liquid', 'crystal', 'injections', 'phytantriol', 'P1', 'biocompatibility', 'anticancer', 'activity', 'drug', 'release', 'feasibility', 'use', 'treatment', 'properties', 'precursor', 'injections', 'subsequent', 'cubic', 'liquid', 'crystal', 'gels', 'visual', 'microscopy', 'gelation', 'experiment', 'Biocompatibility', 'hemolysis', 'histocompatibility', 'cytotoxicity', 'assays', 'Results', 'Precursor', 'injections', 'colorless', 'liquids', 'transparent', 'cubic', 'liquid', 'crystal', 'gels', 'addition', 'excess', 'water', 'precursor', 'injections', 'slight', 'hemolysis', 'agglutination', 'cytotoxic', 'Histocompatibility', 'experiments', 'good', 'histocompatibility', 'P2', 'strong', 'inflammatory', 'responses', 'anti', '-', 'cancer', 'testing', 'SN', 'inhibited', 'cells', 'time-', 'concentration', 'dependent', 'manner', 'synergistic', 'effects', 'vitro', 'release', 'assays', 'preparations', 'release', 'effects', 'cumulative', 'release', 'gt', '%', 'h', 'Conclusion', 'results', 'SN', 'synergistic', 'inhibitory', 'effects', 'cells', 'biocompatible', 'precursor', 'injection', 'useful', 'drug', 'carrier', 'treatment', 'liver', 'cancer', 'sustained', 'release', 'synergistic', 'chemotherapy', 'embolization', 'data', 'precursor', 'injections', 'SN', 'great', 'potential', 'use', 'therapy', 'liver', 'cancer', 'Keywords', 'carcinoma', 'hepatocellular', 'drug', 'carriers', 'action', 'preparations', 'chemoembolization', 'therapeutic']"
433,433,https://www.frontiersin.org/article/10.3389/fimmu.2019.02526/full,A Non-interventional Clinical Trial Assessing Immune Responses After Radiofrequency Ablation of Liver Metastases From Colorectal Cancer,"Background: Radiofrequency ablation (RFA) is an established treatment option for malignancies located in the liver. RFA-induced irreversible coagulation necrosis leads to the release of danger signals and cellular content. Hence, RFA may constitute an endogenous in situ tumor vaccination, stimulating innate and adaptive immune responses, including tumor-antigen specific T cells. This may explain a phenomenon termed abscopal effect, namely tumor regression in untreated lesions evidenced after distant thermal ablation or irradiation. In this study, we therefore assessed systemic and local immune responses in individual patients treated with RFA.Methods: For this prospective clinical trial, patients with liver metastasis from colorectal carcinoma (mCRC) receiving RFA and undergoing metachronous liver surgery for another lesion were recruited (n = 9) during a 5-year period. Tumor and non-malignant liver tissue samples from six patients were investigated by whole transcriptome sequencing and tandem-mass spectrometry, characterizing naturally presented HLA ligands. Tumor antigen-derived HLA-restricted peptides were selected by different predefined approaches. Further, candidate HLA ligands were manually curated. Peripheral blood mononuclear cells were stimulated in vitro with epitope candidate peptides, and functional T cell responses were assessed by intracellular cytokine staining. Immunohistochemical markers were additionally investigated in surgically resected mCRC from patients treated with (n = 9) or without RFA (n = 7).Results: In all six investigated patients, either induced immune responses and/or pre-existing T cell immunity against the selected targets were observed. Multi-cytokine responses were inter alia directed against known tumor antigens such as cyclin D1 but also against a (predicted) mutation contained in ERBB3. Immunohistochemistry did not show a relevant influx of immune cells into distant malignant lesions after RFA treatment (n = 9) as compared to the surgery only mCRC group (n = 7).Conclusions: Using an individualized approach for target selection, RFA induced and/or boosted T cell responses specific for individual tumor antigens were more frequently detectable as compared to previously published observations with well-characterized tumor antigens. However, the witnessed modest RFA-induced immunological effects alone may not be sufficient for the rejection of established tumors. Therefore, these findings warrant further clinical investigation including the assessment of RFA combination therapies e.g., with immune stimulatory agents, cancer vaccination, and/or immune checkpoint inhibitors.",['Markus W. L√∂ffler'],"['colorectal cancer', 'radiofrequency ablation', 'liver metastasis', 'HLA ligandome', 'T cells', 'tumor-associated antigens']",doaj,"['rf-id tags', 'cellular telephone systems', 'checkpointing', 'artificial intelligence', 'particle swarm optimization (pso)', 'wireless', 'radio frequency (rf)', 'cellular radio systems', 'evolutionary algorithms', 'multiagent system', 'mutation operators', 'computer system recovery', 'cellular']",liver carcinoma in situ,"['Non', '-', 'interventional']","['Background', 'Radiofrequency', 'ablation', 'treatment', 'option', 'malignancies', 'liver', 'RFA', 'irreversible', 'coagulation', 'necrosis', 'release', 'danger', 'signals', 'cellular', 'content', 'endogenous', 'situ', 'tumor', 'vaccination', 'innate', 'adaptive', 'immune', 'responses', 'tumor', 'antigen', 'specific', 'cells', 'phenomenon', 'abscopal', 'effect', 'tumor', 'regression', 'untreated', 'lesions', 'distant', 'thermal', 'ablation', 'irradiation', 'study', 'systemic', 'local', 'immune', 'responses', 'individual', 'patients', 'prospective', 'clinical', 'trial', 'patients', 'liver', 'metastasis', 'colorectal', 'carcinoma', 'metachronous', 'liver', 'surgery', 'lesion', 'period', 'Tumor', 'non', '-', 'malignant', 'liver', 'tissue', 'samples', 'patients', 'whole', 'transcriptome', 'sequencing', 'tandem', 'mass', 'spectrometry', 'ligands', 'Tumor', 'antigen', 'peptides', 'different', 'predefined', 'approaches', 'ligands', 'Peripheral', 'blood', 'mononuclear', 'cells', 'vitro', 'epitope', 'candidate', 'peptides', 'functional', 'cell', 'responses', 'intracellular', 'cytokine', 'staining', 'Immunohistochemical', 'markers', 'mCRC', 'patients', '=', '7).Results', 'patients', 'induced', 'immune', 'responses', 'pre', '-', 'cell', 'immunity', 'targets', 'Multi', 'cytokine', 'responses', 'inter', 'alia', 'tumor', 'such', 'cyclin', 'D1', 'predicted', 'mutation', 'Immunohistochemistry', 'relevant', 'influx', 'immune', 'cells', 'distant', 'malignant', 'lesions', 'treatment', 'surgery', 'group', '=', '7).Conclusions', 'individualized', 'approach', 'target', 'selection', 'cell', 'specific', 'individual', 'tumor', 'antigens', 'detectable', 'observations', 'tumor', 'modest', 'immunological', 'effects', 'sufficient', 'rejection', 'tumors', 'findings', 'further', 'clinical', 'investigation', 'assessment', 'RFA', 'combination', 'therapies', 'immune', 'stimulatory', 'agents', 'cancer', 'vaccination', 'immune', 'checkpoint', 'inhibitors']"
434,434,http://www.sciencedirect.com/science/article/pii/S2214330018300348,Hepatic perihilar amphicrine cholangiocarcinoma: A case report,"Mixed neuroendocrine nonneuroendocrine neoplasms (MiNEN) are tumors composed of adenocarcinoma and neuroendocrine neoplasm and include collision, combined, and amphicrine. Within the hepatobiliary tree, tumors of this histologic type are extremely rare, particularly the amphicrine type. In this case study, we describe a 63-year-old man with a hepatic hilar amphicrine tumor. An initial diagnosis of neuroendocrine tumor was made based on biopsy (chromogranin and synaptophysin positivity). On resection, the tumor contained histologic features of both adenocarcinoma and neuroendocrine carcinoma. Immunohistochemically, all tumor cells expressed both chromogranin and synaptophysin, keratin 7, and Cam5.2. Mucin production was evident in both components demonstrated by mucicarmine stain. Albumin RNA in situ hybridization (ISH) was positive, supporting hepatic source. The tumor is classified as an amphicrine carcinoma given the dual expression of both adenocarcinoma and neuroendocrine markers in both components. This is the first amphicrine carcinoma of the hepatic hilum reported in the literature. Keywords: Cholangiocarcinoma, Mixed neuroendocrine-nonneuroendocrine carcinoma, Neuroendocrine tumor, Liver, Immunohistochemistry, Hepatobiliary",['Thomas W. Czeczok'],0,doaj,"['feature space', 'component', 'software', 'classification methods', 'collision problem', 'collision detection', 'motion planning', 'pattern recognition', 'rfid systems', 'collision avoidance']",liver carcinoma in situ,"['Hepatic', 'perihilar', 'amphicrine', 'cholangiocarcinoma', 'case', 'report']","['Mixed', 'neuroendocrine', 'nonneuroendocrine', 'neoplasms', 'tumors', 'adenocarcinoma', 'neuroendocrine', 'neoplasm', 'collision', 'amphicrine', 'hepatobiliary', 'tree', 'tumors', 'histologic', 'type', 'rare', 'amphicrine', 'type', 'case', 'study', '63-year', 'old', 'man', 'hepatic', 'hilar', 'amphicrine', 'tumor', 'initial', 'diagnosis', 'neuroendocrine', 'tumor', 'biopsy', 'chromogranin', 'synaptophysin', 'positivity', 'resection', 'tumor', 'histologic', 'features', 'adenocarcinoma', 'neuroendocrine', 'carcinoma', 'tumor', 'cells', 'chromogranin', 'synaptophysin', 'keratin', 'Cam5.2', 'Mucin', 'production', 'evident', 'components', 'mucicarmine', 'stain', 'Albumin', 'situ', 'hybridization', 'positive', 'hepatic', 'source', 'tumor', 'amphicrine', 'carcinoma', 'dual', 'expression', 'adenocarcinoma', 'neuroendocrine', 'markers', 'components', 'first', 'amphicrine', 'carcinoma', 'hepatic', 'hilum', 'literature', 'Keywords', 'Mixed', 'neuroendocrine', 'nonneuroendocrine', 'carcinoma', 'Neuroendocrine', 'tumor']"
435,435,https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23818848/?tool=EBI,Evidence for novel hepaciviruses in rodents.,"Hepatitis C virus (HCV) is among the most relevant causes of liver cirrhosis and hepatocellular carcinoma. Research is complicated by a lack of accessible small animal models. The systematic investigation of viruses of small mammals could guide efforts to establish such models, while providing insight into viral evolutionary biology. We have assembled the so-far largest collection of small-mammal samples from around the world, qualified to be screened for bloodborne viruses, including sera and organs from 4,770 rodents (41 species); and sera from 2,939 bats (51 species). Three highly divergent rodent hepacivirus clades were detected in 27 (1.8%) of 1,465 European bank voles (Myodes glareolus) and 10 (1.9%) of 518 South African four-striped mice (Rhabdomys pumilio). Bats showed anti-HCV immunoblot reactivities but no virus detection, although the genetic relatedness suggested by the serologic results should have enabled RNA detection using the broadly reactive PCR assays developed for this study. 210 horses and 858 cats and dogs were tested, yielding further horse-associated hepaciviruses but none in dogs or cats. The rodent viruses were equidistant to HCV, exceeding by far the diversity of HCV and the canine/equine hepaciviruses taken together. Five full genomes were sequenced, representing all viral lineages. Salient genome features and distance criteria supported classification of all viruses as hepaciviruses. Quantitative RT-PCR, RNA in-situ hybridisation, and histopathology suggested hepatic tropism with liver inflammation resembling hepatitis C. Recombinant serology for two distinct hepacivirus lineages in 97 bank voles identified seroprevalence rates of 8.3 and 12.4%, respectively. Antibodies in bank vole sera neither cross-reacted with HCV, nor the heterologous bank vole hepacivirus. Co-occurrence of RNA and antibodies was found in 3 of 57 PCR-positive bank vole sera (5.3%). Our data enable new hypotheses regarding HCV evolution and encourage efforts to develop rodent surrogate models for HCV.",['Jan Felix Drexler'],0,doaj,"['standard model', 'evolutionary process', 'security of data', 'evolutionary algorithms', 'worms', 'the standard model', 'electronic document identification systems', 'computer worms', 'computer viruses', 'detection algorithm', 'signal detection']",liver carcinoma in situ,"['Evidence', 'novel', 'hepaciviruses', 'rodents']","['virus', 'relevant', 'causes', 'liver', 'cirrhosis', 'hepatocellular', 'carcinoma', 'Research', 'lack', 'accessible', 'small', 'animal', 'models', 'systematic', 'investigation', 'viruses', 'small', 'mammals', 'efforts', 'such', 'models', 'insight', 'viral', 'evolutionary', 'biology', 'largest', 'collection', 'small', 'mammal', 'samples', 'world', 'qualified', 'bloodborne', 'viruses', 'sera', 'organs', 'rodents', 'species', 'sera', 'bats', 'species', 'divergent', 'rodent', 'hepacivirus', 'clades', '%', 'European', 'bank', 'voles', 'glareolus', '%', 'South', 'African', 'mice', 'pumilio', 'Bats', 'anti', '-', 'HCV', 'immunoblot', 'reactivities', 'virus', 'detection', 'genetic', 'relatedness', 'serologic', 'results', 'detection', 'reactive', 'assays', 'study', 'horses', 'cats', 'dogs', 'further', 'horse', 'hepaciviruses', 'none', 'dogs', 'cats', 'rodent', 'viruses', 'equidistant', 'diversity', 'canine', 'equine', 'hepaciviruses', 'full', 'genomes', 'viral', 'lineages', 'Salient', 'genome', 'features', 'distance', 'criteria', 'classification', 'viruses', 'hepaciviruses', 'situ', 'hybridisation', 'histopathology', 'hepatic', 'tropism', 'liver', 'inflammation', 'serology', 'distinct', 'hepacivirus', 'lineages', 'bank', 'voles', 'seroprevalence', 'rates', '%', 'Antibodies', 'bank', 'vole', 'sera', 'cross', 'heterologous', 'bank', 'vole', 'hepacivirus', 'Co', '-', 'occurrence', 'antibodies', 'positive', 'bank', 'vole', 'sera', '%', 'data', 'new', 'hypotheses', 'evolution', 'efforts', 'rodent', 'surrogate', 'models']"
436,436,http://www.sciencedirect.com/science/article/pii/S2542568419300479,LncRNA RP11-307C12.11 promotes the growth of hepatocellular carcinoma by acting as a molecular sponge of miR-138,"Background: Abnormal expression of long non-coding RNAs (lncRNAs) has been found in almost all tumors in humans, providing numerous potential diagnostic and prognostic biomarkers, and therapeutic targets. Materials and methods: The Cancer Genome Atlas (TCGA) database was used to screen potential LncRNAs, and 30 paired hepatocellular carcinoma (HCC) tissues were used to investigate RP11-307C12.11 expression levels by qRT-PCR and another 105 HCC tissues by in situ hybridizsation (ISH). RP11-307C12.11 overexpression and knockdown experiments were performed to investigate the effects of RP11-307C12.11 on HCC growth through in¬†vitro and in¬†vivo assays (MTT assay, colony formation assay, EdU assay, and xenograft model). The molecular mechanism underlying these effects was confirmed by MS2-RIP-assay, RIP assay, luciferase assay, and rescue experiments. Results: RP11-307C12.11 expression level was significantly higher in tumor tissues than in the adjacent normal tissues. Elevated RP11-307C12.11 expression level was associated with poor prognosis of HCC patients, and it may be represented as an independent prognostic biomarker in patients with HCC. Functionally, RP11-307C12.11 overexpression promoted HCC growth both in¬†vitro and in¬†vivo; however, its knockdown reversed these effects. Mechanistically, we found that RP11-307C12.11 expressed predominantly in the cytoplasm and sponged microRNA (miR)-138 to regulate its common target CCND1 and PDK1. Conclusions: Thus, we found that RP11-307C12.11 acts as an oncogene in HCC by binding to miR-138, which might provide a novel target for HCC therapy. Keywords: Long non-coding RNAs (lncRNAs), LncRNA RP11-307C12.11, Hepatocellular carcinoma (HCC), Growth, MicroRNA (MiR)-138",['Yinan Deng'],0,doaj,"['target tracking', 'computer systems', 'programming theory', 'source coding', 'coding techniques', 'network coding', 'database systems', 'image coding', 'channel coding', 'coding scheme', 'data compression', 'multiple targets', 'signal encoding']",liver carcinoma in situ,"['growth', 'hepatocellular', 'carcinoma', 'molecular', 'sponge']","['Background', 'Abnormal', 'expression', 'long', 'non', '-', 'coding', 'RNAs', 'tumors', 'humans', 'numerous', 'potential', 'diagnostic', 'prognostic', 'biomarkers', 'therapeutic', 'targets', 'Materials', 'methods', 'database', 'potential', 'LncRNAs', 'hepatocellular', 'carcinoma', 'tissues', 'expression', 'levels', 'tissues', 'situ', 'hybridizsation', 'overexpression', 'knockdown', 'experiments', 'effects', 'growth', 'vitro', 'vivo', 'assays', 'assay', 'colony', 'formation', 'assay', 'assay', 'xenograft', 'model', 'molecular', 'mechanism', 'effects', 'MS2-RIP', 'luciferase', 'assay', 'rescue', 'experiments', 'Results', 'expression', 'level', 'higher', 'tumor', 'tissues', 'adjacent', 'normal', 'tissues', 'Elevated', 'expression', 'level', 'poor', 'prognosis', 'patients', 'independent', 'prognostic', 'biomarker', 'patients', 'overexpression', 'growth', 'vitro', 'vivo', 'knockdown', 'effects', 'cytoplasm', 'common', 'target', 'Conclusions', 'oncogene', 'novel', 'target', 'therapy', 'Keywords', 'Long', 'non', '-', 'coding', 'Hepatocellular', 'carcinoma']"
437,437,https://www.mdpi.com/2073-4409/10/5/976,Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver,"Chronic hepatitises of various etiologies are widespread liver diseases in humans. Their final stage, liver cirrhosis (LC), is considered to be one of the main causes of hepatocellular carcinoma (HCC). About 80‚Äì90% of all HCC cases develop in LC patients, which suggests that cirrhotic conditions play a crucial role in the process of hepatocarcinogenesis. Carbohydrate metabolism in LC undergoes profound disturbances characterized by altered glycogen metabolism. Unfortunately, data on the glycogen content in LC are few and contradictory. In this study, the material was obtained from liver biopsies of patients with LC of viral and alcohol etiology and from the liver tissue of rats with CCl<sub>4</sub>-induced LC. The activity of glycogen phosphorylase (GP), glycogen synthase (GS), and glucose-6-phosphatase (G6Pase) was investigated in human and rat liver tissue by biochemical methods. Total glycogen and its labile and stable fractions were measured in isolated individual hepatocytes, using the cytofluorometry technique of PAS reaction<i> </i>in situ. The development of LC in human and rat liver was accompanied by an increase in fibrous tissue (20- and 8.8-fold), an increase in the dry mass of hepatocytes (by 25.6% and 23.7%), and a decrease in the number of hepatocytes (by 50% and 28%), respectively. The rearrangement of the liver parenchyma was combined with changes in glycogen metabolism. The present study showed a significant increase in the glycogen content in the hepatocytes of the human and the rat cirrhotic liver, by 255% and 210%, respectively. An increased glycogen content in cells of the cirrhotic liver can be explained by a decrease in glycogenolysis due to a decreased activity of G6Pase and GP.",['Natalia N. Bezborodkina'],"['liver cirrhosis', 'glycogen', 'hepatocytes', 'glycogen phosphorylase', 'glycogen synthase', 'glucose-6-phosphatase']",doaj,"['multimedia services', 'world wide web', 'digital rights management', 'actuator failures', 'digital contents', 'robust control', 'fault tolerant control', 'linear control systems', 'genetic algorithms', 'multimedia contents', 'computer programming', 'web page', 'genetic programming', 'sufficient conditions']",liver carcinoma in situ,[],"['Chronic', 'hepatitises', 'various', 'etiologies', 'widespread', 'liver', 'diseases', 'humans', 'final', 'stage', 'liver', 'cirrhosis', 'main', 'causes', 'hepatocellular', 'carcinoma', '%', 'cases', 'patients', 'cirrhotic', 'conditions', 'crucial', 'role', 'process', 'hepatocarcinogenesis', 'Carbohydrate', 'metabolism', 'undergoes', 'profound', 'disturbances', 'glycogen', 'metabolism', 'data', 'glycogen', 'content', 'few', 'contradictory', 'study', 'material', 'liver', 'biopsies', 'patients', 'viral', 'alcohol', 'etiology', 'liver', 'tissue', 'rats', 'CCl', 'activity', 'glycogen', 'phosphorylase', 'glycogen', 'synthase', 'G6Pase', 'human', 'rat', 'liver', 'tissue', 'biochemical', 'methods', 'Total', 'glycogen', 'labile', 'stable', 'fractions', 'individual', 'hepatocytes', 'cytofluorometry', 'technique', 'PAS', 'reaction', 'situ', 'development', 'human', 'rat', 'liver', 'increase', 'fibrous', 'tissue', 'increase', 'dry', 'mass', 'hepatocytes', '%', '%', 'decrease', 'number', 'hepatocytes', '%', '%', 'rearrangement', 'liver', 'parenchyma', 'changes', 'glycogen', 'metabolism', 'present', 'study', 'significant', 'increase', 'glycogen', 'content', 'hepatocytes', 'human', 'rat', 'cirrhotic', 'liver', '%', '%', 'glycogen', 'content', 'cells', 'cirrhotic', 'liver', 'decrease', 'glycogenolysis', 'due', 'activity', 'G6Pase']"
438,438,https://www.frontiersin.org/articles/10.3389/fonc.2021.601668/full,Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma,"BackgroundCancer stem cells (CSCs) and Circulating tumor cells (CTCs) have been proposed as fundamental causes for the recurrence of hepatocellular carcinoma (HCC). CTCs isolated from patients with HCC illustrate a unique Nanog expression profile analysis. The aim of this study was to enhance the prediction of recurrence and prognosis of the CTC phenotype in patients with HCC by combining Nanog expression into a combined forecasting model.Subjects, Materials, and MethodsWe collected 320 blood samples from 160 patients with HCC cancer before surgery and used CanPatrol‚Ñ¢ CTC enrichment technology and in situ hybridization (ISH) to enrich and detect CTCs and CSCs. Nanog expression in all CTCs was also determined. In addition, RT-PCR and immunohistochemistry were used to study the expression of Nanog, E-Cadherin, and N-Cadherin in liver cancer tissues and to conduct clinical correlation studies.ResultsThe numbers of EpCAM mRNA+ CTCs and Nanog mRNA+ CTCs were strongly correlated with postoperative HCC recurrence (CTC number (P = 0.03), the total number of mixed CTCS (P = 0.02), and Nanog&gt; 6.7 (P = 0.001), with Nanog &gt; 6.7 (P = 0.0003, HR = 2.33) being the most crucial marker. There are significant differences in the expression of Nanog on different types of CTC: most Epithelial CTCs do not express Nanog, while most of Mixed CTC and Mesenchymal CTC express Nanog, and their positive rates are 38.7%, 66.7%, and 88.7%, respectively, (P=0.0001). Moreover, both CTC (‚â§/&gt; 13.3) and Nanog (‚â§/&gt;6.7) expression were significantly correlated with BCLC stage, vascular invasion, tumor size, and Hbv-DNA (all P‚Äâ&lt;‚Äâ0.05). In the young group and the old group, patients with higher Nanog expression had a higher recurrence rate. (P &lt; 0.001).ConclusionsThe number of Nanog-positive cells showed positive correlation with the poor prognosis of HCC patients. The detection and analysis of CTC markers (EpCAM and CK8, 18, CD45 Vimentin,Twist and 19) and CSCs markers (NANOG) are of great value in the evaluation of tumor progression.",['Yongrong Lei'],"['recurrence', 'cancer stem cells', 'hepatocellular carcinoma', 'circulating tumor cells', 'epithelial-mesenchymal']",doaj,"['forecasting models', 'bit rates', 'signal distortion', 'coding efficiency', 'correlation analysis', 'machine learning', 'h.264/avc', 'signal detection', 'video coding', 'correlation coefficient', 'prediction modes', 'mathematics', 'detection algorithm', 'macro block']",liver carcinoma in situ,"['Association', 'Preoperative']","['stem', 'cells', 'tumor', 'cells', 'fundamental', 'causes', 'recurrence', 'hepatocellular', 'carcinoma', 'CTCs', 'patients', 'unique', 'expression', 'profile', 'analysis', 'aim', 'study', 'prediction', 'recurrence', 'prognosis', 'phenotype', 'patients', 'expression', 'forecasting', 'model', 'Subjects', 'blood', 'samples', 'patients', 'cancer', 'surgery', 'enrichment', 'technology', 'situ', 'hybridization', 'CTCs', 'CSCs', 'expression', 'CTCs', 'addition', 'immunohistochemistry', 'expression', 'liver', 'cancer', 'tissues', 'clinical', 'correlation', 'studies', 'numbers', 'postoperative', 'recurrence', 'number', 'P', 'total', 'number', 'mixed', 'P', 'P', 'P', 'HR', '=', 'crucial', 'marker', 'significant', 'differences', 'expression', 'different', 'types', 'most', 'Epithelial', 'CTCs', 'most', 'positive', 'rates', '%', '%', '%', 'expression', 'stage', 'vascular', 'invasion', 'tumor', 'size', 'P', 'young', 'group', 'old', 'group', 'patients', 'higher', 'expression', 'higher', 'recurrence', 'rate', 'P', 'lt', 'number', 'positive', 'cells', 'positive', 'correlation', 'poor', 'prognosis', 'patients', 'detection', 'analysis', 'markers', 'CSCs', 'markers', 'great', 'value', 'evaluation', 'tumor', 'progression']"
439,439,http://europepmc.org/articles/PMC3049765?pdf=render,Differential expression of CHL1 gene during development of major human cancers.,"CHL1 gene (also known as CALL) on 3p26.3 encodes a one-pass trans-membrane cell adhesion molecule (CAM). Previously CAMs of this type, including L1, were shown to be involved in cancer growth and metastasis.We used Clontech Cancer Profiling Arrays (19 different types of cancers, 395 samples) to analyze expression of the CHL1 gene. The results were further validated by RT-qPCR for breast, renal and lung cancer. Cancer Profiling Arrays revealed differential expression of the gene: down-regulation/silencing in a majority of primary tumors and up-regulation associated with invasive/metastatic growth. Frequent down-regulation (>40% of cases) was detected in 11 types of cancer (breast, kidney, rectum, colon, thyroid, stomach, skin, small intestine, bladder, vulva and pancreatic cancer) and frequent up-regulation (>40% of cases)--in 5 types (lung, ovary, uterus, liver and trachea) of cancer. Using real-time quantitative PCR (RT-qPCR) we found that CHL1 expression was decreased in 61% of breast, 60% of lung, 87% of clear cell and 89% papillary renal cancer specimens (P<0.03 for all the cases). There was a higher frequency of CHL1 mRNA decrease in lung squamous cell carcinoma compared to adenocarcinoma (81% vs. 38%, P‚Ää=‚Ää0.02) without association with tumor progression.Our results suggested that CHL1 is involved in the development of different human cancers. Initially, during the primary tumor growth CHL1 could act as a putative tumor suppressor and is silenced to facilitate in situ tumor growth for 11 cancer types. We also suggested that re-expression of the gene on the edge of tumor mass might promote local invasive growth and enable further metastatic spread in ovary, colon and breast cancer. Our data also supported the role of CHL1 as a potentially novel specific biomarker in the early pathogenesis of two major histological types of renal cancer.",['Vera N Senchenko'],0,doaj,"['cam', 'content addressable memory', 'bandwidth', 'computer aided manufacturing', 'array processing', 'linear arrays', 'frequencies', 'sub-arrays', 'direction of arrival', 'associative storage']",liver carcinoma in situ,"['Differential', 'expression', 'gene', 'development', 'major', 'human', 'cancers']","['gene', 'encodes', 'pass', 'trans', '-', 'membrane', 'cell', 'adhesion', 'molecule', 'CAMs', 'type', 'cancer', 'growth', 'metastasis', 'different', 'types', 'cancers', 'samples', 'expression', 'gene', 'results', 'breast', 'renal', 'lung', 'cancer', 'differential', 'expression', 'gene', 'regulation', 'majority', 'primary', 'tumors', 'regulation', 'invasive', 'metastatic', 'growth', 'Frequent', 'regulation', '%', 'cases', 'types', 'cancer', 'breast', 'kidney', 'rectum', 'colon', 'thyroid', 'stomach', 'skin', 'small', 'intestine', 'bladder', 'vulva', 'pancreatic', 'cancer', 'frequent', 'up', 'regulation', '%', 'types', 'lung', 'ovary', 'uterus', 'liver', 'trachea', 'cancer', 'real', 'time', 'quantitative', 'expression', '%', 'breast', '%', 'lung', '%', 'clear', 'cell', '%', 'papillary', 'renal', 'cancer', 'specimens', 'cases', 'higher', 'frequency', 'decrease', 'lung', 'squamous', 'cell', 'carcinoma', 'adenocarcinoma', '%', 'vs.', '%', 'P', 'association', 'tumor', 'progression', 'results', 'development', 'different', 'human', 'cancers', 'primary', 'tumor', 'growth', 'putative', 'tumor', 'suppressor', 'situ', 'tumor', 'growth', 'cancer', 'types', 're', '-', 'expression', 'gene', 'edge', 'tumor', 'mass', 'local', 'invasive', 'growth', 'further', 'metastatic', 'spread', 'ovary', 'colon', 'breast', 'cancer', 'data', 'role', 'novel', 'specific', 'biomarker', 'early', 'pathogenesis', 'major', 'histological', 'types', 'renal', 'cancer']"
440,440,http://journal.frontiersin.org/article/10.3389/fphar.2018.00229/full,The Cytochrome P450-Mediated Metabolism Alternation of Four Effective Lignans From Schisandra chinensis in Carbon Tetrachloride-Intoxicated Rats and Patients With Advanced Hepatocellular Carcinoma,"It is highly valuable to study the pharmacokinetics of herbal components under the pathological condition of liver dysfunction for safe and rational use of herbal medicines. In this study, the pharmacokinetic profiles of four effective lignans from Schisandra chinensis (SC), schisandrin, schisantherin A, deoxyshisandrin and Œ≥-schisandrin, were investigated in carbon tetrachloride (CCl4)-intoxicated rats. The metabolism of the four lignans was also studied using microsomes from patients with advanced hepatocellular carcinoma. In situ intestinal and hepatic perfusions were conducted to clarify the contributions from impairments of gut and liver on the pharmacokinetics of the four schisandra lignans in CCl4-intoxicated rats. The metabolism in rat and human liver microsomes and transport in Caco-2 monolayer cell model were studied to reveal the key factors for the in vivo disposition of the four lignans. When SC alcoholic extract was orally administrated to CCl4-intoxicated rat for a short term (4 days), the pharmacokinetics of four active SC lignans was significantly changed while its hepatotherapeutic effect was not obviously observed. The plasma concentrations of the four schisandra lignans were dramatically elevated compared with the control. The Cmax, AUC and MRT were all increased or prolonged significantly while parameter CLz/F was obviously reduced in rat pretreated with CCl4. In hepatic perfusion study and liver microsomes incubation, it was found that the hepatic metabolism of the four lignans was markedly decreased mainly due to the activity reduction of multiple CYP450 isoenzymes involved the metabolism, which, eventually, might lead to the alternation of their pharmacokinetic profiles in CCl4-intoxicated rats or patients with advanced hepatocellular carcinoma. The pharmacokinetic studies of SC components in pathological situation of liver dysfunction are expected to provide useful data for rational and safe application of SC preparations in clinic or further pharmacological and toxicological research.",['Rongrong Wu'],"['Schisandra chinensis (SC)', 'lignans', 'pharmacokinetics', 'liver injury', 'cytochrome P450(CYP450)']",doaj,"['switching systems', 'lightpath', 'component', 'software', 'hierarchical system', 'hierarchical model', 'switching control', 'physical impairments', 'differential evolution', 'evolutionary algorithms', 'all-optical networks']",liver carcinoma in situ,"['Effective', 'chinensis']","['valuable', 'pharmacokinetics', 'herbal', 'components', 'pathological', 'condition', 'liver', 'dysfunction', 'safe', 'rational', 'use', 'herbal', 'medicines', 'study', 'pharmacokinetic', 'profiles', 'effective', 'lignans', 'chinensis', 'schisandrin', 'deoxyshisandrin', 'Œ≥', 'schisandrin', 'carbon', 'tetrachloride', 'CCl4)-intoxicated', 'rats', 'metabolism', 'lignans', 'microsomes', 'patients', 'advanced', 'hepatocellular', 'carcinoma', 'situ', 'intestinal', 'hepatic', 'perfusions', 'contributions', 'impairments', 'gut', 'liver', 'pharmacokinetics', 'schisandra', 'lignans', 'CCl4-intoxicated', 'rats', 'metabolism', 'rat', 'human', 'liver', 'microsomes', 'transport', 'monolayer', 'cell', 'model', 'key', 'factors', 'vivo', 'disposition', 'lignans', 'alcoholic', 'extract', 'CCl4-intoxicated', 'rat', 'short', 'term', 'days', 'pharmacokinetics', 'active', 'lignans', 'hepatotherapeutic', 'effect', 'plasma', 'concentrations', 'schisandra', 'lignans', 'control', 'parameter', 'CLz', 'rat', 'hepatic', 'perfusion', 'study', 'liver', 'microsomes', 'incubation', 'hepatic', 'metabolism', 'lignans', 'activity', 'reduction', 'multiple', 'isoenzymes', 'metabolism', 'alternation', 'pharmacokinetic', 'profiles', 'CCl4-intoxicated', 'rats', 'patients', 'advanced', 'hepatocellular', 'carcinoma', 'pharmacokinetic', 'studies', 'components', 'pathological', 'situation', 'liver', 'dysfunction', 'useful', 'data', 'rational', 'safe', 'application', 'preparations', 'clinic', 'further', 'pharmacological', 'toxicological', 'research']"
441,441,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0014/353/A1/US20130014353A1.pdf,"ADAPTER, ASSEMBLY UNIT COMPRISING AN ADAPTER AS WELL AS A METHOD OF INSTALLING SUCH AN ASSEMBLY UNIT","An adapter for the vehicle-side installation of a component, in particular of a lining part, has a first fastening element to which a component-side holding piece can be attached, and a second fastening element to which a vehicle-side retaining element can be attached. The first and second fastening elements are coupled to each other via at least one spring element so as to be movable to a limited extent.","['Loewe Hubert', 'Marx Oliver', 'Hofmann Juergen']",0,uspto,"['noc', 'component', 'software', 'engineering', 'device driver', 'vehicles', 'interfaces (computer)', 'network interface', 'operating systems']",liver carcinoma in situ,"['ASSEMBLY', 'UNIT', 'COMPRISING', 'ADAPTER', 'METHOD', 'ASSEMBLY', 'UNIT']","['adapter', 'vehicle', 'side', 'installation', 'component', 'particular', 'lining', 'part', 'first', 'fastening', 'element', 'component', 'side', 'piece', 'second', 'element', 'vehicle', 'side', 'element', 'first', 'second', 'fastening', 'elements', 'other', 'spring', 'element', 'movable', 'limited', 'extent']"
442,442,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0015/656/A1/US20130015656A1.pdf,HIGH-PRESSURE CONNECTION DEVICE FOR PIPE AND HOSE LINES WITH A BAYONET COUPLING,"A high-pressure connection device for pipe and hose lines with a connection body and a pipe-like end piece insertable into the connection body, including a union nut externally mounted to the connection body, which can be rotated between a released position and a mounted position. Form-locking designs, which act like a bayonet coupling, are arranged on the connection body and union nut in the form of projections on the union nut as well as in the form of interlocking contours formed on an end extension of the connection body for the locking reception of the projections when rotating the union nut. A security element is movable between a secure position and a release position for rotation of the union nut in order to prevent unintentional reverse rotation of the union nut.","['Ehrke Dieter', 'Schippers Carsten', 'M√ºller Thomas', 'Neiske Oliver']",0,uspto,"['target tracking', 'computer aided design', 'robotics', 'object contour', 'target position', 'edge point', 'cad tool', 'active contours', 'portable device', 'object recognition', 'edge detection algorithms', 'portable equipment']",liver carcinoma in situ,"['HIGH', 'PRESSURE', 'CONNECTION', 'DEVICE', 'LINES', 'BAYONET', 'COUPLING']","['high', 'pressure', 'connection', 'device', 'pipe', 'hose', 'lines', 'connection', 'body', 'pipe', 'like', 'end', 'piece', 'insertable', 'connection', 'body', 'union', 'nut', 'connection', 'body', 'position', 'position', 'Form', 'designs', 'bayonet', 'coupling', 'connection', 'body', 'union', 'nut', 'form', 'projections', 'union', 'nut', 'form', 'contours', 'end', 'extension', 'connection', 'body', 'locking', 'reception', 'projections', 'union', 'nut', 'security', 'element', 'movable', 'secure', 'position', 'release', 'position', 'rotation', 'union', 'nut', 'order', 'unintentional', 'reverse', 'rotation', 'union', 'nut']"
443,443,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0015/749/A1/US20130015749A1.pdf,Method for Installing a Side-By-Side Domestic Appliance Combination,"The present invention relates to a method for installing a side-by-side domestic appliance combination, in particular a side-by-side refrigerator unit and/or freezer unit combination, which comprises at least two domestic appliances or refrigerator and/or freezer units. In accordance with the invention, the method includes the steps: Arranging the two domestic appliances next to one another; placing an installation element onto the upper side of the two domestic appliances arranged next to one another; and fastening of the installation element to both domestic appliances such that the installation element prevents or makes difficult a relative movement of the two domestic appliances in the depth direction and in the height direction.","['Hecht Josef', 'Blersch Dietmar', 'Schubert Ralf', 'Weidelener Oliver', 'Schweikart Stefan']",0,uspto,"['electrical appliances', 'electric appliances', 'domestic appliances', 'shack-hartmann wavefront sensors', 'household appliances', 'home appliances', 'energy utilization', 'personal communication systems']",liver carcinoma in situ,"['Side', 'Side']","['present', 'invention', 'method', 'side', 'side', 'domestic', 'appliance', 'combination', 'particular', 'side', 'side', 'refrigerator', 'unit', 'freezer', 'unit', 'combination', 'domestic', 'appliances', 'refrigerator', 'freezer', 'units', 'accordance', 'invention', 'method', 'steps', 'domestic', 'appliances', 'installation', 'element', 'upper', 'side', 'domestic', 'appliances', 'fastening', 'installation', 'element', 'domestic', 'appliances', 'such', 'installation', 'element', 'prevents', 'difficult', 'relative', 'movement', 'domestic', 'appliances', 'depth', 'direction', 'height', 'direction']"
444,444,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0015/847/A1/US20130015847A1.pdf,MAGNETIC FIELD SENSOR AND METHOD FOR DETERMINING AND CORRECTING AN OFFSET VOLTAGE OF A MAGNETIC FIELD SENSOR,"A magnetic field sensor having a Hall sensor with a first terminal contact and with a second terminal contact and with a third terminal contact and with a fourth terminal contact and with a fifth terminal contact, whereby a first switch with a control input is provided between the first terminal contact and the fifth terminal contact, and the first switch connects or disconnects the first terminal contact to/from the fifth terminal contact, and a control unit is provided and the control unit is connected to the control input of the first switch.","['Kaufmann Timo', 'Ruther Patrick', 'Raz Roiy', 'Paul Oliver']",0,uspto,"['electronic commerce', 'mobile telecommunication systems', 'infrared detectors', 'single sensor', 'contracts', 'information technology', 'mobile phones', 'infra-red sensor', 'sensors', 'adaptive control systems', 'multi-sensor', 'mobile terminal', 'control design', 'computer hardware']",liver carcinoma in situ,"['SENSOR', 'METHOD', 'DETERMINING', 'VOLTAGE', 'FIELD', 'SENSOR']","['magnetic', 'field', 'sensor', 'sensor', 'first', 'terminal', 'contact', 'second', 'terminal', 'contact', 'third', 'terminal', 'contact', 'fourth', 'terminal', 'contact', 'fifth', 'terminal', 'contact', 'first', 'switch', 'control', 'input', 'first', 'terminal', 'contact', 'fifth', 'terminal', 'contact', 'first', 'switch', 'connects', 'first', 'terminal', 'contact', 'fifth', 'terminal', 'contact', 'control', 'unit', 'control', 'unit', 'control', 'input', 'first', 'switch']"
445,445,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0015/853/A1/US20130015853A1.pdf,HALL SENSOR,"A Hall sensor is provided having a first Hall element with a first terminal contact and with a second terminal contact and with a third terminal contact, a second Hall element with a fourth terminal contact and with a fifth terminal contact and with a sixth terminal contact, a third Hall element with a seventh terminal contact and with an eighth terminal contact and with a ninth terminal contact, and a fourth Hall element with a tenth terminal contact and with an eleventh terminal contact and with a twelfth terminal contact. The first Hall element and the second Hall element and the third Hall element and the fourth Hall element are connectable in series.","['Raz Roiy', 'Ruther Patrick', 'Kaufmann Timo', 'Paul Oliver']",0,uspto,"['electronic commerce', 'mobile telecommunication systems', 'infrared detectors', 'single sensor', 'contracts', 'information technology', 'mobile phones', 'infra-red sensor', 'sensors', 'multi-sensor', 'mobile terminal', 'computer hardware']",liver carcinoma in situ,['SENSOR'],"['sensor', 'first', 'element', 'first', 'terminal', 'contact', 'second', 'terminal', 'contact', 'third', 'terminal', 'contact', 'second', 'element', 'fourth', 'terminal', 'contact', 'fifth', 'terminal', 'contact', 'sixth', 'terminal', 'contact', 'third', 'element', 'seventh', 'terminal', 'contact', 'eighth', 'terminal', 'contact', 'ninth', 'terminal', 'contact', 'fourth', 'element', 'tenth', 'terminal', 'contact', 'eleventh', 'terminal', 'contact', 'twelfth', 'terminal', 'contact', 'first', 'element', 'second', 'element', 'third', 'element', 'fourth', 'element', 'connectable', 'series']"
446,446,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0015/929/A1/US20130015929A1.pdf,INTELLIGENT SWITCH SYSTEM AND ASSEMBLY HAVING INTEGRATED PROTECTION CIRCUITRY,"A switch system includes a brake pedal having a ferromagnetic target, a main housing that securely retains a brake circuit board and a magnet, a sensor connector subassembly, and a plug connector subassembly. The system also includes a connector circuit board secured within the sensor connector subassembly and in communication with the brake circuit board. The connector circuit board includes at least one positive temperature coefficient (PTC) device electrically connected between the brake circuit board and at least one brake lamp. The connector circuit board may also include at least one circuit to protect against over-voltage or over-current to the at least one brake lamp, detect a fault condition, and determine whether the plug connector subassembly is connected to the sensor connector subassembly.","['Bryan Lyle Stanley', 'Cowan John Steven', 'Banas Thomas Michael', 'Cooper Ralph Melvin', 'Thrush Roger L.', 'Hernandez-Oliver Salvador']",0,uspto,"['clutch', 'integrated circuit testing', 'field programmable gate arrays (fpga)', 'communication', 'infrared detectors', 'flip flop circuits', 'single sensor', 'electric network analysis', 'vehicle suspensions', 'infra-red sensor', 'clutches', 'sensors', 'logic design', 'multi-sensor', 'logic gates', 'computer hardware', 'suspension system']",liver carcinoma in situ,"['ASSEMBLY', 'INTEGRATED', 'PROTECTION', 'CIRCUITRY']","['switch', 'system', 'brake', 'pedal', 'ferromagnetic', 'target', 'main', 'housing', 'brake', 'circuit', 'board', 'magnet', 'sensor', 'connector', 'plug', 'connector', 'system', 'connector', 'circuit', 'board', 'sensor', 'connector', 'communication', 'brake', 'circuit', 'board', 'connector', 'circuit', 'board', 'positive', 'temperature', 'coefficient', 'device', 'brake', 'circuit', 'board', 'brake', 'lamp', 'connector', 'circuit', 'board', 'circuit', 'voltage', 'current', 'brake', 'lamp', 'fault', 'condition', 'plug', 'connector', 'sensor', 'connector']"
447,447,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0016/001/A1/US20130016001A1.pdf,RADAR SENSOR,A radar sensor including an antenna array having multiple antenna elements situated next to one another and at least one feeding point at an outer antenna element. The antenna elements are connected in series via delay lines. The radar sensor has at least two transmitting and receiving units which are each suitable for generating and evaluating a radar signal at a predefined frequency. The at least two transmitting and receiving units are connected to a feeding point of the antenna array. The frequencies of the radar signals of the at least two transmitting and receiving units are predefinable independently of one another.,"['Schoeberl Thomas', 'Meschenmoser Reinhard', 'Zender Arne', 'Hansen Thomas', 'Hilsebecher Joerg', 'Nesemann Karl', 'Lange Oliver']",0,uspto,"['bandwidth', 'beamforming', 'radar signals', 'radar target recognition', 'antenna arrays', 'multiple antenna', 'radar', 'sensors', 'tracking radar', 'signal processing', 'signal to noise ratio', 'mim devices', 'transmitters', 'communication channels (information theory)', 'radar sensors', 'radar measurement', 'antenna element', 'computer hardware', 'matrix algebra', 'mimo systems', 'antennas', 'multiplexing', 'microwaves', 'radar systems', 'frequencies', 'wireless telecommunication systems', 'antenna accessories']",liver carcinoma in situ,"['RADAR', 'SENSOR']","['radar', 'sensor', 'antenna', 'array', 'multiple', 'antenna', 'elements', 'feeding', 'point', 'outer', 'antenna', 'element', 'antenna', 'elements', 'series', 'delay', 'lines', 'radar', 'sensor', 'units', 'suitable', 'radar', 'signal', 'predefined', 'frequency', 'units', 'feeding', 'point', 'antenna', 'array', 'frequencies', 'radar', 'signals', 'units', 'predefinable', 'one']"
448,448,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0016/339/A1/US20130016339A1.pdf,METHOD OF CHARACTERISING A SCATTERING COLOURED PIGMENT,"The invention provides a method of characterising a scattering coloured pigment for use in the determination of the absorption and scattering coefficients of the scattering coloured pigment, the method comprising the step of obtaining a reflectance spectrum of a mixture of the scattering coloured pigment with a substantially non-absorbing scattering pigment at a plurality of different volume fractions wherein the substantially non-absorbing scattering pigment has a particle size greater than 0.6 micron. Also provided is a pigment characterisation system adapted to perform the method of the invention to characterise a scattering coloured pigment.","['Edwards John Lalande', 'Lowry Karl', 'Parnham Emily Ruth', 'Reid Sean Oliver Edward', 'Robb John', 'Tonkin Rebecca Louise']",0,uspto,"['spectrum sensing', 'bidirectional reflectance distribution functions', 'ion implantation', 'adaptive filters', 'filter coefficients', 'frequency bands', 'fir filters', 'cognitive radio network', 'ion bombardment', 'dynamic spectrum access', 'antennas', 'dynamic spectrum', 'distribution functions']",liver carcinoma in situ,"['METHOD', 'SCATTERING', 'PIGMENT']","['invention', 'method', 'scattering', 'coloured', 'pigment', 'use', 'determination', 'absorption', 'scattering', 'coefficients', 'scattering', 'coloured', 'pigment', 'method', 'step', 'reflectance', 'spectrum', 'mixture', 'scattering', 'coloured', 'pigment', 'non', '-', 'absorbing', 'scattering', 'pigment', 'plurality', 'different', 'volume', 'fractions', 'non', '-', 'absorbing', 'scattering', 'pigment', 'particle', 'size', 'greater', 'micron', 'pigment', 'characterisation', 'system', 'method', 'invention', 'scattering', 'coloured', 'pigment']"
449,449,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0016/842/A1/US20130016842A1.pdf,APPARATUS AND A METHOD FOR CONVERTING A FIRST PARAMETRIC SPATIAL AUDIO SIGNAL INTO A SECOND PARAMETRIC SPATIAL AUDIO SIGNAL,"An apparatus for converting a first parametric spatial audio signal representing a first listening position or a first listening orientation in a spatial audio scene to a second parametric spatial audio signal representing a second listening position or a second listening orientation is described, the apparatus including: a spatial audio signal modification unit adapted to modify the first parametric spatial audio signal dependent on a change of the first listening position or the first listening orientation so as to obtain the second parametric spatial audio signal, wherein the second listening position or the second listening orientation corresponds to the first listening position or the first listening orientation changed by the change.","['Schultz-Amling Richard', 'Kuech Fabian', 'Kallinger Markus', 'Del Galdo Giovanni', 'Thiergart Oliver', 'Mahne Dirk', 'Kuntz Achim']",0,uspto,"['audio content', 'audio stream', 'signal analysis', 'audio acoustics', 'spatial audio', 'audio signals', 'audio', 'audio systems']",liver carcinoma in situ,"['METHOD', 'FIRST', 'SPATIAL', 'AUDIO', 'SECOND', 'SPATIAL', 'AUDIO']","['apparatus', 'first', 'parametric', 'spatial', 'audio', 'signal', 'first', 'listening', 'position', 'first', 'listening', 'orientation', 'spatial', 'audio', 'scene', 'second', 'parametric', 'spatial', 'audio', 'signal', 'second', 'listening', 'position', 'second', 'listening', 'orientation', 'apparatus', 'spatial', 'audio', 'signal', 'modification', 'unit', 'first', 'parametric', 'spatial', 'audio', 'signal', 'dependent', 'change', 'first', 'listening', 'position', 'first', 'listening', 'orientation', 'second', 'parametric', 'spatial', 'audio', 'signal', 'second', 'listening', 'position', 'second', 'listening', 'orientation', 'corresponds', 'first', 'listening', 'position', 'first', 'listening', 'orientation', 'change']"
450,450,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0016/913/A1/US20130016913A1.pdf,IMAGE PROCESSING METHOD AND SYSTEM,"A method of comparing two object poses, wherein each object pose is expressed in terms of position, orientation and scale with respect to a common coordinate system, the method comprising:","['Pham Minh-Tri', 'Woodford Oliver', 'Perbet Frank', 'Maki Atsuto', 'Stenger Bjorn', 'Cipolla Roberto']",0,uspto,"['robotics', 'pose estimation', 'computer vision', 'image processing', 'object tracking', 'pattern recognition', 'image quality', 'color images', 'reference image', 'object pose', 'image matching', 'object appearance', 'color image processing']",liver carcinoma in situ,"['IMAGE', 'PROCESSING', 'METHOD']","['method', 'object', 'poses', 'object', 'pose', 'terms', 'position', 'orientation', 'scale', 'respect', 'common', 'coordinate', 'system', 'method', 'comprising']"
451,451,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0017/333/A1/US20130017333A1.pdf,POLYESTER RESINS,"The invention relates to a polyester AB comprising moieties derived from di- or polyfunctional organic acid compounds A and moieties derived from di- or polyfunctional organic hydroxy compounds B, wherein the compounds A comprise ‚Äúhard‚Äù acid compounds A1 having two or more acid groups per molecule, and soft acid compounds A2, and the compounds B comprise ‚Äúhard‚Äù hydroxyfunctional compounds B1 having two or more hydroxyl groups per molecule, and soft hydroxyfunctional compounds B2, and coating compositions prepared from these with crosslinkers selected from the group consisting of isocyanates, capped isocyanates, aminoplast crosslinkers, and phenoplast crosslinkers, as well as their application in coating of metal substrates.","['Feola Roland', 'Gmoser Johann', 'Etz Oliver']",0,uspto,[],liver carcinoma in situ,"['POLYESTER', 'RESINS']","['invention', 'polyester', 'comprising', 'moieties', 'di-', 'polyfunctional', 'organic', 'acid', 'moieties', 'di-', 'polyfunctional', 'organic', 'hydroxy', 'compounds', 'compounds', 'comprise', 'hard', 'acid', 'more', 'acid', 'groups', 'molecule', 'soft', 'acid', 'compounds', 'A2', 'compounds', 'comprise', '‚Äú', 'hard', 'hydroxyfunctional', 'compounds', 'more', 'hydroxyl', 'groups', 'molecule', 'soft', 'hydroxyfunctional', 'compounds', 'B2', 'coating', 'compositions', 'crosslinkers', 'group', 'isocyanates', 'isocyanates', 'aminoplast', 'crosslinkers', 'phenoplast', 'crosslinkers', 'application', 'coating', 'metal', 'substrates']"
452,452,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0017/365/A1/US20130017365A1.pdf,MULTICOLORED INTERIOR TRIM COMPONENTS,"The invention relates to a process for the preparation of multicolored interior trim components of motor vehicles having a defined surface profile, and to the thus obtained interior trim components.","['GUTT Stephen', 'KLEINT Oliver', 'UNGER Roland', 'DITTRICH Alfred', 'RIESINGER Stefan']",0,uspto,"['vehicles', 'software', 'component', 'engineering']",liver carcinoma in situ,"['MULTICOLORED', 'INTERIOR', 'TRIM', 'COMPONENTS']","['invention', 'process', 'preparation', 'interior', 'trim', 'components', 'motor', 'vehicles', 'surface', 'profile', 'interior', 'trim', 'components']"
453,453,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0017/554/A1/US20130017554A1.pdf,SUMO-SPECIFIC AFFINITY TAG,"A new SUMO-specific affinity tag is described herein, based on the amino acid sequence from 403-621 of the SUMO protease Ulp1, and containing a crucial substitution of serine for cysteine. This affinity tag is particularly useful for a range of applications, including detection and affinity purification of sumoylated proteins from cell extracts.","['Kerscher Oliver', 'Donaher Megan', 'Elmore Zachary C.']",0,uspto,"['rf-id tags', 'detection algorithm', 'rfid', 'signal detection']",liver carcinoma in situ,"['SPECIFIC', 'AFFINITY', 'TAG']","['new', 'specific', 'affinity', 'tag', 'herein', 'amino', 'acid', 'sequence', 'protease', 'crucial', 'substitution', 'serine', 'cysteine', 'affinity', 'tag', 'useful', 'range', 'applications', 'detection', 'affinity', 'purification', 'sumoylated', 'proteins', 'cell', 'extracts']"
454,454,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0017/773/A1/US20130017773A1.pdf,REMOVABLE BREAK-AWAY SHACKLE ASSEMBLY,"A removable break-away shackle assembly for suspending an animal carcass during processing includes a shackle connected to a drop rod, where the drop rod is connected to a conveyor system. The drop rod includes an elongated body with a connector at one end. The shackle includes bendable opposing arms forming a widenable gap. The shackle is separable from the drop rod by passing the drop rod through the widenable gap causing the arms to bend and the gap to widen, or by passing the widenable gap across a depression in the drop rod.","['CRISCIONE', 'II Frank J.', 'Hahn Oliver', 'Avey Ronnie Lee', 'Armstrong William Randall']",0,uspto,[],liver carcinoma in situ,['ASSEMBLY'],"['removable', 'break', 'shackle', 'assembly', 'animal', 'carcass', 'processing', 'shackle', 'drop', 'rod', 'drop', 'rod', 'conveyor', 'system', 'drop', 'rod', 'elongated', 'body', 'connector', 'end', 'shackle', 'bendable', 'arms', 'widenable', 'gap', 'shackle', 'separable', 'drop', 'rod', 'drop', 'rod', 'widenable', 'gap', 'arms', 'gap', 'widenable', 'gap', 'depression', 'drop', 'rod']"
455,455,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0018/200/A1/US20130018200A1.pdf,SILAOXACYCLES,"Siloxacycles are synthesized in high yield and purity by reaction of acyloxymethyl (alkoxy) silanes in the presence of a catalyst which is a metal from groups 3 to 15 of the periodic table, or a compound thereof.","['Daiss Juergen Oliver', 'Schmid Stefan']",0,uspto,[],liver carcinoma in situ,[],"['Siloxacycles', 'high', 'yield', 'purity', 'reaction', 'acyloxymethyl', 'alkoxy', 'presence', 'catalyst', 'metal', 'groups', 'periodic', 'table', 'compound']"
456,456,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130117/2013-03/US/2013/0018/490/A1/US20130018490A1.pdf,Web-Based Operator Control Interface to Generator Control Systems,"A web-based operator control interface system can include an operator interface section including a web browser application, a generator exciter section or a static starter section coupled to the operator interface section, a generator coupled to the generator exciter section and a web server application configured to receive processing requests from the web browser application, and further configured to internally process real-time generator functions.","['Caffrey Paul Oliver', 'Casteel Jordan Brantley', 'Damodar Dhanashree Sadanand', 'Fowley Douglas Gregg', 'Jackson Roy', 'Pearson William Robert']",0,uspto,"['linguistics', 'world wide web', 'control systems', 'computer systems', 'information technology', 'internet', 'web servers', 'search engines', 'web page', 'servers', 'web information']",liver carcinoma in situ,['Web'],"['web', 'operator', 'control', 'interface', 'system', 'operator', 'interface', 'section', 'web', 'browser', 'application', 'generator', 'exciter', 'section', 'static', 'starter', 'section', 'operator', 'interface', 'section', 'generator', 'generator', 'exciter', 'section', 'web', 'server', 'application', 'processing', 'requests', 'web', 'browser', 'application', 'real', 'time', 'generator', 'functions']"
457,457,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0019/588/A1/US20130019588A1.pdf,Method Of Controlling A Direct-Injection Gaseous-Fuelled Internal Combustion Engine System With A Selective Catalytic Reduction Converter,"A method controls a direct-injection gaseous-fuelled internal combustion engine system to improve the conversion efficiency of an SCR converter that is operative to reduce levels of NOx. The method comprises detecting when the internal combustion engine is idling and timing the injection of a first quantity of fuel to begin injection when the engine's piston is near top dead center; and controlling the temperature of exhaust gas to be above a predetermined temperature that is defined by an operating temperature range that achieves a desired conversion efficiency for the selective catalytic reduction converter, by: (a) timing injection of the gaseous fuel to begin after timing for injection the first quantity of fuel, and (b) increasing exhaust gas temperature by increasing a delay in timing for injecting the gaseous fuel, while limiting the delay to keep concentration of unburned fuel exiting the combustion chamber below a predetermined concentration.","['Richardson Sean D.', 'Lebastard Oliver P.M.']",0,uspto,"['computational efficiency', 'theoretical computer science', 'engine pistons', 'propagation delays', 'engine cylinders', 'network protocols', 'engineering', 'internal combustion', 'internal combustion engines', 'engine']",liver carcinoma in situ,[],"['method', 'direct', 'injection', 'gaseous', 'internal', 'combustion', 'engine', 'system', 'conversion', 'efficiency', 'converter', 'operative', 'levels', 'NOx', 'method', 'internal', 'combustion', 'engine', 'injection', 'first', 'quantity', 'fuel', 'injection', 'engine', 'piston', 'top', 'dead', 'center', 'temperature', 'exhaust', 'gas', 'predetermined', 'temperature', 'temperature', 'range', 'conversion', 'efficiency', 'selective', 'catalytic', 'reduction', 'converter', 'timing', 'injection', 'gaseous', 'fuel', 'injection', 'first', 'quantity', 'fuel', 'exhaust', 'gas', 'temperature', 'delay', 'timing', 'gaseous', 'fuel', 'delay', 'concentration', 'unburned', 'fuel', 'combustion', 'chamber', 'concentration']"
458,458,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0019/686/A1/US20130019686A1.pdf,Method and apparatus for a railway wheel ultrasonic testing apparatus,"A method and apparatus for collecting ultrasonic test data from a railway wheel with an ultrasonic testing apparatus is described. The railway wheel is supported by two drive rollers, each having an indentation which engages with and rotates the wheel. An indexing transducer moves across the rotating wheel, collecting ultrasonic test data while a fixed transducer correlates a reference position on the wheel to the collected test data. To maintain the accuracy of the reference position to the collected test data, it is desirable to maintain the rotational stability of the wheel, minimizing any dynamic instability caused by dimensional tolerances in the wheel. To mitigate instabilities resulting from dimensional tolerances, the indentation of the drive rollers, which engage and drive the flange of the wheel, is adjustable by the flexing design of the drive rollers to maintain frictional contact between the wheel and the drive roller. This allows the indentation to accommodate the varying dimensional tolerances of the wheel flange, mitigating the possibility of dynamic instability resulting from departure of the wheel flange from the indentation.","['Oliver John R.', 'Oliver John D.']",0,uspto,"['signal processing', 'integrated data', 'data integration', 'ultrasonic testing', 'ultrasonic transducers', 'ultrasonic signals', 'data compression', 'test pattern', 'ultrasonic imaging', 'automatic test pattern generation']",liver carcinoma in situ,"['apparatus', 'railway', 'wheel', 'ultrasonic', 'testing', 'apparatus']","['method', 'apparatus', 'ultrasonic', 'test', 'data', 'railway', 'wheel', 'ultrasonic', 'testing', 'apparatus', 'railway', 'wheel', 'drive', 'rollers', 'indentation', 'wheel', 'indexing', 'transducer', 'wheel', 'ultrasonic', 'test', 'data', 'transducer', 'reference', 'position', 'wheel', 'collected', 'test', 'data', 'accuracy', 'reference', 'position', 'collected', 'test', 'data', 'desirable', 'rotational', 'stability', 'wheel', 'dynamic', 'instability', 'dimensional', 'tolerances', 'wheel', 'instabilities', 'dimensional', 'tolerances', 'indentation', 'drive', 'rollers', 'flange', 'wheel', 'adjustable', 'design', 'drive', 'rollers', 'frictional', 'contact', 'wheel', 'drive', 'roller', 'indentation', 'dimensional', 'tolerances', 'wheel', 'flange', 'possibility', 'dynamic', 'instability', 'departure', 'wheel', 'flange', 'indentation']"
459,459,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0020/181/A1/US20130020181A1.pdf,Elastic Spreading Belt,"An elastic spreading belt with an elastic fabric tape, a coating applied thereon, and perforated strips arranged in longitudinal direction on both sides thereof, into each of which a plate link chain engages, characterized in that the coating is made from polyurethane.","['Kallsen Benjamin', 'Carstensen Oliver']",0,uspto,"['wireless link', 'wireless networks']",liver carcinoma in situ,['Belt'],"['elastic', 'belt', 'elastic', 'fabric', 'tape', 'coating', 'thereon', 'strips', 'longitudinal', 'direction', 'sides', 'plate', 'link', 'chain', 'engages', 'coating', 'polyurethane']"
460,460,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0020/318/A1/US20130020318A1.pdf,Active Packaging Technology,"The invention provides active packaging for food, medicine, or other perishable items. The packaging includes at least one active component to capture moisture and/or gas that may otherwise pass through the packaging wall",['Oliver Gary D.'],0,uspto,"['component', 'software', 'information technology', 'innovative technologies', 'computing technology', 'cloud computing', 'service management']",liver carcinoma in situ,['Technology'],"['invention', 'active', 'packaging', 'food', 'medicine', 'other', 'perishable', 'items', 'packaging', 'active', 'component', 'moisture', 'gas', 'packaging', 'wall']"
461,461,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/190/A1/US20130022190A1.pdf,Systems and Methods for Facilitating Conference Calls Using Security Keys,"Systems and methods are described that facilitate a conference call between a plurality of communication devices. The method can comprise: providing a first control link between a first primary communication device and a conference call controller; providing a second control link between a second primary communication device and the conference call controller; and establishing a media link between the first primary communication device and the second primary communication device via the conference call controller. In certain embodiments, the first control link can facilitate the exchange of a first identification data comprising at least one first security key, which can be configured to contain participation level data indicating at least one participation level of the first primary communication device or the second primary communication device.","['Oliver Brian', 'McDonald Ian', 'Labrador Christopher', 'McAndrews Michael', 'Gisby Douglas']",0,uspto,"['telecommunication networks', 'control systems', 'computer systems', 'communication', 'communication protocols', 'computer network', 'communication networks', 'network protocols', 'wireless communications']",liver carcinoma in situ,['Systems'],"['Systems', 'methods', 'conference', 'call', 'plurality', 'communication', 'devices', 'method', 'first', 'control', 'link', 'first', 'primary', 'communication', 'device', 'conference', 'call', 'controller', 'second', 'control', 'link', 'second', 'primary', 'communication', 'device', 'conference', 'call', 'controller', 'media', 'link', 'first', 'primary', 'communication', 'device', 'second', 'primary', 'communication', 'device', 'conference', 'call', 'controller', 'certain', 'embodiments', 'first', 'control', 'link', 'exchange', 'first', 'identification', 'data', 'comprising', 'first', 'security', 'key', 'participation', 'level', 'data', 'participation', 'level', 'first', 'primary', 'communication', 'device', 'second', 'primary', 'communication', 'device']"
462,462,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/206/A1/US20130022206A1.pdf,SPATIAL AUDIO PROCESSOR AND A METHOD FOR PROVIDING SPATIAL PARAMETERS BASED ON AN ACOUSTIC INPUT SIGNAL,A spatial audio processor for providing spatial parameters based on an acoustic input signal has a signal characteristics determiner and a controllable parameter estimator. The signal characteristics determiner is configured to determine a signal characteristic of the acoustic input signal. The controllable parameter estimator for calculating the spatial parameters for the acoustic input signal in accordance with a variable spatial parameter calculation rule is configured to modify the variable spatial parameter calculation rule in accordance with the determined signal characteristic.,"['THIERGART Oliver', 'KUECH Fabian', 'SCHULTZ-AMLING Richard', 'KALLINGER Markus', 'DEL GALDO Giovanni', 'KUNTZ Achim', 'MAHNE Dirk', 'PULKKI Ville', 'LAITINEN Mikko-Ville']",0,uspto,"['signal processing', 'acoustic waves', 'acoustic signals', 'acoustics', 'acoustic signal processing', 'audio acoustics', 'spatial audio', 'control system analysis', 'control parameters', 'audio', 'audio systems']",liver carcinoma in situ,"['METHOD', 'SPATIAL', 'PARAMETERS']","['spatial', 'audio', 'processor', 'spatial', 'parameters', 'acoustic', 'input', 'signal', 'signal', 'characteristics', 'determiner', 'controllable', 'parameter', 'estimator', 'signal', 'characteristics', 'determiner', 'signal', 'characteristic', 'acoustic', 'input', 'signal', 'controllable', 'parameter', 'estimator', 'spatial', 'parameters', 'acoustic', 'input', 'signal', 'accordance', 'variable', 'spatial', 'parameter', 'calculation', 'rule', 'variable', 'spatial', 'parameter', 'calculation', 'rule', 'accordance', 'determined', 'signal', 'characteristic']"
463,463,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/425/A1/US20130022425A1.pdf,INSULATION HANGER STRIPS AND SAFETY STACK PACKAGING THEREFOR,Hanger strips for securing insulation material to a surface of a structure formed of sheet metal material including a plurality of bases which are connected by one or more breakable tabs integrally formed between each pair of adjacent bases and wherein first open slots extend from each of the breakable tabs toward opposite side edges of the bases and wherein a shank extends from each of the bases in a common direction and wherein pluralities of strips are oriented in first and second assemblies of rows of strips having their shanks opposing one another and their bases overlapping one another such that tips of the shanks are safely enclosed between the bases of the opposing assemblies and seated within the first open slots.,"['Ashton David Fleet', 'Costa Louis Steven', 'Ryding Christopher Allan', 'Oliver Anthony David']",0,uspto,"['multimedia services', 'wireless networks', 'wireless sensor networks', 'suction cup', 'telecommunication equipment', 'computer aided manufacturing', 'insulating materials', 'machining', 'encryption', 'security of data', 'wall climbing robot', 'cryptography', 'time slots']",liver carcinoma in situ,"['INSULATION', 'HANGER', 'STRIPS', 'PACKAGING', 'THEREFOR']","['Hanger', 'insulation', 'material', 'surface', 'structure', 'sheet', 'metal', 'material', 'plurality', 'bases', 'more', 'breakable', 'tabs', 'pair', 'adjacent', 'bases', 'open', 'slots', 'breakable', 'tabs', 'opposite', 'side', 'edges', 'bases', 'shank', 'bases', 'common', 'direction', 'pluralities', 'strips', 'first', 'second', 'assemblies', 'rows', 'strips', 'shanks', 'bases', 'such', 'tips', 'shanks', 'bases', 'assemblies', 'first', 'open', 'slots']"
464,464,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/479/A1/US20130022479A1.pdf,Axial Fan With Additional Flow Channel,"An axial fan, having an inner electric motor and a fan wheel connected to the electric motor so as to rotate with it and has a plurality of wheel blades defining a blade length and extend outwardly from the electric motor. A fan housing surrounds the fan wheel. The fan housing is connected to the motor via holding struts which extend to the outside from the motor to the fan housing. A motor housing is provided on the motor behind the fan wheel and accommodates a motor electronics system. A flow duct having an inflow opening and an outflow opening is fastened to the motor behind the fan wheel such that the inflow opening is arranged offset to the outside with respect to the outflow opening. The outflow opening is oriented in such a way that an air flow which exits the outlet opening is guided onto the motor housing.","['Haaf Oliver', 'Haag Christian', 'Walter Sven']",0,uspto,"['electric power', 'energy harvesting', 'tidal current', 'electronics engineering', 'tidal flow', 'electricity', 'fading (radio)', 'radio transmission', 'electronic systems', 'radio channels', 'antennas', 'internal combustion engines', 'electrical energy', 'engine']",liver carcinoma in situ,['Axial'],"['axial', 'fan', 'inner', 'electric', 'motor', 'fan', 'wheel', 'electric', 'motor', 'plurality', 'wheel', 'blades', 'blade', 'length', 'electric', 'motor', 'fan', 'housing', 'fan', 'wheel', 'fan', 'housing', 'motor', 'struts', 'outside', 'motor', 'fan', 'housing', 'motor', 'housing', 'motor', 'fan', 'wheel', 'motor', 'electronics', 'system', 'flow', 'duct', 'inflow', 'opening', 'outflow', 'opening', 'motor', 'fan', 'wheel', 'such', 'inflow', 'opening', 'outside', 'respect', 'outflow', 'opening', 'outflow', 'opening', 'way', 'air', 'flow', 'outlet', 'opening', 'motor', 'housing']"
465,465,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/572/A1/US20130022572A1.pdf,ORGANIC COMPOUNDS AND THEIR USES,"The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.","['BRANDL Trixi', 'RAMAN Prakash', 'RIGOLLIER Pascal', 'SEEPERSAUD Mohindra', 'SIMIC Oliver']",0,uspto,[],liver carcinoma in situ,"['ORGANIC', 'COMPOUNDS', 'THEIR', 'USES']","['present', 'application', 'organic', 'compounds', 'useful', 'treatment', 'prevention', 'amelioration', 'human', 'diseases']"
466,466,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/770/A1/US20130022770A1.pdf,"DIACYLOXYSILANE-BASED, MOISTURE-CROSSLINKABLE ETHENE POLYMERS","Polyethylene homo or copolymers which further contain grafted or copolymerized vinyldiacyloxysilanes are easily processable without premature crosslinking, are easily formed into shaped articles by conventional processing methods, and yet rapidly crosslink to form crosslinked polymers.",['Daiss Juergen Oliver'],0,uspto,[],liver carcinoma in situ,['POLYMERS'],"['Polyethylene', 'homo', 'copolymers', 'vinyldiacyloxysilanes', 'processable', 'premature', 'crosslinking', 'shaped', 'articles', 'conventional', 'processing', 'methods', 'polymers']"
467,467,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0022/888/A1/US20130022888A1.pdf,FUEL CELL COOLING SYSTEM WITH COUPLING OUT OF HEAT,"A cooling system () for a fuel cell system (), in particular for a vehicle, which comprises a fuel cell cooling circuit () for cooling the fuel cell system (), and a battery cooling circuit () for cooling a battery (), with an exchange of thermal energy between the fuel cell cooling circuit () and the battery cooling circuit ().","['Vollmer Dirk', 'Pfeil Oliver']",0,uspto,"['field programmable gate arrays (fpga)', 'integrated circuit testing', 'information dissemination', 'electronic data interchange', 'flip flop circuits', 'electric network analysis', 'information exchanges', 'information management', 'data exchange', 'data integration', 'engineering', 'vehicles', 'logic design', 'logic gates']",liver carcinoma in situ,"['COOLING', 'SYSTEM', 'HEAT']","['system', 'fuel', 'cell', 'system', 'particular', 'vehicle', 'fuel', 'cell', 'circuit', 'fuel', 'cell', 'system', 'battery', 'circuit', 'battery', 'exchange', 'thermal', 'energy', 'fuel', 'cell', 'circuit', 'battery', 'circuit']"
468,468,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0023/153/A1/US20130023153A1.pdf,ELECTRICAL CONNECTOR,"An electrical connector has a housing that includes a carrier and a shield matable to define the housing. The carrier has terminal channels and terminal latches extending into the terminal channels. The shield having lead-in channels through a face of the shield. Terminals are received in corresponding terminal channels. The terminals are held in the terminal channels by the terminal latches. The carrier and the shield are molded as a single piece with a bridge connecting the carrier and the shield. The bridge is broken during assembly to allow coupling of the shield to the carrier. The lead-in channels are aligned with, and positioned forward of, the terminal channels when the shield is mated with the carrier. The lead-in channels guide mating contacts for mating with the terminals held in the terminal channels.","['MYER JOHN MARK', 'MOLL HURLEY CHESTER', 'CRAWFORD JAMES OLIVER']",0,uspto,"['electronic commerce', 'virtual channels', 'mobile telecommunication systems', 'control channels', 'contracts', 'information technology', 'subchannels', 'mobile phones', 'data channels', 'frequency division multiple access', 'physical channels', 'mobile terminal']",liver carcinoma in situ,['CONNECTOR'],"['electrical', 'connector', 'housing', 'carrier', 'shield', 'matable', 'housing', 'carrier', 'terminal', 'channels', 'terminal', 'latches', 'terminal', 'channels', 'shield', 'lead', 'channels', 'face', 'shield', 'Terminals', 'terminal', 'channels', 'terminals', 'terminal', 'channels', 'terminal', 'latches', 'carrier', 'shield', 'single', 'piece', 'bridge', 'carrier', 'shield', 'bridge', 'assembly', 'coupling', 'shield', 'carrier', 'lead', 'channels', 'terminal', 'channels', 'shield', 'carrier', 'lead', 'channels', 'contacts', 'terminals', 'terminal', 'channels']"
469,469,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0023/519/A1/US20130023519A1.pdf,5-ALKYNYL-PYRIDINES,5-alkynyl-pyridine of general formula (I),"['WUNBERG Tobias', 'KRAEMER Oliver', 'van der VEEN Lars']",0,uspto,[],liver carcinoma in situ,['PYRIDINES'],"['pyridine', 'general', 'formula', 'I']"
470,470,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0023/533/A1/US20130023533A1.pdf,NEW 5-ALKYNYL-PYRIDINES,5-alkynyl-pyridine of general formula (I),"['WUNBERG Tobias', 'KRAEMER Oliver', 'van der VEEN Lars']",0,uspto,[],liver carcinoma in situ,"['NEW', 'PYRIDINES']","['pyridine', 'general', 'formula', 'I']"
471,471,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0023/605/A1/US20130023605A1.pdf,CURABLE COMPOSITIONS,"A curable composition comprising (A) a resin component, comprising (i) an epoxy compound, (ii) a diluent, and (Hi) a first filler and (B) a hardener component, comprising (iv) a curing agent, (v) a second filler, and (vi) a non-reactive polyether block copolymer additive. The resin component and hardener component each having a viscosity of no greater than 30 Pascal-second under an applied shear of 10 reciprocal seconds at 25 degrees Celsius and the curable composition after 120 seconds of mixing the resin component and hardener component together under an applied shear of 10 reciprocal seconds has a viscosity of at least 100 Pascal-second at 25 degrees Celsius.","['Hoevel Bernd', 'Barleben Oliver', 'Koch Matthias']",0,uspto,"['dynamic composition', 'component', 'software', 'web service composition', 'software engineering', 'intelligent agents', 'multiagent system', 'automatic composition', 'service compositions', 'component composition']",liver carcinoma in situ,"['CURABLE', 'COMPOSITIONS']","['curable', 'composition', 'comprising', 'A', 'resin', 'component', 'i', 'epoxy', 'compound', 'diluent', 'first', 'filler', 'hardener', 'component', 'comprising', 'iv', 'agent', 'second', 'filler', 'non', '-', 'reactive', 'polyether', 'block', 'copolymer', 'additive', 'resin', 'component', 'component', 'viscosity', 'greater', 'second', 'applied', 'shear', 'reciprocal', 'seconds', 'degrees', 'curable', 'composition', 'seconds', 'resin', 'component', 'component', 'applied', 'shear', 'reciprocal', 'seconds', 'viscosity', 'least', 'second', 'degrees']"
472,472,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0023/700/A1/US20130023700A1.pdf,PROCESS FOR A CONTINUOUS PRODUCTION OF POLYETHEROLS,"A process for a continuous production of a polyetherol first involves reacting an alcohol with a starter or an alkoxylated precursor, to give a mixture comprising an alcoholate and water. Water is then removed from the mixture. The process further involves feeding the alcoholate into a bubble column and feeding an alkylene oxide into the bottom of a compartment of the bubble column, such that the alkylene oxide rises in the alcoholate. The alkylene oxide then reacts with the alcoholate or a secondary product from the reaction between the alcoholate and alkylene oxide, to give the polyetherol.","['Chilekar Vinit', 'Bey Oliver', 'Brodhagen Andreas', 'L√∂ffler Achim', 'Ahmadnian Fatemeh', 'B√∂hling Ralf', 'Grossmann Christoph', 'Kammel Ulrich', 'Adelmann Ronald', 'Ostrowski Thomas', 'Joshi Milind', 'Waters Gerrit', 'Meckelnburg Dirk']",0,uspto,"['computer aided design', 'product design', 'gaussians', 'gaussian distribution']",liver carcinoma in situ,"['PROCESS', 'PRODUCTION']","['process', 'continuous', 'production', 'polyetherol', 'alcohol', 'starter', 'alkoxylated', 'precursor', 'mixture', 'alcoholate', 'water', 'Water', 'mixture', 'process', 'alcoholate', 'bubble', 'column', 'alkylene', 'oxide', 'bottom', 'compartment', 'bubble', 'column', 'such', 'alkylene', 'oxide', 'rises', 'alcoholate', 'alkylene', 'oxide', 'alcoholate', 'secondary', 'product', 'reaction', 'alcoholate', 'alkylene', 'oxide', 'polyetherol']"
473,473,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0024/077/A1/US20130024077A1.pdf,CRANE CONTROL SYSTEM AND CRANE,"A crane control system with a display and entry unit for showing and entering the crane operating mode information that is required for the load moment limiting and/or the crane control, especially corresponding to its current mechanical layout, wherein the crane control system comprises a logic that determines application and/or outfitting related dependencies between two or more input parameters.","['Abel Peter', 'Cettinich Edwin', 'Fuchs Ulrich', 'Ruoss Oliver']",0,uspto,"['switching systems', 'control systems', 'computer systems', 'image display', 'switching control', 'distributed control system', 'distributed parameter networks', 'image analysis', 'display system', 'display devices']",liver carcinoma in situ,[],"['crane', 'control', 'system', 'display', 'entry', 'unit', 'crane', 'mode', 'information', 'load', 'moment', 'crane', 'control', 'current', 'mechanical', 'layout', 'crane', 'control', 'system', 'logic', 'application', 'related', 'dependencies', 'more', 'input', 'parameters']"
474,474,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0024/513/A1/US20130024513A1.pdf,METHOD OF VIRALLY EXPANDING SOCIAL NETWORKS,"Membership in a social network is virally expanded by suggesting to a user to invite contacts from the user's address book and, in addition, eligible contacts from other address books. Eligible contacts from other address books include those contacts that have e-mail addresses with the same e-mail domain as the user's e-mail address.","['SACKS David Oliver', 'PISONI Adam Marc']",0,uspto,"['world wide web', 'social networks', 'electronic commerce', 'social relationships', 'contracts', 'information technology', 'online social networks', 'spam', 'e-mail address', 'network protocols', 'network architecture', 'online systems']",liver carcinoma in situ,"['METHOD', 'VIRALLY']","['Membership', 'social', 'network', 'user', 'contacts', 'user', 'address', 'book', 'addition', 'eligible', 'contacts', 'other', 'address', 'books', 'Eligible', 'contacts', 'other', 'address', 'books', 'contacts', 'mail', 'addresses', 'same', 'e', 'mail', 'domain', 'user', 'mail', 'address']"
475,475,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130124/2013-04/US/2013/0024/526/A1/US20130024526A1.pdf,METHOD OF MANAGING FEEDS BASED ON CLASSIFICATIONS,"Primary and secondary messages are included in a feed according to a ‚Äúfull thread‚Äù mode or a ‚Äústream‚Äù mode. The ‚Äúfull thread‚Äù mode causes a feed, when viewed, to include both primary and secondary messages. In contrast, the ‚Äústream‚Äù mode causes a feed, when viewed, to include only primary messages. In this way, a feed viewed in ‚Äúfull thread‚Äù mode provides to users a comprehensive view of messages included in the feed. Alternatively, a feed viewed in ‚Äústream‚Äù mode provides to users a concise view messages included in the feed.","['SACKS David Oliver', 'PISONI Adam Marc', 'Gale Kris Branson']",0,uspto,"['software architecture', 'computer systems', 'data stream', 'viewpoint', 'classification methods', 'wireless sensor networks', 'database systems', 'cryptography', 'data mining', 'data packet', 'modes of operation', 'mobile ad hoc networks', 'data communication systems']",liver carcinoma in situ,"['METHOD', 'MANAGING', 'CLASSIFICATIONS']","['Primary', 'secondary', 'messages', 'feed', 'full', 'thread', 'mode', 'stream', 'mode', 'full', 'thread', 'mode', 'feed', 'primary', 'secondary', 'messages', 'contrast', '‚Äú', 'stream', 'mode', 'feed', 'primary', 'messages', 'way', 'feed', 'full', 'thread', 'mode', 'users', 'comprehensive', 'view', 'messages', 'feed', 'feed', 'stream', 'mode', 'users', 'concise', 'view', 'messages', 'feed']"
476,476,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0025/088/A1/US20130025088A1.pdf,HANDLE ARRANGEMENT,"The invention relates to a handle arrangement for a machine component which vibrates in the operating state thereof, with a connecting part for connecting to the machine component and with a handle which is coupled to the connecting part, wherein the handle is assigned an elongate handle section with a hand engagement point and wherein the handle has a damping mass element, the mass center of gravity of which is arranged such that a decrease in vibration in the hand engagement point is achieved.",['Weiss Oliver'],0,uspto,"['technical conferences', 'component', 'software', 'mechanical vibrations']",liver carcinoma in situ,['ARRANGEMENT'],"['invention', 'handle', 'arrangement', 'machine', 'component', 'operating', 'state', 'part', 'machine', 'component', 'handle', 'part', 'handle', 'elongate', 'handle', 'section', 'hand', 'engagement', 'point', 'handle', 'mass', 'element', 'mass', 'center', 'gravity', 'such', 'decrease', 'vibration', 'hand', 'engagement', 'point']"
477,477,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0025/791/A1/US20130025791A1.pdf,METHOD AND APPARATUS FOR INSPECTING A SEMICONDUCTOR CHIP PRIOR TO BONDING,"A chip handling apparatus, unit and method is presented. The chip handling apparatus comprises a chip supply station; a chip mounting station; and one or more chip handling units configured to pick a chip from the supply station, transport the chip to the mounting station, and place the chip at a mounting location; wherein each chip handling unit is configured to temporarily retain the chip in a defined position relative to the chip handling unit. The chip handling apparatus further comprises means for inducing sonic vibrations in the chip when retained by one of the chip handling units; and means for measuring the vibrations induced in the chip.","['Marte Andreas', 'Stadelmann Tim Oliver']",0,uspto,"['logic devices', 'location based', 'integrated circuits', 'electric power supplies to apparatus', 'technical conferences', 'programmable logic controllers', 'asic', 'location based services', 'programmable logic device', 'computer hardware', 'mechanical vibrations']",liver carcinoma in situ,"['METHOD', 'APPARATUS', 'SEMICONDUCTOR', 'CHIP', 'BONDING']","['chip', 'apparatus', 'unit', 'method', 'chip', 'apparatus', 'chip', 'supply', 'station', 'chip', 'station', 'more', 'chip', 'units', 'chip', 'supply', 'station', 'chip', 'station', 'chip', 'location', 'chip', 'unit', 'chip', 'position', 'relative', 'chip', 'unit', 'chip', 'apparatus', 'sonic', 'vibrations', 'chip', 'chip', 'units', 'vibrations', 'chip']"
478,478,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0025/994/A1/US20130025994A1.pdf,DUAL CLUTCH,"A dual clutch for coupling an engine-side input shaft with a first transmission-side and/or a second transmission-side output shaft. A first dutch has a first pressure plate, which is axially mobile relative to a first counter plate, for coupling with a first dutch disk connected to the first output shaft. A second dutch has a second pressure plate, which is axially mobile relative to a second counter plate, for coupling with a dutch disk connected to the second output shaft. A dutch cover is connected to the first and second counter plates. An actuator displaces the first and/or the second pressure plate. The actuator is radially supported on the input side on the input shaft by the clutch cover and a torsional vibration damper, which is connected to the clutch cover and is radially mounted on the output side on one of the output shafts and/or on a transmission housing.","['KREBS Florian', 'NOEHL Oliver', 'DAIKELER Ren√©', 'WOLF Bernhard', 'KRAHTOV Luben', 'BOSNJAK Daniel', 'AGNER Ivo']",0,uspto,"['clutch', 'image retrieval', 'discrete cosine transforms', 'engineering', 'clutches', 'gears', 'flash memory', 'engine', 'hard disks']",liver carcinoma in situ,['DUAL'],"['dual', 'clutch', 'engine', 'side', 'input', 'shaft', 'first', 'transmission', 'side', 'second', 'transmission', 'side', 'output', 'shaft', 'first', 'dutch', 'first', 'pressure', 'plate', 'mobile', 'relative', 'first', 'counter', 'plate', 'first', 'dutch', 'disk', 'first', 'output', 'shaft', 'second', 'dutch', 'second', 'pressure', 'plate', 'mobile', 'relative', 'second', 'counter', 'plate', 'dutch', 'disk', 'second', 'output', 'shaft', 'dutch', 'cover', 'first', 'second', 'counter', 'plates', 'actuator', 'first', 'second', 'pressure', 'plate', 'actuator', 'input', 'side', 'input', 'shaft', 'clutch', 'cover', 'torsional', 'vibration', 'damper', 'clutch', 'cover', 'output', 'side', 'output', 'shafts', 'transmission', 'housing']"
479,479,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0026/038/A1/US20130026038A1.pdf,DEVICES AND METHODS FOR DETERMINING THE LENGTH OF BIOPOLYMERS AND DISTANCES BETWEEN PROBES BOUND THERETO,"Devices and methods for detecting the length of analytes, and/or sequencing analytes are provided in which two or more electrical signals are obtained as an analyte traverses a fluidic channel. Detection of the relative position of probes hybridized to a biopolymer and/or the length of the analyte (e.g., a biopolymer) does not rely on the absolute time between detection events of a given electrical signal to determine a distance associated with the biopolymer. Instead, multiple signals are obtained as functions of time) corresponding to a plurality of detector volumes at known locations along a fluidic channel through which the biopolymer passes, and the distances are determined from the multiple signals.",['Oliver John S.'],0,uspto,"['wireless networks', 'fading (radio)', 'digital signal processors', 'microfabricated', 'signal detection', 'microfabrication', 'radio transmission', 'wireless channel', 'fading channels', 'antennas', 'detection algorithm', 'radio channels', 'digital signals', 'solid-state sensors']",liver carcinoma in situ,"['DEVICES', 'METHODS', 'LENGTH', 'DISTANCES', 'BOUND', 'THERETO']","['Devices', 'methods', 'length', 'analytes', 'sequencing', 'analytes', 'more', 'electrical', 'signals', 'analyte', 'fluidic', 'channel', 'Detection', 'relative', 'position', 'probes', 'biopolymer', 'length', 'analyte', 'biopolymer', 'absolute', 'time', 'detection', 'events', 'electrical', 'signal', 'distance', 'biopolymer', 'multiple', 'signals', 'functions', 'time', 'plurality', 'detector', 'volumes', 'locations', 'fluidic', 'channel', 'biopolymer', 'distances', 'multiple', 'signals']"
480,480,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0026/379/A1/US20130026379A1.pdf,DIRECT CONVERSION X-RAY DETECTOR WITH RADIATION PROTECTION FOR ELECTRONICS,"The present invention relates to an X-ray detector having an X-ray sensor (first X-ray sensor) converting X-radiation directly into electric charge carriers, having signal evaluation electronics electrically connected to the X-ray sensor and preferably formed as integrated circuit(s), having an X-ray absorber formed for protecting the signal evaluation electronics, and having a sensor carrier (first sensor carrier) formed and arranged for positioning the X-ray sensor relative to the X-ray absorber, wherein, viewed in the direction of incidence of the X-radiation, both the signal evaluation electronics are arranged behind the X-ray absorber and in the X-radiation shadow thereof and the X-ray sensor is admittedly likewise positioned by means of the sensor carrier preferably arranged between the X-ray absorber and the signal evaluation electronics at least sectionally behind the X-ray absorber, but outside the X-radiation shadow thereof.","['Lohse Thomas', 'Krueger Peter', 'Oppermann Martin', 'Zerna Thomas', 'Albrecht Oliver', 'Metasch Ren√©', 'Oettl Annika']",0,uspto,"['high refractive index', 'mechatronics', 'infrared detectors', 'integrated circuits', 'single sensor', 'optoelectronic devices', 'communication channels (information theory)', 'robots', 'infra-red sensor', 'sensors', 'ray tracing', 'refractometers', 'multi-sensor', 'optoelectronics', 'computer hardware']",liver carcinoma in situ,"['DIRECT', 'CONVERSION', 'X', '-', 'RAY', 'DETECTOR', 'RADIATION', 'PROTECTION', 'ELECTRONICS']","['present', 'invention', 'X', '-', 'ray', 'detector', 'X', '-', 'ray', 'sensor', 'first', 'X', '-', 'ray', 'sensor', 'X', '-', 'radiation', 'electric', 'charge', 'carriers', 'signal', 'evaluation', 'electronics', 'X', '-', 'ray', 'sensor', 'circuit(s', 'X', '-', 'ray', 'absorber', 'signal', 'evaluation', 'electronics', 'sensor', 'carrier', 'first', 'sensor', 'carrier', 'X', '-', 'ray', 'sensor', 'relative', 'X', '-', 'ray', 'absorber', 'direction', 'incidence', 'X', '-', 'radiation', 'signal', 'evaluation', 'electronics', 'X', '-', 'ray', 'absorber', 'X', '-', 'radiation', 'shadow', 'X', '-', 'ray', 'sensor', 'means', 'sensor', 'carrier', 'X', '-', 'ray', 'absorber', 'signal', 'evaluation', 'electronics', 'least', 'X', '-', 'ray', 'absorber', 'X', '-', 'radiation', 'shadow']"
481,481,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0028/476/A1/US20130028476A1.pdf,POSE TRACKING PIPELINE,A method of tracking a target includes receiving from a source a depth image of a scene including the human subject. The depth image includes a depth for each of a plurality of pixels. The method further includes identifying pixels of the depth image that belong to the human subject and deriving from the identified pixels of the depth image one or more machine readable data structures representing the human subject as a body model including a plurality of shapes.,"['Craig Robert Matthew', 'Leyvand Tommer', 'Peeper Craig', 'Al-Ghosien Momim M.', 'Bronder Matt', 'Williams Oliver', 'Geiss Ryan M.', 'Shotton Jamie Daniel Joseph', 'Lee Johnny', 'Finocchio Mark']",0,uspto,"['image features', 'optical character recognition', 'image retrieval', 'image processing', 'imaging systems', 'digital image', 'image analysis', 'pattern recognition', 'image quality', 'color images', 'digital image storage', 'reference image', 'object recognition', 'document images', 'image matching', 'color image processing']",liver carcinoma in situ,"['TRACKING', 'PIPELINE']","['method', 'target', 'source', 'depth', 'image', 'scene', 'human', 'subject', 'depth', 'image', 'depth', 'plurality', 'pixels', 'method', 'pixels', 'depth', 'image', 'human', 'subject', 'pixels', 'depth', 'image', 'more', 'machine', 'readable', 'data', 'structures', 'human', 'subject', 'body', 'model', 'plurality', 'shapes']"
482,482,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0028/865/A1/US20130028865A1.pdf,"Combination of a Macrocyclic Inhibitor of HCV, A Non-Nucleoside and a Nucleoside","The present invention relates to a combination of a macrocyclic HCV protease inhibitor, a macrocyclic non-nucleoside HCV polymerase inhibitor and a nucleoside HCV polymerase inhibitor.","['Lin Tse-I', 'Lenz Oliver', 'Raboisson Pierre Jean-Marie Bernard']",0,uspto,[],liver carcinoma in situ,"['Combination', 'Nucleoside']","['present', 'invention', 'combination', 'macrocyclic', 'protease', 'inhibitor', 'macrocyclic', 'non', '-', 'nucleoside', 'polymerase', 'inhibitor', 'nucleoside', 'polymerase', 'inhibitor']"
483,483,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0029/100/A1/US20130029100A1.pdf,Material Panel Having a Graphic Surface Structure,"The invention relates to a material plate , in particular for the manufacture of furniture, floor coverings or door elements, comprising at least one central substrate layer  and a decorative layer  on at least one side of the substrate layer . For the decorative design of the material plates, it is provided that the decorative layer  comprises adjacent adjoining areas  which at least partially comprise a course of the decoration and/or structure in different directions, whereby strictly graphic patterns are formed.",['Espe Oliver'],0,uspto,"['upper approximation', 'lower approximation', 'rough set theory', 'software architecture patterns', 'layered', 'approximation algorithms', 'three dimensional computer graphics', 'computer vision', 'lower and upper approximations']",liver carcinoma in situ,['Structure'],"['invention', 'material', 'plate', 'particular', 'manufacture', 'furniture', 'floor', 'coverings', 'door', 'elements', 'central', 'substrate', 'layer', 'decorative', 'layer', 'side', 'substrate', 'layer', 'decorative', 'design', 'material', 'plates', 'decorative', 'layer', 'adjacent', 'areas', 'course', 'decoration', 'structure', 'different', 'directions', 'graphic', 'patterns']"
484,484,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0030/071/A1/US20130030071A1.pdf,END-FUNCTIONALIZED POLYMERS,"This invention relates to end-functionalized living polymers or copolymers having a structure represented by the general formula 1 or 2, wherein Ris a hydrogen atom, a methyl group, or a radically non-polymerizable organic group containing 1 to 20 carbon atoms. Ris a functional end group of a vinyl hetero monomer selected from the group consisting of hydroxy, epoxy, silyl, NH, NH(C-Calkyl), N(C-Calkyl), ‚ÄîCH‚ïêCH, ‚ÄîC‚â°CH, ‚ÄîC(CH)‚ïêCH, -0-CH‚ïêCH, (‚ÄîO‚ÄîCH‚ÄîCH)‚ÄîOH, ‚ÄîOR, ‚ÄîCOOR, ‚ÄîCONHR, ‚ÄîOCONHR, ‚ÄîOCORand ‚ÄîNH‚ÄîCO‚ÄîR, wherein Ris linear or branched C-Calkyl or linear or branched C-Calkyl substituted with hydroxy, epoxy, silyl, NHor N(C-Calkyl); or Ris phenyl, benzyl, ‚ÄîCH‚ïêCH, ‚ÄîC‚â°CH or ‚ÄîC(CH)‚ïêCH, or Ris a residue of an acrylic acid (CH‚ïêCH‚ÄîCOO‚Äî*), methacrylic acid, (CH‚ïêC(CH)‚ÄîCOO‚Äî*) or CH(CH)‚ïêCH‚ÄîCOO‚Äî* or Ris a residue of a dicarboxylic acid HOOC‚ÄîR‚ÄîCOO‚Äî* or C-Calkyl-OOC‚ÄîR‚ÄîCOO‚Äî* wherein Ris C-Calkylene, C-Calkenylene or phenylene; or Ris a residue derived from the reaction of an isocyanate R‚ÄîNCO with the hydroxy group or with the amine group of the vinyl hetero monomer, said residue being R‚ÄîNHCOO‚Äî* or R‚ÄîNHCO‚ÄîNH‚Äî* wherein Ris unsubstituted C-Calkyl, C-Ccycloalkyl or C-Calkyl substituted with hydroxy, epoxy, silyl, NH, NH(C-Calkyl) or N(C-Calkyl); or Ris a residue derived from the reaction of a diisocyanate residue OCN‚ÄîR‚ÄîNCO with the hydroxy group or with the amine group of the vinyl hetero monomer, said residue being *‚ÄîOOC‚ÄîNH‚ÄîR‚ÄîNCO or *‚ÄîHNOC‚ÄîNH‚ÄîR‚ÄîNCO or *‚ÄîOOC‚ÄîNH‚ÄîR‚ÄîNHCORwherein Ris C-Calkylene or C-Ccycloalkylene or phenylene and Ris a residue of hydroxyethylacrylate (CH‚ïêCH‚ÄîCOO‚Äî(CH)-0*), hydroxyethylmethacrylate (CH‚ïêC(CH)‚ÄîCOO‚Äî(CH)-0*), hydroxybutylacrylate (CH‚ïêCH‚ÄîCOO‚Äî(CH)-0*) or hydroxybutylmethacrylate (CH‚ïêC(CH)‚ÄîCOO‚Äî(CH)-0*), A is the hetero atom of the vinyl hetero monomer selected from the group consisting of oxygen, nitrogen, sulfur and silicon; and if Ris silyl and M is a direct bond, A is a direct bond; M is a bond or a divalent group linking the heteroatom of the vinyl hetero monomer and the functional end group of the vinyl hetero monomer said M being selected from the group consisting of Calkylene, C(hetero)alkylene, arylene and heteroarylene; X is a halogen atom, a nitroxide group or a sulphide group, Zis a polymer or copolymer segment of random-, gradient- or block-type structure, which is built up from vinylic monomers selected from the group consisting of isoprene, 1,3-butadiene, Œ±-Calkene, 4-vinyl-pyridine, 2-vinyl-pyridine, vinyl-imidazole, N-vinylpyrrolidone, dimethylacrylamide, 3-dimethylamino-propylmethacrylamide, styrene, substituted styrene and a compound of formula CH‚ïêC(R)‚ÄîC(‚ïêR)‚ÄîR, wherein Ris a hydrogen atom or a methyl group, Ris oxygen atom or sulfur atom; Ris NH, hydroxy, unsubstituted Calkoxy, Calkoxy interrupted by at least one N and/or O atom, hydroxy-substituted Calkoxy, unsubstituted Calkylamino, di(Calkyl)amino, hydroxy-substituted Calkylamino, hydroxy-substituted di(Calkyl)amino or -0-CH‚ÄîCH‚ÄîN(CH); Y is the chain terminus of the polymer/copolymer Zand Y represents the fragment of a polymerization initiator capable of initiating polymerization; Y1 represents a di-, tri- or polyvalent fragment of a di-, tri-, or polyfunctional NMP initiator; m is 2, 3 or 4, preferably 2; n is the number of monomer units Z and is between 10 and 5000.","['Kou Huiguang', 'Moeck Andreas', 'Auschra Clemens', 'Nesvadba Peter', 'Pirrung Frank Oliver Heinrich', 'Gernandt Andreas']",0,uspto,"['medical images', 'gate dielectrics', 'wafer level packaging', 'nanosystems', 'electronics packaging', 'information systems', 'metal gate', 'radiology information systems', 'mems', 'hospital information system', 'technical conferences']",liver carcinoma in situ,"['FUNCTIONALIZED', 'POLYMERS']","['invention', 'end', 'living', 'polymers', 'copolymers', 'structure', 'general', 'formula', 'hydrogen', 'atom', 'methyl', 'group', 'non', '-', 'polymerizable', 'organic', 'group', 'carbon', 'atoms', 'functional', 'end', 'group', 'vinyl', 'hetero', 'monomer', 'group', 'hydroxy', 'epoxy', 'silyl', '‚ÄîCH', '‚ÄîC‚â°CH', '‚ÄîC(CH)', '‚ÄîO', '‚ÄîCOOR', 'linear', 'Calkyl', 'linear', 'Calkyl', 'hydroxy', 'epoxy', 'silyl', 'phenyl', 'benzyl', '‚ÄîCH', '‚ÄîC‚â°CH', '‚ÄîC(CH)', 'CH', 'residue', 'acrylic', 'acid', 'methacrylic', 'acid', 'residue', 'dicarboxylic', 'acid', 'R', 'phenylene', 'residue', 'reaction', 'isocyanate', 'R', 'hydroxy', 'group', 'amine', 'group', 'vinyl', 'hetero', 'monomer', 'residue', 'R', 'NHCOO‚Äî', 'R', 'unsubstituted', 'Calkyl', 'hydroxy', 'epoxy', 'silyl', 'residue', 'reaction', 'diisocyanate', 'residue', 'hydroxy', 'group', 'amine', 'group', 'vinyl', 'hetero', 'monomer', 'residue', '‚ÄîHNOC', 'phenylene', 'residue', 'hydroxyethylacrylate', 'hydroxybutylacrylate', 'hydroxybutylmethacrylate', 'A', 'hetero', 'atom', 'vinyl', 'hetero', 'monomer', 'group', 'oxygen', 'nitrogen', 'sulfur', 'silicon', 'silyl', 'direct', 'bond', 'direct', 'bond', 'bond', 'divalent', 'group', 'heteroatom', 'vinyl', 'hetero', 'monomer', 'functional', 'end', 'group', 'vinyl', 'hetero', 'monomer', 'group', 'arylene', 'heteroarylene', 'X', 'halogen', 'atom', 'nitroxide', 'group', 'sulphide', 'group', 'polymer', 'copolymer', 'segment', 'random-', 'gradient-', 'block', 'type', 'structure', 'vinylic', 'monomers', 'group', 'isoprene', 'Œ±', 'pyridine', 'pyridine', 'vinyl', 'imidazole', 'N', 'vinylpyrrolidone', 'dimethylacrylamide', 'propylmethacrylamide', 'styrene', 'styrene', 'compound', 'formula', 'C(R)‚ÄîC(', 'hydrogen', 'atom', 'methyl', 'group', 'oxygen', 'atom', 'sulfur', 'atom', 'hydroxy', 'unsubstituted', 'N', 'O', 'atom', 'hydroxy', 'unsubstituted', 'hydroxy', 'hydroxy', 'chain', 'terminus', 'polymer', 'copolymer', 'fragment', 'polymerization', 'initiator', 'capable', 'polymerization', 'di-', 'tri-', 'polyvalent', 'fragment', 'di-', 'tri-', 'polyfunctional', 'initiator', 'm', 'number', 'monomer', 'units']"
485,485,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0030/300/A1/US20130030300A1.pdf,Combination Sensor Guidewire and Methods of Use,The present invention provides for an improved combination sensor tip that includes an ultrasound transducer and a pressure sensor both disposed at or in close proximity to the distal end of the combination sensor tip. The present invention also provides for an improved connector to couple a guide wire to a physiology monitor that reduces torsional resistance when maneuvering the guide wire.,"['Ahmed Masood', 'Oliver Edward Anthony', 'Puleo Joseph', 'Ingman Christopher Dee', 'Walker Blair D.']",0,uspto,"['medical images', 'infrared detectors', 'single sensor', 'ultrasound images', 'infra-red sensor', 'sensors', 'multi-sensor', 'ultrasonic imaging', 'computer hardware']",liver carcinoma in situ,[],"['present', 'invention', 'improved', 'combination', 'sensor', 'tip', 'ultrasound', 'transducer', 'pressure', 'sensor', 'close', 'proximity', 'distal', 'end', 'combination', 'sensor', 'tip', 'present', 'invention', 'connector', 'guide', 'wire', 'physiology', 'monitor', 'torsional', 'resistance', 'guide', 'wire']"
486,486,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0030/303/A1/US20130030303A1.pdf,Combination Sensor Guidewire and Methods of Use,The present invention provides for an improved combination sensor tip that includes an ultrasound transducer and a pressure sensor both disposed at or in close proximity to the distal end of the combination sensor tip. The present invention also provides for an improved connector to couple a guide wire to a physiology monitor that reduces torsional resistance when maneuvering the guide wire.,"['Ahmed Masood', 'Oliver Edward Anthony', 'Puleo Joseph', 'Ingman Christopher Dee', 'Walker Blair D.']",0,uspto,"['medical images', 'infrared detectors', 'single sensor', 'ultrasound images', 'infra-red sensor', 'sensors', 'multi-sensor', 'ultrasonic imaging', 'computer hardware']",liver carcinoma in situ,[],"['present', 'invention', 'improved', 'combination', 'sensor', 'tip', 'ultrasound', 'transducer', 'pressure', 'sensor', 'close', 'proximity', 'distal', 'end', 'combination', 'sensor', 'tip', 'present', 'invention', 'connector', 'guide', 'wire', 'physiology', 'monitor', 'torsional', 'resistance', 'guide', 'wire']"
487,487,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0031/116/A1/US20130031116A1.pdf,MODELED BUSINESS OBJECT DATA IMPORT,"A computer-implemented system may include reception of a selection of a business object, reception of a selection of one or more nodes of the business object, creation of a schema definition based on the selected one or more nodes, reception of an eXtended Markup Language file conforming to the schema definition, the eXtended Markup Language file including instance values associated with the one or more nodes of the business object, and population of an instance of the business object with the values associated with the one or more nodes of the business object.",['Klemenz Oliver'],0,uspto,"['business activities', 'electronic commerce', 'information technology', 'database systems', 'information systems', 'relational schemas', 'ebusiness', 'database schemas', 'relational data models', 'business process']",liver carcinoma in situ,"['MODELED', 'BUSINESS', 'OBJECT', 'IMPORT']","['computer', 'system', 'reception', 'selection', 'business', 'object', 'reception', 'selection', 'more', 'nodes', 'business', 'object', 'creation', 'schema', 'definition', 'more', 'nodes', 'reception', 'file', 'schema', 'definition', 'file', 'instance', 'values', 'more', 'nodes', 'business', 'object', 'population', 'instance', 'business', 'object', 'values', 'more', 'nodes', 'business', 'object']"
488,488,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0031/127/A1/US20130031127A1.pdf,MODELED COMMUNICATION BETWEEN DEPLOYMENT UNITS,"A computer-implemented system may include reception of a selection of a first business object, reception of a selection of a second business object, reception of a selection of one or more node elements of the second business object, reception of one or more query parameters, reception of a mapping to map a respective node element of the first business object to each of the selected one or more node elements of the second business object and to each of the one or more query parameters, reception of a script for evaluating a condition associated with the first business object, generation of runtime objects based on the mapping and the script, and execution of a runtime framework to use the runtime objects to evaluate the condition and to create a message mapping the respective node element of the first business object to each of the selected one or more node elements of the second business object and to each of the one or more query parameters.",['Klemenz Oliver'],0,uspto,"['business process management', 'business activities', 'electronic commerce', 'communication', 'information technology', 'information systems', 'ebusiness', 'business process']",liver carcinoma in situ,"['MODELED', 'COMMUNICATION']","['computer', 'system', 'reception', 'selection', 'first', 'business', 'object', 'reception', 'selection', 'second', 'business', 'object', 'reception', 'selection', 'more', 'node', 'elements', 'second', 'business', 'object', 'reception', 'more', 'query', 'parameters', 'reception', 'mapping', 'respective', 'node', 'element', 'first', 'business', 'object', 'more', 'node', 'elements', 'second', 'business', 'object', 'more', 'query', 'parameters', 'reception', 'script', 'condition', 'first', 'business', 'object', 'generation', 'runtime', 'objects', 'mapping', 'script', 'execution', 'runtime', 'framework', 'runtime', 'objects', 'condition', 'message', 'respective', 'node', 'element', 'first', 'business', 'object', 'more', 'node', 'elements', 'second', 'business', 'object', 'more', 'query', 'parameters']"
489,489,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0031/630/A1/US20130031630A1.pdf,Method and Apparatus for Identifying Phishing Websites in Network Traffic Using Generated Regular Expressions,"According to an aspect of this invention, a method to detect phishing URLs involves: creating a whitelist of URLs using a first regular expression; creating a blacklist of URLs using a second regular expression; comparing a URL to the whitelist; and if the URL is not on the whitelist, comparing the URL to the blacklist. False negatives and positives may be avoided by classifying Internet domain names for the target organization as ‚Äúlegitimate‚Äù. This classification leaves a filtered set of URLs with unknown domain names which may be more closely examined to detect a potential phishing URL. Valid domain names may be classified without end-user participation.","['Krishnamurthy Balachander', 'Spatscheck Oliver', 'Van Der Merwe Jacobus', 'Ramachandran Anirudh']",0,uspto,"['phishing', 'world wide web', 'internet protocols', 'electronic mail', 'computer science', 'computer crime', 'network traffic', 'telecommunication traffic', 'internet', 'web page', 'network security', 'domain name system', 'intrusion detection']",liver carcinoma in situ,"['Regular', 'Expressions']","['aspect', 'invention', 'method', 'whitelist', 'first', 'regular', 'expression', 'blacklist', 'second', 'regular', 'expression', 'URL', 'whitelist', 'URL', 'whitelist', 'URL', 'blacklist', 'False', 'negatives', 'positives', 'Internet', 'domain', 'names', 'target', 'organization', 'legitimate', 'classification', 'set', 'unknown', 'domain', 'names', 'potential', 'URL', 'domain', 'names', 'end', 'user', 'participation']"
490,490,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130131/2013-05/US/2013/0031/669/A1/US20130031669A1.pdf,PLANT TRANSCRIPTIONAL REGULATORS OF ABIOTIC STRESS II,"The instant disclosure relates to plant regulatory polypeptides, polynucleotides that encode them, homologs from a variety of plant species, and methods of using the polynucleotides and polypeptides to produce transgenic plants having advantageous properties compared to a reference plant, including improved abiotic stress tolerance. Sequence information related to these polynucleotides and polypeptides can also be used in bioinformatic search methods to identify related sequences and is also disclosed.","['Heard Jacqueline E.', 'Creelman Robert A.', 'Pineda Omaira', 'Jiang Cai-Zhong', 'Ratcliffe Oliver J.', 'Kumimoto Roderick W.', 'Reuber T. Lynne']",0,uspto,"['user information', 'personal information', 'world wide web', 'computer science', 'recommender systems', 'search process', 'evolutionary algorithms', 'search engines', 'bioinformatics']",liver carcinoma in situ,"['PLANT', 'REGULATORS']","['instant', 'disclosure', 'regulatory', 'polypeptides', 'homologs', 'variety', 'plant', 'species', 'methods', 'polynucleotides', 'polypeptides', 'transgenic', 'plants', 'advantageous', 'properties', 'reference', 'plant', 'abiotic', 'stress', 'tolerance', 'Sequence', 'information', 'polynucleotides', 'polypeptides', 'bioinformatic', 'search', 'methods', 'related', 'sequences']"
491,491,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0032/136/A1/US20130032136A1.pdf,SYSTEMS AND METHODS OF GENERATING ENERGY FROM SOLAR RADIATION,A solar reflector assembly is provided for generating energy from solar radiation. The solar reflector assembly is configured to be deployed on a supporting body of liquid and to reflect solar radiation to a solar collector. A solar reflector assembly comprises an inflatable elongated tube having an upper portion formed at least partially of flexible material and a lower ballast portion formed at least partially of flexible material. A reflective sheet is coupled to a wall of the tube to reflect solar radiation. The elongated tube has an axis of rotation oriented generally parallel to a surface of a supporting body of liquid.,"['King John D.H.', 'Oliver Thomas E.', 'Kramer Nicholas A.', 'Willis Keeney D.']",0,uspto,"['parabolic reflector', 'parabolic antennas', 'energy conservation', 'energy utilization']",liver carcinoma in situ,['METHODS'],"['solar', 'reflector', 'assembly', 'energy', 'solar', 'radiation', 'solar', 'reflector', 'assembly', 'body', 'liquid', 'solar', 'radiation', 'solar', 'collector', 'solar', 'reflector', 'assembly', 'inflatable', 'tube', 'upper', 'portion', 'least', 'flexible', 'material', 'lower', 'ballast', 'portion', 'least', 'flexible', 'material', 'reflective', 'sheet', 'wall', 'tube', 'solar', 'radiation', 'elongated', 'tube', 'axis', 'rotation', 'parallel', 'surface', 'body', 'liquid']"
492,492,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0032/256/A1/US20130032256A1.pdf,METHOD FOR MANUFACTURING AND UTILIZING FERRITIC-AUSTENITIC STAINLESS STEEL WITH HIGH FORMABILITY,"The invention relates to a method for manufacturing a ferritic-austenitic stainless steel having good formability and high elongation. The stainless steel is heat treated so that the microstructure of the stainless steel contains 45-75% austenite in the heat treated condition, the remaining microstructure being ferrite, and the measured Mtemperature of the stainless steel is adjusted between 0 and 50¬∞ C. in order to utilize the transformation induced plasticity (TRIP) for improving the formability of the stainless steel.","['Oliver James', 'Jonsson Jan Y.', 'Talonen Juho']",0,uspto,"['carbides', 'cutting tools', 'flexible manufacturing systems', 'flexible manufacturing']",liver carcinoma in situ,"['METHOD', 'MANUFACTURING', 'AUSTENITIC', 'STAINLESS', 'STEEL', 'HIGH', 'FORMABILITY']","['invention', 'method', 'ferritic', 'austenitic', 'stainless', 'steel', 'good', 'formability', 'high', 'elongation', 'stainless', 'steel', 'heat', 'microstructure', 'stainless', 'steel', '%', 'austenite', 'heat', 'condition', 'microstructure', 'ferrite', 'stainless', 'steel', 'order', 'transformation', 'plasticity', 'formability', 'stainless', 'steel']"
493,493,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0032/608/A1/US20130032608A1.pdf,WET TISSUES DISPENSER,"A dispenser () for a pack of wet wipes, has a stiff plastics material body () with a peripheral mounting flange () for attachment to a sidewall of a pack of wipes. A tear-open closure () is integrally formed with the body (). A portion of a periphery of the closure () is tearable away from the body () to leave the closure () attached to the body () by a hinge (). The closure () is mounted at an opening in the body () across which is stretched a silicone membrane having a circular dispensing opening through which wipes are dispensed from a flow-wrap plastics pack of wipes on which the dispenser () is mounted.","['Hood Oliver', 'McCloskey Edward']",0,uspto,"['contact models', 'end effectors']",liver carcinoma in situ,['DISPENSER'],"['dispenser', 'pack', 'wet', 'wipes', 'stiff', 'plastics', 'material', 'body', 'peripheral', 'flange', 'attachment', 'sidewall', 'pack', 'wipes', 'tear', 'open', 'closure', 'body', 'portion', 'periphery', 'closure', 'tearable', 'body', 'closure', 'body', 'hinge', 'closure', 'opening', 'body', 'silicone', 'membrane', 'circular', 'opening', 'wipes', 'flow', 'wrap', 'plastics', 'pack', 'wipes', 'dispenser']"
494,494,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0032/766/A1/US20130032766A1.pdf,METAL COMPLEXES COMPRISING DIAZABENZIMIDAZOLOCARBENE LIGANDS AND THE USE THEREOF IN OLEDS,"The present invention relates to metal-carbene complexes comprising a central atom selected from iridium and platinum, and diazabenzimidazolocarbene ligands, to organic light diodes which comprise such complexes, to light-emitting layers comprising at least one such metal-carbene complex, to a device selected from the group comprising illuminating elements, stationary visual display units and mobile visual display units comprising such an OLED and to the use of such a metal-carbene complex in OLEDs, for example as emitter, matrix material, charge transport material and/or charge or exciton blocker.","['Molt Oliver', 'Lennartz Christian', 'Wagenblast Gerhard', 'Fuchs Evelyn', 'Langer Nicolle', 'Schildknecht Christian', 'Dormann Korinna', 'Watanabe Soichi', 'Schaefer Thomas', 'Wolleb Heinz', 'Figueira Duarte Teresa Marina', 'Metz Stefan', 'Murer Peter']",0,uspto,"['gate dielectrics', 'image display', 'organic thin film transistors', 'cathode ray tubes', 'image analysis', 'visual informations', 'field effect transistors', 'display system', 'visual communication', 'display devices', 'color image processing']",liver carcinoma in situ,"['COMPRISING', 'DIAZABENZIMIDAZOLOCARBENE', 'LIGANDS', 'USE']","['present', 'invention', 'metal', 'carbene', 'complexes', 'central', 'atom', 'iridium', 'platinum', 'diazabenzimidazolocarbene', 'ligands', 'light', 'diodes', 'such', 'complexes', 'light', 'layers', 'such', 'metal', 'carbene', 'complex', 'device', 'group', 'illuminating', 'elements', 'stationary', 'visual', 'display', 'units', 'mobile', 'visual', 'display', 'units', 'use', 'metal', 'carbene', 'complex', 'example', 'emitter', 'matrix', 'material', 'charge', 'transport', 'material', 'charge', 'exciton', 'blocker']"
495,495,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0033/389/A1/US20130033389A1.pdf,DATA VALUE OCCURRENCE INFORMATION FOR DATA COMPRESSION,"A method for generating occurrence data of data values for enabling encoding of a data set includes determining occurrences of data values in a first data batch and determining occurrence count information for a first number of most frequent data values in the first data batch, the occurrence count information identifying the most frequent data values and their occurrence counts. The method also includes generating for rest of the data values in the first data batch at least a first histogram having a second number of buckets and merging the occurrence count information of the first data batch with occurrence count information of a second data batch. The method further includes merging the first histogram of the first data batch to a merged histogram corresponding to the second data batch and processing a next data batch as a first data batch until the data set to be encoded is processed.","['Bendel Peter', 'Draese Oliver', 'Hrle Namik', 'Li Tianchao']",0,uspto,"['user information', 'compression methods', 'image compression', 'boundary value problems', 'integrated data', 'data integration', 'image retrieval', 'color histogram', 'recommender systems', 'graphic methods', 'data compression', 'boundary values', 'initial value problems', 'personal information', 'color image processing']",liver carcinoma in situ,"['VALUE', 'OCCURRENCE', 'INFORMATION', 'COMPRESSION']","['method', 'occurrence', 'data', 'data', 'values', 'encoding', 'data', 'set', 'occurrences', 'data', 'values', 'first', 'data', 'batch', 'occurrence', 'count', 'information', 'first', 'number', 'frequent', 'data', 'values', 'first', 'data', 'batch', 'occurrence', 'count', 'information', 'frequent', 'data', 'values', 'occurrence', 'counts', 'method', 'rest', 'data', 'values', 'first', 'data', 'batch', 'least', 'first', 'histogram', 'second', 'number', 'buckets', 'occurrence', 'count', 'information', 'first', 'data', 'batch', 'occurrence', 'count', 'information', 'second', 'data', 'batch', 'method', 'first', 'histogram', 'first', 'data', 'batch', 'merged', 'histogram', 'second', 'data', 'batch', 'next', 'data', 'batch', 'first', 'data', 'batch', 'data']"
496,496,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0033/443/A1/US20130033443A1.pdf,Method of Operating an Operator Control and Monitoring Device for Safety-Critical Applications,"A method of operating an operator control and monitoring device for safety-critical applications in which the control and monitoring device includes a display and a touch-sensitive sensor, wherein a control element is shown on the display which an operator must touch to obtain an approval for a safety-critical application that is granted for as long as the control element is being touched, wherein first and second numbers of touch points are respectively displayed in first and second control zones, position data of the first and second control zones is selected such that the fingers of a human hand cannot simultaneously touch all touch points of the first and second control zones, and wherein the approval for the safety-critical application is only granted if all touch points from the first and second control zones are being touched.","['J√∂hnssen Oliver', 'Zintel Andreas']",0,uspto,"['switching systems', 'real time systems', 'control systems', 'computer systems', 'switching control', 'image coding', 'safety critical applications', 'splines', 'robotic arms', 'control point', 'portable device', 'curve fitting', 'sensors', 'end effectors', 'human hands', 'portable equipment', 'computer hardware']",liver carcinoma in situ,['Applications'],"['method', 'operator', 'control', 'device', 'safety', 'critical', 'applications', 'control', 'monitoring', 'device', 'display', 'touch', 'sensitive', 'sensor', 'control', 'element', 'display', 'operator', 'approval', 'safety', 'critical', 'application', 'control', 'element', 'second', 'numbers', 'touch', 'points', 'first', 'second', 'control', 'zones', 'position', 'data', 'first', 'second', 'control', 'zones', 'such', 'fingers', 'human', 'hand', 'touch', 'points', 'first', 'second', 'control', 'zones', 'approval', 'safety', 'critical', 'application', 'touch', 'points', 'first', 'second', 'control', 'zones']"
497,497,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0033/636/A1/US20130033636A1.pdf,OPTICAL ASSEMBLY INCLUDING PLENOPTIC MICROLENS ARRAY,"An optical assembly includes a solid spacing layer between a plenoptic microlens array (MLA) and a pixel-level MLA, avoiding the need for an air gap. Such an assembly, and systems and methods for manufacturing same, can yield improved reliability and efficiency of production, and can avoid many of the problems associated with prior art approaches. In at least one embodiment, the plenoptic MLA, the spacing layer, and the pixel-level MLA are created from optically transmissive polymer(s) deposited on the photosensor array and shaped using photolithographic techniques. Such an approach improves precision in placement and dimensions, and avoids other problems associated with conventional polymer-on-glass architectures. Further variations and techniques are described.","['Pitts Colvin', 'Ng Yi-Ren', 'Oliver Steven']",0,uspto,"['multiwavelength', 'optical signals', 'fiber lasers', 'fiber optic networks', 'optoelectronic devices', 'optical transmissions', 'optical fibers', 'light transmission', 'direction of arrival', 'sub-arrays', 'optoelectronics', 'wavelength']",liver carcinoma in situ,"['ASSEMBLY', 'MICROLENS', 'ARRAY']","['optical', 'assembly', 'solid', 'spacing', 'layer', 'plenoptic', 'microlens', 'array', 'MLA', 'pixel', 'level', 'MLA', 'need', 'air', 'gap', 'assembly', 'systems', 'methods', 'manufacturing', 'same', 'improved', 'reliability', 'efficiency', 'production', 'many', 'problems', 'prior', 'art', 'approaches', 'embodiment', 'plenoptic', 'spacing', 'layer', 'pixel', 'level', 'MLA', 'transmissive', 'polymer(s', 'photosensor', 'array', 'photolithographic', 'techniques', 'approach', 'precision', 'placement', 'dimensions', 'other', 'problems', 'conventional', 'polymer', 'glass', 'architectures', 'Further', 'variations', 'techniques']"
498,498,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0033/982/A1/US20130033982A1.pdf,Bulk Data Transport in a Network,"A network is configured to utilize available bandwidth to conduct bulk data transfers without substantially affecting the successful transmission of time-sensitive traffic in the network. In order to avoid this interference, the packets carrying data for bulk data transfers are associated with a low priority class such that the routers of the network will preferentially drop these packets over packets associated with the normal traffic of the network. As such, when the normal traffic peaks or there are link or equipment failures, the normal traffic is preferentially transmitted over the bulk-transfer traffic and thus the bulk-transfer traffic dynamically adapts to changes in the available bandwidth of the network. Further, to reduce the impact of dropped packets for the bulk-transfer traffic, the packets are encoded at or near the source component using a loss-resistant transport protocol so that the dropped packets can be reproduced at a downstream link.","['Spatscheck Oliver', 'Nguyen Han Q.', 'Nurenberg Steven H.', 'Smith Gregory J.']",0,uspto,"['signal processing', 'intelligent systems', 'component', 'software', 'bandwidth', 'telecommunication traffic', 'available bandwidth', 'transport protocols', 'routers', 'traffic networks', 'data communication systems', 'transmission control protocol']",liver carcinoma in situ,[],"['network', 'available', 'bandwidth', 'bulk', 'data', 'transfers', 'successful', 'transmission', 'time', 'sensitive', 'traffic', 'network', 'order', 'interference', 'packets', 'data', 'bulk', 'data', 'transfers', 'low', 'priority', 'class', 'such', 'routers', 'network', 'packets', 'packets', 'normal', 'traffic', 'network', 'such', 'normal', 'traffic', 'peaks', 'link', 'equipment', 'failures', 'normal', 'traffic', 'bulk', 'transfer', 'traffic', 'bulk', 'transfer', 'traffic', 'changes', 'available', 'bandwidth', 'network', 'impact', 'packets', 'bulk', 'transfer', 'traffic', 'packets', 'source', 'component', 'loss', 'resistant', 'transport', 'protocol', 'packets', 'downstream', 'link']"
499,499,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0034/208/A1/US20130034208A1.pdf,DEVICE USING X-RAYS TO HIGHLIGHT SOFT-TISSUE PARTS IN MEDICAL RADIOTHERAPY,"A device and method for using X-rays to highlight soft-tissue parts in medical imaging are provided. The device may be implemented in radiotherapy equipment or used in radiotherapy. A control of the radiation dose needed for the therapy may involve phase-contrast imaging using X-rays to highlight soft-tissue parts. The result of the imaging by highlighting soft-tissue parts can be used for real-time and non-real-time planning of therapy and for adapting the treatment plan or the radiation dose. The radiation dose control may include anatomical imaging for locating tumours before, during and after irradiation and/or real-time adaptation of the treatment plan based on imaging that highlights soft-tissue parts. The positioning and arrangement of the combination of X-ray sources and detector in such a radiotherapy apparatus and of an accelerator may be independent of one another. The accelerator makes it possible to cover the entire body of the patient with X-rays.","['Heid Oliver', 'Heller J√ºrgen']",0,uspto,"['medical images', 'field programmable gate arrays (fpga)', 'hardware accelerators', 'image processing', 'imaging systems', 'program processors', 'portable device', 'image analysis', 'co-processors', 'bioinformatics', 'image reconstruction', 'portable equipment']",liver carcinoma in situ,"['DEVICE', 'USING', 'X', '-', 'RAYS', 'SOFT', 'TISSUE']","['device', 'method', 'X', '-', 'rays', 'soft', 'tissue', 'parts', 'medical', 'imaging', 'device', 'radiotherapy', 'equipment', 'radiotherapy', 'control', 'radiation', 'dose', 'therapy', 'phase', 'contrast', 'X', '-', 'rays', 'soft', 'tissue', 'parts', 'result', 'imaging', 'soft', 'tissue', 'parts', 'real', 'time', 'non', '-', 'real', 'time', 'planning', 'therapy', 'treatment', 'plan', 'radiation', 'dose', 'radiation', 'dose', 'control', 'anatomical', 'imaging', 'tumours', 'irradiation', 'real', 'time', 'adaptation', 'treatment', 'plan', 'soft', 'tissue', 'parts', 'positioning', 'arrangement', 'combination', 'X', '-', 'ray', 'sources', 'detector', 'radiotherapy', 'apparatus', 'accelerator', 'independent', 'accelerator', 'possible', 'entire', 'body', 'patient', 'X', '-', 'rays']"
500,500,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0034/519/A1/US20130034519A1.pdf,ORGANIC COMPOUNDS AND THEIR USES,"The present application describes organic compounds that are useful for the treatment, prevention and/or amelioration of human diseases.","['BRANDL Trixi', 'RAMAN Prakash', 'RIGOLLIER Pascal', 'SEEPERSAUD Mohindra', 'SIMIC Oliver']",0,uspto,[],liver carcinoma in situ,"['ORGANIC', 'COMPOUNDS', 'THEIR', 'USES']","['present', 'application', 'organic', 'compounds', 'useful', 'treatment', 'prevention', 'amelioration', 'human', 'diseases']"
501,501,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0034/521/A1/US20130034521A1.pdf,1'-SUBSTITUTED CARBA-NUCLEOSIDE ANALOGS FOR ANTIVIRAL TREATMENT,"Provided are pyrrolo[1,2-f][1,2,4]triazinyl, imidazo[1,5-f][1,2,4]triazinyl, imidazo[1,2-f][1,2,4]triazinyl, and [1,2,4]triazolo[4,3-f][1,2,4]triazinyl nucleosides, nucleoside phosphates and prodrugs thereof, wherein the 1‚Ä≤ position of the nucleoside sugar is substituted. The compounds, compositions, and methods provided are useful for the treatment of Flaviviridae virus infections, particularly hepatitis C infections.","['BUTLER Thomas', 'CHO Aesop', 'KIM Choung U.', 'PARRISH Jay P.', 'SAUNDERS Oliver L.', 'ZHANG Lijun']",0,uspto,"['target tracking', 'robotics', 'target position', 'security of data', 'malwares', 'malicious codes', 'computer viruses', 'intrusion detection']",liver carcinoma in situ,"['ANALOGS', 'TREATMENT']","['imidazo[1,5-f][1,2,4]triazinyl', 'imidazo[1,2-f][1,2,4]triazinyl', 'nucleosides', 'nucleoside', 'phosphates', 'prodrugs', 'position', 'nucleoside', 'sugar', 'compounds', 'compositions', 'methods', 'useful', 'treatment', 'virus', 'infections', 'infections']"
502,502,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0035/082/A1/US20130035082A1.pdf,CONTROLLING TRAFFIC TRANSMISSIONS TO MANAGE CELLULAR RADIO RESOURCE UTILIZATION,"Techniques for using controlling traffic transmissions to manage radio resource utilization are presented herein. When content is being streamed to user equipment (UE) and is at least initially intended to be streamed in real time at a constant bitrate, a communication management component can determine whether the content being transmitted to the UE can be delayed, instead of being transmitted in real time. In response to determining that the content can be delayed, the communication management component can facilitate buffering data and periodically streaming the data to the UE in data bursts to reduce use of UE power and radio resources. When transmitting a visual image to a UE, the communication management component can adjust resolution of a visual image to correspond to screen dimensions of the UE based on information indicating screen dimensions of the UE that can be received from the UE.","['Sen Subhabrata', 'Spatscheck Oliver', 'Gerber Alexandre', 'Mao Zhuoqing Morley', 'Qian Feng', 'Wang Zhaoguang']",0,uspto,"['radio', 'cellular telephone systems', 'constant bit rate', 'component', 'communication', 'software', 'cognitive radio', 'radio resources', 'wireless networks', 'data mining', 'wireless', 'cellular radio systems', 'frequency division multiple access', 'streaming data', 'wireless telecommunication systems', 'cellular', 'data communication systems', 'variable bit rate']",liver carcinoma in situ,"['TRAFFIC', 'TRANSMISSIONS', 'UTILIZATION']","['Techniques', 'traffic', 'transmissions', 'radio', 'resource', 'utilization', 'herein', 'content', 'equipment', 'least', 'real', 'time', 'constant', 'bitrate', 'communication', 'management', 'component', 'content', 'real', 'time', 'response', 'content', 'communication', 'management', 'component', 'data', 'data', 'data', 'bursts', 'use', 'power', 'radio', 'resources', 'visual', 'image', 'communication', 'management', 'component', 'resolution', 'visual', 'image', 'screen', 'dimensions', 'information', 'screen', 'dimensions']"
503,503,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0036/011/A1/US20130036011A1.pdf,Targeted Advertisement Content Presentation Methods and Systems,"An exemplary method includes a media content presentation system detecting a presentation of a media content instance by way of a primary media content access device, determining that a secondary media content access device is located within a detection zone associated with the primary media content access device during a time period associated with the presentation of the media content instance, selecting, in accordance with a course correction heuristic, advertisement content related to the media content instance and configured to target a user of the secondary media content access device, and presenting the advertisement content to the user by way of the secondary media content access device during the presentation of the media content instance by the primary media content access device. Corresponding methods and systems are also disclosed.","['Roberts Brian F.', 'Lemus Anthony M.', 'Mehta Japan A.', 'Tallapaneni Kishore', 'Relyea Donald H.', 'Oliver Michael R.']",0,uspto,"['multimedia services', 'world wide web', 'digital rights management', 'multimedia systems', 'audio-visual', 'digital contents', 'digital media', 'multimedia contents', 'audio acoustics', 'face recognition', 'web page', 'digital storage']",liver carcinoma in situ,[],"['exemplary', 'method', 'media', 'content', 'presentation', 'system', 'presentation', 'media', 'content', 'instance', 'way', 'primary', 'media', 'content', 'access', 'device', 'secondary', 'media', 'content', 'access', 'device', 'detection', 'zone', 'primary', 'media', 'content', 'access', 'device', 'time', 'period', 'presentation', 'media', 'content', 'instance', 'accordance', 'course', 'correction', 'heuristic', 'advertisement', 'content', 'media', 'content', 'instance', 'user', 'secondary', 'media', 'content', 'access', 'device', 'advertisement', 'content', 'user', 'way', 'secondary', 'media', 'content', 'access', 'device', 'presentation', 'media', 'content', 'instance', 'primary', 'media', 'content', 'access', 'device', 'methods', 'systems']"
504,504,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0036/200/A1/US20130036200A1.pdf,Methods and Systems for Delivering a Personalized Version of an Executable Application to a Secondary Access Device Associated with a User,"An exemplary method includes a media content presentation system 1) delivering a primary media content stream to a primary access device, the primary media content stream comprising data representative of a media content instance that is presented by the primary access device as the primary media content stream is delivered to the primary access device and data representative of an executable application related to the media content instance, 2) determining that a secondary access device associated with a user is located within a detection zone associated with the primary access device during a time period associated with the presentation of the media content instance by the primary access device, and 3) directing the primary access device to generate and deliver a version of the executable application that is personalized for the user to the secondary access device. Corresponding methods and systems are also disclosed.","['Roberts Brian F.', 'Lemus Anthony M.', 'Mehta Japan A.', 'Tallapaneni Kishore', 'Relyea Donald H.', 'Oliver Michael R.']",0,uspto,"['multimedia services', 'digital rights management', 'data stream', 'multimedia systems', 'digital contents', 'digital media', 'database systems', 'data mining', 'portable equipment', 'portable device', 'multimedia contents', 'data communication systems', 'digital storage']",liver carcinoma in situ,"['Methods', 'User']","['exemplary', 'method', 'media', 'content', 'presentation', 'system', 'primary', 'media', 'content', 'stream', 'primary', 'access', 'device', 'primary', 'media', 'content', 'stream', 'data', 'representative', 'media', 'content', 'instance', 'primary', 'access', 'device', 'primary', 'media', 'content', 'stream', 'primary', 'access', 'device', 'data', 'representative', 'executable', 'application', 'media', 'content', 'instance', 'secondary', 'access', 'device', 'user', 'detection', 'zone', 'primary', 'access', 'device', 'time', 'period', 'presentation', 'media', 'content', 'instance', 'primary', 'access', 'device', 'primary', 'access', 'device', 'version', 'executable', 'application', 'user', 'secondary', 'access', 'device', 'methods', 'systems']"
505,505,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130207/2013-06/US/2013/0036/306/A1/US20130036306A1.pdf,METHOD AND SYSTEM FOR HANDLING DEFINED AREAS WITHIN AN ELECTRONIC DOCUMENT,"A method is provided for handling defined areas within an electronic document, which includes: marking at least one area in an electronic source document as indecomposable area which can be processed as a whole content only; generating signature data for the indecomposable area; assigning the signature data to the indecomposable area to create an indecomposable area object; storing the indecomposable object; encrypting and transmitting the indecomposable area object in response to a request of an enhanced content reader application, where the enhanced content reader application decrypts the indecomposable area object and processes the indecomposable area in an electronic target document; and generating and transmitting a protected version of the indecomposable area in response to a request of a regular content reader application, where the regular content reader application outputs the protected version of the indecomposable area in an electronic target document.","['GNECH Thomas H.', 'KOENIG Steffen', 'MAYER Enrico', 'PETRIK Oliver']",0,uspto,"['electronic document', 'multimedia services', 'world wide web', 'digital rights management', 'image processing', 'digital contents', 'word processing', 'character recognition', 'document-processing', 'multimedia contents', 'web page']",liver carcinoma in situ,"['METHOD', 'SYSTEM', 'HANDLING', 'DEFINED', 'ELECTRONIC', 'DOCUMENT']","['method', 'areas', 'electronic', 'document', 'area', 'electronic', 'source', 'document', 'indecomposable', 'area', 'whole', 'content', 'signature', 'data', 'indecomposable', 'area', 'signature', 'data', 'indecomposable', 'area', 'indecomposable', 'area', 'object', 'indecomposable', 'object', 'indecomposable', 'area', 'object', 'response', 'request', 'content', 'reader', 'application', 'content', 'reader', 'application', 'indecomposable', 'area', 'object', 'indecomposable', 'area', 'electronic', 'target', 'document', 'version', 'indecomposable', 'area', 'response', 'request', 'regular', 'content', 'reader', 'application', 'regular', 'content', 'reader', 'application', 'version', 'indecomposable', 'area', 'electronic', 'target', 'document']"
506,506,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0036/951/A1/US20130036951A1.pdf,APPARATUS FOR TRANSPORTING AND/OR STORING BANKNOTES,"The invention relates to a device () for transport and/or storage of notes of value. The device () comprises a roller storage () having a winding drum (). Further, the device () comprises a sensor () for detecting a rotary motion of the winding drum ().","['Dietz Oliver', 'Michels Andre', 'Ringel Sascha']",0,uspto,"['computer systems', 'pneumatic cylinders', 'bevel gears', 'portable device', 'sensors', 'pneumatic drives', 'gear teeth', 'portable equipment', 'storage systems', 'computer hardware']",liver carcinoma in situ,"['APPARATUS', 'TRANSPORTING', 'STORING', 'BANKNOTES']","['invention', 'device', 'transport', 'storage', 'notes', 'value', 'device', 'roller', 'storage', 'drum', 'device', 'sensor', 'rotary', 'motion', 'winding', 'drum']"
507,507,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0038/034/A1/US20130038034A1.pdf,Industrial truck comprising a pair of wheel arms,"An industrial truck comprising a pair of wheel arms, which at their free end in each case comprise a wheel arm end, each of which comprising a bearing body and a pair of load wheels, the load wheels in each case being rotatably mounted on a rocker, and the rocker being pivotably mounted on the bearing body in a region located between the load wheels, the bearing body comprising a bearing projection on which the rocker is mounted such that the rocker laterally defines the wheel arm end.","['Rath Olaf', 'G√∂pner Oliver', 'R√∂der Matthias']",0,uspto,"['automation', 'projection method', 'nanocantilevers', 'industrial automation', 'free end', 'incompressible flow']",liver carcinoma in situ,"['Industrial', 'truck', 'pair', 'wheel', 'arms']","['industrial', 'truck', 'pair', 'wheel', 'arms', 'free', 'end', 'case', 'wheel', 'arm', 'end', 'bearing', 'body', 'pair', 'load', 'wheels', 'load', 'wheels', 'case', 'rocker', 'rocker', 'bearing', 'body', 'region', 'load', 'wheels', 'bearing', 'body', 'bearing', 'projection', 'rocker', 'such', 'rocker', 'wheel', 'arm', 'end']"
508,508,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0038/177/A1/US20130038177A1.pdf,Piezoelectric Component,"A piezo electrical component has a stack of piezo electrical layers arranged over each other and electrode layers arranged therebetween. The stack has at least one first piezo electrical layer having a first piezo electrical charge constant and, directly adjacent thereto, at least one second piezo electrical layer having a second piezo electrical charge constant. The piezo electrical charge constant describes an expansion of the piezo electrical layer perpendicular to an electrical field at a voltage 6 applied to the electrode layers. The first piezo electrical charge constant is different from the second piezo electrical charge constant.","['Glazunov Alexander', 'Dernovsck Oliver']",0,uspto,"['piezoelectric elements', 'component', 'energy harvesting', 'electrostatic actuators', 'software', 'software architecture patterns', 'piezo-resistive', 'layered', 'nanocantilevers', 'mems', 'solid-state sensors']",liver carcinoma in situ,[],"['piezo', 'electrical', 'component', 'stack', 'piezo', 'electrical', 'layers', 'other', 'electrode', 'layers', 'stack', 'first', 'piezo', 'electrical', 'layer', 'first', 'piezo', 'electrical', 'charge', 'constant', 'adjacent', 'thereto', 'second', 'piezo', 'electrical', 'layer', 'second', 'piezo', 'electrical', 'charge', 'constant', 'piezo', 'electrical', 'charge', 'constant', 'expansion', 'piezo', 'electrical', 'layer', 'perpendicular', 'electrical', 'field', 'voltage', 'electrode', 'layers', 'first', 'piezo', 'electrical', 'charge', 'constant', 'different', 'second', 'piezo', 'electrical', 'charge', 'constant']"
509,509,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0039/362/A1/US20130039362A1.pdf,INLINE POWER SYSTEM AND METHOD FOR NETWORK COMMUNICATIONS,"A system and method for coupling a communications device to a primary communications network having a first communications format and to a secondary communications network having a second communications format. The system and method can comprise a first port configured for connecting to the communications device, a second port configured for connecting to the primary communications network and facilitating the communication of the data between the primary communications network and the communications device through the first port.",['Emmanuel Oliver Rex Anto'],0,uspto,"['signal processing', 'communication systems', 'telecommunication networks', 'communication', 'network components', 'computer network', 'communication networks', 'program compilers', 'network protocols', 'network architecture', 'wireless communications']",liver carcinoma in situ,"['METHOD', 'COMMUNICATIONS']","['system', 'method', 'communications', 'device', 'primary', 'communications', 'network', 'first', 'communications', 'format', 'secondary', 'communications', 'network', 'second', 'communications', 'format', 'system', 'method', 'first', 'port', 'communications', 'device', 'second', 'port', 'primary', 'communications', 'network', 'communication', 'data', 'primary', 'communications', 'network', 'communications', 'device', 'first', 'port']"
510,510,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0039/571/A1/US20130039571A1.pdf,METHOD AND SYSTEM FOR LEARNING A SAME-MATERIAL CONSTRAINT IN AN IMAGE,"In a first exemplary embodiment of the present invention, an automated, computerized method is provided for processing an image. According to a feature of the present invention, the method comprises the steps of providing an image file depicting an image, in a computer memory, assembling a feature vector for the image file, the feature vector containing information regarding a likelihood that a selected pair of regions of the image file are of a same intrinsic characteristic, providing a classifier derived from a computer learning technique, computing a classification score for the selected pair of regions of the image file, as a function of the feature vector and the classifier and classifying the regions as being of the same intrinsic characteristic, as a function of the classification score.","['Stein Andrew Neil', 'Nabbe Bartholomeus Christianus Leonardus', 'Smith Casey Arthur', 'Bagnell James Andrew', 'Tolliver David Allen']",0,uspto,"['image features', 'classification methods', 'pattern recognition', 'reference image', 'document images', 'image matching', 'optical character recognition', 'image processing', 'classifiers', 'imaging systems', 'classification models', 'digital image storage', 'learning', 'education', 'image quality', 'object recognition', 'color image processing', 'image retrieval', 'digital image', 'machine learning', 'image analysis', 'color images']",liver carcinoma in situ,"['METHOD', 'SYSTEM', 'CONSTRAINT', 'IMAGE']","['first', 'exemplary', 'embodiment', 'present', 'invention', 'computerized', 'method', 'image', 'feature', 'present', 'invention', 'method', 'steps', 'image', 'file', 'image', 'computer', 'memory', 'feature', 'vector', 'image', 'file', 'feature', 'vector', 'information', 'likelihood', 'pair', 'regions', 'image', 'file', 'same', 'intrinsic', 'characteristic', 'classifier', 'computer', 'learning', 'technique', 'classification', 'score', 'pair', 'regions', 'image', 'file', 'function', 'feature', 'vector', 'classifier', 'regions', 'same', 'intrinsic', 'characteristic', 'function', 'classification', 'score']"
511,511,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0039/839/A1/US20130039839A1.pdf,PRODUCTION OF CARBON NANOTUBES,"The invention relates to a novel process for the production of catalysts for the production of carbon nanotubes in agglomerated form, which are characterised by a low bulk density. This invention likewise provides the catalysts, their use in the production of carbon nanotubes in high catalyst-specific yields, and the carbon nanotubes produced by this process.","['Hocke Heiko', 'Weber Ralph', 'Schl√ºter Oliver Felix-Karl', 'Michele Volker', 'Mileczko Leslaw']",0,uspto,[],liver carcinoma in situ,['PRODUCTION'],"['invention', 'novel', 'process', 'production', 'catalysts', 'production', 'carbon', 'nanotubes', 'form', 'low', 'bulk', 'density', 'invention', 'catalysts', 'use', 'production', 'carbon', 'nanotubes', 'high', 'catalyst', 'specific', 'yields', 'carbon', 'nanotubes', 'process']"
512,512,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0040/116/A1/US20130040116A1.pdf,"METHOD FOR PRODUCING A PANE WITH A PATTERNED SURFACE, AND PANE HAVING A PATTERNED SURFACE",A method for producing a pane of a household appliance or a viewing window of an oven is provided. The method includes the steps of: providing a substrate; applying a sol-gel layer to the substrate; embossing a haptically perceptible pattern using an embossing tool in the sol-gel layer; and curing the sol-gel layer. A pane of a household appliance or piece of furniture is also provided that includes a glass or glass-ceramic substrate with a patterned sol-gel layer which has a haptically perceptible pattern.,"['Henze Inka', 'Spengler Stefan', 'Bockmeyer Matthias', 'Rudigier-Voigt Eveline', 'Schuhmacher Joerg', 'Stolz Claudia', 'Anton Andrea', 'Settelein Jochen', 'Sweeck Tamara', 'Gros Oliver']",0,uspto,"['electrical appliances', 'electric appliances', 'software architecture patterns', 'domestic appliances', 'layered', 'shack-hartmann wavefront sensors', 'household appliances', 'home appliances', 'energy utilization']",liver carcinoma in situ,"['METHOD', 'PANE', 'PATTERNED', 'SURFACE']","['method', 'pane', 'household', 'appliance', 'window', 'oven', 'method', 'steps', 'substrate', 'sol', 'gel', 'layer', 'substrate', 'perceptible', 'pattern', 'embossing', 'tool', 'sol', 'gel', 'layer', 'sol', 'gel', 'layer', 'pane', 'household', 'appliance', 'piece', 'furniture', 'glass', 'glass', 'ceramic', 'substrate', 'patterned', 'sol', 'gel', 'layer', 'perceptible', 'pattern']"
513,513,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0040/142/A1/US20130040142A1.pdf,PROCESS FOR PRODUCING PTFE AND ARTICLES THEREOF,Described herein is a process for making PTFE having a standard specific gravity of less than 2.160 g/cmcomprising: polymerizing a tetrafluoroethylene monomer in an aqueous medium comprising an emulsifier and an initiator in a reaction vessel and contacting the aqueous medium with a fluorinated polyether. Also described herein are the polymerizable compositions and articles thereof.,"['Frey Oliver', 'Hintzer Klaus', 'Neumann Wolfgang', 'Streiter Andr√©']",0,uspto,[],liver carcinoma in situ,"['PROCESS', 'PTFE', 'THEREOF']","['herein', 'process', 'standard', 'specific', 'gravity', 'less', 'g', 'tetrafluoroethylene', 'monomer', 'aqueous', 'medium', 'emulsifier', 'initiator', 'reaction', 'vessel', 'aqueous', 'medium', 'fluorinated', 'polyether', 'herein', 'polymerizable', 'compositions', 'articles']"
514,514,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0040/183/A1/US20130040183A1.pdf,ELECTROCHEMICAL CELLS,The present invention relates to electrochemical cells comprising,"['LEITNER Klaus', 'Garsuch Arnd', 'Gronwald Oliver', 'Schulz-Dobrick Martin']",0,uspto,[],liver carcinoma in situ,['CELLS'],"['present', 'invention', 'electrochemical', 'cells']"
515,515,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0042/009/A1/US20130042009A1.pdf,Network Aware Forward Caching,"A network includes a cache server and a network aware server that operates to determine an optimization between a cost of retrieving content from a communication network and a cost of caching content at the cache server. The optimization is determined as a minimum of a sum of a transit cost, a backbone cost, and a caching cost. The transit cost includes a money cost per data unit. The backbone cost includes a money cost per data unit and time unit. The caching cost includes a money cost per server unit. In response to determining the optimization, the network aware server sends a content identifier to the cache server, and the cache server receives the content identifier, determines a source of a content item, and if the source is the same as the content identifier, then cache the content item.","['Gerber Alexandre', 'Spatscheck Oliver', 'Pei Dan', 'Hajiaghayi Mohammad Taghi', 'Erman Jeffrey']",0,uspto,"['telecommunication networks', 'microprocessor chips', 'digital contents', 'optimization', 'caching', 'investments', 'web servers', 'program processors', 'network architecture', 'prefetches', 'operating systems', 'cache', 'computer network', 'multimedia contents', 'cache miss', 'shared cache', 'servers', 'investment costs', 'prefetching', 'world wide web', 'communication', 'network components', 'storage allocation (computer)', 'correlation analysis', 'network protocols', 'optimization problems', 'chip multiprocessor', 'data caches', 'mathematics', 'multimedia services', 'buffer storage', 'digital rights management', 'l2 cache', 'application servers', 'security of data', 'communication networks', 'program compilers', 'multi-core processor', 'multiprocessing systems', 'web page', 'cache memory', 'capital investment']",liver carcinoma in situ,['Forward'],"['network', 'cache', 'server', 'network', 'aware', 'server', 'optimization', 'cost', 'content', 'communication', 'network', 'cost', 'content', 'cache', 'server', 'optimization', 'minimum', 'sum', 'transit', 'cost', 'backbone', 'cost', 'caching', 'cost', 'transit', 'cost', 'money', 'cost', 'data', 'unit', 'backbone', 'cost', 'money', 'cost', 'data', 'unit', 'time', 'unit', 'caching', 'cost', 'money', 'cost', 'server', 'unit', 'response', 'optimization', 'network', 'aware', 'server', 'content', 'identifier', 'cache', 'server', 'cache', 'server', 'content', 'source', 'content', 'item', 'source', 'same', 'content', 'content', 'item']"
516,516,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0042/117/A1/US20130042117A1.pdf,CRYPTOGRAPHIC DATA DISTRIBUTION AND REVOCATION FOR HANDHELD MEDICAL DEVICES,"A method includes: receiving a revocation list from a remote data server at a configuration device. The revocation list includes N cryptographic certificates associated with N computer software entities, respectively, that are not to be executed by any of a group of medical devices including a handheld medical device. N is an integer greater than or equal to zero The method further includes receiving data from the handheld medical device at the configuration device. The data includes a cryptographic certificate that is associated with a given computer software entity that is presently installed in memory of the handheld medical device for execution by the handheld medical device. The method further includes comparing the cryptographic certificate with the revocation list; and selectively executing a protective function by the configuration device when the cryptographic certificate is the same as one of the N cryptographic certificates of the revocation list.","['Birtwhistle Daniel', 'Tenbarge James', 'Porsch Ulrich', 'Schwenker Kai-Oliver', 'Rachner Eric']",0,uspto,"['software', 'computer science', 'portable equipment', 'handheld', 'public key infrastructure', 'portable device', 'public key cryptography', 'public key certificates', 'public keys', 'certificate revocation', 'hand held computers']",liver carcinoma in situ,"['DISTRIBUTION', 'REVOCATION', 'DEVICES']","['method', 'revocation', 'list', 'remote', 'data', 'server', 'configuration', 'device', 'revocation', 'list', 'cryptographic', 'certificates', 'computer', 'software', 'entities', 'group', 'medical', 'devices', 'handheld', 'medical', 'device', 'integer', 'greater', 'equal', 'method', 'data', 'handheld', 'medical', 'device', 'configuration', 'device', 'data', 'cryptographic', 'certificate', 'computer', 'software', 'entity', 'memory', 'handheld', 'medical', 'device', 'execution', 'handheld', 'medical', 'device', 'method', 'cryptographic', 'certificate', 'revocation', 'list', 'protective', 'function', 'configuration', 'device', 'cryptographic', 'certificate', 'same', 'cryptographic', 'certificates', 'revocation', 'list']"
517,517,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0042/175/A1/US20130042175A1.pdf,PHRASE GENERATION USING PART(S) OF A SUGGESTED PHRASE,"Real-time query expansion (RTQE) is a process of supplementing an original query with addition terms or expansion choices that are ranked according to some figure of merit and presented while users are still formulating their queries. As disclosed herein, phrases may be presented and one or more terms of a focused-on phrase may be pinned (as desirable to the user). Subsequent lists may be presented as a function of pinned terms and/or user input. In one embodiment, a placeholder may be substituted for one or more pinned terms if less than some predetermined threshold of phrases is able to be presented based upon the pinned terms and/or user input, and another list of phrases may be presented as a function of a query using fewer than all the pinned terms. The placeholder may allow out-of-index phrases to be formed, for example, based upon two or more phrases and/or terms input by the user.","['Paek Tim', 'Lee Bongshin', 'Thiesson Bo', 'Voronel Gary', 'Odell Julian James', 'Scholz Oliver']",0,uspto,"['query results', 'user information', 'structured queries', 'part of speech', 'query languages', 'relational database', 'user query', 'natural language processing', 'recommender systems', 'query expansion', 'query processing', 'search engines', 'keyword search', 'keyword queries', 'personal information', 'sql query']",liver carcinoma in situ,"['PHRASE', 'GENERATION', 'PHRASE']","['Real', 'time', 'query', 'expansion', 'process', 'original', 'query', 'addition', 'terms', 'expansion', 'choices', 'figure', 'merit', 'users', 'queries', 'herein', 'phrases', 'more', 'terms', 'phrase', 'desirable', 'user', 'Subsequent', 'lists', 'function', 'terms', 'user', 'input', 'embodiment', 'placeholder', 'pinned', 'terms', 'less', 'threshold', 'phrases', 'able', 'terms', 'user', 'input', 'list', 'phrases', 'function', 'query', 'fewer', 'terms', 'placeholder', 'index', 'phrases', 'example', 'more', 'phrases', 'terms', 'user']"
518,518,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130214/2013-07/US/2013/0042/371/A1/US20130042371A1.pdf,CHEMICALLY INDUCIBLE EXPRESSION OF BIOSYNTHETIC PATHWAYS,"Methods and constructs for the introduction of multiple genes encoding enzymes in a multi-enzyme biosynthetic pathway are provided. In one embodiment, the constructs contain two or more enzyme-encoding genes, each under the control of an inducible promoter and each with a polyadenylation signal. The constructs are used to produce transgenic plants, in which the expression of the enzymes are increased when a chemical inducing agent is applied, and a biosynthetic product of the series of enzymes encoded by the transgenes is produced. Constructs may be used which contain two or more enzyme-encoding genes under the control of one or more promoters activated by activator molecules or complexes expressed from a transgene or transgenes, which are themselves under the control of one or more inducible promoters and switched on following the external application of a chemical. The transgene or transgenes expressing the activator molecules or complexes may be included in the same construct containing multiple genes encoding enzymes in a multi-enzyme biosynthetic pathway. Alternatively, the transgene or transgenes expressing the activator molecules or complexes may be on a different construct from the construct containing multiple genes encoding enzymes in a multi-enzyme biosynthetic pathway. The activator molecule can be expressed using a constitutive promoter in an inactive form which is converted to the active form following application of the chemical inducing agent.","['Kourtz Lauralynn', 'Peoples Oliver P.', 'Snell Kristi D.']",0,uspto,"['switching systems', 'control systems', 'computer systems', 'switching control', 'software agents', 'intelligent agents', 'multiagent system', 'autonomous agents']",liver carcinoma in situ,"['EXPRESSION', 'PATHWAYS']","['Methods', 'introduction', 'multiple', 'genes', 'enzymes', 'multi', '-', 'enzyme', 'biosynthetic', 'pathway', 'embodiment', 'constructs', 'enzyme', 'genes', 'control', 'inducible', 'promoter', 'polyadenylation', 'signal', 'constructs', 'transgenic', 'plants', 'expression', 'enzymes', 'chemical', 'agent', 'biosynthetic', 'product', 'series', 'enzymes', 'transgenes', 'Constructs', 'enzyme', 'genes', 'control', 'more', 'promoters', 'activator', 'molecules', 'complexes', 'transgene', 'transgenes', 'control', 'inducible', 'promoters', 'external', 'application', 'chemical', 'transgene', 'transgenes', 'activator', 'molecules', 'complexes', 'same', 'construct', 'multiple', 'genes', 'enzymes', 'multi', '-', 'enzyme', 'biosynthetic', 'pathway', 'transgene', 'transgenes', 'activator', 'molecules', 'complexes', 'different', 'construct', 'construct', 'multiple', 'genes', 'enzymes', 'multi', '-', 'enzyme', 'biosynthetic', 'pathway', 'activator', 'molecule', 'constitutive', 'promoter', 'inactive', 'form', 'active', 'form', 'application', 'chemical', 'agent']"
519,519,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0042/444/A1/US20130042444A1.pdf,RELEASE APPARATUS FOR A LOAD ON A DEVICE AND UNDERWATER DEVICE,"The invention relates to a release apparatus for a load on a device, in particular on an underwater device, having a hook device, with which a hook is mounted on a hook-holding device such that it can rotate about a rotational axis and can be displaced between a closed and a released position by rotation about the rotational axis with the aid of a hook actuation mechanism, a load rest, which is formed on the hook and in which a holding element of the load rests when in the non-released state, and a restricted guidance device, which is configured to guide the load in an ejection direction when released, wherein, when the holding element of the load rests on the load rest, the hook in the closed position is torque-free with respect to a torque exerted by the load on the hook in relation to the rotation about the rotational axis. An underwater device having the release apparatus is also created.","['Preradovic Oliver', 'Mischnick David']",0,uspto,"['autonomous underwater vehicle (auv)', 'signal processing', 'autonomous underwater vehicles (auv)', 'wireless sensor networks', 'autonomous underwater vehicles', 'portable equipment', 'underwater acoustic communications', 'underwater environments', 'submersibles', 'portable device', 'underwater acoustics', 'sensors', 'sensor networks', 'acoustic communications', 'underwater sensor networks']",liver carcinoma in situ,"['APPARATUS', 'DEVICE', 'UNDERWATER', 'DEVICE']","['invention', 'release', 'apparatus', 'load', 'device', 'particular', 'underwater', 'device', 'hook', 'device', 'hook', 'hook', 'device', 'such', 'rotational', 'axis', 'closed', 'position', 'rotation', 'rotational', 'axis', 'aid', 'hook', 'actuation', 'mechanism', 'load', 'rest', 'hook', 'element', 'load', 'non', '-', 'state', 'restricted', 'guidance', 'device', 'load', 'ejection', 'direction', 'element', 'load', 'load', 'rest', 'hook', 'closed', 'position', 'torque', 'free', 'respect', 'torque', 'load', 'hook', 'relation', 'rotation', 'rotational', 'axis', 'underwater', 'device', 'release', 'apparatus']"
520,520,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0042/553/A1/US20130042553A1.pdf,REVERSIBLE DECORATIVE MOLDINGS BETWEEN FLOOR AND WALL OR WALL AND CEILING,"A reversible molding is disclosed having multiple decorative face which differ from one another by at least one property. Such properties can include texture, color, pattern or design or shape. The molding can suitably be used at the joint between a wall and floor or between a wall and ceiling. In one embodiment, the moldings are manufactured from wood, MDF or HDF, with a decorative surface selected from foil, laminate, veneer, paint, stain or digital printing.",['Stanchfield Oliver O.'],0,uspto,"['color pattern', 'frontal faces', 'face images', 'local binary patterns', 'color printing', 'shape information', 'face features', 'face detection', 'local texture', 'face recognition', 'facial images', 'content based retrieval']",liver carcinoma in situ,"['DECORATIVE', 'MOLDINGS', 'CEILING']","['reversible', 'molding', 'multiple', 'decorative', 'face', 'property', 'Such', 'properties', 'texture', 'color', 'pattern', 'design', 'shape', 'molding', 'joint', 'wall', 'floor', 'wall', 'ceiling', 'embodiment', 'moldings', 'wood', 'decorative', 'surface', 'foil', 'laminate', 'veneer', 'paint', 'digital', 'printing']"
521,521,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0042/660/A1/US20130042660A1.pdf,METHOD AND APPARATUS FOR MAKING COLD-PILGER-ROLLED PIPE,"An apparatus for making a cold-pilger-rolled tube has two grooved pilger work rolls rotatable in a roll frame about respective axes to compress a tubular workpiece moving in a travel direction around a mandrel extending in the direction between a nip formed between the grooved rolls and anchored upstream of the nip in a thrust block. An outside diameter of the workpiece is measured downstream in the direction from the rolls as the workpiece passes through the nip, and an actuator engaging one of the rolls relative the other of the rolls shifts it transversely to the travel direction as the workpiece passes through the nip in accordance with the measured outside diameter for maintaining a uniform outside diameter of the workpiece.","['BAENSCH Michael', 'Thome Verena', 'Krebs Wolfgang', 'Schieren Georg', 'Strehlau Oliver']",0,uspto,"['machining centers', 'structural frames', 'computer aided manufacturing', 'machining', 'frames']",liver carcinoma in situ,"['METHOD', 'APPARATUS', 'PIPE']","['apparatus', 'cold', 'pilger', 'tube', 'grooved', 'pilger', 'work', 'rolls', 'rotatable', 'roll', 'frame', 'respective', 'axes', 'tubular', 'travel', 'direction', 'mandrel', 'direction', 'nip', 'grooved', 'rolls', 'upstream', 'nip', 'thrust', 'block', 'outside', 'diameter', 'workpiece', 'direction', 'rolls', 'workpiece', 'nip', 'actuator', 'rolls', 'other', 'rolls', 'travel', 'direction', 'workpiece', 'nip', 'accordance', 'outside', 'diameter', 'uniform', 'diameter', 'workpiece']"
522,522,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0042/913/A1/US20130042913A1.pdf,"SHIELDED ELECTRICAL CONTACT AND DOPING THROUGH A PASSIVATING DIELECTRIC LAYER IN A HIGH-EFFICIENCY CRYSTALLINE SOLAR CELL, INCLUDING STRUCTURE AND METHODS OF MANUFACTURE","Solar cell structures and formation methods which utilize the surface texture in conjunction with a passivating dielectric layer to provide a practical and controllable technique of forming an electrical contact between a conducting layer and underlying substrate through the passivating dielectric layer, achieving both good surface passivation and electrical contact with low recombination losses, as required for high efficiency solar cells. The passivating dielectric layer is intentionally modified to allow direct contact, or tunnel barrier contact, with the substrate. Additional P-N junctions, and dopant gradients, are disclosed to further limit losses and increase efficiency.","['Crafts Douglas', 'Schultz-Wittman Oliver']",0,uspto,"['electronic commerce', 'computational efficiency', 'software architecture patterns', 'contracts', 'information technology', 'theoretical computer science', 'layered', 'insulating materials', 'dielectric substrates', 'insulating layers', 'antennas']",liver carcinoma in situ,"['PASSIVATING', 'METHODS', 'MANUFACTURE']","['Solar', 'cell', 'structures', 'formation', 'methods', 'surface', 'texture', 'conjunction', 'dielectric', 'layer', 'practical', 'controllable', 'technique', 'electrical', 'contact', 'layer', 'substrate', 'dielectric', 'layer', 'good', 'surface', 'passivation', 'electrical', 'contact', 'low', 'recombination', 'losses', 'high', 'efficiency', 'solar', 'cells', 'dielectric', 'layer', 'direct', 'contact', 'barrier', 'contact', 'substrate', 'Additional', 'junctions', 'dopant', 'gradients', 'losses', 'efficiency']"
523,523,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0043/484/A1/US20130043484A1.pdf,HEMT WITH INTEGRATED LOW FORWARD BIAS DIODE,"A high electron mobility transistor includes a source, gate and drain, a first III-V semiconductor region having a two-dimensional electron gas (2DEG) which provides a first conductive channel controllable by the gate between the source and drain, and a second III-V semiconductor region below the first III-V semiconductor region and having a second conductive channel connected to the source or drain and not controllable by the gate. The first and second III-V semiconductor regions are spaced apart from one another by a region of the high electron mobility transistor having a different band gap than the first and second III-V semiconductor regions.","['Curatola Gilberto', 'H√§berlen Oliver']",0,uspto,"['electron gas', 'two dimensional', 'gan', 'integrated circuits', 'high electron mobility transistors', 'insulating materials', 'insulating layers', 'electron mobility', 'hemt', 'computer hardware']",liver carcinoma in situ,"['INTEGRATED', 'BIAS', 'DIODE']","['high', 'electron', 'mobility', 'transistor', 'source', 'gate', 'drain', 'first', 'V', 'semiconductor', 'region', 'dimensional', 'electron', 'gas', 'first', 'conductive', 'channel', 'controllable', 'gate', 'source', 'drain', 'second', 'V', 'semiconductor', 'region', 'first', 'V', 'semiconductor', 'region', 'second', 'conductive', 'channel', 'source', 'drain', 'controllable', 'gate', 'first', 'second', 'V', 'semiconductor', 'regions', 'region', 'high', 'electron', 'mobility', 'transistor', 'different', 'band', 'gap', 'first', 'second', 'V', 'semiconductor', 'regions']"
524,524,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0043/660/A1/US20130043660A1.pdf,SEAL FOR SEALING A SEALING GAP AND METHOD FOR PRODUCING A SEAL OF THIS TYPE,"In order to provide a seal for sealing a sealing gap between a first component and a second component, comprising a seal body with at least one sealing portion and at least one spring element for biasing the sealing portion against at least one of the components to be sealed, the spring element being at least partially arranged in a receiving space of the seal body, which seal is simply constructed and easily producible and nevertheless ensures a secure retention of the spring element in the receiving space, it is proposed that the spring element has at least one claw element, by means of which the spring element is interlocked with the seal body.","['Daub Oliver', 'Grau G√ºnther', 'Hocker Klaus', 'Konik Adam', 'Neuschwander Werner', 'Kopp Fabian', 'Schuhmacher Walter']",0,uspto,"['communication', 'component', 'software', 'secure communications', 'network security', 'authentication']",liver carcinoma in situ,"['SEAL', 'GAP', 'METHOD', 'SEAL', 'TYPE']","['order', 'seal', 'gap', 'first', 'component', 'second', 'component', 'seal', 'body', 'sealing', 'portion', 'spring', 'element', 'sealing', 'portion', 'components', 'spring', 'element', 'space', 'seal', 'body', 'seal', 'producible', 'secure', 'retention', 'spring', 'element', 'space', 'spring', 'element', 'claw', 'element', 'means', 'spring', 'element', 'seal', 'body']"
525,525,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0044/494/A1/US20130044494A1.pdf,FACETTED FOLDED-OPTIC COLLIMATOR,"A folded circularly symmetric illumination optic comprising a first light transfer mode having a first central refractive surface and a second central refractive surface, wherein one of the first and second central refractive surfaces has at least one peened feature; a second light transfer mode having a first refractive surface, a first TIR surface, a second TIR surface and a second refractive surface; a third light transfer mode having a first refractive surface, a first TIR surface and a second refractive surface, wherein the first TIR surface has at least one peening feature, and wherein the second refractive surface is conical; wherein the first TIR surface and second refractive surface of the second light transfer mode is coincident at least one point, wherein the second refractive surface of the third light transfer mode is coincident with the first TIR surface and second refractive surface of the second light transfer mode.","['Dross Oliver', 'Mohendano Ruben', 'Chaves Julio C.', 'Munoz Fernando', 'Minano Juan Carlos', 'Falicoff Waqidi']",0,uspto,"['aspherics', 'local binary patterns', 'cryptography', 'illumination conditions', 'surface testing', 'face recognition', 'modes of operation', 'lighting conditions', 'content based retrieval']",liver carcinoma in situ,"['FACETTED', 'OPTIC', 'COLLIMATOR']","['symmetric', 'illumination', 'optic', 'first', 'light', 'transfer', 'mode', 'first', 'central', 'refractive', 'surface', 'second', 'central', 'refractive', 'surface', 'first', 'second', 'central', 'refractive', 'surfaces', 'peened', 'feature', 'second', 'light', 'transfer', 'mode', 'first', 'refractive', 'surface', 'first', 'surface', 'second', 'surface', 'second', 'refractive', 'surface', 'third', 'light', 'transfer', 'mode', 'first', 'refractive', 'surface', 'first', 'surface', 'second', 'refractive', 'surface', 'first', 'surface', 'feature', 'second', 'refractive', 'surface', 'conical', 'first', 'surface', 'second', 'refractive', 'surface', 'second', 'light', 'transfer', 'mode', 'coincident', 'point', 'second', 'refractive', 'surface', 'third', 'light', 'transfer', 'mode', 'coincident', 'first', 'surface', 'second', 'refractive', 'surface', 'second', 'light', 'transfer', 'mode']"
526,526,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/199/A1/US20130045199A1.pdf,Antibody Preparations,"An antibody preparation suitable for intravenous administration in humans includes IgG, IgA and at least 5% IgM antibodies by weight of the total amount of antibodies. The preparation is prepared from human plasma, has specific complement activating activity, and, in an in vitro assay with human serum suitable to determine the ability of the antibody preparation to activate complement unspecifically, the antibody preparation generates substantially no C5and/or substantially no C3. The antibody preparation can have medical uses.","['Moeller Wolfgang', 'Rudnick Dieter', 'Maneg Oliver', 'Rodemer Michael', 'Germer Matthias', 'Braun Veit']",0,uspto,[],liver carcinoma in situ,['Preparations'],"['antibody', 'preparation', 'suitable', 'intravenous', 'administration', 'humans', 'IgG', 'IgA', '%', 'antibodies', 'weight', 'total', 'amount', 'antibodies', 'preparation', 'human', 'plasma', 'specific', 'complement', 'activity', 'assay', 'human', 'serum', 'suitable', 'ability', 'antibody', 'preparation', 'complement', 'antibody', 'preparation', 'C3', 'antibody', 'preparation', 'medical', 'uses']"
527,527,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/226/A1/US20130045226A1.pdf,METHOD FOR FORMING AND EXTRACTING SOLID PELLETS COMPRISING OIL-CONTAINING MICROBES,"A process including: (a) mixing a microbial biomass, comprising oil-containing microbes, and at least one grinding agent capable of absorbing oil, to provide a disrupted biomass mix; (b) blending at least one binding agent with said disrupted biomass mix to provide a fixable mix capable of forming a solid pellet; and, (c) forming the solid pellet from the fixable mix. The process optionally includes extracting the solid pellet with a solvent to provide an extracted microbial oil.","['Avgousti Marios', 'Bell Timothy Allan', 'Gutsche Oliver Walter', 'Hutchenson Keith W.', 'Orlandi Robert D.']",0,uspto,"['software agents', 'extracting information', 'intelligent agents', 'multiagent system', 'autonomous agents', 'information extraction', 'agent based']",liver carcinoma in situ,"['METHOD', 'EXTRACTING', 'COMPRISING', 'OIL', 'MICROBES']","['process', 'microbial', 'biomass', 'oil', 'microbes', 'agent', 'capable', 'oil', 'disrupted', 'biomass', 'mix', 'agent', 'disrupted', 'biomass', 'mix', 'fixable', 'mix', 'capable', 'solid', 'pellet', 'c', 'solid', 'pellet', 'fixable', 'mix', 'process', 'solid', 'pellet', 'solvent', 'extracted', 'microbial', 'oil']"
528,528,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/728/A1/US20130045728A1.pdf,System And Method For Receiving And Placing Telephone Calls,"In some embodiments, a method of placing and receiving a telephone call can include: determining that a mobile device has been coupled to a docking station while communicating audio for the telephone call using the mobile device and a wireless telephone network; communicating to a server that the mobile device has been coupled to the docking station; requesting that the server facilitate transfer of the telephone call from the wireless telephone network to a wired network; receiving incoming audio for the telephone call using the docking station and the wired network; and sending outgoing audio for the telephone call using the docking station and the wired network. The audio for the telephone call can include the incoming audio and the outgoing audio. Other embodiments are disclosed.","['Iverson Kent', 'McCoy Mack Ray', 'Mun Hyeun Suk', 'McAtee Megan', 'Mazzei Raffaele', 'Seil Oliver Duncan', 'Kim Ryan Yun', 'Norton John M.', 'Van Harlingen Brian L.']",0,uspto,"['mobile devices', 'radio', 'mobile computing', 'telephone circuits', 'portable equipment', 'telephone', 'wireless', 'engineering', 'portable device', 'telephone networks', 'audio acoustics', 'audio']",liver carcinoma in situ,"['System', 'Telephone', 'Calls']","['embodiments', 'method', 'telephone', 'call', 'mobile', 'device', 'docking', 'station', 'audio', 'telephone', 'call', 'mobile', 'device', 'wireless', 'telephone', 'network', 'server', 'mobile', 'device', 'docking', 'station', 'server', 'facilitate', 'transfer', 'telephone', 'call', 'wireless', 'telephone', 'network', 'wired', 'network', 'incoming', 'audio', 'telephone', 'call', 'docking', 'station', 'wired', 'network', 'outgoing', 'audio', 'telephone', 'call', 'docking', 'station', 'wired', 'network', 'audio', 'telephone', 'call', 'incoming', 'audio', 'outgoing', 'audio', 'Other', 'embodiments']"
529,529,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/753/A1/US20130045753A1.pdf,Geo-Fence Entry and Exit Notification System,"A method is provided for determining when a mobile communications device has crossed a geo-fence. The method comprises (a) providing a mobile communications device () equipped with an operating system and having a location detection application resident thereon, wherein the mobile communications device is in communication with a server () over a network (), and wherein the server maintains a geo-fence database (); (b) receiving, from the operating system, a notification that (i) the location of the mobile communications device has changed by an amount that exceeds a predetermined threshold, or (ii) that a period of time has passed; (c) querying the operating system for a data set comprising the general location of the mobile communications device and the corresponding location accuracy; (d) transmitting the data set to the server; and (e) receiving from the server, in response to the transmission of the data set, a set of geo-fences () proximal to the general location.","['Obermeyer Lance', 'Oliver Andrew', 'Miller Kyle', 'Shetty Prashant', 'Rustgi Aditya']",0,uspto,"['computer systems', 'mobile telecommunication systems', 'communication', 'computer science', 'database systems', 'computer network', 'wireless communications', 'mobile communications', 'operating systems']",liver carcinoma in situ,[],"['method', 'mobile', 'communications', 'device', 'fence', 'method', 'mobile', 'communications', 'device', 'operating', 'system', 'location', 'detection', 'application', 'resident', 'thereon', 'mobile', 'communications', 'device', 'communication', 'server', 'network', 'server', 'fence', 'database', 'receiving', 'operating', 'system', 'notification', 'location', 'mobile', 'communications', 'device', 'amount', 'predetermined', 'threshold', 'period', 'time', 'c', 'operating', 'system', 'data', 'general', 'location', 'mobile', 'communications', 'device', 'corresponding', 'location', 'accuracy', 'd', 'data', 'server', 'server', 'response', 'transmission', 'data', 'set', 'set', 'geo', 'fences', 'proximal', 'general', 'location']"
530,530,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/760/A1/US20130045760A1.pdf,Geo-Fence Entry and Exit Notification System,"A method is provided for determining when a mobile communications device has crossed a geo-fence. The method comprises (a) providing a mobile communications device () equipped with an operating system and having a location detection application resident thereon, wherein the mobile communications device is in communication with a server () over a network (), and wherein the server maintains a geo-fence database (); (b) receiving, from the operating system, a notification that (i) the location of the mobile communications device has changed by an amount that exceeds a predetermined threshold, or (ii) that a period of time has passed; (c) querying the operating system for a data set comprising the general location of the mobile communications device and the corresponding location accuracy; (d) transmitting the data set to the server; and (e) receiving from the server, in response, a set of geo-fences () proximal to the general location.","['Obermeyer Lance', 'Oliver Andrew', 'Miller Kyle', 'Shetty Prashant', 'Rustgi Aditya']",0,uspto,"['computer systems', 'mobile telecommunication systems', 'communication', 'computer science', 'database systems', 'computer network', 'wireless communications', 'mobile communications', 'operating systems']",liver carcinoma in situ,[],"['method', 'mobile', 'communications', 'device', 'fence', 'method', 'mobile', 'communications', 'device', 'operating', 'system', 'location', 'detection', 'application', 'resident', 'thereon', 'mobile', 'communications', 'device', 'communication', 'server', 'network', 'server', 'fence', 'database', 'receiving', 'operating', 'system', 'notification', 'location', 'mobile', 'communications', 'device', 'amount', 'predetermined', 'threshold', 'period', 'time', 'c', 'operating', 'system', 'data', 'general', 'location', 'mobile', 'communications', 'device', 'corresponding', 'location', 'accuracy', 'd', 'data', 'server', 'server', 'response', 'set', 'geo', 'fences', 'proximal', 'general', 'location']"
531,531,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/895/A1/US20130045895A1.pdf,BINDING DOMAINS,"The invention relates to amino acid residues within an immunoglobulin light chain amino acid sequence (V) which stabilize the monomeric state of the immunoglobulin single variable domain. In particular, but not exclusively, the invention describes a number of mutations that stabilize the monomeric state of DP9 framework Vdomain antibodies.","['De Wildt Rudolf Maria', 'Liddament Mark', 'Ramsay Nicola', 'Schon Oliver', 'Stoop Adriaan Allart']",0,uspto,"['formal framework', 'software frameworks', 'formal methods', 'computer programming']",liver carcinoma in situ,"['BINDING', 'DOMAINS']","['invention', 'amino', 'acid', 'residues', 'immunoglobulin', 'light', 'chain', 'amino', 'acid', 'sequence', 'V', 'monomeric', 'state', 'immunoglobulin', 'single', 'variable', 'domain', 'particular', 'invention', 'number', 'mutations', 'monomeric', 'state', 'framework', 'antibodies']"
532,532,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0045/915/A1/US20130045915A1.pdf,METHOD FOR  WEIGHT LOSS AND KETOGENIC COMPOSITIONS,The present disclosure relates to a weight-loss composition including protein and fat and methods of use. The weight loss composition is substantially free of carbohydrates. The composition induces body weight loss when administered to a subject as the only source of nutrition for at least 12 hours.,['DI PIETRO Oliver R.'],0,uspto,"['dynamic composition', 'web service composition', 'software engineering', 'automatic composition', 'service compositions', 'component composition']",liver carcinoma in situ,"['METHOD', 'LOSS', 'KETOGENIC', 'COMPOSITIONS']","['present', 'disclosure', 'weight', 'loss', 'composition', 'protein', 'fat', 'methods', 'use', 'weight', 'loss', 'composition', 'free', 'carbohydrates', 'composition', 'body', 'weight', 'loss', 'subject', 'only', 'source', 'nutrition', 'hours']"
533,533,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0046/105/A1/US20130046105A1.pdf,METHOD FOR OBTAINING A LIPID-CONTAINING COMPOSITION FROM MICROBIAL BIOMASS,"Methods are provided for pelletizing a microbial biomass, extracting a refined lipid composition from the pelletized biomass under supercritical conditions and distilling the refined lipid composition, at least once under short path distillation conditions, to obtain a lipid-containing fraction. Also disclosed are methods of making lipid-containing oil concentrates therefrom, by transesterifying and enriching the lipid-containing fraction.","['Avgousti Marios', 'Bell Timothy Allan', 'Bockrath Richard E.', 'Gutsche Oliver Walter', 'Hutchenson Keith W.', 'Liang Shu-Chien', 'Orlandi Robert D.']",0,uspto,"['dynamic composition', 'single path', 'multi path routing', 'routing algorithms', 'routing scheme', 'web service composition', 'routing protocols', 'software engineering', 'automatic composition', 'service compositions', 'component composition']",liver carcinoma in situ,"['METHOD', 'COMPOSITION']","['Methods', 'microbial', 'biomass', 'refined', 'lipid', 'composition', 'biomass', 'supercritical', 'conditions', 'refined', 'lipid', 'composition', 'least', 'short', 'path', 'distillation', 'conditions', 'lipid', 'fraction', 'methods', 'lipid', 'oil', 'concentrates', 'therefrom', 'lipid', 'fraction']"
534,534,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0046/443/A1/US20130046443A1.pdf,METHOD AND DEVICE FOR SETTING PARAMETERS OF A PLURALITY OF LIGHT SOURCES AND AUDIO SOURCES,"A method and device for setting at least one parameter of at least one light source, wherein the light source is disposed in a vehicle, wherein the at least one parameter of the at least one light source and at least one parameter of at least one audio source are set by means of activation of a first functional profile, wherein the at least one audio source is disposed in the vehicle.","['Ahlers Julia', 'Gaus Imke', 'Wald Stefanie', 'Hengstenberg Oliver', 'Lou Jian', 'Baumgarten Thorb', 'Althoff Frank', 'Hamberger Werner']",0,uspto,"['audio content', 'audio stream', 'engineering', 'vehicles', 'audio acoustics', 'control system analysis', 'control parameters', 'audio', 'audio systems']",liver carcinoma in situ,"['METHOD', 'DEVICE', 'SETTING', 'PARAMETERS', 'PLURALITY', 'SOURCES', 'SOURCES']","['method', 'device', 'parameter', 'light', 'source', 'light', 'source', 'vehicle', 'parameter', 'light', 'source', 'parameter', 'audio', 'source', 'means', 'activation', 'first', 'functional', 'profile', 'audio', 'source', 'vehicle']"
535,535,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0046/546/A1/US20130046546A1.pdf,APPARATUS AND METHOD FOR MODIFYING AN INPUT AUDIO SIGNAL,"An apparatus for modifying an input audio signal has an excitation determiner, a storage device and a signal modifier. The excitation determiner determines a value of an excitation parameter of a subband of a plurality of subbands of the input audio signal based on an energy content of the subband. Further, the storage device stores a lookup table containing a plurality of spectral weighting factors. A spectral weighting factor of the plurality of spectral weighting factors is associated to a predefined value of the excitation parameter and a subband of the plurality of subbands. The storage device provides a spectral weighting factor corresponding to the determined value of the excitation parameter and corresponding to the subband, the value of the excitation parameter is determined for. Further, the signal modifier modifies a content of the subband of the audio signal, the value of the excitation parameter is determined for, based on the provided spectral weighting factor to provide a modified subband.","['UHLE Christian', 'HERRE Juergen', 'HELLMUTH Oliver', 'FINAUER Stefan']",0,uspto,"['look-up table', 'image coding', 'audio', 'multiresolution analysis', 'storage devices', 'image denoising', 'discrete wavelet transform', 'electric filters', 'frequency bands', 'fir filters', 'linear matrix inequalities', 'gabor filter', 'audio signals', 'discrete fourier transforms', 'audio systems', 'audio stream', 'imaging systems', 'signal analysis', 'audio acoustics', 'wavelet', 'flash memory', 'storage systems', 'sub-bands', 'table lookup', 'adaptive filters', 'discrete cosine transforms', 'filter banks']",liver carcinoma in situ,['METHOD'],"['apparatus', 'input', 'audio', 'signal', 'excitation', 'determiner', 'storage', 'device', 'signal', 'excitation', 'determiner', 'value', 'excitation', 'parameter', 'subband', 'plurality', 'subbands', 'input', 'audio', 'signal', 'energy', 'content', 'subband', 'storage', 'device', 'stores', 'lookup', 'table', 'plurality', 'spectral', 'weighting', 'factors', 'spectral', 'weighting', 'factor', 'plurality', 'spectral', 'weighting', 'factors', 'predefined', 'value', 'excitation', 'subband', 'plurality', 'subbands', 'storage', 'device', 'spectral', 'weighting', 'factor', 'value', 'excitation', 'subband', 'value', 'excitation', 'signal', 'modifier', 'content', 'subband', 'audio', 'signal', 'value', 'excitation', 'spectral', 'weighting', 'factor', 'subband']"
536,536,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0046/912/A1/US20130046912A1.pdf,METHODS OF MONITORING OPERATION OF PROGRAMMABLE LOGIC,"Disclosed is a method of monitoring operation of programmable logic for a streaming processor, the method comprising: generating a graph representing the programmable logic to be implemented in hardware, the graph comprising nodes and edges connecting nodes in the graph; inserting, on each edge, monitoring hardware to monitor flow of data along the edge. Also disclosed is a method of monitoring operation of programmable logic for a streaming processor, the method comprising: generating a graph representing the programmable logic to be implemented in hardware, the graph comprising nodes and edges connecting the nodes in the graph; inserting, on at least one edge, data-generating hardware arranged to receive data from an upstream node and generate data at known values having the same flow control pattern as the received data for onward transmission to a connected node.","['Pell Oliver', 'Greenspon Itay', 'Spooner James Barry', 'Dimond Robert Gwilym']",0,uspto,"['general graph', 'hardware resources', 'modal logic', 'ad hoc networks', 'source nodes', 'many valued logics', 'wireless sensor networks', 'pld', 'graphic methods', 'weighted graph', 'pulsed laser deposition', 'gateway nodes', 'hardware design', 'approximation algorithms', 'reconfigurable hardware', 'computer hardware', 'embedded systems', 'field programmable gate arrays (fpga)', 'routing protocols', 'directed graphs', 'integrated data', 'computer science', 'programmable logic device', 'logic gates', 'programmable logic', 'reconfigurable architectures', 'graph theory', 'logic devices', 'data integration', 'graph g', 'reconfigurable logic', 'multivalued logic', 'dynamic logic', 'gateways (computer networks)', 'programmable logic controllers', 'hardware components', 'programmed control systems']",liver carcinoma in situ,['METHODS'],"['method', 'operation', 'programmable', 'logic', 'processor', 'method', 'comprising', 'graph', 'programmable', 'logic', 'hardware', 'graph', 'nodes', 'edges', 'nodes', 'graph', 'inserting', 'edge', 'hardware', 'flow', 'data', 'edge', 'method', 'operation', 'programmable', 'logic', 'processor', 'method', 'comprising', 'graph', 'programmable', 'logic', 'hardware', 'graph', 'nodes', 'edges', 'nodes', 'graph', 'inserting', 'edge', 'data', 'hardware', 'data', 'upstream', 'node', 'data', 'values', 'same', 'flow', 'control', 'pattern', 'data', 'onward', 'transmission', 'connected', 'node']"
537,537,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0047/150/A1/US20130047150A1.pdf,SOFTWARE INSTALLATION AND PROCESS MANAGEMENT SUPPORT,"Methods, systems, and apparatus, including medium-encoded computer program products, for software installation and process management support. In one aspect, a method includes obtaining application information for a software application and an application executable for the software application, the application executable including machine code native to a target platform having an operating system, wherein the application information includes application code that depends on a runtime environment on the target platform to operate; and installing the application executable on the target platform, wherein the application code includes a resource associated with the application executable that runs in the runtime environment when the application executable is run in the operating system, and wherein the operating system maintains and presents the software application as a native application, distinct from other applications that depend on the runtime environment to operate.","['Malasky Ethan', 'Goldman Oliver', 'Brichford Christopher']",0,uspto,"['process engineering', 'component', 'software', 'computer science', 'enterprise resource management', 'software project', 'software design', 'process management', 'operating systems']",liver carcinoma in situ,"['INSTALLATION', 'SUPPORT']","['Methods', 'systems', 'apparatus', 'medium', 'computer', 'program', 'products', 'software', 'installation', 'process', 'management', 'support', 'aspect', 'method', 'application', 'information', 'software', 'application', 'application', 'executable', 'software', 'application', 'application', 'machine', 'code', 'native', 'target', 'platform', 'operating', 'system', 'application', 'information', 'application', 'code', 'runtime', 'environment', 'target', 'platform', 'application', 'target', 'platform', 'application', 'code', 'resource', 'application', 'executable', 'runtime', 'environment', 'application', 'executable', 'operating', 'system', 'operating', 'system', 'maintains', 'software', 'application', 'native', 'application', 'distinct', 'other', 'applications', 'runtime', 'environment']"
538,538,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130221/2013-08/US/2013/0047/165/A1/US20130047165A1.pdf,Context-Aware Request Dispatching in Clustered Environments,"The present disclosure involves systems, software, and computer implemented methods for providing context-aware request dispatching in a clustered environment. One process includes operations for receiving an event at a first computer node. The contents of the event are analyzed to determine a target process instance for handling the event. A target computer node hosting the target process instance is determined, and the event is sent to the target computer node for handling by the target process instance.","['Goetz Oliver C.', 'Drabant Bernhard', 'Dick Erik']",0,uspto,"['software', 'ad hoc networks', 'wireless sensor networks', 'enterprise resource management', 'wireless networks', 'cluster computing', 'mobile devices', 'destination nodes', 'sensor networks', 'network coding', 'routing protocols', 'computer science', 'process instances', 'computing environments', 'intermediate node', 'cloud computing', 'component', 'ubiquitous computing', 'context-awareness', 'cluster environments', 'process mining']",liver carcinoma in situ,"['Aware', 'Request', 'Environments']","['present', 'disclosure', 'systems', 'software', 'computer', 'methods', 'context', 'aware', 'request', 'clustered', 'environment', 'process', 'operations', 'event', 'first', 'computer', 'node', 'contents', 'event', 'target', 'process', 'instance', 'event', 'target', 'computer', 'node', 'target', 'process', 'instance', 'determined', 'event', 'target', 'computer', 'node', 'handling', 'target', 'process', 'instance']"
539,539,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130228/2013-09/US/2013/0049/756/A1/US20130049756A1.pdf,"METHODS, SYSTEMS, AND DEVICES FOR INTRA-SCAN MOTION CORRECTION","Systems, methods, and devices for intra-scan motion correction to compensate not only from one line or acquisition step to the next, but also within each acquisition step or line in k-space. The systems, methods, and devices for intra-scan motion correction can comprise updating geometry parameters, phase, read, and/or other encoding gradients, applying a correction gradient block, and/or correcting residual errors in orientation, pose, and/or gradient/phase.","['Ernst Thomas Michael', 'Speck Oliver']",0,uspto,"['motion data', 'electromagnetic wave attenuation', 'correction method', 'motion estimation', 'motion analysis', 'geometry', 'motion models', 'image analysis', 'human motions']",liver carcinoma in situ,"['DEVICES', 'MOTION', 'CORRECTION']","['Systems', 'methods', 'devices', 'intra', 'scan', 'motion', 'correction', 'line', 'acquisition', 'step', 'next', 'acquisition', 'step', 'line', 'k', 'space', 'systems', 'methods', 'devices', 'intra', 'scan', 'motion', 'correction', 'geometry', 'parameters', 'phase', 'other', 'gradients', 'correction', 'gradient', 'block', 'residual', 'errors', 'orientation', 'pose', 'gradient', 'phase']"
540,540,https://dh-opendata.s3.amazonaws.com/publication_pdf/app_pdf_20130228/2013-09/US/2013/0050/574/A1/US20130050574A1.pdf,System and Method for Retargeting Video Sequences,"A system and method for retargeting video sequences are provided. A method for retargeting a video includes a plurality of frames includes determining saliency information for the plurality of frames, determining a cost metric for the video, and retargeting the video based on the cost metric to produce a retargeted video. The cost metric considers loss due to cropping, scaling, temporal factors, and spatial factors. The retargeting makes use of a crop window for each frame in the plurality of frames.","['Lu Taoran', 'Yuan Zheng', 'Huang Yu', 'Wu Dapeng Oliver', 'Yu Hong Heather']",0,uspto,"['image compression', 'compressed video', 'multimedia systems', 'structural frames', 'video contents', 'video streaming', 'frames', 'visual communication', 'digital videos', 'video signal processing', 'video streams']",liver carcinoma in situ,['Sequences'],"['system', 'method', 'video', 'sequences', 'method', 'video', 'plurality', 'frames', 'saliency', 'information', 'plurality', 'frames', 'cost', 'metric', 'video', 'video', 'cost', 'metric', 'retargeted', 'video', 'cost', 'metric', 'considers', 'loss', 'temporal', 'factors', 'spatial', 'factors', 'retargeting', 'use', 'crop', 'window', 'frame', 'plurality', 'frames']"
541,541,https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=5969593,The minimum time estimation for initiating tumor-cell attachment,"This work presents the first part of a new framework for preventing the tumor-cell of carcinoma in situ transition from one organ to others. Using an ECIS (electric cell-substrate impedance sensing) chip coated with glutaraldehyde (GA)-crosslinked gelatin patterns suitable for cell attachment, the authors monitor the cell adhesion situation not only by optical microscope but also by electrical means. Therefore the authors design an experiment and a microfluidic chip for investigating the relationship between the metastasis and the surface morphology of blood vessels.","['L.J. Yang', 'C.W. Hsu', 'Y.C. Ou']","['Liver', 'Electrodes', 'Impedance', 'Blood', 'Adhesives', 'Microchannel', 'Cancer']",ieeexplore,"['estimation method', 'numerical model', 'microstrip antennas', 'software frameworks', 'electric power supplies to apparatus', 'impedance matching (electric)', 'computer programming', 'asic', 'directional patterns (antenna)', 'input impedance', 'electric impedance']",liver carcinoma in situ,"['minimum', 'time', 'estimation', 'tumor', 'cell', 'attachment']","['work', 'first', 'part', 'new', 'framework', 'tumor', 'cell', 'carcinoma', 'situ', 'transition', 'organ', 'others', 'electric', 'cell', 'substrate', 'impedance', 'sensing', 'chip', 'glutaraldehyde', 'gelatin', 'patterns', 'suitable', 'cell', 'attachment', 'authors', 'cell', 'adhesion', 'situation', 'optical', 'microscope', 'electrical', 'means', 'authors', 'experiment', 'microfluidic', 'chip', 'relationship', 'metastasis', 'surface', 'morphology', 'blood', 'vessels']"
542,542,https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=6610097,Differential network biology reveals a positive correlation between a novel protein-protein interaction and cancer cells migration,"This paper introduces a differential network biology for discovering tumor migration. We applied statistical methods to prioritize PPI candidates and an in situ proximity ligation assay to verify 67 endogenous PPIs among 21 interlinked pathways in two hepatocellular carcinoma (HCC) cells, Huh7 (minimally migratory cells) and Mahlavu (highly migratory cells). Differential network biology analysis was applied to determine the novel interaction, CRKL-FLT1, has a high centrality ranking, and the expression of this interaction is strongly correlated with the migratory ability of HCC and other cancer cell lines. Knockdown of CRKL and FLT1 in HCC cells leads to a decrease in cell migration. This study demonstrated that functional exploration of a disease network with differential network in interlinked pathways via PPIs can be used to discover tumor migration.","['Chia-Hung Liu', 'Tzu-Chi Chen', 'Chun-Houh Chen', 'Cheng-Yan Kao', 'Chi-Ying F. Huang']","['Proteins', 'Cancer', 'Programmable logic arrays', 'Cells (biology)', 'Protein engineering', 'Tumors']",ieeexplore,"['graph theory', 'social networks', 'logic devices', 'network components', 'centrality', 'statistical methods', 'engineering', 'correlation analysis', 'network protocols', 'program compilers', 'complex networks', 'betweenness', 'network architecture', 'social network analysis', 'mathematics', 'logic gates', 'programmable logic', 'programmed control systems']",liver carcinoma in situ,"['Differential', 'network', 'biology', 'positive', 'correlation', 'novel', 'protein', 'protein', 'interaction', 'cancer', 'cells', 'migration']","['paper', 'differential', 'network', 'biology', 'tumor', 'migration', 'statistical', 'methods', 'candidates', 'situ', 'proximity', 'ligation', 'endogenous', 'PPIs', 'interlinked', 'pathways', 'hepatocellular', 'carcinoma', 'cells', 'migratory', 'cells', 'migratory', 'cells', 'Differential', 'network', 'biology', 'analysis', 'novel', 'interaction', 'high', 'centrality', 'ranking', 'expression', 'interaction', 'migratory', 'ability', 'other', 'cancer', 'cell', 'lines', 'cells', 'decrease', 'cell', 'migration', 'study', 'functional', 'exploration', 'disease', 'network', 'differential', 'network', 'pathways', 'PPIs', 'tumor', 'migration']"
543,543,https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=8154477,Hepatic Regeneration after Sublethal Partial Liver Irradiation in Cirrhotic Rats,"Our previous animal study had demonstrated that partial liver irradiation (IR) could stimulate regeneration in the protected liver, which supported the measurements adopted in radiotherapy planning for hepatocellular carcinoma. The purpose of this present study is to investigate whether cirrhotic liver repopulation could be triggered by partial liver IR. The cirrhosis was induced by thioacetamide (TAA) in rats. After cirrhosis establishment, TAA was withdrawn. In Experiment 1, only right-half liver was irradiated with single doses of 5 Gy, 10 Gy and 15 Gy, respectively. In Experiment 2, right-half liver was irradiated to 15 Gy, and the left-half to 2.5 Gy, 5 Gy and 7.5 Gy, respectively. The regeneration endpoints, including liver index (LI); mitotic index (MI); liver proliferation index (LPI); PCNA-labeling index (PCNA-LI); serum HGF, VEGF, TGF-Œ± and IL-6, were evaluated on 0 day, 30-day, 60-day, 90-day, 120-day and 150-day after IR. Serum and in situ TGF-Œ≤1 were also measured. In both experimental groups, the IR injuries were sublethal, inducing no more than 9% animal deaths. Upon TAA withdrawal, hepatic regeneration decelerated in the controls. In Experiment 1 except for LI, all other regeneration parameters were significantly higher than those in controls for both right-half and left-half livers. In Experiment 2 all regeneration parameters were also higher compared with those in controls for both half livers. Serum HGF and VEGF were increased compared with that of controls. Both unirradiated and low dose-irradiated cirrhotic liver were able to regenerate triggered by sublethal partial liver IR and higher doses and IR to both halves liver triggered a more enhanced regeneration.","['Ke Gu', 'Song-Tao Lai', 'Ning-Yi Ma', 'Jian-Dong Zhao', 'Zhi-Gang Ren', 'Jian Wang', 'Jin Liu', 'Guo-Liang Jiang']",0,ieeexplore,"['control system analysis', 'control parameters', 'laser damage', 'fluences']",liver carcinoma in situ,"['Regeneration', 'Rats']","['previous', 'animal', 'study', 'partial', 'liver', 'irradiation', 'regeneration', 'liver', 'measurements', 'radiotherapy', 'planning', 'hepatocellular', 'carcinoma', 'purpose', 'present', 'study', 'cirrhotic', 'liver', 'repopulation', 'partial', 'liver', 'cirrhosis', 'thioacetamide', 'rats', 'cirrhosis', 'establishment', 'right', 'half', 'liver', 'single', 'doses', 'right', 'half', 'liver', 'left', 'half', 'regeneration', 'endpoints', 'liver', 'index', 'mitotic', 'index', 'liver', 'proliferation', 'index', 'PCNA', 'labeling', 'index', 'day', 'situ', 'experimental', 'groups', 'injuries', 'sublethal', 'more', '%', 'animal', 'deaths', 'withdrawal', 'hepatic', 'regeneration', 'controls', 'other', 'regeneration', 'parameters', 'higher', 'controls', 'right', 'half', 'left', 'half', 'livers', 'regeneration', 'parameters', 'higher', 'controls', 'half', 'livers', 'controls', 'unirradiated', 'low', 'dose', 'cirrhotic', 'liver', 'able', 'sublethal', 'partial', 'liver', 'higher', 'doses', 'halves', 'liver', 'enhanced', 'regeneration']"
544,544,https://ieeexplore.ieee.org/stamp/stamp.jsp?tp=&arnumber=8926148,Ultrasound-Guided Gas Embolization Using a Single Linear Array Transducer,"Transarterial chemoembolization is the first line therapy for patients with intermediate stage hepatocellular carcinoma, the third leading cause of cancer related deaths. This procedure is effective in extending patient survival but requires a complicated catheterization procedure and can induce off-target occlusion. Gas embolization has been proposed as an easily administered, more spatially selective alternative. Microbubbles produced in situ using acoustic droplet vaporization can accumulate and form occlusions within the tumor vasculature. While recent studies have demonstrated the efficacy of this method in mouse models, the focused ultrasound used for droplet vaporization has been manually guided, resulting in off-target hemorrhage. A more targeted yet similarly facile to administer insonation method will improve the clinical translatability of the proposed therapy. Here, we demonstrate the development of a custom ultrasound pulse sequence consisting of interleaved real-time imaging and droplet vaporization that operates on a single linear array transducer. GUI controls were developed to afford the user fine control over the localization of the focal spot. We first produced bubble clouds in fibrin gels seeded with droplets to demonstrate the accuracy of spatial control. Then, we successfully generated and tracked occlusions in real-time in a tumor model without the induction of off-target hemorrhage. These preliminary results indicate that gas embolization may serve as an easily administered ultrasound-guided and activated therapy.","['Jonah S. Harmon', 'Foad Kabinejadian', 'Joseph L. Bull']","['Tumors', 'Ultrasonic imaging', 'Imaging', 'Embolization', 'Transducers', 'Real-time systems']",ieeexplore,"['medical images', 'acoustics', 'array processing', 'linear arrays', 'online systems', 'digital signal processing', 'real time systems', 'signal processing', 'partial occlusions', 'mobile robots', 'object oriented programming', 'embedded systems', 'field programmable gate arrays (fpga)', 'fuzzy sets', 'graphical user interfaces', 'object tracking', 'knowledge based systems', 'user interfaces', 'ultrasonic imaging']",liver carcinoma in situ,[],"['Transarterial', 'chemoembolization', 'first', 'line', 'therapy', 'patients', 'intermediate', 'stage', 'hepatocellular', 'carcinoma', 'third', 'cause', 'cancer', 'deaths', 'procedure', 'effective', 'patient', 'survival', 'complicated', 'catheterization', 'procedure', 'target', 'occlusion', 'Gas', 'embolization', 'selective', 'alternative', 'Microbubbles', 'situ', 'acoustic', 'droplet', 'vaporization', 'occlusions', 'tumor', 'vasculature', 'recent', 'studies', 'efficacy', 'method', 'mouse', 'models', 'focused', 'ultrasound', 'droplet', 'vaporization', 'target', 'hemorrhage', 'facile', 'insonation', 'method', 'clinical', 'translatability', 'therapy', 'development', 'custom', 'ultrasound', 'pulse', 'sequence', 'real', 'time', 'imaging', 'droplet', 'vaporization', 'single', 'linear', 'array', 'transducer', 'controls', 'user', 'fine', 'control', 'localization', 'focal', 'spot', 'bubble', 'clouds', 'fibrin', 'gels', 'droplets', 'accuracy', 'spatial', 'control', 'occlusions', 'real', 'time', 'tumor', 'model', 'induction', 'target', 'hemorrhage', 'preliminary', 'results', 'gas', 'embolization', 'ultrasound', 'therapy']"
545,545,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085555267&origin=inward,Internationale Klassifikation von Kopfschmerzerkrankungen,0,0,0,scopus,[],obsolete hereditary sensory neuropathy,[],[]
546,546,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079072516&origin=inward,"Selective Autophagy of the Protein Homeostasis Machinery: Ribophagy, Proteaphagy and ER-Phagy","¬© Copyright ¬© 2020 Beese, Brynj√≥lfsd√≥ttir and Frankel.The eukaryotic cell has developed intricate machineries that monitor and maintain proteome homeostasis in order to ensure cellular functionality. This involves the carefully coordinated balance between protein synthesis and degradation pathways, which are dynamically regulated in order to meet the constantly changing demands of the cell. Ribosomes, together with the endoplasmic reticulum (ER), are the key drivers of protein synthesis, folding, maturation and sorting, while the proteasome plays a pivotal role in terminating the existence of thousands of proteins that are misfolded, damaged or otherwise obsolete. The synthesis, structure and function of these dedicated machines has been studied for decades, however, much less is understood about the mechanisms that control and execute their own turnover. Autophagy, an evolutionarily conserved catabolic pathway, mediates degradation of a large variety of cytosolic substrates, ranging from single proteins to entire organelles or multi-subunit macromolecular complexes. In this review, we focus on selective autophagy of three key components of the protein homeostasis machinery: ribosomes, ER and proteasomes, through the selective autophagy pathways of ribophagy, ER-phagy, and proteaphagy. We discuss newly discovered mechanisms for the selective clearance of these substrates, which are often stress-dependent and involve specialized signals for cargo recognition by a growing number of receptors. We further discuss the interplay between these pathways and their biological impact on key aspects of proteome homeostasis and cellular function in health and disease.",0,0,scopus,"['cellular telephone systems', 'component', 'software', 'digital signal processors', 'ranging', 'ultra-wideband (uwb)', 'cellular radio systems', 'parallel processing systems', 'wireless', 'channel capacity', 'cellular network', 'parallel machine', 'range finding', 'cellular system', 'cellular', 'digital signals']",obsolete hereditary sensory neuropathy,[],"['Copyright', 'eukaryotic', 'cell', 'intricate', 'machineries', 'proteome', 'homeostasis', 'order', 'cellular', 'functionality', 'balance', 'protein', 'synthesis', 'degradation', 'pathways', 'order', 'demands', 'cell', 'Ribosomes', 'endoplasmic', 'reticulum', 'key', 'drivers', 'protein', 'synthesis', 'folding', 'maturation', 'sorting', 'proteasome', 'pivotal', 'role', 'existence', 'thousands', 'proteins', 'obsolete', 'synthesis', 'structure', 'function', 'dedicated', 'machines', 'decades', 'less', 'mechanisms', 'own', 'turnover', 'catabolic', 'pathway', 'degradation', 'large', 'variety', 'cytosolic', 'substrates', 'single', 'proteins', 'organelles', 'multi', '-', 'subunit', 'macromolecular', 'complexes', 'review', 'selective', 'autophagy', 'key', 'components', 'protein', 'homeostasis', 'machinery', 'ribosomes', 'proteasomes', 'selective', 'autophagy', 'pathways', 'ribophagy', 'proteaphagy', 'mechanisms', 'selective', 'clearance', 'substrates', 'stress', 'dependent', 'specialized', 'signals', 'cargo', 'recognition', 'number', 'receptors', 'interplay', 'pathways', 'biological', 'impact', 'key', 'aspects', 'proteome', 'homeostasis', 'cellular', 'function', 'health', 'disease']"
547,547,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84991577773&origin=inward,Application of Mouse Models to Research in Hearing and Balance,"¬© 2016, Association for Research in Otolaryngology.Laboratory mice (Mus musculus) have become the major model species for inner ear research. The major uses of mice include gene discovery, characterization, and confirmation. Every application of mice is founded on assumptions about what mice represent and how the information gained may be generalized. A host of successes support the continued use of mice to understand hearing and balance. Depending on the research question, however, some mouse models and research designs will be more appropriate than others. Here, we recount some of the history and successes of the use of mice in hearing and vestibular studies and offer guidelines to those considering how to apply mouse models.",0,0,scopus,"['user information', 'stochastic processes', 'hierarchical system', 'mathematics', 'hierarchical model', 'standard model', 'correlation analysis', 'recommender systems', 'the standard model', 'electronic document identification systems', 'personal information', 'probability']",obsolete hereditary sensory neuropathy,"['Application', 'Balance']","['Laboratory', 'mice', 'Mus', 'musculus', 'major', 'model', 'species', 'inner', 'ear', 'research', 'major', 'uses', 'mice', 'gene', 'discovery', 'characterization', 'confirmation', 'application', 'mice', 'assumptions', 'mice', 'information', 'host', 'successes', 'use', 'mice', 'hearing', 'balance', 'research', 'question', 'mouse', 'models', 'research', 'designs', 'appropriate', 'others', 'history', 'successes', 'use', 'mice', 'hearing', 'vestibular', 'studies', 'guidelines', 'mouse', 'models']"
548,548,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84973117943&origin=inward,Kaplan's clinical hypertension: Eleventh edition,"¬© 2015 Wolters Kluwer. All rights reserved.Accessible, evidence-based guidance on managing patients with hypertension. Kaplan's Clinical Hypertension provides you with current, practical, evidence-based recommendations for preventing and treating all forms of hypertension. Integrating the latest basic science findings and clinical trial data, this 11th Edition enables you to put the latest approaches to work in managing your patients. Comprehensive updates throughout place the most recent management recommendations at your fingertips. ‚Ä¢ Updated coverage brings you up to speed on the pathogenesis of hypertension and many other evolving areas. ‚Ä¢ Abundant algorithms and flow charts facilitate clinical decision-making. ‚Ä¢ An accessible, straightforward writing style and a user-friendly two-color design makes it easy to find and apply the information you need. ‚Ä¢ Full- text online access includes links to Pub Med for many key bibliographical references. Now with the print edition, enjoy the bundled interactive eBook edition, offering tablet, smartphone, or online access to: ‚Ä¢ Complete content with enhanced navigation ‚Ä¢ A powerful search feature that pulls results from your notes, everything in the book, and even the web ‚Ä¢ Cross-linked pages, references, and more for easy navigation ‚Ä¢ Ability to highlight text for easier reference of key content ‚Ä¢ Ability to share notes with friends and colleagues ‚Ä¢ Ability to save your favorite content for future, quick reference.",0,0,scopus,"['user information', 'smart phones', 'mobile telecommunication systems', 'recommendation', 'social sciences', 'information need', 'navigation systems', 'telephone sets', 'mobile robots', 'recommender systems', 'search engines', 'personal information', 'sociology']",obsolete hereditary sensory neuropathy,"['clinical', 'hypertension', 'edition']","['rights', 'Accessible', 'evidence', 'guidance', 'patients', 'hypertension', 'current', 'practical', 'evidence', 'recommendations', 'forms', 'hypertension', 'latest', 'basic', 'science', 'findings', 'clinical', 'trial', 'data', '11th', 'latest', 'approaches', 'patients', 'Comprehensive', 'updates', 'place', 'recent', 'management', 'recommendations', 'fingertips', 'coverage', 'pathogenesis', 'hypertension', 'many', 'other', 'areas', 'Abundant', 'algorithms', 'flow', 'charts', 'clinical', 'decision', 'making', 'accessible', 'straightforward', 'writing', 'style', 'user', 'friendly', 'color', 'design', 'easy', 'information', 'text', 'online', 'access', 'links', 'many', 'key', 'bibliographical', 'references', 'print', 'edition', 'interactive', 'edition', 'tablet', 'smartphone', 'online', 'access', 'Complete', 'content', 'enhanced', 'navigation', 'powerful', 'search', 'feature', 'results', 'notes', 'everything', 'book', 'web', 'pages', 'references', 'more', 'easy', 'navigation', 'text', 'easier', 'reference', 'key', 'content', 'notes', 'friends', 'colleagues', 'favorite', 'content', 'future', 'quick', 'reference']"
549,549,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84944632349&origin=inward,Colorectal Cancer,0,0,0,scopus,[],obsolete hereditary sensory neuropathy,['Colorectal'],[]
550,550,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84882254367&origin=inward,The role of autophagy in neurodegenerative disease,"Autophagy is a lysosomal degradative process used to recycle obsolete cellular constituents and eliminate damaged organelles and protein aggregates. These substrates reach lysosomes by several distinct mechanisms, including delivery within endosomes as well as autophagosomes. Completion of digestion involves dynamic interactions among compartments of the autophagic and endocytic pathways. Neurons are particularly vulnerable to disruptions of these interactions, especially as the brain ages. Not surprisingly, mutations of genes regulating autophagy cause neurodegenerative diseases across the age spectrum with exceptional frequency. In late-onset disorders such as Alzheimer's disease, amyotrophic lateral sclerosis and familial Parkinson's disease, defects arise at different stages of the autophagy pathway and have different implications for pathogenesis and therapy. This Review provides an overview of the role of autophagy in neurodegenerative disease, focusing particularly on less frequently considered lysosomal clearance mechanisms and their considerable impact on disease. Various therapeutic strategies for modulating specific stages of autophagy and the current state of drug development for this purpose are also evaluated. ¬© 2013 Nature America, Inc. All rights reserved.",0,0,scopus,"['power outage', 'cellular telephone systems', 'fading (radio)', 'wireless', 'outages', 'frequency bands', 'cellular radio systems', 'channel capacity', 'fading channels', 'cellular network', 'cellular system', 'antennas', 'cellular']",obsolete hereditary sensory neuropathy,"['role', 'autophagy', 'neurodegenerative', 'disease']","['lysosomal', 'degradative', 'process', 'obsolete', 'cellular', 'constituents', 'organelles', 'protein', 'aggregates', 'substrates', 'lysosomes', 'several', 'distinct', 'mechanisms', 'delivery', 'endosomes', 'autophagosomes', 'Completion', 'digestion', 'dynamic', 'interactions', 'compartments', 'autophagic', 'endocytic', 'pathways', 'Neurons', 'vulnerable', 'disruptions', 'interactions', 'brain', 'ages', 'mutations', 'genes', 'autophagy', 'neurodegenerative', 'diseases', 'age', 'spectrum', 'exceptional', 'frequency', 'late', 'onset', 'disorders', 'such', 'disease', 'amyotrophic', 'lateral', 'sclerosis', 'familial', 'disease', 'defects', 'different', 'stages', 'autophagy', 'pathway', 'different', 'implications', 'pathogenesis', 'therapy', 'overview', 'role', 'autophagy', 'neurodegenerative', 'disease', 'lysosomal', 'clearance', 'mechanisms', 'considerable', 'impact', 'disease', 'Various', 'therapeutic', 'strategies', 'specific', 'stages', 'autophagy', 'current', 'state', 'drug', 'development', 'purpose', 'rights']"
551,551,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84879990242&origin=inward,"The International Classification of Headache Disorders, 3rd edition (beta version)",0,0,0,scopus,"['computer systems', 'classification methods', 'automatic classification', 'classifiers', 'classification models', 'supervised classification', 'image classification', 'support vector machine']",obsolete hereditary sensory neuropathy,"['3rd', 'edition', 'beta', 'version']",[]
552,552,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79958071410&origin=inward,"Complications in the surgical treatment of 19,360 cases of pediatric scoliosis: A review of the scoliosis research society morbidity and mortality database","Study Design.: Retrospective review of a multicenter database. Objective.: To determine the complication rates associated with surgical treatment of pediatric scoliosis and to assess variables associated with increased complication rates. Summary of Background Data.: Wide variability is reported for complications associated with the operative treatment of pediatric scoliosis. Limited number of patients, surgeons, and diagnoses occur in most reports. The Scoliosis Research Society Morbidity and Mortality (M&M) database aggregates deidentified data, permitting determination of complication rates from large numbers of patients and surgeons. Methods.: Cases of pediatric scoliosis (age ‚â§18 years), entered into the Scoliosis Research Society M&M database between 2004 and 2007, were analyzed. Age, scoliosis type, type of instrumentation used, and complications were assessed. Results.: A total of 19,360 cases fulfilled inclusion criteria. Of these, complications occurred in 1971 (10.2%) cases. Overall complication rates differed significantly among idiopathic, congenital, and neuromuscular cases (P < 0.001). Neuromuscular scoliosis had the highest rate of complications (17.9%), followed by congenital scoliosis (10.6%) and idiopathic scoliosis (6.3%). Rates of neurologic deficit also differed significantly based on the etiology of scoliosis (P < 0.001), with the highest rate among congenital cases (2.0%), followed by neuromuscular types (1.1%) and idiopathic scoliosis (0.8%). Neur-omuscular scoliosis and congenital scoliosis had the highest rates of mortality (0.3% each), followed by idiopathic scoliosis (0.02%). Higher rates of new neurologic deficits were associated with revision procedures (P < 0.001) and with the use of corrective osteotomies (P < 0.001). The rates of new neurologic deficit were significantly higher for procedures using anterior screw-only constructs (2.0%) or wire-only constructs (1.7%), compared with pedicle screw-only constructs (0.7%) (P < 0.001). Conclusion.: In this review of a large multicenter database of surgically treated pediatric scoliosis, neuromuscular scoliosis had the highest morbidity, but relatively high complication rates occurred in all groups. These data may be useful for preoperative counseling and surgical decision-making in the treatment of pediatric scoliosis. Copyright ¬© 2011 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.",0,0,scopus,"['query languages', 'relational database', 'computer systems', 'integrated data', 'data integration', 'management information systems', 'database systems', 'knowledge based systems', 'relational database management systems', 'data-base management systems', 'information storage and retrieval']",obsolete hereditary sensory neuropathy,"['Complications', 'surgical', 'treatment', 'cases', 'pediatric', 'scoliosis', 'review', 'scoliosis', 'research', 'society', 'morbidity', 'mortality', 'database']","['Retrospective', 'review', 'multicenter', 'database', 'Objective', 'complication', 'rates', 'surgical', 'treatment', 'pediatric', 'scoliosis', 'variables', 'complication', 'rates', 'Summary', 'Wide', 'variability', 'complications', 'operative', 'treatment', 'pediatric', 'scoliosis', 'Limited', 'number', 'patients', 'surgeons', 'diagnoses', 'most', 'reports', 'database', 'aggregates', 'data', 'determination', 'complication', 'rates', 'large', 'numbers', 'patients', 'surgeons', 'Methods', 'Cases', 'pediatric', 'scoliosis', 'age', 'years', 'database', 'Age', 'scoliosis', 'type', 'type', 'instrumentation', 'complications', 'Results', 'total', 'cases', 'inclusion', 'criteria', 'complications', '%', 'cases', 'Overall', 'complication', 'rates', 'idiopathic', 'congenital', 'neuromuscular', 'cases', 'P', 'Neuromuscular', 'scoliosis', 'highest', 'rate', 'complications', '%', 'congenital', 'scoliosis', '%', 'idiopathic', 'scoliosis', '%', 'Rates', 'neurologic', 'deficit', 'etiology', 'scoliosis', 'P', 'highest', 'rate', 'congenital', 'cases', '%', 'neuromuscular', 'types', '%', 'idiopathic', 'scoliosis', '%', 'Neur', 'omuscular', 'scoliosis', 'congenital', 'scoliosis', 'highest', 'rates', 'mortality', '%', 'idiopathic', 'scoliosis', '%', 'Higher', 'rates', 'new', 'neurologic', 'deficits', 'revision', 'procedures', 'P', 'use', 'corrective', 'osteotomies', 'P', 'rates', 'new', 'neurologic', 'deficit', 'higher', 'procedures', 'anterior', 'screw', 'constructs', '%', 'wire', 'constructs', '%', 'pedicle', 'screw', 'constructs', '%', 'P', 'Conclusion', 'review', 'large', 'multicenter', 'database', 'pediatric', 'scoliosis', 'neuromuscular', 'scoliosis', 'highest', 'morbidity', 'high', 'complication', 'rates', 'groups', 'data', 'useful', 'preoperative', 'counseling', 'surgical', 'decision', 'making', 'treatment', 'pediatric', 'scoliosis', 'Copyright', 'Unauthorized', 'reproduction', 'article']"
553,553,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77954262695&origin=inward,When are ancillary tests recommended in brain death confirmation?,"It is widely accepted that brain death (BD) is a clinical diagnosis, although ancillary tests are recommended when specific components of the clinical testing cannot reliably be evaluated. The therapeutic use of barbiturates in patients with severe intracranial hypertension or other forms of drug intoxication, hypothermia, and other metabolic disturbances, can prevent determination of BD by clinical criteria. We present a review here about the use of ancillary tests in BD confirmation. Confirmatory tests in BD can be divided in those proving absent cerebral blood flow (CBF) and those that demonstrate loss of bioelectrical activity. We recommend assessing circulatory arrest by transcranial Doppler (TCD), and neuronal function by a neurophysiologic test battery. If TCD fails to validate the absence of CBF, computer tomography angiography can be used to confirm BD diagnosis. ¬© Internet Scientific Publications, LLC., 1996 to 2010.",0,0,scopus,"['component', 'software', 'actuator failures', 'computer science', 'robust control', 'system theory', 'internet', 'fault tolerant control', 'linear control systems', 'system testing', 'software engineering', 'test results', 'sensors', 'sufficient conditions']",obsolete hereditary sensory neuropathy,"['ancillary', 'tests', 'brain', 'death', 'confirmation']","['brain', 'death', 'clinical', 'diagnosis', 'ancillary', 'tests', 'specific', 'components', 'clinical', 'testing', 'therapeutic', 'use', 'barbiturates', 'patients', 'severe', 'intracranial', 'hypertension', 'other', 'forms', 'drug', 'intoxication', 'hypothermia', 'other', 'metabolic', 'disturbances', 'determination', 'clinical', 'criteria', 'review', 'use', 'ancillary', 'tests', 'confirmation', 'Confirmatory', 'tests', 'absent', 'cerebral', 'blood', 'flow', 'loss', 'bioelectrical', 'activity', 'circulatory', 'arrest', 'transcranial', 'neuronal', 'function', 'neurophysiologic', 'test', 'battery', 'absence', 'computer', 'tomography', 'angiography', 'diagnosis', '¬©', 'Internet']"
554,554,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84895329329&origin=inward,Abnormal skeletal phenotypes: From simple signs to complex diagnoses,"This book focuses on the radiographic changes of malformation syndromes and skeletal dysplasias. It is structured such that the reader can identify the radiographic changes and relate them to specific disease entities. The aim is to provide an essential, practical guideline to the recognition of the key radiographic signs for diagnosing malformation syndromes and skeletal dysplasias. The book is intended for radiologists, clinical and medical geneticists, and pediatricians. The material is divided into two parts. The first part is structured in a symptom-oriented form and describes approximately 200 radiographic signs, providing information about their incidence, anatomic location, diagnostic relevance, pathogenesis, and pattern of inheritance, if applicable. The second part presents about 100 syndromes and skeletal dysplasias and provides analytical information concerning symptoms, genetics, causes, radiographic appearance, and major differential diagnosis. ¬© Springer-Verlag Berlin Heidelberg, 2005. All rights are reserved.",0,0,scopus,"['user information', 'location based', 'object tracking', 'recognition algorithm', 'character recognition', 'recommender systems', 'face recognition', 'pattern recognition', 'object appearance', 'personal information', 'location based services']",obsolete hereditary sensory neuropathy,"['Abnormal', 'skeletal', 'phenotypes', 'simple', 'signs', 'complex', 'diagnoses']","['book', 'radiographic', 'changes', 'malformation', 'syndromes', 'skeletal', 'dysplasias', 'such', 'reader', 'radiographic', 'changes', 'specific', 'disease', 'entities', 'aim', 'essential', 'practical', 'guideline', 'recognition', 'key', 'radiographic', 'signs', 'malformation', 'syndromes', 'skeletal', 'dysplasias', 'book', 'radiologists', 'clinical', 'medical', 'geneticists', 'pediatricians', 'material', 'parts', 'first', 'part', 'symptom', 'form', 'radiographic', 'signs', 'information', 'incidence', 'anatomic', 'location', 'diagnostic', 'relevance', 'pathogenesis', 'pattern', 'inheritance', 'applicable', 'second', 'part', 'syndromes', 'skeletal', 'dysplasias', 'analytical', 'information', 'symptoms', 'genetics', 'causes', 'radiographic', 'appearance', 'major', 'differential', 'diagnosis', 'rights']"
555,555,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85006298163&origin=inward,Migraine,0,[],0,scopus,[],obsolete hereditary sensory neuropathy,[],[]
556,556,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85013747310&origin=inward,Neurological Aspects of Substance Abuse: Second Edition,"As more drugs are ""designed,"" more research is being done, and substance abuse remains a serious international problem, this reference remains important to neurologic literature. ¬© 2004 Elsevier Inc. All rights reserved.",0,0,scopus,"['combinatorial problems', 'digital rights', 'digital rights management', 'combinatorial op-timization problem', 'combinatorial mathematics', 'access control', 'polynomial approximation', 'access rights', 'optimization', 'security systems', 'approximation algorithms', 'combinatorial optimization', 'rights management']",obsolete hereditary sensory neuropathy,"['Neurological', 'Aspects']","['more', 'drugs', 'more', 'research', 'substance', 'abuse', 'serious', 'international', 'problem', 'reference', 'important', 'neurologic', 'literature', 'rights']"
557,557,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0032587860&origin=inward,Strumpell's disease in a patient presenting for Cesarean section,"Purpose: The anesthetic management of a parturient with Strumpell's disease (hereditary or familial spastic paraparesis) who presented for Cesarean section is described. This neurological disorder is briefly reviewed and anesthetic implications of the condition are discussed. Clinical Features: A 30-yr-old woman in premature labour presented for Cesarean section. She had bilateral lower limb spastic paresis which had resulted in her being confined to a wheelchair from the age of 13 yr. A diagnosis of Strumpell's disease had been made in childhood. She was currently receiving thromboprophylaxis, having suffered a deep venous thrombosis four weeks after a previous Cesarean section. The patient was in mild respiratory distress. Despite a history of uneventful general anesthesia and the aforementioned complicating factors, epidural anesthesia was considered the most appropriate technique in these circumstances. An epidural catheter was sited at the L3- L4 interspace. Adequate anesthesia for the procedure was obtained after administration of 20 ml lidocaine 2% with 100 Œºg epinephrine and 100 Œºg fentanyl in saline. Postoperatively and at six month follow-up there were no neurological complications related to the use of epidural anesthesia. Conclusion: Strumpell's disease is an inherited progressive spastic paresis predominantly affecting the lower extremities. Epidural anesthesia appears to be an appropriate technique when administering anesthesia for Cesarean section under similar circumstances.",0,0,scopus,"['feature space', 'classification methods', 'information technology', 'database systems', 'information management', 'pattern recognition']",obsolete hereditary sensory neuropathy,"['disease', 'patient', 'Cesarean', 'section']","['Purpose', 'anesthetic', 'management', 'parturient', 'disease', 'hereditary', 'familial', 'spastic', 'paraparesis', 'Cesarean', 'section', 'neurological', 'disorder', 'anesthetic', 'implications', 'condition', 'Clinical', 'Features', 'old', 'woman', 'premature', 'labour', 'Cesarean', 'section', 'bilateral', 'lower', 'limb', 'spastic', 'paresis', 'wheelchair', 'age', 'yr', 'diagnosis', 'disease', 'childhood', 'thromboprophylaxis', 'deep', 'venous', 'thrombosis', 'weeks', 'previous', 'Cesarean', 'section', 'patient', 'mild', 'respiratory', 'distress', 'history', 'uneventful', 'general', 'anesthesia', 'aforementioned', 'complicating', 'factors', 'epidural', 'anesthesia', 'appropriate', 'technique', 'circumstances', 'epidural', 'catheter', 'interspace', 'Adequate', 'anesthesia', 'procedure', 'administration', 'ml', 'lidocaine', '%', 'Œºg', 'epinephrine', 'Œºg', 'fentanyl', 'saline', 'month', 'follow', 'up', 'neurological', 'complications', 'use', 'epidural', 'anesthesia', 'Conclusion', 'disease', 'progressive', 'spastic', 'paresis', 'lower', 'extremities', 'Epidural', 'anesthesia', 'appropriate', 'technique', 'anesthesia', 'Cesarean', 'section', 'similar', 'circumstances']"
558,558,https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84936620623&origin=inward,More on numb cheek syndrome (Roger‚Äôs sign): Reply from the author,0,0,0,scopus,[],obsolete hereditary sensory neuropathy,"['More', 'numb', 'cheek', 'syndrome', 'sign', 'author']",[]
